PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Fenchel, T				Fenchel, T			Biogeography for bacteria	SCIENCE			English	Editorial Material									Univ Copenhagen, Marine Biol Lab, DK-3000 Helsingor, Denmark	University of Copenhagen	Fenchel, T (corresponding author), Univ Copenhagen, Marine Biol Lab, Strandpromenaden 5, DK-3000 Helsingor, Denmark.		Fenchel, Tom/F-8979-2011	Fenchel, Tom/0000-0003-0023-2402				Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Griffin DW, 2002, AM SCI, V90, P228, DOI 10.1511/2002.3.228; ISAKSEN MF, 1994, FEMS MICROBIOL ECOL, V14, P1; Papke RT, 2003, ENVIRON MICROBIOL, V5, P650, DOI 10.1046/j.1462-2920.2003.00460.x; SEGERER AH, 1992, PROKARYOTES, V1, P712; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909	7	99	104	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 15	2003	301	5635					925	926		10.1126/science.1089242	http://dx.doi.org/10.1126/science.1089242			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711RY	12881575				2022-12-28	WOS:000184755900024
J	Heydendael, VMR; Spuls, PI; Opmeer, BC; de Borgie, CAJM; Reitsma, JB; Goldschmidt, WFM; Bossuyt, PMM; Bos, JD; de Rie, MA				Heydendael, VMR; Spuls, PI; Opmeer, BC; de Borgie, CAJM; Reitsma, JB; Goldschmidt, WFM; Bossuyt, PMM; Bos, JD; de Rie, MA			Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERMITTENT SHORT COURSES; TOPICAL THERAPY; MULTICENTER; TERM; GUIDELINES; NEORAL(R); ARTHRITIS; EFFICACY; TOXICITY; EMPHASIS	BACKGROUND Methotrexate and cyclosporine are well-known systemic therapies for moderate-to-severe chronic plaque psoriasis. We conduced a randomized, controlled trial comparing methotrexate and cyclosporine in terms of effectiveness, side effects, and the quality of life. METHODS A total of 88 patients with moderate-to-severe psoriasis were randomly assigned to treatment for 16 weeks with either methotrexate (44 patients; initial dose, 15 mg per week) or cyclosporine (44 patients; initial dose, 3 mg per kilogram of body weight per day) and were followed for another 36 weeks. The primary outcome was the difference between groups in the psoriasis area-and-severity index after 16 weeks of treatment, after adjustment for base-line values; scores were determined in a blinded fashion by trained observers. RESULTS Two patients were excluded from the analysis after randomization because they were found to be ineligible, and one patient withdrew his consent. Twelve patients in the methotrexate group had to discontinue treatment because of reversible elevations in liver-enzyme levels, and 1 patient in the cyclosporine group had to do so because of an elevation in the bilirubin level, but all 13 were included in the analysis. After 16 weeks of treatment, the mean (+/-SE) score for the psoriasis area-and-severity index decreased from 13.4+/-3.6 at base line to 5.0+/-0.7 among 43 patients treated with methotrexate, whereas the score decreased from 14.0+/-6.6 to 3.8+/-0.5 among 42 patients treated with cyclosporine. After adjustment for base-line values, the mean absolute difference in values at 16 weeks was 1.3 (95 percent confidence interval, -0.2 to 2.8; P=0.09). The physician's global assessment of the extent of psoriasis, the time to and the rates of remission, and the quality of life were similar in the two groups. CONCLUSIONS No significant differences in efficacy were found between methotrexate and cyclosporine for the treatment of moderate-to-severe psoriasis.	Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1100 DE Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1100 DE Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	de Rie, MA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Dermatol, Rm A0-222,POB 22700, NL-1100 DE Amsterdam, Netherlands.		Bossuyt, Patrick M/AAR-1183-2021; Bossuyt, Patrick M./B-4557-2016; Spuls, Phyllis/G-4052-2010; de Rie, Menno/GSD-4660-2022	Bossuyt, Patrick M/0000-0003-4427-0128; Bossuyt, Patrick M./0000-0003-4427-0128; de Rie, Menno/0000-0002-1867-3559				Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; BerthJones J, 1997, BRIT J DERMATOL, V136, P527, DOI 10.1111/j.1365-2133.1997.tb02135.x; Chaudhari U, 2001, LANCET, V357, P1842, DOI 10.1016/S0140-6736(00)04954-0; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238, DOI 10.1159/000250839; GRIFFITHS CEM, 1989, BRIT J DERMATOL, V120, P253; Ho VC, 1999, BRIT J DERMATOL, V141, P283; Ho VCY, 2001, J AM ACAD DERMATOL, V44, P643, DOI 10.1067/mjd.2001.112400; Koo J, 1996, DERMATOL CLIN, V14, P485, DOI 10.1016/S0733-8635(05)70376-4; Lebwohl M, 1998, J AM ACAD DERMATOL, V39, P464, DOI 10.1016/S0190-9622(98)70325-1; Lebwohl M, 2001, J AM ACAD DERMATOL, V45, P649, DOI 10.1067/mjd.2001.117047; Lebwohl M, 2001, J AM ACAD DERMATOL, V45, P487, DOI 10.1067/mjd.2001.117046; ORTIZ Z, 2001, COCHRANE DATABASE SY, V2, P951; ROENIGK HH, 1988, J AM ACAD DERMATOL, V19, P145, DOI 10.1016/S0190-9622(88)80237-8; Spuls PI, 1997, BRIT J DERMATOL, V137, P943, DOI 10.1046/j.1365-2133.1997.19902071.x; Spuls PI, 1998, ARCH DERMATOL, V134, P1591, DOI 10.1001/archderm.134.12.1591; van Ede AE, 2001, ARTHRITIS RHEUM-US, V44, P1515, DOI 10.1002/1529-0131(200107)44:7&lt;1515::AID-ART273&gt;3.0.CO;2-7; WEINSTEIN GD, 1993, J AM ACAD DERMATOL, V28, P454, DOI 10.1016/0190-9622(93)70067-4; WEINSTEIN GD, 1971, ARCH DERMATOL, V103, P33, DOI 10.1001/archderm.103.1.33; Wollina U, 2001, CLIN RHEUMATOL, V20, P406, DOI 10.1007/s100670170004	20	338	359	2	20	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2003	349	7					658	665		10.1056/NEJMoa021359	http://dx.doi.org/10.1056/NEJMoa021359			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711FL	12917302	Green Published, Bronze			2022-12-28	WOS:000184728900006
J	Hoebe, K; Du, X; Georgel, P; Janssen, E; Tabeta, K; Kim, SO; Goode, J; Lin, P; Mann, N; Mudd, S; Crozat, K; Sovath, S; Han, J; Beutler, B				Hoebe, K; Du, X; Georgel, P; Janssen, E; Tabeta, K; Kim, SO; Goode, J; Lin, P; Mann, N; Mudd, S; Crozat, K; Sovath, S; Han, J; Beutler, B			Identification of Lps2 as a key transducer of MyD88-independent TIR signalling	NATURE			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; ADAPTER MOLECULE; RECEPTOR; ACTIVATION; LIPOPOLYSACCHARIDE; MICE; RECOGNITION; ENDOTOXIN; RESPONSES	In humans, ten Toll-like receptor (TLR) paralogues sense molecular components of microbes, initiating the production of cytokine mediators that create the inflammatory response. Using N-ethyl-N-nitrosourea, we induced a germline mutation called Lps2, which abolishes cytokine responses to double-stranded RNA and severely impairs responses to the endotoxin lipopolysaccharide (LPS), indicating that TLR3 and TLR4 might share a specific, proximal transducer. Here we identify the Lps2 mutation: a distal frameshift error in a Toll/interleukin-1 receptor/resistance (TIR) adaptor protein known as Trif or Ticam-1. Trif Lps2 homozygotes are markedly resistant to the toxic effects of LPS, and are hypersusceptible to mouse cytomegalovirus, failing to produce type I interferons when infected. Compound homozygosity for mutations at Trif and MyD88 (a cytoplasmic TIR-domain-containing adaptor protein) loci ablates all responses to LPS, indicating that only two signalling pathways emanate from the LPS receptor. However, a Trif-independent cell population is detectable when Trif Lps2 mutant macrophages are stimulated with LPS. This reveals that an alternative MyD88-dependent 'adaptor X' pathway is present in some, but not all, macrophages, and implies afferent immune specialization.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA	Scripps Research Institute; La Jolla Institute for Immunology	Beutler, B (corresponding author), Scripps Res Inst, Dept Immunol, IMM-31,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bruce@scripps.edu	Han, J/G-4671-2010; TABTA, KOICHI/AAG-6481-2020; Kim, Sung Ouk/AAO-1795-2020; georgel, philippe/P-5676-2016; Crozat, Karine/L-7297-2019; KIM, Sung Ouk/A-1309-2008	TABTA, KOICHI/0000-0002-7019-1872; Kim, Sung Ouk/0000-0002-0282-6661; georgel, philippe/0000-0001-6853-7080; Crozat, Karine/0000-0003-4761-3675; Hoebe, Kasper/0000-0002-3626-8098				Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Beutler B, 2002, CURR TOP MICROBIOL, V270, P1; Beutler B, 2001, BIOCHEM SOC T, V29, P853, DOI 10.1042/0300-5127:0290853; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Du X, 1999, BLOOD CELL MOL DIS, V25, P328, DOI 10.1006/bcmd.1999.0262; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; HEPPNER G, 1965, J BACTERIOL, V90, P696, DOI 10.1128/JB.90.3.696-703.1965; Hoebe K, 2003, J ENDOTOXIN RES, V9, P250, DOI 10.1179/096805103225001459; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kim SO, 2001, AM J PHYSIOL-LUNG C, V281, pL1095, DOI 10.1152/ajplung.2001.281.5.L1095; Orange JS, 1996, J IMMUNOL, V156, P4746; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Poltorak A, 1998, BLOOD CELL MOL DIS, V24, P340, DOI 10.1006/bcmd.1998.0201; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yamaji M, 2002, PHOTOCH PHOTOBIO SCI, V1, P169, DOI 10.1039/b110092k; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182	32	969	1032	0	44	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 14	2003	424	6950					743	748		10.1038/nature01889	http://dx.doi.org/10.1038/nature01889			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711HQ	12872135				2022-12-28	WOS:000184733900030
J	Wu, LA; Nishimura, RA				Wu, LA; Nishimura, RA			Pulsus paradoxus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Mayo Clin & Mayo Grad Sch Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Mayo Med Sch, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Wu, LA (corresponding author), Mayo Clin & Mayo Grad Sch Med, Rochester, MN 55905 USA.								0	2	2	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2003	349	7					666	666		10.1056/NEJMicm010436	http://dx.doi.org/10.1056/NEJMicm010436			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711FL	12917303				2022-12-28	WOS:000184728900007
J	Howe, A; Anderson, J				Howe, A; Anderson, J			Involving patients in medical education	BRITISH MEDICAL JOURNAL			English	Article							INFORMED CONSENT; GENERAL-PRACTICE; PATIENTS VIEWS; STUDENTS; CONFIDENTIALITY; PARTICIPATION; SATISFACTION; EXPERIENCES; PERSPECTIVE; ATTITUDES		Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Howe, A (corresponding author), Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England.							CARMAN D, 1995, BRIT J GEN PRACT, V45, P485; COHEN DL, 1987, J MED EDUC, V62, P789; COHEN DL, 1988, J MED EDUC, V63, P821; Cooke F, 1996, BRIT J GEN PRACT, V46, P361; *DEP HLTH, 2001, CONS 12 KEY POINTS C; Department of Health, 2001, INV PAT PUBL HEALTHC; General Medical Council, 1993, TOM DOCT; Hajioff D, 1999, MED EDUC, V33, P669, DOI 10.1046/j.1365-2923.1999.00422.x; Hendry GD, 1999, MED EDUC, V33, P674, DOI 10.1046/j.1365-2923.1999.00524.x; Howe A, 2001, MED EDUC, V35, P666, DOI 10.1046/j.1365-2923.2001.00925.x; Jones S, 1996, MED EDUC, V30, P14, DOI 10.1111/j.1365-2923.1996.tb00711.x; Lynoe N, 1998, MED EDUC, V32, P465; MAGRANE D, 1994, ACAD MED, V69, P1004, DOI 10.1097/00001888-199412000-00023; NAIR BR, 1997, MED EDUC, V31, P241; OFlynn N, 1997, BRIT MED J, V315, P1142; PILL RM, 1993, MED EDUC, V27, P238, DOI 10.1111/j.1365-2923.1993.tb00262.x; Sayer M, 2002, BRIT MED J, V324, P404, DOI 10.1136/bmj.324.7334.404; Seidel John., 1995, COMPUTER AIDED QUALI; Stacy R, 1999, MED EDUC, V33, P688, DOI 10.1046/j.1365-2923.1999.00454.x; Thomas EJ, 1999, MED TEACH, V21, P311; WEISS BD, 1982, JAMA-J AM MED ASSOC, V247, P2695, DOI 10.1001/jama.247.19.2695; Welfare MR, 1999, MED EDUC, V33, P165; Westberg K, 2001, BRIT MED J, V323, P488, DOI 10.1136/bmj.323.7311.488; WRIGHT HJ, 1974, BRIT MED J, V1, P372, DOI 10.1136/bmj.1.5904.372	24	87	90	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 9	2003	327	7410					326	328		10.1136/bmj.327.7410.326	http://dx.doi.org/10.1136/bmj.327.7410.326			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	710JE	12907488	Bronze, Green Published			2022-12-28	WOS:000184676400023
J	Lo, B; Bayer, R				Lo, B; Bayer, R		Ethics Working Grp HIV Prevention	Establishing ethical trials for treatment and prevention of AIDS in developing countries	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COMMUNITIES		Univ Calif San Francisco, Program Med Eth, San Francisco, CA 94143 USA; Joseph P Mailman Sch Publ Hlth, Dept Sociomed Sci, Program Hist & Eth Publ Hlth, New York, NY USA	University of California System; University of California San Francisco	Lo, B (corresponding author), Univ Calif San Francisco, Program Med Eth, 521 Parnassus Ave, San Francisco, CA 94143 USA.	bernie@medicine.ucsf.edu	Lo, Bruce/AAV-1510-2021	Lo, Bruce/0000-0001-6210-9667	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI046749] Funding Source: NIH RePORTER; NIAID NIH HHS [U01-AI-46749] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		*CDCP, 1998, BUILD COMM PARTN RES; Council for International Organizations of Medical Sciences WHO, 2002, INT ETH GUID BIOM RE; *HIV PREV TRIALS N, ETH GUID RES; Juengst ET, 2000, J LAW MED ETHICS, V28, P52, DOI 10.1111/j.1748-720X.2000.tb00316.x; National Bioethics Advisory Commission, 2001, ETH POL ISS INT RES; Nuffield Council on Bioethics, 2002, ETH RES REL HEALTHC; Reilly PR, 1998, AM J HUM GENET, V63, P682, DOI 10.1086/302028; Sharp RR, 2000, J LAW MED ETHICS, V28, P41, DOI 10.1111/j.1748-720X.2000.tb00315.x; Strauss RP, 2001, AM J PUBLIC HEALTH, V91, P1938, DOI 10.2105/AJPH.91.12.1938; Weijer C, 2000, SCIENCE, V289, P1142, DOI 10.1126/science.289.5482.1142; World Medical Association, DECL HELS ETH PRINC	11	27	27	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2003	327	7410					337	339		10.1136/bmj.327.7410.337	http://dx.doi.org/10.1136/bmj.327.7410.337			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	710JE	12907493	Green Published			2022-12-28	WOS:000184676400029
J	Rayment, R; Birchall, J; Yarranton, H; Hewertson, J; Allen, D; Murphy, MF; Roberts, DJ				Rayment, R; Birchall, J; Yarranton, H; Hewertson, J; Allen, D; Murphy, MF; Roberts, DJ			Neonatal alloimmune thrombocytopenia	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MANAGEMENT		John Radcliffe Hosp, Natl Blood Serv, Oxford OX3 9DU, England; Southmead Gen Hosp, Natl Blood Serv, Bristol BS10 5ND, Avon, England; Norfolk & Norwich Univ Hosp NHS Trust, Dept Haematol, Norwich NR4 7UY, Norfolk, England; Northampton Gen Hosp, Northampton NN1 5BD, England	University of Oxford; Southmead Hospital; Norfolk & Norwich University Hospitals NHS Foundation Trust	Roberts, DJ (corresponding author), John Radcliffe Hosp, Natl Blood Serv, Oxford OX3 9DU, England.	david.roberts@ndcls.ox.ac.uk						Blanchette VS, 2000, BEST PRACT RES CL HA, V13, P365, DOI 10.1053/beha.2000.0083; BURROWS RF, 1993, NEW ENGL J MED, V329, P1463, DOI 10.1056/NEJM199311113292005; KAPLAN C, 1991, COLLOQ INSE, V206, P267; KIEFEL V, 1987, BLOOD, V70, P1722; MARZUSCH K, 1993, ACTA OBSTET GYN SCAN, V72, P583, DOI 10.3109/00016349309058169; Moulinier J, 1953, P 6 C EUR SOC HAEM, P817; MUELLERECKHARDT C, 1989, LANCET, V1, P363; Murphy MF, 1999, BRIT J HAEMATOL, V105, P123, DOI 10.1111/j.1365-2141.1999.01276.x; Ouwehand WH, 2000, ARCH DIS CHILD-FETAL, V82, pF173, DOI 10.1136/fn.82.3.F173; PROULX C, 1994, BRIT J HAEMATOL, V87, P813, DOI 10.1111/j.1365-2141.1994.tb06742.x; VALENTIN N, 1990, HUM IMMUNOL, V27, P73, DOI 10.1016/0198-8859(90)90104-W; VONDEMBORNE AEGK, 1978, BRIT J HAEMATOL, V39, P195; Williamson LM, 1998, BLOOD, V92, P2280, DOI 10.1182/blood.V92.7.2280.2280_2280_2287; ZALNERAITIS EL, 1979, J PEDIATR-US, V95, P611, DOI 10.1016/S0022-3476(79)80781-7	14	8	11	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2003	327	7410					331	332		10.1136/bmj.327.7410.331	http://dx.doi.org/10.1136/bmj.327.7410.331			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	710JE	12907491	Green Published			2022-12-28	WOS:000184676400026
J	Sherratt, DJ				Sherratt, DJ			Bacterial chromosome dynamics	SCIENCE			English	Review							DNA TOPOISOMERASES; CELL-DIVISION; SMC PROTEINS; REPLICATION; SEGREGATION; ACTIN; ORGANIZATION; POLYMERASE; RESOLUTION; MODEL	Bacterial chromosomes are highly compacted structures and share many properties with their eukaryote counterparts, despite not being organized into chromatin or being contained within a cell nucleus. Proteins conserved across all branches of life act in chromosome organization, and common mechanisms maintain genome integrity and ensure faithful replication. The principles that underlie chromosome segregation in bacteria and eukaryotes share similarities, although bacteria segregate DNA as it replicates and lack a eukaryote-like mitotic apparatus for segregating chromosomes. This may be because the distances that newly replicated bacterial chromosomes move apart before cell division are small as compared to those in eukaryotes. Bacteria specify positional information, which determines where cell division will occur and which places the replication machinery and chromosomal loci at defined locations that change during cell cycle progression.	Univ Oxford, Dept Biochem, Div Mol Genet, Oxford OX1 3QU, England	University of Oxford	Sherratt, DJ (corresponding author), Univ Oxford, Dept Biochem, Div Mol Genet, S Parks Rd, Oxford OX1 3QU, England.	sherratt@bioch.ox.ac.uk						Aussel L, 2002, CELL, V108, P195, DOI 10.1016/S0092-8674(02)00624-4; Autret S, 2003, MOL MICROBIOL, V47, P159, DOI 10.1046/j.1365-2958.2003.03264.x; Barre FX, 2001, P NATL ACAD SCI USA, V98, P8189, DOI 10.1073/pnas.111008998; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bernander R, 2000, TRENDS MICROBIOL, V8, P278, DOI 10.1016/S0966-842X(00)01760-1; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Davey MJ, 2000, CURR OPIN CHEM BIOL, V4, P581, DOI 10.1016/S1367-5931(00)00134-4; Dervyn E, 2001, SCIENCE, V294, P1716, DOI 10.1126/science.1066351; Draper GC, 2002, ANNU REV MICROBIOL, V56, P567, DOI 10.1146/annurev.micro.56.012302.160729; Dworkin J, 2002, P NATL ACAD SCI USA, V99, P14089, DOI 10.1073/pnas.182539899; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Harry EJ, 2001, MOL MICROBIOL, V40, P795, DOI 10.1046/j.1365-2958.2001.02370.x; HELMSTETTER CE, 1996, ESCHERICHIA COLI SAL, P1627; Hirano T, 2002, GENE DEV, V16, P399, DOI 10.1101/gad.955102; JACOB F, 1963, COLD SPRING HARB SYM, V28, P329, DOI 10.1101/SQB.1963.028.01.048; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kobryn K, 2001, CURR OPIN MICROBIOL, V4, P558, DOI 10.1016/S1369-5274(00)00251-4; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Lee PS, 2003, J BACTERIOL, V185, P1326, DOI 10.1128/JB.185.4.1326-1337.2003; Lemon KP, 2001, GENE DEV, V15, P2031, DOI 10.1101/gad.913301; Lemon KP, 1998, SCIENCE, V282, P1516, DOI 10.1126/science.282.5393.1516; Lewis PJ, 1997, MOL MICROBIOL, V25, P945, DOI 10.1111/j.1365-2958.1997.mmi530.x; Li YF, 2002, MOL MICROBIOL, V46, P985, DOI 10.1046/j.1365-2958.2002.03234.x; Margolin W, 2001, CURR OPIN MICROBIOL, V4, P647, DOI 10.1016/S1369-5274(01)00264-8; Maurizi Michael R., 2001, EMBO Reports, V2, P980, DOI 10.1093/embo-reports/kve229; McGlynn P, 2002, TRENDS GENET, V18, P413, DOI 10.1016/S0168-9525(02)02720-8; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Niki H, 2000, GENE DEV, V14, P212; Nurse P, 2003, J BIOL CHEM, V278, P8653, DOI 10.1074/jbc.M211211200; Pettijohn D.E., 1996, ESCHERICHIA COLI SAL, P158; Postow L, 2001, P NATL ACAD SCI USA, V98, P8219, DOI 10.1073/pnas.111006998; Postow L, 2001, J BIOL CHEM, V276, P2790, DOI 10.1074/jbc.M006736200; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; SIGAL BH, 2003, SCIENCE, V299, P532; Soppa J, 2001, GENE, V278, P253, DOI 10.1016/S0378-1119(01)00733-8; Sunako Y, 2001, MOL MICROBIOL, V42, P1233, DOI 10.1046/j.1365-2958.2001.02680.x; van den Ent F, 2001, CURR OPIN MICROBIOL, V4, P634, DOI 10.1016/S1369-5274(01)00262-4; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Weller GR, 2002, SCIENCE, V297, P1686, DOI 10.1126/science.1074584; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Woldringh CL, 2002, MOL MICROBIOL, V45, P17, DOI 10.1046/j.1365-2958.2002.02993.x	44	154	156	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2003	301	5634					780	785		10.1126/science.1084780	http://dx.doi.org/10.1126/science.1084780			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907786				2022-12-28	WOS:000184615700029
J	Dennis, M				Dennis, M			Commentary: an imperfect compromise	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Dennis, M (corresponding author), Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland.							Lewis SC, 2001, STROKE, V32, P1640, DOI 10.1161/01.STR.32.7.1640	1	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 2	2003	327	7409					286	286		10.1136/bmj.327.7409.286	http://dx.doi.org/10.1136/bmj.327.7409.286			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708KP	12896946	Green Submitted, Green Published			2022-12-28	WOS:000184566300027
J	McLellan, F				McLellan, F			NIH director reviews first year on the job	LANCET			English	News Item														McLellan, Faith/0000-0003-0744-1450					0	1	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 2	2003	362	9381					381	382		10.1016/S0140-6736(03)14064-0	http://dx.doi.org/10.1016/S0140-6736(03)14064-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707FB	12911017	Bronze			2022-12-28	WOS:000184498700020
J	Sejnowski, TJ				Sejnowski, TJ			Tap into Science 24-7	SCIENCE			English	Editorial Material									Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego	Sejnowski, TJ (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.		Sejnowski, Terrence/AAV-5558-2021					Donato G, 1999, IEEE T PATTERN ANAL, V21, P974, DOI 10.1109/34.799905; FRANTZICH S, 1996, CSPAN REVOLUTION	2	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2003	301	5633					601	601		10.1126/science.1084463	http://dx.doi.org/10.1126/science.1084463			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893928				2022-12-28	WOS:000184473600023
J	Song, TRA; Simons, M				Song, TRA; Simons, M			Large trench-parallel gravity variations predict seismogenic behavior in subduction zones	SCIENCE			English	Article							RUPTURE PROCESS; ASPERITY DISTRIBUTION; STRAIN ACCUMULATION; GREAT EARTHQUAKES; TOPOGRAPHY; ISLANDS; CHILE; LONG; SLIP	We demonstrate that great earthquakes occur predominantly in regions with a strongly negative trench-parallel gravity anomaly (TPGA), whereas regions with strongly positive TPGA are relatively aseismic. These observations suggest that, over time scales up to at least 1 million years, spatial variations of seismogenic behavior within a given subduction zone are stationary and linked to the geological structure of the fore-arc. The correlations we observe are consistent with a model in which spatial variations in frictional properties on the plate interface control trench-parellel variations in fore-arc topography, gravity, and seismogenic behavior.	CALTECH, Div Geol & Planetary Sci, Seismol Lab, Pasadena, CA 91125 USA	California Institute of Technology	Song, TRA (corresponding author), CALTECH, Div Geol & Planetary Sci, Seismol Lab, Pasadena, CA 91125 USA.	alex@gps.caltech.edu	Song, Teh-Ru Alex/I-7563-2012; Simons, Mark/N-4397-2015	Simons, Mark/0000-0003-1412-6395				BARRIENTOS SE, 1990, GEOPHYS J INT, V103, P589, DOI 10.1111/j.1365-246X.1990.tb05673.x; BECK SL, 1991, J GEOPHYS RES-SOLID, V96, P2205, DOI 10.1029/90JB02092; Billen MI, 2001, EARTH PLANET SC LETT, V193, P227, DOI 10.1016/S0012-821X(01)00482-4; Buiter SJH, 2001, GEOPHYS J INT, V147, P415, DOI 10.1046/j.1365-246X.2001.00545.x; Cattin R, 1997, GEOPHYS RES LETT, V24, P1563, DOI 10.1029/97GL01550; DEMETS C, 1994, GEOPHYS RES LETT, V21, P2191, DOI 10.1029/94GL02118; DZIEWONSKI AM, 1981, J GEOPHYS RES, V86, P2825, DOI 10.1029/JB086iB04p02825; Engdahl ER, 1998, B SEISMOL SOC AM, V88, P722; Fletcher HJ, 2001, GEOPHYS RES LETT, V28, P443, DOI 10.1029/2000GL012258; Freymueller JT, 1999, GEOPHYS RES LETT, V26, P3233, DOI 10.1029/1999GL008356; Gudmundsson O, 1998, J GEOPHYS RES-SOL EA, V103, P7121, DOI 10.1029/97JB02488; HAGER BH, 1983, TECTONOPHYSICS, V99, P165, DOI 10.1016/0040-1951(83)90101-4; JOHNSON J, 1998, ADV GEOPHYS, V29, P1; Johnson JM, 1999, PURE APPL GEOPHYS, V154, P541, DOI 10.1007/s000240050243; KAGAN YY, 1995, J GEOPHYS RES-SOL EA, V100, P3943, DOI 10.1029/94JB03014; KANAMORI H, 1986, ANNU REV EARTH PL SC, V14, P293, DOI 10.1146/annurev.ea.14.050186.001453; KELLEHER J, 1976, J GEOPHYS RES, V81, P4885, DOI 10.1029/JB081i026p04885; LARSON KM, 1994, GEOPHYS RES LETT, V21, P489, DOI 10.1029/94GL00417; LAY T, 1982, EARTHQUAKE PRED RES, V1, P3; Marone C, 1998, ANNU REV EARTH PL SC, V26, P643, DOI 10.1146/annurev.earth.26.1.643; *NAT GEOPH DAT CTR, 1996, TOT SED THICKN WORLD; *NAT GEOPH DAT CTR, 1993, GLOB REL DAT; NISHENKO SP, 1991, PURE APPL GEOPHYS, V135, P169, DOI 10.1007/BF00880240; RUFF L, 1983, PHYS EARTH PLANET IN, V31, P202, DOI 10.1016/0031-9201(83)90099-7; RUFF LJ, 1996, AM GEOPHYS UNION GEO, V96, P105; Sandwell DT, 1997, J GEOPHYS RES-SOL EA, V102, P10039, DOI 10.1029/96JB03223; SCHOLZ CH, 1995, J GEOPHYS RES-SOL EA, V100, P22103, DOI 10.1029/95JB01869; SHEMENDA AI, 1994, SUBDUCTION INSIGHTS, V11; SUGIYAMA Y, 1994, GEOFIS INT, V33, P53; Tanioka Y, 2001, EARTH PLANETS SPACE, V53, P235, DOI 10.1186/BF03352380; UYEDA S, 1979, J GEOPHYS RES, V84, P1049, DOI 10.1029/JB084iB03p01049; WDOWINSKI S, 1992, J GEOPHYS RES-SOL EA, V97, P17651, DOI 10.1029/92JB01337; ZHONG SJ, 1994, J GEOPHYS RES-SOL EA, V99, P15683, DOI 10.1029/94JB00809; ZHONG SJ, 1992, GEOPHYS RES LETT, V19, P1891, DOI 10.1029/92GL02142; ZWECK CJ, 2002, J GEOPHYS RES, V107, DOI DOI 10.1029/2001B000409; [No title captured]	37	207	208	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2003	301	5633					630	633		10.1126/science.1085557	http://dx.doi.org/10.1126/science.1085557			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893939				2022-12-28	WOS:000184473600035
J	Losos, JB; Leal, M; Glor, RE; de Queiroz, K; Hertz, PE; Schettino, LR; Lara, AC; Jackman, TR; Larson, A				Losos, JB; Leal, M; Glor, RE; de Queiroz, K; Hertz, PE; Schettino, LR; Lara, AC; Jackman, TR; Larson, A			Niche lability in the evolution of a Caribbean lizard community	NATURE			English	Article							ANOLIS LIZARDS; PHYLOGENETIC-RELATIONSHIPS; ECOLOGY; SYSTEMS; MODEL	Niche conservatism-the tendency for closely related species to be ecologically similar - is widespread(1-3). However, most studies compare closely related taxa that occur in allopatry(3); in sympatry, the stabilizing forces that promote niche conservatism(4,5), and thus inhibit niche shifts, may be countered by natural selection favouring ecological divergence to minimize the intensity of interspecific interactions(6,7). Consequently, the relative importance of niche conservatism versus niche divergence in determining community structure has received little attention(7). Here, we examine a tropical lizard community in which species have a long evolutionary history of ecological interaction. We find that evolutionary divergence overcomes niche conservatism: closely related species are no more ecologically similar than expected by random divergence and some distantly related species are ecologically similar, leading to a community in which the relationship between ecological similarity and phylogenetic relatedness is very weak. Despite this lack of niche conservatism, the ecological structuring of the community has a phylogenetic component: niche complementarity only occurs among distantly related species, which suggests that the strength of ecological interactions among species may be related to phylogeny, but it is not necessarily the most closely related species that interact most strongly.	Washington Univ, Dept Biol, St Louis, MO 63130 USA; Union Coll, Dept Biol Sci, Schenectady, NY 12308 USA; Smithsonian Inst, Natl Museum Amer Hist, Div Amphibians & Reptiles, Washington, DC 20560 USA; Columbia Univ Barnard Coll, Dept Biol, New York, NY 10027 USA; CITGMA, Inst Ecol & Sistemat, Havana 10800, Cuba; Villanova Univ, Dept Biol, Villanova, PA 19085 USA	Washington University (WUSTL); Union College; Smithsonian Institution; Smithsonian National Museum of Natural History; Columbia University; Villanova University	Losos, JB (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.		Glor, Richard/N-4656-2013; Leal, Manuel/A-7220-2010	Glor, Richard/0000-0002-3359-1631; Jackman, Todd/0000-0002-5391-8136				Butler MA, 2002, ECOL MONOGR, V72, P541, DOI 10.1890/0012-9615(2002)072[0541:MSDSSA]2.0.CO;2; Danley PD, 2001, MOL ECOL, V10, P1075, DOI 10.1046/j.1365-294X.2001.01283.x; de Queiroz Kevin, 1998, American Museum Novitates, V3249, P1; Gerber GP, 2000, OECOLOGIA, V124, P599, DOI 10.1007/s004420000414; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jackman TR, 1999, SYST BIOL, V48, P254, DOI 10.1080/106351599260283; LANGLEY CH, 1974, J MOL EVOL, V3, P161, DOI 10.1007/BF01797451; Leal M, 1998, OECOLOGIA, V117, P273, DOI 10.1007/s004420050658; LOSOS JB, 1994, ANNU REV ECOL SYST, V25, P467, DOI 10.1146/annurev.es.25.110194.002343; Losos JB, 1999, ECOLOGY, V80, P252, DOI 10.1890/0012-9658(1999)080[0252:DCSAAI]2.0.CO;2; Macey JR, 1998, MOL PHYLOGENET EVOL, V10, P118, DOI 10.1006/mpev.1997.0478; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Petren K, 1999, P ROY SOC B-BIOL SCI, V266, P321, DOI 10.1098/rspb.1999.0641; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prinzing A, 2001, P ROY SOC B-BIOL SCI, V268, P2383, DOI 10.1098/rspb.2001.1801; REAGAN DP, 1992, COPEIA, P392; RICHMAN AD, 1992, NATURE, V355, P817, DOI 10.1038/355817a0; SCHOENER TW, 1980, J ANIM ECOL, V49, P19, DOI 10.2307/4276; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; SHOCHAT D, 1981, COMP BIOCHEM PHYS A, V68, P67, DOI 10.1016/0300-9629(81)90319-4; Silvertown J, 2001, J ECOL, V89, P428, DOI 10.1046/j.1365-2745.2001.00553.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448	22	244	252	1	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					542	545		10.1038/nature01814	http://dx.doi.org/10.1038/nature01814			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891355				2022-12-28	WOS:000184454700040
J	Mackenbach, JP				Mackenbach, JP			Dead body with mourners: medical reflections on the entombment of Christ	BRITISH MEDICAL JOURNAL			English	Article							BEREAVEMENT		Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Mackenbach, JP (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, POB 1738, NL-3000 DR Rotterdam, Netherlands.							Aries Philippe, 1977, HOMME DEVANT MORT; Boase T. S. R., 1972, DEATH MIDDLE AGES MO; Bonanno GA, 1999, PSYCHOL BULL, V125, P760, DOI 10.1037/0033-2909.125.6.760; BREURE I, 1987, DOODSBELEVING LEVENS; Elias Norbert, 1969, PROZESS ZIVILISATION; Flinn MW., 1981, EUROPEAN DEMOGRAPHIC; FORSYTH WH, 1970, EMTOMBMENT CHRIST FR; FREUD S, 1980, PELICAN FREUD LIB, V14; GATRAD AR, 1994, BRIT MED J, V309, P521, DOI 10.1136/bmj.309.6953.521; HUIZINGA J, 1976, WANING MIDDLE AGES; Kubler Ross Elisabeth, 1969, DEATH DYING; Kurtz Leonard Paul, 1934, DANCE DEATH MACABRE; MACKENBACH JP, 1995, AM J PUBLIC HEALTH, V85, P1285, DOI 10.2105/AJPH.85.9.1285; MALE E, 1986, RELIG ART FRANCE LAT; Marrow James H., 1979, PASSION ICONOGRAPHY; Martin Michel, 1997, STATUAIRE MISE TOMBE; VANOS H, 1994, ART DEVOTION LATE MI; WRIGLEY EA, 1981, POPULATION HIST BRIT	18	1	1	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2003	327	7408					215	218		10.1136/bmj.327.7408.215	http://dx.doi.org/10.1136/bmj.327.7408.215			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	706DL	12881269	Green Submitted, Green Published			2022-12-28	WOS:000184437300025
J	Masutomi, K; Yu, EY; Khurts, S; Ben-Porath, I; Currier, JL; Metz, GB; Brooks, MW; Kaneko, S; Murakami, S; DeCaprio, JA; Weinberg, RA; Stewart, SA; Hahn, WC				Masutomi, K; Yu, EY; Khurts, S; Ben-Porath, I; Currier, JL; Metz, GB; Brooks, MW; Kaneko, S; Murakami, S; DeCaprio, JA; Weinberg, RA; Stewart, SA; Hahn, WC			Telomerase maintains telomere structure in normal human cells	CELL			English	Article							REVERSE-TRANSCRIPTASE HTERT; HUMAN-DIPLOID FIBROBLASTS; CATALYTIC SUBUNIT; LIFE-SPAN; G-STRAND; SACCHAROMYCES-CEREVISIAE; HUMAN-LYMPHOCYTES; IMMORTAL CELLS; RNA COMPONENT; MOUSE CELLS	In normal human cells, telomeres shorten with successive rounds of cell division, and immortalization correlates with stabilization of telomere length. These observations suggest that human cancer cells achieve immortalization in large part through the illegitimate activation of telomerase expression. Here, we demonstrate that the rate-limiting telomerase catalytic subunit hTERT is expressed in cycling primary presenescent human fibroblasts, previously believed to lack hTERT expression and telomerase activity. Disruption of telomerase activity in normal human cells slows cell proliferation, restricts cell lifespan, and alters the maintenance of the 3' single-stranded telomeric overhang without changing the rate of overall telomere shortening. Together, these observations support the view that telomerase and telomere structure are dynamically regulated in normal human cells and that telomere length alone is unlikely to trigger entry into replicative senescence.	Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Kanazawa Univ, Canc Res Inst, Dept Mol Oncol, Kanazawa, Ishikawa 9200934, Japan; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa 9208641, Japan	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Kanazawa University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Kanazawa University	Hahn, WC (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.		Stewart, Sheila A/C-5213-2012		NATIONAL CANCER INSTITUTE [F32CA093033, K01CA094223, R01CA078461] Funding Source: NIH RePORTER; NCI NIH HHS [F32 CA93033, R01 CA78461, K01 CA94223] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allsopp RC, 2001, J EXP MED, V193, P917, DOI 10.1084/jem.193.8.917; Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Cimino-Reale G, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e35; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; Counter CM, 1998, ONCOGENE, V16, P1217, DOI 10.1038/sj.onc.1201882; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dionne I, 1996, P NATL ACAD SCI USA, V93, P13902, DOI 10.1073/pnas.93.24.13902; Enomoto S, 2002, MOL BIOL CELL, V13, P2626, DOI 10.1091/mbc.02-02-0012; Etheridge KT, 2002, J BIOL CHEM, V277, P24764, DOI 10.1074/jbc.M201227200; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089; Goytisolo FA, 2001, MOL CELL BIOL, V21, P3642, DOI 10.1128/MCB.21.11.3642-3651.2001; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HARA E, 1991, BIOCHEM BIOPH RES CO, V179, P528, DOI 10.1016/0006-291X(91)91403-Y; HarleBachor C, 1996, P NATL ACAD SCI USA, V93, P6476, DOI 10.1073/pnas.93.13.6476; HARLEY CB, 1994, COLD SPRING HARB SYM, V59, P307, DOI 10.1101/SQB.1994.059.01.035; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hiyama E, 1996, INT J ONCOL, V9, P453; HIYAMA K, 1995, J IMMUNOL, V155, P3711; Ijpma AS, 2003, MOL BIOL CELL, V14, P987, DOI 10.1091/mbc.02-04-0057; Jacob NK, 2003, MOL CELL, V11, P1021, DOI 10.1016/S1097-2765(03)00131-X; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kilian A, 1997, HUM MOL GENET, V6, P2011, DOI 10.1093/hmg/6.12.2011; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Kirk KE, 1997, SCIENCE, V275, P1478, DOI 10.1126/science.275.5305.1478; Kolquist KA, 1998, NAT GENET, V19, P182, DOI 10.1038/554; Li GZ, 2003, P NATL ACAD SCI USA, V100, P527, DOI 10.1073/pnas.0235444100; Liu KB, 1999, P NATL ACAD SCI USA, V96, P5147, DOI 10.1073/pnas.96.9.5147; Martin-Rivera L, 1998, P NATL ACAD SCI USA, V95, P10471, DOI 10.1073/pnas.95.18.10471; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Masutomi K, 2000, J BIOL CHEM, V275, P22568, DOI 10.1074/jbc.M000622200; Matthews P, 2001, J PATHOL, V194, P183, DOI 10.1002/path.848; Nakamura TM, 1998, CELL, V92, P587, DOI 10.1016/S0092-8674(00)81123-X; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; SHAY JW, 1989, EXP CELL RES, V184, P109, DOI 10.1016/0014-4827(89)90369-8; Smogorzewska A, 2002, EMBO J, V21, P4338, DOI 10.1093/emboj/cdf433; Son NH, 2000, J IMMUNOL, V165, P1191, DOI 10.4049/jimmunol.165.3.1191; Steinert S, 2000, BIOCHEM BIOPH RES CO, V273, P1095, DOI 10.1006/bbrc.2000.3080; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Stewart SA, 2003, NAT GENET, V33, P492, DOI 10.1038/ng1127; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Tahara H, 1999, ONCOGENE, V18, P1561, DOI 10.1038/sj.onc.1202458; Ulaner GA, 1998, CANCER RES, V58, P4168; Vaziri H, 1999, MOL CELL BIOL, V19, P2373; Wei WY, 1999, EXP CELL RES, V253, P519, DOI 10.1006/excr.1999.4665; Wong JMY, 2002, NAT CELL BIOL, V4, P731, DOI 10.1038/ncb846; Wright WE, 2002, NAT BIOTECHNOL, V20, P682, DOI 10.1038/nbt0702-682; Yasumoto S, 1996, ONCOGENE, V13, P433; Yuan XM, 1999, GENES CELLS, V4, P563, DOI 10.1046/j.1365-2443.1999.00284.x; Zhu XL, 1996, P NATL ACAD SCI USA, V93, P6091, DOI 10.1073/pnas.93.12.6091	60	600	665	4	68	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 25	2003	114	2					241	253		10.1016/S0092-8674(03)00550-6	http://dx.doi.org/10.1016/S0092-8674(03)00550-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887925	Green Submitted, Bronze			2022-12-28	WOS:000184378700013
J	Kim, SO; Solak, HH; Stoykovich, MP; Ferrier, NJ; de Pablo, JJ; Nealey, PF				Kim, SO; Solak, HH; Stoykovich, MP; Ferrier, NJ; de Pablo, JJ; Nealey, PF			Epitaxial self-assembly of block copolymers on lithographically defined nanopatterned substrates	NATURE			English	Article							THIN-FILMS; NANOSTRUCTURES; ARRAYS; SIMULATIONS; MICRODOMAIN	Parallel processes for patterning densely packed nanometre- scale structures are critical for many diverse areas of nanotechnology. ;Thin films of diblock copolymers(1-11) can self-assemble into ordered periodic structures at the molecular scale (similar to5 to 50 nm), and have been used as templates to fabricate quantum dots(1,2), nanowires(3-5), magnetic storage media(6), nanopores(7) and silicon capacitors(8). Unfortunately, perfect periodic domain ordering can only be achieved over micrometre-scale areas at best(12,13) and defects exist at the edges of grain boundaries. These limitations preclude the use of block-copolymer lithography for many advanced applications(14). Graphoepitaxy(12,15), in-plane electric fields(3,16), temperature gradients(17), and directional solidification(14,18) have also been demonstrated to induce orientation or long-range order with varying degrees of success. Here we demonstrate the integration of thin films of block copolymer with advanced lithographic techniques to induce epitaxial self-assembly of domains. The resulting patterns are defect-free, are oriented and registered with the underlying substrate and can be created over arbitrarily large areas. These structures are determined by the size and quality of the lithographically defined surface pattern rather than by the inherent limitations of the self-assembly process. Our results illustrate how hybrid strategies to nanofabrication allow for molecular level control in existing manufacturing processes.	Univ Wisconsin, Dept Chem Engn, Madison, WI 53706 USA; Univ Wisconsin, Ctr Nanotechnol, Madison, WI 53706 USA; Univ Wisconsin, Dept Mech Engn, Madison, WI 53706 USA; Paul Scherrer Inst, Lab Micro & Nanotechnol, CH-5232 Villigen, Switzerland	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Nealey, PF (corresponding author), Univ Wisconsin, Dept Chem Engn, 1415 Johnson Dr, Madison, WI 53706 USA.	nealey@engr.wisc.edu	de Pablo, Juan/AAJ-9161-2021; Kim, Sang Ouk/C-1632-2011; Lee, Junyoung/D-5463-2012	Kim, Sang Ouk/0000-0003-1513-6042; Lee, Junyoung/0000-0001-6689-2759; Ferrier, Nicola/0000-0003-1444-0624				BATES FS, 1990, ANNU REV PHYS CHEM, V41, P525, DOI 10.1146/annurev.pc.41.100190.002521; Black CT, 2001, APPL PHYS LETT, V79, P409, DOI 10.1063/1.1383805; Bodycomb J, 1999, MACROMOLECULES, V32, P2075, DOI 10.1021/ma981538g; Chan VZH, 1999, SCIENCE, V286, P1716, DOI 10.1126/science.286.5445.1716; Cheng JY, 2002, APPL PHYS LETT, V81, P3657, DOI 10.1063/1.1519356; Cheng JY, 2001, ADV MATER, V13, P1174, DOI 10.1002/1521-4095(200108)13:15<1174::AID-ADMA1174>3.0.CO;2-Q; De Rosa C, 2000, NATURE, V405, P433, DOI 10.1038/35013018; Dulcey CS, 1996, LANGMUIR, V12, P1638, DOI 10.1021/la9509514; Fasolka MJ, 2001, ANN REV MATER RES, V31, P323, DOI 10.1146/annurev.matsci.31.1.323; Harrison C, 2000, SCIENCE, V290, P1558, DOI 10.1126/science.290.5496.1558; Huang E, 1998, NATURE, V395, P757, DOI 10.1038/27358; Kim HC, 2001, ADV MATER, V13, P795, DOI 10.1002/1521-4095(200106)13:11<795::AID-ADMA795>3.0.CO;2-1; Li RR, 2000, APPL PHYS LETT, V76, P1689, DOI 10.1063/1.126137; Lopes WA, 2001, NATURE, V414, P735, DOI 10.1038/414735a; Mansky P, 1997, SCIENCE, V275, P1458, DOI 10.1126/science.275.5305.1458; Morkved TL, 1996, SCIENCE, V273, P931, DOI 10.1126/science.273.5277.931; Park C, 2001, APPL PHYS LETT, V79, P848, DOI 10.1063/1.1389766; Park M, 1997, SCIENCE, V276, P1401, DOI 10.1126/science.276.5317.1401; Petera D, 1998, J CHEM PHYS, V109, P5101, DOI 10.1063/1.477124; Rockford L, 2001, MACROMOLECULES, V34, P1487, DOI 10.1021/ma001747c; Rockford L, 1999, PHYS REV LETT, V82, P2602, DOI 10.1103/PhysRevLett.82.2602; Segalman RA, 2001, ADV MATER, V13, P1152, DOI 10.1002/1521-4095(200108)13:15<1152::AID-ADMA1152>3.0.CO;2-5; Solak HH, 2003, MICROELECTRON ENG, V67-8, P56, DOI 10.1016/S0167-9317(03)00059-5; Thurn-Albrecht T, 2000, SCIENCE, V290, P2126, DOI 10.1126/science.290.5499.2126; Wang Q, 2000, J CHEM PHYS, V112, P9996, DOI 10.1063/1.481635; Wang Q, 2003, MACROMOLECULES, V36, P1731, DOI 10.1021/ma020996t; Yang XM, 2000, MACROMOLECULES, V33, P9575, DOI 10.1021/ma001326v	27	1474	1594	17	703	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2003	424	6947					411	414		10.1038/nature01775	http://dx.doi.org/10.1038/nature01775			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879065				2022-12-28	WOS:000184318400038
J	Virtamo, J; Pietinen, P; Huttunen, JK; Malila, N; Virtanen, MJ; Albanes, D; Taylor, PR; Albert, P				Virtamo, J; Pietinen, P; Huttunen, JK; Malila, N; Virtanen, MJ; Albanes, D; Taylor, PR; Albert, P		ATBC Study Grp	Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation - A postintervention follow-up	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONTROLLED TRIAL FINLAND; LUNG-CANCER; CARDIOVASCULAR-DISEASE; CIGARETTE-SMOKE; PROSTATE-CANCER; VITAMIN-A; PREVENTION; MICRONUTRIENTS; FERRETS; RISK	Context In the Finnish Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) study, alpha-tocopherol supplementation decreased prostate cancer incidence, whereas beta-carotene increased the risk of lung cancer and total mortality. Postintervention follow-up provides information regarding duration of the intervention effects and may reveal potential late effects of these antioxidants. Objective To analyze postintervention effects of alpha-tocopherol and beta-carotene on cancer incidence and total and cause-specific mortality. Design, Setting, and Participants Postintervention follow-up assessment of cancer incidence and cause-specific mortality (6 years [May 1, 1993-April 30, 1999]) and total mortality (8 years [May 1, 1993-April 30, 2001]) of 25563 men. In the ATBC Study, 29133 male smokers aged 50 to 69 years received a-tocopherol (50 mg), beta-carotene (20 mg), both agents, or placebo daily for 5 to 8 years. End point information was obtained from the Finnish Cancer Registry and the Register of Causes of Death. Cancer cases were, confirmed through medical record review. Main Outcome Measures Site-specific cancer incidence and total and cause-specific mortality and calendar time-specific risk for lung cancer incidence and total mortality. Results Overall posttrial relative risk (RR) for lung cancer incidence (n = 1037) was 1.06 (95% confidence interval [CI], 0.94-1.20) among recipients of beta-carotene compared with nonrecipients. For prostate cancer incidence (n=672), the RR was 0.88 (95% CI, 0.76-1.03) for participants receiving alpha-tocopherol compared with nonrecipients. No late preventive effects on other cancers were observed for either supplement. There were 7261 individuals who died by April 30, 2001, during the posttrial follow-up period; the RR was 1.01 (95% CI, 0.96-1.05) for alpha-tocopherol recipients vs nonrecipients and 1.07 (95% CI, 1.02-1.12) for beta-carotene recipients vs nonrecipients. Regarding duration of intervention effects and potential late effects, the excess risk for beta-carotene recipients was no longer evident 4 to 6 years after ending the intervention and was primarily due to cardiovascular diseases. Conclusions The beneficial and adverse effects of supplemental alpha-tocopherol and beta-carotene disappeared during postintervention follow-up. The preventive effects of alpha-tocopherol on prostate cancer require confirmation in other trials. Smokers should avoid beta-carotene supplementation.	Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, FIN-00300 Helsinki, Finland; NCI, Bethesda, MD 20892 USA; Univ Helsinki, Cent Hosp, FIN-00014 Helsinki, Finland; Univ Turku, Cent Hosp, SF-20500 Turku, Finland; Jorvi Hosp, SF-02740 Espoo, Finland; Finnish Canc Registry, FIN-00170 Helsinki, Finland	Finland National Institute for Health & Welfare; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Helsinki; Helsinki University Central Hospital; University of Turku; Finnish Cancer Registry	Virtamo, J (corresponding author), Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Mannerheimintie 166, FIN-00300 Helsinki, Finland.		Albanes, Demetrius/B-9749-2015		NCI NIH HHS [N01-CN-45165] Funding Source: Medline; CCR NIH HHS [N01-RC-45035] Funding Source: Medline; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN045165] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CCR NIH HHS; DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albanes D, 1996, J NATL CANCER I, V88, P1560, DOI 10.1093/jnci/88.21.1560; Albanes D, 2000, CANCER CAUSE CONTROL, V11, P197, DOI 10.1023/A:1008936214087; Arora A, 2001, CARCINOGENESIS, V22, P1173, DOI 10.1093/carcin/22.8.1173; *ATBC CANC PREV ST, 1994, ANN EPIDEMIOL, V4, P1; BLOT WJ, 1993, JNCI-J NATL CANCER I, V85, P1483, DOI 10.1093/jnci/85.18.1483; Breslow NE., 1987, STAT METHODS CANC RE, P81; Chan JM, 2001, EPIDEMIOL REV, V23, P82, DOI 10.1093/oxfordjournals.epirev.a000799; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; De Flora S, 1999, MUTAGENESIS, V14, P153, DOI 10.1093/mutage/14.2.153; DORGAN JF, 1991, HEMATOL ONCOL CLIN N, V5, P43, DOI 10.1016/S0889-8588(18)30453-2; Greenberg ER, 1996, JAMA-J AM MED ASSOC, V275, P699, DOI 10.1001/jama.275.9.699; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; HEINONEN OP, 1994, NEW ENGL J MED, V330, P1029; Heinonen OP, 1998, J NATL CANCER I, V90, P440, DOI 10.1093/jnci/90.6.440; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; Klein EA, 2001, J UROLOGY, V166, P1311, DOI 10.1016/S0022-5347(05)65759-X; Korhonen P, 2002, ACTA ONCOL, V41, P381, DOI 10.1080/028418602760169442; Liu C, 2000, CARCINOGENESIS, V21, P2245, DOI 10.1093/carcin/21.12.2245; Malila N, 2002, CANCER CAUSE CONTROL, V13, P617, DOI 10.1023/A:1019556227014; Mayne ST, 1996, J NATL CANCER I, V88, P1513; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Paolini M, 1999, NATURE, V398, P760, DOI 10.1038/19655; Paolini M, 2001, CARCINOGENESIS, V22, P1483, DOI 10.1093/carcin/22.9.1483; PETO R, 1981, NATURE, V290, P201, DOI 10.1038/290201a0; Rautalahti MT, 1999, CANCER-AM CANCER SOC, V86, P37, DOI 10.1002/(SICI)1097-0142(19990701)86:1&lt;37::AID-CNCR7&gt;3.0.CO;2-F; Shklar G, 2000, CANCER INVEST, V18, P214, DOI 10.3109/07357900009031826; Virtamo J, 2000, CANCER CAUSE CONTROL, V11, P933, DOI 10.1023/A:1026546803917; Wang XD, 1999, J NATL CANCER I, V91, P60, DOI 10.1093/jnci/91.1.60	28	300	312	0	16	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2003	290	4					476	485						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703JB	12876090				2022-12-28	WOS:000184275300019
J	Bergh, J				Bergh, J			Breast-cancer prevention: is the risk-benefit ratio in favour of tamoxifen?	LANCET			English	Editorial Material							SURGICAL ADJUVANT BREAST; WOMEN		Karolinska Hosp & Inst, Radiumhemmet, S-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Bergh, J (corresponding author), Karolinska Hosp & Inst, Radiumhemmet, S-17176 Stockholm, Sweden.	jonas.bergh@cck.ki.se		Bergh, Jonas/0000-0001-5526-1847				Abe O, 1998, LANCET, V352, P930; Bergh J, 2001, J Natl Cancer Inst Monogr, P103; Cauley JA, 2001, BREAST CANCER RES TR, V65, P125, DOI 10.1023/A:1006478317173; Clarke M, 1998, LANCET, V351, P1451; Cuzick J, 2002, LANCET, V360, P817; Cuzick J, 2003, LANCET, V361, P296, DOI 10.1016/S0140-6736(03)12342-2; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Fisher B, 1999, J CLIN ONCOL, V17, P1632, DOI 10.1200/JCO.1999.17.5.1632; Freedman AN, 2003, JNCI-J NATL CANCER I, V95, P526, DOI 10.1093/jnci/95.7.526; Powles T, 1998, LANCET, V352, P98; Schwartsmann G, 2002, J CLIN ONCOL, V20, p47S, DOI 10.1200/JCO.2002.07.122; Smith IE, 2003, NEW ENGL J MED, V348, P2431, DOI 10.1056/NEJMra023246; Veronesi U, 2002, LANCET, V359, P1122, DOI 10.1016/S0140-6736(02)08159-X	13	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2003	362	9379					183	184		10.1016/S0140-6736(03)13951-7	http://dx.doi.org/10.1016/S0140-6736(03)13951-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702PJ	12885476				2022-12-28	WOS:000184232000005
J	Gunn, J; Grech, ED; Crossman, D; Cumberland, D				Gunn, J; Grech, ED; Crossman, D; Cumberland, D			ABC of interventional cardiology - New developments in percutaneous coronary intervention	BRITISH MEDICAL JOURNAL			English	Review							ARTERY BYPASS-SURGERY; ELUTING STENT; RESTENOSIS; DISEASE		No Gen Hosp, Cardiovasc Res Grp, Ctr Clin Sci, Sheffield S5 7AU, S Yorkshire, England; Hlth Sci Ctr, Winnipeg, MB, Canada; St Boniface Gen Hosp, Winnipeg, MB, Canada; Univ Manitoba, Winnipeg, MB, Canada; Ampang Puteri Specialist Hosp, Kuala Lumpur, Malaysia	Northern General Hospital; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba	Gunn, J (corresponding author), No Gen Hosp, Cardiovasc Res Grp, Ctr Clin Sci, Sheffield S5 7AU, S Yorkshire, England.							Hariawala MD, 1997, J ROY SOC MED, V90, P307, DOI 10.1177/014107689709000604; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Park SJ, 2003, NEW ENGL J MED, V348, P1537, DOI 10.1056/NEJMoa021007; RACO DL, 2002, PRACTICAL INTERVENTI, P263; Serruys PW, 2001, NEW ENGL J MED, V344, P1117, DOI 10.1056/NEJM200104123441502; Sigwart U, 2002, LANCET, V360, P965; Teirstein PS, 2001, CIRCULATION, V104, P2620, DOI 10.1161/hc4601.099465; Tsuji Takafumi, 2003, Int J Cardiovasc Intervent, V5, P13	8	5	8	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 19	2003	327	7407					150	153		10.1136/bmj.327.7407.150	http://dx.doi.org/10.1136/bmj.327.7407.150			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702WJ	12869460	Green Published			2022-12-28	WOS:000184247500023
J	Kalra, PR; Collier, T; Cowie, MR; Fox, KF; Wood, DA; Poole-Wilson, PA; Coats, AJS; Sutton, GC				Kalra, PR; Collier, T; Cowie, MR; Fox, KF; Wood, DA; Poole-Wilson, PA; Coats, AJS; Sutton, GC			Haemoglobin concentration and prognosis in new cases of heart failure	LANCET			English	Article							ANEMIA; POPULATION	Anaemia is common in severe chronic heart failure and is reported to be a predictor of death. We investigated 552 patients (median age 76 years, range 29-95; 54% men [n=296]), in whom the duration of heart failure was sufficiently short that it would be unlikely to affect haemoglobin concentrations. By contrast with studies in established chronic heart failure, haemoglobin was not independently associated with prognosis when age and serum creatinine concentration were included in the analysis. The adverse effects of anaemia on survival might be a consequence of chronic heart failure rather than a separate process causing disease progression.	Natl Heart & Lung Inst, Imperial Coll Sch Med, London SW3 6LY, England; London Sch Hyg & Trop Med, Med Stat Unit, London WC1, England	Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Kalra, PR (corresponding author), Natl Heart & Lung Inst, Imperial Coll Sch Med, Dovehouse St, London SW3 6LY, England.		Cowie, Martin R/AAQ-2818-2020; Coats, Andrew J Stewart/E-4451-2012	Cowie, Martin R/0000-0001-7457-2552; Coats, Andrew J Stewart/0000-0002-2771-4260				Cowie MR, 2000, HEART, V83, P505, DOI 10.1136/heart.83.5.505; Cromie N, 2002, HEART, V87, P377, DOI 10.1136/heart.87.4.377; Fox KF, 2001, EUR HEART J, V22, P228, DOI 10.1053/euhj.2000.2289; Horwich TB, 2002, J AM COLL CARDIOL, V39, P1780, DOI 10.1016/S0735-1097(02)01854-5; Silverberg DS, 2000, J AM COLL CARDIOL, V35, P1737, DOI 10.1016/S0735-1097(00)00613-6	5	57	64	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 19	2003	362	9379					211	212		10.1016/S0140-6736(03)13912-8	http://dx.doi.org/10.1016/S0140-6736(03)13912-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702PJ	12885484				2022-12-28	WOS:000184232000013
J	Albrecht, C; Blank, K; Lalic-Multhaler, M; Hirler, S; Mai, T; Gilbert, I; Schiffmann, S; Bayer, T; Clausen-Schaumann, H; Gaub, HE				Albrecht, C; Blank, K; Lalic-Multhaler, M; Hirler, S; Mai, T; Gilbert, I; Schiffmann, S; Bayer, T; Clausen-Schaumann, H; Gaub, HE			DNA: A programmable force sensor	SCIENCE			English	Article							SINGLE; SPECTROSCOPY; MECHANICS	Direct quanti. cation of biomolecular interaction by single-molecule force spectroscopy has evolved into a powerful tool for materials and life sciences. We introduce an approach in which the unbinding forces required to break intermolecular bonds are measured in a differential format by comparison with a known reference bond (here, a short DNA duplex). In addition to a marked increase in sensitivity and force resolution, which enabled us to resolve single base pair mismatches, this concept allows for highly specific parallel assays. This option was exploited to overcome cross-reactions of antibodies in a protein biochip application.	Nanotype GmbH, D-82166 Grafelfing, Germany; Lehrstuhl Angew Phys, D-80799 Munich, Germany; Ctr Nanosci, D-80799 Munich, Germany	University of Munich; University of Munich	Clausen-Schaumann, H (corresponding author), Nanotype GmbH, Lochhamer Schlag 12, D-82166 Grafelfing, Germany.	hauke.clausen-schaumann@nanotype.de	Clausen-Schaumann, Hauke/W-1830-2017; Blank, Kerstin/C-6323-2008	Clausen-Schaumann, Hauke/0000-0002-9413-0310; Blank, Kerstin/0000-0001-5410-6984; Schiffmann, Susanne/0000-0001-5035-2504				Abbott A, 2002, NATURE, V415, P112, DOI 10.1038/415112a; Bernard A, 2001, ANAL CHEM, V73, P8, DOI 10.1021/ac0008845; Bockelmann U, 1997, PHYS REV LETT, V79, P4489, DOI 10.1103/PhysRevLett.79.4489; Bustamante C, 2000, NAT REV MOL CELL BIO, V1, P130, DOI 10.1038/35040072; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Clausen-Schaumann H, 2000, CURR OPIN CHEM BIOL, V4, P524, DOI 10.1016/S1367-5931(00)00126-5; Cutler P, 2003, PROTEOMICS, V3, P3, DOI 10.1002/pmic.200390007; EKINS RP, 1994, TRENDS BIOTECHNOL, V12, P89, DOI 10.1016/0167-7799(94)90111-2; EKINS RP, 1989, J PHARMACEUT BIOMED, V7, P155, DOI 10.1016/0731-7085(89)80079-2; EssevazRoulet B, 1997, P NATL ACAD SCI USA, V94, P11935, DOI 10.1073/pnas.94.22.11935; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Gittes F, 1998, EUR BIOPHYS J BIOPHY, V27, P75, DOI 10.1007/s002490050113; Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727; HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/RevModPhys.62.251; Hugel T, 2002, SCIENCE, V296, P1103, DOI 10.1126/science.1069856; Janshoff A, 2000, ANGEW CHEM INT EDIT, V39, P3213; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; Krautbauer R, 2003, NANO LETT, V3, P493, DOI 10.1021/nl034049p; KUMAR A, 1995, ACCOUNTS CHEM RES, V28, P219, DOI 10.1021/ar00053a003; Lavery R, 2002, J PHYS-CONDENS MAT, V14, pR383, DOI 10.1088/0953-8984/14/14/202; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037; Mehta AD, 1999, SCIENCE, V283, P1689, DOI 10.1126/science.283.5408.1689; Mendoza LG, 1999, BIOTECHNIQUES, V27, P778, DOI 10.2144/99274rr01; Merkel R, 2001, PHYS REP, V346, P344; Mitchell P, 2002, NAT BIOTECHNOL, V20, P225, DOI 10.1038/nbt0302-225; MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660; Naef F, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.040902; Nollau P, 1997, J Int Fed Clin Chem, V9, P162; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143; Petach H, 2002, CURR OPIN BIOTECH, V13, P309, DOI 10.1016/S0958-1669(02)00329-4; PORSCHKE D, 1971, J MOL BIOL, V62, P361, DOI 10.1016/0022-2836(71)90433-5; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1999, NAT STRUCT BIOL, V6, P346; SCHILDKRAUT C, 1965, BIOPOLYMERS, V3, P195, DOI 10.1002/bip.360030207; Schwesinger F, 2000, P NATL ACAD SCI USA, V97, P9972, DOI 10.1073/pnas.97.18.9972; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Strunz T, 1999, P NATL ACAD SCI USA, V96, P11277, DOI 10.1073/pnas.96.20.11277; Viani MB, 1999, J APPL PHYS, V86, P2258, DOI 10.1063/1.371039; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153	43	139	146	3	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2003	301	5631					367	370		10.1126/science.1084713	http://dx.doi.org/10.1126/science.1084713			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869761				2022-12-28	WOS:000184207300044
J	Schultz, TF; Kay, SA				Schultz, TF; Kay, SA			Circadian clocks in daily and seasonal control of development	SCIENCE			English	Review							QUANTITATIVE TRAIT LOCUS; PHOTOPERIOD SENSITIVITY; TIME MEASUREMENT; FLOWERING TIME; ARABIDOPSIS; PROTEIN; RICE; GENE; PATHWAYS; MUTATION	The rotation of the earth results in regular changes in the light environment, and organisms have evolved a molecular oscillator that allows them to anticipate these changes. This daily molecular oscillator, known as the circadian clock, regulates a diverse array of physiologies across a wide variety of organisms. This review highlights a few of the insights we have into circadian clock regulation of development, in both plants and animals. A common thread linking plants and animals is the use of the circadian clock to sense changes in day length and to mediate a diverse number of photoperiodic responses.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Kay, SA (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torey Pines Rd, La Jolla, CA 92037 USA.	stevek@scripps.edu	Kay, Steve A/F-6025-2011	Kay, Steve A/0000-0002-0402-2878; Schultz, Thomas/0000-0001-9694-9920				Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Beaver LM, 2002, P NATL ACAD SCI USA, V99, P2134, DOI 10.1073/pnas.032426699; Dowson-Day MJ, 1999, PLANT J, V17, P63, DOI 10.1046/j.1365-313X.1999.00353.x; Goldman BD, 2001, J BIOL RHYTHM, V16, P283, DOI 10.1177/074873001129001980; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kazimi N, 1999, DEV BRAIN RES, V117, P47, DOI 10.1016/S0165-3806(99)00096-6; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Liu XL, 2001, PLANT CELL, V13, P1293, DOI 10.1105/tpc.13.6.1293; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Mas P, 2003, PLANT CELL, V15, P223, DOI 10.1105/tpc.006734; McWatters HG, 2000, NATURE, V408, P716, DOI 10.1038/35047079; Millar AJ, 1996, P NATL ACAD SCI USA, V93, P15491, DOI 10.1073/pnas.93.26.15491; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Myers EM, 2003, CURR BIOL, V13, P526, DOI 10.1016/S0960-9822(03)00167-2; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Nitabach MN, 2002, NAT GENET, V32, P559, DOI 10.1038/ng1202-559; Poethig RS, 2003, SCIENCE, V301, P334, DOI 10.1126/science.1085328; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Saunders D. S., 1997, Invertebrate Neuroscience, V3, P155, DOI 10.1007/BF02480370; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Shimomura K, 1997, J BIOL RHYTHM, V12, P423, DOI 10.1177/074873049701200504; Somers DE, 1998, DEVELOPMENT, V125, P485; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Sugano S, 1999, P NATL ACAD SCI USA, V96, P12362, DOI 10.1073/pnas.96.22.12362; Takahashi Y, 2001, P NATL ACAD SCI USA, V98, P7922, DOI 10.1073/pnas.111136798; Tauber E, 2001, J BIOL RHYTHM, V16, P381, DOI 10.1177/074873001129002088; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996	30	74	82	3	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2003	301	5631					326	328		10.1126/science.1085935	http://dx.doi.org/10.1126/science.1085935			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869749				2022-12-28	WOS:000184207300029
J	Kulasingam, SL; Myers, ER				Kulasingam, SL; Myers, ER			Potential health and economic impact of adding a human papillomavirus vaccine to screening programs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATYPICAL SQUAMOUS CELLS; CERVICAL-CANCER; COST-EFFECTIVENESS; NATURAL-HISTORY; FOLLOW-UP; STRATEGIES; NEOPLASIA; BENEFITS; WOMEN; ABNORMALITIES	Context Recently published results suggest that effective vaccines against cervical cancer-associated human papillomavirus (HPV) may become available within the next decade. Objective To examine the potential health and economic effects of an HPV vaccine in a setting of existing screening. Design, Setting, and Population A Markov model was used to estimate the lifetime (age 12-85 years) costs and life expectancy of a hypothetical cohort of women screened for cervical cancer in the United States. Three strategies were compared: (1) vaccination only; (2) conventional cytological screening only; and (3) vaccination followed by screening. Two of the strategies incorporated a vaccine targeted against a defined proportion of high-risk (oncogenic) HPV types. Screening intervals of 1, 2, 3, and 5 years and starting ages for screening of 18, 22, 24, 26, and 30 years were chosen for 2 of the strategies (conventional cytological screening only and vaccination followed by screening). Main Outcome Measures Incremental cost per life-year gained. Results Vaccination only or adding vaccination to screening conducted every 3 and 5 years was not cost-effective. However, at more frequent screening intervals, strategies combining vaccination and screening were preferred. Vaccination plus biennial screening delayed until age 24 years had the most attractive cost-effectiveness ratio ($44889) compared with screening only beginning at age 18 years and conducted every 3 years. However, the strategy of vaccination with annual screening beginning at age 18 years had the largest overall reduction in cancer incidence and mortality at a cost of $236250 per life-year gained compared with vaccination and annual screening beginning at age 22 years. The cost-effectiveness of vaccination plus delayed screening was highly sensitive to age of vaccination, duration of vaccine efficacy, and cost of vaccination. Conclusions Vaccination for HPV in combination with screening can be a cost-effective health intervention, but it depends on maintaining effectiveness during the ages of peak oncogenic HPV incidence. Identifying the optimal age for vaccination should be a top research priority.	Duke Univ, Ctr Clin Hlth Policy Res, Durham, NC 27705 USA; Duke Univ, Dept Obstet & Gynecol, Durham, NC 27705 USA	Duke University; Duke University	Kulasingam, SL (corresponding author), Duke Univ, Ctr Clin Hlth Policy Res, 1st Union Tower,Suite 220,2200 W Main St, Durham, NC 27705 USA.	kulas002@mc.duke.edu		Kulasingam, Shalini/0000-0002-0932-9166				ANDERSON RM, 1995, P ROY SOC B-BIOL SCI, V261, P147, DOI 10.1098/rspb.1995.0129; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Brown AD, 1999, JAMA-J AM MED ASSOC, V281, P347, DOI 10.1001/jama.281.4.347; Conaglen HM, 2001, INT J STD AIDS, V12, P651, DOI 10.1258/0956462011923877; Coste J, 2003, BMJ-BRIT MED J, V326, P733, DOI 10.1136/bmj.326.7392.733; Crum CP, 2002, NEW ENGL J MED, V347, P1702; CUZICK J, 1995, LANCET, V345, P1533, DOI 10.1016/S0140-6736(95)91086-7; EDDY DM, 1990, ANN INTERN MED, V113, P214, DOI 10.7326/0003-4819-113-3-214; FAHS MC, 1992, ANN INTERN MED, V117, P520, DOI 10.7326/0003-4819-117-6-520; Gold MR, 1996, COST EFFECTIVENESS H; Goldie SJ, 2001, JAMA-J AM MED ASSOC, V285, P3107, DOI 10.1001/jama.285.24.3107; Gustafsson L, 1997, CANCER CAUSE CONTROL, V8, P755, DOI 10.1023/A:1018435522475; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Hueston WJ, 2000, J COMMUN HEALTH, V25, P23, DOI 10.1023/A:1005136817158; Hughes JP, 2002, EPIDEMIOLOGY, V13, P631, DOI 10.1097/00001648-200211000-00006; Jacobs MV, 2000, INT J CANCER, V87, P221, DOI 10.1002/1097-0215(20000715)87:2&lt;221::AID-IJC11&gt;3.0.CO;2-2; Jones MH, 1996, J ROY SOC MED, V89, P257, DOI 10.1177/014107689608900506; Kim JJ, 2002, JAMA-J AM MED ASSOC, V287, P2382, DOI 10.1001/jama.287.18.2382; Klee M, 2000, GYNECOL ONCOL, V76, P5, DOI 10.1006/gyno.1999.5644; Koutsky LA, 2000, J NATL CANCER I, V92, P397, DOI 10.1093/jnci/92.5.397; KOUTSKY LA, 1992, NEW ENGL J MED, V327, P1272, DOI 10.1056/NEJM199210293271804; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; KULASINGAM S, 2002, 20 INT PAP C OCT 5 9; Kulasingam SL, 2002, JAMA-J AM MED ASSOC, V288, P1749, DOI 10.1001/jama.288.14.1749; LEIGH BC, 1994, J ADOLESCENT HEALTH, V15, P117, DOI 10.1016/1054-139X(94)90538-X; Li CR, 1999, MATURITAS, V32, P95, DOI 10.1016/S0378-5122(99)00020-1; Liaw KL, 1999, J NATL CANCER I, V91, P954, DOI 10.1093/jnci/91.11.954; Mandelblatt JS, 2002, JAMA-J AM MED ASSOC, V287, P2372, DOI 10.1001/jama.287.18.2372; Maxwell GL, 2002, OBSTET GYNECOL, V100, P740, DOI 10.1016/S0029-7844(02)02195-6; MCCRORY DC, 1999, PUBLICATION AG HLTH; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Myers ER, 2000, OBSTET GYNECOL, V96, P645, DOI 10.1016/S0029-7844(00)00979-0; Myers ER, 2000, AM J EPIDEMIOL, V151, P1158, DOI 10.1093/oxfordjournals.aje.a010166; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; *NAT CANC I, 2000, SURV EP END RES; Obwegeser JH, 2001, ACTA CYTOL, V45, P709, DOI 10.1159/000328292; PHELPS CE, 1988, MED DECIS MAKING, V8, P279, DOI 10.1177/0272989X8800800409; Ratnam S, 2000, CANCER EPIDEM BIOMAR, V9, P945; Saslow D, 2002, CA-CANCER J CLIN, V52, P342, DOI 10.3322/canjclin.52.6.342; SherlawJohnson C, 1997, INT J CANCER, V72, P210, DOI 10.1002/(SICI)1097-0215(19970717)72:2&lt;210::AID-IJC2&gt;3.0.CO;2-U; Solomon D, 2001, J NATL CANCER I, V93, P293, DOI 10.1093/jnci/93.4.293; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Stratton KR, 2001, VACCINES 21 CENTURY; Thomas KK, 2000, J INFECT DIS, V182, P1097, DOI 10.1086/315805; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Winkelmayer WC, 2002, MED DECIS MAKING, V22, P417, DOI 10.1177/027298902236927	46	248	254	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2003	290	6					781	789		10.1001/jama.290.6.781	http://dx.doi.org/10.1001/jama.290.6.781			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	709VU	12915431	Bronze			2022-12-28	WOS:000184647700029
J	McWilliams, JM; Zaslavsky, AM; Meara, E; Ayanian, JZ				McWilliams, JM; Zaslavsky, AM; Meara, E; Ayanian, JZ			Impact of Medicare coverage on basic clinical services for previously uninsured adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-INSURANCE COVERAGE; RIGHT HEART CATHETERIZATION; SUPPLEMENTAL INSURANCE; PREVENTIVE-SERVICES; ELDERLY PATIENTS; MAMMOGRAPHY; CARE; CANCER; TERMINATION; PREDICTORS	Context Uninsured adults receive less appropriate care and have more adverse health consequences than insured adults. Longitudinal studies would help to more clearly define the effects of health insurance on health care and health. Objective To assess the differential effects of gaining Medicare coverage on use of basic clinical services and medications by previously insured and uninsured adults. Design and Setting Household survey data from the nationally representative Health and Retirement Study were used to analyze differences in receipt of basic clinical services by adults in 1996 and 2000, before and after becoming eligible for Medicare at age 65 years. Participants A total of 2203 adults aged 60 to 64 years in 1996 who were classified as continuously uninsured (n=167), intermittently uninsured (n=216), or continuously insured (n=1820) in 1994 and 1996, prior to Medicare eligibility. Main Outcome Measures Individuals' reports of receiving cholesterol testing, mammography (in women), prostate examination (in men), and treatment of arthritis and hypertension in the prior 2 years. Results The difference in cholesterol testing between continuously insured and continuously uninsured adults was significantly reduced after Medicare eligibility (35.4% vs 17.7%; change of -17.7% [95% Cl, -29.3 % to -6.2%]; P=.003), and the reduction was substantially greater among those with hypertension or diabetes than among other adults (29.2% vs 7.7%; difference of 21.5% [95% Cl, 0.2% to 42.9%1; P=.048). Differences in use were similarly reduced after Medicare eligibility for mammography in women (30.3% vs 15.0%; change of -15.3% [95% Cl, -29.9% to -0.7%1; P=.04) and prostate examination in men (45.2% vs 20.0%; change of -25.2% [95% Cl, -45.4% to -5.1 %]; P=.01). Continuously uninsured adults with arthritis reported significantly greater increases in arthritis-related medical visits and limitations of activity than continuously insured adults after Medicare eligibility, but not greater increases in arthritis treatments. Among adults with hypertension, differences in use of antihypertensive medications between continuously uninsured and insured adults were essentially unchanged after Medicare coverage. Conclusions Previously uninsured adults substantially increased their use of covered basic clinical services but not medications after gaining Medicare coverage. An affordable option through which near-elderly uninsured adults could purchase Medicare coverage might have similar effects.	Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Gen Med & Primary Care, Boston, MA 02115 USA; Natl Bur Econ Res, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; National Bureau of Economic Research	Ayanian, JZ (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	ayanian@hcp.med.harvard.edu		Meara, Ellen/0000-0003-0211-1970				Ayanian JZ, 2000, JAMA-J AM MED ASSOC, V284, P2061, DOI 10.1001/jama.284.16.2061; AYANIAN JZ, 1993, NEW ENGL J MED, V329, P326, DOI 10.1056/NEJM199307293290507; Ayanian JZ, 2002, NEW ENGL J MED, V347, P1678, DOI 10.1056/NEJMsa020080; AYANIAN JZ, IN PRESS AM J PUBLIC; Baker DW, 2001, NEW ENGL J MED, V345, P1106, DOI 10.1056/NEJMsa002887; BLUSTEIN J, 1995, NEW ENGL J MED, V332, P1138, DOI 10.1056/NEJM199504273321706; BOWLIN SJ, 1993, J CLIN EPIDEMIOL, V46, P561, DOI 10.1016/0895-4356(93)90129-O; BRENNAN N, 2000, NEW FEDERALISM NAT B; Brown ME, 1998, MED CARE RES REV, V55, P177, DOI 10.1177/107755879805500203; Chulis G S, 1993, Health Care Financ Rev, V14, P163; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; *COMM FUND COMM EL, 1993, UNF AG IMPR WELL BEI; Connors AF, 1996, JAMA-J AM MED ASSOC, V276, P889, DOI 10.1001/jama.276.11.889; Cummings DM, 2000, ARCH FAM MED, V9, P870, DOI 10.1001/archfami.9.9.870; Davis K, 1997, HEALTH SERV RES, V31, P641; Decker S., 2002, 8761 NAT BUR EC RES; DEGNAN D, 1992, AM J PUBLIC HEALTH, V82, P1386, DOI 10.2105/AJPH.82.10.1386; Federman AD, 2001, JAMA-J AM MED ASSOC, V286, P1732, DOI 10.1001/jama.286.14.1732; Feinberg E, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e29; FIHN SD, 1988, J GEN INTERN MED, V3, P356, DOI 10.1007/BF02595794; Harris R, 2002, ANN INTERN MED, V137, P917, DOI 10.7326/0003-4819-137-11-200212030-00014; Heeringa S.G., 1995, TECHNICAL DESCRIPTIO; Huttin C, 2000, CLIN DRUG INVEST, V20, P181, DOI 10.2165/00044011-200020030-00006; Institute of Medicine, 2002, CAR COV TOO LITTL TO; Institute of Medicine, 2001, COV MATT INS HLTH CA; Johnson RW, 1997, HEALTH CARE FINANC R, V18, P123; JOHNSON RW, 2002, MED BUY IN NEAR ELDE; Kasper JD, 2000, MED CARE RES REV, V57, P298, DOI 10.1177/107755870005700302; Kinsella K., 2001, AGEING WORLD, DOI [10.1037/e407472005-001, DOI 10.1037/E407472005-001]; LANDRUM MB, 2001, HLTH SERV OUTCOMES R, V2, P221, DOI DOI 10.1023/A:1020367111374; Lemon S, 2001, AM J PUBLIC HEALTH, V91, P1264, DOI 10.2105/AJPH.91.8.1264; LURIE N, 1984, NEW ENGL J MED, V311, P480, DOI 10.1056/NEJM198408163110735; LURIE N, 1986, NEW ENGL J MED, V314, P1266, DOI 10.1056/NEJM198605083141934; MEYER BD, 1995, J BUS ECON STAT, V13, P151, DOI 10.2307/1392369; Pearlman DN, 1996, AM J PREV MED, V12, P327, DOI 10.1016/S0749-3797(18)30287-3; Petersen LA, 2000, NEW ENGL J MED, V343, P1934, DOI 10.1056/NEJM200012283432606; Polanczyk CA, 2001, JAMA-J AM MED ASSOC, V286, P309, DOI 10.1001/jama.286.3.309; Powell-Griner E, 1999, AM J PUBLIC HEALTH, V89, P882, DOI 10.2105/AJPH.89.6.882; RHOADES J, 2000, AHRQ PUBLICATION, V23; RHOADES J, 2001, AHRQ PUBLICATION; Roetzheim RG, 1999, J NATL CANCER I, V91, P1409, DOI 10.1093/jnci/91.16.1409; Sarndal C.-E., 1991, MODEL ASSISTED SURVE; Schoen C, 2000, HEALTH SERV RES, V35, P187; SCHOEN C, 2000, COUNTING MED PERSPEC; Shea DG, 2001, HEALTH AFFAIR, V20, P219, DOI 10.1377/hlthaff.20.1.219; SHEILS J, 2001, MED BUY IN OPTIONS E; Sudano JJ, 2003, AM J PUBLIC HEALTH, V93, P130, DOI 10.2105/AJPH.93.1.130; Sundararajan V, 2002, ANN INTERN MED, V136, P349, DOI 10.7326/0003-4819-136-5-200203050-00007; *US GEN ACC OFF, 2001, GAO01374 US GEN ACC; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18	50	148	148	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2003	290	6					757	764		10.1001/jama.290.6.757	http://dx.doi.org/10.1001/jama.290.6.757			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	709VU	12915428				2022-12-28	WOS:000184647700026
J	Sheridan, RL				Sheridan, RL			Burn care - Results of technical and organizational progress	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TOXIC EPIDERMAL NECROLYSIS; ACUTE HAND BURNS; HYPERBARIC-OXYGEN; 10-YEAR EXPERIENCE; CHILDREN; MANAGEMENT; INJURIES; TRIAL		Shriners Hosp Children, Burn Surg Serv, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Surg, Div Burns & Trauma, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Sheridan, RL (corresponding author), Shriners Hosp Children, Burn Surg Serv, 51 Blossom St, Boston, MA 02114 USA.	rsheridan@partners.org						American Burn Association/American College of Surgeons, 1995, B AM COLL SURG, V80, P34; Brannen AL, 1997, AM SURGEON, V63, P205; Brigham Peter A., 1996, Journal of Burn Care and Rehabilitation, V17, P95, DOI 10.1097/00004630-199603000-00003; Celis MM, 2003, J BURN CARE REHABIL, V24, P57, DOI 10.1097/00004630-200301000-00014; Debroy MA, 1999, J TRAUMA, V47, P904, DOI 10.1097/00005373-199911000-00015; Herndon DN, 2001, NEW ENGL J MED, V345, P1223, DOI 10.1056/NEJMoa010342; Herndon DN, 1996, HORM RES, V45, P29, DOI 10.1159/000184825; Janzekovic Z, 1970, J Trauma, V10, P1103; Palmieri TL, 2002, J BURN CARE REHABIL, V23, P87, DOI 10.1097/00004630-200203000-00004; Radke A, 2000, CRIT CARE MED, V28, P3224, DOI 10.1097/00003246-200009000-00018; Ryan CM, 1998, NEW ENGL J MED, V338, P362, DOI 10.1056/NEJM199802053380604; Saxe G, 2001, J AM ACAD CHILD PSY, V40, P915, DOI 10.1097/00004583-200108000-00013; Scheinkestel CD, 1999, MED J AUSTRALIA, V170, P203, DOI 10.5694/j.1326-5377.1999.tb140318.x; Sheridan R, 1999, J BURN CARE REHABIL, V20, P347, DOI 10.1097/00004630-199909000-00002; Sheridan R. L., 1997, Journal of Burn Care and Rehabilitation, V18, P455; Sheridan RL, 2000, JAMA-J AM MED ASSOC, V283, P69, DOI 10.1001/jama.283.1.69; Sheridan RL, 1999, J TRAUMA, V47, P426, DOI 10.1097/00005373-199908000-00045; SHERIDAN RL, 1995, J TRAUMA, V38, P406, DOI 10.1097/00005373-199503000-00022; Sheridan RL, 2000, ARCH PEDIAT ADOL MED, V154, P245, DOI 10.1001/archpedi.154.3.245; Sheridan RL, 2002, PEDIATRICS, V109, P74, DOI 10.1542/peds.109.1.74; Sheridan RL, 1999, BURNS, V25, P97, DOI 10.1016/S0305-4179(98)00176-4; Sheridan RL, 2001, CURR PROB SURG, V38, P657, DOI 10.1067/msg.2001.115979; Sheridan RL, 2001, NEW ENGL J MED, V345, P1271, DOI 10.1056/NEJM200110253451710; Sheridan RL, 2001, BURNS, V27, P272, DOI 10.1016/S0305-4179(00)00110-8; Sheridan RL, 1999, ANN SURG, V229, P558, DOI 10.1097/00000658-199904000-00016; Sheridan Robert L., 2001, Pediatr Crit Care Med, V2, P223, DOI 10.1097/00130478-200107000-00006; Spies M, 2003, LANCET, V361, P989, DOI 10.1016/S0140-6736(03)12824-3; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121; Yu YM, 1996, AM J CLIN NUTR, V64, P60, DOI 10.1093/ajcn/64.1.60	29	57	62	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2003	290	6					719	722		10.1001/jama.290.6.719	http://dx.doi.org/10.1001/jama.290.6.719			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	709VU	12915409				2022-12-28	WOS:000184647700002
J	Celeste, A; Difilippantonio, S; Difilippantonio, MJ; Fernandez-Capetillo, O; Pilch, DR; Sedelnikova, OA; Eckhaus, M; Ried, T; Bonner, WM; Nussenzweig, A				Celeste, A; Difilippantonio, S; Difilippantonio, MJ; Fernandez-Capetillo, O; Pilch, DR; Sedelnikova, OA; Eckhaus, M; Ried, T; Bonner, WM; Nussenzweig, A			H2AX haploinsufficiency modifies genomic stability and tumor susceptibility	CELL			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2AX; CHROMOSOMAL-ABERRATIONS; HAPLO-INSUFFICIENCY; V(D)J RECOMBINATION; GENE AMPLIFICATION; DNA; MICE; P53; REPAIR	Histone H2AX becomes phosphorylated in chromatin domains flanking sites of DNA double-strand breakage associated with gamma-irradiation, meiotic recombination, DNA replication, and antigen receptor rearrangements. Here, we show that loss of a single H2AX allele compromises genomic integrity and enhances the susceptibility to cancer in the absence of p53. In comparison with heterozygotes, tumors arise earlier in the H2AX homozygous null background, and H2AX(-/-) p53(-/-) lymphomas harbor an increased frequency of clonal nonreciprocal translocations and amplifications. These include complex rearrangements that juxtapose the c-myc oncogene to antigen receptor loci. Restoration of the H2AX null allele with wild-type H2AX restores genomic stability and radiation resistance, but this effect is abolished by substitution of the conserved serine phosphorylation sites in H2AX with alanine or glutamic acid residues. Our results establish H2AX as genomic caretaker that requires the function of both gene alleles for optimal protection against tumorigenesis.	NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; NCI, Genet Branch, NIH, Bethesda, MD 20892 USA; NIH, Vet Resources Program, Off Res Serv, Bethesda, MD 20892 USA; NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Nussenzweig, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA.	andre_nussenzweig@nih.gov	Difilippantonio, Michael/AAF-2839-2021; Fernandez-Capetillo, Oscar/H-3508-2015	Difilippantonio, Michael/0000-0002-4676-7034; Fernandez-Capetillo, Oscar/0000-0002-2690-6885; Martin (nee Sedelnikova), Olga/0000-0003-3470-2935	Intramural NIH HHS [Z99 CA999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Agrawal A, 1997, CELL, V89, P43, DOI 10.1016/S0092-8674(00)80181-6; Alt JR, 2003, EMBO J, V22, P1442, DOI 10.1093/emboj/cdg133; Bai F, 2003, MOL CELL BIOL, V23, P1269, DOI 10.1128/MCB.23.4.1269-1277.2003; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Cook WD, 2000, ONCOGENE, V19, P3434, DOI 10.1038/sj.onc.1203653; Coquelle A, 1997, CELL, V89, P215, DOI 10.1016/S0092-8674(00)80201-9; Desiderio S, 1996, CURR TOP MICROBIOL, V217, P45; Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Essers J, 1997, CELL, V89, P195, DOI 10.1016/S0092-8674(00)80199-3; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Gladdy RA, 2003, CANCER CELL, V3, P37, DOI 10.1016/S1535-6108(02)00236-2; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Goss KH, 2002, SCIENCE, V297, P2051, DOI 10.1126/science.1074340; Gruber SB, 2002, SCIENCE, V297, P2013, DOI 10.1126/science.1074399; Guidos CJ, 1996, GENE DEV, V10, P2038, DOI 10.1101/gad.10.16.2038; Hiom K, 1998, MOL CELL, V1, P1011, DOI 10.1016/S1097-2765(00)80101-X; Inoue K, 2001, GENE DEV, V15, P2934, DOI 10.1101/gad.929901; Karanjawala ZE, 1999, CURR BIOL, V9, P1501, DOI 10.1016/S0960-9822(00)80123-2; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; KNUDSON AG, 1985, CANCER RES, V45, P1437; Lim DS, 2000, MOL CELL BIOL, V20, P3772, DOI 10.1128/MCB.20.11.3772-3780.2000; Liyanage M, 1996, NAT GENET, V14, P312, DOI 10.1038/ng1196-312; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Magee JA, 2003, CANCER CELL, V3, P273, DOI 10.1016/S1535-6108(03)00047-3; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Mak TW, 2000, NAT IMMUNOL, V1, P77, DOI 10.1038/76950; Monni O, 2001, LEUKEMIA LYMPHOMA, V40, P259, DOI 10.3109/10428190109057924; Nacht M, 1996, GENE DEV, V10, P2055, DOI 10.1101/gad.10.16.2055; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Quon KC, 2001, GENE DEV, V15, P2917, DOI 10.1101/gad.949001; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Sharpless NE, 2001, MOL CELL, V8, P1187, DOI 10.1016/S1097-2765(01)00425-7; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Stankovic T, 2002, LEUKEMIA LYMPHOMA, V43, P1563, DOI 10.1080/1042819021000002884; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Vanasse GJ, 1999, J CLIN INVEST, V103, P1669, DOI 10.1172/JCI6658; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Weaver ZA, 1999, GENE CHROMOSOME CANC, V25, P251, DOI 10.1002/(SICI)1098-2264(199907)25:3<251::AID-GCC7>3.0.CO;2-3; Xu Y, 1998, MOL CELL BIOL, V18, P4385, DOI 10.1128/MCB.18.7.4385; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	62	457	477	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 8	2003	114	3					371	383		10.1016/S0092-8674(03)00567-1	http://dx.doi.org/10.1016/S0092-8674(03)00567-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914701	Bronze, Green Accepted			2022-12-28	WOS:000184679200013
J	Green, PHR; Jabri, B				Green, PHR; Jabri, B			Coeliac disease	LANCET			English	Review							TISSUE TRANSGLUTAMINASE ANTIBODIES; MAJOR HISTOCOMPATIBILITY COMPLEX; GLUTEN-FREE DIET; QUALITY-OF-LIFE; REFRACTORY SPRUE; INTRAEPITHELIAL LYMPHOCYTES; CLINICAL PRESENTATION; GLIADIN PEPTIDES; ADULT-POPULATION; LINKAGE ANALYSIS	Coeliac disease is a genetically-determined chronic inflammatory intestinal disease induced by an environmental precipitant, gluten. Patients with the disease might have mainly non-gastrointestinal symptoms, and as a result patients present to various medical practitioners. Epidemiological studies have shown that coeliac disease is very common and affects about one in 250 people. The disease is associated with an increased rate of osteoporosis, infertility, autoimmune diseases, and malignant disease, especially lymphomas. The mechanism of the intestinal immune-mediated response is not completely clear, but involves an HLA-DQ2 or HLA-DQ8 restricted T-cell immune reaction in the lamina propria as well as an immune reaction in the intestinal epithelium. An important component of the disease is the intraepithelial lymphocyte that might become clonally expanded in refractory sprue and enteropathy-associated T-cell lymphoma. Study of the mechanism of the immune response in coeliac disease could provide Insight into the mechanism of inflammatory and autoimmune responses and lead to innovations in treatment.	Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Univ Chicago, Dept Pathol Med & Pediat, Chicago, IL 60637 USA	Columbia University; University of Chicago	Green, PHR (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, 161 Ft Washington Ave,Room 645, New York, NY 10032 USA.	pg11@columbia.edu						AINE L, 1990, J ORAL PATHOL MED, V19, P241, DOI 10.1111/j.1600-0714.1990.tb00834.x; Alaedini A, 2002, J NEUROIMMUNOL, V127, P145, DOI 10.1016/S0165-5728(02)00102-9; Anderson RP, 2000, NAT MED, V6, P337, DOI 10.1038/73200; Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; *ASS AG, 2001, GASTROENTEROLOGY, V120, P1522; Bagdi E, 1999, BLOOD, V94, P260, DOI 10.1182/blood.V94.1.260.413k40_260_264; BARDELLA MT, 1995, HEPATOLOGY, V22, P833, DOI 10.1002/hep.1840220322; Bevan S, 1999, J MED GENET, V36, P687; BODVARSSON S, 1993, SCAND J IMMUNOL, V38, P546, DOI 10.1111/j.1365-3083.1993.tb03239.x; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; CAMPBELL CB, 1977, MED J AUSTRALIA, V1, P89, DOI 10.5694/j.1326-5377.1977.tb130530.x; Carbonnel F, 1998, BLOOD, V92, P3879, DOI 10.1182/blood.V92.10.3879.422k34_3879_3886; Carroccio A, 2001, GUT, V49, P506, DOI 10.1136/gut.49.4.506; Carroccio A, 1995, DIGEST DIS SCI, V40, P2555, DOI 10.1007/BF02220441; Cataldo F, 1998, GUT, V42, P362, DOI 10.1136/gut.42.3.362; Cataldo F, 2000, GUT, V47, P366, DOI 10.1136/gut.47.3.366; Catassi C, 1996, ACTA PAEDIATR, V85, P29, DOI 10.1111/j.1651-2227.1996.tb14244.x; Catassi C, 1999, LANCET, V354, P647, DOI 10.1016/S0140-6736(99)02609-4; Catassi C, 2002, JAMA-J AM MED ASSOC, V287, P1413, DOI 10.1001/jama.287.11.1413; Cellier C, 1998, GASTROENTEROLOGY, V114, P471, DOI 10.1016/S0016-5085(98)70530-X; Cellier C, 2000, LANCET, V356, P203, DOI 10.1016/S0140-6736(00)02481-8; Chin RL, 2003, NEUROLOGY, V60, P1581, DOI 10.1212/01.WNL.0000063307.84039.C7; CHOTT A, 1992, AM J PATHOL, V141, P1361; Ciacci C, 1996, AM J GASTROENTEROL, V91, P718; Ciacci C, 1998, EUR J GASTROEN HEPAT, V10, P649; COLLIN P, 1994, GUT, V35, P1215, DOI 10.1136/gut.35.9.1215; Collin P, 1996, GUT, V39, P382, DOI 10.1136/gut.39.3.382; Collin P, 1997, SCAND J GASTROENTERO, V32, P1129, DOI 10.3109/00365529709002992; Corazza GR, 1997, LANCET, V350, P106, DOI 10.1016/S0140-6736(97)01042-8; Corazza GR, 1996, BONE, V18, P525, DOI 10.1016/8756-3282(96)00071-3; Corrao G, 2001, LANCET, V358, P356, DOI 10.1016/S0140-6736(01)05554-4; Cottone M, 1999, DIGEST DIS SCI, V44, P2538, DOI 10.1023/A:1026655609906; COUNSELL CE, 1994, GUT, V35, P844, DOI 10.1136/gut.35.6.844; Dahele AVM, 2001, QJM-INT J MED, V94, P195, DOI 10.1093/qjmed/94.4.195; de Serre NPM, 2000, HISTOPATHOLOGY, V37, P70, DOI 10.1046/j.1365-2559.2000.00926.x; DERITIS G, 1988, GASTROENTEROLOGY, V94, P41, DOI 10.1016/0016-5085(88)90607-5; Dickey W, 2000, SCAND J GASTROENTERO, V35, P181; Dickey W, 1998, GUT, V43, P300, DOI 10.1136/gut.43.2.300; Dickey W, 2001, SCAND J GASTROENTERO, V36, P511, DOI 10.1080/003655201750153359; Dickey W, 1997, J CLIN GASTROENTEROL, V25, P328, DOI 10.1097/00004836-199707000-00006; Dieterich W, 1998, GASTROENTEROLOGY, V115, P1317, DOI 10.1016/S0016-5085(98)70007-1; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; EGAN LJ, 1995, J CLIN GASTROENTEROL, V21, P123, DOI 10.1097/00004836-199509000-00012; FARTHING MJG, 1982, GUT, V23, P608, DOI 10.1136/gut.23.7.608; Fasano A, 2000, LANCET, V355, P1518, DOI 10.1016/S0140-6736(00)02169-3; Fasano A, 2001, GASTROENTEROLOGY, V120, P636, DOI 10.1053/gast.2001.22123; Fehniger TA, 2001, BLOOD CELL MOL DIS, V27, P223, DOI 10.1006/bcmd.2001.0379; Fickling WE, 2001, POSTGRAD MED J, V77, P33, DOI 10.1136/pmj.77.903.33; Fine KD, 1998, HUM PATHOL, V29, P1433, DOI 10.1016/S0046-8177(98)90012-0; Fonager K, 1999, LANCET, V354, P1561, DOI 10.1016/S0140-6736(05)76595-8; Frustaci A, 2002, CIRCULATION, V105, P2611, DOI 10.1161/01.CIR.0000017880.86166.87; Gale L, 1997, GUT, V40, P492, DOI 10.1136/gut.40.4.492; Gandolfi L, 2000, AM J GASTROENTEROL, V95, P689, DOI 10.1111/j.1572-0241.2000.01847.x; Gillett HR, 2002, GASTROENTEROLOGY, V122, P800, DOI 10.1053/gast.2002.31874; Greco L, 2002, GUT, V50, P624, DOI 10.1136/gut.50.5.624; Greco L, 1998, AM J HUM GENET, V62, P669, DOI 10.1086/301754; Green PHR, 2000, GASTROINTEST ENDOSC, V51, P60, DOI 10.1016/S0016-5107(00)70389-0; Green PHR, 2003, GASTROENTEROLOGY, V124, P585, DOI 10.1053/gast.2003.50084; Green PHR, 2002, GASTROENTEROL CLIN N, V31, P625, DOI 10.1016/S0889-8553(02)00010-9; Green PHR, 2001, AM J GASTROENTEROL, V96, P126, DOI 10.1111/j.1572-0241.2001.03462.x; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Hadjivassiliou M, 1998, LANCET, V352, P1582, DOI 10.1016/S0140-6736(98)05342-2; Hallert C, 1998, SCAND J GASTROENTERO, V33, P933, DOI 10.1080/003655298750026949; Hoffenberg EJ, 2000, J PEDIATR-US, V137, P361, DOI 10.1067/mpd.2000.109003; HOLMES GKT, 1980, GUT, V21, P1010, DOI 10.1136/gut.21.11.1010; HOLMES GKT, 1989, GUT, V30, P333, DOI 10.1136/gut.30.3.333; Iltanen S, 1999, AM J GASTROENTEROL, V94, P1042; Isaacson PG, 2000, LANCET, V356, P178, DOI 10.1016/S0140-6736(00)02472-7; Ivarsson A, 2002, AM J CLIN NUTR, V75, P914, DOI 10.1093/ajcn/75.5.914; Jabri B, 2000, GASTROENTEROLOGY, V118, P867, DOI 10.1016/S0016-5085(00)70173-9; JABRI B, 1999, P 8 INT S COEL DIS N; Janatuinen EK, 2002, GUT, V50, P332, DOI 10.1136/gut.50.3.332; JENSEN K, 1995, SCAND J IMMUNOL, V42, P166, DOI 10.1111/j.1365-3083.1995.tb03640.x; KASARDA DD, 1996, P 7 INT S COEL DIS, P195; Kaukinen K, 2002, AM J GASTROENTEROL, V97, P695, DOI 10.1111/j.1572-0241.2002.05471.x; Kaukinen K, 2002, GASTROENTEROLOGY, V122, P881, DOI 10.1053/gast.2002.32416; Kolho KL, 1999, BRIT J OBSTET GYNAEC, V106, P171, DOI 10.1111/j.1471-0528.1999.tb08218.x; Kolsteren MMP, 2001, J PEDIATR-US, V138, P593, DOI 10.1067/mpd.2001.111504; KUMAR V, 1989, IMMUNOL INVEST, V18, P533, DOI 10.3109/08820138909112261; Laahteenoja H, 1998, EUR J ORAL SCI, V106, P899, DOI 10.1046/j.0909-8836.1998.eos106501.x; Lankisch PG, 1996, Z GASTROENTEROL, V34, P473; Lee SK, 2003, GASTROINTEST ENDOSC, V57, P187, DOI 10.1067/mge.2003.54; Leon F, 2001, GASTROENTEROLOGY, V120, P586, DOI 10.1053/gast.2001.22161; LEONARD JN, 1983, BRIT MED J, V286, P16, DOI 10.1136/bmj.286.6358.16; Lepore L, 1996, J PEDIATR-US, V129, P311, DOI 10.1016/S0022-3476(96)70262-7; LINDH E, 1992, J INTERN MED, V231, P403, DOI 10.1111/j.1365-2796.1992.tb00951.x; Liu JJ, 2002, AM J HUM GENET, V70, P51, DOI 10.1086/338453; Lo WS, 2003, DIGEST DIS SCI, V48, P395, DOI 10.1023/A:1021956200382; LOGAN RFA, 1983, BMJ-BRIT MED J, V286, P95, DOI 10.1136/bmj.286.6359.95; LOGAN RFA, 1989, GASTROENTEROLOGY, V97, P265, DOI 10.1016/0016-5085(89)90060-7; LONGSTRETH GF, 1993, ANN INTERN MED, V119, P1014, DOI 10.7326/0003-4819-119-10-199311150-00008; Ludvigsson JF, 2001, GUT, V49, P169, DOI 10.1136/gut.49.2.169; Maiuri L, 2001, GUT, V48, P418, DOI 10.1136/gut.48.3.418; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Martinelli P, 2000, GUT, V46, P332, DOI 10.1136/gut.46.3.332; Meloni GF, 1999, HUM REPROD, V14, P2759, DOI 10.1093/humrep/14.11.2759; Meyer D, 2001, AM J GASTROENTEROL, V96, P112; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; MOLTENI N, 1988, AM J GASTROENTEROL, V83, P992; Monteleone G, 2001, EUR J IMMUNOL, V31, P2247, DOI 10.1002/1521-4141(200108)31:8<2247::AID-IMMU2247>3.0.CO;2-4; Murray JA, 2000, CLIN DIAGN LAB IMMUN, V7, P584, DOI 10.1128/CDLI.7.4.584-587.2000; Mustalahti Kirsi, 2002, Eff Clin Pract, V5, P105; Naluai AT, 2001, EUR J HUM GENET, V9, P938, DOI 10.1038/sj.ejhg.5200752; Niveloni S, 1998, GASTROINTEST ENDOSC, V47, P223, DOI 10.1016/S0016-5107(98)70317-7; Not T, 1998, SCAND J GASTROENTERO, V33, P494; Nuti R, 2001, J INTERN MED, V250, P361, DOI 10.1046/j.1365-2796.2001.00895.x; O'Leary C, 2002, QJM-INT J MED, V95, P79, DOI 10.1093/qjmed/95.2.79; Roberts AI, 2001, J IMMUNOL, V167, P5527, DOI 10.4049/jimmunol.167.10.5527; Rostami K, 1999, AM J GASTROENTEROL, V94, P888; RUBIN CE, 1960, GASTROENTEROLOGY, V39, P260; Ryan BM, 2000, GASTROENTEROLOGY, V119, P243, DOI 10.1053/gast.2000.8530; Sanders DS, 2001, LANCET, V358, P1504, DOI 10.1016/S0140-6736(01)06581-3; SATEGNAGUIDETTI C, 1993, J CLIN GASTROENTEROL, V17, P123, DOI 10.1097/00004836-199309000-00007; Sblattero D, 2000, AM J GASTROENTEROL, V95, P1253; Schweizer JJ, 2001, J PEDIATR GASTR NUTR, V33, P97, DOI 10.1097/00005176-200107000-00020; Scotta MS, 1997, AM J GASTROENTEROL, V92, P1331; Shah VH, 2000, GASTROINTEST ENDOSC, V51, P717, DOI 10.1067/mge.2000.104977; SHAHBAZKHANI B, 2000, J PEDIAT GASTROENTER, V31, P54; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; SHER KS, 1994, DIGESTION, V55, P243, DOI 10.1159/000201155; Sher KS, 1996, ACTA PAEDIATR, V85, P76, DOI 10.1111/j.1651-2227.1996.tb14258.x; SHIDRAWI RG, 1994, J CLIN PATHOL, V47, P693, DOI 10.1136/jcp.47.8.693; SIGNORINI M, 1988, BIOL CHEM H-S, V369, P275, DOI 10.1515/bchm3.1988.369.1.275; Smecuol E, 1996, EUR J GASTROEN HEPAT, V8, P63, DOI 10.1097/00042737-199601000-00012; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Sood A, 2001, AM J GASTROENTEROL, V96, P2804, DOI 10.1111/j.1572-0241.2001.04150.x; Sulkanen S, 1998, GASTROENTEROLOGY, V115, P1322, DOI 10.1016/S0016-5085(98)70008-3; SWINSON CM, 1983, LANCET, V1, P111; Talal AH, 1997, AM J GASTROENTEROL, V92, P1280; Toscano V, 2000, AM J GASTROENTEROL, V95, P1742, DOI 10.1111/j.1572-0241.2000.02187.x; Tursi A, 2001, HEPATO-GASTROENTEROL, V48, P462; Tursi A, 2001, AM J GASTROENTEROL, V96, P1507; Usai P, 1989, Recenti Prog Med, V80, P137; Vader W, 2002, GASTROENTEROLOGY, V122, P1729, DOI 10.1053/gast.2002.33606; Vaidya A, 1999, AM J GASTROENTEROL, V94, P1967; VALDIMARSSON T, 1994, SCAND J GASTROENTERO, V29, P457, DOI 10.3109/00365529409096838; van de Wal Y, 1998, J IMMUNOL, V161, P1585; Vazquez H, 2001, AM J GASTROENTEROL, V96, P798, DOI 10.1111/j.1572-0241.2001.03625.x; Ventura A, 1999, GASTROENTEROLOGY, V117, P297, DOI 10.1053/gast.1999.0029900297; Ventura A, 2000, J PEDIATR-US, V137, P263, DOI 10.1067/mpd.2000.107160; WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909; Whelan A, 1996, EUR J GASTROEN HEPAT, V8, P961, DOI 10.1097/00042737-199610000-00005	142	657	687	2	101	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2003	362	9381					383	391		10.1016/S0140-6736(03)14027-5	http://dx.doi.org/10.1016/S0140-6736(03)14027-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707FB	12907013				2022-12-28	WOS:000184498700021
J	Greenland, P; Gaziano, JM				Greenland, P; Gaziano, JM			Selecting asymptomatic patients for coronary computed tomography or electrocardiographic exercise testing	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEALTH-CARE PROFESSIONALS; AMERICAN-HEART-ASSOCIATION; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; RISK-ASSESSMENT; TASK-FORCE; PRACTICE GUIDELINES; PROGNOSTIC VALUE; COLLEGE; MORTALITY		Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Vet Affairs Boston Healthcare Syst, Cooperat Studies Program, Boston, MA USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Greenland, P (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA.		Greenland, Philip/ABD-5528-2021					AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Arad Y, 2000, J AM COLL CARDIOL, V36, P1253, DOI 10.1016/S0735-1097(00)00872-X; *BLUE CROSS BLUE S, 1999, TEC ASS PROGR, V13; BRUCE RA, 1983, J AM COLL CARDIOL, V2, P565, DOI 10.1016/S0735-1097(83)80286-1; CARR J, 2001, NETW MAG, V16, P24; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Detrano RC, 2000, CIRCULATION, V101, P1355; Detrano RC, 2000, CIRCULATION, V101, P697; Detrano RC, 1999, CIRCULATION, V99, P2633, DOI 10.1161/01.CIR.99.20.2633; Eagle KA, 1999, CIRCULATION, V100, P1464, DOI 10.1161/01.CIR.100.13.1464; EKELUND LG, 1989, J AM COLL CARDIOL, V14, P556, DOI 10.1016/0735-1097(89)90092-2; *EXP PAN DET EV TR, 2001, 10 YEAR RISK CALC; Gibbons LW, 2000, AM J CARDIOL, V86, P53, DOI 10.1016/S0002-9149(00)00827-4; Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15; GORDON DJ, 1986, CIRCULATION, V74, P252, DOI 10.1161/01.CIR.74.2.252; Greenland P, 2001, CIRCULATION, V104, P1863, DOI 10.1161/hc4201.097189; GRINER PF, 1981, ANN INTERN MED, V94, P553, DOI 10.7326/0003-4819-94-4-571; GROVER SA, 1995, BRIT MED J, V310, P975, DOI 10.1136/bmj.310.6985.975; Grundy SM, 1999, CIRCULATION, V100, P988, DOI 10.1161/01.CIR.100.9.988; Grundy SM, 1999, CIRCULATION, V100, P1481, DOI 10.1161/01.CIR.100.13.1481; Horton KM, 2002, CIRCULATION, V106, P532, DOI 10.1161/01.CIR.0000027136.56615.DE; Hunold P, 2001, EUR HEART J, V22, P1748, DOI 10.1053/euhj.2000.2586; Jacobson TA, 2000, ARCH INTERN MED, V160, P1361, DOI 10.1001/archinte.160.9.1361; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; Morin RL, 2003, CIRCULATION, V107, P917, DOI 10.1161/01.CIR.0000048965.56529.C2; Nallamothu BK, 2001, ARCH INTERN MED, V161, P833, DOI 10.1001/archinte.161.6.833; O'Malley PG, 2000, AM J CARDIOL, V85, P945, DOI 10.1016/S0002-9149(99)00906-6; O'Malley PG, 2003, JAMA-J AM MED ASSOC, V289, P2215, DOI 10.1001/jama.289.17.2215; O'Rourke RA, 2000, CIRCULATION, V102, P126, DOI 10.1161/01.CIR.102.1.126; OKIN PM, 1991, CIRCULATION, V83, P866, DOI 10.1161/01.CIR.83.3.866; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; *PREV SERV TASK FO, 1996, GUID CLIN PREV SERV, P3; RAUTAHARJU PM, 1986, J AM COLL CARDIOL, V8, P1, DOI 10.1016/S0735-1097(86)80084-5; Smith S C Jr, 2000, Circulation, V101, P111; Smith SC, 2001, CIRCULATION, V104, P1577, DOI 10.1161/hc3801.097475; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Wong ND, 1996, AM J CARDIOL, V78, P1220, DOI 10.1016/S0002-9149(96)00599-1; Wood D, 1998, ATHEROSCLEROSIS, V140, P199, DOI 10.1016/S0021-9150(98)90209-X; WOOLF SH, 1996, HLTH PROMOTION DIS P, P448	41	104	106	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2003	349	5					465	473		10.1056/NEJMcp023197	http://dx.doi.org/10.1056/NEJMcp023197			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706FV	12890846				2022-12-28	WOS:000184443700009
J	McGee, DM; Connolly, SA; Young, RH; Scully, RE; Harris, NL				McGee, DM; Connolly, SA; Young, RH; Scully, RE; Harris, NL			A 10-year-old girl with recurrent bouts of abdominal pain - Massive edema of the ovary with torsion.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CHILDREN; MASSES; ADOLESCENCE; CHILDHOOD		Massachusetts Gen Hosp, Vincent Obstet & Gynecol Serv, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	McGee, DM (corresponding author), Massachusetts Gen Hosp, Vincent Obstet & Gynecol Serv, Boston, MA 02114 USA.							BROWN MF, 1993, J PEDIATR SURG, V28, P930, DOI 10.1016/0022-3468(93)90700-U; Chervenak F A, 1980, Obstet Gynecol Surv, V35, P677, DOI 10.1097/00006254-198010000-00001; Dunn JS, 1998, OBSTET GYNECOL, V92, P648, DOI 10.1016/S0029-7844(98)00130-6; EIN SH, 1970, J PEDIATR SURG, V5, P148, DOI 10.1016/0022-3468(70)90270-8; ELKINS TE, 1990, FEMALE PATIENT, V15, P43; GRAIF M, 1988, AM J ROENTGENOL, V150, P647, DOI 10.2214/ajr.150.3.647; HIBBARD LT, 1985, AM J OBSTET GYNECOL, V152, P456, DOI 10.1016/S0002-9378(85)80157-5; KALSTONE CE, 1969, OBSTET GYNECOL, V34, P564; KIM SK, 1976, RADIOLOGY, V118, P689, DOI 10.1148/118.3.689; Kokoska ER, 2000, AM J SURG, V180, P462, DOI 10.1016/S0002-9610(00)00503-1; MEIGS JV, 1954, AM J OBSTET GYNECOL, V67, P962, DOI 10.1016/0002-9378(54)90258-6; OELSNER G, 1993, FERTIL STERIL, V60, P976; Piippo S, 1999, J Pediatr Adolesc Gynecol, V12, P223, DOI 10.1016/S1083-3188(99)00020-0; ROTH LM, 1979, AM J SURG PATHOL, V3, P11, DOI 10.1097/00000478-197902000-00002; Scully R.E., 1998, ATLAS TUMOR PATHOL, P409; SKINNER MA, 1993, ARCH SURG-CHICAGO, V128, P849; Tanner JM, 1962, GROWTH ADOLESCENCE G; Templeman C, 2000, OBSTET GYNECOL, V96, P229, DOI 10.1016/S0029-7844(00)00929-7; Templeman C, 2000, J PEDIATR SURG, V35, P1385, DOI 10.1053/jpsu.2000.9347; VANWINTER JT, 1994, AM J OBSTET GYNECOL, V170, P1780; YOUNG RH, 1984, INT J GYNECOL PATHOL, V3, P153, DOI 10.1097/00004347-198402000-00005	21	6	7	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2003	349	5					486	494		10.1056/NEJMcpc030019	http://dx.doi.org/10.1056/NEJMcpc030019			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706FV	12890848				2022-12-28	WOS:000184443700011
J	Mak, YYW; Elwyn, G; Finlay, IG				Mak, YYW; Elwyn, G; Finlay, IG			Patients' voices are needed in debates on euthanasia	BRITISH MEDICAL JOURNAL			English	Article							PHYSICIAN-ASSISTED SUICIDE; TERMINALLY ILL; DESIRE; PEOPLE; DEATH		Bradbury Hospice, Shatin, Hong Kong, Peoples R China; Univ Coll Swansea, Swansea Clin Sch, Primary Care Res Grp, Swansea SA2 8PP, W Glam, Wales; Univ Wales Coll Med, Sch Med, Cardiff CF14 7XL, S Glam, Wales	Swansea University; Cardiff University	Mak, YYW (corresponding author), Bradbury Hospice, A Kung Kok Shan Rd, Shatin, Hong Kong, Peoples R China.		Elwyn, G./L-4292-2015; Elwyn, Glyn/B-4798-2009	Elwyn, Glyn/0000-0002-0917-6286				Back AL, 1996, JAMA-J AM MED ASSOC, V275, P919, DOI 10.1001/jama.275.12.919; Bolton G., 2001, REFLECTIVE PRACTICE; Breitbart W, 1996, AM J PSYCHIAT, V153, P238; Chochinov HM, 1999, LANCET, V354, P816, DOI 10.1016/S0140-6736(99)80011-7; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; EMANUEL F, 1996, LANCET, V347, P1805; Foley KM, 1997, NEW ENGL J MED, V336, P54, DOI 10.1056/NEJM199701023360109; *HOUS LORDS SEL CO, 2003, REP MED ETH; Hurwitz B, 2002, BMJ-BRIT MED J, V325, P667, DOI 10.1136/bmj.325.7366.667; JOHANSEN S, IN PRESS PALLIAT MED; Lavery JV, 2001, LANCET, V358, P362, DOI 10.1016/S0140-6736(01)05555-6; Mak Y, 2003, PALLIATIVE MED, V17, P395, DOI 10.1191/0269216303pm775oa; Malterud K, 2001, LANCET, V358, P397, DOI 10.1016/S0140-6736(01)05548-9; MISHARA B, 1999, OMEGA, V39, pR2; PIJNENBORG L, 1993, LANCET, V341, P1196, DOI 10.1016/0140-6736(93)91014-D; ROY D, 1998, OXFORD TXB PALLIATIV, P120; SEALE C, 1994, SOC SCI MED, V39, P647, DOI 10.1016/0277-9536(94)90021-3; Sullivan M, 1997, J PALLIAT CARE, V13, P18, DOI 10.1177/082585979701300304; WOODRUFF R, 1999, EUTHANASIA PHYSICIAN	19	23	24	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2003	327	7408					213	215		10.1136/bmj.327.7408.213	http://dx.doi.org/10.1136/bmj.327.7408.213			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	706DL	12881268	Green Published			2022-12-28	WOS:000184437300024
J	Pasterkamp, RJ; Peschon, JJ; Spriggs, MK; Kolodkin, AL				Pasterkamp, RJ; Peschon, JJ; Spriggs, MK; Kolodkin, AL			Semaphorin 7A promotes axon outgrowth through integrins and MAPKs	NATURE			English	Article								Striking parallels exist between immune and nervous system cellular signalling mechanisms. Molecules originally shown to be critical for immune responses also serve neuronal functions, and similarly neural guidance cues can modulate immune function. We show here that semaphorin 7A (Sema7A), a membrane-anchored member of the semaphorin family of guidance proteins previously known for its immunomodulatory effects, can also mediate neuronal functions. Unlike many other semaphorins, which act as repulsive guidance cues, Sema7A enhances central and peripheral axon growth and is required for proper axon tract formation during embryonic development. Unexpectedly, Sema7A enhancement of axon outgrowth requires integrin receptors and activation of MAPK signalling pathways. These findings define a previously unknown biological function for semaphorins, identify an unexpected role for integrins and integrin-dependent intracellular signalling in mediating semaphorin responses, and provide a framework for understanding and interfering with Sema7A function in both immune and nervous systems.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Amgen Corp, Dept Mol Biol, Seattle, WA 98119 USA; Amgen Corp, Dept Funct Genom, Seattle, WA 98119 USA	Johns Hopkins University	Kolodkin, AL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	kolodkin@jhmi.edu		Pasterkamp, Jeroen/0000-0003-1631-6440				Angelisova P, 1999, IMMUNOBIOLOGY, V200, P234, DOI 10.1016/S0171-2985(99)80073-4; Bagnard D, 1998, DEVELOPMENT, V125, P5043; BISMUTH G, 2002, SCI STKE, pRE4; BOBOLIS KA, 1992, BLOOD, V79, P1574; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; de Castro F, 1999, J NEUROSCI, V19, P4428; de Fougerolles AR, 2002, IMMUNOL REV, V186, P208, DOI 10.1034/j.1600-065X.2002.18617.x; Doherty P, 2000, MOL CELL NEUROSCI, V16, P283, DOI 10.1006/mcne.2000.0907; Frank I, 1996, AIDS, V10, P1611, DOI 10.1097/00002030-199612000-00004; Fujioka S, 2003, BIOCHEM BIOPH RES CO, V301, P304, DOI 10.1016/S0006-291X(02)03023-1; Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X; He Zhigang, 2002, Sci STKE, V2002, pre1, DOI 10.1126/stke.2002.119.re1; Hirata T, 1997, J NEUROBIOL, V32, P415, DOI 10.1002/(SICI)1097-4695(199704)32:4<415::AID-NEU5>3.0.CO;2-9; Holmes S, 2002, SCAND J IMMUNOL, V56, P270, DOI 10.1046/j.1365-3083.2002.01129.x; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ivankovic-Dikic I, 2000, NAT CELL BIOL, V2, P574, DOI 10.1038/35023515; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; Kikutani H, 2003, NAT REV IMMUNOL, V3, P159, DOI 10.1038/nri1003; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; Lange C, 1998, GENOMICS, V51, P340, DOI 10.1006/geno.1998.5256; Milner R, 2002, J NEUROSCI RES, V69, P286, DOI 10.1002/jnr.10321; Mine T, 2000, TISSUE ANTIGENS, V55, P429, DOI 10.1034/j.1399-0039.2000.550505.x; Nguyen-Ba-Charvet KT, 2002, J NEUROSCI, V22, P5473; Pasterkamp RJ, 2003, CURR OPIN NEUROBIOL, V13, P79, DOI 10.1016/S0959-4388(03)00003-5; Pasterkamp RJ, 1998, J NEUROSCI, V18, P9962; PFAFF M, 1994, CELL ADHES COMMUN, V2, P491, DOI 10.3109/15419069409014213; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sakai T, 1999, J BIOL CHEM, V274, P29666, DOI 10.1074/jbc.274.42.29666; Schlaepfer DD, 1998, TRENDS CELL BIOL, V8, P151, DOI 10.1016/S0962-8924(97)01172-0; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; SCHWOB JE, 1984, J COMP NEUROL, V223, P177, DOI 10.1002/cne.902230204; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Soussi-Yanicostas N, 2002, CELL, V109, P217, DOI 10.1016/S0092-8674(02)00713-4; Sugisaki N, 1996, J NEUROBIOL, V29, P127, DOI 10.1002/(SICI)1097-4695(199602)29:2<127::AID-NEU1>3.0.CO;2-C; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Xu XM, 1998, J BIOL CHEM, V273, P22428, DOI 10.1074/jbc.273.35.22428; Yamada A, 1999, J IMMUNOL, V162, P4094; Yip PM, 1998, MOL BIOL CELL, V9, P277, DOI 10.1091/mbc.9.2.277; Zhou XF, 2001, J NEUROSCI RES, V66, P1054, DOI 10.1002/jnr.10029.abs; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	46	377	389	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2003	424	6947					398	405		10.1038/nature01790	http://dx.doi.org/10.1038/nature01790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879062				2022-12-28	WOS:000184318400035
J	Sadler, JE				Sadler, JE			Aortic stenosis, von Willebrand factor, and bleeding	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Washington Univ, Sch Med, Dept Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL)	Sadler, JE (corresponding author), Washington Univ, Sch Med, Dept Med, Howard Hughes Med Inst, St Louis, MO 63110 USA.		Sadler, Evan/D-8556-2011	Sadler, J. Evan/0000-0001-5705-469X				HEYDE EC, 1958, NEW ENGL J MED, V259, P196	1	68	71	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2003	349	4					323	325		10.1056/NEJMp030055	http://dx.doi.org/10.1056/NEJMp030055			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703ZH	12878737				2022-12-28	WOS:000184312800003
J	Muller, MM; Malinowski, P; Gruber, T; Hillyard, SA				Muller, MM; Malinowski, P; Gruber, T; Hillyard, SA			Sustained division of the attentional spotlight	NATURE			English	Article							SPATIAL SELECTIVE ATTENTION; VISUAL-EVOKED POTENTIALS; FOCAL ATTENTION; EXTRASTRIATE; ALLOCATION; LOCATIONS; STRIATE; BRAIN; SPACE; TASKS	By voluntarily directing attention to a specific region of a visual scene, we can improve our perception of stimuli at that location(1). This ability to focus attention upon specific zones of the visual field has been described metaphorically as a moveable spotlight or zoom lens that facilitates the processing of stimuli within its 'beam'(2,3). A long-standing controversy has centred on the question of whether the spotlight of spatial attention has a unitary beam or whether it can be divided flexibly to disparate locations(2,4-6). Evidence supporting the unitary spotlight view has come from numerous behavioural(3,7-10) and electrophysiological(11,12) studies. Recent experiments, however, indicate that the spotlight of spatial attention may be divided between noncontiguous zones of the visual field for very brief stimulus exposures (<100 ms)(13,14). Here we use an electrophysiological measure of attentional allocation (the steady-state visual evoked potential) to show that the spotlight may be divided between spatially separated locations (excluding interposed locations) over more extended time periods. This spotlight division appears to be accomplished at an early stage of visual-cortical processing.	Univ Leipzig, Inst Allgemeine Psychol, D-04103 Leipzig, Germany; Liverpool John Moores Univ, Sch Psychol, Liverpool L3 2ET, Merseyside, England; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Leipzig University; Liverpool John Moores University; University of Liverpool; University of California System; University of California San Diego	Muller, MM (corresponding author), Univ Leipzig, Inst Allgemeine Psychol, Seeburgstr 14-20, D-04103 Leipzig, Germany.	m.mueller@rz.uni-leipzig.de	Malinowski, Peter/A-4394-2009	Malinowski, Peter/0000-0001-5074-4508				Awh E, 2000, J EXP PSYCHOL HUMAN, V26, P834, DOI 10.1037/0096-1523.26.2.834; CASTIELLO U, 1992, J EXP PSYCHOL HUMAN, V18, P837, DOI 10.1037/0096-1523.18.3.837; Clark V.P., 1994, HUMAN BRAIN MAPPING, V2, P170, DOI [10.1002/hbm.460020306, DOI 10.1002/HBM.460020306]; Clark VP, 1996, J COGNITIVE NEUROSCI, V8, P387, DOI 10.1162/jocn.1996.8.5.387; Di Russo F, 1999, NEUROREPORT, V10, P2755; DUNCAN J, 1994, NATURE, V369, P313, DOI 10.1038/369313a0; Eimer M, 1999, PSYCHOPHYSIOLOGY, V36, P491, DOI 10.1017/S0048577299980915; Hahn S, 1998, VIS COGN, V5, P217, DOI 10.1080/713756781; HEINZE HJ, 1994, PERCEPT PSYCHOPHYS, V56, P42, DOI 10.3758/BF03211689; Hillyard SA, 1997, HUM BRAIN MAPP, V5, P287, DOI 10.1002/(SICI)1097-0193(1997)5:4<287::AID-HBM14>3.0.CO;2-B; KIEFER RJ, 1987, CAN J PSYCHOL, V41, P474, DOI 10.1037/h0084168; LABERGE D, 1989, PSYCHOL REV, V96, P101, DOI 10.1037/0033-295X.96.1.101; LaBerge D., 1995, ATTENTIONAL PROCESSI; Martinez A, 2001, VISION RES, V41, P1437, DOI 10.1016/S0042-6989(00)00267-4; McCormick PA, 1998, J EXP PSYCHOL HUMAN, V24, P350, DOI 10.1037/0096-1523.24.1.350; Moore CM, 1996, PSYCHON B REV, V3, P360, DOI 10.3758/BF03210761; MULLER M, 1994, NATO ADV SCI INST SE, V271, P325; Muller MM, 1997, BRAIN TOPOGR, V9, P163, DOI 10.1007/BF01190385; Muller MM, 1998, COGNITIVE BRAIN RES, V6, P249, DOI 10.1016/S0926-6410(97)00036-0; Muller MM, 1998, NAT NEUROSCI, V1, P631, DOI 10.1038/2865; PAN KY, 1993, PERCEPT PSYCHOPHYS, V53, P134, DOI 10.3758/BF03211723; Peterson MS, 2000, J GEN PSYCHOL, V127, P6, DOI 10.1080/00221300009598568; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; REEVES A, 1986, PSYCHOL REV, V93, P180, DOI 10.1037/0033-295X.93.2.180; Regan D., 1989, HUMAN BRAIN ELECTROP; SHAW ML, 1977, J EXP PSYCHOL HUMAN, V3, P201, DOI 10.1037/0096-1523.3.2.201; WEICHSELGARTNER E, 1987, SCIENCE, V238, P778, DOI 10.1126/science.3672124	30	307	309	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					309	312		10.1038/nature01812	http://dx.doi.org/10.1038/nature01812			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867981				2022-12-28	WOS:000184183900041
J	Spodick, DH				Spodick, DH			Current concepts - Acute cardiac tamponade	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PERICARDIAL CONSTRAINT; ELECTRIC ALTERNATION; PRESSURE; VOLUME; HEMODYNAMICS; PHYSIOLOGY; DIAGNOSIS; EFFUSION; SURGERY; HEART		St Vincent Hosp, Worcester Med Ctr, Div Cardiovasc Med, Worcester, MA 01604 USA		Spodick, DH (corresponding author), St Vincent Hosp, Worcester Med Ctr, Div Cardiovasc Med, Worcester, MA 01604 USA.							ANGEL J, 1997, CIRCULATION S1, V96, P30; BELOUCIF S, 1992, AM J PHYSIOL, V263, pH125, DOI 10.1152/ajpheart.1992.263.1.H125; BOLTWOOD CM, 1987, CIRCULATION, V75, P941, DOI 10.1161/01.CIR.75.5.941; BOMMER WJ, 1995, AM HEART J, V130, P1216, DOI 10.1016/0002-8703(95)90145-0; Callahan JA, 1997, ECHOCARDIOGR-J CARD, V14, P497, DOI 10.1111/j.1540-8175.1997.tb00757.x; COGSWELL TL, 1986, CIRCULATION, V74, P173, DOI 10.1161/01.CIR.74.1.173; COOPER JP, 1995, BRIT HEART J, V73, P351; DCruz I, 1997, ECHOCARDIOGR-J CARD, V14, P207, DOI 10.1111/j.1540-8175.1997.tb00712.x; FRIEDMAN HS, 1977, AM J PHYSIOL, V232, pH5, DOI 10.1152/ajpheart.1977.232.1.H5; GASCHO JA, 1981, AM J PHYSIOL, V240, pH49, DOI 10.1152/ajpheart.1981.240.1.H49; GROSE R, 1984, BASIC RES CARDIOL, V79, P531, DOI 10.1007/BF01910482; HANCOCK EW, 1971, CIRCULATION, V43, P183, DOI 10.1161/01.CIR.43.2.183; Hashim R, 2002, J TRAUMA, V53, P1183, DOI 10.1097/00005373-200212000-00027; Hurrell David G., 1996, Journal of the American College of Cardiology, V27, p212A; KLOPFENSTEIN HS, 1990, AM J PHYSIOL, V259, pH512, DOI 10.1152/ajpheart.1990.259.2.H512; MARTINS JB, 1980, AM J CARDIOL, V46, P59, DOI 10.1016/0002-9149(80)90606-2; Merce T, 1998, AM J MED, V105, P106, DOI 10.1016/S0002-9343(98)00192-2; PEPI M, 1994, BRIT HEART J, V72, P327; RAMSARAN EK, 1995, CARDIOLOGY, V86, P77, DOI 10.1159/000176835; REDDY PS, 1990, AM J CARDIOL, V66, P1487, DOI 10.1016/0002-9149(90)90540-H; REDDY PS, 1978, CIRCULATION, V58, P265, DOI 10.1161/01.CIR.58.2.265; REYDEL B, 1990, AM HEART J, V119, P1160, DOI 10.1016/S0002-8703(05)80248-0; SANTAMORE WP, 1990, CARDIOVASC RES, V24, P768, DOI 10.1093/cvr/24.9.768; Schrier RW, 1999, NEW ENGL J MED, V341, P577, DOI 10.1056/NEJM199908193410806; SHABETAI R, 1988, CIRCULATION, V77, P1, DOI 10.1161/01.CIR.77.1.1; SHABETAI R, 1994, HURSTS HEART ARTERIE, V1, P1647; SPODICK DH, 1989, AM J CARDIOL, V63, P1271, DOI 10.1016/0002-9149(89)90189-6; SPODICK DH, 1985, J AM COLL CARDIOL, V6, P296, DOI 10.1016/S0735-1097(85)80163-7; SPODICK DH, 1962, AM J CARDIOL, V10, P155, DOI 10.1016/0002-9149(62)90290-4; Spodick DH, 1998, CLIN CARDIOL, V21, P427; SPODICK DH, 1975, AM J CARDIOL, V35, P357, DOI 10.1016/0002-9149(75)90027-2; SPODICK DH, 1983, J AM COLL CARDIOL, V1, P240, DOI 10.1016/S0735-1097(83)80025-4; SPODICK DH, 1968, DIS CHEST, V54, P62, DOI 10.1378/chest.54.1.62; SPODICK DH, 2001, HEART DIS TXB CARDIO, V2, P1823; Spodick DH, 1991, CURA INTENSIVA CARDI, P265; THOMPSON RC, 1991, MAYO CLIN PROC, V66, P391, DOI 10.1016/S0025-6196(12)60663-6	36	391	418	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2003	349	7					684	690		10.1056/NEJMra022643	http://dx.doi.org/10.1056/NEJMra022643			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711FL	12917306				2022-12-28	WOS:000184728900011
J	Kettenberger, H; Armache, KJ; Cramer, P				Kettenberger, H; Armache, KJ; Cramer, P			Architecture of the RNA polymerase II-TFIIS complex and implications for mRNA cleavage	CELL			English	Article							ELONGATION-FACTOR TFIIS; FACILITATED TRANSCRIPT CLEAVAGE; STRUCTURAL BASIS; EXONUCLEASE ACTIVITY; NASCENT TRANSCRIPT; CRYSTAL-STRUCTURE; SUBUNIT RPB9; ACTIVE-SITE; INITIATION; DOMAIN	The transcription elongation factor TFIIS induces mRNA cleavage by enhancing the intrinsic nuclease activity of RNA polymerase (Pol) II. We have diffused TFIIS into Pol II crystals and derived a model of the Pol II-TFIIS complex from X-ray diffraction data to 3.8 Angstrom resolution. TFIIS extends from the polymerase surface via a pore to the internal active site, spanning a distance of 100 Angstrom. Two essential and invariant acidic residues in a TFIIS loop complement the Pol II active site and could position a metal ion and a water molecule for hydrolytic RNA cleavage. TFIIS also induces extensive structural changes in Pol II that would realign nucleic acids in the active center. Our results support the idea that Pol II contains a single tunable active site for RNA polymerization and cleavage, in contrast to DNA polymerases with two separate active sites for DNA polymerization and cleavage.	Univ Munich, Inst Biochem, Gene Ctr, D-81377 Munich, Germany	University of Munich	Cramer, P (corresponding author), Univ Munich, Inst Biochem, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@LMB.uni-muenchen.de						Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Awrey DE, 1997, J BIOL CHEM, V272, P14747, DOI 10.1074/jbc.272.23.14747; Awrey DE, 1998, J BIOL CHEM, V273, P22595, DOI 10.1074/jbc.273.35.22595; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Booth V, 2000, J BIOL CHEM, V275, P31266, DOI 10.1074/jbc.M002595200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUDISA N, 1995, EUR J BIOCHEM, V230, P788; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Bushnell DA, 2002, P NATL ACAD SCI USA, V99, P1218, DOI 10.1073/pnas.251664698; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Chedin S, 1998, GENE DEV, V12, P3857, DOI 10.1101/gad.12.24.3857; CIPRESPALACIN G, 1994, P NATL ACAD SCI USA, V91, P8087, DOI 10.1073/pnas.91.17.8087; Cramer P, 2002, BIOESSAYS, V24, P724, DOI 10.1002/bies.10127; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Davie JK, 2000, MOL CELL BIOL, V20, P5960, DOI 10.1128/MCB.20.16.5960-5973.2000; Ederth J, 2002, J BIOL CHEM, V277, P37456, DOI 10.1074/jbc.M207038200; Erie DA, 2002, BBA-GENE STRUCT EXPR, V1577, P224, DOI 10.1016/S0167-4781(02)00454-2; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gu WG, 1995, J BIOL CHEM, V270, P30441, DOI 10.1074/jbc.270.51.30441; Hausner W, 2000, J BIOL CHEM, V275, P12393, DOI 10.1074/jbc.275.17.12393; Hemming SA, 2000, J BIOL CHEM, V275, P35506, DOI 10.1074/jbc.M004721200; HORIKOSHI M, 1984, J BIOL CHEM, V259, P608; IZBAN MG, 1992, GENE DEV, V6, P1342, DOI 10.1101/gad.6.7.1342; IZBAN MG, 1993, J BIOL CHEM, V268, P12874; IZBAN MG, 1993, J BIOL CHEM, V268, P12864; Jeon C, 1996, P NATL ACAD SCI USA, V93, P13677, DOI 10.1073/pnas.93.24.13677; JEON CJ, 1994, P NATL ACAD SCI USA, V91, P9106, DOI 10.1073/pnas.91.19.9106; JOHNSON TL, 1994, CELL, V77, P217, DOI 10.1016/0092-8674(94)90314-X; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Koulich D, 1997, J BIOL CHEM, V272, P7201, DOI 10.1074/jbc.272.11.7201; Markovtsov V, 1996, P NATL ACAD SCI USA, V93, P3221, DOI 10.1073/pnas.93.8.3221; Morin PE, 1996, P NATL ACAD SCI USA, V93, P10604, DOI 10.1073/pnas.93.20.10604; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NEDLALKOV YA, 2003, J BIOL CHEM, V278, P18303; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Olmsted VK, 1998, J BIOL CHEM, V273, P22589, DOI 10.1074/jbc.273.35.22589; Palangat M, 2001, J MOL BIOL, V311, P265, DOI 10.1006/jmbi.2001.4842; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Powell W, 1996, J BIOL CHEM, V271, P22301, DOI 10.1074/jbc.271.37.22301; QIAN XQ, 1993, BIOCHEMISTRY-US, V32, P9944, DOI 10.1021/bi00089a010; REINES D, 1992, J BIOL CHEM, V267, P3795; RUDD MD, 1994, P NATL ACAD SCI USA, V91, P8057, DOI 10.1073/pnas.91.17.8057; Rudd MD, 1996, J BIOL CHEM, V271, P21549, DOI 10.1074/jbc.271.35.21549; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SEKIMIZU K, 1976, BIOCHEMISTRY-US, V15, P5064, DOI 10.1021/bi00668a018; Shaw RJ, 2002, J BIOL CHEM, V277, P24420, DOI 10.1074/jbc.M202059200; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Shimasaki NB, 2000, J BIOL CHEM, V275, P36541, DOI 10.1074/jbc.M005834200; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; STEBBINS CE, 1995, NATURE, V373, P636, DOI 10.1038/373636a0; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; WANG DG, 1993, P NATL ACAD SCI USA, V90, P843, DOI 10.1073/pnas.90.3.843; Weilbaecher RG, 2003, J BIOL CHEM, V278, P24189, DOI 10.1074/jbc.M211197200; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3; Wu JS, 1996, P NATL ACAD SCI USA, V93, P11552, DOI 10.1073/pnas.93.21.11552	62	258	277	3	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 8	2003	114	3					347	357		10.1016/S0092-8674(03)00598-1	http://dx.doi.org/10.1016/S0092-8674(03)00598-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914699	Bronze, Green Published			2022-12-28	WOS:000184679200011
J	Passafaro, M; Nakagawa, T; Sala, C; Sheng, M				Passafaro, M; Nakagawa, T; Sala, C; Sheng, M			Induction of dendritic spines by an extracellular domain of AMPA receptor subunit GluR2	NATURE			English	Article							N-TERMINAL DOMAINS; NMDA RECEPTORS; GLUTAMATE RECEPTORS; BINDING-PROTEINS; EXPRESSION; SYNAPSES; NEURONS; DESENSITIZATION; DEPENDENCE; CHANNELS	Synaptic transmission from excitatory nerve cells in the mammalian brain is largely mediated by AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid)-type glutamate receptors located at the surface of dendritic spines. The abundance of postsynaptic AMPA receptors correlates with the size of the synapse and the dimensions of the dendritic spine head(1-4). Moreover, long-term potentiation is associated with the formation of dendritic spines as well as synaptic delivery of AMPA receptors(5-8). The molecular mechanisms that coordinate AMPA receptor delivery and spine morphogenesis are unknown. Here we show that overexpression of the glutamate receptor 2 (GluR2) subunit of AMPA receptors increases spine size and density in hippocampal neurons, and more remarkably, induces spine formation in GABA-releasing interneurons that normally lack spines. The extracellular N-terminal domain (NTD) of GluR2 is responsible for this effect, and heterologous fusion proteins of the NTD of GluR2 inhibit spine morphogenesis. We propose that the NTD of GluR2 functions at the cell surface as part of a receptor-ligand interaction that is important for spine growth and/or stability.	MIT, Howard Hughes Med Inst, RIKEN,Neurosci Res Ctr, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA; Univ Milan, Dept Pharmacol, CNR, Inst Neurosci Cellular & Mol Pharmacol, I-20129 Milan, Italy	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; Consiglio Nazionale delle Ricerche (CNR); University of Milan	Sheng, M (corresponding author), MIT, Howard Hughes Med Inst, RIKEN,Neurosci Res Ctr, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA.		Sala, Carlo/A-2493-2009	Sala, Carlo/0000-0003-0662-9523; Sheng, Morgan/0000-0002-8703-5366	Telethon [TCP01014] Funding Source: Medline	Telethon(Fondazione Telethon)		Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fayyazuddin A, 2000, NEURON, V25, P683, DOI 10.1016/S0896-6273(00)81070-3; Hayashi T, 1999, NATURE, V397, P72, DOI 10.1038/16269; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; Krupp JJ, 1998, NEURON, V20, P317, DOI 10.1016/S0896-6273(00)80459-6; Leuschner WD, 1999, J BIOL CHEM, V274, P16907, DOI 10.1074/jbc.274.24.16907; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Masuko T, 1999, MOL PHARMACOL, V55, P957, DOI 10.1124/mol.55.6.957; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Nusser Z, 2000, CURR OPIN NEUROBIOL, V10, P337, DOI 10.1016/S0959-4388(00)00086-6; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Pasternack A, 2002, J BIOL CHEM, V277, P49662, DOI 10.1074/jbc.M208349200; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Villarroel A, 1998, NEURON, V20, P329, DOI 10.1016/S0896-6273(00)80460-2; Washburn MS, 1997, J NEUROSCI, V17, P9393	30	249	257	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					677	681		10.1038/nature01781	http://dx.doi.org/10.1038/nature01781			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904794				2022-12-28	WOS:000184578800046
J	Stewart, A; Zimmern, R				Stewart, A; Zimmern, R			(Almost) three cheers for UK genetics White Paper	LANCET			English	Editorial Material							PUBLIC-HEALTH; MEDICINE		Strangeways Res Lab, Cambridge Genet Knowledge Pk, Publ Hlth Genet Unit, Cambridge CB1 8RN, England		Stewart, A (corresponding author), Strangeways Res Lab, Cambridge Genet Knowledge Pk, Publ Hlth Genet Unit, Cambridge CB1 8RN, England.	allson.stewart@srl.cam.ac.uk						Bell J, 1998, BMJ-BRIT MED J, V316, P618, DOI 10.1136/bmj.316.7131.618; Burke W, 2002, AM J EPIDEMIOL, V156, P311, DOI 10.1093/aje/kwf055; BURTON H, 2002, ED GENETICS HLTH PRO; Collins FS, 1999, NEW ENGL J MED, V341, P28, DOI 10.1056/NEJM199907013410106; *DEP HLTH, PATH MOD PROGR; Department of Health, 2003, OUR INH OUR FUT REAL; Holtzman NA, 2000, NEW ENGL J MED, V343, P141, DOI 10.1056/NEJM200007133430213; Juengst ET, 2003, BRIT MED J, V326, P1410, DOI 10.1136/bmj.326.7404.1410; Omenn GS, 2002, GENET MED, V4, p21S, DOI 10.1097/00125817-200211001-00005; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Roses AD, 2001, HUM MOL GENET, V10, P2261, DOI 10.1093/hmg/10.20.2261; Yoon PW, 2002, GENET MED, V4, P304, DOI 10.1097/00125817-200207000-00009; ZIMMERN R, 2000, GENETICS HLTH	13	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2003	362	9381					341	342		10.1016/S0140-6736(03)14054-8	http://dx.doi.org/10.1016/S0140-6736(03)14054-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707FB	12907002				2022-12-28	WOS:000184498700003
J	Straume, T; Rugel, G; Marchetti, AA; Ruhm, W; Korschinek, G; McAninch, JE; Carroll, K; Egbert, S; Faestermann, T; Knie, K; Martinelli, R; Wallner, A; Wallner, C				Straume, T; Rugel, G; Marchetti, AA; Ruhm, W; Korschinek, G; McAninch, JE; Carroll, K; Egbert, S; Faestermann, T; Knie, K; Martinelli, R; Wallner, A; Wallner, C			Measuring fast neutrons in Hiroshima at distances relevant to atomic-bomb survivors	NATURE			English	Article							ACCELERATOR MASS-SPECTROMETRY; DOSIMETRY SYSTEM 1986; NI-63; NAGASAKI; EU-152; CO-60; CL-36; MAGNET; CA-41; IONS	Data from the survivors of the atomic bombs serve as the major basis for risk calculations of radiation-induced cancer in humans(1). A controversy has existed for almost two decades, however, concerning the possibility that neutron doses in Hiroshima may have been much larger than estimated. This controversy was based on measurements of radioisotopes activated by thermal neutrons that suggested much higher fluences at larger distances than expected(2-6). For fast neutrons, which contributed almost all the neutron dose, clear measurement validation has so far proved impossible at the large distances (900 to 1,500 m) most relevant to survivor locations(6). Here, the first results are reported for the detection of Ni-63 produced predominantly by fast neutrons (above about 1 MeV) in copper samples from Hiroshima. This breakthrough was made possible by the development of chemical extraction methods(7,8) and major improvements in the sensitivity of accelerator mass spectrometry for detection of Ni-63 atoms (refs 8-11). When results are compared with Ni-63 activation predicted by neutron doses for Hiroshima survivors(6), good agreement is observed at the distances most relevant to survivor data. These findings provide, for the first time, clear measurement validation of the neutron doses to survivors in Hiroshima.	Univ Utah, Salt Lake City, UT 84108 USA; Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; Tech Univ Munich, D-85747 Garching, Germany; Univ Munich, D-80336 Munich, Germany; Sci Applicat Int Corp, San Diego, CA 92121 USA	Utah System of Higher Education; University of Utah; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Technical University of Munich; University of Munich; Science Applications International Corporation (SAIC)	Straume, T (corresponding author), Univ Utah, 729 Arapeen Dr,Suite 2334, Salt Lake City, UT 84108 USA.		Wallner, Anton/G-1480-2011; Faestermann, Thomas/ABE-2360-2020; Rühm, Werner/C-4302-2011	Wallner, Anton/0000-0003-2804-3670; Faestermann, Thomas/0000-0002-6603-8787; Ruhm, Werner/0000-0002-6354-7359				ARAKATSU B, 1953, COLLECTION INVESTIGA, P34; BARNES IL, 1971, INT J APPL RADIAT IS, V22, P781; *BEIR, 1990, 5 BEIR; Feldman GJ, 1998, PHYS REV D, V57, P3873, DOI 10.1103/PhysRevD.57.3873; GRITZNER ML, 1987, US JAPAN JOINT REASS, V2, P283; HABERSTOCK G, 1986, RADIOCARBON, V28, P204, DOI 10.1017/S0033822200007281; HASHIZUME T, 1967, HEALTH PHYS, V13, P149, DOI 10.1097/00004032-196702000-00004; HOSHI M, 1989, HEALTH PHYS, V57, P831; JOHNSON JO, 1999, USERS MANUAL MASH V; KATO K, 1990, INT J RADIAT BIOL, V58, P661, DOI 10.1080/09553009014552011; Knie K, 1997, NUCL INSTRUM METH B, V123, P128, DOI 10.1016/S0168-583X(96)00753-7; KORSCHINEK G, 1987, NUCL INSTRUM METH B, V29, P67, DOI 10.1016/0168-583X(87)90206-0; Marchetti AA, 1996, APPL RADIAT ISOTOPES, V47, P97, DOI 10.1016/0969-8043(95)00240-5; Marchetti AA, 1997, NUCL INSTRUM METH B, V123, P230, DOI 10.1016/S0168-583X(96)00611-8; McAninch JE, 1997, NUCL INSTRUM METH B, V123, P137, DOI 10.1016/S0168-583X(96)00411-9; NAKANISHI T, 1983, NATURE, V302, P132, DOI 10.1038/302132a0; ROESCH WC, 1987, US JAP JOINT REASS A; ROSE PF, 1991, ENDF B 6 SUMMARY DOC; Rugel G, 2000, NUCL INSTRUM METH B, V172, P934, DOI 10.1016/S0168-583X(00)00108-7; Ruhm W, 2000, HEALTH PHYS, V79, P358, DOI 10.1097/00004032-200010000-00003; RUHM W, 1992, Z PHYS A-HADRON NUCL, V341, P235, DOI 10.1007/BF01298486; Ruhm W, 1998, RADIAT ENVIRON BIOPH, V37, P293, DOI 10.1007/s004110050131; SHIBATA T, 1994, J PHYS SOC JPN, V63, P3546, DOI 10.1143/JPSJ.63.3546; SHIZUMA K, 1993, HEALTH PHYS, V65, P272, DOI 10.1097/00004032-199309000-00004; Shizuma K, 1998, HEALTH PHYS, V75, P278, DOI 10.1097/00004032-199809000-00006; STRANDBERG TE, 1992, CIRCULATION, V86, P63; Straume T, 1996, RADIAT PROT DOSIM, V67, P5, DOI 10.1093/oxfordjournals.rpd.a031797; STRAUME T, 1994, RADIAT RES, V138, P193, DOI 10.2307/3578589; STRAUME T, 1990, NUCL INSTRUM METH B, V52, P552, DOI 10.1016/0168-583X(90)90475-A; YAMASAKI F, 1953, COLLECTION INVESTIGA, P18	30	49	50	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					539	542		10.1038/nature01815	http://dx.doi.org/10.1038/nature01815			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891354				2022-12-28	WOS:000184454700039
J	Teng, M; Wolf, M; Lowrie, E; Ofsthun, N; Lazarus, JM; Thadhani, R				Teng, M; Wolf, M; Lowrie, E; Ofsthun, N; Lazarus, JM; Thadhani, R			Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SECONDARY HYPERPARATHYROIDISM; ARTERY CALCIFICATION; PARATHYROID-HORMONE; DIALYSIS PATIENTS; MORTALITY RISK; ADYNAMIC BONE; YOUNG-ADULTS; CORONARY; ASSOCIATION; DISEASE	BACKGROUND: Elevated calcium and phosphorus levels after therapy with injectable vitamin D for secondary hyperparathyroidism may accelerate vascular disease and hasten death in patients undergoing long-term hemodialysis. Paricalcitol, a new vitamin D analogue, appears to lessen the elevations in serum calcium and phosphorus levels, as compared with calcitriol, the standard form of injectable vitamin D. METHODS: We conducted a historical cohort study to compare the 36-month survival rate among patients undergoing long-term hemodialysis who started to receive treatment with paricalcitol (29,021 patients) or calcitriol (38,378 patients) between 1999 and 2001. Crude and adjusted survival rates were calculated and stratified analyses were performed. A subgroup of 16,483 patients who switched regimens was also evaluated. RESULTS: The mortality rate among patients receiving paricalcitol was 3417 per 19,031 person-years (0.180 per person-year), as compared with 6805 per 30,471 person-years (0.223 per person-year) among those receiving calcitriol (P<0.001). The difference in survival was significant at 12 months and increased with time (P<0.001). In the adjusted analysis, the mortality rate was 16 percent lower (95 percent confidence interval, 10 to 21 percent) among paricalcitol-treated patients than among calcitriol-treated patients. A significant survival benefit was evident in 28 of 42 strata examined, and in no stratum was calcitriol favored. At 12 months, calcium and phosphorus levels had increased by 6.7 and 11.9 percent, respectively, in the paricalcitol group, as compared with 8.2 and 13.9 percent, respectively, in the calcitriol group (P<0.001). The two-year survival rate among patients who switched from calcitriol to paricalcitol was 73 percent, as compared with 64 percent among those who switched from paricalcitol to calcitriol (P=0.04). CONCLUSIONS: Patients who receive paricalcitol while undergoing long-term hemodialysis appear to have a significant survival advantage over those who receive calcitriol. A prospective, randomized study is critical to confirm these findings.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Renal Unit, Boston, MA 02114 USA; Fresenius Med Care N Amer, Lexington, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Thadhani, R (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Renal Unit, Bullfinch 127,55 Fruit St, Boston, MA 02114 USA.	thadhani.r@mgh.harvard.edu						ASSAF AR, 1993, NEW ENGL J MED, V329, P931, DOI 10.1056/NEJM199309233291307; Atsumi K, 1999, AM J KIDNEY DIS, V33, P287, DOI 10.1016/S0272-6386(99)70302-1; Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; Brown AJ, 2000, J AM SOC NEPHROL, V11, P2088, DOI 10.1681/ASN.V11112088; Brown AJ, 2001, AM J KIDNEY DIS, V38, pS3, DOI 10.1053/ajkd.2001.28111; Chertow GM, 2002, KIDNEY INT, V62, P245, DOI 10.1046/j.1523-1755.2002.00434.x; Coco M, 2000, AM J KIDNEY DIS, V36, P1115, DOI 10.1053/ajkd.2000.19812; Collins AJ, 2000, SEMIN NEPHROL, V20, P345; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Couttenye MM, 1996, NEPHROL DIAL TRANSPL, V11, P1065; Davies MR, 2001, KIDNEY INT, V60, P472, DOI 10.1046/j.1523-1755.2001.060002472.x; Finch JL, 1999, J AM SOC NEPHROL, V10, P980; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Ganesh SK, 2001, J AM SOC NEPHROL, V12, P2131, DOI 10.1681/ASN.V12102131; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; GOODMAN WG, 1994, KIDNEY INT, V46, P1160, DOI 10.1038/ki.1994.380; Gupta A, 2000, J AM SOC NEPHROL, V11, P330, DOI 10.1681/ASN.V112330; Ifudu O, 1998, NEW ENGL J MED, V339, P1054, DOI 10.1056/NEJM199810083391507; Kuizon BD, 1998, KIDNEY INT, V53, P205, DOI 10.1046/j.1523-1755.1998.00724.x; Liu YY, 1997, J BIOL CHEM, V272, P3336, DOI 10.1074/jbc.272.6.3336; Llach F, 1998, AM J KIDNEY DIS, V32, pS3; Llach F, 2001, AM J KIDNEY DIS, V38, pS45, DOI 10.1053/ajkd.2001.28114; LOWRIE EG, 1981, NEW ENGL J MED, V305, P1176, DOI 10.1056/NEJM198111123052003; LOWRIE EG, 1990, AM J KIDNEY DIS, V15, P458, DOI 10.1016/S0272-6386(12)70364-5; Lowrie EG, 2001, KIDNEY INT, V60, P1917, DOI 10.1046/j.1523-1755.2001.00029.x; MALLICK NP, 1968, LANCET, V2, P1316; Martin KJ, 1998, AM J KIDNEY DIS, V32, pS61, DOI 10.1053/ajkd.1998.v32.pm9808145; Martin KJ, 2001, AM J KIDNEY DIS, V38, pS34, DOI 10.1053/ajkd.2001.28109; MILLINER DS, 1990, KIDNEY INT, V38, P931, DOI 10.1038/ki.1990.293; Moe SM, 2002, KIDNEY INT, V61, P638, DOI 10.1046/j.1523-1755.2002.00170.x; *NAT I DIAB DIG KI, 2000, REN DAT SYST USRDS 2; Oh J, 2002, CIRCULATION, V106, P100, DOI 10.1161/01.CIR.0000020222.63035.C0; OWEN WF, 1993, NEW ENGL J MED, V329, P1001, DOI 10.1056/NEJM199309303291404; PELEG S, 1995, J BIOL CHEM, V270, P10551, DOI 10.1074/jbc.270.18.10551; QUNIBI WY, 2002, KIDNEY INT S, V82, P73; Ritz E, 1999, KIDNEY INT, V56, pS94, DOI 10.1046/j.1523-1755.1999.07314.x; SJODEN G, 1985, P SOC EXP BIOL MED, V178, P432; Sprague SM, 2001, AM J KIDNEY DIS, V38, pS51, DOI 10.1053/ajkd.2001.28110; VINCENTI F, 1981, JAMA-J AM MED ASSOC, V245, P930, DOI 10.1001/jama.245.9.930; World Health Organization, 1980, INT CLASSIFICATION D; Zager RA, 1999, AM J PATHOL, V154, P1899, DOI 10.1016/S0002-9440(10)65448-X	41	775	815	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2003	349	5					446	456		10.1056/NEJMoa022536	http://dx.doi.org/10.1056/NEJMoa022536			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706FV	12890843				2022-12-28	WOS:000184443700006
J	Ezzati, M; Vander Hoorn, S; Rodgers, A; Lopez, AD; Mathers, CD; Murray, CJL				Ezzati, M; Vander Hoorn, S; Rodgers, A; Lopez, AD; Mathers, CD; Murray, CJL		Comparative Risk Assessment Collab	Estimates of global and regional potential health gains from reducing multiple major risk factors	LANCET			English	Article							CORONARY-HEART-DISEASE; LIFE; PREVENTION; COUNTRIES	Background Estimates of the disease burden due to multiple risk factors can show the potential gain from combined preventive measures. But few such investigations have been attempted, and none on a global scale. Our aim was to estimate the potential health benefits from removal of multiple major risk factors. Methods We assessed the burden of disease and injury attributable to the joint effects of 20 selected leading risk factors in 14 epidemiological subregions of the world. We estimated population attributable fractions, defined as the proportional reduction in disease or mortality that would occur if exposure to a risk factor were reduced to an alternative level, from data for risk factor prevalence and hazard size. For every disease, we estimated joint population attributable fractions, for multiple risk factors, by age and sex, from the direct contributions of individual risk factors. To obtain the direct hazards, we reviewed publications and re-analysed cohort data to account for that part of hazard that is mediated through other risks. Results Globally, an estimated 47% of premature deaths and 39% of total disease burden in 2000 resulted from the joint effects of the risk factors considered. These risks caused a substantial proportion of important diseases, including diarrhoea (92%-94%), lower respiratory infections (55-62%), lung cancer (72%), chronic obstructive pulmonary disease (60%), ischaemic heart disease (83-89%), and stroke (70-76%). Removal of these risks would have increased global healthy life expectancy by 9.3 years (17%) ranging from 4.4 years (6%) in the developed countries of the western Pacific to 16.1 years (43%) in parts of sub-Saharan Africa. Interpretation Removal of major risk factors would not only increase healthy life expectancy in every region, but also reduce some of the differences between regions, The potential for disease prevention and health gain from tackling major known risks simultaneously would be substantial.	Resources Future Inc, Resk Resources & Enviornm Management Div, Washington, DC USA; Univ Auckland, Clin Trial Res Unit, Auckland 1, New Zealand; Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; WHO, CH-1211 Geneva, Switzerland	Resources for the Future; University of Auckland; University of Queensland; World Health Organization	Ezzati, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	mezzati@hsph.harvard.edu	Lopez, Alan D/F-1487-2010; Rem, Jürgen/H-1309-2011; Lopez, Alan/AAA-2734-2022	Lopez, Alan D/0000-0001-5818-6512; Mathers, Colin/0000-0002-0617-6731; Rodgers, Anthony/0000-0003-1282-1896	NATIONAL INSTITUTE ON AGING [P01AG017625] Funding Source: NIH RePORTER; NIA NIH HHS [1-PO1-AG17625] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Eide GE, 2001, STAT METHODS MED RES, V10, P159, DOI 10.1191/096228001680195148; EVANS AS, 1978, AM J EPIDEMIOL, V108, P249, DOI 10.1093/oxfordjournals.aje.a112617; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; GREENLAND S, 1984, STAT MED, V3, P131, DOI 10.1002/sim.4780030206; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; HIRAYAMA T, 1990, LIFESTYLE MORTALITY; Kruijshaar ME, 2002, B WORLD HEALTH ORGAN, V80, P622; Manton KG, 1993, FORECASTING HLTH ELD; Mathers CD, 2001, LANCET, V357, P1685, DOI 10.1016/S0140-6736(00)04824-8; Mathers CD, 2002, SUMMARY MEASURES OF POPULATION HEALTH: CONCEPTS, ETHICS, MEASUREMENT AND APPLICATIONS, P177; MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617; Murray Christopher JL, 2003, Popul Health Metr, V1, P1, DOI 10.1186/1478-7954-1-1; NEATON JD, 1992, ARCH INTERN MED, V152, P56, DOI 10.1001/archinte.152.1.56; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Robins J.M., 2000, STAT MODELS EPIDEMIO, P95, DOI DOI 10.1007/978-1-4612-1284-3_2; ROTHMAN KJ, 1976, AM J EPIDEMIOL, V104, P587, DOI 10.1093/oxfordjournals.aje.a112335; Smith KR, 1999, EPIDEMIOLOGY, V10, P573, DOI 10.1097/00001648-199909000-00027; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; WALTER SD, 1980, AM J EPIDEMIOL, V112, P409, DOI 10.1093/oxfordjournals.aje.a113007; WALTER SD, 1976, BIOMETRICS, V32, P829, DOI 10.2307/2529268; Willett WC, 2002, SCIENCE, V296, P695, DOI 10.1126/science.1071055; World Health Organization, 2001, MACR HLTH INV HLTH E; YERUSHALMY J, 1959, J Chronic Dis, V10, P27, DOI 10.1016/0021-9681(59)90015-3	25	417	426	0	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2003	362	9380					271	280		10.1016/S0140-6736(03)13968-2	http://dx.doi.org/10.1016/S0140-6736(03)13968-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705UL	12892956				2022-12-28	WOS:000184413400008
J	Lanczik, O; Szabo, K; Gass, A; Hennerici, MG				Lanczik, O; Szabo, K; Gass, A; Hennerici, MG			Tinnitus after cycling	LANCET			English	Editorial Material							INTERNAL CAROTID-ARTERY; DISSECTION		Univ Heidelberg, Klinikum Mannheim, Dept Neurol, D-68137 Mannheim, Germany	Ruprecht Karls University Heidelberg	Lanczik, O (corresponding author), Univ Heidelberg, Klinikum Mannheim, Dept Neurol, D-68137 Mannheim, Germany.	lanczik@neuro.ma.uni-heidelberg.de						Haussermann P, 2002, ARCH NEUROL-CHICAGO, V59, P1484, DOI 10.1001/archneur.59.9.1484; Meairs S, 2000, LANCET, V356, P40, DOI 10.1016/S0140-6736(00)02433-8; NELSON EE, 1995, ANN EMERG MED, V25, P103, DOI 10.1016/S0196-0644(95)70363-2; Schievink WI, 1998, AM J EMERG MED, V16, P179, DOI 10.1016/S0735-6757(98)90042-0; STRINGER WL, 1980, NEUROSURGERY, V6, P123	5	7	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2003	362	9380					292	292		10.1016/S0140-6736(03)13972-4	http://dx.doi.org/10.1016/S0140-6736(03)13972-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705UL	12892960				2022-12-28	WOS:000184413400012
J	Barnhart, BC; Peter, ME				Barnhart, BC; Peter, ME			The TNF receptor 1: A split personality complex	CELL			English	Editorial Material							SIGNALING COMPLEX; APOPTOSIS; CASPASE-8		Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA	University of Chicago	Barnhart, BC (corresponding author), Univ Chicago, Ben May Inst Canc Res, 924 E 57th St, Chicago, IL 60637 USA.			Peter, Marcus Ernst/0000-0003-3216-036X				Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; Harper N, 2003, J BIOL CHEM, V278, P25534, DOI 10.1074/jbc.M303399200; Lee JC, 2003, IMMUNOL REV, V193, P39, DOI 10.1034/j.1600-065X.2003.00043.x; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Schutze S, 1999, J BIOL CHEM, V274, P10203, DOI 10.1074/jbc.274.15.10203; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954	10	54	56	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 25	2003	114	2					148	150		10.1016/S0092-8674(03)00561-0	http://dx.doi.org/10.1016/S0092-8674(03)00561-0			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887914	Bronze			2022-12-28	WOS:000184378700002
J	Grill, SW; Howard, J; Schaffer, E; Stelzer, EHK; Hyman, A				Grill, SW; Howard, J; Schaffer, E; Stelzer, EHK; Hyman, A			The distribution of active force generators controls mitotic spindle position	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS EMBRYOS; C-ELEGANS; CELL-DIVISION; POLARITY; MECHANISMS; DROSOPHILA; GEOMETRY; MITOSIS; PROTEIN; COMPLEX	During unequal cell divisions a mitotic spindle is eccentrically positioned before cell cleavage. To determine the basis of the net force imbalance that causes spindle displacement in one-cell Caenorhabditis elegans embryos, we fragmented centrosomes with an ultraviolet laser. Analysis of the mean and variance of fragment speeds suggests that the force imbalance is due to a larger number of force generators pulling on astral microtubules of the posterior aster relative to the anterior aster. Moreover, activation of heterotrimeric guanine nucleotide-binding protein (G protein) alpha subunits is required to generate these astral forces.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; European Mol Biol Lab, D-69117 Heidelberg, Germany	Max Planck Society; European Molecular Biology Laboratory (EMBL)	Grill, SW (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	grill@mpi-cbg.de; howard@mpi-cbg.de	Howard, Jonathon/J-7492-2016; Hyman, Tony/F-1923-2011; Howard, Jonathon/D-4229-2011; Grill, Stephan/D-9427-2012; Stelzer, Ernst H K/A-7648-2011; Hyman, Anthony A/B-3917-2017; Schäffer, Erik/A-4664-2010	Howard, Jonathon/0000-0003-0086-1196; Howard, Jonathon/0000-0003-0086-1196; Stelzer, Ernst H K/0000-0003-1545-0736; Hyman, Anthony A/0000-0003-3664-154X; Schäffer, Erik/0000-0001-7876-085X				ALBERTSON DG, 1984, DEV BIOL, V101, P61, DOI 10.1016/0012-1606(84)90117-9; Cai Y, 2003, CELL, V112, P51, DOI 10.1016/S0092-8674(02)01170-4; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Gonczy P, 2002, TRENDS CELL BIOL, V12, P332, DOI 10.1016/S0962-8924(02)02306-1; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Hannak E, 2002, J CELL BIOL, V157, P591, DOI 10.1083/jcb.200202047; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; KEMPHUES KJ, 1997, C ELEGANS, V0002, P00335; Lyczak R, 2002, DEV CELL, V3, P157, DOI 10.1016/S1534-5807(02)00226-5; Mitchison TJ, 2001, NAT CELL BIOL, V3, pE17, DOI 10.1038/35050656; Pellettieri J, 2002, SCIENCE, V298, P1946, DOI 10.1126/science.1072162; Sachs L, 1984, APPL STAT HDB TECHNI; SCHMIDT DMZ, UNPUB; Schuyler SC, 2001, J CELL SCI, V114, P247; Severson AF, 2002, CURR BIOL, V12, P2066, DOI 10.1016/S0960-9822(02)01355-6; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; SIGWORTH FJ, 1977, NATURE, V270, P265, DOI 10.1038/270265a0; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Tsou MFB, 2003, J CELL BIOL, V160, P845, DOI 10.1083/jcb.200209079	26	264	275	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2003	301	5632					518	521		10.1126/science.1086560	http://dx.doi.org/10.1126/science.1086560			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12881570				2022-12-28	WOS:000184340500043
J	Caspi, A; Sugden, K; Moffitt, TE; Taylor, A; Craig, IW; Harrington, H; McClay, J; Mill, J; Martin, J; Braithwaite, A; Poulton, R				Caspi, A; Sugden, K; Moffitt, TE; Taylor, A; Craig, IW; Harrington, H; McClay, J; Mill, J; Martin, J; Braithwaite, A; Poulton, R			Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene	SCIENCE			English	Article							MAJOR DEPRESSION; EVENTS; HISTORY; PERSPECTIVES; LIABILITY; GENOMICS; ONSET	In a prospective-longitudinal study of a representative birth cohort, we tested why stressful experiences lead to depression in some people but not in others. A functional polymorphism in the promoter region of the serotonin transporter (5-HTT) gene was found to moderate the influence of stressful life events on depression. Individuals with one or two copies of the short allele of the 5-HTT promoter polymorphism exhibited more depressive symptoms, diagnosable depression, and suicidality in relation to stressful life events than individuals homozygous for the long allele. This epidemiological study thus provides evidence of a gene-by-environment interaction, in which an individual's response to environmental insults is moderated by his or her genetic makeup.	Kings Coll London, Inst Psychiat, PSychiat Res Ctr, MRC Social Genet & Dev Psychiat Res Ctr, London SE5 8AF, England; Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; Univ Otago, Dept Pathol, Dunedin, New Zealand; Univ Otago, Dunedin Sch Med, Dunedin, New Zealand	University of London; King's College London; University of Wisconsin System; University of Wisconsin Madison; University of Otago; University of Otago	Moffitt, TE (corresponding author), Kings Coll London, Inst Psychiat, PSychiat Res Ctr, MRC Social Genet & Dev Psychiat Res Ctr, PO80 De Crespigny Pk, London SE5 8AF, England.	t.moffitt@iop.kcl.ac.uk	caspi, avshalom/AAJ-5874-2020; Sugden, Karen/O-6046-2019; Craig, Ian/AAF-9167-2019; Mill, Jonathan S/B-3276-2010; Mill, Jonathan/B-5678-2014; Sugden, Karen/I-8531-2016; McClay, Joseph/C-9931-2009; anand, amit/A-7222-2009; Moffitt, Terrie E/D-5295-2011; caspi, avshalom/D-5294-2011; Zhang, Xiao/V-9027-2017	caspi, avshalom/0000-0003-0082-4600; Sugden, Karen/0000-0002-4076-5927; Mill, Jonathan S/0000-0003-1115-3224; Mill, Jonathan/0000-0003-1115-3224; Sugden, Karen/0000-0002-4076-5927; McClay, Joseph/0000-0002-3628-2447; Moffitt, Terrie E/0000-0002-8589-6760; caspi, avshalom/0000-0003-0082-4600; Zhang, Xiao/0000-0002-2932-5875; Craig, Ian/0000-0002-4063-1005	NIMH NIH HHS [MH49414, MH45070] Funding Source: Medline; Economic and Social Research Council [L330253002] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH049414, R01MH045070, R01MH049414] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aiken L.S., 1991, MULTIPLE REGRESSION; APA, 1994, DIAGN STAT MAN MENT; Belli RF, 2001, PUBLIC OPIN QUART, V65, P45, DOI 10.1086/320037; Bennett AJ, 2002, MOL PSYCHIATR, V7, P118, DOI 10.1038/sj/mp/4000949; Brown GW, 1998, SOC PSYCH PSYCH EPID, V33, P363, DOI 10.1007/s001270050067; Caspi A, 1996, INT J METHOD PSYCH, V6, P101, DOI 10.1002/(SICI)1234-988X(199607)6:2<101::AID-MPR156>3.3.CO;2-E; Costello EJ, 2002, BIOL PSYCHIAT, V52, P529, DOI 10.1016/S0006-3223(02)01372-0; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Hamer D, 2002, SCIENCE, V298, P71, DOI 10.1126/science.1077582; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hill AVS, 1999, BRIT MED BULL, V55, P401, DOI 10.1258/0007142991902457; Kendler KS, 1997, PSYCHOL MED, V27, P539, DOI 10.1017/S0033291797004716; KENDLER KS, 1995, AM J PSYCHIAT, V152, P833; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lesch KP, 2003, BEHAVIORAL GENETICS IN THE POSTGENOMIC ERA, P389, DOI 10.1037/10480-020; Lesch KP, 2002, MOL GENETICS HUMAN P, P109; MONROE SM, 1991, PSYCHOL BULL, V110, P406, DOI 10.1037/0033-2909.110.3.406; Murphy DL, 2001, BRAIN RES BULL, V56, P487, DOI 10.1016/S0361-9230(01)00622-0; Pine DS, 2002, J AFFECT DISORDERS, V68, P49, DOI 10.1016/S0165-0327(00)00331-1; PLOMIN R, 1991, BEHAV BRAIN SCI, V14, P373, DOI 10.1017/S0140525X00070278; Robins L, 1995, DIAGNOSTIC INTERVIEW; Salichon N, 2001, J NEUROSCI, V21, P884, DOI 10.1523/JNEUROSCI.21-03-00884.2001; Tamminga CA, 2002, BIOL PSYCHIAT, V52, P589, DOI 10.1016/S0006-3223(02)01470-1; TANG CJ, 1997, LANCET, V349, P1498	29	5381	5541	29	1461	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2003	301	5631					386	389		10.1126/science.1083968	http://dx.doi.org/10.1126/science.1083968			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	702CG	12869766				2022-12-28	WOS:000184207300050
J	Bryant, Z; Stone, MD; Gore, J; Smith, SB; Cozzarelli, NR; Bustamante, C				Bryant, Z; Stone, MD; Gore, J; Smith, SB; Cozzarelli, NR; Bustamante, C			Structural transitions and elasticity from torque measurements on DNA	NATURE			English	Article								Knowledge of the elastic properties of DNA is required to understand the structural dynamics of cellular processes such as replication and transcription. Measurements of force and extension on single molecules of DNA(1-3) have allowed direct determination of the molecule's mechanical properties, provided rigorous tests of theories of polymer elasticity(4), revealed unforeseen structural transitions induced by mechanical stresses(3,5-7), and established an experimental and conceptual framework for mechanical assays of enzymes that act on DNA(8). However, a complete description of DNA mechanics must also consider the effects of torque, a quantity that has hitherto not been directly measured in micromanipulation experiments. We have measured torque as a function of twist for stretched DNA-torsional strain in over- or underwound molecules was used to power the rotation of submicrometre beads serving as calibrated loads. Here we report tests of the linearity of DNA's twist elasticity, direct measurements of the torsional modulus (finding a value similar to40% higher than generally accepted), characterization of torque-induced structural transitions, and the establishment of a framework for future assays of torque and twist generation by DNA-dependent enzymes. We also show that cooperative structural transitions in DNA can be exploited to construct constant-torque wind-up motors and force-torque converters.	Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.			Bustamante, Carlos/0000-0002-2970-0073				Allemand JF, 1998, P NATL ACAD SCI USA, V95, P14152, DOI 10.1073/pnas.95.24.14152; Bouchiat C, 1998, PHYS REV LETT, V80, P1556, DOI 10.1103/PhysRevLett.80.1556; Bustamante C, 2003, NATURE, V421, P423, DOI 10.1038/nature01405; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cluzel P, 1996, SCIENCE, V271, P792, DOI 10.1126/science.271.5250.792; CROTHERS DM, 1992, METHOD ENZYMOL, V212, P3; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; DAVIS MH, 1969, CHEM ENG SCI, V24, P1769, DOI 10.1016/0009-2509(69)87020-X; Harada Y, 2001, NATURE, V409, P113, DOI 10.1038/35051126; Heath PJ, 1996, J MOL BIOL, V260, P718, DOI 10.1006/jmbi.1996.0432; HOROWITZ DS, 1984, J MOL BIOL, V173, P75, DOI 10.1016/0022-2836(84)90404-2; Leger JF, 1999, PHYS REV LETT, V83, P1066, DOI 10.1103/PhysRevLett.83.1066; MILLAR DP, 1980, P NATL ACAD SCI USA, V77, P5593, DOI 10.1073/pnas.77.10.5593; Moroz JD, 1998, MACROMOLECULES, V31, P6333, DOI 10.1021/ma971804a; Sarkar A, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.051903; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; SELVIN PR, 1992, SCIENCE, V255, P82, DOI 10.1126/science.1553534; SHORE D, 1983, J MOL BIOL, V170, P983, DOI 10.1016/S0022-2836(83)80199-5; Smith SB, 2003, METHOD ENZYMOL, V361, P134; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; Soong RK, 2000, SCIENCE, V290, P1555, DOI 10.1126/science.290.5496.1555; Strick TR, 1999, GENETICA, V106, P57, DOI 10.1023/A:1003772626927; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; Vologodskii AV, 1997, BIOPHYS J, V73, P123, DOI 10.1016/S0006-3495(97)78053-6; Williams MC, 2002, ACCOUNTS CHEM RES, V35, P159, DOI 10.1021/ar010045k; WOBBE CR, 1985, P NATL ACAD SCI USA, V82, P5710, DOI 10.1073/pnas.82.17.5710; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yasuda R, 1996, J MOL BIOL, V263, P227, DOI 10.1006/jmbi.1996.0571	29	439	460	1	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					338	341		10.1038/nature01810	http://dx.doi.org/10.1038/nature01810			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867987				2022-12-28	WOS:000184183900048
J	Chen, XM				Chen, XM			A microRNA as a translational repressor of APETALA2 in Arabidopsis flower development	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; EXPRESSION; PROTEIN; TARGETS; PLANTS; MIRNA; HEN1	Plant microRNAs ( miRNAs) show a high degree of sequence complementarity to, and are believed to guide the cleavage of, their target messenger RNAs. Here, I show that miRNA172, which can base-pair with the messenger RNA of a. oral homeotic gene, APETALA2, regulates APETALA2 expression primarily through translational inhibition. Elevated miRNA172 accumulation results in. oral organ identity defects similar to those in loss-of-function apetala2 mutants. Elevated levels of mutant APETALA2 RNA with disrupted miRNA172 base pairing, but not wild-type APETALA2 RNA, result in elevated levels of APETALA2 protein and severe. oral patterningdefects. Therefore, miRNA172 likely acts in cell-fate specification as a translational repressor of APETALA2 in Arabidopsis flower development.	Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Chen, XM (corresponding author), Rutgers State Univ, Waksman Inst, POB 759, Piscataway, NJ 08854 USA.	xuemei@waksman.rutgers.edu		Chen, Xuemei/0000-0002-5209-1157	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM61146, R01 GM061146] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061146] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; AUKERMAN M, PLANT CELL, V15, P2730; Bartel B, 2003, PLANT PHYSIOL, V132, P709, DOI 10.1104/pp.103.023630; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Chen XM, 2002, DEVELOPMENT, V129, P1085; Chen XM, 1999, MOL CELL, V3, P349, DOI 10.1016/S1097-2765(00)80462-1; CHEN XQ, UNPUB; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; JOFUKU KD, 1994, PLANT CELL, V6, P1211, DOI 10.1105/tpc.6.9.1211; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lohmann JU, 2002, DEV CELL, V2, P135, DOI 10.1016/S1534-5807(02)00122-3; MIZUKAMI Y, 1992, CELL, V71, P119, DOI 10.1016/0092-8674(92)90271-D; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Pasquinelli AE, 2002, ANNU REV CELL DEV BI, V18, P495, DOI 10.1146/annurev.cellbio.18.012502.105832; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1	19	1288	1483	23	266	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2004	303	5666					2022	2025		10.1126/science.1088060	http://dx.doi.org/10.1126/science.1088060			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806JI	12893888	Green Accepted			2022-12-28	WOS:000220429800043
J	Ross, L; Johansen, C; Dalton, SO; Mellemkjae, L; Thomassen, LH; Mortensen, PB; Olsen, JH				Ross, L; Johansen, C; Dalton, SO; Mellemkjae, L; Thomassen, LH; Mortensen, PB; Olsen, JH			Psychiatric hospitalizations among survivors of cancer in childhood or adolescence	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VOLUME CHANGES; SCHIZOPHRENIA; DISORDER; REGISTER; CONSEQUENCES; RADIATION; DENMARK	BACKGROUND We investigated whether children and adolescents who survive cancer are at increased risk for psychiatric hospitalization. METHODS In a nationwide, population-based, retrospective cohort study, 3710 persons who survived at least three years after a diagnosis of cancer in childhood or adolescence in the period from 1943 to 1990, and who were alive on January 1, 1970, or were born after that date, were identified in the Danish Cancer Registry. This population was followed up for psychiatric hospitalization from January 1, 1970, through 1993 by linkage with the Danish national Psychiatric Central Register. The number of expected cases was based on the national rates of hospitalization for psychiatric disease. RESULTS Among the 3710 survivors of cancer in childhood or adolescence, there was a total of 88 psychiatric hospitalizations. The risk of hospitalization for any psychiatric disease was higher among the survivors than in the general population, but the excess risk was restricted to survivors of brain tumor (the standardized hospitalization ratio [SHR], corresponding to the ratio of observed to expected cases of hospitalization for psychiatric disease, was 1.8; 95 percent confidence interval, 1.5 to 2.2). An increased risk of psychoses of somatic, cerebral causes (SHR, 7.7; 95 percent confidence interval, 4.1 to 13.2), psychiatric disorders in somatic disease (SHR, 5.1; 95 percent confidence interval, 2.5 to 9.1), and schizophrenia and related disorders (SHR, 2.4; 95 percent confidence interval, 1.2 to 4.4) was observed among survivors of brain tumor. There was no evidence of a significantly increased risk of major depression. CONCLUSIONS The risk of hospitalization for a psychiatric disorder is not increased among survivors of cancer in childhood or adolescence, except among survivors of brain tumor.	Danish Canc Soc, Inst Canc Epidemiol, DK-2100 Copenhagen, Denmark; Aarhus Univ, Natl Ctr Register Based Res, Aarhus, Denmark	Danish Cancer Society; Aarhus University	Johansen, C (corresponding author), Danish Canc Soc, Inst Canc Epidemiol, Strandblvd 49, DK-2100 Copenhagen, Denmark.	christof@cancer.dk	Mortensen, Preben B/D-2358-2015; Johansen, Christoffer/AAG-7916-2020	Mortensen, Preben B/0000-0002-5230-9865; Johansen, Christoffer/0000-0002-4384-206X; Olsen, Jorgen Helge/0000-0001-9633-5662; Ross, Lone/0000-0002-4406-604X; Dalton, Susanne Oksbjerg/0000-0002-5485-2730				Arvidson J, 1999, PSYCHO-ONCOLOGY, V8, P123; BIRCH JM, 1987, INT J CANCER, V40, P620, DOI 10.1002/ijc.2910400508; BROWN PD, 1995, ACTA PAEDIATR, V84, P316, DOI 10.1111/j.1651-2227.1995.tb13636.x; COUSENS P, 1988, J CHILD PSYCHOL PSYC, V29, P839, DOI 10.1111/j.1469-7610.1988.tb00757.x; *DAN NAT BOARD HLT, 2003, CANC INC DENM 1998; *DAN NAT BOARD HLT, 1976, KLASS SYGD; Eiser C, 1998, J CHILD PSYCHOL PSYC, V39, P621, DOI 10.1111/1469-7610.00362; Garwicz S, 2000, INT J CANCER, V88, P672, DOI 10.1002/1097-0215(20001115)88:4<672::AID-IJC24>3.0.CO;2-N; GLAUSER TA, 1991, CHILD NERV SYST, V7, P2, DOI 10.1007/BF00263824; Gray R. E., 1992, PSYCHO-ONCOLOGY, V1, P235, DOI [10.1002/pon.2960010406, DOI 10.1002/PON.2960010406]; GREENBERG HS, 1989, J PEDIATR-US, V114, P488, DOI 10.1016/S0022-3476(89)80581-5; Hulshoff HE, 2002, AM J PSYCHIAT, V159, P244, DOI 10.1176/appi.ajp.159.2.244; *I PSYCH DEM, 1994, ANN REP 1993; Kessing LV, 1998, EUR PSYCHIAT, V13, P392, DOI 10.1016/S0924-9338(99)80685-3; Kokkonen J, 1997, PEDIATR HEMAT ONCOL, V14, P223, DOI 10.3109/08880019709009492; LESKO LM, 1990, PROG CLIN BIOL RES, V352, P423; Lieberman JA, 1999, BIOL PSYCHIAT, V46, P729, DOI 10.1016/S0006-3223(99)00147-X; LOFFLER W, 1994, ACTA PSYCHIAT SCAND, V90, P196, DOI 10.1111/j.1600-0447.1994.tb01577.x; Loganovsky KN, 2000, SCHIZOPHRENIA BULL, V26, P751, DOI 10.1093/oxfordjournals.schbul.a033492; Mathalon DH, 2001, ARCH GEN PSYCHIAT, V58, P148, DOI 10.1001/archpsyc.58.2.148; McGlashan TH, 2000, ARCH GEN PSYCHIAT, V57, P637, DOI 10.1001/archpsyc.57.7.637; MunkJorgensen P, 1997, DAN MED BULL, V44, P82; MUNKJORGENSEN P, 1992, BRIT J PSYCHIAT, V161, P489, DOI 10.1192/bjp.161.4.489; Percy C., 1990, INT CLASSIFICATION D; ROMAN DD, 1995, INT J RADIAT ONCOL, V31, P983, DOI 10.1016/0360-3016(94)00550-8; Rothman K, 1979, NIH PUBL; SCHMALE AH, 1983, PSYCHOSOM MED, V45, P163, DOI 10.1097/00006842-198305000-00008; Storm HH, 1997, DAN MED BULL, V44, P535; TETA MJ, 1986, J CHRON DIS, V39, P751, DOI 10.1016/0021-9681(86)90158-X; Woods BT, 1998, AM J PSYCHIAT, V155, P1661, DOI 10.1176/ajp.155.12.1661	30	50	51	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2003	349	7					650	657		10.1056/NEJMoa022672	http://dx.doi.org/10.1056/NEJMoa022672			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	711FL	12917301				2022-12-28	WOS:000184728900005
J	Simone, JV				Simone, JV			Childhood leukemia - Successes and challenges for survivors	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Simone Consulting, Dunwoody, GA 30338 USA		Simone, JV (corresponding author), Simone Consulting, Dunwoody, GA 30338 USA.								0	8	8	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2003	349	7					627	628		10.1056/NEJMp030094	http://dx.doi.org/10.1056/NEJMp030094			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711FL	12917297				2022-12-28	WOS:000184728900001
J	Stein, BD; Jaycox, LH; Kataoka, SH; Wong, M; Tu, WL; Elliott, MN; Fink, A				Stein, BD; Jaycox, LH; Kataoka, SH; Wong, M; Tu, WL; Elliott, MN; Fink, A			A mental health intervention for schoolchildren exposed to violence - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTTRAUMATIC-STRESS-DISORDER; NO SAFE HAVEN; COMMUNITY VIOLENCE; CHILDREN; ADOLESCENTS; SYMPTOMS; PSYCHOTHERAPY; PTSD; DEPRESSION; TRAUMA	Context No randomized controlled studies have been conducted to date on the effectiveness of psychological interventions for children with symptoms of posttraumatic stress disorder (PTSD) that has resulted from personally witnessing or being personally exposed to violence. Objective To evaluate the effectiveness of a collaboratively designed school-based intervention for reducing children's symptoms of PTSD and depression that has resulted from exposure to violence. Design A randomized controlled trial conducted during the 2001-2002 academic year. Setting and Participants Sixth-grade students at 2 large middle schools in Los Angeles who reported exposure to violence and had clinical levels of symptoms of PTSD. Intervention Students were randomly assigned to a 10-session standardized cognitive-behavioral therapy (the Cognitive-Behavioral Intervention for Trauma in Schools) early intervention group (n = 61) or to a wait-list delayed intervention comparison group (n = 65) conducted by trained school mental health clinicians. Main Outcome Measures Students were assessed before the intervention and 3 months after the intervention on measures assessing child-reported symptoms of PTSD (Child PTSD Symptom Scale; range, 0-51 points) and depression (Child Depression Inventory; range, 0-52 points), parent-reported psychosocial dysfunction (Pediatric Symptom Checklist; range, 0-70 points), and teacher-reported classroom problems using the Teacher-Child Rating Scale (acting out, shyness/anxiousness, and learning problems; range of subscales, 6-30 points). Results Compared with the wait-list delayed intervention group (no intervention), after 3 months of intervention students who were randomly assigned to the early intervention group had significantly lower scores on symptoms of PTSD (8.9 vs 15.5, adjusted mean difference, -7.0; 95% confidence interval [CI], -10.8 to -3.2), depression (9.4 vs 12.7, adjusted mean difference, -3.4; 95% CI, -6.5 to -0.4), and psychosocial dysfunction (12.5 vs 16.5, adjusted mean difference, -6.4; 95% CI, -10.4 to -2.3). Adjusted mean differences between the 2 groups at 3 months did not show significant differences for teacher-reported classroom problems in acting out (-1.0; 95% CI, -2.5 to 0.5), shyness/anxiousness (0.1; 95% CI, -1.5 to 1.7), and learning (-1.1, 95% CI, -2.9 to 0.8). At 6 months, after both groups had received the intervention, the differences between the 2 groups were not significantly different for symptoms of PTSD and depression; showed similar ratings for psychosocial function; and teachers did not report significant differences in classroom behaviors. Conclusion A standardized 10-session cognitive-behavioral group intervention can significantly decrease symptoms of PTSD and depression in students who are exposed to violence and can be effectively delivered on school campuses by trained school-based mental health clinicians.	RAND Corp, Santa Monica, CA 90407 USA; RAND Corp, Arlington, VA USA; Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA; Los Angeles Unified Sch Dist, Los Angeles, CA USA	RAND Corporation; RAND Corporation; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Stein, BD (corresponding author), RAND Corp, 1700 Main St, Santa Monica, CA 90407 USA.	stein@rand.org	Stein, Bradley/O-8403-2019; Stein, Bradley/A-7978-2009		NATIONAL INSTITUTE OF MENTAL HEALTH [K12MH000990] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; ADELMAN HS, 1993, J CLIN CHILD PSYCHOL, V22, P52, DOI 10.1207/s15374424jccp2201_5; BELL CC, 1993, PSYCHIATRY, V56, P46; Berman SL, 1996, AM J ORTHOPSYCHIAT, V66, P329, DOI 10.1037/h0080183; Berton MW, 1996, ADOLESCENCE, V31, P489; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; *BUR JUST STAT, 1997, AG PATT FICT SER VIO; BURNS BJ, 1995, HEALTH AFFAIR, V14, P147, DOI 10.1377/hlthaff.14.3.147; Cantwell DP, 1997, J AM ACAD CHILD PSY, V36, P610, DOI 10.1097/00004583-199705000-00011; *CDCP, 2002, YOUTH VIOL; Chemtob CM, 2002, ARCH PEDIAT ADOL MED, V156, P211, DOI 10.1001/archpedi.156.3.211; CHRISTOFFEL KK, 1990, AM J DIS CHILD, V144, P697, DOI 10.1001/archpedi.1990.02150300095025; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cohen JA, 1996, J AM ACAD CHILD PSY, V35, P42, DOI 10.1097/00004583-199601000-00011; Cohen S, 1998, ARTFORUM, V37, P10; *CTR HLTH HLTH CAR, SCH BAS HLTH CTR RES; Cuffe SP, 1998, J AM ACAD CHILD PSY, V37, P147, DOI 10.1097/00004583-199802000-00006; DEBLINGER E, 1996, TREATING SEXUALLY AB, V256; Delaney-Black V, 2002, ARCH PEDIAT ADOL MED, V156, P280, DOI 10.1001/archpedi.156.3.280; DRYFOOS J, 1997, SCH HLTH OUR NATIONS, P373; Dumas JE, 1999, APPL PREV PSYCHOL, V8, P175, DOI 10.1016/S0962-1849(05)80076-9; Farrell AD, 1997, J CLIN CHILD PSYCHOL, V26, P2, DOI 10.1207/s15374424jccp2601_1; Farrell SP, 1998, BEHAV THER, V29, P241, DOI 10.1016/S0005-7894(98)80005-1; FINCH AJ, 1985, J CONSULT CLIN PSYCH, V53, P424, DOI 10.1037/0022-006X.53.3.424; FITZPATRICK KM, 1993, J AM ACAD CHILD PSY, V32, P424, DOI 10.1097/00004583-199303000-00026; Flaherty LT, 1998, J SCHOOL HEALTH, V68, P420, DOI 10.1111/j.1746-1561.1998.tb06321.x; Foa EB, 2001, J CLIN CHILD PSYCHOL, V30, P376, DOI 10.1207/S15374424JCCP3003_9; Gall G, 2000, J SCHOOL HEALTH, V70, P292, DOI 10.1111/j.1746-1561.2000.tb07254.x; Garrison EG, 1999, CLIN PSYCHOL REV, V19, P199, DOI 10.1016/S0272-7358(98)00070-1; Goenjian AK, 1997, AM J PSYCHIAT, V154, P536; HIGHTOWER AD, 1986, SCHOOL PSYCHOL REV, V15, P393; HOAGWOOD K, 1995, J CONSULT CLIN PSYCH, V63, P683, DOI 10.1037/0022-006X.63.5.683; HOROWITZ K, 1995, J AM ACAD CHILD PSY, V34, P1353, DOI 10.1097/00004583-199510000-00021; Hurt H, 2001, ARCH PEDIAT ADOL MED, V155, P1351, DOI 10.1001/archpedi.155.12.1351; JAYCOX L, IN PRESS COGNITIVE B; Jaycox LH, 2002, J AM ACAD CHILD PSY, V41, P1104, DOI 10.1097/00004583-200209000-00011; Jellinek MS, 1999, ARCH PEDIAT ADOL MED, V153, P254; JELLINEK MS, 1986, J PEDIATR-US, V109, P371, DOI 10.1016/S0022-3476(86)80408-5; Kataoka SH, 2003, J AM ACAD CHILD PSY, V42, P311, DOI 10.1097/00004583-200303000-00011; Kataoka SH, 2002, AM J PSYCHIAT, V159, P1548, DOI 10.1176/appi.ajp.159.9.1548; KENDALL PC, 1989, COGNITIVE THER RES, V13, P109, DOI 10.1007/BF01173268; Kliewer W, 1998, J CONSULT CLIN PSYCH, V66, P199, DOI 10.1037/0022-006X.66.1.199; KOOP CE, 1992, JAMA-J AM MED ASSOC, V267, P3075, DOI 10.1001/jama.267.22.3075; KOVACS M, 1985, PSYCHOPHARMACOL BULL, V21, P995; KOVACS M, 1981, ACTA PAEDOPSYCHIATR, V46, P305; March JS, 1998, J AM ACAD CHILD PSY, V37, P585, DOI 10.1097/00004583-199806000-00008; MARTINEZ P, 1993, PSYCHIATRY, V56, P22; *MICR, 2001, MICR EXC MAC 2001; MURPHY JM, 1992, J AM ACAD CHILD PSY, V31, P1105, DOI 10.1097/00004583-199211000-00019; Pine DS, 2002, BIOL PSYCHIAT, V51, P519, DOI 10.1016/S0006-3223(01)01352-X; Pynoos Robert S., 1996, P331; RICHTERS JE, 1993, PSYCHIATRY, V56, P7; Rones M, 2000, Clin Child Fam Psychol Rev, V3, P223, DOI 10.1023/A:1026425104386; Saigh PA, 1997, BEHAV RES THER, V35, P429, DOI 10.1016/S0005-7967(96)00111-8; Schoenwald SK, 2001, PSYCHIATR SERV, V52, P1190, DOI 10.1176/appi.ps.52.9.1190; SCHUBINER H, 1993, J ADOLESCENT HEALTH, V14, P214, DOI 10.1016/1054-139X(93)90008-D; Schwab-Stone M, 1999, J AM ACAD CHILD PSY, V38, P359, DOI 10.1097/00004583-199904000-00007; SCHWABSTONE ME, 1995, J AM ACAD CHILD PSY, V34, P1343, DOI 10.1097/00004583-199510000-00020; SIECUS/Advocates for Youth, 1999, SURVEY AM VIEWS SEXU; SINGER MI, 1995, JAMA-J AM MED ASSOC, V273, P477, DOI 10.1001/jama.273.6.477; STATA, 2001, STAT STAT SOFTW REL; Stein BD, 2002, J BEHAV HEALTH SER R, V29, P318, DOI 10.1007/BF02287371; U.S. Public Health Service, 2000, SURG GEN C CHILDR ME; *US DEP HHS, 2001, YOUGH VIOL REP SURG; WEISZ JR, 1987, J CONSULT CLIN PSYCH, V55, P542, DOI 10.1037/0022-006X.55.4.542; Weisz JR, 2000, ARCH GEN PSYCHIAT, V57, P837, DOI 10.1001/archpsyc.57.9.837; WEISZ JR, 1992, AM PSYCHOL, V47, P1578, DOI 10.1037/0003-066X.47.12.1578; WEISZ JR, 1995, J CONSULT CLIN PSYCH, V63, P688, DOI 10.1037/0022-006X.63.5.688; Zima BT., 2000, J CHILD FAM STUD, V9, DOI DOI 10.1023/A:1009415800475	69	414	416	1	57	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2003	290	5					603	611		10.1001/jama.290.5.603	http://dx.doi.org/10.1001/jama.290.5.603			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	708GH	12902363	Bronze			2022-12-28	WOS:000184558500014
J	Cass, HD; Smith, I; Unthank, C; Starling, C; Collins, JE				Cass, HD; Smith, I; Unthank, C; Starling, C; Collins, JE			Improving compliance with requirements on junior doctors' hours	BRITISH MEDICAL JOURNAL			English	Article								Problem Compliance with UK regulations on junior doctors' working hours cannot be achieved by manipulating rotas that maintain existing tiers of cover and work practices. More radical solutions are needed. Design Audit of change. Setting Paediatric night rota in large children's hospital. Key measures for improvement Compliance with regulations on working hours assessed by diary cards, workload assessed by staff attendance on wards; patient safety assessed through critical incident reports. Strategies for change Development of new staff I roles, followed by change from a partial shift rota comprising 11 doctors and one senior nurse, to a full shift night team comprising three middle grade doctors and two senior nurses. Effects of change Compliance with regulations on working hours increased from 33% to 77%. Workload changed little and was well within the capacity of the new night team. The effect on patient care and on medical staff requires further evaluation. Lessons learnt Reduction of junior doctors' working hours requires changes to roles, processes, and practices throughout the organisation.	Great Ormond St Hosp Children NHS Trust, London WC1N 3JH, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Cass, HD (corresponding author), Great Ormond St Hosp Children NHS Trust, Great Ormond St, London WC1N 3JH, England.		Cass, Hilary/L-6780-2019	Cass, Hilary/0000-0001-8598-9134				Blundell Adrian, 2002, BMJ, V325, pS23, DOI 10.1136/bmj.325.7356.S23; *DEP HLTH, 1991, NEW DEAL; Moss F, 2000, BRIT MED J, V320, P1224, DOI 10.1136/bmj.320.7244.1224	3	22	22	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 2	2003	327	7409					270	273		10.1136/bmj.327.7409.270	http://dx.doi.org/10.1136/bmj.327.7409.270			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708KP	12896942	Green Published			2022-12-28	WOS:000184566300023
J	Baldwin, MP; Stephenson, DB; Thompson, DWJ; Dunkerton, TJ; Charlton, AJ; O'Neill, A				Baldwin, MP; Stephenson, DB; Thompson, DWJ; Dunkerton, TJ; Charlton, AJ; O'Neill, A			Stratospheric memory and skill of extended-range weather forecasts	SCIENCE			English	Article							ARCTIC OSCILLATION; SURFACE CLIMATE; ANNULAR MODES; POLAR VORTEX; TROPOSPHERE; PROPAGATION	We use an empirical statistical model to demonstrate significant skill in making extended-range forecasts of the monthly-mean Arctic Oscillation (AO). Forecast skill derives from persistent circulation anomalies in the lowermost stratosphere and is greatest during boreal winter. A comparison to the Southern Hemisphere provides evidence that both the time scale and predictability of the AO depend on the presence of persistent circulation anomalies just above the tropopause. These circulation anomalies most likely affect the troposphere through changes to waves in the upper troposphere, which induce surface pressure changes that correspond to the AO.	NW Res Associates Inc, Bellevue, WA 98007 USA; Univ Reading, Dept Meteorol, Reading RG6 6BB, Berks, England; Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA	NorthWest Research Associates; University of Reading; Colorado State University	Baldwin, MP (corresponding author), NW Res Associates Inc, 14508 NE 20th St, Bellevue, WA 98007 USA.		Thompson, David W J/F-9627-2012; Baldwin, Mark/J-6720-2012; Charlton-Perez, Andrew/F-4079-2010; Stephenson, David/A-9903-2011	Thompson, David W J/0000-0002-5413-4376; Charlton-Perez, Andrew/0000-0001-8179-6220; 				Baldwin MP, 1999, J GEOPHYS RES-ATMOS, V104, P30937, DOI 10.1029/1999JD900445; Baldwin MP, 2001, SCIENCE, V294, P581, DOI 10.1126/science.1063315; Black RX, 2002, J CLIMATE, V15, P268, DOI 10.1175/1520-0442(2002)015<0268:SFOSCI>2.0.CO;2; CHARLTON AJ, IN PRESS Q J R METEO; Charney J.G., 1981, MONSOON DYNAMICS, P99, DOI [10.1017/cbo9780511897580.009, DOI 10.1017/CBO9780511897580.009]; CHEN P, 1992, J ATMOS SCI, V49, P2533, DOI 10.1175/1520-0469(1992)049<2533:POPWBT>2.0.CO;2; HAYNES PH, 1989, Q J ROY METEOR SOC, V115, P1181, DOI 10.1002/qj.49711549002; HAYNES PH, 1991, J ATMOS SCI, V48, P651, DOI 10.1175/1520-0469(1991)048<0651:OTCOED>2.0.CO;2; Hoerling M, 2003, SCIENCE, V299, P691, DOI 10.1126/science.1079053; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; JOLLIFFE IT, 2003, FORECAST VERIFICATIO, P203; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1019, DOI 10.1175/1520-0477(2002)083<1019:NDSFS>2.3.CO;2; Limpasuvan V, 2000, J CLIMATE, V13, P4414, DOI 10.1175/1520-0442(2000)013<4414:WMAMOC>2.0.CO;2; Lorenz DJ, 2003, J CLIMATE, V16, P1212, DOI 10.1175/1520-0442(2003)16<1212:EFFITN>2.0.CO;2; MADDEN RA, 1971, J ATMOS SCI, V28, P702, DOI 10.1175/1520-0469(1971)028<0702:DOADOI>2.0.CO;2; Norton WA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016958; Perlwitz J, 2001, GEOPHYS RES LETT, V28, P271, DOI 10.1029/2000GL012405; PERLWITZ J, IN PRESS J CLIMATE; Shepherd TG, 2002, J METEOROL SOC JPN, V80, P769, DOI 10.2151/jmsj.80.769; Thompson DWJ, 2000, J CLIMATE, V13, P1000, DOI 10.1175/1520-0442(2000)013<1018:AMITEC>2.0.CO;2; Thompson DWJ, 2001, SCIENCE, V293, P85, DOI 10.1126/science.1058958; Thompson DWJ, 1998, GEOPHYS RES LETT, V25, P1297, DOI 10.1029/98GL00950; Thompson DWJ, 2002, J CLIMATE, V15, P1421, DOI 10.1175/1520-0442(2002)015<1421:SCTNHW>2.0.CO;2; VONSTORCH H, 1999, STAT ANAL CLIMATE RE, P321; Wallace JM, 2000, Q J ROY METEOR SOC, V126, P791, DOI 10.1256/smsqj.56401; *WORLD MET ORG, 1992, MAN GLOB DAT PROC SY, V1	26	387	428	10	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2003	301	5633					636	640		10.1126/science.1087143	http://dx.doi.org/10.1126/science.1087143			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893941				2022-12-28	WOS:000184473600037
J	Knorr, G; Lohmann, G				Knorr, G; Lohmann, G			Southern Ocean origin for the resumption of Atlantic thermohaline circulation during deglaciation	NATURE			English	Article							LAST DEGLACIATION; CLIMATE; WATER; ICE; FLUXES; CYCLE; CO2	During the two most recent deglaciations, the Southern Hemisphere warmed before Greenland(1,2). At the same time, the northern Atlantic Ocean was exposed to meltwater discharge(3), which is generally assumed to reduce the formation of North Atlantic Deep Water(4,5). Yet during deglaciation, the Atlantic thermohaline circulation became more vigorous, in the transition from a weak glacial to a strong interglacial mode(6). Here we use a three-dimensional ocean circulation model(7) to investigate the impact of Southern Ocean warming and the associated sea-ice retreat(8) on the Atlantic thermohaline circulation. We find that a gradual warming in the Southern Ocean during deglaciation induces an abrupt resumption of the interglacial mode of the thermohaline circulation, triggered by increased mass transport into the Atlantic Ocean via the warm (Indian Ocean) and cold (Pacific Ocean) water route(9,10). This effect prevails over the influence of meltwater discharge, which would oppose a strengthening of the thermohaline circulation. A Southern Ocean trigger for the transition into an interglacial mode of circulation provides a consistent picture of Southern and Northern hemispheric climate change at times of deglaciation, in agreement with the available proxy records.	Univ Hamburg, Inst Meteorol, D-20146 Hamburg, Germany; Univ Bremen, Fachbereich Geowissensch, D-28334 Bremen, Germany; Univ Bremen, Forschungszentrum Ozeanrander, D-28334 Bremen, Germany	University of Hamburg; University of Bremen; University of Bremen	Knorr, G (corresponding author), Univ Hamburg, Inst Meteorol, Bundesstr 55, D-20146 Hamburg, Germany.		Lohmann, Gerrit/M-7453-2016	Lohmann, Gerrit/0000-0003-2089-733X; Knorr, Gregor/0000-0002-8317-5046				Bard E, 2000, SCIENCE, V289, P1321, DOI 10.1126/science.289.5483.1321; Berger WH, 1996, SOUTH ATLANTIC, P363; Broecker W.S., 1991, OCEANOGRAPHY, V4, P79, DOI DOI 10.5670/0CEAN0G.1991.07; Crowley TJ, 1992, PALEOCEANOGRAPHY, V7, P489, DOI 10.1029/92PA01058; Ganopolski A, 2001, NATURE, V409, P153, DOI 10.1038/35051500; GORDON AL, 1992, J GEOPHYS RES-OCEANS, V97, P7223, DOI 10.1029/92JC00485; Kim SJ, 1998, SCIENCE, V280, P728, DOI 10.1126/science.280.5364.728; Koutavas A, 2002, SCIENCE, V297, P226, DOI 10.1126/science.1072376; Lohmann G, 2000, PALEOCEANOGRAPHY, V15, P537, DOI 10.1029/1999PA000471; Lohmann G, 2000, J GEOPHYS RES-ATMOS, V105, P17417, DOI 10.1029/2000JD900189; Macdonald AM, 1996, NATURE, V382, P436, DOI 10.1038/382436a0; MAIERREIMER E, 1993, J PHYS OCEANOGR, V23, P731, DOI 10.1175/1520-0485(1993)023<0731:MCOTHL>2.0.CO;2; Marshall SJ, 1999, QUATERNARY RES, V52, P300, DOI 10.1006/qres.1999.2079; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Prange M, 2003, J PHYS OCEANOGR, V33, P1707, DOI 10.1175/2389.1; PRANGE M, 2002, GEOPHYS RES LETT, V29; Ruhlemann C, 1999, NATURE, V402, P511, DOI 10.1038/990069; Sachs JP, 2001, SCIENCE, V293, P2077, DOI 10.1126/science.1063584; SARNTHEIN M, 1994, PALEOCEANOGRAPHY, V9, P209, DOI 10.1029/93PA03301; Schott W., 1935, WISSENSCHAFTLICHE ER, V3, P43; SCHOUTEN MW, 2002, J GEOPHYS RES, V107; Shemesh A., 2002, PALEOCEANOGRAPHY, V17; Shin SI, 2003, CLIM DYNAM, V20, P127, DOI 10.1007/s00382-002-0260-x; SOWERS T, 1995, SCIENCE, V269, P210, DOI 10.1126/science.269.5221.210; Stephens BB, 2000, NATURE, V404, P171, DOI 10.1038/35004556; Stocker TF, 2001, CONTINUUM MECHANICS AND APPLICATIONS IN GEOPHYSICS AND THE ENVIRONMENT, P337; STOCKER TF, 1991, NATURE, V351, P729, DOI 10.1038/351729a0; STOMMEL H, 1961, TELLUS, V13, P224, DOI 10.1111/j.2153-3490.1961.tb00079.x; Toggweiler JR, 1999, PALEOCEANOGRAPHY, V14, P571, DOI 10.1029/1999PA900033; Weijer W, 2002, GLOBAL PLANET CHANGE, V34, P293, DOI 10.1016/S0921-8181(02)00121-2	30	210	214	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					532	536		10.1038/nature01855	http://dx.doi.org/10.1038/nature01855			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891352				2022-12-28	WOS:000184454700037
J	Reefhuis, J; Honein, MA; Whitney, CG; Chamany, S; Mann, EA; Biernath, KR; Broder, K; Manning, S; Avashia, S; Victor, M; Costa, P; Devine, O; Graham, A; Boyle, C				Reefhuis, J; Honein, MA; Whitney, CG; Chamany, S; Mann, EA; Biernath, KR; Broder, K; Manning, S; Avashia, S; Victor, M; Costa, P; Devine, O; Graham, A; Boyle, C			Risk of bacterial meningitis in children with cochlear implants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECURRENT MENINGITIS; DYSPLASIA	BACKGROUND: In June 2002, the Food and Drug Administration received reports of bacterial meningitis in patients with cochlear implants for treatment of hearing loss. Implants that included a positioner (a wedge inserted next to the implanted electrode to facilitate transmission of the electrical signal by pushing the electrode against the medial wall of the cochlea) were voluntarily recalled in the United States in July 2002. METHODS: We identified patients with meningitis and conducted a cohort study and a nested case-control investigation involving 4264 children who had received cochlear implants in the United States between January 1, 1997, and August 6, 2002, and who were less than six years of age when they received the implants. We calculated the incidence of meningitis in the cohort and assessed risk factors for meningitis among patients and among 199 controls, using data from interviews with parents and abstracted from medical records. RESULTS: We identified 26 children with bacterial meningitis. The incidence of meningitis caused by Streptococcus pneumoniae was 138.2 cases per 100,000 person-years - more than 30 times the incidence in a cohort of the same age in the general U.S. population. Postimplantation bacterial meningitis was strongly associated with the use of an implant with a positioner (odds ratio, 4.5 [95 percent confidence interval, 1.3 to 17.9], with adjustment for medical, surgical, and environmental factors) and with the joint presence of radiographic evidence of a malformation of the inner ear and a cerebrospinal fluid leak (adjusted odds ratio, 9.3 [95 percent confidence interval, 1.2 to 94.5]). The incidence of meningitis among patients who had received an implant with a positioner remained higher than the incidence among those whose implants did not have a positioner for the duration of follow-up (24 months from the time of implantation). CONCLUSIONS: Parents and health care providers should ensure that all children who receive cochlear implants are appropriately vaccinated and are then monitored and treated promptly for any bacterial infections after receiving the implant.	Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Epidemiol Program Off, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA 30333 USA; US FDA, Rockville, MD 20857 USA; New York City Dept Hlth & Mental Hyg, New York, NY USA; Texas Dept Hlth, Austin, TX 78756 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; US Food & Drug Administration (FDA); New York City Department of Health & Mental Hygiene; Texas Department of State Health Services	Reefhuis, J (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, 1600 Clifton Rd NE,MS E-86, Atlanta, GA 30333 USA.		Reefhuis, Jennita/E-1793-2011	Reefhuis, Jennita/0000-0002-4747-4831				*ADV BION CORP, EL POS; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Arnold W, 2002, ORL J OTO-RHINO-LARY, V64, P382, DOI 10.1159/000067579; BERMAN S, 1995, NEW ENGL J MED, V332, P1560, DOI 10.1056/NEJM199506083322307; GATES GA, 1995, JAMA-J AM MED ASSOC, V274, P1955, DOI 10.1001/jama.1995.03530240065043; Govaerts PJ, 2002, OTOL NEUROTOL, V23, P885, DOI 10.1097/00129492-200211000-00013; Greenland S., 1998, MODERN EPIDEMIOLOGY; Hammes DM, 2002, ANN OTO RHINOL LARYN, V111, P74, DOI 10.1177/00034894021110S516; HAYASHI N, 1989, CLIN PEDIATR, V28, P139, DOI 10.1177/000992288902800308; HERTHER C, 1985, LARYNGOSCOPE, V95, P655; Iles K, 2001, J PAEDIATR CHILD H, V37, P388, DOI 10.1046/j.1440-1754.2001.00698.x; JACKLER RK, 1987, LARYNGOSCOPE, V97, P2; KLEIN JO, 1994, CLIN INFECT DIS, V19, P823, DOI 10.1093/clinids/19.5.823; KLINE MW, 1989, PEDIATR INFECT DIS J, V8, P630, DOI 10.1097/00006454-198909000-00013; *NAT I DEAFN OTH C, 2003, COCHL IMPL; Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002; OHLMS LA, 1990, ARCH OTOLARYNGOL, V116, P608; PHELPS PD, 1994, AM J OTOL, V15, P551; Richter B, 2002, J LARYNGOL OTOL, V116, P507, DOI 10.1258/002221502760132584; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; Sharman RL, 2002, AM BOOK REV, V23, P9; VALMARI P, 1986, INFECTION, V14, P36, DOI 10.1007/BF01644809; 2002, MMWR MORB MORTAL WKL, V51, P931; 2003, MMWR MORB MORTAL WKL, V52, P191; 2002, MMWR MORB MORTAL WKL, V51, P706; 2003, MMWR MORB MORTAL WKL, V52, pQ1	26	185	197	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2003	349	5					435	445		10.1056/NEJMoa031101	http://dx.doi.org/10.1056/NEJMoa031101			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706FV	12890842				2022-12-28	WOS:000184443700005
J	Schaak, RE; Klimczuk, T; Foo, ML; Cava, RJ				Schaak, RE; Klimczuk, T; Foo, ML; Cava, RJ			Superconductivity phase diagram of NaxCoO2 center dot 1.3H(2)O	NATURE			English	Article							NACO2O4	The microscopic origin of superconductivity in the high-transition-temperature (high-T-c) copper oxides remains the subject of active inquiry; several of their electronic characteristics are well established as universal to all the known materials, forming the experimental foundation that all theories must address. The most fundamental of those characteristics, for both the copper oxides and other superconductors, is the dependence of the superconducting T-c on the degree of electronic band filling. The recent report of superconductivity 1 near 4 K in the layered sodium cobalt oxyhydrate, Na0.35CoO2.1.3H(2)O, is of interest owing to both its triangular cobalt-oxygen lattice and its generally analogous chemical and structural relationships to the copper oxide superconductors. Here we show that the superconducting T-c of this compound displays the same kind of behaviour on chemical doping that is observed in the high-T-c copper oxides. Specifically, the optimal superconducting Tc occurs in a narrow range of sodium concentrations (and therefore electron concentrations) and decreases for both underdoped and overdoped materials, as observed in the phase diagram of the copper oxide superconductors. The analogy is not perfect, however, suggesting that NaxCoO2.1.3H(2)O, with its triangular lattice geometry and special magnetic characteristics, may provide insights into systems where coupled charge and spin dynamics play an essential role in leading to superconductivity.	Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; Gdansk Univ Technol, Fac Appl Phys & Math, PL-80952 Gdansk, Poland; Princeton Univ, Princeton Mat Inst, Princeton, NJ 08540 USA	Princeton University; Fahrenheit Universities; Gdansk University of Technology; Princeton University	Cava, RJ (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.		Foo, Maw Lin/H-9273-2012; Klimczuk, Tomasz/M-1716-2013	Klimczuk, Tomasz/0000-0003-2602-5049; Klimczuk, Tomasz/0000-0002-7089-4631; Foo, Maw Lin/0000-0002-6217-7368				BASKARAN G, 2003, ELECT MODEL COO2 LAY; Foo ML, 2003, SOLID STATE COMMUN, V127, P33, DOI 10.1016/S0038-1098(03)00334-X; FOUSSASSIER C, 1973, J SOLID STATE CHEM, V6, P532; HONERCAMP C, 2003, INSTABILITIES INTERA; KUMAR B, 2003, SUPERCONDUCTIVITY CO; LORENZ B, 2003, EFFECT HYDROSTATIC P; Singh DJ, 2000, PHYS REV B, V61, P13397, DOI 10.1103/PhysRevB.61.13397; Takada K, 2003, NATURE, V422, P53, DOI 10.1038/nature01450; TANAKA H, 2003, POSSIBLE SPIN TRIPLE; WANG QH, 2003, DOPED T J MODEL TRIA; Wang YY, 2003, NATURE, V423, P425, DOI 10.1038/nature01639	13	288	289	0	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					527	529		10.1038/nature01877	http://dx.doi.org/10.1038/nature01877			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891350	Green Submitted			2022-12-28	WOS:000184454700035
J	Ganzini, L; Goy, ER; Miller, LL; Harvath, TA; Jackson, A; Delorit, MA				Ganzini, L; Goy, ER; Miller, LL; Harvath, TA; Jackson, A; Delorit, MA			Nurses' experiences with hospice patients who refuse food and fluids to hasten death	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHYSICIAN-ASSISTED SUICIDE; AMYOTROPHIC-LATERAL-SCLEROSIS; VOLUNTARY ACTIVE EUTHANASIA; TERMINALLY ILL PATIENTS; LAST RESORT; ATTITUDES; HYDRATION; CONVERSATION; DEHYDRATION; ONCOLOGISTS	Background: Voluntary refusal of food and fluids has been proposed as an alternative to physician-assisted suicide for terminally ill patients who wish to hasten death. There are few reports of patients who have made this choice. Methods: We mailed a questionnaire to all nurses employed by hospice programs in Oregon and analyzed the results. Results: Of 429 eligible nurses, 307 (72 percent) returned the questionnaire, and 102 of the respondents (33 percent) reported that in the previous four years they had cared for a patient who deliberately hastened death by voluntary refusal of food and fluids. Nurses reported that patients chose to stop eating and drinking because they were ready to die, saw continued existence as pointless, and considered their quality of life poor. The survey showed that 85 percent of patients died within 15 days after stopping food and fluids. On a scale from 0 (a very bad death) to 9 (a very good death), the median score for the quality of these deaths, as rated by the nurses, was 8. On the basis of the hospice nurses' reports, the patients who stopped eating and drinking were older than 55 patients who died by physician-assisted suicide (74 vs. 64 years of age, P<0.001), less likely to want to control the circumstances of their death (P<0.001), and less likely to be evaluated by a mental health professional (9 percent vs. 45 percent, P<0.001). Conclusions: On the basis of reports by nurses, patients in hospice care who voluntarily choose to refuse food and fluids are elderly, no longer find meaning in living, and usually die a "good'' death within two weeks after stopping food and fluids.	Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR USA; Oregon Hlth & Sci Univ, Sch Nursing, Portland, OR USA; Oregon Hospice Assoc, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University	Ganzini, L (corresponding author), Oregon Hlth Sci Univ, Vet Affairs Med Ctr, Div Mental Hlth, P3MHDC,POB 1034, Portland, OR 97207 USA.		Harvath, Theresa/L-1115-2019					Back AL, 1996, JAMA-J AM MED ASSOC, V275, P919, DOI 10.1001/jama.275.12.919; BERNAT JL, 1993, ARCH INTERN MED, V153, P2723, DOI 10.1001/archinte.153.24.2723; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; EDDY DM, 1994, JAMA-J AM MED ASSOC, V272, P179, DOI 10.1001/jama.272.3.179; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V284, P2460, DOI 10.1001/jama.284.19.2460; Emanuel LL, 1998, JAMA-J AM MED ASSOC, V280, P643, DOI 10.1001/jama.280.7.643; GANZINI L, 1994, AM J PSYCHIAT, V151, P1631; Ganzini L, 2000, NEW ENGL J MED, V342, P1538; Ganzini L, 2002, NEW ENGL J MED, V347, P582, DOI 10.1056/NEJMsa020562; Ganzini L, 1998, NEW ENGL J MED, V339, P967, DOI 10.1056/NEJM199810013391406; Jansen LA, 2002, ANN INTERN MED, V136, P845, DOI 10.7326/0003-4819-136-11-200206040-00014; Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; Miller FG, 1998, ANN INTERN MED, V128, P559, DOI 10.7326/0003-4819-128-7-199804010-00007; Passik SD, 1998, J CLIN ONCOL, V16, P1594, DOI 10.1200/JCO.1998.16.4.1594; Quill TE, 2000, ANN INTERN MED, V132, P1011, DOI 10.7326/0003-4819-132-5-200003070-00012; Quill TE, 1997, JAMA-J AM MED ASSOC, V278, P2099, DOI 10.1001/jama.278.23.2099; Rowland LP, 1998, NEW ENGL J MED, V339, P987, DOI 10.1056/NEJM199810013391409; Stead WW, 1998, ANN INTERN MED, V129, P1080, DOI 10.7326/0003-4819-129-12-199812150-00033; SULLIVAN RJ, 1993, J GEN INTERN MED, V8, P220, DOI 10.1007/BF02599271; Sulmasy DP, 2000, ANN INTERN MED, V133, P562, DOI 10.7326/0003-4819-133-7-200010030-00023; Sulmasy DP, 2000, ANN INTERN MED, V133, P560, DOI 10.7326/0003-4819-133-7-200010030-00021; Wilson KG, 2000, ARCH INTERN MED, V160, P2454, DOI 10.1001/archinte.160.16.2454	23	136	140	0	16	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2003	349	4					359	365		10.1056/NEJMsa035086	http://dx.doi.org/10.1056/NEJMsa035086			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703ZH	12878744				2022-12-28	WOS:000184312800011
J	Krzyzanowska, MK; Pintilie, M; Tannock, IF				Krzyzanowska, MK; Pintilie, M; Tannock, IF			Factors associated with failure to publish large randomized trials presented at an oncology meeting	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	38th Annual Meeting of the American-Society-of-Clinical-Oncology	MAY 18-21, 2002	ORLANDO, FL	Amer Soc Clin Oncol			PUBLICATION BIAS; CLINICAL-TRIALS; ABSTRACTS; METAANALYSIS; COHORT; FATE; TIME	Context Large clinical trials are the criterion standard for making treatment decisions, and nonpublication of the results of such trials can lead to bias in the literature and contribute to inappropriate medical decisions. Objectives To determine the rate of full publication of large randomized trials presented at annual meetings of the American Society of Clinical Oncology (ASCO), quantify bias against publishing nonsignificant results, and identify factors associated with time to publication. Design Survey of 510 abstracts from large (sample size, greater than or equal to200), phase 3, randomized controlled trials presented at ASCO meetings between 1989 and 1998. Trial results were classified as significant (Pless than or equal to.05 for the primary outcome measure) or nonsignificant (P>.05 or not reported), and the type of presentation and sponsorship were identified. Subsequent full publication was,identified using a search of MEDLINE and EMBASE, completed November 1, 2001; the search was updated in November 2002, using the Cochrane Register of Controlled Trials. Authors were contacted if the searches did not find evidence of publication. Main Outcome Measures Publication rate at 5 years; time from presentation to full publication. Results Of 510 randomized trials, 26% were not published in full within 5 years after presentation at the meeting. Eighty-one percent of the studies with significant results had been published by this time compared with 68% of the studies with nonsignificant results (P<.001). Studies with oral or plenary presentation were published sooner than those not presented (P=.002), and studies with pharmaceutical sponsorship were published sooner than studies with cooperative group sponsorship or studies for which sponsorship was not specified (P=.02). These factors remained significant in a multivariable model. The most frequent reason cited by authors for not publishing was lack of time, funds, or other resources. Conclusions A substantial number of large phase 3 trials presented at an international oncology meeting remain unpublished 5 years after presentation. Bias against publishing nonsignificant results is a problem even for large randomized trials. Non-publication breaks the contract that investigators make with trial participants, funding agencies, and ethics boards.	Univ Toronto, Princess Margaret Hosp, Dept Med Oncol, Toronto, ON M5G 2M9, Canada; Dana Farber Canc Inst, Dept Adult Oncol, Ctr Outcomes & Policy Res, Boston, MA 02115 USA; Princess Margaret Hosp, Dept Biostat, Toronto, ON M4X 1K9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Harvard University; Dana-Farber Cancer Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Tannock, IF (corresponding author), Univ Toronto, Princess Margaret Hosp, Dept Med Oncol, 610 Univ Ave,Room 5-208, Toronto, ON M5G 2M9, Canada.	ian.tannock@uhn.on.ca	Krzyzanowska, Monika K./ABG-3505-2020	Krzyzanowska, Monika K./0000-0001-5533-7418				*BIOM CENTR, J NEG RES BIOM; CHALMERS I, 1990, JAMA-J AM MED ASSOC, V263, P1401, DOI 10.1001/jama.263.10.1401; CHALMERS I, 1990, JAMA-J AM MED ASSOC, V263, P1405, DOI 10.1001/jama.263.10.1405; Cheng K, 1998, PEDIATR PULM, V26, P101, DOI 10.1002/(SICI)1099-0496(199808)26:2<101::AID-PPUL5>3.3.CO;2-C; DAVIDSON RA, 1986, J GEN INTERN MED, V1, P155, DOI 10.1007/BF02602327; DEBELLEFEUILLE C, 1992, ANN ONCOL, V3, P187, DOI 10.1093/oxfordjournals.annonc.a058147; DICKERSIN K, 1993, ANN NY ACAD SCI, V703, P135, DOI 10.1111/j.1749-6632.1993.tb26343.x; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; Dickersin K, 1997, AIDS EDUC PREV, V9, P15; DICKERSIN K, 1987, CONTROL CLIN TRIALS, V8, P343, DOI 10.1016/0197-2456(87)90155-3; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; EGGER M, 1995, BMJ-BRIT MED J, V310, P752, DOI 10.1136/bmj.310.6982.752; GOLDMAN L, 1980, NEW ENGL J MED, V303, P255, DOI 10.1056/NEJM198007313030504; HOPEWELL S, 2002, COCHRANE LIB; Horton R, 1997, LANCET, V350, P756, DOI 10.1016/S0140-6736(05)62564-0; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Klassen TP, 2002, ARCH PEDIAT ADOL MED, V156, P474, DOI 10.1001/archpedi.156.5.474; KOREN G, 1989, LANCET, V2, P1440; Manheimer E, 2002, BRIT MED J, V325, P528, DOI 10.1136/bmj.325.7363.528; ROCHON PA, 1994, ARCH INTERN MED, V154, P157, DOI 10.1001/archinte.154.2.157; Savulescu J, 1996, BMJ-BRIT MED J, V313, P1390, DOI 10.1136/bmj.313.7069.1390; SCHERER RW, 1994, JAMA-J AM MED ASSOC, V272, P158, DOI 10.1001/jama.272.2.158; SCHERER RW, 2002, COCHRANE LIB; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; STERLING TD, 1959, J AM STAT ASSOC, V54, P30, DOI 10.2307/2282137; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Timmer Antje, 2002, BMC Med Res Methodol, V2, P7, DOI 10.1186/1471-2288-2-7; Weber EJ, 1998, JAMA-J AM MED ASSOC, V280, P257, DOI 10.1001/jama.280.3.257	28	243	244	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2003	290	4					495	501		10.1001/jama.290.4.495	http://dx.doi.org/10.1001/jama.290.4.495			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	703JB	12876092	Bronze			2022-12-28	WOS:000184275300021
J	Fazel, M; Stein, A				Fazel, M; Stein, A			Mental health of refugee children: comparative study	BRITISH MEDICAL JOURNAL			English	Article									Univ Oxford, Warneford Hosp, Dept Psychiat, Sect Child & Adolescent Psychiat, Oxford OX3 7JX, England	University of Oxford	Fazel, M (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Sect Child & Adolescent Psychiat, Oxford OX3 7JX, England.			Stein, Alan/0000-0001-8207-2822; Fazel, Mina/0000-0001-9342-2365				Fazel M, 2002, ARCH DIS CHILD, V87, P366, DOI 10.1136/adc.87.5.366; Goodman R, 2000, BRIT J PSYCHIAT, V177, P534, DOI 10.1192/bjp.177.6.534; GOODMAN R, 2002, BRIT MED J, V321, P1496; *HOM OFF, 2003, ASYL STAT 4 QUART 20; Meltzer H., 2000, MENTAL HLTH CHILDREN	5	92	92	1	15	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 19	2003	327	7407					134	134		10.1136/bmj.327.7407.134	http://dx.doi.org/10.1136/bmj.327.7407.134			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702WJ	12869455	Green Published, Bronze			2022-12-28	WOS:000184247500018
J	Kim, PJ; Plescia, J; Clevers, H; Fearon, ER; Altieri, DC				Kim, PJ; Plescia, J; Clevers, H; Fearon, ER; Altieri, DC			Survivin and molecular pathogenesis of colorectal cancer	LANCET			English	Article							ANTI-APOPTOSIS GENE; BETA-CATENIN; C-MYC; COLON-CARCINOMA; EXPRESSION; APC; ACTIVATION; IDENTIFICATION; TRANSFORMATION; TRANSCRIPTION	Background Colorectal cancer is thought to originate in the expansion of colonic crypt cells as a result of aberrant gene expression caused by transcription factors of the T-cell factor (TCF)/beta-catenin family. Survivin is a bifunctional regulator of cell death and cell proliferation expressed during embryonic development but undetectable in healthy adult tissues and re-expressed in many cancers, including colorectal cancer. Methods We investigated gene expression by promoter analysis, mutagenesis, and electrophoretic mobility shift assay in colorectal cancer cells. Survivin expression in human and mouse embryonic intestine was determined by in-situ hybridisation and immunohistochemistry. Changes in apoptosis were monitored in cell lines engineered to express stabilising mutations in beta catenin. Findings TCF/beta catenin stimulated a six-fold to 12-fold increased expression of the survivin gene in colorectal cancer cells. Three TCF-binding elements (TBE) in the survivin promoter were occupied by nuclear factors in colorectal cancer cells, and mutagenesis of the two proximal TBE sites abolished survivin gene expression by 75-79%. Strongly expressed at the bottom of human and mouse embryonic intestinal crypts, expression of survivin was lost in TCF-4 knockout animals, and a TCF-4 dominant negative mutant blocked survivin gene transcription in colorectal cancer cells. Expression of non-destructible beta catenin mutants increased survivin expression and protected against ultraviolet-B-induced apoptosis. Interpretation Stimulation of survivin expression by TCF/beta catenin might impose a stem cell-like phenotype to colonic crypt epithelium coupling enhanced cell proliferation with resistance to apoptosis, and contribute to the molecular pathogenesis of colorectal cancer.	Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01605 USA; Ctr Biomed Genet, Humbrecht Lab, NL-3584 CT Utrecht, Netherlands; Univ Michigan, Sch Med, Div Med & Mol Genet, Ann Arbor, MI USA; Univ Michigan, Sch Med, Ctr Canc, Ann Arbor, MI USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Altieri, DC (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, LRB-428,364 Plantat St, Worcester, MA 01605 USA.				NCI NIH HHS [CA78810, CA85463, CA90917] Funding Source: Medline; NHLBI NIH HHS [HL54131] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078810, R01CA085463, R01CA090917] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL054131, R01HL054131] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adida C, 1998, LANCET, V351, P882, DOI 10.1016/S0140-6736(05)70294-4; Adida C, 1998, AM J PATHOL, V152, P43; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Grossman D, 1999, J INVEST DERMATOL, V113, P1076, DOI 10.1046/j.1523-1747.1999.00776.x; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Kawasaki H, 1998, CANCER RES, V58, P5071; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Li FZ, 1999, BIOCHEM J, V344, P305, DOI 10.1042/0264-6021:3440305; Mesri M, 2001, J CLIN INVEST, V108, P981, DOI 10.1172/JCI12983; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; NUSSE R, WNT GENE HOMEPAGE; Polakis P, 2000, GENE DEV, V14, P1837; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Sarela AI, 2001, ANN SURG ONCOL, V8, P305; Smith SD, 2001, JAMA-J AM MED ASSOC, V285, P324, DOI 10.1001/jama.285.3.324; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; You ZB, 2002, J CELL BIOL, V157, P429, DOI 10.1083/jcb.200201110; Zhang T, 2001, CANCER RES, V61, P8664	28	283	305	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 19	2003	362	9379					205	209		10.1016/S0140-6736(03)13910-4	http://dx.doi.org/10.1016/S0140-6736(03)13910-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702PJ	12885482				2022-12-28	WOS:000184232000011
J	Markowitz, AJ; Rabow, MW				Markowitz, AJ; Rabow, MW			Practical considerations in dialysis withdrawal - "To have that option is a blessing"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material														Markowitz, Amy/0000-0001-9314-2814				Cohen LM, 2003, JAMA-J AM MED ASSOC, V289, P2113, DOI 10.1001/jama.289.16.2113	1	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2003	290	6					815	815		10.1001/jama.290.6.815	http://dx.doi.org/10.1001/jama.290.6.815			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	709VU	12915435				2022-12-28	WOS:000184647700033
J	Bouchon, M; Vallee, M				Bouchon, M; Vallee, M			Observation of long supershear rupture during the magnitude 8.1 Kunlunshan earthquake	SCIENCE			English	Article							SHEAR; SIMULATION; CRACKS	The 2001 Kunlunshan earthquake was an extraordinary event that produced a 400-km-long surface rupture. Regional broadband recordings of this event provide an opportunity to accurately observe the speed at which a fault ruptures during an earthquake, which has important implications for seismic risk and for understanding earthquake physics. We determined that rupture propagated on the 400-km-long fault at an average speed of 3.7 to 3.9 km/s, which exceeds the shear velocity of the brittle part of the crust. Rupture started at sub - Rayleigh wave velocity and became supershear, probably approaching 5 km/s, after about 100 km of propagation.	Univ Grenoble 1, F-38041 Grenoble, France; CNRS, Lab Geophys Interne & Tectonophys, F-38041 Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	Bouchon, M (corresponding author), Univ Grenoble 1, Boite Postal 53, F-38041 Grenoble, France.	Michel.Bouchon@ujf-grenoble.fr	Vallée, Martin/K-5192-2012	Vallée, Martin/0000-0001-8049-4634				ANDREWS DJ, 1976, J GEOPHYS RES, V81, P5679, DOI 10.1029/JB081i032p05679; ARCHULETA RJ, 1984, J GEOPHYS RES, V89, P4559, DOI 10.1029/JB089iB06p04559; BERNARD P, 2002, EUR SEISM COMM 28 M; Bouchon M, 2000, GEOPHYS RES LETT, V27, P3013, DOI 10.1029/2000GL011761; BOUCHON M, 1981, B SEISMOL SOC AM, V71, P959; BURRIDGE R, 1973, GEOPHYS J ROY ASTR S, V35, P439, DOI 10.1111/j.1365-246X.1973.tb00608.x; DAS S, 1977, GEOPHYS J ROY ASTR S, V50, P643, DOI 10.1111/j.1365-246X.1977.tb01339.x; DAY SM, 1982, B SEISMOL SOC AM, V72, P1881; Dunham EM, 2003, SCIENCE, V299, P1557, DOI 10.1126/science.1080650; ELLSWORTH WL, 1999, AM GEOPH UN FALL M S, V80, pF648; FREUND LB, 1979, J GEOPHYS RES, V84, P2199, DOI 10.1029/JB084iB05p02199; Lin AM, 2002, SCIENCE, V296, P2015, DOI 10.1126/science.1070879; Madariaga R., 2002, INT HDB EARTHQUAKE A, V81A, P175, DOI DOI 10.1016/S0074-6142%2802%2980215-7; OKUBO PG, 1989, J GEOPHYS RES-SOLID, V94, P12321, DOI 10.1029/JB094iB09p12321; Olsen KB, 1997, SCIENCE, V278, P834, DOI 10.1126/science.278.5339.834; Rosakis AJ, 1999, SCIENCE, V284, P1337, DOI 10.1126/science.284.5418.1337; Rosakis AJ, 2000, MATER RES INNOV, V3, P236, DOI 10.1007/s100190050009; SPUDICH P, 1984, B SEISMOL SOC AM, V74, P2083; Weertman J, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013916; Xu X., 2002, SEISMOL RES LETT, V73, P884, DOI [10.1785/gssrl.73.6.884, DOI 10.1785/GSSRL.73.6.884]	20	221	228	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2003	301	5634					824	826		10.1126/science.1086832	http://dx.doi.org/10.1126/science.1086832			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907799				2022-12-28	WOS:000184615700042
J	Santarelli, L; Saxe, M; Gross, C; Surget, A; Battaglia, F; Dulawa, S; Weisstaub, N; Lee, J; Duman, R; Arancio, O; Belzung, C; Hen, R				Santarelli, L; Saxe, M; Gross, C; Surget, A; Battaglia, F; Dulawa, S; Weisstaub, N; Lee, J; Duman, R; Arancio, O; Belzung, C; Hen, R			Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants	SCIENCE			English	Article							CHOLINERGIC SYSTEMS; CELL-PROLIFERATION; MAJOR DEPRESSION; ANXIETY DISORDER; DENTATE GYRUS; ANIMAL-MODEL; GREY-MATTER; ADULT; STRESS; DESIPRAMINE	Various chronic antidepressant treatments increase adult hippocampal neurogenesis, but the functional importance of this phenomenon remains unclear. Here, using genetic and radiological methods, we show that disrupting antidepressant-induced neurogenesis blocks behavioral responses to antidepressants. Serotonin 1A receptor null mice were insensitive to the neurogenic and behavioral effects of fluoxetine, a serotonin selective reuptake inhibitor. X-irradiation of a restricted region of mouse brain containing the hippocampus prevented the neurogenic and behavioral effects of two classes of antidepressants. These findings suggest that the behavioral effects of chronic antidepressants may be mediated by the stimulation of neurogenesis in the hippocampus.	Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Univ Tours, F-37200 Tours, France; NYU, Sch Med, Nathan Kline Res Inst, New York, NY 10016 USA; Yale Univ, Lab Mol Psychiat, Dept Psychiat, New Haven, CT 06508 USA	Columbia University; Universite de Tours; Nathan Kline Institute for Psychiatric Research; New York University; Yale University	Hen, R (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA.		Dulawa, Stephanie/M-8070-2016; Surget, Alexandre/C-6630-2013; Belzung, Catherine/P-6512-2016; arancio, ottavio/AAB-7959-2019; Weisstaub, Noelia/ABA-1706-2021	Dulawa, Stephanie/0000-0003-1281-782X; Surget, Alexandre/0000-0002-0333-4634; Belzung, Catherine/0000-0001-6095-5974; arancio, ottavio/0000-0001-6335-164X				Bannerman DM, 2002, BEHAV NEUROSCI, V116, P884, DOI 10.1037//0735-7044.116.5.884; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; Czeh B, 2001, P NATL ACAD SCI USA, V98, P12796, DOI 10.1073/pnas.211427898; Deacon RMJ, 2002, BEHAV NEUROSCI, V116, P494, DOI 10.1037//0735-7044.116.3.494; Degroot A, 2002, BRAIN RES, V949, P60, DOI 10.1016/S0006-8993(02)02965-7; Delgado PL, 1999, BIOL PSYCHIAT, V46, P212, DOI 10.1016/S0006-3223(99)00014-1; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Eichenbaum H, 1999, CURR BIOL, V9, pR482, DOI 10.1016/S0960-9822(99)80301-7; File SE, 2000, PHARMACOL BIOCHEM BE, V66, P65, DOI 10.1016/S0091-3057(00)00198-2; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; Gorman JM, 2002, J CLIN PSYCHIAT, V63, P17; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Gray JA, 2000, NEUROPSYCHOLOGY ANXI; Griebel G, 2002, P NATL ACAD SCI USA, V99, P6370, DOI 10.1073/pnas.092012099; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Gurvits TV, 1996, BIOL PSYCHIAT, V40, P1091, DOI 10.1016/S0006-3223(96)00229-6; Kempermann G, 2002, BIPOLAR DISORD, V4, P17, DOI 10.1034/j.1399-5618.2002.40101.x; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; McNaughton N, 1997, PHARMACOL BIOCHEM BE, V56, P603, DOI 10.1016/S0091-3057(96)00419-4; Menard J, 2001, BRAIN RES, V888, P163, DOI 10.1016/S0006-8993(00)03046-8; Menard J, 1998, BEHAV PHARMACOL, V9, P93; Moore GJ, 2000, LANCET, V356, P1241, DOI 10.1016/S0140-6736(00)02793-8; Nagai R, 2000, SURG NEUROL, V53, P503, DOI 10.1016/S0090-3019(00)00214-7; Page ME, 1999, PSYCHOPHARMACOLOGY, V147, P162, DOI 10.1007/s002130051156; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Sapolsky RM, 1992, STRESS AGING BRAIN M; Sargent PA, 2000, ARCH GEN PSYCHIAT, V57, P174, DOI 10.1001/archpsyc.57.2.174; Shah PJ, 1998, BRIT J PSYCHIAT, V172, P527, DOI 10.1192/bjp.172.6.527; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Tada E, 2000, NEUROSCIENCE, V99, P33, DOI 10.1016/S0306-4522(00)00151-2; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wong ML, 2001, NAT REV NEUROSCI, V2, P343, DOI 10.1038/35072566	37	3273	3465	13	477	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2003	301	5634					805	809		10.1126/science.1083328	http://dx.doi.org/10.1126/science.1083328			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907793				2022-12-28	WOS:000184615700036
J	Sulston, J				Sulston, J			Beyond release: the equitable use of genomic information	LANCET			English	Editorial Material									Wellcome Trust Sanger Inst, Cambridge CB10 1RQ, England	Wellcome Trust Sanger Institute	Sulston, J (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1RQ, England.	jes@sanger.ac.uk						Commission on Intellectual Property Rights, INT INT PROP RIGHTS; *DEP INT DEV, GOV RESP REP COMM IN; HUBBARD T, 2003, NEW SCI, V178, P29; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; *NUFF COUNC BIOETH, ETH PAT DNA; *ROYAL SOC, KEEP SCI OP EFF INT; Thambisetty S, 2002, NAT BIOTECHNOL, V20, P775, DOI 10.1038/nbt0802-775a; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	8	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2003	362	9381					400	402		10.1016/S0140-6736(03)14030-5	http://dx.doi.org/10.1016/S0140-6736(03)14030-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707FB	12907016				2022-12-28	WOS:000184498700024
J	Gershon, D				Gershon, D			Probing the proteome	NATURE			English	Article																			0	31	35	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					581	+		10.1038/424581a	http://dx.doi.org/10.1038/424581a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891368	Bronze			2022-12-28	WOS:000184454700049
J	Gordon, JM; Feuermann, D; Huleihil, M; Mizrahi, S; Shaco-Levy, R				Gordon, JM; Feuermann, D; Huleihil, M; Mizrahi, S; Shaco-Levy, R			Fibre optics - Surgery by sunlight on live animals	NATURE			English	Editorial Material							SOLAR SURGERY		Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Dept Solar Energy & Environm Phys, IL-84990 Sede Boqer, Israel; Ben Gurion Univ Negev, Dept Mech Engn, Pearlstone Ctr Aeronaut Engn Studies, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Dept Surg A, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Dept Pathol, Soroka Med Ctr, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University	Gordon, JM (corresponding author), Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Dept Solar Energy & Environm Phys, IL-84990 Sede Boqer, Israel.		GORDON, JEFFREY/F-1432-2012; feuermann, daniel/G-7545-2011	feuermann, daniel/0000-0002-9381-2387				De Sanctis JT, 1998, CARDIOVASC INTER RAD, V21, P273, DOI 10.1007/s002709900263; Feuermann D, 1998, OPT ENG, V37, P2760, DOI 10.1117/1.601813; Feuermann D, 2002, SOL ENERGY, V72, P459, DOI 10.1016/S0038-092X(02)00025-7; Fujitomi Y, 1999, LASER SURG MED, V24, P14, DOI 10.1002/(SICI)1096-9101(1999)24:1<14::AID-LSM4>3.0.CO;2-2; Gordon JM, 2003, J APPL PHYS, V93, P4843, DOI 10.1063/1.1558999; Gordon JM, 2002, APPL PHYS LETT, V81, P2653, DOI 10.1063/1.1510942; Katzir A., 1993, LASERS OPTICAL FIBER	7	14	14	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					510	510		10.1038/424510a	http://dx.doi.org/10.1038/424510a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891346	Bronze			2022-12-28	WOS:000184454700030
J	Harris, KD; Csicsvari, J; Hirase, H; Dragoi, G; Buzsaki, G				Harris, KD; Csicsvari, J; Hirase, H; Dragoi, G; Buzsaki, G			Organization of cell assemblies in the hippocampus	NATURE			English	Article							PYRAMIDAL CELLS; PHASE PRECESSION; BEHAVING RAT; PLACE CELLS; NEURONS; OSCILLATIONS; ENSEMBLE; CODE; DYNAMICS; PATTERNS	Neurons can produce action potentials with high temporal precision(1). A fundamental issue is whether, and how, this capability is used in information processing. According to the 'cell assembly' hypothesis, transient synchrony of anatomically distributed groups of neurons underlies processing of both external sensory input and internal cognitive mechanisms(2-4). Accordingly, neuron populations should be arranged into groups whose synchrony exceeds that predicted by common modulation by sensory input. Here we find that the spike times of hippocampal pyramidal cells can be predicted more accurately by using the spike times of simultaneously recorded neurons in addition to the animals location in space. This improvement remained when the spatial prediction was refined with a spatially dependent theta phase modulation(5-8). The time window in which spike times are best predicted from simultaneous peer activity is 10-30 ms, suggesting that cell assemblies are synchronized at this timescale. Because this temporal window matches the membrane time constant of pyramidal neurons(9), the period of the hippocampal gamma oscillation(10) and the time window for synaptic plasticity(11), we propose that cooperative activity at this timescale is optimal for information transmission and storage in cortical circuits.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.		Hirase, Hajime/A-3709-2012; Harris, Kenneth/B-3469-2009	Hirase, Hajime/0000-0003-3806-6905; Buzsaki, Gyorgy/0000-0002-3100-4800; Harris, Kenneth/0000-0002-5930-6456				Brown EN, 1998, J NEUROSCI, V18, P7411; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; Cox D., 1980, POINT PROCESSES; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; deCharms RC, 2000, ANNU REV NEUROSCI, V23, P613, DOI 10.1146/annurev.neuro.23.1.613; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fenton AA, 1998, P NATL ACAD SCI USA, V95, P3182, DOI 10.1073/pnas.95.6.3182; Freiwald W A, 2001, Prog Brain Res, V130, P111; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hebb Donald O., 1949, ORG BEHAV; Hirase H, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-10-j0003.2001; Jensen O, 2000, J NEUROPHYSIOL, V83, P2602, DOI 10.1152/jn.2000.83.5.2602; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Quirk MC, 1999, J NEUROSCI METH, V94, P41, DOI 10.1016/S0165-0270(99)00124-7; Redish AD, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-05-j0004.2001; Reinagel P, 2002, J NEUROSCI, V22, P6837; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SPRUSTON N, 1992, J NEUROPHYSIOL, V67, P508, DOI 10.1152/jn.1992.67.3.508; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605	30	554	559	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					552	556		10.1038/nature01834	http://dx.doi.org/10.1038/nature01834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891358				2022-12-28	WOS:000184454700043
J	Hu, ZP; Yang, QD; Bo, X; Li, JH				Hu, ZP; Yang, QD; Bo, X; Li, JH			Clinical picture - Herpes simplex encephalitis	LANCET			English	Editorial Material									Second Xiangya Hosp, Dept Neurol, Changsha 410011, Peoples R China; Xiangya Hosp, Changsha 410011, Peoples R China; Cent S Univ, Dept Pathol, Changsha 410011, Peoples R China	Central South University; Central South University	Hu, ZP (corresponding author), Second Xiangya Hosp, Dept Neurol, Changsha 410011, Peoples R China.								0	3	3	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2003	362	9380					280	280		10.1016/S0140-6736(03)13969-4	http://dx.doi.org/10.1016/S0140-6736(03)13969-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705UL	12892957				2022-12-28	WOS:000184413400009
J	Marquet, RL; Bartelds, A; Visser, GJ; Spreeuwenberg, P; Peters, L				Marquet, RL; Bartelds, A; Visser, GJ; Spreeuwenberg, P; Peters, L			Twenty five years of requests for euthanasia and physician assisted suicide in Dutch general practice: trend analysis	BRITISH MEDICAL JOURNAL			English	Article									Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands	Netherlands Institute for Health Services Research	Marquet, RL (corresponding author), Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands.							de Wit MAS, 2001, EMERG INFECT DIS, V7, P82, DOI 10.3201/eid0701.010113; Hughes J, 2000, J Appl Philos, V17, P213, DOI 10.1111/1468-5930.00155; Lavery JV, 2001, LANCET, V358, P362, DOI 10.1016/S0140-6736(01)05555-6; ONWUTEAKAPHILIP.BD, 1990, LANCET; Thynne Kelisiana, 2002, J Law Med, V10, P232	5	30	30	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2003	327	7408					201	202		10.1136/bmj.327.7408.201	http://dx.doi.org/10.1136/bmj.327.7408.201			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706DL	12881262	Bronze, Green Published			2022-12-28	WOS:000184437300018
J	Saunders, Y; Ross, JR; Riley, J				Saunders, Y; Ross, JR; Riley, J			Planning for a good death: responding to unexpected events	BRITISH MEDICAL JOURNAL			English	Article							CRITICALLY ILL; PHYSICIANS; CARE; FUTILITY; PATIENT; CANCER		Royal Marsden Hosp, Dept Palliat Med, London SW3 6JJ, England	Royal Marsden NHS Foundation Trust	Saunders, Y (corresponding author), Royal Marsden Hosp, Dept Palliat Med, London SW3 6JJ, England.							BARRY PW, 1994, ARCH DIS CHILD, V71, P8, DOI 10.1136/adc.71.1.8; BRODY H, 1994, J AM GERIATR SOC, V42, P875, DOI 10.1111/j.1532-5415.1994.tb06562.x; Choudhry NK, 2003, ANN INTERN MED, V138, P65, DOI 10.7326/0003-4819-138-1-200301070-00014; FABERLANGENDOEN K, 1991, ARCH INTERN MED, V151, P235, DOI 10.1001/archinte.151.2.235; Finlay I, 1996, BRIT J HOSP MED, V56, P264; Flabouris A, 1999, ANAESTH INTENS CARE, V27, P385, DOI 10.1177/0310057X9902700410; HAVILL JH, 1995, NEW ZEAL MED J, V108, P378; Iserson KV, 1996, ANN EMERG MED, V28, P51, DOI 10.1016/S0196-0644(96)70139-7; JASTREMSKI MS, 1993, CRIT CARE MED, V21, P931; SCHNEIDERMAN LJ, 1994, J AM GERIATR SOC, V42, P883, DOI 10.1111/j.1532-5415.1994.tb06564.x; SLEVIN ML, 1990, BRIT MED J, V300, P1458, DOI 10.1136/bmj.300.6737.1458; Smith R, 2000, BMJ-BRIT MED J, V320, P129, DOI 10.1136/bmj.320.7228.129; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; VEATCH RM, 1994, J AM GERIATR SOC, V42, P871, DOI 10.1111/j.1532-5415.1994.tb06561.x	14	20	21	1	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2003	327	7408					204	206		10.1136/bmj.327.7408.204	http://dx.doi.org/10.1136/bmj.327.7408.204			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706DL	12881264	Green Published			2022-12-28	WOS:000184437300020
J	Manoharan, VN; Elsesser, MT; Pine, DJ				Manoharan, VN; Elsesser, MT; Pine, DJ			Dense packing and symmetry in small clusters of microspheres	SCIENCE			English	Article							SPHERE PACKINGS; COLLOIDS; PARTICLES; POLYHEDRA; SAUSAGES; LIQUIDS	When small numbers of colloidal microspheres are attached to the surfaces of liquid emulsion droplets, removing fluid from the droplets leads to packings of spheres that minimize the second moment of the mass distribution. The structures of the packings range from sphere doublets, triangles, and tetrahedra to exotic polyhedra not found in infinite lattice packings, molecules, or minimum-potential energy clusters. The emulsion system presents a route to produce new colloidal structures and a means to study how different physical constraints affect symmetry in small parcels of matter.	Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Pine, DJ (corresponding author), Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA.	pine@mrl.ucsb.edu	Manoharan, Vinothan N/C-1292-2008; Pine, David J/B-7740-2016	Manoharan, Vinothan N/0000-0003-0370-6095; Pine, David J/0000-0002-3304-6684				Aizenberg J, 2000, PHYS REV LETT, V84, P2997, DOI 10.1103/PhysRevLett.84.2997; BERNAL JD, 1960, NATURE, V185, P68, DOI 10.1038/185068a0; BETKE U, 1995, DISCRETE COMPUT GEOM, V13, P297, DOI 10.1007/BF02574046; BOERDIJK AH, 1952, PHILIPS RES REP, V7, P303; CLARE BW, 1986, P ROY SOC LOND A MAT, V405, P329, DOI 10.1098/rspa.1986.0056; Conway JH, 1999, SPHERE PACKINGS LATT; FejesToth L., 1964, REGULAR FIGURES; Hales TC, 1997, DISCRETE COMPUT GEOM, V17, P1, DOI 10.1007/BF02770863; Hales TC, 1997, DISCRETE COMPUT GEOM, V18, P135, DOI 10.1007/PL00009312; Hidalgo-Alvarez R, 1996, ADV COLLOID INTERFAC, V67, P1, DOI 10.1016/0001-8686(96)00297-7; Hinton R. H., 1976, LAB TECHNIQUES BIO 1, V6; HOARE MR, 1971, ADV PHYS, V20, P161, DOI 10.1080/00018737100101231; JOHNSON NW, 1966, CANADIAN J MATH, V18, P169, DOI 10.4153/CJM-1966-021-8; Kelton KF, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.195504; LEVINE S, 1989, COLLOID SURFACE, V38, P325, DOI 10.1016/0166-6622(89)80271-9; Liu AJ, 1998, NATURE, V396, P21, DOI 10.1038/23819; Mackowski DW, 1996, J OPT SOC AM A, V13, P2266, DOI 10.1364/JOSAA.13.002266; NELSON DR, 1989, SOLID STATE PHYS, V42, P1; O'Hern CS, 2001, PHYS REV LETT, V86, P111, DOI 10.1103/PhysRevLett.86.111; Reichert H, 2000, NATURE, V408, P839, DOI 10.1038/35048537; Saunders BR, 1999, ADV COLLOID INTERFAC, V80, P1, DOI 10.1016/S0001-8686(98)00071-2; Schenk T, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.075507; SLOANE NJA, 1995, DISCRETE COMPUT GEOM, V14, P237, DOI 10.1007/BF02570704; Spaepen F, 2000, NATURE, V408, P781, DOI 10.1038/35048652; Takayasu MM, 1998, J COLLOID INTERF SCI, V202, P84, DOI 10.1006/jcis.1998.5428; WILLIAMS RE, 1971, INORG CHEM, V10, P210, DOI 10.1021/ic50095a046; Wills JM, 1998, MATH INTELL, V20, P16, DOI 10.1007/BF03024394; WOLFE MS, 1989, J COLLOID INTERF SCI, V133, P265, DOI 10.1016/0021-9797(89)90301-9; Yin YD, 2001, ADV MATER, V13, P267, DOI 10.1002/1521-4095(200102)13:4<267::AID-ADMA267>3.0.CO;2-9	29	911	927	8	327	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2003	301	5632					483	487		10.1126/science.1086189	http://dx.doi.org/10.1126/science.1086189			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12881563				2022-12-28	WOS:000184340500033
J	Roman, J; Palumbi, SR				Roman, J; Palumbi, SR			Whales before whaling in the North Atlantic	SCIENCE			English	Article							POPULATION-SIZE; HUMPBACK WHALES; CONSERVATION; POLYMORPHISM; JAPANESE; COLLAPSE	It is well known that hunting dramatically reduced all baleen whale populations, yet reliable estimates of former whale abundances are elusive. Based on coalescent models for mitochondrial DNA sequence variation, the genetic diversity of North Atlantic whales suggests population sizes of approximately 240,000 humpback, 360,000 fin, and 265,000 minke whales. Estimates for fin and humpback whales are far greater than those previously calculated for prewhaling populations and 6 to 20 times higher than present-day population estimates. Such discrepancies suggest the need for a quantitative reevaluation of historical whale populations and a fundamental revision in our conception of the natural state of the oceans.	Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University	Roman, J (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, 16 Divin Ave, Cambridge, MA 02138 USA.							Angliss RP, 1995, REP INT WHAL COMM, V45, P313; [Anonymous], 1999, WALKERS MAMMALS WORL; AVISE JC, 1988, MOL BIOL EVOL, V5, P331; Baker CS, 2000, P ROY SOC B-BIOL SCI, V267, P1191, DOI 10.1098/rspb.2000.1128; BAKER CS, 1993, P NATL ACAD SCI USA, V90, P8239, DOI 10.1073/pnas.90.17.8239; Barlow J, 1997, ECOLOGY, V78, P535; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; CHITTLEBOROUGH R. G., 1965, AUSTRALIAN J MAR FRESHWATER RES, V16, P33; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Horwood J., 1990, BIOL EXPLOITATION MI; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kellogg R., 1922, Proceedings of the United States National Museum, V61, P1; KISHINO H, 1991, ANN I STAT MATH, V43, P435, DOI 10.1007/BF00053365; Klinowska M., 1991, DOLPHINS PORPOISES W; Lockyer C, 1977, Report int Whal Commn, V27, P427; Lockyer C., 1984, REP INT WHAL COMMN S, V6, P27; Lockyer C, 1981, REP INT WHAL COMMN, V31, P389; MATHER R, 1850, J R MATHER; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Neigel JE, 2002, CONSERV GENET, V3, P167, DOI 10.1023/A:1015213626922; NUNNEY L, 1993, EVOLUTION, V47, P1329, DOI 10.1111/j.1558-5646.1993.tb02158.x; Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487; Rand DM, 1996, CONSERV BIOL, V10, P665, DOI 10.1046/j.1523-1739.1996.10020665.x; ROMAN JM, UNPUB; Rooney AP, 2001, EVOLUTION, V55, P1678; Rosenbaum HC, 2002, J HERED, V93, P389, DOI 10.1093/jhered/93.6.389; Sergeant D. E., 1977, Report int. Whal. Commn, V27, P460; Sigurjonsson J, 1995, DEV MAR BIO, V4, P425; Smith TD, 1999, MAR MAMMAL SCI, V15, P1, DOI 10.1111/j.1748-7692.1999.tb00779.x; Soule M., 1976, Molecular evolution., P60; STEVICK PT, 2001, SC53NAH2 IWC; WADA S, 1991, REPORTS INT WHALING, V13, P125; WAPLES R, 1991, REP INT WHALING COMM, V15, P279; Weller David W., 2002, Journal of Cetacean Research and Management, V4, P7; Winn H.E., 1985, HDB MARINE MAMMALS, V3, P241	36	219	238	2	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2003	301	5632					508	510		10.1126/science.1084524	http://dx.doi.org/10.1126/science.1084524			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12881568				2022-12-28	WOS:000184340500040
J	Wozny, C; Kivi, A; Lehmann, TN; Dehnicke, C; Heinemann, U; Behr, J				Wozny, C; Kivi, A; Lehmann, TN; Dehnicke, C; Heinemann, U; Behr, J			Comment on "On the origin of interictal activity in human temporal lobe epilepsy in vitro"	SCIENCE			English	Editorial Material							HIPPOCAMPAL SCLEROSIS		Humboldt Univ, Charite, Neurosci Res Ctr, D-10117 Berlin, Germany; Humboldt Univ, Charite, Dept Neurosurg, D-13353 Berlin, Germany; Epilepsy Ctr Berlin Brandenburg, D-10365 Berlin, Germany; Humboldt Univ, Charite, Johannes Muller Inst Physiol, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Wozny, C (corresponding author), Humboldt Univ, Charite, Neurosci Res Ctr, Schumannstr 20-21, D-10117 Berlin, Germany.	joachim.behr@charite.de	Wozny, Christian/A-1498-2015	Wozny, Christian/0000-0003-4220-2033				Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; Fisher PD, 1998, BRAIN DEV-JPN, V20, P563, DOI 10.1016/S0387-7604(98)00069-2; MATHERN GW, 1997, EPILEPSY COMPREHENSI; O'Mara SM, 2001, PROG NEUROBIOL, V64, P129, DOI 10.1016/S0301-0082(00)00054-X; WYLER AR, 1992, J EPILEPSY, V5, P220, DOI 10.1016/S0896-6974(05)80120-3; Yaari Y, 2002, BRAIN PATHOL, V12, P234	6	67	67	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2003	301	5632					463	463						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12881553				2022-12-28	WOS:000184340500021
J	de Craen, AJ; Gussekloo, J; Teng, YKO; Macfarlane, PW; Westendorp, RGJ				de Craen, AJ; Gussekloo, J; Teng, YKO; Macfarlane, PW; Westendorp, RGJ			Prevalence of five common clinical abnormalities in very elderly people: population based cross sectional study	BRITISH MEDICAL JOURNAL			English	Article									Leiden Univ, Med Ctr, Sect Gerontol & Geriatr, Dept Gen Internal Med, NL-2300 RC Leiden, Netherlands; Univ Glasgow, Dept Med Cardiol, Glasgow G31 2ER, Lanark, Scotland	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Glasgow	de Craen, AJ (corresponding author), Leiden Univ, Med Ctr, Sect Gerontol & Geriatr, Dept Gen Internal Med, POB 9600, NL-2300 RC Leiden, Netherlands.		Teng, Yoe Kie Onno/S-1765-2019; Gussekloo, Jacobijn/ABE-3879-2021	Teng, Yoe Kie Onno/0000-0001-9920-2195; Gussekloo, Jacobijn/0000-0001-7186-8278				IZAKS GJ, 1999, JAMA-J AM MED ASSOC, V18, P714; Macfarlane PW, 1996, J ELECTROCARDIOL, V29, P29, DOI 10.1016/S0022-0736(96)80016-1; TOPOL E.J., 1998, TXB CARDIOVASCULAR M; von Faber M, 2001, ARCH INTERN MED, V161, P2694, DOI 10.1001/archinte.161.22.2694; *WHO, 1996, GUID ATC CLASS DDD A	5	7	7	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 19	2003	327	7407					131	132		10.1136/bmj.327.7407.131	http://dx.doi.org/10.1136/bmj.327.7407.131			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702WJ	12869453	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000184247500016
J	Grimsby, J; Sarabu, R; Corbett, WL; Haynes, NE; Bizzarro, FT; Coffey, JW; Guertin, KR; Hilliard, DW; Kester, RF; Mahaney, PE; Marcus, L; Qi, LD; Spence, CL; Tengi, J; Magnuson, MA; Chu, CA; Dvorozniak, MT; Matschinsky, FM; Grippo, JF				Grimsby, J; Sarabu, R; Corbett, WL; Haynes, NE; Bizzarro, FT; Coffey, JW; Guertin, KR; Hilliard, DW; Kester, RF; Mahaney, PE; Marcus, L; Qi, LD; Spence, CL; Tengi, J; Magnuson, MA; Chu, CA; Dvorozniak, MT; Matschinsky, FM; Grippo, JF			Allosteric activators of glucokinase: Potential role in diabetes therapy	SCIENCE			English	Article							GLUCOSE-HOMEOSTASIS; BETA-CELL; MUTATIONS; MELLITUS; MUTANTS; MODY-2; LIVER; MICE	Glucokinase (GK) plays a key role in whole-body glucose homeostasis by catalyzing the phosphorylation of glucose in cells that express this enzyme, such as pancreatic beta cells and hepatocytes. We describe a class of antidiabetic agents that act as nonessential, mixed-type GK activators (GKAs) that increase the glucose affinity and maximum velocity (V-max) of GK. GKAs augment both hepatic glucose metabolism and glucose-induced insulin secretion from isolated rodent pancreatic islets, consistent with the expression and function of GK in both cell types. In several rodent models of type 2 diabetes mellitus, GKAs lowered blood glucose levels, improved the results of glucose tolerance tests, and increased hepatic glucose uptake. These findings may lead to the development of new drug therapies for diabetes.	Hoffmann La Roche Inc, Dept Metab Dis, Nutley, NJ 07110 USA; Vanderbilt Univ, Dept Physiol & Mol Biophys, Nashville, TN 37232 USA; Univ Penn, Sch Med, Dept Biochem, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Diabet, Philadelphia, PA 19104 USA	Roche Holding; Vanderbilt University; University of Pennsylvania; University of Pennsylvania	Grippo, JF (corresponding author), Hoffmann La Roche Inc, Dept Metab Dis, 340 Kingsland St, Nutley, NJ 07110 USA.		Magnuson, Mark/AAY-7172-2021; Magnuson, Mark A/B-1335-2009	Magnuson, Mark/0000-0002-8824-6499; Magnuson, Mark A/0000-0002-8824-6499				BELL GI, 2002, ENCY MOL MED, P1437; Christesen HBT, 2002, DIABETES, V51, P1240, DOI 10.2337/diabetes.51.4.1240; Clement K, 1996, DIABETOLOGIA, V39, P82; Davis EA, 1999, DIABETOLOGIA, V42, P1175, DOI 10.1007/s001250051289; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Desai UJ, 2001, DIABETES, V50, P2287, DOI 10.2337/diabetes.50.10.2287; Ferre T, 1996, P NATL ACAD SCI USA, V93, P7225, DOI 10.1073/pnas.93.14.7225; GIDHJAIN M, 1993, P NATL ACAD SCI USA, V90, P1932, DOI 10.1073/pnas.90.5.1932; Glaser B, 1998, NEW ENGL J MED, V338, P226, DOI 10.1056/NEJM199801223380404; GRIMSBY J, UNPUB; KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066; LIANG Y, 1995, BIOCHEM J, V309, P167, DOI 10.1042/bj3090167; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Miller SP, 1999, DIABETES, V48, P1645, DOI 10.2337/diabetes.48.8.1645; Morral N, 2002, HUM GENE THER, V13, P1561, DOI 10.1089/10430340260201653; Segel I.H., 1993, ENZYME KINETICS, P227; Shiota M, 2001, DIABETES, V50, P622, DOI 10.2337/diabetes.50.3.622; Sweet IR, 1996, AM J PHYSIOL-ENDOC M, V271, pE606, DOI 10.1152/ajpendo.1996.271.3.E606; TAKEDA J, 1993, J BIOL CHEM, V268, P15200; Velho G, 1996, J CLIN INVEST, V98, P1755, DOI 10.1172/JCI118974; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0	21	404	459	2	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2003	301	5631					370	373		10.1126/science.1084073	http://dx.doi.org/10.1126/science.1084073			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869762				2022-12-28	WOS:000184207300045
J	Vroman, D; Solomon, KD				Vroman, D; Solomon, KD			Relapsing polychondritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Med Univ S Carolina, Charleston, SC 29425 USA	Medical University of South Carolina	Vroman, D (corresponding author), Med Univ S Carolina, Charleston, SC 29425 USA.								0	0	0	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2003	349	3					E3	E3		10.1056/ENEJMicm020188	http://dx.doi.org/10.1056/ENEJMicm020188			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701KA	12867623				2022-12-28	WOS:000184165700010
J	Gardner, TA; Cote, IM; Gill, JA; Grant, A; Watkinson, AR				Gardner, TA; Cote, IM; Gill, JA; Grant, A; Watkinson, AR			Long-term region-wide declines in Caribbean corals	SCIENCE			English	Article							MASS MORTALITY; DIADEMA-ANTILLARUM; REEFS; DEGRADATION; ECOSYSTEMS; ABUNDANCE; DYNAMICS; SCALE	We report a massive region-wide decline of corals across the entire Caribbean basin, with the average hard coral cover on reefs being reduced by 80%, from about 50% to 10% cover, in three decades. Our meta-analysis shows that patterns of change in coral cover are variable across time periods but largely consistent across subregions, suggesting that local causes have operated with some degree of synchrony on a region-wide scale. Although the rate of coral loss has slowed in the past decade compared to the 1980s, significant declines are persisting. The ability of Caribbean coral reefs to cope with future local and global environmental change may be irretrievably compromised.	Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; Tyndall Ctr Climate Change Res, Norwich NR4 7TJ, Norfolk, England	University of East Anglia; University of East Anglia; University of East Anglia	Cote, IM (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.	i.cote@uea.ac.uk	Grant, Alastair/L-7301-2018; Gardner, Toby/B-7516-2008; Gill, Jennifer A/A-7759-2008; Cote, Isabelle/ABD-5898-2021; Watkinson, Andrew R/N-1649-2013	Grant, Alastair/0000-0002-1147-2375; 	Natural Environment Research Council [NER/J/S/2002/00612] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Aronson RB, 2000, NATURE, V405, P36, DOI 10.1038/35011132; Aronson RB, 2002, ECOL MONOGR, V72, P233, DOI 10.1890/0012-9615(2002)072[0233:TESOST]2.0.CO;2; Aronson RB, 2001, EVOLUTIONARY PALEOECOLOGY, P171; Bryant D., 1998, REEFS RISK MAP BASED; CARPENTER RC, 1990, MAR BIOL, V104, P67, DOI 10.1007/BF01313159; Cho L.L., 2002, P 9 INT COR REEF S B, V1, P331; Cortes Jorge, 1997, P335; Edmunds PJ, 2002, CORAL REEFS, V21, P357, DOI 10.1007/s00338-002-0258-1; Edmunds PJ, 2001, P NATL ACAD SCI USA, V98, P5067, DOI 10.1073/pnas.071524598; GINSBURG RN, P C GLOB ASP COR REE; GLADFELTER EH, 1978, B MAR SCI, V28, P728; Greenstein BJ, 1998, CORAL REEFS, V17, P249, DOI 10.1007/s003380050125; GRIGG RW, 1990, CORAL REEFS, P439; HEDGES LV, 1985, STAT METHODS META AN; Hodgson G, 2002, GLOBAL CORAL REEF CR; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; Jackson JBC, 2001, P NATL ACAD SCI USA, V98, P5411, DOI 10.1073/pnas.091092898; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; LESSIOS HA, 1984, SCIENCE, V226, P335, DOI 10.1126/science.226.4672.335; McField M.D., 2002, P63; Rogers CS, 2000, SCIENCE, V289, P391; Rogers CS, 2001, ENVIRON CONSERV, V28, P312, DOI 10.1017/S0376892901000340; ROSENBERG MS, 2000, METAWIN VERSION 2 ST; VANSTEVENINCK EDD, 1986, MAR ECOL PROG SER, V34, P87; Wilkinson C, 2000, STATUS CORAL REEFS W; Wilkinson CR, 1999, MAR FRESHWATER RES, V50, P867, DOI 10.1071/MF99121; WILKINSON CR, 1997, P 8 INT COR REEF S, V1, P277	28	1459	1517	12	410	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2003	301	5635					958	960		10.1126/science.1086050	http://dx.doi.org/10.1126/science.1086050			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711RY	12869698				2022-12-28	WOS:000184755900037
J	Pui, CH; Cheng, C; Leung, W; Rai, SN; Rivera, GK; Sandlund, JT; Ribeiro, RC; Relling, MV; Kun, LE; Evans, WE; Hudson, MM				Pui, CH; Cheng, C; Leung, W; Rai, SN; Rivera, GK; Sandlund, JT; Ribeiro, RC; Relling, MV; Kun, LE; Evans, WE; Hudson, MM			Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SECONDARY BRAIN-TUMORS; CENTRAL-NERVOUS-SYSTEM; CRANIAL RADIOTHERAPY; ADOLESCENT CANCER; ADULT SURVIVORS; COMPETING RISK; LATE MORTALITY; 2ND NEOPLASMS; TOTAL-THERAPY; CHILDREN	BACKGROUND Children who survive acute lymphoblastic leukemia are at risk for leukemia-related or treatment-related complications, which can adversely affect survival and socioeconomic status. We determined the long-term survival and the rates of health insurance coverage, marriage, and employment among patients who had attained at least 10 years of event-free survival. METHODS A total of 856 eligible patients were treated between 1962 and 1992 in 13 consecutive clinical trials. Survival rates, the cumulative risk of a second neoplasm, and selected indicators of socioeconomic status were analyzed for the entire group and for patients who did or did not receive cranial or craniospinal radiation therapy during initial treatment. RESULTS Fifty-six patients had major adverse events, including 8 deaths during remission, 4 relapses, and 44 second neoplasms (41 of them radiation-related); most of the second neoplasms were benign or of a low grade of malignant potential. The risk of a second neoplasm was significantly higher in the 597 patients who received radiation therapy (irradiated group) than in the 259 patients who did not receive radiation therapy (nonirradiated group) (P=0.04; estimated cumulative risk [+/-SE] at 20 years, 20.9+/-3.9 percent vs. 0.95+/-0.9 percent). The death rate for the irradiated group slightly exceeded the expected rate in the general U.S. population (standardized mortality ratio, 1.90; 95 percent confidence interval, 1.12 to 3.00), whereas that for the nonirradiated group did not differ from the population norm (standardized mortality ratio, 1.75; 95 percent confidence interval, 0.34 to 5.00). The rates of health insurance coverage, marriage, and employment in the nonirradiated group were similar to the age- and sex-adjusted national averages. Despite having health insurance rates similar to those in the general population, men and women in the irradiated group had higher-than-average unemployment rates (15.1 percent vs. 5.4 percent and 35.4 percent vs. 5.2 percent, respectively), and women in the irradiated group were less likely to be married (35.2 percent vs. 48.8 percent). CONCLUSIONS Children with acute lymphoblastic leukemia who did not receive radiation therapy and who have attained 10 or more years of event-free survival can expect a normal long-term survival. Irradiation is associated with the development of second neoplasms, a slight excess in mortality, and an increased unemployment rate.	St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Radiat Oncol, Memphis, TN 38105 USA; Univ Tennessee, Hlth Sci Ctr, Coll Med, Knoxville, TN 37996 USA; Univ Tennessee, Hlth Sci Ctr, Coll Pharm, Knoxville, TN 37996 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Pui, CH (corresponding author), St Jude Childrens Res Hosp, Dept Hematol Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA.	pui@stjude.org	Hudson, Melissa M/N-4441-2018; Relling, Mary/N-5032-2018; Pui, Ching-Hon/N-8076-2018; Cheng, Cheng/N-8075-2018; Evans, William E./C-2069-2012	Hudson, Melissa M/0000-0001-6984-2407; Pui, Ching-Hon/0000-0003-0303-5658; Evans, William E./0000-0002-9333-5322; Leung, Wing Hang/0000-0002-2996-7229	PHS HHS [21765] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bhatia S, 2002, BLOOD, V99, P4257, DOI 10.1182/blood.V99.12.4257; Blackwell D. L., 2002, VITAL HLTH STAT SERI; Brenner H, 2001, CANCER, V92, P1977, DOI 10.1002/1097-0142(20011001)92:7<1977::AID-CNCR1717>3.0.CO;2-W; Breslow N E, 1987, IARC Sci Publ, P1; *BUR LAB STAT, 2002, CURR POP SURV REP; BYRNE J, 1989, JAMA-J AM MED ASSOC, V262, P2693, DOI 10.1001/jama.262.19.2693; CHRISTIE D, 1995, ARCH DIS CHILD, V73, P136, DOI 10.1136/adc.73.2.136; *CTR COST FIN STUD, 2000, MED EXP PAN SURV HOU; Dalton VMK, 1998, J CLIN ONCOL, V16, P2848, DOI 10.1200/JCO.1998.16.8.2848; *EP SOFTW, 1993, EP PLUS STAT PACK EP; Evans WE, 1998, NEW ENGL J MED, V338, P499, DOI 10.1056/NEJM199802193380803; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; GREEN DM, 1991, CANCER, V67, P206, DOI 10.1002/1097-0142(19910101)67:1<206::AID-CNCR2820670134>3.0.CO;2-2; Green DM, 1999, J CLIN ONCOL, V17, P3207, DOI 10.1200/JCO.1999.17.10.3207; HAUPT R, 1994, JAMA-J AM MED ASSOC, V272, P1427, DOI 10.1001/jama.272.18.1427; HAYS DM, 1992, J CLIN ONCOL, V10, P1397, DOI 10.1200/JCO.1992.10.9.1397; Hoffman B, 1999, ONCOLOGY-NY, V13, P841; HOLMES GE, 1986, CANCER, V57, P190, DOI 10.1002/1097-0142(19860101)57:1<190::AID-CNCR2820570136>3.0.CO;2-8; Hudson MM, 1997, J CLIN ONCOL, V15, P2205, DOI 10.1200/JCO.1997.15.6.2205; Kamps WA, 2002, LEUKEMIA, V16, P1099, DOI 10.1038/sj.leu.2402489; Loning L, 2000, BLOOD, V95, P2770, DOI 10.1182/blood.V95.9.2770.009k16_2770_2775; Manera R, 2000, LEUKEMIA, V14, P1354, DOI 10.1038/sj.leu.2401835; Marina N, 1997, PEDIATR CLIN N AM, V44, P1021, DOI 10.1016/S0031-3955(05)70543-5; Mertens AC, 2001, J CLIN ONCOL, V19, P3163, DOI 10.1200/JCO.2001.19.13.3163; NEGLIA JP, 1991, NEW ENGL J MED, V325, P1330, DOI 10.1056/NEJM199111073251902; Novakovic B, 1997, J PEDIAT HEMATOL ONC, V19, P220, DOI 10.1097/00043426-199705000-00008; NYGAARD R, 1991, ACTA PAEDIATR SCAND, V80, P1220, DOI 10.1111/j.1651-2227.1991.tb11812.x; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; PINKEL D, 1979, AM CANC SOC P NAT C, P191; Pui CH, 2003, J CLIN ONCOL, V21, P179, DOI 10.1200/JCO.2003.10.032; Pui CH, 1998, NEW ENGL J MED, V339, P605, DOI 10.1056/NEJM199808273390907; PUI CH, 1991, J CLIN ONCOL, V9, P1341, DOI 10.1200/JCO.1991.9.8.1341; Pui CH, 1998, BLOOD, V92, P411, DOI 10.1182/blood.V92.2.411.414k34_411_415; Rauck AM, 1999, MED PEDIATR ONCOL, V33, P60, DOI 10.1002/(SICI)1096-911X(199907)33:1<60::AID-MPO11>3.0.CO;2-H; Reis L.A.G., 2001, SEER CANC STAT REV 1; Relling MV, 1999, LANCET, V354, P34, DOI 10.1016/S0140-6736(98)11079-6; RIVERA GK, 1993, NEW ENGL J MED, V329, P1289, DOI 10.1056/NEJM199310283291801; RIVERA GK, 1991, LANCET, V337, P61, DOI 10.1016/0140-6736(91)90733-6; Schrappe M, 2000, BLOOD, V95, P3310; Silverman LB, 2001, BLOOD, V97, P1211, DOI 10.1182/blood.V97.5.1211; SIMONE J, 1972, CANCER-AM CANCER SOC, V30, P1488, DOI 10.1002/1097-0142(197212)30:6<1488::AID-CNCR2820300612>3.0.CO;2-D; TEBBI CK, 1989, CANCER, V63, P213, DOI 10.1002/1097-0142(19890101)63:1<213::AID-CNCR2820630134>3.0.CO;2-T; TEETER M A, 1987, Journal of Psychosocial Oncology, V5, P59; TETA MJ, 1986, J CHRON DIS, V39, P751, DOI 10.1016/0021-9681(86)90158-X; *US BUR CENS, 2001, CURR POP SURV REP; VANN JCJ, 1995, MED PEDIATR ONCOL, V25, P389, DOI 10.1002/mpo.2950250505; Vilmer E, 2000, LEUKEMIA, V14, P2257, DOI 10.1038/sj.leu.2401960; von der Weid N, 2003, EUR J CANCER, V39, P359, DOI 10.1016/S0959-8049(02)00260-5; Vora A, 1998, BLOOD, V92, P2334, DOI 10.1182/blood.V92.7.2334.2334_2334_2337; Waber Deborah P, 1997, Oncology (Williston Park), V11, P259; Walter AW, 1998, J CLIN ONCOL, V16, P3761, DOI 10.1200/JCO.1998.16.12.3761; ZEVON MA, 1990, AM J PEDIAT HEMATOL, V12, P454; 1991, FED REG, V56, P35725	54	312	325	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2003	349	7					640	649		10.1056/NEJMoa035091	http://dx.doi.org/10.1056/NEJMoa035091			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711FL	12917300				2022-12-28	WOS:000184728900004
J	DePamphilis, ML				DePamphilis, ML			Eukaryotic DNA replication origins: Reconciling disparate data	CELL			English	Editorial Material							ORC-BINDING; COMPLEX; CELLS	In this issue of Cell, Anglana and coworkers provide new insight into the nature of mammalian replication origins that helps to reconcile the divergent views that emerged over the past decade. Taken together with other studies, we can see how replication origins have evolved in response to the demands of animal development.	NICHHD, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	DePamphilis, ML (corresponding author), NICHHD, NIH, Bldg 6,Room 416,9000 Rockville Pike, Bethesda, MD 20892 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000506] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000506] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Anglana M, 2003, CELL, V114, P385, DOI 10.1016/S0092-8674(03)00569-5; Beall EL, 2002, NATURE, V420, P833, DOI 10.1038/nature01228; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; DePamphilis ML, 1999, BIOESSAYS, V21, P5, DOI 10.1002/(SICI)1521-1878(199901)21:1<5::AID-BIES2>3.0.CO;2-6; HANDELI S, 1989, CELL, V57, P909, DOI 10.1016/0092-8674(89)90329-2; Kong DC, 2002, EMBO J, V21, P5567, DOI 10.1093/emboj/cdf546; Prioleau MN, 2003, MOL CELL BIOL, V23, P3536, DOI 10.1128/MCB.23.10.3536-3549.2003; Takahashi T, 2003, EMBO J, V22, P964, DOI 10.1093/emboj/cdg079; VAUGHN JP, 1990, CELL, V61, P1075, DOI 10.1016/0092-8674(90)90071-L	9	22	23	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 8	2003	114	3					274	275		10.1016/S0092-8674(03)00604-4	http://dx.doi.org/10.1016/S0092-8674(03)00604-4			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914691	Bronze			2022-12-28	WOS:000184679200003
J	Huntress, WT				Huntress, WT			Planetary science - Human space exploration is about more than just science	SCIENCE			English	Editorial Material									Planetary Soc, Washington, DC 20015 USA; Carnegie Inst Washington, Geophys Lab, Washington, DC 20015 USA	Carnegie Institution for Science	Huntress, WT (corresponding author), Planetary Soc, Washington, DC 20015 USA.							COMPARE M, 2003, NY TIMES        0629, pA13; *NAT RES COUNC, 1997, HUM EXPL SPAC 3, P12	2	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2003	301	5634					771	771		10.1126/science.1089117	http://dx.doi.org/10.1126/science.1089117			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907780				2022-12-28	WOS:000184615700023
J	Hammami, A; Raymond, N; Armand, M				Hammami, A; Raymond, N; Armand, M			Runaway risk of forming toxic compounds	NATURE			English	Editorial Material									Univ Montreal, CNRS, UMR 2289, UdM,Lab Int Mat Electroactifs, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Hammami, A (corresponding author), Univ Montreal, CNRS, UMR 2289, UdM,Lab Int Mat Electroactifs, POB 6122, Montreal, PQ H3C 3J7, Canada.							BERGMANN ED, 1966, J CHEM SOC C, P899, DOI 10.1039/j39660000899; GITTER S, 1953, K NED AKAD WETENSC C, V56, P427	2	272	279	7	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					635	636		10.1038/424635b	http://dx.doi.org/10.1038/424635b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904779				2022-12-28	WOS:000184578800031
J	Silva, JE				Silva, JE			The thermogenic effect of thyroid hormone and its clinical implications	ANNALS OF INTERNAL MEDICINE			English	Review							BROWN ADIPOSE-TISSUE; UNCOUPLING PROTEIN; MESSENGER-RNA; ENERGY-EXPENDITURE; REPTILE MACHINE; SKELETAL-MUSCLE; NERVOUS-SYSTEM; MAMMAL MACHINE; METABOLIC-RATE; RECEPTOR-BETA		Jewish Gen Hosp, Div Endocrinol, Montreal, PQ H3T 1E2, Canada	McGill University	Silva, JE (corresponding author), Jewish Gen Hosp, Div Endocrinol, Room E-104,3755 Chemin Cote Ste Catherine, Montreal, PQ H3T 1E2, Canada.	enrique.silva@staff.mcgill.ca						Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; AlAdsani H, 1997, J CLIN ENDOCR METAB, V82, P1118, DOI 10.1210/jc.82.4.1118; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; BARKER SB, 1952, AM J PHYSIOL, V170, P81, DOI 10.1152/ajplegacy.1952.170.1.81; Bartalena L, 1998, EUR J ENDOCRINOL, V138, P603, DOI 10.1530/eje.0.1380603; Berry M. N., 1989, ENERGY TRANSFORMATIO, P18; BIANCO AC, 1987, AM J PHYSIOL, V253, pE255, DOI 10.1152/ajpendo.1987.253.3.E255; BIANCO AC, 1987, J CLIN INVEST, V79, P295, DOI 10.1172/JCI112798; BLENNEMANN B, 1995, MOL CELL ENDOCRINOL, V110, P1, DOI 10.1016/0303-7207(95)03509-6; Boivin M, 2000, J CLIN ENDOCR METAB, V85, P1975, DOI 10.1210/jc.85.5.1975; Brand MD, 1997, J EXP BIOL, V200, P193; Calza L, 2000, NEUROSCIENCE, V101, P1001, DOI 10.1016/S0306-4522(00)00420-6; CANNON B, 1985, ESSAYS BIOCHEM, V20, P110; CARVALHO SD, 1991, ENDOCRINOLOGY, V128, P2149, DOI 10.1210/endo-128-4-2149; CLARKE SD, 1990, J NUTR, V120, P625, DOI 10.1093/jn/120.6.625; CLAUSEN T, 1991, PHYSIOL REV, V71, P733, DOI 10.1152/physrev.1991.71.3.733; Dollberg S, 2000, AM J PERINAT, V17, P47, DOI 10.1055/s-2000-7293; ELSE PL, 1981, AM J PHYSIOL, V240, pR3, DOI 10.1152/ajpregu.1981.240.1.R3; Forrest D, 2000, THYROID, V10, P41, DOI 10.1089/thy.2000.10.41; FREAKE HC, 1988, MOL ENDOCRINOL, V2, P986, DOI 10.1210/mend-2-10-986; Gloss B, 2001, ENDOCRINOLOGY, V142, P544, DOI 10.1210/en.142.2.544; Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199; HARPER ME, 1993, J BIOL CHEM, V268, P14850; HARPER ME, 1993, BIOCHEM SOC T, V21, P785, DOI 10.1042/bst0210785; HODIN RA, 1990, J CLIN INVEST, V85, P101, DOI 10.1172/JCI114398; HULBERT AJ, 1981, AM J PHYSIOL, V241, pR350, DOI 10.1152/ajpregu.1981.241.5.R350; JOHANSSON C, 1999, AM J PHYSL, V276; Laloi M, 1997, NATURE, V389, P135, DOI 10.1038/38156; Larsen PR, 1996, J CLIN INVEST, V98, P242, DOI 10.1172/JCI118784; LEE YP, 1965, J BIOL CHEM, V240, P1427; Lehninger A., 1993, PRINCIPLES BIOCH; LEIJENDEKKER WJ, 1987, AM J PHYSIOL, V253, pE214, DOI 10.1152/ajpendo.1987.253.2.E214; Lopez M, 2001, NEUROSCI LETT, V300, P171, DOI 10.1016/S0304-3940(01)01569-5; Magnus-Levy A., 1895, BERL KLIN WOCHENSCHR, V32, P650; Meguid MM, 2000, NUTRITION, V16, P843, DOI 10.1016/S0899-9007(00)00449-4; MOORADIAN AD, 1990, EXP GERONTOL, V25, P29, DOI 10.1016/0531-5565(90)90006-N; MORY G, 1981, J ENDOCRINOL, V91, P515, DOI 10.1677/joe.0.0910515; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; NIELSEN HV, 1987, CLIN PHYSIOL, V7, P297, DOI 10.1111/j.1475-097X.1987.tb00172.x; OPPENHEIMER JH, 1991, J CLIN INVEST, V87, P125, DOI 10.1172/JCI114961; Pijl H, 2001, J CLIN ENDOCR METAB, V86, P5848, DOI 10.1210/jc.86.12.5848; READ NW, 1992, P NUTR SOC, V51, P7, DOI 10.1079/PNS19920004; Ribeiro MO, 2001, J CLIN INVEST, V108, P97, DOI 10.1172/JCI12584; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; RUBIO A, 1995, ENDOCRINOLOGY, V136, P3277, DOI 10.1210/en.136.8.3277; SEYDOUX J, 1982, MOL CELL ENDOCRINOL, V25, P213, DOI 10.1016/0303-7207(82)90054-5; SILVA JE, 1986, AM J PHYSIOL, V251, pE639, DOI 10.1152/ajpendo.1986.251.6.E639; SILVA JE, 1986, J CLIN INVEST, V77, P1214, DOI 10.1172/JCI112424; Silva JE, 1995, THYROID, V5, P481, DOI 10.1089/thy.1995.5.481; Silva JE, 1997, EUR J ENDOCRINOL, V136, P251, DOI 10.1530/eje.0.1360251; Silva JE, 2000, WERNER INGBARS THYRO, P820; SILVA JE, 2000, WERNER INGBARS THYRO, P642; Sood A, 1996, BIOCHEM BIOPH RES CO, V222, P287, DOI 10.1006/bbrc.1996.0736; SUNDIN U, 1981, AM J PHYSIOL, V241, pC134, DOI 10.1152/ajpcell.1981.241.3.C134; Syed MA, 1999, THYROID, V9, P503, DOI 10.1089/thy.1999.9.503; TRIANDAFILLOU J, 1982, CAN J BIOCHEM CELL B, V60, P530, DOI 10.1139/o82-065; Vianna CR, 2001, PHYSIOL GENOMICS, V5, P137, DOI 10.1152/physiolgenomics.2001.5.3.137; WEIRICH RT, 1987, ENDOCRINOLOGY, V120, P664, DOI 10.1210/endo-120-2-664; WEISS M, 1993, J CLIN ENDOCR METAB, V76, P680, DOI 10.1210/jc.76.3.680; Weiss RE, 1998, ENDOCRINOLOGY, V139, P4945, DOI 10.1210/en.139.12.4945; Wikstrom L, 1998, EMBO J, V17, P455, DOI 10.1093/emboj/17.2.455; Wilding JPH, 2002, DIABETIC MED, V19, P619, DOI 10.1046/j.1464-5491.2002.00790.x; WOLEDGE RC, 1989, ENERGY TRANSFORMATIO, P36; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097	64	186	196	2	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2003	139	3					205	213		10.7326/0003-4819-139-3-200308050-00010	http://dx.doi.org/10.7326/0003-4819-139-3-200308050-00010			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707RH	12899588				2022-12-28	WOS:000184523300006
J	O'Brien, KL; Moulton, LH; Reid, R; Weatherholtz, R; Oski, J; Brown, L; Kumar, G; Parkinson, A; Hu, D; Hackell, J; Chang, I; Kohberger, R; Siber, G; Santosham, M				O'Brien, KL; Moulton, LH; Reid, R; Weatherholtz, R; Oski, J; Brown, L; Kumar, G; Parkinson, A; Hu, D; Hackell, J; Chang, I; Kohberger, R; Siber, G; Santosham, M			Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial	LANCET			English	Article							UNITED-STATES; DISEASE; EPIDEMIOLOGY; IMMUNOGENICITY; OPPORTUNITIES; ALASKA	Background Streptococcus pneumoniae is the main cause of invasive bacterial disease in children aged younger than 2 years. Navajo and White Mountain Apache children have some of the highest rates of invasive pneumococcal disease documented in the world. We aimed to assess the safety and efficacy of a seven-valent polysaccharide protein conjugate pneumococcal vaccine (PnCRM7) against such disease. Methods In a group-randomised study, we gave this vaccine to children younger than 2 years from the Navajo and White Mountain Apache Indian reservations; meningococcal type C conjugate vaccine (MnCC) served as the control vaccine. Vaccine schedules were determined by age at enrolment. We recorded episodes of invasive pneumococcal disease and serotyped isolates. Analyses were by intention to treat and per protocol. Findings 8292 children enrolled in the trial. In the per protocol analysis of the primary efficacy group (children enrolled by 7 months of age) there were eight cases of vaccine serotype disease in the controls and two in the PnCRM7 group; in the intention-to-treat analysis we noted 11 cases of vaccine serotype disease in the MnCC control group and two in the PnCRM7 group. After group randomisation had been controlled for, the per protocol primary efficacy of PnCRM7 was 76.8% (95% CI -9.4% to 95.1%) and the intention-to-treat total primary efficacy was 82.6% (21.4% to 96.1%). Interpretation PnCRM7 vaccine prevents vaccine serotype invasive pneumococcal disease even in a high risk population. Other regions with similar disease burden should consider including this vaccine in the routine childhood vaccine schedule.	Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Amer Indian Hlth, Baltimore, MD USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; Ctr Dis Control & Prevent, Arctic Invest Program, Anchorage, AK USA; Dept Hlth & Human Serv, Indian Hlth Serv, Tuba City, AZ USA; Wyeth Vaccines, Pearl River, NY USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Centers for Disease Control & Prevention - USA; Pfizer	O'Brien, KL (corresponding author), 621 N Washington St, Baltimore, MD 21205 USA.	klobrien@jhsph.edu		O'Brien, Katherine/0000-0002-0164-4030; Moulton, Lawrence/0000-0001-7041-7387				[Anonymous], 1993, ANN EMERG MED, V22, P628; BARAFF LJ, 1993, PEDIATRICS, V92, P1; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; CORTESE MM, 1992, ARCH INTERN MED, V152, P2277, DOI 10.1001/archinte.152.11.2277; DAVIDSON M, 1989, JAMA-J AM MED ASSOC, V261, P715, DOI 10.1001/jama.261.5.715; DAVIDSON M, 1994, J INFECT DIS, V170, P368, DOI 10.1093/infdis/170.2.368; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; HALLORAN ME, 1991, AM J EPIDEMIOL, V133, P323, DOI 10.1093/oxfordjournals.aje.a115884; Karstaedt AS, 2000, PEDIATR INFECT DIS J, V19, P454, DOI 10.1097/00006454-200005000-00012; KILPI T, 2000, AM SOC MICR 40 INT C; Moulton LH, 2001, CONTROL CLIN TRIALS, V22, P438, DOI 10.1016/S0197-2456(01)00132-5; OBRIEN KL, 1999, 39 INT C ANT AG CHEM; Rennels MB, 1998, PEDIATRICS, V101, P604, DOI 10.1542/peds.101.4.604; Robinson KA, 2001, JAMA-J AM MED ASSOC, V285, P1729, DOI 10.1001/jama.285.13.1729; Usen S, 1998, PEDIATR INFECT DIS J, V17, P23, DOI 10.1097/00006454-199801000-00006; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0	16	280	311	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2003	362	9381					355	361		10.1016/S0140-6736(03)14022-6	http://dx.doi.org/10.1016/S0140-6736(03)14022-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707FB	12907008				2022-12-28	WOS:000184498700008
J	van der Heide, A; Deliens, L; Faisst, K; Nilstun, T; Norup, M; Paci, E; van der Wal, G; van der Maas, PJ				van der Heide, A; Deliens, L; Faisst, K; Nilstun, T; Norup, M; Paci, E; van der Wal, G; van der Maas, PJ		EURELD Consortium	End-of-life decision-making in six European countries: descriptive study	LANCET			English	Article							PALLIATIVE-CARE; MEDICAL-PRACTICE; NATIONAL SURVEY; INTENSIVE-CARE; ILL PATIENTS; EUTHANASIA; PHYSICIANS; ATTITUDES; SUPPORT	Background Empirical data about end-of-life decision-making practices are scarce. We aimed to investigate frequency and characteristics of end-of-life decision-making practices in six European countries: Belgium, Denmark, Italy, the Netherlands, Sweden, and Switzerland. Methods In all participating countries, deaths reported to death registries were stratified for cause (apart from in Switzerland), and samples were drawn from every stratum. Reporting doctors received a mailed questionnaire about the medical decision-making that had preceded the death of the patient. The data-collection procedure precluded identification of any of the doctors or patients. All deaths arose between June, 2001, and February, 2002. We weighted data to correct for stratification and to make results representative for all deaths: results were presented as weighted percentages. Findings The questionnaire response rate was 75% for the Netherlands, 67% for Switzerland, 62% for Denmark, 61% for Sweden, 59% for Belgium, and 44% for Italy. Total number of deaths studied was 20 480. Death happened suddenly and unexpectedly in about a third of cases in all countries. The proportion of deaths that were preceded by any end-of-life decision ranged between 23% (Italy) and 51% (Switzerland). Administration of drugs with the explicit intention of hastening death varied between countries: about 1% or less in Denmark, Italy, Sweden, and Switzerland, 1.82% in Belgium, and 3.40% in the Netherlands. Large variations were recorded in the extent to which decisions were discussed with patients, relatives, and other caregivers. Interpretation Medical end-of-life decisions frequently precede dying in all participating countries. Patients and relatives are generally involved in decision-making in countries in which the frequency of making these decisions is high.	Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, NL-3000 DR Rotterdam, Netherlands; Free Univ Brussels, Dept Med Sociol & Hlth Sci, Brussels, Belgium; Univ Zurich, Inst Social & Prevent Med, CH-8006 Zurich, Switzerland; Lund Univ, Dept Med Eth, Lund, Sweden; Univ Copenhagen, Dept Med Philosophy & Clin Theory, Copenhagen, Denmark; Ctr Study & Prevent Canc, Epidemiol Unit, Florence, Italy; Vrije Univ Amsterdam, Med Ctr, Dept Social Med, Amsterdam, Netherlands; Inst Res Extramural Med, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Zurich; Lund University; University of Copenhagen; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	van der Heide, A (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, POB 1738, NL-3000 DR Rotterdam, Netherlands.			Deliens, Luc/0000-0002-8158-2422				[Anonymous], 1993, HIST PUBLIC HLTH; BERNARD HR, 1984, ANNU REV ANTHROPOL, V13, P495, DOI 10.1146/annurev.an.13.100184.002431; Bittel N, 2002, SUPPORT CARE CANCER, V10, P265, DOI 10.1007/s00520-001-0325-0; Cuttini M, 2000, LANCET, V355, P2112, DOI 10.1016/S0140-6736(00)02378-3; Deliens L, 2000, LANCET, V356, P1806, DOI 10.1016/S0140-6736(00)03233-5; DiMola G, 1996, ANN ONCOL, V7, P907, DOI 10.1093/oxfordjournals.annonc.a010792; FaberLangendoen K, 1996, ARCH INTERN MED, V156, P2130, DOI 10.1001/archinte.156.18.2130; Folker AP, 1996, BIOETHICS, V10, P233, DOI 10.1111/j.1467-8519.1996.tb00122.x; Forde R, 1997, SOC SCI MED, V45, P887, DOI 10.1016/S0277-9536(96)00430-3; Hofmann JC, 1997, ANN INTERN MED, V127, P1, DOI 10.7326/0003-4819-127-1-199707010-00001; Kuhse H, 1997, MED J AUSTRALIA, V166, P191, DOI 10.5694/j.1326-5377.1997.tb140074.x; Nilstun T, 1996, Lakartidningen, V93, P1350; Parens E, 1996, HASTINGS CENT REP, V26, P13, DOI 10.2307/3527601; Prendergast TJ, 1998, AM J RESP CRIT CARE, V158, P1163, DOI 10.1164/ajrccm.158.4.9801108; Sepulveda C, 2002, J PAIN SYMPTOM MANAG, V24, P91, DOI 10.1016/S0885-3924(02)00440-2; Shah N, 1998, LANCET, V352, P1360, DOI 10.1016/S0140-6736(05)60751-9; Sjokvist P, 1999, INTENS CARE MED, V25, P949, DOI 10.1007/s001340050987; Teno J, 1997, J AM GERIATR SOC, V45, P500, DOI 10.1111/j.1532-5415.1997.tb05178.x; TENO J, 2001, CLIN EPIDEMIOLOGICAL; van der Maas PJ, 1991, LANCET, V338, P669, DOI 10.1016/0140-6736(91)91241-L; van der Maas PJ, 1996, NEW ENGL J MED, V335, P1699, DOI 10.1056/NEJM199611283352227; VANDERWAL G, 1996, EUTHANASIA OTHER MED; Vincent JL, 1999, CRIT CARE MED, V27, P1626, DOI 10.1097/00003246-199908000-00042; WEHKAMP KH, 1998, BERLINER MEDIZINETHI; Weiss SC, 2001, LANCET, V357, P1311, DOI 10.1016/S0140-6736(00)04515-3	25	483	488	3	76	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 2	2003	362	9381					345	350		10.1016/S0140-6736(03)14019-6	http://dx.doi.org/10.1016/S0140-6736(03)14019-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	707FB	12907005				2022-12-28	WOS:000184498700006
J	Chen, HD; Kandasamy, S; Orszag, S; Shock, R; Succi, S; Yakhot, V				Chen, HD; Kandasamy, S; Orszag, S; Shock, R; Succi, S; Yakhot, V			Extended Boltzmann kinetic equation for turbulent flows	SCIENCE			English	Article							H-THEOREM; MODELS	Complex fluid physics can be modeled using an extended kinetic (Boltzmann) equation in a more efficient way than using the continuum Navier-Stokes equations. Here, we explain this method for modeling fluid turbulence and show its effectiveness with the use of a computationally efficient implementation in terms of a discrete or "lattice" Boltzmann equation.	CNR, Ist Applicaz Calcolo, I-00161 Rome, Italy; EXA Corp, Lexington, MA 02420 USA; Yale Univ, Dept Math, New Haven, CT 06520 USA; Boston Univ, Dept Aerosp & Mech Engn, Boston, MA 02215 USA	Consiglio Nazionale delle Ricerche (CNR); Yale University; Boston University	Succi, S (corresponding author), CNR, Ist Applicaz Calcolo, Viale Policlin 137, I-00161 Rome, Italy.	succi@iac.rm.cnr.it	Succi, Sauro/E-4606-2015	Succi, Sauro/0000-0002-3070-3079				Ansumali S, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.056312; Ansumali S, 2000, PHYS REV E, V62, P7999, DOI 10.1103/PhysRevE.62.7999; BARTELHEIMER W, 2001, 20015332 SAE; BENZI R, 1992, PHYS REP, V222, P145, DOI 10.1016/0370-1573(92)90090-M; BHATNAGAR PL, 1954, PHYS REV, V94, P511, DOI 10.1103/PhysRev.94.511; Bobylev A. V., 1982, Soviet Physics - Doklady, V27, P29; Boghosian BM, 2001, P ROY SOC A-MATH PHY, V457, P717, DOI 10.1098/rspa.2000.0689; Boltzmann L, 1872, WIEN BER, V66, P275, DOI DOI 10.1007/978-3-322-84986-1_3; Boussinesq J., 1870, CR HEBD ACAD SCI, V71, P389; Cercignani C., 1975, THEORY APPL BOLTZMAN; Chapman S., 1990, MATH THEORY NONUNIFO; CHEN HD, 1992, PHYS REV A, V45, pR5339, DOI 10.1103/PhysRevA.45.R5339; Chen HD, 1998, INT J MOD PHYS C, V9, P1281, DOI 10.1142/S0129183198001151; Chen HD, 1999, PHYS REV E, V59, pR2527, DOI 10.1103/PhysRevE.59.R2527; Chen S, 1998, ANNU REV FLUID MECH, V30, P329, DOI 10.1146/annurev.fluid.30.1.329; FRISCH U, 1990, PHYS TODAY, V43, P24, DOI 10.1063/1.881235; Frisch U., 1996, TURBULENCE LEGACY KO; HIGUERA FJ, 1989, EUROPHYS LETT, V9, P345, DOI 10.1209/0295-5075/9/4/008; Karlin IV, 2002, ANN PHYS-BERLIN, V11, P783, DOI 10.1002/1521-3889(200211)11:10/11<783::AID-ANDP783>3.0.CO;2-V; Kolmogoroff A, 1941, CR ACAD SCI URSS, V30, P301, DOI 10.1098/rspa.1991.0075; Landau L.D., 1987, PHYS TODAY, V6; Launder B. E., 1974, Computer Methods in Applied Mechanics and Engineering, V3, P269, DOI 10.1016/0045-7825(74)90029-2; LIETZ R, 2002, 20020154 SAE; Lockard DP, 2002, J STAT PHYS, V107, P423, DOI 10.1023/A:1014539411062; MCNAMARA GR, 1988, PHYS REV LETT, V61, P2332, DOI 10.1103/PhysRevLett.61.2332; Pashko O, 2000, INT J MOD PHYS B, V14, P555, DOI 10.1142/S0217979200000509; QIAN YH, 1992, EUROPHYS LETT, V17, P479, DOI 10.1209/0295-5075/17/6/001; Shock RA, 2002, J AIRCRAFT, V39, P434, DOI 10.2514/2.2969; Sreenivasan KR, 1999, REV MOD PHYS, V71, pS383, DOI 10.1103/RevModPhys.71.S383; Succi S, 2002, REV MOD PHYS, V74, P1203, DOI 10.1103/RevModPhys.74.1203; Succi S, 2002, J STAT PHYS, V107, P261, DOI 10.1023/A:1014570923357; Succi S, 2000, PHYSICA A, V280, P92, DOI 10.1016/S0378-4371(99)00623-8; Succi S., 2001, NUMERICAL MATH SCI C; WANNIER GH, 1966, STAT PHYSICS; YAKHOT V, 1992, PHYS FLUIDS A-FLUID, V4, P1510, DOI 10.1063/1.858424; Yakhot V., 1986, Journal of Scientific Computing, V1, P3, DOI 10.1007/BF01061452	36	386	409	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2003	301	5633					633	636		10.1126/science.1085048	http://dx.doi.org/10.1126/science.1085048			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893940				2022-12-28	WOS:000184473600036
J	Dye, JL				Dye, JL			Electrons as anions	SCIENCE			English	Editorial Material							INORGANIC ELECTRIDES; ALKALI-METALS; ZEOLITES; SALTS		Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA	Michigan State University	Dye, JL (corresponding author), Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.							DYE JL, 1990, SCIENCE, V247, P663, DOI 10.1126/science.247.4943.663; Dye JL, 1997, INORG CHEM, V36, P3816, DOI 10.1021/ic970551z; DYE JL, 1970, J AM CHEM SOC, V92, P5226, DOI 10.1021/ja00720a043; Edwards PP, 1996, ACCOUNTS CHEM RES, V29, P23, DOI 10.1021/ar950152c; EDWARDS PP, 1982, ADV INORG CHEM RAD, V25, P135, DOI 10.1016/S0898-8838(08)60140-3; Ichimura AS, 2002, J AM CHEM SOC, V124, P1170, DOI 10.1021/ja016554z; Kim J, 1999, J AM CHEM SOC, V121, P10666, DOI 10.1021/ja992667v; Kraus CA, 1907, J AM CHEM SOC, V29, P1557, DOI 10.1021/ja01965a003; Li ZY, 2003, J AM CHEM SOC, V125, P6050, DOI 10.1021/ja034020n; Markham J.J., 1966, F CTR ALKALI HALIDES; Matsuishi S, 2003, SCIENCE, V301, P626, DOI 10.1126/science.1083842; Petkov V, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.075502; SRDANOV VI, 1992, J PHYS CHEM-US, V96, P9039, DOI 10.1021/j100201a064; WAGNER MJ, 1996, MOL RECOGNITION RECE, V1, P477; Wernette DP, 2003, CHEM MATER, V15, P1441, DOI 10.1021/cm020906z	15	252	260	5	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2003	301	5633					607	608		10.1126/science.1088103	http://dx.doi.org/10.1126/science.1088103			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893933				2022-12-28	WOS:000184473600028
J	Huang, YF; Lemieux, MJ; Song, JM; Auer, M; Wang, DN				Huang, YF; Lemieux, MJ; Song, JM; Auer, M; Wang, DN			Structure and mechanism of the glycerol-3-phosphate transporter from Escherichia coli	SCIENCE			English	Article								The major facilitator superfamily represents the largest group of secondary membrane transporters in the cell. Here we report the 3.3 angstrom resolution structure of a member of this superfamily, GlpT, which transports glycerol-3-phosphate into the cytoplasm and inorganic phosphate into the periplasm. The amino- and carboxyl-terminal halves of the protein exhibit a pseudo two-fold symmetry. Closed off to the periplasm, a centrally located substrate-translocation pore contains two arginines at its closed end, which comprise the substrate-binding site. Upon substrate binding, the protein adopts a more compact conformation. We propose that GlpT operates by a single-binding site, alternating-access mechanism through a rocker-switch type of movement.	NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University	Wang, DN (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, 540 1st Ave, New York, NY 10016 USA.			Wang, Da-Neng/0000-0002-6496-4699; Lemieux, Joanne/0000-0003-4745-9153				AMBUDKAR SV, 1990, J BIOL CHEM, V265, P12287; AMBUDKAR SV, 1986, J BIOL CHEM, V261, P9083; ASANO T, 1992, FEBS LETT, V298, P129, DOI 10.1016/0014-5793(92)80038-I; Auer M, 2001, BIOCHEMISTRY-US, V40, P6628, DOI 10.1021/bi010138+; Chamberlain AK, 2003, ADV PROTEIN CHEM, V63, P19; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Chen LY, 2002, HUM MOL GENET, V11, P3199, DOI 10.1093/hmg/11.25.3199; CHIN JJ, 1986, J BIOL CHEM, V261, P7101; CREIGHTON TE, 1983, PROTEINS STRUCTURES, P137; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; ELVIN CM, 1985, J BACTERIOL, V161, P1054, DOI 10.1128/JB.161.3.1054-1058.1985; Fann MC, 1998, J MEMBRANE BIOL, V164, P187, DOI 10.1007/s002329900404; Fann MC, 1998, J BIOL CHEM, V273, P33735, DOI 10.1074/jbc.273.50.33735; GOTT P, 1988, MOL MICROBIOL, V2, P655, DOI 10.1111/j.1365-2958.1988.tb00074.x; Green AL, 2000, J BIOL CHEM, V275, P23240, DOI 10.1074/jbc.M909202199; Hall JA, 1999, J BIOL CHEM, V274, P6148, DOI 10.1074/jbc.274.10.6148; HAYASHI S, 1964, J BIOL CHEM, V239, P3098; Henderson PJF, 1993, CURR OPIN CELL BIOL, V5, P708, DOI 10.1016/0955-0674(93)90144-F; Hirai T, 2003, J BACTERIOL, V185, P1712, DOI 10.1128/JB.185.5.1712-1718.2003; Hirai T, 2002, NAT STRUCT BIOL, V9, P597, DOI 10.1038/nsb821; Jencks W P, 1980, Adv Enzymol Relat Areas Mol Biol, V51, P75; JessenMarshall AE, 1996, J BIOL CHEM, V271, P1400, DOI 10.1074/jbc.271.3.1400; JUNG EKY, 1986, J BIOL CHEM, V261, P9155; Kaback HR, 1997, Q REV BIOPHYS, V30, P333, DOI 10.1017/S0033583597003387; KAHN BB, 1992, J CLIN INVEST, V89, P1367, DOI 10.1172/JCI115724; LEMIEUX MA, UNPUB; Levy SB, 2002, J APPL MICROBIOL, V92, p65S, DOI 10.1046/j.1365-2672.92.5s1.4.x; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; MAIDEN MCJ, 1987, NATURE, V325, P641, DOI 10.1038/325641a0; MALONEY PC, 1990, MICROBIOL REV, V54, P1; Matos M, 1996, J BIOL CHEM, V271, P18571, DOI 10.1074/jbc.271.31.18571; Mitchell P, 1963, BIOCH SOC S, V22, P141; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OLSEN SG, 1993, J BACTERIOL, V175, P6269, DOI 10.1128/JB.175.19.6269-6275.1993; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; REIZER J, 1993, PROTEIN SCI, V2, P20, DOI 10.1002/pro.5560020103; RIORDAN JF, 1979, MOL CELL BIOCHEM, V26, P71; ROCK CO, 1985, BIOCH LIPIDS MEMBRAN, P73; Sato M, 1999, J BIOL CHEM, V274, P24721, DOI 10.1074/jbc.274.35.24721; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; TANFORD C, 1983, ANNU REV BIOCHEM, V52, P379, DOI 10.1146/annurev.bi.52.070183.002115; Wang D, 2000, HUM MUTAT, V16, P224, DOI 10.1002/1098-1004(200009)16:3<224::AID-HUMU5>3.0.CO;2-P; West IC, 1997, BBA-REV BIOMEMBRANES, V1331, P213, DOI 10.1016/S0304-4157(97)00007-5	44	823	849	2	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2003	301	5633					616	620		10.1126/science.1087619	http://dx.doi.org/10.1126/science.1087619			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893936				2022-12-28	WOS:000184473600031
J	Gates, GA; Miyamoto, RT				Gates, GA; Miyamoto, RT			Cochlear implants	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Washington, Bloedel Hearing Res Ctr, Seattle, WA 98195 USA; Indiana Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Indianapolis, IN 46202 USA	University of Washington; University of Washington Seattle; Indiana University System; Indiana University-Purdue University Indianapolis	Gates, GA (corresponding author), Univ Washington, Bloedel Hearing Res Ctr, Seattle, WA 98195 USA.								0	24	25	0	5	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2003	349	5					421	423		10.1056/NEJMp038107	http://dx.doi.org/10.1056/NEJMp038107			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706FV	12890839				2022-12-28	WOS:000184443700002
J	Takaoka, A; Hayakawa, S; Yanai, H; Stoiber, D; Negishi, H; Kikuchi, H; Sasaki, S; Imai, K; Shibue, T; Honda, K; Taniguchi, T				Takaoka, A; Hayakawa, S; Yanai, H; Stoiber, D; Negishi, H; Kikuchi, H; Sasaki, S; Imai, K; Shibue, T; Honda, K; Taniguchi, T			Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence	NATURE			English	Article							DNA-DAMAGE; TRANSCRIPTIONAL ACTIVATION; P53-INDUCED APOPTOSIS; CANCER-CELLS; GENE; PHOSPHORYLATION; VIRUSES; PROTEIN; PATHWAY; AGENTS	Swift elimination of undesirable cells is an important feature in tumour suppression and immunity. The tumour suppressor p53 and interferon-alpha and -beta (IFN-alpha/beta) are essential for the induction of apoptosis in cancerous cells and in antiviral immune responses, respectively, but little is known about their interrelationship. Here we show that transcription of the p53 gene is induced by IFN-alpha/beta, accompanied by an increase in p53 protein level. IFN-alpha/beta signalling itself does not activate p53; rather, it contributes to boosting p53 responses to stress signals. We show examples in which p53 gene induction by IFN-alpha/beta contributes to tumour suppression. Furthermore, we show that p53 is activated in virally infected cells to evoke an apoptotic response and that p53 is critical for antiviral defence of the host. Our study reveals a hitherto unrecognized link between p53 and IFN-alpha/beta in tumour suppression and antiviral immunity, which may have therapeutic implications.	Univ Tokyo, Fac Med, Dept Immunol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; Sapporo Med Univ, Sch Med, Dept Internal Med 1, Chuo Ku, Sapporo, Hokkaido 0608556, Japan	University of Tokyo; University of Tokyo; Sapporo Medical University	Taniguchi, T (corresponding author), Univ Tokyo, Fac Med, Dept Immunol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.		Yang, Chen/G-1379-2010; Honda, Kenya/N-5297-2015; Yanai, Hideyuki/AGK-5933-2022	Yanai, Hideyuki/0000-0002-0115-9000; Stoiber-Sakaguchi, Dagmar/0000-0002-8824-0767				Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Biron CA, 2001, IMMUNITY, V14, P661, DOI 10.1016/S1074-7613(01)00154-6; Bluyssen Hans A. R., 1996, Cytokine and Growth Factor Reviews, V7, P11, DOI 10.1016/1359-6101(96)00005-6; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; BUTZ K, 1995, ONCOGENE, V10, P927; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Demaeyer E., 1988, INTERFERONS OTHER RE; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; FUJITA T, 1985, CELL, V41, P489, DOI 10.1016/S0092-8674(85)80022-2; GINSBERG D, 1990, ONCOGENE, V5, P1285; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Gresser I, 2002, CYTOKINE GROWTH F R, V13, P111, DOI 10.1016/S1359-6101(01)00035-1; GUTTERMAN JU, 1994, P NATL ACAD SCI USA, V91, P1198, DOI 10.1073/pnas.91.4.1198; HAQUE SJ, 1994, J BIOL CHEM, V269, P19523; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HSU IC, 1993, CARCINOGENESIS, V14, P987, DOI 10.1093/carcin/14.5.987; Jacks T, 1996, NATURE, V381, P643, DOI 10.1038/381643a0; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kimura T, 1996, GENES CELLS, V1, P115, DOI 10.1046/j.1365-2443.1996.08008.x; Koromilas AE, 2001, CYTOKINE GROWTH F R, V12, P157, DOI 10.1016/S1359-6101(00)00023-X; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Mendonca MS, 1999, CANCER RES, V59, P3972; Miyamoto A, 2000, J GASTROEN HEPATOL, V15, P1447, DOI 10.1046/j.1440-1746.2000.02289.x; Neil JC, 1997, TRENDS MICROBIOL, V5, P115, DOI 10.1016/S0966-842X(96)10083-4; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; OREN M, 1994, SEMIN CANCER BIOL, V5, P221; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Pfeffer LM, 1998, CANCER RES, V58, P2489; Polyak K, 1996, GENE DEV, V10, P1945, DOI 10.1101/gad.10.15.1945; Prives C, 1999, J PATHOL, V187, P112; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Strander H, 1996, BIOTHERAPY, V8, P213, DOI 10.1007/BF01877207; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; TSUKADA T, 1993, ONCOGENE, V8, P3313; Veldman T, 2001, J VIROL, V75, P4467, DOI 10.1128/JVI.75.9.4467-4472.2001; VILCEK J, 1996, FIELDS VIROLOGY, P375; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; WADLER S, 1990, CANCER RES, V50, P3473; Westphal CH, 1997, CANCER RES, V57, P1664; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	50	692	772	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					516	523		10.1038/nature01850	http://dx.doi.org/10.1038/nature01850			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12872134	Bronze			2022-12-28	WOS:000184454700033
J	Cheng, EHY; Sheiko, TV; Fisher, JK; Craigen, WJ; Korsmeyer, SJ				Cheng, EHY; Sheiko, TV; Fisher, JK; Craigen, WJ; Korsmeyer, SJ			VDAC2 inhibits BAK activation and mitochondrial apoptosis	SCIENCE			English	Article							DEPENDENT ANION CHANNEL; BCL-X-L; CYTOCHROME-C; PERMEABILITY TRANSITION; PROTEIN; FAMILY; DEATH; RELEASE; DYSFUNCTION; RESPIRATION	The multidomain proapoptotic molecules BAK or BAX are required to initiate the mitochondrial pathway of apoptosis. How cells maintain the potentially lethal proapoptotic effector BAK in a monomeric inactive conformation at mitochondria is unknown. In viable cells, we found BAK complexed with mitochondrial outer-membrane protein VDAC2, a VDAC isoform present in low abundance that interacts specifically with the inactive conformer of BAK. Cells deficient in VDAC2, but not cells lacking the more abundant VDAC1, exhibited enhanced BAK oligomerization and were more susceptible to apoptotic death. Conversely, overexpression of VDAC2 selectively prevented BAK activation and inhibited the mitochondrial apoptotic pathway. Death signals activate "BH3-only" molecules such as tBID, BIM, or BAD, which displace VDAC2 from BAK, enabling homo-oligomerization of BAK and apoptosis. Thus, VDAC2, an isoform restricted to mammals, regulates the activity of BAK and provides a connection between mitochondrial physiology and the core apoptotic pathway.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Baylor College of Medicine	Korsmeyer, SJ (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst, 44 Binney St, Boston, MA 02115 USA.	stanley_korsmeyer@dfci.harvard.edu			NATIONAL CANCER INSTITUTE [R37CA050239] Funding Source: NIH RePORTER; NCI NIH HHS [R37CA50239] Funding Source: Medline; NINDS NIH HHS [NS42319] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anflous K, 2001, J BIOL CHEM, V276, P1954, DOI 10.1074/jbc.M006587200; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; CHENG EH, UNPUB; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; CRAIGEN WJ, UNPUB; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Heiden MGV, 2001, J BIOL CHEM, V276, P19414, DOI 10.1074/jbc.M101590200; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Roucou X, 2002, BIOCHEM J, V368, P915, DOI 10.1042/BJ20020972; Sampson MJ, 2001, J BIOL CHEM, V276, P39206, DOI 10.1074/jbc.M104724200; Sampson MJ, 1997, J BIOL CHEM, V272, P18966, DOI 10.1074/jbc.272.30.18966; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 2000, J BIOL CHEM, V275, P12321, DOI 10.1074/jbc.275.16.12321; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Vander Heiden MG, 1999, MOL CELL, V3, P159; Weeber EJ, 2002, J BIOL CHEM, V277, P18891, DOI 10.1074/jbc.M201649200; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Wu SL, 1999, BBA-MOL CELL RES, V1452, P68, DOI 10.1016/S0167-4889(99)00120-2; Xu X, 1999, J MEMBRANE BIOL, V170, P89, DOI 10.1007/s002329900540; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	29	619	643	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2003	301	5632					513	517		10.1126/science.1083995	http://dx.doi.org/10.1126/science.1083995			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12881569				2022-12-28	WOS:000184340500042
J	Ahmed, AR; Kelly, JL; Avram, MM; McCluskey, RT; Ryan, DP; Duncan, LM				Ahmed, AR; Kelly, JL; Avram, MM; McCluskey, RT; Ryan, DP; Duncan, LM			A 79-year-old woman with gastric lymphoma and erosive mucosal and cutaneous lesions - Paraneoplastic pemphigus associated with gastric marginal-zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							STEVENS-JOHNSON SYNDROME; ERYTHEMA MULTIFORME; RITUXIMAB; NEOPLASIA		New England Baptist Hosp, Dept Oral Med, Boston, MA 02120 USA; Harvard Univ, Sch Dent Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Dermatopathol Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	New England Baptist Hospital; Harvard University; Harvard School of Dental Medicine; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Ahmed, AR (corresponding author), New England Baptist Hosp, Dept Oral Med, Boston, MA 02120 USA.		Duncan, Lyn/E-9878-2013					Anhalt G J, 1997, Adv Dermatol, V12, P77; ANHALT GJ, 1990, NEW ENGL J MED, V323, P1729, DOI 10.1056/NEJM199012203232503; ASSIER H, 1995, ARCH DERMATOL, V131, P539, DOI 10.1001/archderm.131.5.539; BASTUJIGARIN S, 1993, ARCH DERMATOL, V129, P92, DOI 10.1001/archderm.129.1.92; Bickle KM, 2002, AM FAM PHYSICIAN, V65, P1861; Borradori L, 2001, ARCH DERMATOL, V137, P269; CARNISA C, 1993, ARCH DERMATOL, V129, P883; Fleming TE, 2000, J AM ACAD DERMATOL, V43, P571, DOI 10.1067/mjd.2000.107248; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; HASHIMOTO T, 1995, J INVEST DERMATOL, V104, P829, DOI 10.1111/1523-1747.ep12607012; Hashimoto T, 2001, CLIN DERMATOL, V19, P675, DOI 10.1016/S0738-081X(00)00192-9; Heizmann M, 2001, AM J HEMATOL, V66, P142, DOI 10.1002/1096-8652(200102)66:2<142::AID-AJH1032>3.3.CO;2-S; Kimyai-Asadi A, 2001, INT J DERMATOL, V40, P367, DOI 10.1046/j.1365-4362.2001.01169.x; KURZROCK R, 1995, AM J MED, V99, P207, DOI 10.1016/S0002-9343(99)80141-7; Mimouni D, 2002, BRIT J DERMATOL, V147, P725, DOI 10.1046/j.1365-2133.2002.04992.x; Nagata Y, 2001, J INVEST DERMATOL, V116, P556, DOI 10.1046/j.1523-1747.2001.01263.x; Nousari HC, 1999, LANCET, V354, P667, DOI 10.1016/S0140-6736(99)03007-X; Ohyama M, 2001, J AM ACAD DERMATOL, V44, P593, DOI 10.1067/mjd.2001.112222; Osmanski JP, 1997, CHEST, V112, P1704, DOI 10.1378/chest.112.6.1704; Robinson ND, 1999, J AM ACAD DERMATOL, V40, P649, DOI 10.1016/S0190-9622(99)70145-3; YOUNUS J, 1990, J AM ACAD DERMATOL, V23, P498, DOI 10.1016/0190-9622(90)70249-H	21	31	34	1	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2003	349	4					382	391		10.1056/NEJMcpc030016	http://dx.doi.org/10.1056/NEJMcpc030016			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703ZH	12878746				2022-12-28	WOS:000184312800013
J	Buffelli, M; Burgess, RW; Feng, GP; Lobe, CG; Lichtman, JW; Sanes, JR				Buffelli, M; Burgess, RW; Feng, GP; Lobe, CG; Lichtman, JW; Sanes, JR			Genetic evidence that relative synaptic efficacy biases the outcome of synaptic competition	NATURE			English	Article								Synaptic activity drives synaptic rearrangement in the vertebrate nervous system; indeed, this appears to be a main way in which experience shapes neural connectivity(1,2). One rearrangement that occurs in many parts of the nervous system during early postnatal life is a competitive process called 'synapse elimination'(3,4). At the neuromuscular junction, where synapse elimination has been analysed in detail, muscle fibres are initially innervated by multiple axons, then all but one are withdrawn and the 'winner' enlarges(4-6). In support of the idea that synapse elimination is activity dependent, it is slowed or speeded when total neuromuscular activity is decreased or increased, respectively(4,7-13). However, most hypotheses about synaptic rearrangement postulate that change depends less on total activity than on the relative activity of the competitors(1-4,13,14). Intuitively, it seems that the input best able to excite its postsynaptic target would be most likely to win the competition, but some theories and results make other predictions(14-18). Here we use a genetic method to selectively inhibit neurotransmission from one of two inputs to a single target cell. We show that more powerful inputs are strongly favoured competitors during synapse elimination.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Univ Verona, Dipartimento Sci Neurol & Vis, I-37129 Verona, Italy; Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON MN4 3M5, Canada	Washington University (WUSTL); University of Verona; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Sanes, JR (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid, St Louis, MO 63110 USA.	sanesj@pcg.wustl.edu	Buffelli, Mario/C-6953-2018; Feng, Guoping/Y-2827-2019	Buffelli, Mario/0000-0002-3709-013X; Burgess, Robert/0000-0002-9229-3407				Barber MJ, 1999, J NEUROSCI, V19, P9975; BENOIT P, 1975, BRAIN RES, V99, P354, DOI 10.1016/0006-8993(75)90036-0; Brandon EP, 2003, J NEUROSCI, V23, P539, DOI 10.1523/JNEUROSCI.23-02-00539.2003; Buffelli M, 2002, P NATL ACAD SCI USA, V99, P13200, DOI 10.1073/pnas.202471199; Busetto G, 2000, J NEUROSCI, V20, P685, DOI 10.1523/JNEUROSCI.20-02-00685.2000; CALLAWAY EM, 1987, NATURE, V328, P422, DOI 10.1038/328422a0; Costanzo EM, 2000, NAT NEUROSCI, V3, P694, DOI 10.1038/76649; DING R, 1983, J NEUROCYTOL, V12, P887, DOI 10.1007/BF01153341; DUXSON MJ, 1982, J NEUROCYTOL, V11, P395, DOI 10.1007/BF01257985; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Guo CY, 2002, GENESIS, V32, P8, DOI 10.1002/gene.10021; Hata Y, 1999, NEURON, V22, P375, DOI 10.1016/S0896-6273(00)81097-1; Kasthuri N, 2003, NATURE, V424, P426, DOI 10.1038/nature01836; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Keller-Peck CR, 2001, NEURON, V31, P381, DOI 10.1016/S0896-6273(01)00383-X; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Lewandoski M, 1997, NAT GENET, V17, P223, DOI 10.1038/ng1097-223; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; OBRIEN RAD, 1978, J PHYSIOL-LONDON, V282, P571, DOI 10.1113/jphysiol.1978.sp012482; Personius KE, 2002, NEUROSCIENTIST, V8, P414, DOI 10.1177/107385802236970; Personius KE, 2001, NEURON, V31, P395, DOI 10.1016/S0896-6273(01)00369-5; RIDGE RMAP, 1984, J NEUROSCI, V4, P2614; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sengpiel F, 2002, CURR BIOL, V12, pR818, DOI 10.1016/S0960-9822(02)01318-0; THOMPSON W, 1983, NATURE, V302, P614, DOI 10.1038/302614a0; THOMPSON W, 1979, NEUROSCIENCE, V4, P271, DOI 10.1016/0306-4522(79)90088-5; Walsh MK, 2003, NEURON, V37, P67, DOI 10.1016/S0896-6273(02)01142-X	30	231	234	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2003	424	6947					430	434		10.1038/nature01844	http://dx.doi.org/10.1038/nature01844			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879071				2022-12-28	WOS:000184318400044
J	Punglia, RS; D'Amico, AV; Catalona, WJ; Roehl, KA; Kuntz, KM				Punglia, RS; D'Amico, AV; Catalona, WJ; Roehl, KA; Kuntz, KM			Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RADICAL PROSTATECTOMY; REFERENCE RANGES; BIOPSY STRATEGY; 4.0 NG/ML; FREE PSA; MEN; POPULATION; DISEASE; AGE; HYPERPLASIA	Background: The sensitivity and specificity of a screening test are biased when disease status is not verified in all subjects and when the likelihood of confirmation depends on the test result itself. We assessed the screening characteristics of the prostate-specific antigen (PSA) measurement after correction for verification bias. Methods: Between 1995 and 2001, 6691 men underwent PSA-based screening for prostate cancer. Of these men, 705 (11 percent) subsequently underwent biopsy of the prostate. Under the assumption that the chance of undergoing a biopsy depends only on the PSA-test result and other observed clinical variables, we used a mathematical model to estimate adjusted receiver-operating-characteristic (ROC) curves. Results: Adjusting for verification bias significantly increased the area under the ROC curve (i.e., the overall diagnostic performance) of the PSA test, as compared with an unadjusted analysis (0.86 vs. 0.69, P<0.001, for men less than 60 years of age; 0.72 vs. 0.62, P=0.008, for men 60 years of age or older). If the threshold PSA value for undergoing biopsy were set at 4.1 ng per milliliter, 82 percent of cancers in younger men and 65 percent of cancers in older men would be missed. A digital rectal examination that is abnormal but not suspicious for cancer does not affect the overall performance characteristics of the test. Conclusions: A lower threshold level of PSA for recommending prostate biopsy, particularly in younger men, may improve the clinical value of the PSA test.	Harvard Univ, Sch Med, Joint Ctr Radiat Therapy, Boston, MA USA; Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Washington Univ, Sch Med, Div Urol Surg, St Louis, MO USA; Northwestern Univ, Fineberg Sch Med, Dept Urol, Chicago, IL USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Washington University (WUSTL); Northwestern University; Feinberg School of Medicine; Harvard University; Harvard T.H. Chan School of Public Health	Kuntz, KM (corresponding author), Harvard Univ, Sch Publ Hlth, Ctr Risk Anal, 718 Huntington Ave, Boston, MA 02115 USA.				AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000020] Funding Source: NIH RePORTER; AHRQ HHS [T32 HS00020-16] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Babaian RJ, 2000, J UROLOGY, V163, P152, DOI 10.1016/S0022-5347(05)67993-1; Babaian RJ, 2001, J UROLOGY, V165, P757, DOI 10.1016/S0022-5347(05)66519-6; BEGG CB, 1983, BIOMETRICS, V39, P207, DOI 10.2307/2530820; Carvalhal GF, 1999, J UROLOGY, V161, P835, DOI 10.1016/S0022-5347(01)61785-3; Catalona WJ, 2000, UROLOGY, V55, P791, DOI 10.1016/S0090-4295(99)00602-0; CATALONA WJ, 1993, JAMA-J AM MED ASSOC, V270, P948, DOI 10.1001/jama.270.8.948; Catalona WJ, 1997, JAMA-J AM MED ASSOC, V277, P1452, DOI 10.1001/jama.277.18.1452; Cotter MP, 2002, PROSTATE, V50, P216, DOI 10.1002/pros.10051; Durkan GC, 2002, BJU INT, V89, P33, DOI 10.1046/j.1464-410X.2002.02555.x; Eskew LA, 1997, J UROLOGY, V157, P199, DOI 10.1016/S0022-5347(01)65322-9; Froelicher VF, 1998, ANN INTERN MED, V128, P965, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00001; GANN PH, 1995, JAMA-J AM MED ASSOC, V273, P289, DOI 10.1001/jama.273.4.289; GIANROSSI R, 1989, CIRCULATION, V80, P87, DOI 10.1161/01.CIR.80.1.87; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Holmberg L, 2002, NEW ENGL J MED, V347, P781, DOI 10.1056/NEJMoa012794; Krumholtz JS, 2002, UROLOGY, V60, P469, DOI 10.1016/S0090-4295(02)01875-7; Meigs JB, 1996, J GEN INTERN MED, V11, P505, DOI 10.1007/BF02599596; Miller MC, 2001, UROLOGY, V57, P1105, DOI 10.1016/S0090-4295(01)00953-0; Morgan TO, 1996, NEW ENGL J MED, V335, P304, DOI 10.1056/NEJM199608013350502; NADLER RB, 1995, J UROLOGY, V154, P407, DOI 10.1016/S0022-5347(01)67064-2; Naughton CK, 2000, J UROLOGY, V164, P388, DOI 10.1016/S0022-5347(05)67367-3; OESTERLING JE, 1993, JAMA-J AM MED ASSOC, V270, P860, DOI 10.1001/jama.270.7.860; Richter F, 2001, J CANCER EDUC, V16, P38; Sirovich BE, 2002, J GEN INTERN MED, V17, P212; Smith DS, 1998, J UROLOGY, V160, P1734, DOI 10.1016/S0022-5347(01)62395-4; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Walsh P C, 1994, Important Adv Oncol, P211; Wolff JM, 1996, UROL INT, V57, P170, DOI 10.1159/000282904	28	237	261	2	11	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2003	349	4					335	342		10.1056/NEJMoa021659	http://dx.doi.org/10.1056/NEJMoa021659			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703ZH	12878740				2022-12-28	WOS:000184312800006
J	Vincentelli, A; Susen, S; Le Tourneau, T; Six, I; Fabre, O; Juthier, F; Bauters, A; Decoene, C; Goudemand, J; Prat, A; Jude, B				Vincentelli, A; Susen, S; Le Tourneau, T; Six, I; Fabre, O; Juthier, F; Bauters, A; Decoene, C; Goudemand, J; Prat, A; Jude, B			Acquired von Willebrand syndrome in aortic stenosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLEEDING GASTROINTESTINAL ANGIODYSPLASIA; VONWILLEBRAND-FACTOR; SHEAR-STRESS; VALVE REPLACEMENT; DISEASE; PLASMA; PROTEOLYSIS; SUBTYPES; CLEAVAGE; TESTS	Background: Aortic-valve stenosis can be complicated by bleeding that is associated with acquired type 2A von Willebrand syndrome. However, the prevalence and cause of the hemostatic abnormality in aortic stenosis are unknown. Methods: We enrolled 50 consecutive patients with aortic stenosis, who completed a standardized screening questionnaire to detect a history of bleeding. Forty-two patients with severe aortic stenosis underwent valve replacement. Platelet function under conditions of high shear stress, von Willebrand factor collagen-binding activity and antigen levels, and the multimeric structure of von Willebrand factor were assessed at base line and one day, seven days, and six months postoperatively. Results: Skin or mucosal bleeding occurred in 21 percent of the patients with severe aortic stenosis. Platelet-function abnormalities under conditions of high shear stress, decreased von Willebrand factor collagen-binding activity and the loss of the largest multimers, or a combination of these was present in 67 to 92 percent of patients with severe aortic stenosis and correlated significantly with the severity of valve stenosis. Primary hemostatic abnormalities were completely corrected on the first day after surgery but tended to recur at six months, especially when there was a mismatch between patient and prosthesis (with an effective orifice area of less than 0.8 cm(sup 2) per square meter of body-surface area). Conclusions: Type 2A von Willebrand syndrome is common in patients with severe aortic stenosis. Von Willebrand factor abnormalities are directly related to the severity of aortic stenosis and are improved by valve replacement in the absence of mismatch between patient and prosthesis.	Univ Lille 2, Equipe Accueil 2693, Fac Med, Lille, France; Clin Chirurg Cardiovasc, Lille, France; Inst Hematol Biol & Hemobiol Transfus, Lille, France; Serv Explorat Fonct Cardiol, Lille, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille	Jude, B (corresponding author), Hop Cardiol, Inst Hematol Biol & Hemobiol Transfus, Blvd Prof J Leclercq, F-59037 Lille, France.		Le Tourneau, Thierry/D-5428-2015; susen, sophie/G-4337-2018	Susen, Sophie/0000-0001-5953-163X; Juthier, Francis/0000-0002-5072-9073; Vincentelli, Andre/0000-0003-4081-786X				Anderson RP, 1996, LANCET, V347, P689, DOI 10.1016/S0140-6736(96)91240-4; BLERY C, 1986, LANCET, V1, P139; Bonow R O, 1998, J Heart Valve Dis, V7, P672; CAPPELL MS, 1986, ANN INTERN MED, V105, P54, DOI 10.7326/0003-4819-105-1-54; Carabello BA, 2002, NEW ENGL J MED, V346, P677, DOI 10.1056/NEJMcp010846; DENT JA, 1990, P NATL ACAD SCI USA, V87, P6306, DOI 10.1073/pnas.87.16.6306; Favaloro EJ, 2000, THROMB HAEMOSTASIS, V84, P541; Federici, 2000, THROMB HAEMOSTASIS, V84, P739; Federici AB, 2000, THROMB HAEMOSTASIS, V84, P345; Fressinaud E, 1998, BLOOD, V91, P1325, DOI 10.1182/blood.V91.4.1325; GILL JC, 1986, BLOOD, V67, P758; GREENSTEIN RJ, 1986, AM J SURG, V151, P347, DOI 10.1016/0002-9610(86)90465-4; HEYDE EC, 1958, NEW ENGL J MED, V259, P196; KING RM, 1987, ANN THORAC SURG, V44, P514, DOI 10.1016/S0003-4975(10)62112-1; MAMMEN EF, 1995, SEMIN THROMB HEMOST, V21, P113; Mazurier C, 1998, HAEMOPHILIA, V4, P40; Pareti FI, 2000, CIRCULATION, V102, P1290, DOI 10.1161/01.CIR.102.11.1290; RAPAPORT SI, 1983, BLOOD, V61, P229; RUGGERI ZM, 1980, J CLIN INVEST, V65, P1318, DOI 10.1172/JCI109795; Siedlecki CA, 1996, BLOOD, V88, P2939, DOI 10.1182/blood.V88.8.2939.bloodjournal8882939; Sugimoto M, 2003, BLOOD, V101, P915, DOI 10.1182/blood-2002-03-0944; TSAI HM, 1994, BLOOD, V83, P2171; Veyradier A, 2001, GASTROENTEROLOGY, V120, P346, DOI 10.1053/gast.2001.21204; Veyradier A, 2000, THROMB HAEMOSTASIS, V84, P175, DOI 10.1055/s-0037-1613993; WARKENTIN TE, 1992, LANCET, V340, P35, DOI 10.1016/0140-6736(92)92434-H; Warkentin TE, 2002, NEW ENGL J MED, V347, P858, DOI 10.1056/NEJM200209123471122; ZIMMERMAN TS, 1986, J CLIN INVEST, V77, P947, DOI 10.1172/JCI112394	27	570	589	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2003	349	4					343	349		10.1056/NEJMoa022831	http://dx.doi.org/10.1056/NEJMoa022831			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703ZH	12878741				2022-12-28	WOS:000184312800007
J	Rini, M; Magnes, BZ; Pines, E; Nibbering, ETJ				Rini, M; Magnes, BZ; Pines, E; Nibbering, ETJ			Real-time observation of bimodal proton transfer in acid-base pairs in water	SCIENCE			English	Article							RECOMBINATION; DYNAMICS	The neutralization reaction between an acid and a base in water, triggered after optical excitation, was studied by femtosecond vibrational spectroscopy. Bimodal dynamics were observed. In hydrogen-bonded acid-base complexes, the proton transfer proceeds extremely fast (within 150 femtoseconds). In encounter pairs formed by diffusion of uncomplexed photoacid and base molecules, the reaction upon contact was an order of magnitude slower, in agreement with earlier reported values. These results call for a refinement of the traditional Eigen-Weller picture of acid-base reactions: A three-stage model is introduced to account for all observed dynamics.	Ben Gurion Univ Negev, Dept Chem, IL-84105 Beer Sheva, Israel; Max Born Inst Nichtlineare Opt & Kurzzeitspektros, D-12489 Berlin, Germany	Ben Gurion University; Max Born Institute for Nonlinear Optics & Short Term Spectroscopy	Pines, E (corresponding author), Ben Gurion Univ Negev, Dept Chem, POB 653, IL-84105 Beer Sheva, Israel.	epines@bgumail.bgu.ac.il; nibberin@mbi-berlin.de						Ando K, 1999, ADV CHEM PHYS, V110, P381, DOI 10.1002/9780470141694.ch6; Ando K, 1999, J PHYS CHEM A, V103, P10398, DOI 10.1021/jp992481i; Bell R.P., 1973, PROTON CHEM; DOUHAL A, 1995, NATURE, V378, P260, DOI 10.1038/378260a0; EIGEN M, 1964, PROG REACT KINET MEC, V2, P285; EIGEN M, 1964, ANGEW CHEM INT EDIT, V3, P1, DOI 10.1002/anie.196400011; Elsaesser T, 2002, UNDERS CH R, V23, P119; Geissler PL, 2001, SCIENCE, V291, P2121, DOI 10.1126/science.1056991; Genosar L, 2000, J PHYS CHEM A, V104, P6689, DOI 10.1021/jp000317l; HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/RevModPhys.62.251; Kuhlbrandt W, 2000, NATURE, V406, P569, DOI 10.1038/35020654; LEGGETT AJ, 1987, REV MOD PHYS, V59, P1, DOI 10.1103/RevModPhys.59.1; Marx D, 1999, NATURE, V397, P601, DOI 10.1038/17579; NATZLE WC, 1985, J PHYS CHEM-US, V89, P2605, DOI 10.1021/j100258a035; OPPENLANDER A, 1989, PHYS REV LETT, V63, P1432, DOI 10.1103/PhysRevLett.63.1432; Pines E, 2002, UNDERS CH R, V23, P155; PINES E, 1988, J CHEM PHYS, V88, P5620, DOI 10.1063/1.454572; Pines E, 1997, CHEM PHYS LETT, V281, P413, DOI 10.1016/S0009-2614(97)01245-1; Silverman DN, 2000, BBA-BIOENERGETICS, V1458, P88, DOI 10.1016/S0005-2728(00)00061-X; SKINNER JL, 1988, J CHEM PHYS, V89, P897, DOI 10.1063/1.455213; SZABO A, 1989, J PHYS CHEM-US, V93, P6929, DOI 10.1021/j100356a011; Tolbert LM, 2002, ACCOUNTS CHEM RES, V35, P19, DOI 10.1021/ar990109f; Tran-Thi TH, 2000, CHEM PHYS LETT, V329, P421, DOI 10.1016/S0009-2614(00)01037-X; WELLER A, 1961, PROG REACT KINET MEC, V1, P187; Zundel G, 2000, ADV CHEM PHYS, V111, P1	25	397	398	1	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2003	301	5631					349	352		10.1126/science.1085762	http://dx.doi.org/10.1126/science.1085762			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869756				2022-12-28	WOS:000184207300038
J	Murakami, S; Nagaosa, N; Zhang, SC				Murakami, S; Nagaosa, N; Zhang, SC			Dissipationless quantum spin current at room temperature	SCIENCE			English	Article							INJECTION; CONDUCTANCE	Although microscopic laws of physics are invariant under the reversal of the arrow of time, the transport of energy and information in most devices is an irreversible process. It is this irreversibility that leads to intrinsic dissipations in electronic devices and limits the possibility of quantum computation. We theoretically predict that the electric field can induce a substantial amount of dissipationless quantum spin current at room temperature, in hole-doped semiconductors such as Si, Ge, and GaAs. On the basis of a generalization of the quantum Hall effect, the predicted effect leads to efficient spin injection without the need for metallic ferromagnets. Principles found here could enable quantum spintronic devices with integrated information processing and storage units, operating with low power consumption and performing reversible quantum computation.	Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan; Natl Inst Adv Ind Sci & Technol, Tsukuba Cent 4, Tsukuba, Ibaraki 3058562, Japan; Japan Sci & Technol Corp, CREST, Tokyo, Japan; Stanford Univ, Dept Phys, Stanford, CA 94305 USA	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST); Stanford University	Murakami, S (corresponding author), Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan.	murakami@appi.t.u-tokyo.ac.jp	Nagaosa, Naoto/G-7057-2012; Murakami, Shuichi/AAC-2297-2019; Zhang, Shou-Cheng/B-2794-2010; Murakami, Shuichi/F-4855-2012	Murakami, Shuichi/0000-0002-2033-9402; Murakami, Shuichi/0000-0002-2033-9402				Arovas DP, 1998, PHYS REV B, V57, P12302, DOI 10.1103/PhysRevB.57.12302; BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; Bulgakov EN, 1999, PHYS REV LETT, V83, P376, DOI 10.1103/PhysRevLett.83.376; Feynman Richard Phillips, 2000, FEYNMAN LECT COMPUTA; Fiederling R, 1999, NATURE, V402, P787, DOI 10.1038/45502; Hammar PR, 1999, PHYS REV LETT, V83, P203, DOI 10.1103/PhysRevLett.83.203; Hilton DJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.146601; Hirsch JE, 1999, PHYS REV LETT, V83, P1834, DOI 10.1103/PhysRevLett.83.1834; Jackson J. D, 1998, CLASSICAL ELECTRODYN, VThird; Johnston-Halperin E, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.041306; Jungwirth T, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.207208; Kohda M, 2003, J SUPERCOND, V16, P167, DOI 10.1023/A:1023282012059; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; LUTTINGER JM, 1956, PHYS REV, V102, P1030, DOI 10.1103/PhysRev.102.1030; MADELUNG O, 1982, LANDOLTBORNSTEIN NUM, V17, P62907; Mattana R, 2003, PHYS REV LETT, V90, DOI [10.1103/PhysRevLett.90.166601, 10.1103/PhysRevLett.166601]; Meier F., 1984, OPTICAL ORIENTATION; Ohno Y, 1999, PHYS REV LETT, V83, P4196, DOI 10.1103/PhysRevLett.83.4196; Ohno Y, 1999, NATURE, V402, P790, DOI 10.1038/45509; PRANGE P, 1997, QUANTUM HALL EFFECT; Prinz GA, 1998, SCIENCE, V282, P1660, DOI 10.1126/science.282.5394.1660; Schmidt G, 2000, PHYS REV B, V62, pR4790, DOI 10.1103/PhysRevB.62.R4790; Sundaram G, 1999, PHYS REV B, V59, P14915, DOI 10.1103/PhysRevB.59.14915; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; ZEE A, 1988, PHYS REV A, V38, P1, DOI 10.1103/PhysRevA.38.1; Zhang SC, 1999, PHYS REV B, V60, P13070, DOI 10.1103/PhysRevB.60.13070; Zhang SC, 2001, SCIENCE, V294, P823, DOI 10.1126/science.294.5543.823	28	1636	1668	18	376	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2003	301	5638					1348	1351		10.1126/science.1087128	http://dx.doi.org/10.1126/science.1087128			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717XQ	12907808	Bronze, Green Submitted			2022-12-28	WOS:000185116400031
J	Corrie, P; Shaw, J; Harris, R				Corrie, P; Shaw, J; Harris, R			Rate limiting factors in recruitment of patients to clinical trials in cancer research: descriptive study	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Addenbrookes NHS Trust, Ctr Oncol, Cambridge CB2 2QQ, England	Addenbrooke's Hospital	Corrie, P (corresponding author), Addenbrookes NHS Trust, Ctr Oncol, Box 193, Cambridge CB2 2QQ, England.	pippa.corrie@addenbrookes.nhs.uk						Baum M, 2002, EUR J CANCER, V38, P1984, DOI 10.1016/S0959-8049(02)00154-5; Comis RL, 2003, J CLIN ONCOL, V21, P830, DOI 10.1200/JCO.2003.02.105; KMIETOWICZ Z, 2001, BRIT MED J, V325, P920; *NAT CANC RES I, 2002, STRAT AN OV CANC RES	4	31	31	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2003	327	7410					320	321		10.1136/bmj.327.7410.320	http://dx.doi.org/10.1136/bmj.327.7410.320			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	710JE	12907485	Green Published, Bronze			2022-12-28	WOS:000184676400017
J	Dalton, MA; Sargent, JD; Beach, ML; Titus-Ernstoff, L; Gibson, JJ; Ahrens, MB; Tickle, JJ; Heatherton, TF				Dalton, MA; Sargent, JD; Beach, ML; Titus-Ernstoff, L; Gibson, JJ; Ahrens, MB; Tickle, JJ; Heatherton, TF			Effect of viewing smoking in movies on adolescent smoking initiation: a cohort study	LANCET			English	Article							TOBACCO USE; UNITED-STATES; POPULAR FILMS; ALCOHOL-USE; SUSCEPTIBILITY; MEDIA; CIGARETTES; BEHAVIORS; PROMOTION; HOLLYWOOD	Background Exposure to smoking in movies has been linked with adolescent smoking initiation in cross-sectional studies. We undertook a prospective study to ascertain whether exposure to smoking in movies predicts smoking initiation. Method We assessed exposure to smoking shown in movies in 3547 adolescents, aged 10-14 years, who reported in a baseline survey that they had never tried smoking. Exposure to smoking in movies was estimated for individual respondents on the basis of the number of smoking occurrences viewed in unique samples of 50 movies, which were randomly selected from a larger sample pool of popular contemporary movies. We successfully re-contacted 2603 (73%) students 13-26 months later for a follow-up interview to determine whether they had initiated smoking. Findings Overall, 10% (n = 259) of students initiated smoking during the follow-up period. In the highest quartile of exposure to movie smoking, 17% (107) of students had initiated smoking, compared with only 3% (22) in the lowest quartile. After controlling for baseline characteristics, adolescents in the highest quartile of exposure to movie smoking were 2.71 (95% Cl 1.73-4-25) times more likely to initiate smoking compared with those in the lowest quartile. The effect of exposure to movie smoking was stronger in adolescents with non-smoking parents than in those whose parent smoked. In this cohort, 52.2% (30.0-67-3) of smoking initiation can be attributed to exposure to smoking in movies. Interpretation Our results provide strong evidence that viewing smoking in movies promotes smoking initiation among adolescents.	Dartmouth Coll Sch Med, Dept Paediat, Lebanon, NH 03756 USA; Dartmouth Coll Sch Med, Dept Anaesthesia, Lebanon, NH 03756 USA; Dartmouth Coll Sch Med, Dept Community & Family Med, Lebanon, NH 03756 USA; Dartmouth Coll Sch Med, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA; RTI Int, Dept Hlth Social & Econ Res, Res Triangle Pk, NC USA; Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; Research Triangle Institute; Dartmouth College	Dalton, MA (corresponding author), Dartmouth Coll Sch Med, Dept Paediat, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	Madeline.Dalton@Dartmouth.edu	Sargent, James D/I-2773-2013; Heatherton, Todd F/H-5478-2011		NATIONAL CANCER INSTITUTE [R01CA077026] Funding Source: NIH RePORTER; NCI NIH HHS [CA-77026] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altman DG, 1996, AM J PUBLIC HEALTH, V86, P1590, DOI 10.2105/AJPH.86.11.1590; Bandura A, 1965, J ABNORMAL SOCIAL PS, V66, P575; BASIL MD, 1997, HEALTH COMMUN, V9, P190; Biener L, 2000, AM J PUBLIC HEALTH, V90, P407, DOI 10.2105/AJPH.90.3.407; Bushman BJ, 2001, AM PSYCHOL, V56, P477, DOI 10.1037//0003-066X.56.6-7.477; Carvajal SC, 2000, J ADOLESCENT HEALTH, V27, P255, DOI 10.1016/S1054-139X(00)00124-5; Choi WS, 2002, AM J PREV MED, V22, P228, DOI 10.1016/S0749-3797(02)00420-8; Connors AF, 1996, JAMA-J AM MED ASSOC, V276, P889, DOI 10.1001/jama.276.11.889; Dalton MA, 2002, PREV MED, V34, P516, DOI 10.1006/pmed.2002.1013; Distefan JM, 1999, PREV MED, V28, P1, DOI 10.1006/pmed.1998.0409; Escamilla G, 2000, AM J PUBLIC HEALTH, V90, P412, DOI 10.2105/AJPH.90.3.412; EVANS N, 1995, J NATL CANCER I, V87, P1538, DOI 10.1093/jnci/87.20.1538; Everett SA, 1998, J COMMUN HEALTH, V23, P317, DOI 10.1023/A:1018727606500; Goldstein AO, 1999, JAMA-J AM MED ASSOC, V281, P1131, DOI 10.1001/jama.281.12.1131; HAZAN AR, 1994, AM J PUBLIC HEALTH, V84, P998, DOI 10.2105/AJPH.84.6.998; Jackson C, 1998, HEALTH EDUC BEHAV, V25, P319, DOI 10.1177/109019819802500307; KLEIN JD, 1993, PEDIATRICS, V92, P24; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; McIntosh WD, 1998, ADDICT BEHAV, V23, P395, DOI 10.1016/S0306-4603(97)00071-3; Pechmann C, 1999, J MARKETING, V63, P1, DOI 10.2307/1251772; Pierce J.P, 1993, TOBACCO USE CALIFORN; Pierce JP, 1996, HEALTH PSYCHOL, V15, P355, DOI 10.1037/0278-6133.15.5.355; PIERCE JP, 1995, HEALTH PSYCHOL, V14, P500, DOI 10.1037/0278-6133.14.6.500; Pierce JP, 1998, JAMA-J AM MED ASSOC, V279, P511, DOI 10.1001/jama.279.7.511; RUSSO MF, 1993, J PSYCHOPATHOL BEHAV, V15, P69, DOI 10.1007/BF00960609; Sargent JD, 2001, BRIT MED J, V323, P1394, DOI 10.1136/bmj.323.7326.1394; Sargent JD, 2001, LANCET, V357, P29, DOI 10.1016/S0140-6736(00)03568-6; Sargent JD, 2001, PEDIATRICS, V108, P1256, DOI 10.1542/peds.108.6.1256; Sargent JD, 2000, PREV MED, V30, P320, DOI 10.1006/pmed.1999.0629; Schooler C, 1996, AM J PUBLIC HEALTH, V86, P1216, DOI 10.2105/AJPH.86.9.1216; TERRE L, 1991, J APPL SOC PSYCHOL, V21, P1303, DOI 10.1111/j.1559-1816.1991.tb00472.x; Tickle JJ, 2001, TOB CONTROL, V10, P16, DOI 10.1136/tc.10.1.16; ZUCKERMAN M, 1972, J CONSULT CLIN PSYCH, V39, P308, DOI 10.1037/h0033398	33	305	309	3	50	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2003	362	9380					281	285		10.1016/S0140-6736(03)13970-0	http://dx.doi.org/10.1016/S0140-6736(03)13970-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	705UL	12892958				2022-12-28	WOS:000184413400010
J	Haga, SB; Venter, JC				Haga, SB; Venter, JC			Genetics - FDA races in wrong direction	SCIENCE			English	Editorial Material							MOLECULAR-BASIS; THERAPY; HISTORY		Ctr Advancement Genom, Rockville, MD 20850 USA	J. Craig Venter Institute	Haga, SB (corresponding author), Ctr Advancement Genom, Rockville, MD 20850 USA.							Bamshad MJ, 2003, AM J HUM GENET, V72, P578, DOI 10.1086/368061; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Carvalho-Silva DR, 2001, AM J HUM GENET, V68, P281, DOI 10.1086/316931; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Ginsburg GS, 2001, TRENDS BIOTECHNOL, V19, P491, DOI 10.1016/S0167-7799(01)01814-5; Goldstein DB, 2002, ANNU REV GENOM HUM G, V3, P129, DOI 10.1146/annurev.genom.3.022502.103200; Hahn RA, 1996, EPIDEMIOLOGY, V7, P75, DOI 10.1097/00001648-199601000-00013; Higashi MK, 2002, JAMA-J AM MED ASSOC, V287, P1690, DOI 10.1001/jama.287.13.1690; Jain KK, 2002, CURR OPIN MOL THER, V4, P548; JOHNSON CE, 1974, 31 US BUR CENS; Jorde LB, 2001, HUM MOL GENET, V10, P2199, DOI 10.1093/hmg/10.20.2199; Krynetski EY, 1999, PHARM RES-DORDR, V16, P342, DOI 10.1023/A:1011909315614; Lee S S, 2001, Yale J Health Policy Law Ethics, V1, P33; Nobles M, 2000, AM J PUBLIC HEALTH, V90, P1738, DOI 10.2105/AJPH.90.11.1738; Rankin J, 1999, BRIT MED J, V318, P1696, DOI 10.1136/bmj.318.7199.1696; Relling MV, 1999, JNCI-J NATL CANCER I, V91, P2001, DOI 10.1093/jnci/91.23.2001; Risch N., 2002, GENOME BIOL, V3, pcomm, DOI [10.1186/gb-2002-3-7-comment2007, 10.1186/GB-2002-3-7-COMMENT2007]; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Roses AD, 2001, HUM MOL GENET, V10, P2261, DOI 10.1093/hmg/10.20.2261; SENIOR PA, 1994, BRIT MED J, V309, P327, DOI 10.1136/bmj.309.6950.327; Shriver MD, 1997, AM J HUM GENET, V60, P957; US Office of Management and Budget, 1997, FED REGISTER, V62, P58781; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Xie HG, 2001, ANNU REV PHARMACOL, V41, P815, DOI 10.1146/annurev.pharmtox.41.1.815; Yates CR, 1997, ANN INTERN MED, V126, P608, DOI 10.7326/0003-4819-126-8-199704150-00003; 1998, FED REG         0610, V63, P31790; 2003, FED REG         0130, V68, P4788	27	37	38	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2003	301	5632					466	466		10.1126/science.1087004	http://dx.doi.org/10.1126/science.1087004			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12881555				2022-12-28	WOS:000184340500025
J	Ahlborg, HG; Johnell, O; Turner, CH; Rannevik, G; Karlsson, MK				Ahlborg, HG; Johnell, O; Turner, CH; Rannevik, G; Karlsson, MK			Bone loss and bone size after menopause	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VOLUMETRIC DENSITY; MINERAL DENSITY; SEX-DIFFERENCES; HEALTHY WOMEN; HIP FRACTURE; BODY-SIZE; AGE; RISK; MEN; OSTEOPOROSIS	Background: Bone loss increases after menopause. However, bone strength also depends on structural characteristics such as bone size. Whether bone size increases as a result of periosteal apposition and whether a strength index accounting for both bone density and bone size might predict the risk of fracture better than bone density alone are unclear. Methods: Bone mass and the skeletal structure of the distal radius were evaluated by single-photon absorptiometry every other year in 108 women, all of whom were followed from the time of menopause for a mean period of 15 years. Postmenopausal serum estradiol levels and fractures of the distal radius were noted. Results: The mean (+/-SD) annual decrease in bone mineral density was 1.9+/-0.7 percent. The medullary bone diameter increased annually by 1.1+/-0.9 percent, and the periosteal diameter by 0.7+/-0.3 percent; the strength index decreased by 0.7+/-0.7 percent. The expansion of the medullary diameter and the expansion of the periosteal diameter were correlated with one another (r = 0.54, P<0.001), and women in the highest quartile of medullary expansion had more loss of bone mineral density and greater periosteal apposition than women in the lowest quartile (P<0.001 for both comparisons). The postmenopausal serum estradiol level was correlated with changes in the periosteal diameter (r = -0.25, P=0.009) and with changes in bone mineral density (r = 0.34, P<0.001). A 1-SD decrement in the strength index at base line was associated with a risk ratio for fracture of the distal radius of 3.8 (95 percent confidence interval, 1.8 to 8.0). Conclusions: Increased bone loss after menopause is associated with increased periosteal apposition, which partially preserves bone strength. A strength index may be a helpful predictor of the risk of fracture.	Malmo Univ Hosp, Dept Orthoped, SE-20502 Malmo, Sweden; Malmo Univ Hosp, Dept Obstet & Gynecol, SE-20502 Malmo, Sweden; Indiana Univ, Dept Orthoped Surg, Indianapolis, IN 46204 USA; Indiana Univ, Biomech & Biomat Res Ctr, Indianapolis, IN 46204 USA	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Ahlborg, HG (corresponding author), Malmo Univ Hosp, Dept Orthoped, SE-20502 Malmo, Sweden.	henrik.ahlborg@skane.se						Ahlborg HG, 2001, BONE, V28, P327, DOI 10.1016/S8756-3282(00)00451-8; Augat P, 1996, J BONE MINER RES, V11, P1356; BALENA R, 1992, J BONE MINER RES, V7, P1475; BENGNER U, 1985, ACTA ORTHOP SCAND, V56, P158, DOI 10.3109/17453678508994345; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; BOUXSEIN ML, 1994, CALCIFIED TISSUE INT, V54, P113, DOI 10.1007/BF00296061; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Duan YB, 2001, J BONE MINER RES, V16, P2276, DOI 10.1359/jbmr.2001.16.12.2276; Duan YB, 1999, J BONE MINER RES, V14, P1796, DOI 10.1359/jbmr.1999.14.10.1796; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P2124; Ferretti JL, 1996, BONE, V18, P97, DOI 10.1016/8756-3282(95)00438-6; Frost HM, 1999, J BONE MINER RES, V14, P1473, DOI 10.1359/jbmr.1999.14.9.1473; HAYES WC, 1982, SCIENCE, V217, P945, DOI 10.1126/science.7112107; Heaney RP, 1997, OSTEOPOROSIS INT, V7, P426, DOI 10.1007/PL00004150; HSU ES, 1993, J BIOMECH, V26, P1307, DOI 10.1016/0021-9290(93)90354-H; JOHNELL O, 1984, CALCIFIED TISSUE INT, V36, P354, DOI 10.1007/BF02405345; JONSSON B, 1994, J EPIDEMIOL COMMUN H, V48, P489, DOI 10.1136/jech.48.5.489; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; MOSEKILDE L, 1990, BONE, V11, P67, DOI 10.1016/8756-3282(90)90052-Z; Naucler L, 1974, OPUSC MED TECH LUND, V12, P19; PARFITT AM, 1994, J CELL BIOCHEM, V55, P273, DOI 10.1002/jcb.240550303; RANNEVIK G, 1995, MATURITAS, V21, P103, DOI 10.1016/0378-5122(94)00869-9; Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763; RIGGS BL, 1986, J CLIN INVEST, V77, P1487, DOI 10.1172/JCI112462; RUFF CB, 1988, J ORTHOP RES, V6, P886, DOI 10.1002/jor.1100060613; Seeman E, 2001, J BONE MINER RES, V16, P120, DOI 10.1359/jbmr.2001.16.1.120; SMITH RW, 1964, SCIENCE, V145, P156, DOI 10.1126/science.145.3628.156; THORELL JI, 1978, RADIOIMMUNOASSAY REL, P137; TURNER RT, 1987, J BONE MINER RES, V2, P115; World Health Organization (WHO), 1981, WHO TECHN REP SER, V670, P1	31	440	459	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2003	349	4					327	334		10.1056/NEJMoa022464	http://dx.doi.org/10.1056/NEJMoa022464			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703ZH	12878739	Green Published			2022-12-28	WOS:000184312800005
J	Serini, G; Valdembri, D; Zanivan, S; Morterra, G; Burkhardt, C; Caccavari, F; Zammataro, L; Primo, L; Tamagnone, L; Logan, M; Tesssier-Lavigne, M; Taniguchi, M; Puschel, AW; Bussolino, F				Serini, G; Valdembri, D; Zanivan, S; Morterra, G; Burkhardt, C; Caccavari, F; Zammataro, L; Primo, L; Tamagnone, L; Logan, M; Tesssier-Lavigne, M; Taniguchi, M; Puschel, AW; Bussolino, F			Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function	NATURE			English	Article							SUPPRESSES TUMOR-FORMATION; ENDOTHELIAL-CELLS; MOUSE EMBRYOS; SEMAPHORIN; ACTIVATION; GROWTH; GENE; ALPHA(V)BETA(3); ALPHA-V-BETA-3; ANGIOGENESIS	The motility and morphogenesis of endothelial cells is controlled by spatio-temporally regulated activation of integrin adhesion receptors, and integrin activation is stimulated by major determinants of vascular remodelling. In order for endothelial cells to be responsive to changes in activator gradients, the adhesiveness of these cells to the extracellular matrix must be dynamic, and negative regulators of integrins could be required. Here we show that during vascular development and experimental angiogenesis, endothelial cells generate autocrine chemorepulsive signals of class 3 semaphorins (SEMA3 proteins) that localize at nascent adhesive sites in spreading endothelial cells. Disrupting endogenous SEMA3 function in endothelial cells stimulates integrin-mediated adhesion and migration to extracellular matrices, whereas exogenous SEMA3 proteins antagonize integrin activation. Misexpression of dominant negative SEMA3 receptors in chick embryo endothelial cells locks integrins in an active conformation, and severely impairs vascular remodelling. Sema3a null mice show vascular defects as well. Thus during angiogenesis endothelial SEMA3 proteins endow the vascular system with the plasticity required for its reshaping by controlling integrin function.	Univ Turin, Sch Med, Div Mol Angiogenesis, I-10060 Candiolo, TO, Italy; Univ Turin, Sch Med, Inst Canc Res & Treatment, IRCC,Div Mol Oncol, I-10060 Candiolo, TO, Italy; Univ Turin, Sch Med, Dept Oncol Sci, I-10060 Candiolo, TO, Italy; Univ Munster, Inst Allgemeine Zool & Genet, Mol Biol Abt, D-48149 Munster, Germany; Natl Inst Med Res, Div Dev Biol, London NW7 1AA, England; Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA; Univ Tokyo, Grad Sch Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan	University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; University of Turin; University of Munster; MRC National Institute for Medical Research; Howard Hughes Medical Institute; Stanford University; University of Tokyo	Serini, G (corresponding author), Univ Turin, Sch Med, Div Mol Angiogenesis, I-10060 Candiolo, TO, Italy.	guido.serini@ircc.it; federico.bussolino@ircc.it	Zanivan, Sara/C-4340-2008; Serini, Guido/AAF-2873-2021; Bussolino, Federico/AES-3951-2022; Tamagnone, Luca/J-8948-2018; Zanivan, Sara/GOV-5505-2022; Bussolino, Federico/K-2500-2016	Serini, Guido/0000-0002-3502-8367; Tamagnone, Luca/0000-0002-2884-7946; PRIMO, Luca/0000-0002-1294-0441; Bussolino, Federico/0000-0002-5348-1341; Zanivan, Sara/0000-0002-9880-9099; Valdembri, Donatella/0000-0003-4590-417X; Zammataro, Luca/0000-0002-4348-6341				Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Brown CB, 2001, DEVELOPMENT, V128, P3071; Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6; Cho SY, 2002, J CELL BIOL, V156, P725, DOI 10.1083/jcb.200111032; Cruz MT, 1997, J CELL SCI, V110, P2647; Evans HM, 1909, ANAT REC, V3, P498, DOI 10.1002/ar.1090030903; Feiner L, 2001, DEVELOPMENT, V128, P3061; Francis SE, 2002, ARTERIOSCL THROM VAS, V22, P927, DOI 10.1161/01.ATV.0000016045.93313.F2; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; Garlanda C, 1997, ARTERIOSCL THROM VAS, V17, P1193, DOI 10.1161/01.ATV.17.7.1193; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Grignani F, 1998, CANCER RES, V58, P14; Gu JG, 1999, J CELL BIOL, V146, P389, DOI 10.1083/jcb.146.2.389; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; Kiosses WB, 2001, NAT CELL BIOL, V3, P316, DOI 10.1038/35060120; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Logan M, 1998, METHODS, V14, P407, DOI 10.1006/meth.1998.0595; Martin-Bermudo MD, 1998, J CELL BIOL, V141, P1073, DOI 10.1083/jcb.141.4.1073; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Miao HQ, 1999, J CELL BIOL, V146, P233, DOI 10.1083/jcb.146.1.233; Neufeld G, 2002, TRENDS CARDIOVAS MED, V12, P13, DOI 10.1016/S1050-1738(01)00140-2; NEUGEBAUER KM, 1991, NATURE, V350, P68, DOI 10.1038/350068a0; Pampori N, 1999, J BIOL CHEM, V274, P21609, DOI 10.1074/jbc.274.31.21609; Pasterkamp RJ, 2003, CURR OPIN NEUROBIOL, V13, P79, DOI 10.1016/S0959-4388(03)00003-5; Primo L, 2000, ONCOGENE, V19, P3632, DOI 10.1038/sj.onc.1203708; Robson Paul, 2002, P97; Sabin FR, 1917, CONTRIB EMBRYOL, V6, P63; SEIFERT R, 1992, ANAT EMBRYOL, V186, P601; Sigmund CD, 2000, ARTERIOSCL THROM VAS, V20, P1425, DOI 10.1161/01.ATV.20.6.1425; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; STUPACK DG, 2002, SCI STKE, V119, pPE7; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Trusolino L, 1998, J CELL BIOL, V142, P1145, DOI 10.1083/jcb.142.4.1145; Tse C, 2002, CANCER RES, V62, P542; Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639; Xiang RH, 2002, CANCER RES, V62, P2637; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215	49	464	497	4	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2003	424	6947					391	397		10.1038/nature01784	http://dx.doi.org/10.1038/nature01784			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879061				2022-12-28	WOS:000184318400034
J	Chiasson, JL; Josse, RG; Gomis, R; Hanefeld, M; Karasik, A; Laakso, M				Chiasson, JL; Josse, RG; Gomis, R; Hanefeld, M; Karasik, A; Laakso, M		STOP-NIDDM Trial Res Grp	Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance - The STOP-NIDDM Ttrial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; DIABETES-MELLITUS; OXIDATIVE STRESS; FASTING GLUCOSE; PLASMA-GLUCOSE; HYPERGLYCEMIA; MORTALITY; INSULIN; POPULATION; ATHEROSCLEROSIS	Context The worldwide explosive increase in type 2 diabetes mellitus and its cardiovascular morbidity are becoming major health concerns. Objective To evaluate the effect of decreasing postprandial hyperglycemia with acarbose, an alpha-glucosidase inhibitor, on the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance (IGT). Design, Setting, and Participants International, multicenter double-blind, placebo-controlled, randomized trial, undertaken in hospitals in Canada, Germany, Austria, Norway, Denmark, Sweden, Finland, Israel, and Spain from July 1998 through August 2001. A total of 1429 patients with IGT were randomized with 61 patients (4%) excluded because they did not have IGT or had no postrandomization data, leaving 1368 patients for a modified intent-to-treat analysis. Both men (49%) and women (51%) participated with a mean (SD) age of 54.5 (7.9) years and body mass index of 30.9 (4.2). These patients were followed up for a mean (SD) of 3.3 (1.2) years. Intervention Patients with IGT were randomized to receive either placebo (n=715) or 100 mg of acarbose 3 times a day (n = 714). Main Outcome Measures The development of major cardiovascular events (coronary heart disease, cardiovascular death, congestive heart failure, cerebrovascular event, and peripheral vascular disease) and hypertension (greater than or equal to140/90 mm Hg). Results Three hundred forty-one patients (24%) discontinued their participation prematurely, 211 in the acarbose-treated group and 130 in the placebo group; these patients were also followed up for outcome parameters. Decreasing postprandial hyperglycemia with acarbose was associated with a 49% relative risk reduction in the development of cardiovascular events (hazard ratio [HR], 0.51; 95% confidence interval [CI]; 0.28-0.95; P=.03) and a 2.5% absolute risk reduction. Among cardiovascular events, the major reduction was in the risk of myocardial infarction (HR, 0.09; 95% CI, 0.01-0.72; P=.02). Acarbose was also associated with a 34% relative risk reduction in the incidence of new cases of hypertension (HR, 0.66; 95% CI, 0.49-0.89; P=.006) and a 5.3% absolute risk reduction. Even after adjusting for major risk factors, the reduction in the risk of cardiovascular events (HR, 0.47; 95% CI, 0.24-0.90; P=.02) and hypertension (HR, 0.62; 95% CI, 0.45-0.86; P=.004) associated with acarbose treatment was still statistically significant. Conclusion This study suggests that treating IGT patients with acarbose is associated with a significant reduction in the risk of cardiovascular disease and hypertension.	Univ Montreal, Ctr Hosp, Hotel Dieu, Res Ctr, Montreal, PQ H2W 1T7, Canada; Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; Univ Barcelona, Hosp Clin, Diabet Unit, Barcelona, Spain; Tech Univ Dresden, Ctr Clin Studies GWT, D-8027 Dresden, Germany; Chaim Sheba Med Ctr, Inst Endocrinol, IL-52621 Tel Hashomer, Israel; Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland	Laval University; Universite de Montreal; Universite de Montreal; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Barcelona; Hospital Clinic de Barcelona; Technische Universitat Dresden; Chaim Sheba Medical Center; University of Eastern Finland	Chiasson, JL (corresponding author), Univ Montreal, Ctr Hosp, Hotel Dieu, Res Ctr, 3850 St Urbain St,Room 8-202, Montreal, PQ H2W 1T7, Canada.	jean.louis.chiasson@umontreal.ca	קרסיק, אברהם/AAV-1374-2021					Barzilay JI, 1999, LANCET, V354, P622, DOI 10.1016/S0140-6736(98)12030-5; Beks PHJ, 1997, DIABETOLOGIA, V40, P290, DOI 10.1007/s001250050676; Bonora E, 2000, DIABETOLOGIA, V43, P156, DOI 10.1007/s001250050024; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397; Ceriello A, 1998, DIABETES CARE, V21, P1529, DOI 10.2337/diacare.21.9.1529; Ceriello A, 1997, DIABETES CARE, V20, P194, DOI 10.2337/diacare.20.2.194; Ceriello A, 2002, DIABETES, V51, P1076, DOI 10.2337/diabetes.51.4.1076; Ceriello A, 1996, DIABETOLOGIA, V39, P469, DOI 10.1007/BF00400679; Chiasson JL, 1998, DIABETES CARE, V21, P1720, DOI 10.2337/diacare.21.10.1720; Chiasson JL, 1996, DIABETES CARE, V19, P1190, DOI 10.2337/diacare.19.11.1190; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; de Marco R, 1999, DIABETES CARE, V22, P756, DOI 10.2337/diacare.22.5.756; de Vegt F, 2000, DIABETES CARE, V23, P40, DOI 10.2337/diacare.23.1.40; DESPRES JP, 1990, ARTERIOSCLEROSIS, V10, P497, DOI 10.1161/01.ATV.10.4.497; DESPRES JP, 1988, J CLIN EPIDEMIOL, V41, P889, DOI 10.1016/0895-4356(88)90106-0; El Midaoui A, 2002, J HYPERTENS, V20, P1407, DOI 10.1097/00004872-200207000-00028; FONTBONNE A, 1989, DIABETOLOGIA, V32, P300, DOI 10.1007/BF00265546; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FULLER JH, 1980, LANCET, V1, P1373; GOKE B, 1994, EUR J CLIN INVEST, V24, P25; HAFFNER SM, 1990, JAMA-J AM MED ASSOC, V263, P2893, DOI 10.1001/jama.263.21.2893; HAFFNER SM, 1992, DIABETES CARE, V15, P1277, DOI 10.2337/diacare.15.10.1277; Haffner Steven M, 2003, Diabetes Care, V26 Suppl 1, pS83; HAMMAN RF, 1989, AM J EPIDEMIOL, V129, P295, DOI 10.1093/oxfordjournals.aje.a115134; Hanefeld M, 1999, ATHEROSCLEROSIS, V144, P229, DOI 10.1016/S0021-9150(99)00059-3; Hanefeld M, 1996, DIABETOLOGIA, V39, P1577, DOI 10.1007/s001250050617; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Kawano H, 1999, J AM COLL CARDIOL, V34, P146, DOI 10.1016/S0735-1097(99)00168-0; Laakso M, 1999, DIABETES, V48, P937, DOI 10.2337/diabetes.48.5.937; LAAKSO M, 1993, CIRCULATION, V88, P1421, DOI 10.1161/01.CIR.88.4.1421; Manley SE, 1997, DIABETES CARE, V20, P1683; MANSON JE, 1991, ARCH INTERN MED, V151, P1141, DOI 10.1001/archinte.151.6.1141; Marfella R, 2001, J CLIN INVEST, V108, P635, DOI 10.1172/JCI13727; OLEARY DH, 1992, STROKE, V23, P1752, DOI 10.1161/01.STR.23.12.1752; Pyorala K, 1979, Diabetes Care, V2, P131, DOI 10.2337/diacare.2.2.131; Saydah SH, 2001, DIABETES CARE, V24, P1397, DOI 10.2337/diacare.24.8.1397; Seifarth C, 1998, DIABETIC MED, V15, P485, DOI 10.1002/(SICI)1096-9136(199806)15:6&lt;485::AID-DIA610&gt;3.0.CO;2-Y; SOBEY WJ, 1989, BIOCHEM J, V260, P535, DOI 10.1042/bj2600535; Sowers JR, 2001, HYPERTENSION, V37, P1053, DOI 10.1161/01.HYP.37.4.1053; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Temelkova-Kurktschiev TS, 2000, DIABETES CARE, V23, P1830, DOI 10.2337/diacare.23.12.1830; Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920; TURNER RC, 1993, J HYPERTENS, V11, P309; W.H. Organization, 1999, DEFINITION DIAGNOSIS; WARNICK GR, 1982, CLIN CHEM, V28, P1379; YAMASAKI Y, 1995, DIABETOLOGIA, V38, P585, DOI 10.1007/s001250050323	47	1189	1283	1	80	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2003	290	4					486	494		10.1001/jama.290.4.486	http://dx.doi.org/10.1001/jama.290.4.486			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703JB	12876091	Bronze			2022-12-28	WOS:000184275300020
J	Coppin, H; Bensaid, M; Fruchon, S; Borot, N; Blanche, H; Roth, MP				Coppin, H; Bensaid, M; Fruchon, S; Borot, N; Blanche, H; Roth, MP			Longevity and carrying the C282Y mutation for haemochromatosis on the HFE gene: case control study of 492 French centenarians	BRITISH MEDICAL JOURNAL			English	Article							RISK		CHU Purpan, Unite Physiopathol Cellulaire, CNRS, UPR 2163, F-31059 Toulouse 3, France; Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, F-75010 Paris, France	Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse; Foundation Jean Dausset-CEPH	Roth, MP (corresponding author), CHU Purpan, Unite Physiopathol Cellulaire, CNRS, UPR 2163, F-31059 Toulouse 3, France.		Roth, Marie-Paule/Q-2866-2018; Coppin, Hélène/G-4326-2013	Roth, Marie-Paule/0000-0001-9691-4234; Coppin, Hélène/0000-0001-7911-6353; bensaid, Mounia/0000-0001-7322-0627				Beutler E, 2002, LANCET, V359, P211, DOI 10.1016/S0140-6736(02)07447-0; Blanche H, 2001, CR ACAD SCI III-VIE, V324, P129, DOI 10.1016/S0764-4469(00)01274-9; Fruchon S, 2003, CLIN CHEM, V49, P822, DOI 10.1373/49.5.822; Fuchs J, 2002, TOXICOLOGY, V180, P169, DOI 10.1016/S0300-483X(02)00389-X; Worwood M, 2002, BEST PRACT RES CL HA, V15, P295, DOI 10.1053/beha.2002.0005	5	35	37	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 19	2003	327	7407					132	133		10.1136/bmj.327.7407.132	http://dx.doi.org/10.1136/bmj.327.7407.132			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702WJ	12869454	Green Published, Bronze			2022-12-28	WOS:000184247500017
J	Vessey, M; Painter, R; Yeates, D				Vessey, M; Painter, R; Yeates, D			Mortality in relation to oral contraceptive use and cigarette smoking	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; MULTICENTER CASE-CONTROL; CERVICAL-CANCER; FOLLOW-UP; WOMEN; RISK; STROKE; COHORT	Background As part of the Oxford Family Planning Association study, we compared mortality in relation to oral contraceptive use and smoking to highlight the differences between them from the perspective of public health. Methods The study consisted of 17 032 women, aged 25-39 years at entry, recruited between May 1, 1968, and July 31, 1974, who had used oral contraceptives, a diaphragm, or an intrauterine device. We assessed mortality from follow-up data recorded until Dec 31, 2000. The analysis is based on woman-years of observation. Findings We analysed 889 deaths. Women who had ever used oral contraceptives had increased mortality from cervical cancer (rate ratio 7.2, 95% CI 1.1-303), and decreased mortality from other uterine (0.2, 0.0-0.8) and ovarian cancers (0.4, 0.2-0.7). Oral contraceptives had some adverse effect on deaths from ischaemic heart disease in women who smoked 15 or more cigarettes per day. For all causes of mortality, the rate ratio for death in women who ever used oral contraceptives was 0.89 (95% CI 0.77-1.02). By contrast, this rate ratio was 1.24 (1.03-1.49) in those who smoked one to 14 cigarettes per day, and 2.14 (1.81-2.53) in those who smoked 15 or more cigarettes per day. Interpretation There was no harmful effect of oral contraceptive use on overall mortality. By contrast, death from all causes was more than twice as high in smokers of 15 or more cigarettes a day as in non-smokers. The harmful effect was already apparent in women aged 35-44 years.	Univ Oxford, Inst Hlth Sci, Dept Publ Hlth, Unit Hlth Care Epidemiol, Oxford OX3 7LF, England	University of Oxford	Vessey, M (corresponding author), Univ Oxford, Inst Hlth Sci, Dept Publ Hlth, Unit Hlth Care Epidemiol, Oxford OX3 7LF, England.		Painter, Rebecca/O-8973-2019; /W-5933-2019	Painter, Rebecca/0000-0001-9336-6033; 				Beral V, 1999, BRIT MED J, V318, P96, DOI 10.1136/bmj.318.7176.96; BRESLOW NE, 1987, DESIGN ANAL COHORT S, V2, P81; Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5; Centers for Disease Control and Prevention, 2001, WOM SMOK REP SURG GE; COLDITZ GA, 1994, ANN INTERN MED, V120, P821, DOI 10.7326/0003-4819-120-10-199405150-00002; CROFT P, 1989, BRIT MED J, V298, P165, DOI 10.1136/bmj.298.6667.165; Feskanich D, 1999, BRIT J CANCER, V81, P918, DOI 10.1038/sj.bjc.6690787; Franceschi S, 1998, CONTRACEPTION, V58, P335, DOI 10.1016/S0010-7824(98)00128-0; Mant J, 1998, BRIT J OBSTET GYNAEC, V105, P890, DOI 10.1111/j.1471-0528.1998.tb10235.x; Moreno V, 2002, LANCET, V359, P1085, DOI 10.1016/S0140-6736(02)08150-3; Poulter NR, 1996, LANCET, V348, P505; POULTER NR, 1995, LANCET, V346, P1575; Poulter NR, 1996, LANCET, V348, P498; Poulter NR, 1997, LANCET, V349, P1202, DOI 10.1016/S0140-6736(97)02358-1; *ROYAL COLL GEN PR, 1978, J R COLL GEN PRACT, V28, P393; STAMPFER MJ, 1988, NEW ENGL J MED, V319, P1313, DOI 10.1056/NEJM198811173192004; VESSEY M, 1976, Journal of Biosocial Science, V8, P373; VESSEY M, 1986, BRIT MED J, V292, P526, DOI 10.1136/bmj.292.6519.526; VESSEY MP, 1984, BRIT MED J, V289, P530, DOI 10.1136/bmj.289.6444.530-a; VESSEY MP, 1989, BMJ-BRIT MED J, V299, P1487, DOI 10.1136/bmj.299.6714.1487; VESSEY MP, 1977, LANCET, V2, P731; VESSEY MP, 1981, LANCET, V1, P549; VESSEY MP, 1998, TRENDS UROL GYNAECOL, V3, P26; Zondervan KT, 1996, BRIT J CANCER, V73, P1291, DOI 10.1038/bjc.1996.247	24	69	72	1	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 19	2003	362	9379					185	191		10.1016/S0140-6736(03)13907-4	http://dx.doi.org/10.1016/S0140-6736(03)13907-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702PJ	12885478				2022-12-28	WOS:000184232000007
J	Kikuchi, S; Satoh, K; Nagata, T; Kawagashira, N; Doi, K; Kishimoto, N; Yazaki, J; Ishikawa, M; Yamada, H; Ooka, H; Hotta, I; Kojima, K; Namiki, T; Ohneda, E; Yahagi, W; Suzuki, K; Li, CJ; Ohtsuki, K; Shishiki, T; Otomo, Y; Murakami, K; Iida, Y; Sugano, S; Fujimura, T; Suzuki, Y; Tsunoda, Y; Kurosaki, T; Kodama, T; Masuda, H; Kobayashi, M; Xie, QH; Lu, M; Narikawa, R; Sugiyama, A; Mizuno, K; Yokomizo, S; Niikura, J; Ikeda, R; Ishibiki, J; Kawamata, M; Yoshimura, A; Miura, J; Kusumegi, T; Oka, M; Ryu, R; Ueda, M; Matsubara, K; Kawai, J; Carninci, P; Adachi, J; Aizawa, K; Arakawa, T; Fukuda, S; Hara, A; Hashizume, W; Hayatsu, N; Imotani, K; Ishii, Y; Itoh, M; Kagawa, I; Kondo, S; Konno, H; Miyazaki, A; Osato, N; Ota, Y; Saito, R; Sasaki, D; Sato, K; Shibata, K; Shinagawa, A; Shiraki, T; Yoshino, M; Hayashizaki, Y; Yasunishi, A				Kikuchi, S; Satoh, K; Nagata, T; Kawagashira, N; Doi, K; Kishimoto, N; Yazaki, J; Ishikawa, M; Yamada, H; Ooka, H; Hotta, I; Kojima, K; Namiki, T; Ohneda, E; Yahagi, W; Suzuki, K; Li, CJ; Ohtsuki, K; Shishiki, T; Otomo, Y; Murakami, K; Iida, Y; Sugano, S; Fujimura, T; Suzuki, Y; Tsunoda, Y; Kurosaki, T; Kodama, T; Masuda, H; Kobayashi, M; Xie, QH; Lu, M; Narikawa, R; Sugiyama, A; Mizuno, K; Yokomizo, S; Niikura, J; Ikeda, R; Ishibiki, J; Kawamata, M; Yoshimura, A; Miura, J; Kusumegi, T; Oka, M; Ryu, R; Ueda, M; Matsubara, K; Kawai, J; Carninci, P; Adachi, J; Aizawa, K; Arakawa, T; Fukuda, S; Hara, A; Hashizume, W; Hayatsu, N; Imotani, K; Ishii, Y; Itoh, M; Kagawa, I; Kondo, S; Konno, H; Miyazaki, A; Osato, N; Ota, Y; Saito, R; Sasaki, D; Sato, K; Shibata, K; Shinagawa, A; Shiraki, T; Yoshino, M; Hayashizaki, Y; Yasunishi, A		Rice Full-length cDNA Consortium; Natl Inst Agrobological Sci; Fdn Adv Int Sci Genome Sequencing; RIKEN	Collection, mapping, and annotation of over 28,000 cDNA clones from japonica rice	SCIENCE			English	Article							DRAFT SEQUENCE; DATABASE	We collected and completely sequenced 28,469 full-length complementary DNA clones from Oryza sativa L. ssp. japonica cv. Nipponbare. Through homology searches of publicly available sequence data, we assigned tentative protein functions to 21,596 clones (75.86%). Mapping of the cDNA clones to genomic DNA revealed that there are 19,000 to 20,500 transcription units in the rice genome. Protein informatics analysis against the InterPro database revealed the existence of proteins presented in rice but not in Arabidopsis. Sixty-four percent of our cDNAs are homologous to Arabidopsis proteins.	Natl Inst Agrobiol Sci, Dept Mol Biol, Tsukuba, Ibaraki 3058602, Japan; Hitachi Software Engn Co, Naka Ku, Yokohama, Kanagawa 2310015, Japan; FAIS, Lab Genome Sequencing, Tsukuba, Ibaraki 3050062, Japan; Univ Tokyo, Inst Med Sci, Dept Virol, Minato Ku, Tokyo 1088639, Japan; Univ Tsukuba, Inst Agr & Forest Engn, Tsukuba, Ibaraki 3058577, Japan; NAIST, Nara 6300101, Japan; RIKEN, RIKEN Yokohama Inst, Inst Phys & Chem Res, Lab Genome Explorat Res Grp,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Genome Sci Lab, Wako, Saitama 3510198, Japan; FAIS, Anal Grp, Tsukuba, Ibaraki 3050062, Japan	National Institute of Agrobiological Sciences - Japan; University of Tokyo; University of Tsukuba; Nara Institute of Science & Technology; RIKEN	Kikuchi, S (corresponding author), Natl Inst Agrobiol Sci, Dept Mol Biol, 2-1-2 Kannon Dai, Tsukuba, Ibaraki 3058602, Japan.	skikuchi@nias.affrc.go.jp	Hayashizaki, Yoshihide/N-6590-2015; Carninci, Piero/K-1568-2014; Yazaki, Junshi/B-1557-2012; shibata, kazuhiro/A-9527-2008; Konno, Hideaki/A-9191-2012; Kurosaki, Tomohiro/D-1306-2009; Kawai, Jun/A-6451-2016; Konno, Hideaki/N-4366-2014; Itoh, Masayoshi/N-5363-2015	Carninci, Piero/0000-0001-7202-7243; Kurosaki, Tomohiro/0000-0002-6352-304X; Konno, Hideaki/0000-0002-8470-4835; Itoh, Masayoshi/0000-0002-1772-318X; Fukuda, Shiro/0000-0002-0065-662X; Osato, Naoki/0000-0002-7584-5388; Osato, Naoki/0000-0001-9716-6725				Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Feng Q, 2002, NATURE, V420, P316, DOI 10.1038/nature01183; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; NAGATA T, COMMUNICATION; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Sasaki T, 2002, NATURE, V420, P312, DOI 10.1038/nature01184; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	13	681	3048	8	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2003	301	5631					376	379		10.1126/science.1081288	http://dx.doi.org/10.1126/science.1081288			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869764				2022-12-28	WOS:000184207300047
J	Crook, R; Graham, AC; Smith, CG; Farrer, I; Beere, HE; Ritchie, DA				Crook, R; Graham, AC; Smith, CG; Farrer, I; Beere, HE; Ritchie, DA			Erasable electrostatic lithography for quantum components	NATURE			English	Article							POINT-CONTACT; PROBE; CONDUCTANCE	Quantum electronic components(1,2)-such as quantum antidots and one-dimensional channels-are usually defined from doped GaAs/AlGaAs heterostructures using electron-beam lithography or local oxidation by conductive atomic force microscopy(3,4). In both cases, lithography and measurement are performed in very different environments, so fabrication and test cycles can take several weeks. Here we describe a different lithographic technique, which we call erasable electrostatic lithography (EEL), where patterns of charge are drawn on the device surface with a negatively biased scanning probe in the same low-temperature high-vacuum environment used for measurement. The charge patterns locally deplete electrons from a subsurface two-dimensional electron system (2DES) to define working quantum components. Charge patterns are erased locally with the scanning probe biased positive or globally by illuminating the device with red light. We demonstrate and investigate EEL by drawing and erasing quantum antidots, then develop the technique to draw and tune high-quality one-dimensional channels(5,6). The quantum components are imaged using scanned gate microscopy(7-11).A technique similar to EEL has been reported previously, where tip-induced charging of the surface or donor layer was used to locally perturb a 2DES before charge accumulation imaging(12).	Univ Cambridge, Dept Phys, Cambridge CB3 0HE, England	University of Cambridge	Smith, CG (corresponding author), Univ Cambridge, Dept Phys, Madingley Rd, Cambridge CB3 0HE, England.	cgs4@cam.ac.uk	Farrer, Ian/A-7671-2009; Ritchie, David/K-2206-2014	Farrer, Ian/0000-0002-3033-4306; Ritchie, David/0000-0002-9844-8350				BEENAKKER CWJ, 1991, SOLID STATE PHYS, V44, P1; Bennett CH, 2000, NATURE, V404, P247, DOI 10.1038/35005001; BUTTIKER M, 1990, PHYS REV B, V41, P7906, DOI 10.1103/PhysRevB.41.7906; Crook R, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.121301; Crook R, 2002, PHYSICA E, V12, P695, DOI 10.1016/S1386-9477(01)00381-2; Crook R, 2000, J PHYS-CONDENS MAT, V12, pL735, DOI 10.1088/0953-8984/12/50/102; Curson NJ, 2001, APPL PHYS LETT, V78, P3466, DOI 10.1063/1.1374225; Eriksson MA, 1996, SUPERLATTICE MICROST, V20, P435, DOI 10.1006/spmi.1996.0100; Eriksson MA, 1996, APPL PHYS LETT, V69, P671, DOI 10.1063/1.117801; FIELD M, 1993, PHYS REV LETT, V70, P1311, DOI 10.1103/PhysRevLett.70.1311; Held R, 1997, APPL PHYS LETT, V71, P2689, DOI 10.1063/1.120137; Ihn T, 2002, PHYSICA E, V12, P691, DOI 10.1016/S1386-9477(01)00379-4; Johnson KL., 1985, CONTACT MECH, DOI [10.1017/CBO9781139171731, DOI 10.1201/B17588-12]; Micolich AP, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.036802; Smith CG, 1996, REP PROG PHYS, V59, P235, DOI 10.1088/0034-4885/59/2/003; STARIKOV AA, 2002, ARXIVORGABSCONDMAT02; Tessmer SH, 1998, NATURE, V392, P51, DOI 10.1038/32112; Thomas KJ, 1998, PHYS REV B, V58, P4846, DOI 10.1103/PhysRevB.58.4846; Topinka MA, 2001, NATURE, V410, P183, DOI 10.1038/35065553; TORTONESE M, 1993, APPL PHYS LETT, V62, P834, DOI 10.1063/1.108593; VANWEES BJ, 1988, PHYS REV LETT, V60, P848, DOI 10.1103/PhysRevLett.60.848; WHARAM DA, 1988, J PHYS C SOLID STATE, V21, pL209, DOI 10.1088/0022-3719/21/8/002; WILLIAMSON JG, 1990, PHYS REV B, V42, P7675, DOI 10.1103/PhysRevB.42.7675; Woodside MT, 2002, SCIENCE, V296, P1098, DOI 10.1126/science.1069923; Yacoby A, 1996, PHYS REV LETT, V77, P4612, DOI 10.1103/PhysRevLett.77.4612	25	51	52	3	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2003	424	6950					751	754		10.1038/nature01841	http://dx.doi.org/10.1038/nature01841			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711HQ	12917677				2022-12-28	WOS:000184733900032
J	Anglana, M; Apiou, F; Bensimon, A; Debatisse, M				Anglana, M; Apiou, F; Bensimon, A; Debatisse, M			Dynamics of DNA replication in mammalian somatic cells: Nucleotide pool modulates origin choice and interorigin spacing	CELL			English	Article							SINGLE-MOLECULE ANALYSIS; CHINESE-HAMSTER; S-PHASE; SACCHAROMYCES-CEREVISIAE; INITIATION SITES; ADENYLATE DEAMINASE; SEQUENCE ELEMENTS; BUDDING YEAST; EGG EXTRACTS; LOCUS	Selection of active origins and regulation of interorigin spacing are poorly understood in mammalian cells. Using tricolor analysis of combed DNA molecules, we studied an amplified locus containing the known origin, oriGNAI3. We visualized replication firing events at this and other discrete regions and established a strict correlation between AT richness and initiation sites. We found that oriGNAI3 is the prominent origin of the domain, the firing of which correlates with silencing of neighboring sites and establishes large interorigin distances. We demonstrate that cells reversibly respond to a reduction in nucleotide availability by slowing the rate of replication fork progression; in addition, the efficiency of initiation at oriGNAI3 is lowered while other normally dormant origins in the region are activated, which results in an overall increase in the density of initiation events. Thus, nucleotide pools are involved in the specification of active origins, which in turn defines their density along chromosomes.	Inst Curie, F-75248 Paris, France; Inst Pasteur, Genomes Stabil Unit, F-75724 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Debatisse, M (corresponding author), Inst Curie, FRE 2584,26 Rue Ulm, F-75248 Paris, France.	michelle.debatisse@curie.fr						Abdurashidova G, 2000, SCIENCE, V287, P2023, DOI 10.1126/science.287.5460.2023; Aladjem MI, 1998, SCIENCE, V281, P1005, DOI 10.1126/science.281.5379.1005; Aladjem MI, 2002, MOL CELL BIOL, V22, P442, DOI 10.1128/MCB.22.2.442-452.2002; Altman AL, 2001, MOL CELL BIOL, V21, P1098, DOI 10.1128/MCB.21.4.1098-1110.2001; Angus SP, 2002, J BIOL CHEM, V277, P44376, DOI 10.1074/jbc.M205911200; ATEN JA, 1992, HISTOCHEM J, V24, P251, DOI 10.1007/BF01046839; Baron B, 1996, MAMM GENOME, V7, P429, DOI 10.1007/s003359900127; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bogan JA, 2000, J CELL PHYSIOL, V184, P139, DOI 10.1002/1097-4652(200008)184:2<139::AID-JCP1>3.0.CO;2-8; BREWER BJ, 1994, P NATL ACAD SCI USA, V91, P3418, DOI 10.1073/pnas.91.8.3418; COLLINS JM, 1978, J BIOL CHEM, V253, P8570; DEBATISSE M, 1988, MOL CELL BIOL, V8, P17, DOI 10.1128/MCB.8.1.17; DEBATISSE M, 1982, MOL CELL BIOL, V2, P1346, DOI 10.1128/MCB.2.11.1346; DePamphilis ML, 2000, J STRUCT BIOL, V129, P186, DOI 10.1006/jsbi.2000.4219; DEPAMPHILLIS M, 1996, DNA REPLICATION EUKA; Devault A, 2002, CURR BIOL, V12, P689, DOI 10.1016/S0960-9822(02)00768-6; DIJKWEL PA, 1991, MOL CELL BIOL, V11, P3850, DOI 10.1128/MCB.11.8.3850; Dijkwel PA, 2002, MOL CELL BIOL, V22, P3053, DOI 10.1128/MCB.22.9.3053-3065.2002; Fernandez MA, 1997, J CELL BIOCHEM, V67, P541, DOI 10.1002/(SICI)1097-4644(19971215)67:4<541::AID-JCB11>3.0.CO;2-C; Gilbert DM, 2001, SCIENCE, V294, P96, DOI 10.1126/science.1061724; Herrick J, 2000, J MOL BIOL, V300, P1133, DOI 10.1006/jmbi.2000.3930; Herrick J, 2002, J MOL BIOL, V320, P741, DOI 10.1016/S0022-2836(02)00522-3; Herrick J, 1999, BIOCHIMIE, V81, P859, DOI 10.1016/S0300-9084(00)87170-9; HOUSMAN D, 1975, J MOL BIOL, V94, P173, DOI 10.1016/0022-2836(75)90076-5; HYRIEN O, 1988, EMBO J, V7, P407, DOI 10.1002/j.1460-2075.1988.tb02828.x; HYRIEN O, 1995, SCIENCE, V270, P994, DOI 10.1126/science.270.5238.994; Kim SM, 2001, EMBO J, V20, P6115, DOI 10.1093/emboj/20.21.6115; Kobayashi T, 1998, MOL CELL BIOL, V18, P3266, DOI 10.1128/MCB.18.6.3266; Koc A, 2003, J BIOL CHEM, V278, P9345, DOI 10.1074/jbc.M213013200; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; Lengronne A, 2001, NUCLEIC ACIDS RES, V29, P1433, DOI 10.1093/nar/29.7.1433; Li F, 2003, J CELL BIOL, V161, P257, DOI 10.1083/jcb.200211127; Malinsky J, 2001, J CELL SCI, V114, P747; MARAHRENS Y, 1994, EMBO J, V13, P3395, DOI 10.1002/j.1460-2075.1994.tb06642.x; Marheineke K, 2001, J BIOL CHEM, V276, P17092, DOI 10.1074/jbc.M100271200; Mechali M, 2001, NAT REV GENET, V2, P640, DOI 10.1038/35084598; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; Norio P, 2001, SCIENCE, V294, P2361, DOI 10.1126/science.1064603; Okuno Y, 2001, EMBO J, V20, P4263, DOI 10.1093/emboj/20.15.4263; Pasero P, 2002, GENE DEV, V16, P2479, DOI 10.1101/gad.232902; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Santocanale C, 1999, GENE DEV, V13, P2360, DOI 10.1101/gad.13.18.2360; Santocanale C, 1996, EMBO J, V15, P6671, DOI 10.1002/j.1460-2075.1996.tb01057.x; Sasaki T, 1999, MOL CELL BIOL, V19, P547; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; SKOOG L, 1971, EUR J BIOCHEM, V19, P81, DOI 10.1111/j.1432-1033.1971.tb01290.x; Stevenson JB, 1999, GENE DEV, V13, P146, DOI 10.1101/gad.13.2.146; Svetlova EY, 2001, J CELL BIOCHEM, P170; Toledo F, 1999, NUCLEIC ACIDS RES, V27, P1600, DOI 10.1093/nar/27.7.1600; Toledo F, 1998, NUCLEIC ACIDS RES, V26, P2313, DOI 10.1093/nar/26.10.2313; Visser AE, 1998, EXP CELL RES, V243, P398, DOI 10.1006/excr.1998.4144; Vujcic M, 1999, MOL CELL BIOL, V19, P6098; Waiter J, 1997, SCIENCE, V275, P993, DOI 10.1126/science.275.5302.993; Wu JR, 1996, SCIENCE, V271, P1270, DOI 10.1126/science.271.5253.1270; ZANNISHADJOPOULOS M, 1980, J CELL BIOL, V85, P777, DOI 10.1083/jcb.85.3.777	55	260	270	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 8	2003	114	3					385	394		10.1016/S0092-8674(03)00569-5	http://dx.doi.org/10.1016/S0092-8674(03)00569-5			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914702	Bronze			2022-12-28	WOS:000184679200014
J	Dodds, PS; Muhamad, R; Watts, DJ				Dodds, PS; Muhamad, R; Watts, DJ			An experimental study of search in global social networks	SCIENCE			English	Article							SMALL-WORLD; INTERNET	We report on a global social-search experiment in which more than 60,000 e-mail users attempted to reach one of 18 target persons in 13 countries by forwarding messages to acquaintances. We find that successful social search is conducted primarily through intermediate to weak strength ties, does not require highly connected "hubs" to succeed, and, in contrast to unsuccessful social search, disproportionately relies on professional relationships. By accounting for the attrition of message chains, we estimate that social searches can reach their targets in a median of five to seven steps, depending on the separation of source and target, although small variations in chain lengths and participation rates generate large differences in target reachability. We conclude that although global social networks are, in principle, searchable, actual success depends sensitively on individual incentives.	Columbia Univ, Inst Social & Econ Res & Policy, New York, NY 10027 USA; Columbia Univ, Dept Sociol, New York, NY 10027 USA	Columbia University; Columbia University	Watts, DJ (corresponding author), Columbia Univ, Inst Social & Econ Res & Policy, 420 W 118th St, New York, NY 10027 USA.	djw24@columbia.edu	Watts, Duncan J/J-6483-2012; Dodds, Peter S/C-9119-2014	Dodds, Peter S/0000-0003-1973-8614				Adamic LA, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.046135; Adamic LA, 1999, LECT NOTES COMPUT SC, V1696, P443; Adamic LA, 2000, SCIENCE, V287, DOI 10.1126/science.287.5461.2115a; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BERNARD HR, 1988, ETHNOLOGY, V27, P155, DOI 10.2307/3773626; Ebel H, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.035103; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Haythornthwaite C., 2002, INTERNET EVERYDAY LI, P74; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; KILLWORTH PD, 1978, SOC NETWORKS, V1, P159, DOI 10.1016/0378-8733(78)90018-7; Kleinberg JM, 2000, NATURE, V406, P845, DOI 10.1038/35022643; Kleinfeld JS, 2002, SOCIETY, V39, P61, DOI 10.1007/BF02717530; KORTE C, 1970, J PERS SOC PSYCHOL, V15, P101, DOI 10.1037/h0029198; Lin N, 1977, ANN INT COMMUN ASS, V1, P107; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.016131; POOL ID, 1978, SOC NETWORKS, V1, P5, DOI 10.1016/0378-8733(78)90011-4; Sheehan K, 2001, J COMPUT MED COMMUN, V6, P0; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; TRAVERS J, 1969, SOCIOMETRY, V32, P425, DOI 10.2307/2786545; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Watts DJ, 2002, SCIENCE, V296, P1302, DOI 10.1126/science.1070120; WHITE HC, 1970, SOC FORCES, V49, P259, DOI 10.2307/2576525	26	394	417	5	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2003	301	5634					827	829		10.1126/science.1081058	http://dx.doi.org/10.1126/science.1081058			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	709FT	12907800	Green Submitted			2022-12-28	WOS:000184615700043
J	Ruddick, B				Ruddick, B			Sounding out ocean fine structure	SCIENCE			English	Editorial Material									Dalhousie Univ, Dept Oceanog, Halifax, NS B3H 4J1, Canada	Dalhousie University	Ruddick, B (corresponding author), Dalhousie Univ, Dept Oceanog, Halifax, NS B3H 4J1, Canada.							ARMI L, 1989, J PHYS OCEANOGR, V19, P354, DOI 10.1175/1520-0485(1989)019<0354:TYITLO>2.0.CO;2; Holbrook WS, 2003, SCIENCE, V301, P821, DOI 10.1126/science.1085116; May BD, 1997, J PHYS OCEANOGR, V27, P1997, DOI 10.1175/1520-0485(1997)027<1997:EOBODD>2.0.CO;2; Richards K, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000971; RICHARDS KJ, UNPUB	5	16	19	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2003	301	5634					772	773		10.1126/science.1086924	http://dx.doi.org/10.1126/science.1086924			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907781				2022-12-28	WOS:000184615700024
J	Zhu, J; Shendure, J; Mitra, RD; Church, GM				Zhu, J; Shendure, J; Mitra, RD; Church, GM			Single molecule profiling of alternative pre-mRNA splicing	SCIENCE			English	Article							EPITHELIAL-CELLS; CD44; DIVERSITY; NONSENSE	Alternative pre-messenger RNA splicing is an important mechanism for generating protein diversity and may explain in part how mammalian complexity arises from a surprisingly small complement of genes. Here, we describe "digital polony exon profiling," a single molecule - based technology for studying complex alternative pre-messenger RNA splicing. This technology allows researchers to monitor the combinatorial diversity of exon inclusion in individual transcripts. A minisequencing strategy provides single nucleotide resolution, and the digital nature of the technology allows quantitation of individual splicing variants. Digital polony exon pro. ling can be used to investigate the physiological and pathological roles of alternately spliced messenger RNAs, as well as the mechanisms by which these messenger RNAs are produced.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Harvard University; Harvard Medical School; Washington University (WUSTL)	Church, GM (corresponding author), Harvard Univ, Sch Med, Dept Genet, 200 Longwood Ave, Boston, MA 02115 USA.			church, george/0000-0001-6232-9969; Mitra, Robi/0000-0002-2680-4264; Shendure, Jay/0000-0002-1516-1865	NIGMS NIH HHS [5U54GM62119] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062119] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bajorath J, 2000, PROTEINS, V39, P103, DOI 10.1002/(SICI)1097-0134(20000501)39:2<103::AID-PROT1>3.3.CO;2-7; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bell MV, 1998, MOL CELL BIOL, V18, P5930, DOI 10.1128/MCB.18.10.5930; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Delacourte Andre, 2000, Current Opinion in Neurology, V13, P371, DOI 10.1097/00019052-200008000-00002; Herrlich P, 2000, ANN NY ACAD SCI, V910, P106; Kan ZY, 2001, GENOME RES, V11, P889, DOI 10.1101/gr.155001; LESLEY J, 1998, FRONT BIOSCI, V3, P616; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Mitra RD, 2003, P NATL ACAD SCI USA, V100, P5926, DOI 10.1073/pnas.0936399100; MITRA RD, IN PRESS ANAL BIOCH; Mitra RD, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.24.e34; Pinkas J, 2002, CANCER RES, V62, P4781; Roca X, 1998, AM J PATHOL, V153, P183, DOI 10.1016/S0002-9440(10)65559-9; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Sergeant N, 2001, HUM MOL GENET, V10, P2143, DOI 10.1093/hmg/10.19.2143; Soukka T, 1997, CANCER RES, V57, P2281; Valentine CR, 1998, MUTAT RES-REV MUTAT, V411, P87, DOI 10.1016/S1383-5742(98)00010-6; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Yeakley JM, 2002, NAT BIOTECHNOL, V20, P353, DOI 10.1038/nbt0402-353	24	83	101	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2003	301	5634					836	838		10.1126/science.1085792	http://dx.doi.org/10.1126/science.1085792			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907803	Green Submitted			2022-12-28	WOS:000184615700046
J	Yonekura, K; Maki-Yonekura, S; Namba, K				Yonekura, K; Maki-Yonekura, S; Namba, K			Complete atomic model of the bacterial flagellar filament by electron cryomicroscopy	NATURE			English	Article							SALMONELLA-TYPHIMURIUM; MEMBRANE-PROTEINS; TUBULAR CRYSTALS; ANGSTROM RESOLUTION; MOLECULAR-DYNAMICS; FIBER DIFFRACTION; EXPORT APPARATUS; ESCHERICHIA-COLI; TERMINAL REGIONS; CRYSTALLOGRAPHY	The bacterial flagellar filament is a helical propeller for bacterial locomotion. It is a helical assembly of a single protein, flagellin, and its tubular structure is formed by 11 protofilaments in two distinct conformations, L- and R- type, for supercoiling. The X-ray crystal structure of a flagellin fragment lacking about 100 terminal residues revealed the protofilament structure, but the full filament structure is still essential for understanding the mechanism of supercoiling and polymerization. Here we report a complete atomic model of the R-type filament by electron cryomicroscopy. A density map obtained from image data up to 4Angstrom resolution shows the feature of alpha-helical backbone and some large side chains. The atomic model built on the map reveals intricate molecular packing and an alpha-helical coiled coil formed by the terminal chains in the inner core of the filament, with its intersubunit hydrophobic interactions having an important role in stabilizing the filament.	ERATO, JST, Proton NanoMachine Project, Tokyo, Japan; Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 565, Japan; ICORP, JST, Dynam NanoMachine Project, Kyoto 6190237, Japan	Japan Science & Technology Agency (JST); Osaka University; Japan Science & Technology Agency (JST)	Namba, K (corresponding author), ERATO, JST, Proton NanoMachine Project, Tokyo, Japan.		YONEKURA, Koji/N-5060-2015; Namba, Keiichi/A-9406-2016	Yonekura, Koji/0000-0001-5520-4391				Asakura S, 1970, Adv Biophys, V1, P99; BERG HC, 1973, NATURE, V245, P380, DOI 10.1038/245380a0; Beroukhim R, 1997, ULTRAMICROSCOPY, V70, P57, DOI 10.1016/S0304-3991(97)00070-3; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; CALLADINE CR, 1976, J THEOR BIOL, V57, P469, DOI 10.1016/0022-5193(76)90016-3; CALLADINE CR, 1978, J MOL BIOL, V118, P457, DOI 10.1016/0022-2836(78)90285-1; CALLADINE CR, 1975, NATURE, V225, P121; Delahay RM, 2002, MOL MICROBIOL, V45, P905, DOI 10.1046/j.1365-2958.2002.03083.x; DeRosier DJ, 2000, ULTRAMICROSCOPY, V81, P83, DOI 10.1016/S0304-3991(99)00120-5; Drenth J, 1994, PRINCIPLES PROTEIN X; Fan F, 1997, MOL MICROBIOL, V26, P1035, DOI 10.1046/j.1365-2958.1997.6412010.x; Fujiyoshi Y, 1998, ADV BIOPHYS, V35, P25, DOI 10.1016/S0065-227X(98)90004-1; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; HOMMA M, 1990, J MOL BIOL, V213, P819, DOI 10.1016/S0022-2836(05)80266-9; HYMAN HC, 1991, J MOL BIOL, V220, P79, DOI 10.1016/0022-2836(91)90382-G; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KANTO S, 1991, J MOL BIOL, V219, P471, DOI 10.1016/0022-2836(91)90187-B; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; KUDO S, 1990, NATURE, V346, P677, DOI 10.1038/346677a0; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; LARSEN SH, 1974, NATURE, V249, P74, DOI 10.1038/249074a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MACNAB RM, 1977, J MOL BIOL, V112, P1, DOI 10.1016/S0022-2836(77)80153-8; Maki S, 1998, J MOL BIOL, V277, P771, DOI 10.1006/jmbi.1998.1663; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MIMORI Y, 1995, J MOL BIOL, V249, P69, DOI 10.1006/jmbi.1995.0281; Mimori-Kiyosue Y, 1998, J MOL BIOL, V284, P521, DOI 10.1006/jmbi.1998.2184; MimoriKiyosue Y, 1997, J MOL BIOL, V270, P222, DOI 10.1006/jmbi.1997.1111; MimoriKiyosue Y, 1996, P NATL ACAD SCI USA, V93, P15108, DOI 10.1073/pnas.93.26.15108; Minamino T, 1999, J BACTERIOL, V181, P1388, DOI 10.1128/JB.181.5.1388-1394.1999; MORGAN DG, 1995, J MOL BIOL, V249, P88, DOI 10.1006/jmbi.1995.0282; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; OBRIEN EJ, 1972, J MOL BIOL, V70, P133, DOI 10.1016/0022-2836(72)90168-4; Ryu WS, 2000, NATURE, V403, P444, DOI 10.1038/35000233; Samatey FA, 2001, NATURE, V410, P331, DOI 10.1038/35066504; SILVERMAN M, 1974, NATURE, V249, P73, DOI 10.1038/249073a0; Toyoshima C, 2000, ULTRAMICROSCOPY, V84, P1, DOI 10.1016/S0304-3991(00)00010-3; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; VONDERVISZT F, 1989, J MOL BIOL, V209, P127, DOI 10.1016/0022-2836(89)90176-9; WANG H, 1993, ACTA CRYSTALLOGR A, V49, P504, DOI 10.1107/S0108767392011255; Yamashita I, 1998, NAT STRUCT BIOL, V5, P125; Yonekura K, 2000, SCIENCE, V290, P2148, DOI 10.1126/science.290.5499.2148; Yonekura K, 2000, ULTRAMICROSCOPY, V84, P29, DOI 10.1016/S0304-3991(00)00008-5	47	542	567	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					643	650		10.1038/nature01830	http://dx.doi.org/10.1038/nature01830			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904785				2022-12-28	WOS:000184578800037
J	Bacon, CG; Mittleman, MA; Kawachi, I; Giovannucci, E; Glasser, DB; Rimm, EB				Bacon, CG; Mittleman, MA; Kawachi, I; Giovannucci, E; Glasser, DB; Rimm, EB			Sexual function in men older than 50 years of age: Results from the health professionals follow-up study	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; TIME PHYSICAL-ACTIVITY; ERECTILE DYSFUNCTION; RISK-FACTORS; PROSTATE-CANCER; PREVALENCE; COMMUNITY; QUESTIONNAIRE; EPIDEMIOLOGY; PREDICTORS	Background: Although many studies have provided data on erectile dysfunction in specific settings, few studies have been large enough to precisely examine age-specific prevalence and correlates. Objective: To describe the association between age and several aspects of sexual functioning in men older than 50 years of age. Design: Cross-sectional analysis of data from a prospective cohort study. Setting: U.S. health professionals. Participants: 31 742 men, age 53 to 90 years. Measurements: Questionnaires mailed in 2000 asked about sexual function, physical activity, body weight, smoking, marital status, medical conditions, and medications. Previous biennial questionnaires since 1986 asked about date of birth, alcohol intake, and other health information. Results: When men with prostate cancer were excluded, the age-standardized prevalence of erectile dysfunction in the previous 3 months was 33%. Many aspects of sexual function (including overall function, desire, orgasm, and overall ability) decreased sharply by decade after 50 years of age. Physical activity was associated with lower risk for erectile dysfunction (multivariable relative risk, 0.7 [95% CI, 0.6 to 0.7] for >32.6 metabolic equivalent hours of exercise per week vs. 0 to 2.7 metabolic equivalent hours of exercise per week), and obesity was associated with higher risk (relative risk, 1.3 [CI, 1.2 to 1.4] for body mass index >28.7 kg/m(2) VS. <23.2 kg/m(2)). Smoking, alcohol consumption, and television viewing time were also associated with increased prevalence of erectile dysfunction. Men who had no chronic medical conditions and engaged in healthy behaviors had the lowest prevalence. Conclusions: several modifiable health behaviors were associated with maintenance of good erectile function, even after comorbid conditions were considered. Lifestyle factors most strongly associated with erectile dysfunction were physical activity and leanness.	Harvard Univ, Sch Publ Hlth, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Pfizer Inc, New York, NY USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Pfizer	Bacon, CG (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.			Mittleman, Murray/0000-0001-9788-7274	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464] Funding Source: NIH RePORTER; NCI NIH HHS [CA55075] Funding Source: Medline; NHLBI NIH HHS [HL35464] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ansong KS, 2000, ANN EPIDEMIOL, V10, P293, DOI 10.1016/S1047-2797(00)00050-8; Aytac IA, 2000, SOC SCI MED, V51, P771, DOI 10.1016/S0277-9536(00)00022-8; Bacon CG, 2001, J UROLOGY, V166, P1804, DOI 10.1016/S0022-5347(05)65679-0; Blanker MH, 2001, UROLOGY, V57, P763, DOI 10.1016/S0090-4295(00)01091-8; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Chew KK, 2000, INT J IMPOT RES, V12, P41, DOI 10.1038/sj.ijir.3900457; Derby CA, 2000, UROLOGY, V56, P302, DOI 10.1016/S0090-4295(00)00614-2; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; Fung TT, 2000, AM J EPIDEMIOL, V152, P1171, DOI 10.1093/aje/152.12.1171; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; KINSEY AC, 1948, SEXUAL BEHAV HUMAN M, P218; Kongkanand A, 2000, INT J ANDROL, V23, P77, DOI 10.1046/j.1365-2605.2000.00022.x; Kronenberg F, 2000, ATHEROSCLEROSIS, V153, P433, DOI 10.1016/S0021-9150(00)00426-3; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537; Leitzmann MF, 1998, ANN INTERN MED, V128, P417, DOI 10.7326/0003-4819-128-6-199803150-00001; Lewis RW, 2001, UROL CLIN N AM, V28, P209, DOI 10.1016/S0094-0143(05)70132-4; Litwin MS, 1998, MED CARE, V36, P1002, DOI 10.1097/00005650-199807000-00007; Litwin MS, 1998, J GEN INTERN MED, V13, P159, DOI 10.1046/j.1525-1497.1998.00050.x; Malmsten UGH, 1997, J UROLOGY, V158, P1733, DOI 10.1016/S0022-5347(01)64113-2; MANNINO DM, 1994, AM J EPIDEMIOL, V140, P1003, DOI 10.1093/oxfordjournals.aje.a117189; Masumori N, 1999, UROLOGY, V54, P335, DOI 10.1016/S0090-4295(99)00108-9; McVary KT, 2001, J UROLOGY, V166, P1624, DOI 10.1016/S0022-5347(05)65641-8; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; PANSER LA, 1995, J AM GERIATR SOC, V43, P1107, DOI 10.1111/j.1532-5415.1995.tb07009.x; Parazzini F, 2000, EUR UROL, V37, P43, DOI 10.1159/000020098; Pinnock CB, 1999, MED J AUSTRALIA, V171, P353, DOI 10.5694/j.1326-5377.1999.tb123691.x; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Rothman K., 1998, MODERN EPIDEMIOLOGY; SOLSTAD K, 1993, ARCH SEX BEHAV, V22, P51, DOI 10.1007/BF01552912; Sullivan ME, 2001, BJU INT, V87, P838, DOI 10.1046/j.1464-410x.2001.02211.x; Ventegodt S, 1998, ARCH SEX BEHAV, V27, P295, DOI 10.1023/A:1018655219133; WEI M, 1994, AM J EPIDEMIOL, V140, P930, DOI 10.1093/oxfordjournals.aje.a117181	33	500	517	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2003	139	3					161	168		10.7326/0003-4819-139-3-200308050-00005	http://dx.doi.org/10.7326/0003-4819-139-3-200308050-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	707RH	12899583				2022-12-28	WOS:000184523300001
J	Kaye, GC				Kaye, GC			ABC of interventional cardiology - Percutaneous interventional electrophysiology	BRITISH MEDICAL JOURNAL			English	Review							CATHETER ABLATION; TACHYCARDIA		Castle Hill Hosp, Hull & E Yorkshire Trust, Kingston Upon Hull, N Humberside, England	University of Hull	Kaye, GC (corresponding author), Castle Hill Hosp, Hull & E Yorkshire Trust, Kingston Upon Hull, N Humberside, England.		Kaye, Gerald/F-6182-2012; Kaye, Gerald/T-8056-2019	Kaye, Gerald/0000-0002-0702-3681; 				CALKINS H, 1994, AM J CARDIOL, V73, P353, DOI 10.1016/0002-9149(94)90007-8; JACKMAN WM, 1992, NEW ENGL J MED, V327, P313, DOI 10.1056/NEJM199207303270504; MCGUIRE MA, 1995, CURR OPIN CARDIOL, V10, P3, DOI 10.1097/00001573-199501000-00002; OLGIN JE, 2001, HEART DIS, P1877; Schilling RJ, 1999, CIRCULATION, V99, P2543, DOI 10.1161/01.CIR.99.19.2543	5	0	0	1	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 2	2003	327	7409					280	283		10.1136/bmj.327.7409.280	http://dx.doi.org/10.1136/bmj.327.7409.280			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708KP	12896944	Green Published			2022-12-28	WOS:000184566300025
J	Whyte, MP; Wenkert, D; Clements, KL; McAlister, WH; Mumm, S				Whyte, MP; Wenkert, D; Clements, KL; McAlister, WH; Mumm, S			Brief report: Bisphosphonate-induced osteopetrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AUTOSOMAL-DOMINANT OSTEOPETROSIS; OSTEOGENESIS IMPERFECTA; BONE TURNOVER; CHILDREN; PAMIDRONATE; DISEASE; ADOLESCENTS; MUTATIONS; TISSUE; GENE		Shriners Hosp Children, Ctr Metab Bone Dis & Mol Res, St Louis, MO 63131 USA; Washington Univ, Sch Med, Barnes Jewish Hosp, Div Bone & Mineral Dis, St Louis, MO USA; Washington Univ, Sch Med, St Louis Childrens Hosp, Mallinckrodt Inst Radiol, St Louis, MO USA	Barnes-Jewish Hospital; Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL)	Whyte, MP (corresponding author), Shriners Hosp Children, Ctr Metab Bone Dis & Mol Res, 2001 S Lindbergh Blvd, St Louis, MO 63131 USA.							Bachrach LK, 1999, J CLIN ENDOCR METAB, V84, P4702, DOI 10.1210/jc.84.12.4702; BOLLERSLEV J, 1988, BONE, V9, P7, DOI 10.1016/8756-3282(88)90021-X; Brumsen C, 1997, MEDICINE, V76, P266, DOI 10.1097/00005792-199707000-00005; Camacho NP, 2001, CALCIFIED TISSUE INT, V69, P94, DOI 10.1007/s002230010045; Cleiren E, 2001, HUM MOL GENET, V10, P2861, DOI 10.1093/hmg/10.25.2861; Cole D.E.C., 1996, STUDIES STOMATOLOGY, P245; Cundy Tim, 2002, Semin Musculoskelet Radiol, V6, P307, DOI 10.1055/s-2002-36729; Fleisch H, 2002, PRINCIPLES BONE BIOL, V2nd, P1361; FOLLIS RH, 1952, AM J ROENTGENOL, V68, P709; Glorieux FH, 1998, NEW ENGL J MED, V339, P947, DOI 10.1056/NEJM199810013391402; Isaia GC, 2002, CALCIFIED TISSUE INT, V71, P121, DOI 10.1007/s00223-001-1098-7; Kinoshita A, 2000, NAT GENET, V26, P19, DOI 10.1038/79128; KRUSE K, 1985, J PEDIATR-US, V106, P946, DOI 10.1016/S0022-3476(85)80247-X; Lindsay R, 2002, J CLIN INVEST, V110, P1239, DOI 10.1172/JCI200217051; Martin RP, 1997, J BONE JOINT SURG AM, V79A, P1685, DOI 10.2106/00004623-199711000-00010; Mumm S, 2002, MOL GENET METAB, V75, P143, DOI 10.1006/mgme.2001.3283; Rauch F, 2002, J CLIN INVEST, V110, P1293, DOI 10.1172/JCI200215952; Shoemaker LR, 1999, J PEDIATR-US, V134, P264, DOI 10.1016/S0022-3476(99)70447-6; Srivastava T, 1999, CLIN PEDIATR, V38, P687, DOI 10.1177/000992289903801201; THOMPSON B H, 1974, Birth Defects Original Article Series, V10, P245; van Doorn KJ, 2001, NEPHRON, V89, P467, DOI 10.1159/000046123; VANMEERTEN ELV, 1992, RADIOLOGY, V184, P249; Whyte M.P., 1998, METABOLIC BONE DIS, P697; Whyte MP, 2002, NEW ENGL J MED, V347, P175, DOI 10.1056/NEJMoa013096; Whyte MP, 1996, J BONE MINER RES, V11, P1438, DOI 10.1002/jbmr.5650111010; Whyte MP., 2002, CONNECTIVE TISSUE IT, V2, P789, DOI [10.1002/0471221929.ch19, DOI 10.1002/0471221929.CH19]	26	306	318	0	7	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2003	349	5					457	463		10.1056/NEJMoa023110	http://dx.doi.org/10.1056/NEJMoa023110			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706FV	12890844				2022-12-28	WOS:000184443700007
J	Meyerson, M				Meyerson, M			Human genetic variation and disease	LANCET			English	Editorial Material							DNA-SEQUENCES; ASSOCIATION		Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Meyerson, M (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	Matthew_Meyerson@dfci.harvard.edu	Meyerson, Matthew L/E-7123-2012					Britten RJ, 2002, P NATL ACAD SCI USA, V99, P13633, DOI 10.1073/pnas.172510699; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Hallberg P, 2002, J HYPERTENS, V20, P2089, DOI 10.1097/00004872-200210000-00030; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lindblad-Toh K, 2000, NAT BIOTECHNOL, V18, P1001, DOI 10.1038/79269; Reich DE, 2003, NAT GENET, V33, P457, DOI 10.1038/ng1133; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878	11	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2003	362	9380					259	260		10.1016/S0140-6736(03)14002-0	http://dx.doi.org/10.1016/S0140-6736(03)14002-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705UL	12892951				2022-12-28	WOS:000184413400003
J	Drazen, JM				Drazen, JM			SARS - Looking back over the first 100 days	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material													Drazen, Jeffrey M/E-5841-2012	Drazen, Jeffrey/0000-0003-2715-9890				Holmes KV, 2003, NEW ENGL J MED, V348, P1948, DOI 10.1056/NEJMp030078	1	26	27	0	6	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2003	349	4					319	320		10.1056/NEJMp038118	http://dx.doi.org/10.1056/NEJMp038118			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703ZH	12878735				2022-12-28	WOS:000184312800001
J	Sinha, A; Nightingale, JMD; West, KP; Berlanga-Acosta, J; Playford, RJ				Sinha, A; Nightingale, JMD; West, KP; Berlanga-Acosta, J; Playford, RJ			Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							5-AMINOSALICYLIC ACID; EXPERIMENTAL-MODEL; FACTOR-RECEPTOR; EXPRESSION; UROGASTRONE; APPEARANCES; STABILITY; PEPTIDES; THERAPY	Background: Epidermal growth factor (EGF) is a potent mitogenic peptide produced by salivary glands. We examined whether EGF enemas are an effective treatment for active left-sided ulcerative colitis and ulceration limited to the rectum (proctitis). Methods: In a randomized, double-blind clinical trial conducted at Leicester Royal Infirmary, 12 patients with mild-to-moderate left-sided ulcerative colitis received daily enemas of 5 microg of EGF in 100 ml of an inert carrier and 12 received daily enemas with carrier alone for 14 days. All also began to receive 1.2 g of oral mesalamine per day or had their dose increased by 1.2 g per day. Patients were assessed clinically at 0, 2, 4, and 12 weeks and by sigmoidoscopy and biopsy at 0, 2, and 4 weeks. The primary end point was disease remission (defined by a St. Marks score of 4 or less without sigmoidoscopic evidence of inflammation) at two weeks. Secondary end points were clinically significant improvements in disease activity (defined by a decrease of more than 3 points in the St. Marks score or the ulcerative colitis disease-activity index) at two and four weeks. Analyses were performed according to the intention-to-treat principle. Results: After two weeks, 10 of the 12 patients given EGF enemas were in remission, as compared with 1 of 12 in the control group (83 percent vs. 8 percent, P<0.001). At the 2-week assessment, disease-activity scores, sigmoidoscopic score, and histologic scores were all significantly better in the EGF group than in the placebo group (P<0.01 for all comparisons), and this benefit was maintained at 4 weeks and at 12 weeks. Conclusions: This study provides preliminary data suggesting that EGF enemas are an effective treatment for active left-sided ulcerative colitis.	Leicester Royal Infirm, Gastroenterol Ctr, Dept Gastroenterol, Leicester LE1 5WW, Leics, England; Leicester Royal Infirm, Dept Pathol, Leicester LE1 5WW, Leics, England; Ctr Genet Engn & Biotechnol, Havana, Cuba; Univ London Imperial Coll Sci Technol & Med, Fac Med, Gastroenterol Sect, London, England	University of Leicester; University of Leicester; Centro de Ingenieria Genetica y Biotecnologia; Imperial College London	Nightingale, JMD (corresponding author), Leicester Royal Infirm, Gastroenterol Ctr, Dept Gastroenterol, Leicester LE1 5WW, Leics, England.	jeremy.nightingale@uhl-tr.nhs.uk		Playford, Raymond/0000-0003-1235-8504				ARAKI F, 1989, CHEM PHARM BULL, V37, P404; BARON JH, 1964, BRIT MED J, V1, P89, DOI 10.1136/bmj.1.5375.89; BELL GI, 1986, NUCLEIC ACIDS RES, V14, P8427, DOI 10.1093/nar/14.21.8427; Berlanga J, 2002, AM J PATHOL, V161, P373, DOI 10.1016/S0002-9440(10)64192-2; BROWN GL, 1989, NEW ENGL J MED, V321, P76, DOI 10.1056/NEJM198907133210203; Calnan DP, 2000, GUT, V47, P622, DOI 10.1136/gut.47.5.622; CHINERY R, 1995, CLIN SCI, V88, P401, DOI 10.1042/cs0880401; DRUMM B, 1988, LANCET, V1, P111; Farrell RJ, 2002, LANCET, V359, P331, DOI 10.1016/S0140-6736(02)07499-8; HANAUER SB, 1993, LANCET, V342, P412, DOI 10.1016/0140-6736(93)92819-F; HEITZ PU, 1978, GUT, V19, P408, DOI 10.1136/gut.19.5.408; Hoffmann P, 2000, SCAND J GASTROENTERO, V35, P1174; ITOH M, 1992, J CLIN GASTROENTEROL, V14, pS127, DOI 10.1097/00004836-199206001-00022; KELLY SM, 1994, GUT, V35, P611, DOI 10.1136/gut.35.5.611; Klotz U, 2000, EUR J CLIN PHARMACOL, V56, P353, DOI 10.1007/s002280000163; MEYERS S, 1989, J CLIN GASTROENTEROL, V11, P33, DOI 10.1097/00004836-198902000-00008; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Playford RJ, 1997, GUT, V40, P286, DOI 10.1136/gut.40.2.286; PLAYFORD RJ, 1993, LANCET, V341, P843, DOI 10.1016/0140-6736(93)93057-8; PLAYFORD RJ, 1995, GASTROENTEROLOGY, V108, P92, DOI 10.1016/0016-5085(95)90012-8; PLAYFORD RJ, 1995, GUT, V37, P595, DOI 10.1136/gut.37.5.595; Playford RJ, 1996, GUT, V39, P262, DOI 10.1136/gut.39.2.262; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; POWELLTUCK J, 1982, DIGEST DIS SCI, V27, P533, DOI 10.1007/BF01296733; PROCACCINO F, 1994, GASTROENTEROLOGY, V107, P12, DOI 10.1016/0016-5085(94)90055-8; Safdi M, 1997, AM J GASTROENTEROL, V92, P1867; Sinha A, 2000, GASTROENTEROLOGY, V118, pA316, DOI 10.1016/S0016-5085(00)83352-1; SULLIVAN PB, 1991, LANCET, V338, P53, DOI 10.1016/0140-6736(91)90042-N; SUTHERLAND LR, 1987, GASTROENTEROLOGY, V92, P1894, DOI 10.1016/0016-5085(87)90621-4; SUTHERLAND LR, 1993, ANN INTERN MED, V118, P540, DOI 10.7326/0003-4819-118-7-199304010-00009; WRIGHT NA, 1993, GASTROENTEROLOGY, V104, P12, DOI 10.1016/0016-5085(93)90830-6	31	229	241	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2003	349	4					350	357		10.1056/NEJMoa013136	http://dx.doi.org/10.1056/NEJMoa013136			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703ZH	12878742	Green Published, Bronze			2022-12-28	WOS:000184312800008
J	Huber, DL; Manginell, RP; Samara, MA; Kim, BI; Bunker, BC				Huber, DL; Manginell, RP; Samara, MA; Kim, BI; Bunker, BC			Programmed adsorption and release of proteins in a microfluidic device	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; SURFACE-PROPERTIES; SILICA; SYSTEMS; SILVER; GOLD	A microfluidic device has been developed that can adsorb proteins from solution, hold them with negligible denaturation, and release them on command. The active element in the device is a 4-nanometer-thick polymer film that can be thermally switched between an antifouling hydrophilic state and a protein-adsorbing state that is more hydrophobic. This active polymer has been integrated into a microfluidic hot plate that can be programmed to adsorb and desorb protein monolayers in less than 1 second. The rapid response characteristics of the device can be manipulated for proteomic functions, including preconcentration and separation of soluble proteins on an integrated fluidics chip.	Sandia Natl Labs, Albuquerque, NM 87185 USA	United States Department of Energy (DOE); Sandia National Laboratories	Bunker, BC (corresponding author), Sandia Natl Labs, POB 5800, Albuquerque, NM 87185 USA.		Huber, Dale L./A-6006-2008	Huber, Dale L./0000-0001-6872-8469; Kim, Byung/0000-0003-4484-1728				ABBOTT NL, 1995, LANGMUIR, V11, P16, DOI 10.1021/la00001a005; Berne B. J., 2000, DYNAMIC LIGHT SCATTE; Burns MA, 1996, P NATL ACAD SCI USA, V93, P5556, DOI 10.1073/pnas.93.11.5556; Figeys D, 2001, ELECTROPHORESIS, V22, P208, DOI 10.1002/1522-2683(200101)22:2<208::AID-ELPS208>3.0.CO;2-O; Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z; JOYCE SA, 1991, REV SCI INSTRUM, V62, P710, DOI 10.1063/1.1142072; Kanazawa H, 1996, ANAL CHEM, V68, P100, DOI 10.1021/ac950359j; Kidoaki S, 2001, LANGMUIR, V17, P2402, DOI 10.1021/la001522v; Kleijn M, 1995, HETEROGEN CHEM REV, V2, P157; Lahann J, 2003, SCIENCE, V299, P371, DOI 10.1126/science.1078933; Lakhiari H, 1998, BBA-GEN SUBJECTS, V1379, P303, DOI 10.1016/S0304-4165(97)00110-4; Liang L, 1998, MACROMOLECULES, V31, P7845; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; Ostuni E, 1999, COLLOID SURFACE B, V15, P3, DOI 10.1016/S0927-7765(99)00004-1; Pelton R, 2000, ADV COLLOID INTERFAC, V85, P1, DOI 10.1016/S0001-8686(99)00023-8; PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164; Revillon A, 1995, REACT FUNCT POLYM, V26, P105, DOI 10.1016/1381-5148(95)00009-5; TAKEI YG, 1994, MACROMOLECULES, V27, P6163, DOI 10.1021/ma00099a035; Whitesides GM, 2001, PHYS TODAY, V54, P42, DOI 10.1063/1.1387591; ZHANG J, 1995, LANGMUIR, V11, P2301	20	479	493	5	181	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2003	301	5631					352	354		10.1126/science.1080759	http://dx.doi.org/10.1126/science.1080759			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869757				2022-12-28	WOS:000184207300039
J	King, N; Hittinger, CT; Carroll, SB				King, N; Hittinger, CT; Carroll, SB			Evolution of key cell signaling and adhesion protein families predates animal origins	SCIENCE			English	Article							TYROSINE KINASE; UNICELLULAR RELATIVES; MITOGENIC AGENTS; PHOSPHORYLATION; SEQUENCE	The evolution of animals from a unicellular ancestor involved many innovations. Choanoflagellates, unicellular and colonial protozoa closely related to Metazoa, provide a potential window into early animal evolution. We have found that choanoflagellates express representatives of a surprising number of cell signaling and adhesion protein families that have not previously been isolated from nonmetazoans, including cadherins, C-type lectins, several tyrosine kinases, and tyrosine kinase signaling pathway components. Choanoflagellates have a complex and dynamic tyrosine phosphoprotein pro. le, and cell proliferation is selectively affected by tyrosine kinase inhibitors. The expression in choanoflagellates of proteins involved in cell interactions in Metazoa demonstrates that these proteins evolved before the origin of animals and were later co-opted for development.	Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, 1525 Linden Dr, Madison, WI 53706 USA.				NIGMS NIH HHS [GM-20734] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Burger G, 2003, P NATL ACAD SCI USA, V100, P892, DOI 10.1073/pnas.0336115100; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; COOPER JA, 1984, MOL CELL BIOL, V4, P30, DOI 10.1128/MCB.4.1.30; Dodd RB, 2001, GLYCOBIOLOGY, V11, p71R, DOI 10.1093/glycob/11.5.71R; HIBBERD DJ, 1975, J CELL SCI, V17, P191; King N, 2001, P NATL ACAD SCI USA, V98, P15032, DOI 10.1073/pnas.261477698; Kumar P, 2001, J BIOL CHEM, V276, P21039, DOI 10.1074/jbc.M009099200; Lang BF, 2002, CURR BIOL, V12, P1773, DOI 10.1016/S0960-9822(02)01187-9; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; MIYAZAWA K, 1992, BLOOD, V80, P1685; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; PASQUALE EB, 1988, J CELL PHYSIOL, V137, P146, DOI 10.1002/jcp.1041370118; Porter AC, 1998, ONCOGENE, V17, P1343, DOI 10.1038/sj.onc.1202171; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Saville Kent W., 1880, MANUAL INFUSORIA; SHAPIRO L, 1995, P NATL ACAD SCI USA, V92, P6793, DOI 10.1073/pnas.92.15.6793; Snell EA, 2001, CURR BIOL, V11, P967, DOI 10.1016/S0960-9822(01)00275-5; WAINRIGHT PO, 1993, SCIENCE, V260, P340, DOI 10.1126/science.8469985; Watkins RF, 1999, J MOL EVOL, V48, P542, DOI 10.1007/PL00006497; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724	23	286	304	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2003	301	5631					361	363		10.1126/science.1083853	http://dx.doi.org/10.1126/science.1083853			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869759				2022-12-28	WOS:000184207300042
J	Cahan, SH; Keller, L				Cahan, SH; Keller, L			Complex hybrid origin of genetic caste determination in harvester ants	NATURE			English	Article								Caste differentiation and division of labour are the hallmarks of insect societies(1) and at the root of their ecological success(2). Kin selection predicts that caste determination should result from environmentally induced differences in gene expression(3,4), a prediction largely supported by empirical data(5). However, two exceptional cases of genetically determined caste differentiation have recently been found in harvester ants(6-8). Here we show that genetic caste determination evolved in these populations after complex hybridization events. We identified four distinct genetic lineages, each consisting of unique blends of the genomes of the parental species, presumably Pogonomyrmex barbatus and P. rugosus. Crosses between lineages H1 and H2 and between J1 and J2 give rise to workers, whereas queens develop from within-lineage matings. Although historical gene flow is evident, genetic exchange among lineages and between lineages and the parental species no longer occurs. This unusual system of caste determination seems to be evolutionarily stable.	Univ Lausanne, Inst Ecol, CH-1015 Lausanne, Switzerland	University of Lausanne	Cahan, SH (corresponding author), Univ Lausanne, Inst Ecol, CH-1015 Lausanne, Switzerland.		keller, laurent/AAI-7175-2020	keller, laurent/0000-0002-5046-9953				[Anonymous], 1971, INSECT SOC; Bourke AFG, 1997, P ROY SOC B-BIOL SCI, V264, P277, DOI 10.1098/rspb.1997.0039; Buschinger A., 1990, P37; Cahan SH, 2002, P ROY SOC B-BIOL SCI, V269, P1871, DOI 10.1098/rspb.2002.2061; CAVALLISFORZA LL, 1967, EVOLUTION, V21, P550, DOI 10.1111/j.1558-5646.1967.tb03411.x; Cole AC, 1968, POGONOMYRMEX HARVEST; Crozier R.H., 1996, EVOLUTION SOCIAL INS; Foitzik S, 1997, INSECT SOC, V44, P219, DOI 10.1007/s000400050043; JONES TR, 1995, MOL PHYLOGENET EVOL, V4, P194, DOI 10.1006/mpev.1995.1019; Julian GE, 2002, P NATL ACAD SCI USA, V99, P8157, DOI 10.1073/pnas.112222099; OSTER GF, 1975, CASTE ECOLOGY SOCIAL; Parker JD, 2002, EVOLUTION, V56, P2017, DOI 10.1111/j.0014-3820.2002.tb00128.x; SEGER J, 1981, J THEOR BIOL, V91, P191, DOI 10.1016/0022-5193(81)90380-5; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Taber S. W., 1998, WORLD HARVESTER ANTS; Volny VP, 2002, P NATL ACAD SCI USA, V99, P6108, DOI 10.1073/pnas.092066699; Volny VP, 2002, MOL ECOL NOTES, V2, P302, DOI 10.1046/j.1471-8286.2002.00243.x; Welch ME, 2002, EVOLUTION, V56, P2126, DOI 10.1111/j.0014-3820.2002.tb00138.x; WHEELER DE, 1986, AM NAT, V128, P13, DOI 10.1086/284536; Xu SZ, 2000, MOL BIOL EVOL, V17, P897, DOI 10.1093/oxfordjournals.molbev.a026370	20	131	134	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					306	309		10.1038/nature01744	http://dx.doi.org/10.1038/nature01744			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867980	Green Published			2022-12-28	WOS:000184183900040
J	Sheehy, E; Conrad, SL; Brigham, LE; Luskin, R; Weber, P; Eakin, M; Schkade, L; Hunsicker, L				Sheehy, E; Conrad, SL; Brigham, LE; Luskin, R; Weber, P; Eakin, M; Schkade, L; Hunsicker, L			Estimating the number of potential organ donors in the United States.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SOLID ORGANS; PROCUREMENT; TRANSPLANTATION; DONATION; POOL	BACKGROUND As the need for transplantable organs increases, waiting lists of patients become longer. We studied the size and composition of the national pool of brain-dead organ donors during a three-year period and, on the basis of these data, considered ways to increase the rate of donation. METHODS We reviewed hospital medical records of deaths occurring in the intensive care unit from 1997 through 1999 in the service areas of 36 organ-procurement organizations to identify brain-dead potential organ donors. We examined data on characteristics of the potential donors, the processes of referral to organ-procurement organizations and of requesting donations, and the hospitals. RESULTS We identified a total of 18,524 brain-dead potential organ donors during the study period. The predicted annual number of brain-dead potential organ donors is between 10,500 and 13,800. The overall consent rate (the number of families agreeing to donate divided by the number of families asked to donate) for 1997 through 1999 was 54 percent, and the overall conversion rate (the number of actual donors divided by the number of potential donors) was 42 percent. Hospitals with 150 or more beds were more likely than smaller hospitals to have potential donors and actual donors (P<0.001); 19 percent of hospitals accounted for 80 percent of all potential donors. Calculations of the number of donors per million persons in the general population did not correlate well with the performance of organ-procurement organizations as measured by the conversion rate. CONCLUSIONS Lack of consent to a request for donation was the primary cause of the gap between the number of potential donors and the number of actual donors. Since potential and actual donors are highly concentrated in larger hospitals, resources invested to improve the process of obtaining consent in larger hospitals should maximize the rate of organ recovery. The performance of organ-procurement organizations can be assessed objectively through the comparison of the number of actual donors with the number of potential donors in the given service area.	Assoc Organ Procurement Org, Mclean, VA 22101 USA; Univ Iowa, Iowa Donor Network, Iowa City, IA USA; Washington Reg Transplant Consortium, Falls Church, VA USA; New England Organ Bank Inc, Newton, MA USA; Calif Transplant Donor Network, Oakland, CA USA; Univ Texas, Dept Informat Syst, Arlington, TX 76019 USA; Univ Texas, Coll Business, Arlington, TX 76019 USA	University of Iowa; University of Texas System; University of Texas Arlington; University of Texas System; University of Texas Arlington	Sheehy, E (corresponding author), Assoc Organ Procurement Org, 1364 Beverly Rd,Suite 100, Mclean, VA 22101 USA.	organdonation@aopo.org						[Anonymous], 1998, Fed Regist, V63, P33856; Baxter David, 2001, 51 URB FUT I; Beasley C L, 1997, J Transpl Coord, V7, P6; Christiansen CL, 1998, AM J PUBLIC HEALTH, V88, P1645, DOI 10.2105/AJPH.88.11.1645; DeJong W, 1998, Am J Crit Care, V7, P13; EVANS RW, 1992, JAMA-J AM MED ASSOC, V267, P239, DOI 10.1001/jama.267.2.239; *GEN ACC OFF, 1997, GAOHEHS9826; Gortmaker S L, 1998, J Transpl Coord, V8, P210; Gortmaker SL, 1996, CRIT CARE MED, V24, P432, DOI 10.1097/00003246-199603000-00012; Hauptman PJ, 1997, NEW ENGL J MED, V336, P422, DOI 10.1056/NEJM199702063360607; Klassen A C, 1999, J Transpl Coord, V9, P87; NATHAN HM, 1991, TRANSPLANTATION, V51, P142, DOI 10.1097/00007890-199101000-00022; *OFF ORG TRANSPL, 1986, ORG TRANSPL ISS REC, P32; Ojo AO, 1999, TRANSPLANTATION, V67, P548, DOI 10.1097/00007890-199902270-00011; Siminoff LA, 2001, JAMA-J AM MED ASSOC, V286, P71, DOI 10.1001/jama.286.1.71; *UN NETW ORG SHAR, 2003, NUMB PAT WAIT ORG	16	348	358	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2003	349	7					667	674		10.1056/NEJMsa021271	http://dx.doi.org/10.1056/NEJMsa021271			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711FL	12917304				2022-12-28	WOS:000184728900009
J	Belandia, B; Parker, MG				Belandia, B; Parker, MG			Nuclear receptors: A rendezvous for chromatin remodeling factors	CELL			English	Review							WILLIAMS-SYNDROME; VITAMIN-D; COMPLEX; SELECTIVITY; TARGETS; SWI/SNF; HORMONE	Nuclear receptors (NRs) are a large family of ligand- induced transcription factors that include the vitamin D receptor. The recent discovery of WINAC, a novel ATP-dependent chromatin remodeling complex, has shed new light on the molecular mechanisms by which the vitamin D receptor controls gene expression with unexpected clinical implications.	Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, Fac Med, London W12 0NN, England	Imperial College London	Parker, MG (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, Fac Med, Du Cane Rd, London W12 0NN, England.		Belandia, Borja/H-1509-2015	Belandia, Borja/0000-0003-2448-206X				Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bozhenok L, 2002, EMBO J, V21, P2231, DOI 10.1093/emboj/21.9.2231; Dilworth FJ, 2000, MOL CELL, V6, P1049, DOI 10.1016/S1097-2765(00)00103-9; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Hassan AH, 2002, CELL, V111, P369, DOI 10.1016/S0092-8674(02)01005-X; Huang ZQ, 2003, EMBO J, V22, P2146, DOI 10.1093/emboj/cdg219; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kitagawa H, 2003, CELL, V113, P905, DOI 10.1016/S0092-8674(03)00436-7; Koszewski NJ, 1999, MOL ENDOCRINOL, V13, P455, DOI 10.1210/me.13.3.455; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Li DY, 1998, J CLIN INVEST, V102, P1783, DOI 10.1172/JCI4487; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Morris CA, 2000, ANNU REV GENOM HUM G, V1, P461; MURCHARDT C, 1993, EMBO J, V12, P4279; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Sutton ALM, 2003, MOL ENDOCRINOL, V17, P777, DOI 10.1210/me.2002-0363; YOSHINAGA SK, 1992, SCIENCE, V258, P1598, DOI 10.1126/science.1360703	18	94	95	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 8	2003	114	3					277	280		10.1016/S0092-8674(03)00599-3	http://dx.doi.org/10.1016/S0092-8674(03)00599-3			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914692	Green Submitted, Bronze			2022-12-28	WOS:000184679200004
J	Zschokke, S				Zschokke, S			Spider-web silk from the Early Cretaceous	NATURE			English	Editorial Material							ORB-WEBS		Univ Basel, Dept Integrat Biol, Sect Conservat Biol, CH-4056 Basel, Switzerland	University of Basel	Zschokke, S (corresponding author), Univ Basel, Dept Integrat Biol, Sect Conservat Biol, CH-4056 Basel, Switzerland.		Zschokke, Samuel/B-2583-2009	Zschokke, Samuel/0000-0002-5307-9010				Bachofen-Echt A., 1934, Biologia Generalis Wien Bd, V10, P179; Benjamin SP, 2003, BIOL J LINN SOC, V78, P293, DOI 10.1046/j.1095-8312.2003.00110.x; Coddington J., 1986, P319; ESKOV KY, 1984, NEUES JB GEOLOGIE PA, P645; Opell BD, 2002, J ARACHNOL, V30, P494, DOI 10.1636/0161-8202(2002)030[0494:ETSOIA]2.0.CO;2; Opell BD, 1998, FUNCT ECOL, V12, P613, DOI 10.1046/j.1365-2435.1998.00222.x; Penney D, 2002, J ARACHNOL, V30, P487, DOI 10.1636/0161-8202(2002)030[0487:TOLSIL]2.0.CO;2; SCHLEE D, 1970, NEUES JB GEOLOGIE PA, P40; SELDEN PA, 1989, NATURE, V340, P711, DOI 10.1038/340711a0; SHEAR WA, 1989, SCIENCE, V246, P479, DOI 10.1126/science.246.4929.479; VOLLRATH F, 1990, NATURE, V345, P526, DOI 10.1038/345526a0	11	28	31	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					636	637		10.1038/424636a	http://dx.doi.org/10.1038/424636a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904780				2022-12-28	WOS:000184578800032
J	Luk, YY; Abbott, NL				Luk, YY; Abbott, NL			Surface-driven switching of liquid-crystals using redox-active groups on electrodes	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; ORIENTATION; GOLD	Electrochemical control of the oxidation state of ferrocene-decorated electrodes leads to surface-driven changes in the orientations of thermotropic liquid crystals. When the electrodes possess nanometer-scale topography, voltages of 0.0 to 0.3 volts (versus a counter electrode in a two-electrode cell) can drive changes in the orientation of the liquid crystals in the plane and/or out of the plane of the electrodes. Electrodes not supporting ferrocene do not lead to surface-driven orientational transitions. The in-plane transitions are driven by the reorganization of the monolayer of ferrocene upon oxidation of ferrocene to ferrocenium. The out-of-plane transition reflects a dielectric coupling between the liquid crystal and the diffuse part of an electrical double layer that evolves upon oxidation of ferrocene to ferrocenium. These results suggest new ways to couple the orientations of liquid crystals to chemical and electrical stimuli in electro-optical devices and chemical sensors.	Univ Wisconsin, Dept Biol & Chem Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Abbott, NL (corresponding author), Univ Wisconsin, Dept Biol & Chem Engn, Madison, WI 53706 USA.	abbott@engr.wisc.edu						BARBERO G, 1986, LIQ CRYST, V1, P483, DOI 10.1080/02678298608086271; Bard AJ., 2001, ELECTROCHEMICAL METH; BASHKIN JK, 1990, INORG CHEM, V29, P4507, DOI 10.1021/ic00347a034; BLINOV LM, 1993, ELECTROOPTIC EFFECTS, pR14; Bryan-Brown GP, 1999, NATURE, V399, P338, DOI 10.1038/20646; CHIDSEY CED, 1991, SCIENCE, V251, P919, DOI 10.1126/science.251.4996.919; COGNARD J, 1982, MOL CRYST LIQ CRYST, P1; Collings P.J, 1997, HDB LIQUID CRYSTAL R; Comiskey B, 1998, NATURE, V394, P253, DOI 10.1038/28349; DEGENNES PG, 1974, PHYSICS LIQUID CRYST; Freedericksz V, 1933, T FARADAY SOC, V29, P0919, DOI 10.1039/tf9332900919; Gallardo BS, 1999, SCIENCE, V283, P57, DOI 10.1126/science.283.5398.57; Gupta VK, 1996, LANGMUIR, V12, P2587, DOI 10.1021/la960003i; Gupta VK, 1997, SCIENCE, V276, P1533, DOI 10.1126/science.276.5318.1533; IKEDA T, 1995, SCIENCE, V268, P1873, DOI 10.1126/science.268.5219.1873; JEROME B, 1991, REP PROG PHYS, V54, P391, DOI 10.1088/0034-4885/54/3/002; Kondo T, 1999, J AM CHEM SOC, V121, P391, DOI 10.1021/ja982007a; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; Marcus RA, 2000, J ELECTROANAL CHEM, V483, P2, DOI 10.1016/S0022-0728(00)00011-5; Noviandri I, 1999, J PHYS CHEM B, V103, P6713, DOI 10.1021/jp991381+; Poulin P, 1997, SCIENCE, V275, P1770, DOI 10.1126/science.275.5307.1770; Rogers JA, 2001, P NATL ACAD SCI USA, V98, P4835, DOI 10.1073/pnas.091588098; Russell TP, 2002, SCIENCE, V297, P964, DOI 10.1126/science.1075997; SCHADT M, 1971, APPL PHYS LETT, V18, P127, DOI 10.1063/1.1653593; SERRA AM, 1986, J ELECTROCHEM SOC, V133, P2226, DOI 10.1149/1.2108378; Shah RR, 2001, J PHYS CHEM B, V105, P4936, DOI 10.1021/jp004073g; Shah RR, 1999, J AM CHEM SOC, V121, P11300, DOI 10.1021/ja9844837; Skaife JJ, 1999, CHEM MATER, V11, P612, DOI 10.1021/cm9804822; Viana AS, 2001, J ELECTROANAL CHEM, V500, P290, DOI 10.1016/S0022-0728(00)00422-8; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Ye S, 1997, LANGMUIR, V13, P3157, DOI 10.1021/la9700432	31	128	128	0	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2003	301	5633					623	626		10.1126/science.1084527	http://dx.doi.org/10.1126/science.1084527			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893937				2022-12-28	WOS:000184473600033
J	Marini, JC				Marini, JC			Do bisphosphonates make children's bones better or brittle?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NICHHD, Heritable Disorders Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Marini, JC (corresponding author), NICHHD, Heritable Disorders Branch, Bethesda, MD 20892 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000408] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000408] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))			0	103	107	0	4	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2003	349	5					423	426		10.1056/NEJMp038103	http://dx.doi.org/10.1056/NEJMp038103			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706FV	12890840				2022-12-28	WOS:000184443700003
J	Micheau, O; Tschopp, J				Micheau, O; Tschopp, J			Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes	CELL			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; FLICE-INHIBITORY PROTEINS; DEATH RECEPTORS; C-FLIP; FAS; ACTIVATION; FADD; RECRUITMENT; REQUIREMENT	Apoptosis induced by TNF-receptor I (TNFR1) is thought to proceed via recruitment of the adaptor FADD and caspase-8 to the receptor complex. TNFR1 signaling is also known to activate the transcription factor NF-kappaB and promote survival. The mechanism by which this decision between cell death and survival is arbitrated is not clear. We report that TNFR1-induced apoptosis involves two sequential signaling complexes. The initial plasma membrane bound complex (complex I) consists of TNFR1, the adaptor TRADD, the kinase RIP1, and TRAF2 and rapidly signals activation of NF-kappaB. In a second step, TRADD and RIP1 associate with FADD and caspase-8, forming a cytoplasmic complex (complex II). When NF-kappaB is activated by complex I, complex II harbors the caspase-8 inhibitor FLIPL and the cell survives. Thus, TNFR1-mediated-signal transduction includes a checkpoint, resulting in cell death (via complex II) in instances where the initial signal (via complex I, NF-kappaB) fails to be activated.	Univ Lausanne, Inst Biochem, BIL Biomed Res Ctr, CH-1066 Epalinges, Switzerland	University of Lausanne	Tschopp, J (corresponding author), Univ Lausanne, Inst Biochem, BIL Biomed Res Ctr, Chem Boveresses 155, CH-1066 Epalinges, Switzerland.		micheau, olivier/C-3574-2011	micheau, olivier/0000-0001-8499-7984				Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Devin A, 2001, MOL CELL BIOL, V21, P3986, DOI 10.1128/MCB.21.12.3986-3994.2001; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jones SJ, 1999, J IMMUNOL, V162, P1042; Juo P, 1999, CELL GROWTH DIFFER, V10, P797; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kischkel FC, 2001, J BIOL CHEM, V276, P46639, DOI 10.1074/jbc.M105102200; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Krueger A, 2001, MOL CELL BIOL, V21, P8247, DOI 10.1128/MCB.21.24.8247-8254.2001; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Micheau O, 1999, J BIOL CHEM, V274, P7987, DOI 10.1074/jbc.274.12.7987; Morgan M, 2002, J CELL BIOL, V157, P975, DOI 10.1083/jcb.200204039; Poyet JL, 2000, J BIOL CHEM, V275, P37966, DOI 10.1074/jbc.M006643200; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; Scaffidi C, 1999, CURR OPIN IMMUNOL, V11, P277, DOI 10.1016/S0952-7915(99)80045-4; Schutze S, 1999, J BIOL CHEM, V274, P10203, DOI 10.1074/jbc.274.15.10203; Sprick MR, 2002, EMBO J, V21, P4520, DOI 10.1093/emboj/cdf441; Thomas LR, 2002, J BIOL CHEM, V277, P34343, DOI 10.1074/jbc.M204169200; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Tschopp J, 1998, CURR OPIN IMMUNOL, V10, P552, DOI 10.1016/S0952-7915(98)80223-9; Varfolomeev EE, 1996, J EXP MED, V183, P1271, DOI 10.1084/jem.183.3.1271; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang L, 2001, P NATL ACAD SCI USA, V98, P13884, DOI 10.1073/pnas.241358198; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	39	1882	1964	2	120	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 25	2003	114	2					181	190		10.1016/S0092-8674(03)00521-X	http://dx.doi.org/10.1016/S0092-8674(03)00521-X			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887920	Green Submitted, Bronze			2022-12-28	WOS:000184378700008
J	Jacobs, S				Jacobs, S			Behind the research - Death by voluntary dehydration - What the caregivers say	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	13	13	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2003	349	4					325	326		10.1056/NEJMp038115	http://dx.doi.org/10.1056/NEJMp038115			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703ZH	12878738				2022-12-28	WOS:000184312800004
J	Wellik, DM; Capecchi, MR				Wellik, DM; Capecchi, MR			Hox10 and Hox11 genes are required to globally pattern the mammalian skeleton	SCIENCE			English	Article							AXIAL SKELETON; MICE LACKING; EXPRESSION; COMPLEX; FORELIMB; HOXD-11	Mice in which all members of the Hox10 or Hox11 paralogous group are disrupted provide evidence that these Hox genes are involved in global patterning of the axial and appendicular skeleton. In the absence of Hox10 function, no lumbar vertebrae are formed. Instead, ribs project from all posterior vertebrae, extending caudally from the last thoracic vertebrae to beyond the sacral region. In the absence of Hox11 function, sacral vertebrae are not formed and instead these vertebrae assume a lumbar identity. The redundancy among these paralogous family members is so great that this global aspect of Hox patterning is not apparent in mice that are mutant for five of the six paralogous alleles.	Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; Univ Utah, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Capecchi, MR (corresponding author), Howard Hughes Med Inst, Salt Lake City, UT 84112 USA.							BURKE AC, 1995, DEVELOPMENT, V121, P333; Cohn MJ, 1999, NATURE, V399, P474, DOI 10.1038/20944; CONDIE BG, 1994, NATURE, V370, P304, DOI 10.1038/370304a0; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; DOLLE P, 1991, GENE DEV, V5, P1767, DOI 10.1101/gad.5.10.1767; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; Favier B, 1996, DEVELOPMENT, V122, P449; FromentalRamain C, 1996, DEVELOPMENT, V122, P461; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Herault Y, 1999, DEV BIOL, V208, P157, DOI 10.1006/dbio.1998.9179; Hildebrand M., 1995, ANAL VERTEBRATE STRU; HORAN GSB, 1995, GENE DEV, V9, P1667, DOI 10.1101/gad.9.13.1667; Hostikka SL, 1998, MECH DEVELOP, V70, P133, DOI 10.1016/S0925-4773(97)00182-2; Kmita M, 2002, DEVELOPMENT, V129, P5521, DOI 10.1242/dev.00151; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Nowicki JL, 2000, DEVELOPMENT, V127, P4265; Suzuki M, 2002, MECH DEVELOP, V118, P241, DOI 10.1016/S0925-4773(02)00257-5; van den Akker E, 2001, DEVELOPMENT, V128, P1911; Wahba GM, 2001, DEV BIOL, V231, P87, DOI 10.1006/dbio.2000.0130	19	388	398	3	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2003	301	5631					363	367		10.1126/science.1085672	http://dx.doi.org/10.1126/science.1085672			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869760				2022-12-28	WOS:000184207300043
J	Rocap, G; Larimer, FW; Lamerdin, J; Malfatti, S; Chain, P; Ahlgren, NA; Arellano, A; Coleman, M; Hauser, L; Hess, WR; Johnson, ZI; Land, M; Lindell, D; Post, AF; Regala, W; Shah, M; Shaw, SL; Steglich, C; Sullivan, MB; Ting, CS; Tolonen, A; Webb, EA; Zinser, ER; Chisholm, SW				Rocap, G; Larimer, FW; Lamerdin, J; Malfatti, S; Chain, P; Ahlgren, NA; Arellano, A; Coleman, M; Hauser, L; Hess, WR; Johnson, ZI; Land, M; Lindell, D; Post, AF; Regala, W; Shah, M; Shaw, SL; Steglich, C; Sullivan, MB; Ting, CS; Tolonen, A; Webb, EA; Zinser, ER; Chisholm, SW			Genome divergence in two Prochlorococcus ecotypes reflects oceanic niche differentiation	NATURE			English	Article							CYANOBACTERIUM PROCHLOROCOCCUS; PHOTOSYNTHETIC PROKARYOTE; RIBOSOMAL DNA; PACIFIC-OCEAN; SARGASSO SEA; SYNECHOCOCCUS; EVOLUTION; GROWTH; LIGHT; PROCHLOROPHYTE	The marine unicellular cyanobacterium Prochlorococcus is the smallest-known oxygen-evolving autotroph(1). It numerically dominates the phytoplankton in the tropical and subtropical oceans(2,3), and is responsible for a significant fraction of global photosynthesis. Here we compare the genomes of two Prochlorococcus strains that span the largest evolutionary distance within the Prochlorococcus lineage(4) and that have different minimum, maximum and optimal light intensities for growth(5). The high-light-adapted ecotype has the smallest genome (1,657,990 base pairs, 1,716 genes) of any known oxygenic phototroph, whereas the genome of its low-light-adapted counterpart is significantly larger, at 2,410,873 base pairs (2,275 genes). The comparative architectures of these two strains reveal dynamic genomes that are constantly changing in response to myriad selection pressures. Although the two strains have 1,350 genes in common, a significant number are not shared, and these have been differentially retained from the common ancestor, or acquired through duplication or lateral transfer. Some of these genes have obvious roles in determining the relative fitness of the ecotypes in response to key environmental variables, and hence in regulating their distribution and abundance in the oceans.	MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; Joint Genome Inst, Walnut Creek, CA 94598 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; MIT, Joint Program Biol Oceanog, Woods Hole Oceanog Inst, Cambridge, MA 02139 USA; Lawrence Livermore Natl lab, Livermore, CA 94550 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; Interuniv Inst Marine Sci, IL-88103 Elat, Israel; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	Massachusetts Institute of Technology (MIT); University of Washington; University of Washington Seattle; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Woods Hole Oceanographic Institution; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Massachusetts Institute of Technology (MIT); Humboldt University of Berlin; Woods Hole Oceanographic Institution	Chisholm, SW (corresponding author), MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA.	chisholm@mit.edu	Chain, Patrick/O-4140-2019; Sullivan, Matthew B/H-3256-2011; chain, patrick/B-9777-2013; Johnson, Zackary I/E-4601-2011; Hauser, Loren J/H-3881-2012; Land, Miriam L/A-6200-2011	Chain, Patrick/0000-0003-3949-3634; Sullivan, Matthew B/0000-0003-4040-9831; Johnson, Zackary I/0000-0003-0793-8512; Land, Miriam L/0000-0001-7102-0031; Malfatti, Stephanie/0000-0003-4225-9857; Tolonen, Andrew/0000-0001-5907-4504; Rocap, Gabrielle/0000-0001-7253-611X; Coleman, Maureen/0000-0001-5065-0106; Chisholm, Sallie/0000-0003-1480-2445; Ahlgren, Nathan/0000-0001-7617-4435; Lindell, Debbie/0000-0003-0612-4517				Campbell L, 1997, DEEP-SEA RES PT I, V44, P167, DOI 10.1016/S0967-0637(96)00102-1; CHISHOLM SW, 1988, NATURE, V334, P340, DOI 10.1038/334340a0; DUFRESNE A, IN PRESS P NATL ACAD; DuRand MD, 2001, DEEP-SEA RES PT II, V48, P1983, DOI 10.1016/S0967-0645(00)00166-1; Frankenberg N, 2001, PLANT CELL, V13, P965, DOI 10.1105/tpc.13.4.965; Garczarek L, 2001, PLANT MOL BIOL, V46, P683, DOI 10.1023/A:1011681726654; GOLDMAN BD, 1989, LIVING COLD, V2, P5; Hagstrom A, 2002, APPL ENVIRON MICROB, V68, P3628, DOI 10.1128/AEM.68.7.3628-3633.2002; Hess WR, 2001, PHOTOSYNTH RES, V70, P53, DOI 10.1023/A:1013835924610; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Johnson Z, 1999, DEEP-SEA RES PT II, V46, P1719, DOI 10.1016/S0967-0645(99)00041-7; Karl DM, 2001, DEEP-SEA RES PT II, V48, P1449, DOI 10.1016/S0967-0645(00)00149-1; LaRoche J, 1996, P NATL ACAD SCI USA, V93, P15244; LINDELL D, 1995, LIMNOL OCEANOGR, V40, P1130, DOI 10.4319/lo.1995.40.6.1130; Mann EL, 2002, LIMNOL OCEANOGR, V47, P976, DOI 10.4319/lo.2002.47.4.0976; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; MOORE LR, 1995, MAR ECOL PROG SER, V116, P259, DOI 10.3354/meps116259; Moore LR, 2002, LIMNOL OCEANOGR, V47, P989, DOI 10.4319/lo.2002.47.4.0989; Moore LR, 1999, LIMNOL OCEANOGR, V44, P628, DOI 10.4319/lo.1999.44.3.0628; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Nakamura Y, 2002, DNA RES, V9, P123, DOI 10.1093/dnares/9.4.123; Palenik B, 2003, NATURE, V424, P1037, DOI 10.1038/nature01943; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; SCANLAN DJ, 1993, MOL MICROBIOL, V10, P181, DOI 10.1111/j.1365-2958.1993.tb00914.x; Shen JR, 1998, BIOCHEMISTRY-US, V37, P1551, DOI 10.1021/bi971676i; Stickforth P, 2003, ARCH MICROBIOL, V179, P409, DOI 10.1007/s00203-003-0545-4; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; Ting CS, 2001, MICROBIOL-SGM, V147, P3171, DOI 10.1099/00221287-147-11-3171; VAULOT D, 1995, SCIENCE, V268, P1480, DOI 10.1126/science.268.5216.1480; West NJ, 2001, MICROBIOL-SGM, V147, P1731, DOI 10.1099/00221287-147-7-1731	30	863	1697	6	203	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2003	424	6952					1042	1047		10.1038/nature01947	http://dx.doi.org/10.1038/nature01947			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715QR	12917642				2022-12-28	WOS:000184984200040
J	Modlin, JF; Grant, PE; Makar, RS; Roberts, DJ; Krishnamoorthy, KS; Walsh, S; Harris, NL; Catlin, EA; Casavant, DW				Modlin, JF; Grant, PE; Makar, RS; Roberts, DJ; Krishnamoorthy, KS; Walsh, S; Harris, NL; Catlin, EA; Casavant, DW			A newborn boy with petechiae and thrombocytopenia - Congenital cytomegalovirus infection.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PRENATAL-DIAGNOSIS; TRANSMISSION; CARE; MANIFESTATIONS; PREGNANCY; CHILDREN; PLACENTA; ANTIBODY; DISEASE		Dartmouth Hitchcock Med Ctr, Dept Pediat, Lebanon, NH 03766 USA; Dartmouth Hitchcock Med Ctr, Dept Med, Lebanon, NH 03766 USA; Dartmouth Coll Sch Med, Lebanon, NH USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Dartmouth College; Dartmouth College; Dartmouth College; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Modlin, JF (corresponding author), Dartmouth Hitchcock Med Ctr, Dept Pediat, Lebanon, NH 03766 USA.		Roberts, Drucilla/AAB-6379-2022; Grant, Peter/HIR-3733-2022	Grant, Patricia/0000-0003-1005-4013				ADLER SP, 1988, PEDIATR INFECT DIS J, V7, P279, DOI 10.1097/00006454-198804000-00009; ALKALAY AL, 1987, J PEDIATR-US, V111, P320, DOI 10.1016/S0022-3476(87)80447-X; Azam AZ, 2001, OBSTET GYNECOL, V97, P443, DOI 10.1016/S0029-7844(00)01140-6; BENIRSCHKE K, 1974, VIRCHOWS ARCH B, V16, P121, DOI 10.1007/BF02894070; Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804; COOPER LZ, 1965, AM J DIS CHILD, V110, P416, DOI 10.1001/archpedi.1965.02090030436011; DWORSKY ME, 1983, NEW ENGL J MED, V309, P950, DOI 10.1056/NEJM198310203091604; Eberhardt MS, 2001, URBAN RURAL HLTH CHA; FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003; Fowler KB, 1997, J PEDIATR-US, V130, P624, DOI 10.1016/S0022-3476(97)70248-8; GERSELL DJ, 1993, SEMIN DIAGN PATHOL, V10, P251; GLEAVES CA, 1984, J CLIN MICROBIOL, V19, P917, DOI 10.1128/JCM.19.6.917-919.1984; GUERINA NG, 1994, NEW ENGL J MED, V330, P1858, DOI 10.1056/NEJM199406303302604; Guerra B, 2000, AM J OBSTET GYNECOL, V183, P476, DOI 10.1067/mob.2000.106347; Hodinka Richard L., 1995, P884; HUTTO C, 1987, J PEDIATR-US, V110, P97, DOI 10.1016/S0022-3476(87)80298-6; Kimberlin David W, 2002, Semin Pediatr Infect Dis, V13, P22, DOI 10.1053/spid.2002.29754; KIMBERLIN DW, 2000, 40 INT C ANT AG CHEM; KIMBERLIN DW, IN PRESS J PEDIAT; Lazzarotto T, 1998, J CLIN MICROBIOL, V36, P3540, DOI 10.1128/JCM.36.12.3540-3544.1998; MILLARD DD, 1990, PEDIATR INFECT DIS J, V9, P929, DOI 10.1097/00006454-199012000-00017; MUHLEMANN K, 1992, HUM PATHOL, V23, P1234, DOI 10.1016/0046-8177(92)90290-J; Noyola DE, 2001, J PEDIATR-US, V138, P325, DOI 10.1067/mpd.2001.112061; REYES MP, 1993, CLIN INFECT DIS, V17, P1041, DOI 10.1093/clinids/17.6.1041; Roberts D, 2002, NEW ENGL J MED, V347, P57, DOI 10.1056/NEJMe020061; RUDIN C, 1993, PEDIATR INFECT DIS J, V12, P411, DOI 10.1097/00006454-199305000-00016; SPAGNO S, 2001, INFECT DIS FETUS NEW, P389; STAGNO S, 1986, JAMA-J AM MED ASSOC, V256, P1904, DOI 10.1001/jama.256.14.1904; STAGNO S, 1983, SEMIN PERINATOL, V7, P31; STAGNO S, 1977, NEW ENGL J MED, V296, P1254, DOI 10.1056/NEJM197706022962203; STAGNO S, 1982, Clinical Obstetrics and Gynecology, V25, P563, DOI 10.1097/00003081-198209000-00014; WELLER TH, 1962, NEW ENGL J MED, V266, P1233, DOI 10.1056/NEJM196206142662401; Whitley RJ, 1997, J INFECT DIS, V175, P1080, DOI 10.1086/516445; Whitley RJ, 1997, CLIN PERINATOL, V24, P267, DOI 10.1016/S0095-5108(18)30196-9; 2001, MMWR MORB MORTAL WKL, V50, P573	35	8	8	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2003	349	7					691	700		10.1056/NEJMcpc030017	http://dx.doi.org/10.1056/NEJMcpc030017			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711FL	12917307				2022-12-28	WOS:000184728900012
J	Szapary, PO; Wolfe, ML; Bloedon, LT; Cucchiara, AJ; DerMarderosian, AH; Cirigliano, MD				Szapary, PO; Wolfe, ML; Bloedon, LT; Cucchiara, AJ; DerMarderosian, AH; Cirigliano, MD			Guggulipid for the treatment of hypercholesterolemia - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMMIPHORA-MUKUL; NATURAL PRODUCT; BILE-ACID; CHOLESTEROL; GUM; ANTAGONIST; RECEPTOR; HYPERLIPIDEMIA; GUGGULSTERONE; THERAPY	Context Herbal extracts from Commiphora mukul (guggul) have been widely used in Asia as cholesterol-lowering agents, and their popularity is increasing in the United States. Recently, guggulsterones, the purported bioactive compounds of guggul, have been shown to be potent antagonists of 2 nuclear hormone receptors involved in cholesterol metabolism, establishing a plausible mechanism of action for the hypolipidemic effects of these extracts. However, there are currently no published safety or efficacy data on the use of guggul extracts in Western populations. Objective To study the short-term safety and efficacy of 2 doses of a standardized guggul extract (guggulipid, containing 2.5% guggulsterones) in healthy adults with hyperlipidemia. eating a typical Western diet. Design Double-blind, randomized, placebo-controlled trial using a parallel design, conducted March 2000-August 2001. Participants and Setting A total of 103 ambulatory, community-dwelling, healthy adults with hypercholesterolemia in the Philadelphia, Pa, metropolitan area. Intervention Oral, 3 times daily doses of standard-dose guggulipid (1000 mg), high-dose guggulipid (2000 mg), or matching placebo. Main Outcome Measures Percentage change in levels of directly measured low-density lipoprotein cholesterol (LDL-C) after 8 weeks of therapy. Secondary outcome measures included levels of total cholesterol, high-density lipoprotein cholesterol (HDL-C), triglycerides, and directly measured very low-density lipoprotein cholesterol (VLDL-C), as well as adverse events reports and laboratory safety measures including electrolyte levels and hepatic and renal function. Results Compared with participants randomized to placebo (n=36), in whom levels of LDL-C decreased by 5%,both standard-dose guggulipid (n = 33) and high -dose guggulipid (n=34) raised levels of LDL-C by 4% (P=.01 vs placebo) and 5% (P=.006 vs placebo), respectively, at 8 weeks, for a net positive change of 9% to 10%. There were no significant changes in levels of total cholesterol, HDL-C, triglycerides, or VLDL-C in response to treatment with guggulipid in the intention-to-treat analysis. While guggulipid was generally well tolerated, 6 participants treated with guggulipid developed a hypersensitivity rash compared with none in the placebo group. Conclusions Despite plausible mechanisms of action, guggulipid did not appear to improve levels of serum cholesterol over the short term in this population of adults with hypercholesterolemia, and might in fact raise levels of LDL-C. Guggulipid also appeared to cause a dermatologic hypersensitivity reaction in some patients.	Univ Penn, Sch Med, Dept Med, Div Gen Internal Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Expt Therapeut, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Gen Clin Res Ctr, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Sci, Dept Med & Biol Chem, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Szapary, PO (corresponding author), Univ Penn, Sch Med, Dept Med, Div Gen Internal Med, 1222 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.				NCCIH NIH HHS [K-23 AT-00058] Funding Source: Medline; NCRR NIH HHS [M01-RR00040] Funding Source: Medline; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [K23AT000058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000040] Funding Source: NIH RePORTER	NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AGARWAL RC, 1986, INDIAN J MED RES, V84, P626; ARORA RB, 1972, INDIAN J MED RES, V60, P929; Chawla A, 2000, CELL, V103, P1, DOI 10.1016/S0092-8674(00)00097-0; Cui J, 2003, J BIOL CHEM, V278, P10214, DOI 10.1074/jbc.M209323200; Das Gupta R, 1990, J Assoc Physicians India, V38, P186; DASGUPTA R, 1990, J ASSOC PHYSICIAN I, V38, P598; De Smet PAGM, 2002, NEW ENGL J MED, V347, P2046, DOI 10.1056/NEJMra020398; Dev S, 1997, CURR SCI INDIA, V73, P909; DUWIEJUA M, 1993, PLANTA MED, V59, P12, DOI 10.1055/s-2006-959594; Ghorai M, 2000, PHYTOTHER RES, V14, P200, DOI 10.1002/(SICI)1099-1573(200005)14:3&lt;200::AID-PTR548&gt;3.0.CO;2-T; Goldman P, 2001, ANN INTERN MED, V135, P594, DOI 10.7326/0003-4819-135-8_Part_1-200110160-00010; Gopal K, 1986, J Assoc Physicians India, V34, P249; Kuppurajan K, 1978, J Assoc Physicians India, V26, P367; MALHOTRA SC, 1971, INDIAN J MED RES, V59, P1621; MALHOTRA SC, 1977, INDIAN J MED RES, V65, P390; Nagarajan M, 2001, J AOAC INT, V84, P24; Nityanand S, 1989, J Assoc Physicians India, V37, P323; NITYANAND S, 1973, INDIAN J EXP BIOL, V11, P395; Panda S, 1999, LIFE SCI, V65, pPL137, DOI 10.1016/S0024-3205(99)00369-0; Russell DW, 1999, CELL, V97, P539, DOI 10.1016/S0092-8674(00)80763-1; SATYAVATI GV, 1988, INDIAN J MED RES, V87, P327; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; SINGH RB, 1994, CARDIOVASC DRUG THER, V8, P659, DOI 10.1007/BF00877420; TRIPATHI YB, 1984, PLANTA MED, V1, P78; Urizar NL, 2002, SCIENCE, V296, P1703, DOI 10.1126/science.1072891; VERMA SK, 1988, INDIAN J MED RES, V87, P356; Wu J, 2002, MOL ENDOCRINOL, V16, P1590, DOI 10.1210/me.16.7.1590	27	156	165	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2003	290	6					765	772		10.1001/jama.290.6.765	http://dx.doi.org/10.1001/jama.290.6.765			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	709VU	12915429	Bronze			2022-12-28	WOS:000184647700027
J	van der Mei, IAF; Ponsonby, AL; Dwyer, T; Blizzard, L; Simmons, R; Taylor, BV; Butzkueven, H; Kilpatrick, T				van der Mei, IAF; Ponsonby, AL; Dwyer, T; Blizzard, L; Simmons, R; Taylor, BV; Butzkueven, H; Kilpatrick, T			Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study	BRITISH MEDICAL JOURNAL			English	Article							VITAMIN-D; 1,25-DIHYDROXYVITAMIN D-3; MELANIN DENSITY; PREVALENCE; ENCEPHALOMYELITIS; SPECTROPHOTOMETRY; DETERMINANTS; GUIDELINES; CAUCASIANS; POPULATION	Objective To examine whether past high sun exposure is associated with a reduced risk of multiple sclerosis. Design Population based case-control study. Setting Tasmania, latitudes 41-3degreesS. Participants 136 cases with multiple sclerosis and 272 controls randomly drawn from the community and matched on sex and year of birth. Main outcome measure Multiple sclerosis defined by both clinical and magnetic resonance imaging criteria. Results Higher sun exposure when aged 6-15 years (average 2-3 hours or more a day in summer during weekends and holidays) was associated with a decreased risk of multiple sclerosis (adjusted odds ratio 0.31, 95% confidence interval 0.16 to 0.59). Higher exposure in winter seemed more important than higher exposure in summer. Greater actinic damage was also independently associated with a decreased risk of multiple sclerosis (0.32, 0.11 to 0.88 for grades 4-6 disease). A dose-response relation was observed between multiple sclerosis and decreasing sun exposure when aged 6-15 years and with actinic damage. Conclusion Higher sun exposure during childhood and early adolescence is associated with a reduced risk of multiple sclerosis. insufficient ultraviolet radiation may therefore influence the development of multiple sclerosis.	Univ Tasmania, Menzies Ctr Populat Hlth Res, Hobart, Tas 7000, Australia; Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; Canberra Hosp, Australian MS Longitudinal Study, Canberra, ACT, Australia; Royal Hobart Hosp, Hobart, Tas, Australia; Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	University of Tasmania; Australian National University; Australian National University; Canberra Hospital; Royal Hobart Hospital; Walter & Eliza Hall Institute	van der Mei, IAF (corresponding author), Univ Tasmania, Menzies Ctr Populat Hlth Res, Hobart, Tas 7000, Australia.		van der Mei, Ingrid/J-7457-2014; van der Mei, Ingrid/AAI-2566-2020	van der Mei, Ingrid/0000-0001-9009-7472; van der Mei, Ingrid/0000-0001-9009-7472; Kilpatrick, Trevor/0000-0003-3999-085X; Butzkueven, Helmut/0000-0003-3940-8727				ACHESON E. D., 1960, ACTA PSYCHIATR ET NEUROL SCAND SUPPL, V35, P132, DOI 10.1111/j.1600-0447.1960.tb08674.x; Beagley J, 1980, CHANGES SKIN CONDITI; Boiko A, 1997, NEUROLOGY, V49, pS75, DOI 10.1212/WNL.49.2_Suppl_2.S75; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; Cantorna MT, 1998, J IMMUNOL, V160, P5314; Dwyer T, 1998, CANCER EPIDEM BIOMAR, V7, P203; Dwyer T, 1996, MELANOMA RES, V6, P231, DOI 10.1097/00008390-199606000-00006; Dwyer T, 2002, AM J EPIDEMIOL, V155, P614, DOI 10.1093/aje/155.7.614; EBERS GC, 1993, NEUROEPIDEMIOLOGY, V12, P1, DOI 10.1159/000110293; Embry AF, 2000, ANN NEUROL, V48, P271, DOI 10.1002/1531-8249(200008)48:2<271::AID-ANA28>3.0.CO;2-O; English DR, 1998, CANCER EPIDEM BIOMAR, V7, P857; Forbes RB, 1999, J NEUROL, V246, P1033, DOI 10.1007/s004150050509; FRANCIS DA, 1991, HUM IMMUNOL, V32, P119, DOI 10.1016/0198-8859(91)90108-L; Freedman DM, 2000, OCCUP ENVIRON MED, V57, P418, DOI 10.1136/oem.57.6.418; FRITSCHI L, 1995, AUST J PUBLIC HEALTH, V19, P383; Garssen J, 2001, CRIT REV IMMUNOL, V21, P359; GIES HP, 1994, SPIE ULTRAVIOLET TEC, V2282, P272; GOLDBERG P, 1986, MED HYPOTHESES, V21, P193, DOI 10.1016/0306-9877(86)90010-1; GREEN AC, 1991, MED J AUSTRALIA, V155, P473, DOI 10.5694/j.1326-5377.1991.tb93845.x; GREEN AC, 1991, MED J AUSTRALIA, V155, P477; HAMMOND SR, 1988, BRAIN, V111, P1, DOI 10.1093/brain/111.1.1; Hammond SR, 2000, BRAIN, V123, P968, DOI 10.1093/brain/123.5.968; HAUSER SL, 1984, J IMMUNOL, V132, P1276; Hayes CE, 2000, P NUTR SOC, V59, P531, DOI 10.1017/S0029665100000768; Hemmer B, 2002, CURR OPIN NEUROL, V15, P227, DOI 10.1097/00019052-200206000-00001; HILLERT J, 1993, NEUROLOGY, V43, P2426, DOI 10.1212/WNL.43.11.2426-a; HOLMAN CDJ, 1984, AM J EPIDEMIOL, V120, P414, DOI 10.1093/oxfordjournals.aje.a113906; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; Jones G, 1999, EUR J CLIN NUTR, V53, P824, DOI 10.1038/sj.ejcn.1600858; McMichael AJ, 1997, EPIDEMIOLOGY, V8, P642, DOI 10.1097/00001648-199710000-00005; NIEVES J, 1994, NEUROLOGY, V44, P1687, DOI 10.1212/WNL.44.9.1687; PATY DW, 1988, NEUROLOGY, V38, P180, DOI 10.1212/WNL.38.2.180; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Rosati G, 2001, NEUROL SCI, V22, P117, DOI 10.1007/s100720170011; Rubio JP, 2002, AM J HUM GENET, V70, P1125, DOI 10.1086/339932; van der Mei IAF, 2001, NEUROEPIDEMIOLOGY, V20, P168, DOI 10.1159/000054783; Vieth R, 2001, AM J CLIN NUTR, V73, P288; WEINSHENKER BG, 1989, BRAIN, V112, P133, DOI 10.1093/brain/112.1.133	39	385	392	3	35	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 9	2003	327	7410					316	320		10.1136/bmj.327.7410.316	http://dx.doi.org/10.1136/bmj.327.7410.316			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	710JE	12907484	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000184676400016
J	Bassing, CH; Suh, H; Ferguson, DO; Chua, KF; Manis, J; Eckersdorff, M; Gleason, M; Bronson, R; Lee, C; Alt, FW				Bassing, CH; Suh, H; Ferguson, DO; Chua, KF; Manis, J; Eckersdorff, M; Gleason, M; Bronson, R; Lee, C; Alt, FW			Histone H2AX: A dosage-dependent suppressor of oncogenic translocations and tumors	CELL			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE CHECKPOINT; GENOMIC INSTABILITY; V(D)J RECOMBINATION; GENE AMPLIFICATION; THYMIC LYMPHOMA; PATHOGENIC ROLE; MICE; 53BP1; ATM	We employed gene targeting to study H2AX, a histone variant phosphorylated in chromatin surrounding DNA double-strand breaks. Mice deficient for both H2AX and p53 ((HP-/-)-P-Delta/Delta) rapidly developed immature T and B lymphomas and solid tumors. Moreover, H2AX haploinsufficiency caused genomic instability in normal cells and, on a p53-deficient background, early onset of various tumors including more mature B lymphomas. Most H2AX(Delta/Delta)p53(-/-) or H2AX(+/Delta) p53(-/-) B lineage lymphomas harbored chromosome 12 (IgH)/15 (c-myc) translocations with hallmarks of either aberrant V(D)J or class switch recombination. In contrast, H2AX(Delta/Delta)p53(-/-) thymic lymphomas had clonal translocations that did not involve antigen receptor loci and which likely occurred during cellular expansion. Thus, H2AX helps prevent aberrant repair of both programmed and general DNA breakage and, thereby, functions as a dosage-dependent suppressor of genomic instability and tumors in mice. Notably, H2AX maps to a cytogenetic region frequently altered in human cancers, possibily implicating similar functions in man.	Harvard Univ, Sch Med, Childrens Hosp, Howard Hughes Med Inst,Dept Genet, Boston, MA 02115 USA; Ctr Blood Res, Boston, MA 02115 USA; Tufts Univ, Sch Vet Med, North Grafton, MA 01536 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cytogenet, Boston, MA 02155 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02155 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Tufts University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Alt, FW (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Howard Hughes Med Inst,Dept Genet, Boston, MA 02115 USA.				NATIONAL CANCER INSTITUTE [P01CA092625] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL067580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035714] Funding Source: NIH RePORTER; NCI NIH HHS [CA92625] Funding Source: Medline; NHLBI NIH HHS [K08 HL67580-03] Funding Source: Medline; NIAID NIH HHS [AI35714] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson G, 1999, IMMUNOL TODAY, V20, P463, DOI 10.1016/S0167-5699(99)01524-8; Bachelier R, 2003, ONCOGENE, V22, P528, DOI 10.1038/sj.onc.1206208; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bosco G, 1998, GENETICS, V150, P1037; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; CHERIF D, 1994, LEUKEMIA, V8, P578; COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4; Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Fodde R, 2002, SCIENCE, V298, P761, DOI 10.1126/science.1077707; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Gladdy RA, 2003, CANCER CELL, V3, P37, DOI 10.1016/S1535-6108(02)00236-2; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; HARVEY M, 1993, FASEB J, V7, P938, DOI 10.1096/fasebj.7.10.8344491; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Jack MT, 2002, P NATL ACAD SCI USA, V99, P9825, DOI 10.1073/pnas.152053599; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Liao MJ, 1998, MOL CELL BIOL, V18, P3495, DOI 10.1128/MCB.18.6.3495; Liyanage M, 2000, BLOOD, V96, P1940, DOI 10.1182/blood.V96.5.1940.h8001940_1940_1946; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Mak TW, 2000, NAT IMMUNOL, V1, P77, DOI 10.1038/76950; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Monteiro ANA, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.4.e51; NOTTENBURG C, 1987, J IMMUNOL, V139, P1718; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schaffner C, 1999, BLOOD, V94, P748, DOI 10.1182/blood.V94.2.748.414k02_748_753; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Sleckman BP, 1997, IMMUNITY, V7, P505, DOI 10.1016/S1074-7613(00)80372-6; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stilgenbauer S, 1999, BLOOD, V94, P3262, DOI 10.1182/blood.V94.9.3262.421a33_3262_3264; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	53	411	422	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 8	2003	114	3					359	370		10.1016/S0092-8674(03)00566-X	http://dx.doi.org/10.1016/S0092-8674(03)00566-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914700	Bronze			2022-12-28	WOS:000184679200012
J	Granovetter, M				Granovetter, M			Ignorance, knowledge, and outcomes in a small world	SCIENCE			English	Editorial Material									Stanford Univ, Dept Sociol, Stanford, CA 94305 USA	Stanford University	Granovetter, M (corresponding author), Stanford Univ, Dept Sociol, Stanford, CA 94305 USA.							BARABASI AL, 2002, LINKED; Dodds PS, 2003, SCIENCE, V301, P827, DOI 10.1126/science.1081058; FELD SL, 1991, AM J SOCIOL, V96, P1464, DOI 10.1086/229693; Granovetter Mark., 1995, GETTING JOB STUDY CO, V2nd; MILGRAM S, 1967, PSYCHOL TODAY, V2, P60, DOI DOI 10.1145/335305.335325; Watts DJ, 2002, SCIENCE, V296, P1302, DOI 10.1126/science.1070120	6	26	27	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2003	301	5634					773	774		10.1126/science.1088508	http://dx.doi.org/10.1126/science.1088508			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907782				2022-12-28	WOS:000184615700025
J	Hoffmann, G				Hoffmann, G			Taking the pulse of the tropical water cycle	SCIENCE			English	Editorial Material							ICE CORES; PRECIPITATION; PACIFIC; PERU		LSCE, F-91191 Gif Sur Yvette, France	UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	Hoffmann, G (corresponding author), LSCE, F-91191 Gif Sur Yvette, France.							[Anonymous], [No title captured]; BRADLEY R, 2003, GEOPHYYS RES LETT, V30; Bush MB, 2002, J PALEOLIMNOL, V27, P341, DOI 10.1023/A:1016059415848; Cobb KM, 2001, GEOPHYS RES LETT, V28, P2209, DOI 10.1029/2001GL012919; Dai A, 1997, J CLIMATE, V10, P2943, DOI 10.1175/1520-0442(1997)010<2943:SOGLPV>2.0.CO;2; HOFFMANN G, 2003, GEOPHYS RES LETT, V30; Kaplan A, 1998, J GEOPHYS RES-OCEANS, V103, P18567, DOI 10.1029/97JC01734; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Rao VB, 1998, J GEOPHYS RES-ATMOS, V103, P13713, DOI 10.1029/98JD00943; SEIMON A, IN PRESS GEOPHYS RES; Thompson LG, 1998, SCIENCE, V282, P1858, DOI 10.1126/science.282.5395.1858; THOMPSON LG, 1985, SCIENCE, V229, P971, DOI 10.1126/science.229.4717.971; THOMPSON LG, 1995, SCIENCE, V269, P46, DOI 10.1126/science.269.5220.46	13	33	35	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2003	301	5634					776	777		10.1126/science.1085066	http://dx.doi.org/10.1126/science.1085066			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907784				2022-12-28	WOS:000184615700027
J	Lee, JS; Lee, YJ; Tae, EL; Park, YS; Yoon, KB				Lee, JS; Lee, YJ; Tae, EL; Park, YS; Yoon, KB			Synthesis of zeolite as ordered multicrystal arrays	SCIENCE			English	Article							MOLECULAR-SIEVE CRYSTALS; MATERIALS CHEMISTRY; GLASS; SYSTEM; GROWTH	Zeolites are crystalline nanoporous aluminosilicates widely used in industry. In order for zeolites to find applications as innovative materials, they need to be organized into large two- and three-dimensional (2D and 3D) arrays. We report that uniformly aligned polyurethane films can serve as templates for the synthesis of uniformly aligned 2D and possibly 3D arrays of silicalite-1 crystals, in which the orientations of the crystals are controlled by the nature of the polymers. We propose that the supramolecularly organized organic-inorganic composites that consist of the hydrolyzed organic products and the seed crystals are responsible for this phenomenon.	Sogang Univ, Dept Chem, Seoul 121742, South Korea	Sogang University	Yoon, KB (corresponding author), Sogang Univ, Dept Chem, Seoul 121742, South Korea.							ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531; Calzaferri G, 2002, J MATER CHEM, V12, P1, DOI 10.1039/b106141k; CARO J, 1992, ADV MATER, V4, P273, DOI 10.1002/adma.19920040405; Choi SY, 2000, J AM CHEM SOC, V122, P5201, DOI 10.1021/ja000113i; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Dujardin E, 2002, ADV ENG MATER, V4, P461, DOI 10.1002/1527-2648(20020717)4:7<461::AID-ADEM461>3.0.CO;2-K; FENG S, 1994, SCIENCE, V265, P1839, DOI 10.1126/science.265.5180.1839; FENG S, 1994, NATURE, V368, P834, DOI 10.1038/368834a0; Kirschhock CEA, 1999, J PHYS CHEM B, V103, P11021, DOI 10.1021/jp992272y; Kirschhock CEA, 2002, J PHYS CHEM B, V106, P4897, DOI 10.1021/jp015617x; Koegler JH, 1997, ZEOLITES, V19, P262, DOI 10.1016/S0144-2449(97)00088-2; Lai ZP, 2003, SCIENCE, V300, P456, DOI 10.1126/science.1082169; Lee GS, 2001, J AM CHEM SOC, V123, P9769, DOI 10.1021/ja010517q; Lee YJ, 2001, ADV MATER, V13, P1259, DOI 10.1002/1521-4095(200108)13:16<1259::AID-ADMA1259>3.0.CO;2-U; MANN S, 1993, NATURE, V365, P499, DOI 10.1038/365499a0; OZIN GA, 1989, ANGEW CHEM INT EDIT, V28, P359, DOI 10.1002/anie.198903591; Park JS, 2002, J AM CHEM SOC, V124, P13366, DOI 10.1021/ja0270569; Pavia D.L, 1996, INTRO SPECTROSCOPY, Vsecond; Treacy M. M. J., 2001, COLLECTION SIMULATED; Vietze U, 1998, PHYS REV LETT, V81, P4628, DOI 10.1103/PhysRevLett.81.4628; Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j	21	158	169	2	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2003	301	5634					818	821		10.1126/science.1086441	http://dx.doi.org/10.1126/science.1086441			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907797				2022-12-28	WOS:000184615700040
J	Rosen, JM				Rosen, JM			Striking it rich by data mining	CELL			English	Editorial Material							C/EBP-BETA; BREAST-CANCER; EXPRESSION; ALPHA	In this issue of Cell, Lamb et al. have used a combination of molecular genetics, DNA microarray, and data mining of human tumor expression databases to identify a cdk-independent mechanism by which the interaction of cyclin D1 with the transcription factor C/EBPbeta may mediate tumorigenesis.	Baylor Coll Med, Dept Cellular & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine	Rosen, JM (corresponding author), Baylor Coll Med, Dept Cellular & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.							Calkhoven CF, 2000, GENE DEV, V14, P1920; Coqueret O, 2002, GENE, V299, P35, DOI 10.1016/S0378-1119(02)01055-7; Hui R, 1996, CLIN CANCER RES, V2, P923; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Milde-Langosch K, 2003, BREAST CANCER RES TR, V79, P175, DOI 10.1023/A:1023929504884; XU M, 2003, BREAST CANCER RES, V22, P893; Zahnow CA, 1997, J NATL CANCER I, V89, P1887, DOI 10.1093/jnci/89.24.1887; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299	9	2	2	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 8	2003	114	3					271	272		10.1016/S0092-8674(03)00601-9	http://dx.doi.org/10.1016/S0092-8674(03)00601-9			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914689	Bronze			2022-12-28	WOS:000184679200001
J	Stengaard-Pedersen, K; Thiel, S; Gadjeva, M; Moller-Kristensen, M; Sorensen, R; Jensen, LT; Sjoholm, AG; Fugger, L; Jensenius, JC				Stengaard-Pedersen, K; Thiel, S; Gadjeva, M; Moller-Kristensen, M; Sorensen, R; Jensen, LT; Sjoholm, AG; Fugger, L; Jensenius, JC			Inherited deficiency of mannan-binding lectin-associated serine protease 2	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SERINE PROTEASES; COMPLEMENT; MBL; PATHWAY; PROTEIN; IMMUNOLOGY; COMPLEXES; C1Q; 2ND		Aarhus Univ, Dept Med Microbiol & Immunol, DK-8000 Aarhus, Denmark; Aarhus Univ Hosp, Dept Rheumatol, DK-8000 Aarhus, Denmark; Aarhus Univ Hosp, Dept Clin Immunol, DK-8000 Aarhus, Denmark; John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England; Lund Univ, Inst Lab Med, Sect Microbiol Immunol & Glycobiol, Lund, Sweden	Aarhus University; Aarhus University; Aarhus University; University of Oxford; Lund University	Thiel, S (corresponding author), Aarhus Univ, Dept Med Microbiol & Immunol, DK-8000 Aarhus, Denmark.	st@microbiology.au.dk		Bjerre, Mette/0000-0002-5511-8829; Thiel, Steffen/0000-0002-4817-155X				BRANDSLUND I, 1981, J IMMUNOL METHODS, V44, P63, DOI 10.1016/0022-1759(81)90107-1; Chen CB, 2001, J BIOL CHEM, V276, P25894, DOI 10.1074/jbc.M103539200; Dahl MR, 2001, IMMUNITY, V15, P127, DOI 10.1016/S1074-7613(01)00161-3; FIGUEROA JE, 1991, CLIN MICROBIOL REV, V4, P359, DOI 10.1128/CMR.4.3.359-395.1991; Gadjeva M, 2001, CURR OPIN IMMUNOL, V13, P74, DOI 10.1016/S0952-7915(00)00185-0; Jack DL, 2001, IMMUNOL REV, V180, P86, DOI 10.1034/j.1600-065X.2001.1800108.x; JOHNSON U, 1983, ACTA PATH MICRO IM C, V91, P147; MARTENSSON U, 1992, SCAND J IMMUNOL, V35, P735, DOI 10.1111/j.1365-3083.1992.tb02982.x; Matsushita M, 2001, IMMUNOL REV, V180, P78, DOI 10.1034/j.1600-065X.2001.1800107.x; MOLLNES TE, 1996, WEIRS HDB EXPT IMMUN, P71; Petersen SV, 2001, J IMMUNOL METHODS, V257, P107, DOI 10.1016/S0022-1759(01)00453-7; PETERSEN SV, 2001, THESIS U AARHUS DENM; Romao MJ, 1997, J MOL BIOL, V274, P650, DOI 10.1006/jmbi.1997.1423; Roy S, 2002, LANCET, V359, P1569, DOI 10.1016/S0140-6736(02)08516-1; Sjoholm AG, 1997, J RHEUMATOL, V24, P871; Sjoholm AG, 2001, METH MOLEC MED, V67, P529, DOI 10.1385/1-59259-149-3:529; Steffensen R, 2000, J IMMUNOL METHODS, V241, P33, DOI 10.1016/S0022-1759(00)00198-8; Stover CM, 1999, J IMMUNOL, V162, P3481; Thiel S, 2000, J IMMUNOL, V165, P878, DOI 10.4049/jimmunol.165.2.878; Thiel S, 2002, IMMUNOBIOLOGY, V205, P446, DOI 10.1078/0171-2985-00145; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Thielens NM, 2001, J IMMUNOL, V166, P5068, DOI 10.4049/jimmunol.166.8.5068; Vorup-Jensen T, 2000, J IMMUNOL, V165, P2093, DOI 10.4049/jimmunol.165.4.2093; Vorup-Jensen T, 2001, INT IMMUNOPHARMACOL, V1, P677, DOI 10.1016/S1567-5769(00)00052-7; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; WISNIESKI JJ, 1995, MEDICINE, V74, P24, DOI 10.1097/00005792-199501000-00003	27	177	203	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2003	349	6					554	560		10.1056/NEJMoa022836	http://dx.doi.org/10.1056/NEJMoa022836			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708JL	12904520				2022-12-28	WOS:000184563500006
J	Dorin, RI; Qualls, CR; Crapo, LM				Dorin, RI; Qualls, CR; Crapo, LM			Diagnosis of adrenal insufficiency	ANNALS OF INTERNAL MEDICINE			English	Review							LOW-DOSE ACTH; SHORT SYNACTHEN TEST; 1 MU-G; PITUITARY-ADRENOCORTICAL FUNCTION; CORTICOTROPIN-RELEASING HORMONE; INSULIN TOLERANCE-TEST; GLUCOCORTICOID-TREATED PATIENTS; SEVERELY STRESSED PATIENTS; NORMAL CORTISOL RESPONSE; CRITICALLY-ILL PATIENTS	Background: The cosyntropin stimulation test is the initial endocrine evaluation of suspected primary or secondary adrenal insufficiency. Purpose: To critically review the utility of the cosyntropin stimulation test for evaluating adrenal insufficiency. Data Sources: The MEDLINE database was searched from 1966 to 2002 for all English-language papers related to the diagnosis of adrenal insufficiency. Study Selection: Studies with fewer than 5 persons with primary or secondary adrenal insufficiency or with fewer than 10 persons as normal controls were excluded. For secondary adrenal insufficiency, only studies that stratified participants by integrated tests of adrenal function were included. Data Extraction: Summary receiver-operating characteristic (ROC) curves were generated from all studies that provided sensitivity and specificity data for 250-mug and 1-mug cosyntropin tests; these curves were then compared by using area under the curve (AUC) methods. All estimated values are given with 95% Cis. Data Synthesis: At a specificity of 95%, sensitivities were 97%, 57%, and 61% for summary ROC curves in tests for primary adrenal insufficiency (250-mug cosyntropin test), secondary adrenal insufficiency (250-mug cosyntropin test), and secondary adrenal insufficiency (1-mug cosyntropin test), respectively. The area under the curve for primary adrenal insufficiency was significantly greater than the AUC for secondary adrenal insufficiency for the high-dose cosyntropin test (P < 0.001), but AUCs for the 250-mug and 1-mug cosyntropin tests did not differ significantly (P > 0.5) for secondary adrenal insufficiency. At a specificity of 95%, summary ROC analysis for the 250-mug cosyntropin test yielded a positive likelihood ratio of 11.5 (95% CI, 8.7 to 14.2) and a negative likelihood ratio of 0.45 (CI, 0.30 to 0.60) for the diagnosis of secondary adrenal insufficiency. Conclusions: Cortisol response to cosyntropin varies considerably among healthy persons. The cosyntropin test performs well in patients with primary adrenal insufficiency, but the lower sensitivity in patients with secondary adrenal insufficiency necessitates use of tests involving stimulation of the hypothalamus if the pretest probability is sufficiently high. The operating characteristics of the 250-mug and 1-mug cosyntropin tests are similar.	New Mexico Vet Adm Hlth Care Syst, Div Endocrinol & Metab, Med Serv 111, Albuquerque, NM 87108 USA; Univ New Mexico, Albuquerque, NM 87131 USA; Santa Clara Valley Med Ctr, San Jose, CA 95128 USA; Stanford Univ, Palo Alto, CA 94304 USA	University of New Mexico; Santa Clara Valley Medical Center; Stanford University	Dorin, RI (corresponding author), New Mexico Vet Adm Hlth Care Syst, Div Endocrinol & Metab, Med Serv 111, 1501 San Pedro Blvd SE, Albuquerque, NM 87108 USA.	rdorin@salud.unm.edu						Abdu TAM, 1999, J CLIN ENDOCR METAB, V84, P2973; Abdu TAM, 1999, J CLIN ENDOCR METAB, V84, P838, DOI 10.1210/jc.84.3.838; Ambrosi B, 1998, EUR J ENDOCRINOL, V139, P575, DOI 10.1530/eje.0.1390575; Ammari F, 1996, CLIN ENDOCRINOL, V44, P473, DOI 10.1046/j.1365-2265.1996.712533.x; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; BALDWIN WA, 1993, ARCH SURG-CHICAGO, V128, P673; Bangar V, 1998, EUR J ENDOCRINOL, V139, P580, DOI 10.1530/eje.0.1390580; BARTON RN, 1987, J TRAUMA, V27, P384, DOI 10.1097/00005373-198704000-00007; BLICHERTTOFT M, 1980, ACTA MED SCAND, V207, P115; Bollaert PE, 1998, CRIT CARE MED, V26, P645, DOI 10.1097/00003246-199804000-00010; BOSCARO M, 1994, J CLIN ENDOCR METAB, V79, P452, DOI 10.1210/jc.79.2.452; BOUACHOUR G, 1994, INTENS CARE MED, V20, P138, DOI 10.1007/BF01707669; BOUACHOUR G, 1995, ANN INTERN MED, V123, P962, DOI 10.7326/0003-4819-123-12-199512150-00018; Briegel J, 1996, INTENS CARE MED, V22, P894; BROWNLIE BE, 1969, AUSTRALAS ANN MED, V18, P50; CHERNOW B, 1987, ARCH INTERN MED, V147, P1273, DOI 10.1001/archinte.147.7.1273; CHROUSOS GP, 1985, ANN INTERN MED, V102, P344, DOI 10.7326/0003-4819-102-3-344; Clark PM, 1998, CLIN ENDOCRINOL, V49, P287; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; CROWLEY S, 1991, J ENDOCRINOL, V130, P475, DOI 10.1677/joe.0.1300475; CROWLEY S, 1993, J ENDOCRINOL, V136, P167, DOI 10.1677/joe.0.1360167; CUNNINGHAM SK, 1983, ARCH INTERN MED, V143, P2276, DOI 10.1001/archinte.143.12.2276; DAIDOH H, 1995, CLIN ENDOCRINOL, V43, P311, DOI 10.1111/j.1365-2265.1995.tb02037.x; Davis TME, 1997, J CLIN ENDOCR METAB, V82, P3029, DOI 10.1210/jc.82.9.3029; Dickstein G, 1998, J CLIN ENDOCR METAB, V83, P4531, DOI 10.1210/jc.83.12.4531; DICKSTEIN G, 1991, J CLIN ENDOCR METAB, V72, P773, DOI 10.1210/jcem-72-4-773; Dickstein G, 1997, ENDOCRINOLOGIST, V7, P285, DOI 10.1097/00019616-199707050-00002; DLUHY RG, 1974, ANN INTERN MED, V80, P693, DOI 10.7326/0003-4819-80-6-693; DONALD RA, 1993, CLIN ENDOCRINOL, V38, P609, DOI 10.1111/j.1365-2265.1993.tb02142.x; ElDeiry SS, 1997, J CLIN ENDOCR METAB, V82, P856, DOI 10.1210/jc.82.3.856; Erturk E, 1998, J CLIN ENDOCR METAB, V83, P2350, DOI 10.1210/jc.83.7.2350; FIAD TM, 1994, CLIN ENDOCRINOL, V40, P603, DOI 10.1111/j.1365-2265.1994.tb03011.x; FINDLING JW, 1994, J CLIN ENDOCR METAB, V79, P1091, DOI 10.1210/jc.79.4.1091; FINLAY WEI, 1982, LANCET, V1, P1414; FISH HR, 1986, METABOLISM, V35, P763, DOI 10.1016/0026-0495(86)90245-3; Gandhi P G, 2002, J Postgrad Med, V48, P280; Gonzalez-Gonzalez JG, 1998, J ENDOCRINOL, V159, P275, DOI 10.1677/joe.0.1590275; GRAYBEAL ML, 1985, ACTA ENDOCRINOL-COP, V108, P401, DOI 10.1530/acta.0.1080401; GREIG WR, 1966, J ENDOCRINOL, V34, P411, DOI 10.1677/joe.0.0340411; GREIG WR, 1969, POSTGRAD MED J, V45, P307, DOI 10.1136/pgmj.45.523.307; GRINSPOON SK, 1994, J CLIN ENDOCR METAB, V79, P923, DOI 10.1210/jc.79.4.923; HARRIS MJ, 1990, SURG GYNECOL OBSTET, V170, P513; HARTZBAND PI, 1988, J ENDOCRINOL INVEST, V11, P769, DOI 10.1007/BF03350221; Holm Ingrid A., 1995, P45; Hurel SJ, 1996, CLIN ENDOCRINOL, V44, P141, DOI 10.1046/j.1365-2265.1996.555381.x; JACKSON RS, 1994, ANN CLIN BIOCHEM, V31, P46, DOI 10.1177/000456329403100108; JASANI MK, 1967, Q J MED, V36, P261; JURNEY TH, 1987, CHEST, V92, P292, DOI 10.1378/chest.92.2.292; KANE KF, 1995, QJM-MON J ASSOC PHYS, V88, P263; KEHLET H, 1976, BRIT MED J, V1, P249, DOI 10.1136/bmj.1.6004.249; KEHLET H, 1973, BRIT J ANAESTH, V45, P1043, DOI 10.1093/bja/45.10.1043; KEHLET H, 1973, BRIT MED J, V2, P147, DOI 10.1136/bmj.2.5859.147; KETCHUM CH, 1984, J CLIN ENDOCR METAB, V58, P1166, DOI 10.1210/jcem-58-6-1166; KIDESS AI, 1993, MAYO CLIN PROC, V68, P435, DOI 10.1016/S0025-6196(12)60188-8; KONG MF, 1994, CLIN ENDOCRINOL, V41, P757, DOI 10.1111/j.1365-2265.1994.tb02790.x; Kong MF, 1999, J CLIN ENDOCR METAB, V84, P4295, DOI 10.1210/jc.84.11.4295; Kong WM, 1999, J CLIN ENDOCR METAB, V84, P3093, DOI 10.1210/jc.84.9.3093; LANDON J, 1967, LANCET, V2, P697; Laureti S, 1999, J CLIN ENDOCR METAB, V84, P1762, DOI 10.1210/jc.84.5.1762; Laureti S, 2000, CLIN ENDOCRINOL, V53, P107, DOI 10.1046/j.1365-2265.2000.01050.x; LINDHOLM J, 1978, J CLIN ENDOCR METAB, V47, P272, DOI 10.1210/jcem-47-2-272; LINDHOLM J, 1987, CLIN ENDOCRINOL, V26, P53, DOI 10.1111/j.1365-2265.1987.tb03638.x; LITTENBERG B, 1993, MED DECIS MAKING, V13, P313, DOI 10.1177/0272989X9301300408; Mayenknecht J, 1998, J CLIN ENDOCR METAB, V83, P1558, DOI 10.1210/jc.83.5.1558; MCGILL PE, 1967, ANN RHEUM DIS, V26, P123, DOI 10.1136/ard.26.2.123; MCKEE JI, 1983, LANCET, V1, P484; MELBY JC, 1958, J CLIN INVEST, V37, P1791, DOI 10.1172/JCI103772; Metz CE, 1998, MED DECIS MAKING, V18, P110, DOI 10.1177/0272989X9801800118; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; Mukherjee JJ, 1997, CLIN ENDOCRINOL, V47, P51, DOI 10.1046/j.1365-2265.1997.2151035.x; NAITO Y, 1991, J CLIN ENDOCR METAB, V73, P111, DOI 10.1210/jcem-73-1-111; NELSON JC, 1978, AM J MED SCI, V275, P165, DOI 10.1097/00000441-197803000-00006; Nye EJ, 1999, ENDOCRINOLOGIST, V9, P161, DOI 10.1097/00019616-199905000-00003; Nye EJ, 2001, CLIN ENDOCRINOL, V55, P625, DOI 10.1046/j.1365-2265.2001.01389.x; Oelkers W, 1999, J CLIN ENDOCR METAB, V84, P2973, DOI 10.1210/jc.84.8.2973; OELKERS W, 1992, J CLIN ENDOCR METAB, V75, P259, DOI 10.1210/jc.75.1.259; Oelkers W, 1998, EUR J ENDOCRINOL, V139, P567, DOI 10.1530/eje.0.1390567; Orme SM, 1996, CLIN ENDOCRINOL, V45, P135, DOI 10.1046/j.1365-2265.1996.d01-1562.x; ORTH DN, 1992, ENDOCR REV, V13, P164, DOI 10.1210/er.13.2.164; PATEL SR, 1991, CLIN ENDOCRINOL, V35, P259, DOI 10.1111/j.1365-2265.1991.tb03532.x; Rasmuson S, 1996, CLIN ENDOCRINOL, V44, P151, DOI 10.1046/j.1365-2265.1996.600482.x; REINCKE M, 1993, J CLIN ENDOCR METAB, V77, P151, DOI 10.1210/jc.77.1.151; Rivers EP, 2001, CHEST, V119, P889, DOI 10.1378/chest.119.3.889; ROTHWELL PM, 1991, LANCET, V337, P582, DOI 10.1016/0140-6736(91)91641-7; SCHEIN RMH, 1990, CRIT CARE MED, V18, P259, DOI 10.1097/00003246-199003000-00002; SCHLAGHECKE R, 1992, NEW ENGL J MED, V326, P226, DOI 10.1056/NEJM199201233260403; SIBBALD WJ, 1977, ANN SURG, V186, P29, DOI 10.1097/00000658-197707000-00005; SONI A, 1995, AM J MED, V98, P266, DOI 10.1016/S0002-9343(99)80373-8; Soule S, 1999, CLIN ENDOCRINOL, V50, P115, DOI 10.1046/j.1365-2265.1999.00625.x; Soule S, 2000, CLIN ENDOCRINOL, V53, P221, DOI 10.1046/j.1365-2265.2000.01057.x; SPECKART PF, 1971, ARCH INTERN MED, V128, P761, DOI 10.1001/archinte.128.5.761; STEWART PM, 1988, LANCET, V1, P1208; Streeten DHP, 1999, J CLIN ENDOCR METAB, V84, P835, DOI 10.1210/jc.84.3.835; STREETEN DHP, 1984, ENDOCR REV, V5, P371, DOI 10.1210/edrv-5-3-371; Suliman AM, 2002, CLIN ENDOCRINOL, V56, P533, DOI 10.1046/j.1365-2265.2002.01509.x; Talwar V, 1998, QJM-MON J ASSOC PHYS, V91, P285, DOI 10.1093/qjmed/91.4.285; TAYLOR AL, 1988, NEW ENGL J MED, V319, P213, DOI 10.1056/NEJM198807283190405; Thaler LM, 1998, J CLIN ENDOCR METAB, V83, P2726, DOI 10.1210/jc.83.8.2726; Tordjman K, 2000, CLIN ENDOCRINOL, V52, P633, DOI 10.1046/j.1365-2265.2000.00984.x; VERMES I, 1995, J CLIN ENDOCR METAB, V80, P1238, DOI 10.1210/jc.80.4.1238; Vestergaard P, 1997, HORM METAB RES, V29, P106, DOI 10.1055/s-2007-979000; VOERMAN HJ, 1992, METABOLISM, V41, P934, DOI 10.1016/0026-0495(92)90117-S; WADE CE, 1988, J CLIN ENDOCR METAB, V67, P223, DOI 10.1210/jcem-67-2-223; Walter SD, 2002, STAT MED, V21, P1237, DOI 10.1002/sim.1099; Weintrob N, 1998, J CLIN ENDOCR METAB, V83, P88, DOI 10.1210/jc.83.1.88; Willis AC, 1997, POSTGRAD MED J, V73, P286, DOI 10.1136/pgmj.73.859.286; WOOD JB, 1965, LANCET, V1, P243; Zarkovic M, 1999, J CLIN ENDOCR METAB, V84, P3170, DOI 10.1210/jc.84.9.3170	109	284	298	0	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2003	139	3					194	204		10.7326/0003-4819-139-3-200308050-00009	http://dx.doi.org/10.7326/0003-4819-139-3-200308050-00009			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707RH	12899587				2022-12-28	WOS:000184523300005
J	Norvig, P				Norvig, P			PowerPoint: shot with its own bullets	LANCET			English	Editorial Material									NASA, Washington, DC 20546 USA	National Aeronautics & Space Administration (NASA)			Norvig, Peter/ABF-7770-2021					KELLER J, 2003, CHICAGO TRIBUNE 0122; NORVIG P, 1999, COMMUNICATION    JAN; Tufte E. R., 2003, COGNITIVE STYLE POWE; WADE M, 2002, SPACEDAILY      0626; [No title captured]	5	18	18	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 2	2003	362	9381					343	344		10.1016/S0140-6736(03)14056-1	http://dx.doi.org/10.1016/S0140-6736(03)14056-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707FB	12907004				2022-12-28	WOS:000184498700005
J	Lee, JW				Lee, JW			Child survival: a global health challenge	LANCET			English	Editorial Material									WHO, CH-1211 Geneva 27, Switzerland	World Health Organization	Lee, JW (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.	Leej@who.int						Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Claeson M, 2003, LANCET, V362, P323, DOI 10.1016/S0140-6736(03)13977-3	2	31	33	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2003	362	9380					262	262		10.1016/S0140-6736(03)14006-8	http://dx.doi.org/10.1016/S0140-6736(03)14006-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705UL	12892954				2022-12-28	WOS:000184413400006
J	Li, Z; Hannigan, M; Mo, ZC; Liu, B; Lu, W; Wu, Y; Smrcka, AV; Wu, GQ; Li, L; Liu, MY; Huang, CK; Wu, DQ				Li, Z; Hannigan, M; Mo, ZC; Liu, B; Lu, W; Wu, Y; Smrcka, AV; Wu, GQ; Li, L; Liu, MY; Huang, CK; Wu, DQ			Directional sensing requires G beta gamma-mediated PAK1 and PIX alpha-dependent activation of cdc42	CELL			English	Article							NUCLEOTIDE EXCHANGE FACTOR; ADAPTER PROTEIN NCK; P21-ACTIVATED KINASES; SIGNALING PATHWAYS; MEMBRANE LOCALIZATION; HUMAN NEUTROPHILS; MAMMALIAN-CELLS; LIPID PRODUCTS; RHO-GTPASES; CHEMOTAXIS	Efficient chemotaxis requires directional sensing and cell polarization. We describe a signaling mechanism involving Gbetagamma, PAK-associated guanine nucleotide exchange factor (PIXalpha), Cdc42, and p21-activated kinase (PAK) 1. This pathway is utilized by chemoattractants to regulate directional sensing and directional migration of myeloid cells. Our results suggest that Gbetagamma binds PAKI and, via PAK-associated PIXa, activates Cdc42, which in turn activates PAK1. Thus, in this pathway, PAKII is not only an effector for Cdc42, but it also functions as a scaffold protein required for Cdc42 activation. This Gbetagamma-PAK1/PIXalpha/Cdc42 pathway is essential for the localization of F-actin formation to the leading edge, the exclusion of PTEN from the leading edge, directional sensing, and the persistent directional migration of chemotactic leukocytes. Although ligand-induced production Of PIP3 is not required for activation of this pathway, PIP3 appears to localize the activation of Cdc42 by the pathway.	Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA; Texas A&M Univ, Syst Hlth Sci Ctr, Alkek Inst Biosci & Technol, Dept Med Biochem & Genet, Houston, TX 77030 USA; Univ Connecticut, Ctr Hlth, Dept Pathol, Farmington, CT 06030 USA; Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; Vanderbilt Univ, Dept Med Med Genet, Nashville, TN 37232 USA; Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China	University of Connecticut; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Connecticut; University of Rochester; Vanderbilt University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wu, DQ (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA.	dwu@neuron.uchc.edu		Liu, Mingyao/0000-0001-7339-5048				Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bokoch GM, 2000, IMMUNOL RES, V21, P139, DOI 10.1385/IR:21:2-3:139; Bourne HR, 2002, NATURE, V419, P21, DOI 10.1038/419021a; Butty AC, 1998, SCIENCE, V282, P1511, DOI 10.1126/science.282.5393.1511; Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X; Chung CY, 1999, J CELL BIOL, V147, P559, DOI 10.1083/jcb.147.3.559; Daniels RH, 1999, TRENDS BIOCHEM SCI, V24, P350, DOI 10.1016/S0968-0004(99)01442-5; Daniels RH, 1999, J BIOL CHEM, V274, P6047, DOI 10.1074/jbc.274.10.6047; Dharmawardhane S, 1999, J LEUKOCYTE BIOL, V66, P521, DOI 10.1002/jlb.66.3.521; Erickson JW, 2001, CURR OPIN CELL BIOL, V13, P153, DOI 10.1016/S0955-0674(00)00192-7; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feng QY, 2002, J BIOL CHEM, V277, P5644, DOI 10.1074/jbc.M107704200; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Galisteo ML, 1996, J BIOL CHEM, V271, P20997, DOI 10.1074/jbc.271.35.20997; Hannigan M, 2002, P NATL ACAD SCI USA, V99, P3603, DOI 10.1073/pnas.052010699; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; HUANG CK, 1991, J LEUKOCYTE BIOL, V49, P158, DOI 10.1002/jlb.49.2.158; Huang RY, 1998, MOL CELL BIOL, V18, P7130, DOI 10.1128/MCB.18.12.7130; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; Kiosses WB, 1999, J CELL BIOL, V147, P831, DOI 10.1083/jcb.147.4.831; KNAUS UG, 1995, SCIENCE, V269, P221, DOI 10.1126/science.7618083; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; Leeuw T, 1998, NATURE, V391, P191, DOI 10.1038/34448; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Lim L, 1996, EUR J BIOCHEM, V242, P171, DOI 10.1111/j.1432-1033.1996.0171r.x; Lu WG, 1999, ONCOGENE, V18, P797, DOI 10.1038/sj.onc.1202361; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Nern A, 1999, J CELL BIOL, V144, P1187, DOI 10.1083/jcb.144.6.1187; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Rudolph MG, 1998, J BIOL CHEM, V273, P18067, DOI 10.1074/jbc.273.29.18067; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Wang J, 1999, J BIOL CHEM, V274, P31641, DOI 10.1074/jbc.274.44.31641; Wang YJ, 2001, CANCER LETT, V164, P69, DOI 10.1016/S0304-3835(00)00723-0; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153; ZIGMOND SH, 1988, METHOD ENZYMOL, V162, P65	50	319	322	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 25	2003	114	2					215	227		10.1016/S0092-8674(03)00559-2	http://dx.doi.org/10.1016/S0092-8674(03)00559-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887923	Bronze			2022-12-28	WOS:000184378700011
J	Rolff, J; Siva-Jothy, MT				Rolff, J; Siva-Jothy, MT			Invertebrate ecological immunology	SCIENCE			English	Review							LARVAL COMPETITIVE ABILITY; IMMUNE-RESPONSE; TRADE-OFFS; PARASITOID RESISTANCE; EVOLUTIONARY ECOLOGY; DISEASE RESISTANCE; MANDUCA-SEXTA; DROSOPHILA; DEFENSE; HOST	Ecological immunology is a rapidly expanding field that examines the causes and consequences of variation in immune function in the context of evolution and of ecology. Millions of invertebrate species rely solely on innate immunity, compared with only 45,000 vertebrate species that rely additionally on an acquired immune system. Despite this difference in diversity, most studies of ecological immunology focus on vertebrates. Here we review recent progress derived largely from the mechanistic analysis of invertebrate innate immunity. Using this empirical base, we pose general questions in areas that are of central importance for the development of ecological immunology.	Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Rolff, J (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	jor@sheffield.ac.uk		Rolff, Jens/0000-0002-1529-5409				Adamo SA, 2000, CAN J ZOOL, V78, P1580, DOI 10.1139/cjz-78-9-1580; Agrawal A, 2002, EVOL ECOL RES, V4, P79; Boots M, 1999, J THEOR BIOL, V201, P13, DOI 10.1006/jtbi.1999.1009; Brommer JE, 2000, BIOL REV, V75, P377, DOI 10.1017/S000632310000551X; Carius HJ, 2001, EVOLUTION, V55, P1136, DOI 10.1111/j.0014-3820.2001.tb00633.x; Christe P, 2003, ECOL LETT, V6, P19, DOI 10.1046/j.1461-0248.2003.00395.x; Coltman DW, 2001, PARASITOLOGY, V122, P571, DOI 10.1017/S0031182001007570; Coustau C, 2000, TRENDS ECOL EVOL, V15, P378, DOI 10.1016/S0169-5347(00)01929-7; Feder D, 1997, J INSECT PHYSIOL, V43, P513, DOI 10.1016/S0022-1910(97)00010-3; Fellowes MDE, 1999, EVOLUTION, V53, P966, DOI 10.2307/2640737; Fellowes MDE, 2000, HEREDITY, V84, P1, DOI 10.1046/j.1365-2540.2000.00685.x; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Frank SA, 2000, J THEOR BIOL, V202, P283, DOI 10.1006/jtbi.1999.1054; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Guillemaud T, 1998, EVOLUTION, V52, P443, DOI [10.2307/2411080, 10.1111/j.1558-5646.1998.tb01644.x]; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Hazel WN, 2002, EVOLUTION, V56, P342, DOI 10.1111/j.0014-3820.2002.tb01344.x; HIRUMA K, 1993, INT J INSECT MORPHOL, V22, P103, DOI 10.1016/0020-7322(93)90003-J; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Hufbauer RA, 1999, EVOLUTION, V53, P1435, DOI 10.1111/j.1558-5646.1999.tb05408.x; Hurst GDD, 2003, INSECT MOL BIOL, V12, P93, DOI 10.1046/j.1365-2583.2003.00380.x; Hurst LD, 1999, CURR BIOL, V9, P747, DOI 10.1016/S0960-9822(99)80334-0; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Khafagi WE, 2001, J INSECT PHYSIOL, V47, P1249, DOI 10.1016/S0022-1910(01)00110-X; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; Kraaijeveld AR, 2001, P ROY SOC B-BIOL SCI, V268, P259, DOI 10.1098/rspb.2000.1354; Kurtz J, 2002, MICROSC RES TECHNIQ, V57, P456, DOI 10.1002/jemt.10099; Kurtz J, 2002, EVOL ECOL RES, V4, P431; MCKENZIE JA, 1994, TRENDS ECOL EVOL, V9, P166, DOI 10.1016/0169-5347(94)90079-5; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; Moret Y, 2003, OIKOS, V102, P213, DOI 10.1034/j.1600-0706.2003.12496.x; ORR HA, 1992, AM NAT, V140, P725, DOI 10.1086/285437; Poirie M, 2000, P ROY SOC B-BIOL SCI, V267, P1417, DOI 10.1098/rspb.2000.1158; Poulsen M, 2002, BEHAV ECOL SOCIOBIOL, V52, P151, DOI 10.1007/s00265-002-0489-8; Raberg L, 2002, P ROY SOC B-BIOL SCI, V269, P817, DOI 10.1098/rspb.2001.1953; Rigby MC, 2000, P ROY SOC B-BIOL SCI, V267, P171, DOI 10.1098/rspb.2000.0983; Rolff J, 2002, P ROY SOC B-BIOL SCI, V269, P867, DOI 10.1098/rspb.2002.1959; Rolff J, 2002, P NATL ACAD SCI USA, V99, P9916, DOI 10.1073/pnas.152271999; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; Schmid-Hempel P, 2003, P ROY SOC B-BIOL SCI, V270, P357, DOI 10.1098/rspb.2002.2265; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Shudo E, 2001, J THEOR BIOL, V209, P233, DOI 10.1006/jtbi.2000.2259; Sorrentino RP, 2002, DEV BIOL, V243, P65, DOI 10.1006/dbio.2001.0542; Stearns S.C., 1992, pi; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; Sugumaran M, 2000, ARCH BIOCHEM BIOPHYS, V379, P252, DOI 10.1006/abbi.2000.1884; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Wilson K, 2002, P NATL ACAD SCI USA, V99, P5471, DOI 10.1073/pnas.082461999; Wilson K, 1998, ECOL ENTOMOL, V23, P100, DOI 10.1046/j.1365-2311.1998.00107.x; Wilson K, 2001, ECOL LETT, V4, P637, DOI 10.1046/j.1461-0248.2001.00279.x; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131	54	381	403	5	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2003	301	5632					472	475		10.1126/science.1080623	http://dx.doi.org/10.1126/science.1080623			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12881560				2022-12-28	WOS:000184340500030
J	Xu, JS; Wang, F; Van Keymeulen, A; Herzmark, P; Straight, A; Kelly, K; Takuwa, Y; Sugimoto, N; Mitchison, T; Bourne, HR				Xu, JS; Wang, F; Van Keymeulen, A; Herzmark, P; Straight, A; Kelly, K; Takuwa, Y; Sugimoto, N; Mitchison, T; Bourne, HR			Divergent signals and cytoskeletal assemblies regulate self-organizing polarity in neutrophils	CELL			English	Article							BIOLOGICAL PATTERN FORMATION; BINDING PROTEIN-RHO; CELL POLARITY; LYSOPHOSPHATIDIC ACID; FOCAL ADHESIONS; CULTURED-CELLS; DISTINCT ROLES; LEADING-EDGE; P115 RHOGEF; CHEMOTAXIS	Like neutrophilic leukocytes, differentiated HL-60 cells respond to chemoattractant by adopting a polarized morphology, with F-actin in a protruding pseudopod at the leading edge and contractile actin-myosin complexes at the back and sides. Experiments with pharmacological inhibitors, toxins, and mutant proteins show that this polarity depends on divergent, opposing "frontness" and "backness" signals generated by different receptor-activated trimeric G proteins. Frontness depends upon Gi-mediated production of X-phosphoinositol lipids (PI3Ps), the activated form of Rac, a small GTPase, and F-actin. G12 and G13 trigger backness signals, including activation of a second GTPase (Rho), a Rho-dependent kinase, and myosin If. Functional incompatibility causes the two resulting actin assemblies to aggregate into separate domains, making the leading edge more sensitive to attractant than the back. The latter effect explains both the neutrophil's ability to polarize in uniform concentrations of chemoattractant and its response to reversal of an attractant gradient by performing a U-turn.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Free Univ Brussels, Inst Rech Interdisciplinaire Biol Humaine & Mol, B-1070 Brussels, Belgium; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; NCI, Ctr Canc Res, Cell & Canc Biol Branch, NIH, Bethesda, MD 20892 USA; Kanazawa Univ, Dept Physiol, Kanazawa, Ishikawa 9208640, Japan	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Kanazawa University	Bourne, HR (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	bourne@cmp.ucsf.edu	Wang, Fei/A-7968-2013; Sugimoto, Naotoshi/C-4739-2015	Sugimoto, Naotoshi/0000-0003-1995-5002; Straight, Aaron/0000-0001-5885-7881	NHLBI NIH HHS [HL07713] Funding Source: Medline; NIGMS NIH HHS [GM 27810] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alblas J, 2001, MOL BIOL CELL, V12, P2137, DOI 10.1091/mbc.12.7.2137; Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Cassimeris L, 1990, Semin Cell Biol, V1, P125; Chung CY, 1999, J CELL BIOL, V147, P559, DOI 10.1083/jcb.147.3.559; Chung CY, 2001, MOL CELL, V7, P937, DOI 10.1016/S1097-2765(01)00247-7; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; DOWNEY GP, 1994, CURR OPIN IMMUNOL, V6, P113, DOI 10.1016/0952-7915(94)90042-6; Eddy RJ, 2000, J CELL SCI, V113, P1287; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Firtel RA, 2000, CURR OPIN GENET DEV, V10, P421, DOI 10.1016/S0959-437X(00)00107-6; Fishburn CS, 2000, P NATL ACAD SCI USA, V97, P1085, DOI 10.1073/pnas.97.3.1085; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Gohla A, 1998, J BIOL CHEM, V273, P4653, DOI 10.1074/jbc.273.8.4653; GOLDMAN DW, 1985, J EXP MED, V162, P145, DOI 10.1084/jem.162.1.145; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hauert AB, 2002, INT J BIOCHEM CELL B, V34, P838, DOI 10.1016/S1357-2725(02)00010-9; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Just I, 1996, J BIOL CHEM, V271, P10149, DOI 10.1074/jbc.271.17.10149; Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105; KELLER HU, 1993, CELL MOTIL CYTOSKEL, V25, P10, DOI 10.1002/cm.970250103; Kirschner M, 2000, CELL, V100, P79, DOI 10.1016/S0092-8674(00)81685-2; KOLEGA J, 1986, J CELL BIOL, V102, P1400, DOI 10.1083/jcb.102.4.1400; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; MAUPIN P, 1994, J CELL SCI, V107, P3077; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; MEINHARDT H, 1974, J CELL SCI, V15, P321; Niggli V, 2000, FEBS LETT, V473, P217, DOI 10.1016/S0014-5793(00)01534-9; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2001, J CELL SCI, V114, P2713; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Sah VP, 1996, J BIOL CHEM, V271, P31185, DOI 10.1074/jbc.271.49.31185; Sehr P, 1998, BIOCHEMISTRY-US, V37, P5296, DOI 10.1021/bi972592c; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Seveau S, 2001, MOL BIOL CELL, V12, P3550, DOI 10.1091/mbc.12.11.3550; Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000; SHEFCYK J, 1985, BIOCHEM BIOPH RES CO, V126, P1174, DOI 10.1016/0006-291X(85)90309-2; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sugimoto N, 2003, MOL CELL BIOL, V23, P1534, DOI 10.1128/MCB.23.5.1534-1545.2003; Suzuki N, 2003, P NATL ACAD SCI USA, V100, P733, DOI 10.1073/pnas.0234057100; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Verkhovsky AB, 1999, CURR BIOL, V9, P11, DOI 10.1016/S0960-9822(99)80042-6; VLAHOS CJ, 1995, J IMMUNOL, V154, P2413; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Ward Y, 2002, J CELL BIOL, V157, P291, DOI 10.1083/jcb.200111026; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; WESSELS D, 1988, DEV BIOL, V128, P164, DOI 10.1016/0012-1606(88)90279-5; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; ZIGMOND SH, 1981, J CELL BIOL, V89, P585, DOI 10.1083/jcb.89.3.585	67	542	550	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 25	2003	114	2					201	214		10.1016/S0092-8674(03)00555-5	http://dx.doi.org/10.1016/S0092-8674(03)00555-5			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887922	Bronze			2022-12-28	WOS:000184378700010
J	Steel, WH; Walker, RA				Steel, WH; Walker, RA			Measuring dipolar width across liquid-liquid interfaces with 'molecular rulers'	NATURE			English	Article							2ND-HARMONIC GENERATION; WATER-VAPOR; POLARITY; SURFACTANT; MONOLAYERS; REFLECTIVITY	Molecular dynamics simulations have previously described how the physical properties across immiscible liquid-liquid interfaces should converge from aqueous to organic limits(1-5), but these predictions have largely gone untested, owing to difficulties associated with probing buried interfaces. X-ray and neutron scattering experiments have created detailed pictures of molecular structure at these boundaries(6-8), but such scattering studies cannot probe how surface-altered solvent structures affect interfacial solvating properties. Given that surface-mediated solvent properties control interfacial solute concentrations and reactivities, identifying the characteristic dimensions of interfacial solvation is essential for formulating predictive models of solution phase surface chemistry. Here we use specially synthesized solvatochromic surfactants that act as 'molecular rulers'(9) and resonance-enhanced second-harmonic generation(10-13) to measure the dipolar width of weakly and strongly associating liquid-liquid interfaces. Dipolar width describes the distance required for a dielectric environment to change from one phase to another. Our results show that polarity converges to a nonpolar limit on subnanometre length scales across a water-cyclohexane interface. However, polarity across the strongly associating, water-1-octanol interface is dominated by a nonpolar, alkane-like region. These data call into question the use of continuum descriptions of liquids to characterize interfacial solvation, and demonstrate that interfacial environments can vary in a non-additive manner from bulk solution limits.	Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Walker, RA (corresponding author), Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.	rw158@umail.umd.edu						Antoine R, 1997, J CHEM SOC FARADAY T, V93, P3833, DOI 10.1039/a703711b; BARTON AFM, 1984, IUPAC SOLUBILITY DAT; Benjamin I, 1998, J PHYS CHEM A, V102, P9500, DOI 10.1021/jp982058u; Chang TM, 1996, J CHEM PHYS, V104, P6772, DOI 10.1063/1.471344; Chipot C, 1997, J PHYS CHEM B, V101, P782, DOI 10.1021/jp961513o; CORN RM, 1994, CHEM REV, V94, P107, DOI 10.1021/cr00025a004; da Rocha SRP, 2002, J PHYS CHEM B, V106, P13250, DOI 10.1021/jp021485b; Eisenthal KB, 1996, J PHYS CHEM-US, V100, P12997, DOI 10.1021/jp9603187; Ishizaka S, 2001, ANAL CHEM, V73, P2421, DOI 10.1021/ac001124x; LAURENCE C, 1994, J PHYS CHEM-US, V98, P5807, DOI 10.1021/j100074a003; LEE LT, 1994, PHYSICA B, V198, P83, DOI 10.1016/0921-4526(94)90133-3; Li ZX, 1998, J PHYS CHEM B, V102, P9473, DOI 10.1021/jp9821432; Penfold J, 2002, PHYS CHEM CHEM PHYS, V4, P2648, DOI 10.1039/b108698g; Penfold J, 1997, J CHEM SOC FARADAY T, V93, P3899, DOI 10.1039/a702836i; Sangster J.M., 1997, WILEY S SOL CHEM; Schweighofer KJ, 1997, J PHYS CHEM B, V101, P3793, DOI 10.1021/jp963460g; Senapati S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.176101; SHEN YR, 1989, NATURE, V337, P519, DOI 10.1038/337519a0; Steel WH, 2003, J AM CHEM SOC, V125, P1132, DOI 10.1021/ja028468k; Steel WH, 2002, J AM CHEM SOC, V124, P4824, DOI 10.1021/ja012457u; Tikhonov AM, 2000, J PHYS CHEM B, V104, P6336, DOI 10.1021/jp001377u; Tikhonov AM, 2003, J PHYS CHEM B, V107, P3344, DOI 10.1021/jp0271817; TSONOPOULOS C, 1983, AM I CHEM J, V31, P376; Vieceli J, 2002, J PHYS CHEM B, V106, P7898, DOI 10.1021/jp020068w; Wang HF, 1997, J PHYS CHEM A, V101, P713, DOI 10.1021/jp962074w; Wang HF, 1998, J PHYS CHEM B, V102, P4927, DOI 10.1021/jp9806563; Zhang XY, 2001, LANGMUIR, V17, P4486, DOI 10.1021/la0104828; Zhang ZJ, 1999, J CHEM PHYS, V110, P7421, DOI 10.1063/1.478644; Zhuang X, 1999, PHYS REV B, V59, P12632, DOI 10.1103/PhysRevB.59.12632	29	130	132	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2003	424	6946					296	299		10.1038/nature01791	http://dx.doi.org/10.1038/nature01791			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867977				2022-12-28	WOS:000184183900037
J	Deb, A; Tefferi, A				Deb, A; Tefferi, A			Systemic mastocytosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA	Mayo Clinic	Deb, A (corresponding author), Mayo Clin & Mayo Fdn, 200 1st St SW, Rochester, MN 55905 USA.								0	3	3	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2003	349	7					E7	E7		10.1056/ENEJMicm010831	http://dx.doi.org/10.1056/ENEJMicm010831			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711FL	12917319				2022-12-28	WOS:000184728900008
J	Conaway, RC; Kong, SE; Conaway, JW				Conaway, RC; Kong, SE; Conaway, JW			TFIIS and GreB: Two like-minded transcription elongation factors with sticky fingers	CELL			English	Editorial Material							RNA-POLYMERASE-II; RESOLUTION	How the structurally distinct transcription factor TFIIS from eukaryotes and its bacterial counterpart GreB act to convert their cognate RNA polymerases into ribonucleases has been a longstanding question. Now, two new structures of these factors bound to their respective RNA polymerases (Opalka et al. and Kettenberger et al. [this issue of Cell]) suggest how they accomplish this feat.	Stowers Inst Med Res, Kansas City, MO 64110 USA; Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Conaway, RC (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.			Conaway, Joan/0000-0002-2786-0663				Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Opalka N, 2003, CELL, V114, P335, DOI 10.1016/S0092-8674(03)00600-7; RUDD MD, 1994, P NATL ACAD SCI USA, V91, P8057, DOI 10.1073/pnas.91.17.8057; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	10	8	8	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 8	2003	114	3					272	274		10.1016/S0092-8674(03)00607-X	http://dx.doi.org/10.1016/S0092-8674(03)00607-X			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914690	Bronze			2022-12-28	WOS:000184679200002
J	Xu, XZS; Sternberg, PW				Xu, XZS; Sternberg, PW			A C-elegans sperm TRP protein required for sperm-egg interactions during fertilization	CELL			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; CA2+ ENTRY; CALCIUM-ENTRY; MOUSE SPERM; CHANNELS; GENE; FUSION; MICE; EXPRESSION; DIFFERENTIATION	Fertilization, a critical step in animal reproduction, is triggered by a series of specialized sperm-egg interactions. However, the molecular mechanisms underlying fertilization are not well understood. Here, we identify a sperm-enriched C. elegans TRPC homolog, TRP-3. Mutations in trp-3 lead to sterility in both hermaphrodites and males due to a defect in their sperm. trp-3 mutant sperm are motile, but fail to fertilize oocytes after gamete contact. TRP-3 is initially localized in intracellular vesicles, and then translocates to the plasma membrane during sperm activation. This translocation coincides with a marked increase in store-operated calcium entry, providing an in vivo mechanism for the regulation of TRP-3 activity. As C. elegans oocytes lack egg coats, our data suggest that some TRPC family channels might function to mediate calcium influx during sperm-egg plasma membrane interactions leading to fertilization.	CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Sternberg, PW (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.			Sternberg, Paul/0000-0002-7699-0173				Achanzar WE, 1997, J CELL SCI, V110, P1073; Bahner M, 2002, NEURON, V34, P83, DOI 10.1016/S0896-6273(02)00630-X; Bernheim L, 2002, NEWS PHYSIOL SCI, V17, P22; Browning H, 1996, DEVELOPMENT, V122, P391; Castellano LE, 2003, FEBS LETT, V541, P69, DOI 10.1016/S0014-5793(03)00305-3; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; Kelly WG, 1998, DEVELOPMENT, V125, P2451; L'Hernault SW, 1997, C ELEGANS, P271; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; LHERNAULT SW, 1988, GENETICS, V120, P435; Machaca K, 1996, DEV BIOL, V176, P1, DOI 10.1006/dbio.1996.9999; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; O'Toole CMB, 2000, MOL BIOL CELL, V11, P1571, DOI 10.1091/mbc.11.5.1571; OKAMOTO H, 1985, J NEUROSCI, V5, P643; Park JY, 2002, BIOCHEM BIOPH RES CO, V290, P1176, DOI 10.1006/bbrc.2001.6323; Primakoff P, 2002, SCIENCE, V296, P2183, DOI 10.1126/science.1072029; Putney JW, 2001, J CELL SCI, V114, P2223; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; SHAINBERG A, 1969, EXP CELL RES, V58, P163, DOI 10.1016/0014-4827(69)90127-X; Singson A, 1998, CELL, V93, P71, DOI 10.1016/S0092-8674(00)81147-2; Singson A, 2001, DEV BIOL, V230, P101, DOI 10.1006/dbio.2000.0118; Singson A, 1999, GENETICS, V152, P201; SPENCE AM, 1990, CELL, V60, P981, DOI 10.1016/0092-8674(90)90346-G; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; TETI A, 1993, AM J PHYSIOL, V265, pC113, DOI 10.1152/ajpcell.1993.265.1.C113; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; Wassarman PM, 1999, CELL, V96, P175, DOI 10.1016/S0092-8674(00)80558-9; Yanagimachi R., 1994, P189; YANAGIMACHI R, 1978, BIOL REPROD, V19, P949, DOI 10.1095/biolreprod19.5.949; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7	41	94	106	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 8	2003	114	3					285	297		10.1016/S0092-8674(03)00565-8	http://dx.doi.org/10.1016/S0092-8674(03)00565-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914694	Bronze			2022-12-28	WOS:000184679200006
J	Kassutto, S; Wolf, MA				Kassutto, S; Wolf, MA			A wrinkle in time	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HENOCH-SCHONLEIN PURPURA; NEPHRITIS; ADULTS; CHILDREN; PATIENT		Beth Israel Deaconess Med Ctr, Dept Infect Dis, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Brigham & Womens Hosp, Dept Med Educ, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Wolf, MA (corresponding author), 75 Francis St, Boston, MA 02115 USA.							Bhullar N, 2002, ARCH INTERN MED, V162, P222, DOI 10.1001/archinte.162.2.222; Blanco R, 1997, ARTHRITIS RHEUM, V40, P859, DOI 10.1002/art.1780400513; Coppo R, 1997, NEPHROL DIAL TRANSPL, V12, P2277, DOI 10.1093/ndt/12.11.2277; GAMBOA F, 1995, ANN PHARMACOTHER, V29, P84, DOI 10.1177/106002809502900119; McCarthy R, 2001, ARCH DERMATOL, V137, P19; MIURA M, 1992, INTERNAL MED, V31, P232, DOI 10.2169/internalmedicine.31.232; Pertuiset E, 2000, SEMIN ARTHRITIS RHEU, V29, P360, DOI 10.1053/sarh.2000.6988; Pillebout E, 2002, J AM SOC NEPHROL, V13, P1271, DOI 10.1097/01.ASN.0000013883.99976.22; Pons R, 2001, NEFROLOGIA, V21, P209; Rieu P, 1999, ANN MED INTERNE, V150, P151; Rudiger JJ, 2002, DEUT MED WOCHENSCHR, V127, P1382, DOI 10.1055/s-2002-32350	11	2	3	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2003	349	6					597	601		10.1056/NEJMcps021630	http://dx.doi.org/10.1056/NEJMcps021630			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708JL	12904525				2022-12-28	WOS:000184563500012
J	Boter, H; van Delden, JJM; de Haan, RJ; Rinkel, GJE				Boter, H; van Delden, JJM; de Haan, RJ; Rinkel, GJE		Home Evaluation Stroke Induced Aid	Modified informed consent procedure: consent to postponed information	BRITISH MEDICAL JOURNAL			English	Article							MEDICAL-RESEARCH; STROKE; TRIALS	How do you obtain a valid assessment of subjective outcomes in a trial in which the participants cannot be blinded to the intervention? Bias is inevitable from unblinded patients, but trials that have not told patients about treatment in all arms have been heavily criticised. Asking participants to consent to postponed information could be a solution.	Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, NL-3508 GA Utrecht, Netherlands; Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1100 DD Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	Boter, H (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, POB 85500, NL-3508 GA Utrecht, Netherlands.							Clement S, 1999, BRIT MED J, V318, P736; de Craen A J, 2000, Ned Tijdschr Geneeskd, V144, P1301; Dennis M, 1997, BRIT MED J, V314, P1071, DOI 10.1136/bmj.314.7087.1071; Doyal L, 1998, BRIT MED J, V316, P1000, DOI 10.1136/bmj.316.7136.1000; Doyal L, 1997, BMJ-BRIT MED J, V314, P1107, DOI 10.1136/bmj.314.7087.1107; Lambert MF, 2000, J CLIN EPIDEMIOL, V53, P163, DOI 10.1016/S0895-4356(99)00146-8; POUND P, 1994, CLIN REHABIL, V8, P7, DOI DOI 10.1177/026921559400800102; Rodgers H, 1997, CLIN REHABIL, V11, P280, DOI 10.1177/026921559701100403; Smith R, 1998, BMJ-BRIT MED J, V316, P949, DOI 10.1136/bmj.316.7136.949; Smith R, 1997, BRIT MED J, V314, P1059, DOI 10.1136/bmj.314.7087.1059; Stott DJ, 1997, BRIT MED J, V315, P253; Tobias JS, 1997, BRIT MED J, V314, P1111, DOI 10.1136/bmj.314.7087.1111; Wyller TB, 1997, CLIN REHABIL, V11, P139, DOI 10.1177/026921559701100207; 1997, BMJ, V314, P1477; 1998, BMJ, V317, P947; 1997, BMJ, V315, P247	16	44	44	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 2	2003	327	7409					284	285		10.1136/bmj.327.7409.284	http://dx.doi.org/10.1136/bmj.327.7409.284			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708KP	12896945	Green Submitted, Green Published			2022-12-28	WOS:000184566300026
J	Quattrocchi, CC; Huang, C; Niu, S; Sheldon, M; Benhayon, D; Cartwright, J; Mosier, DR; Keller, F; D'Arcangelo, G				Quattrocchi, CC; Huang, C; Niu, S; Sheldon, M; Benhayon, D; Cartwright, J; Mosier, DR; Keller, F; D'Arcangelo, G			RETRACTED: Reelin promotes peripheral synapse elimination and maturation (Retracted Article. See vol 303, pg 1974, 2004)	SCIENCE			English	Article; Retracted Publication							NEUROMUSCULAR-JUNCTIONS; VLDL RECEPTOR; MOUSE; BRAIN; EXPRESSION; SCRAMBLER; THROMBIN; PATHWAY; PROTEIN; LACKING	Reelin is an extracellular protein that is crucial for layer formation in the embryonic brain. Here, we demonstrate that Reelin functions postnatally to regulate the development of the neuromuscular junction. Reelin is required for motor end-plate maturation and proper nerve-muscle connectivity, and it directly promotes synapse elimination. Unlike layer formation, neuromuscular junction development requires a function of Reelin that is not mediated by Disabled1 or very-low-density lipoprotein receptors and apolipoprotein E receptor 2 receptors but by a distinct mechanism involving its protease activity.	Cain Fdn Labs, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Univ Brescia, Program Neurosci, I-25123 Brescia, Italy; Div Hematol Oncol, Houston, TX 77030 USA; Texas Childrens Canc Ctr, Houston, TX 77030 USA; Univ Tennessee, Dept Anat & Neurobiol, Memphis, TN 38163 USA; Vet Adm Med Ctr, Houston, TX 77030 USA; Lab Dev Neurosci & Neural Plast, I-00155 Rome, Italy	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Brescia; Texas Children's Cancer Center; University of Tennessee System; University of Tennessee Health Science Center; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA)	D'Arcangelo, G (corresponding author), Cain Fdn Labs, Houston, TX 77030 USA.	gangelo@bcm.tmc.edu		D'Arcangelo, Gabriella/0000-0003-1575-1010; Quattrocchi, Carlo Cosimo/0000-0001-6823-7707; Keller, Flavio/0000-0002-6449-6960				Borrell V, 1999, J NEUROSCI, V19, P1345; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; deBergeyck V, 1997, MOL BRAIN RES, V50, P85, DOI 10.1016/S0169-328X(97)00166-6; Derer P, 2001, J COMP NEUROL, V440, P136, DOI 10.1002/cne.1375; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Liu WS, 2001, P NATL ACAD SCI USA, V98, P3477, DOI 10.1073/pnas.051614698; LIU Y, 1994, P NATL ACAD SCI USA, V91, P10300, DOI 10.1073/pnas.91.22.10300; MARIANI J, 1977, PHILOS T R SOC B, V281, P1, DOI 10.1098/rstb.1977.0121; Marques MJ, 2000, J NEUROSCI, V20, P3663, DOI 10.1523/JNEUROSCI.20-10-03663.2000; Martinez-Cerdeno V, 2002, CEREB CORTEX, V12, P1298, DOI 10.1093/cercor/12.12.1298; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Persico AM, 2001, MOL PSYCHIATR, V6, P150, DOI 10.1038/sj.mp.4000850; Quattrocchi CC, 2002, J BIOL CHEM, V277, P303, DOI 10.1074/jbc.M106996200; Rafuse VF, 2000, J NEUROSCI, V20, P6529, DOI 10.1523/JNEUROSCI.20-17-06529.2000; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Rice DS, 2001, NEURON, V31, P929, DOI 10.1016/S0896-6273(01)00436-6; Ross ME, 2002, NATURE, V418, P376, DOI 10.1038/418376a; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schiffmann SN, 1997, EUR J NEUROSCI, V9, P1055, DOI 10.1111/j.1460-9568.1997.tb01456.x; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Ware ML, 1997, NEURON, V19, P239, DOI 10.1016/S0896-6273(00)80936-8; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Zoubine MN, 1996, DEV BIOL, V179, P447, DOI 10.1006/dbio.1996.0274	29	28	29	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2003	301	5633					649	653		10.1126/science.1082690	http://dx.doi.org/10.1126/science.1082690			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893944				2022-12-28	WOS:000184473600041
J	Hohenberger, P; Gretschel, S				Hohenberger, P; Gretschel, S			Gastric cancer	LANCET			English	Review							HELICOBACTER-PYLORI INFECTION; LYMPH-NODE DISSECTION; MARUYAMA COMPUTER-PROGRAM; RANDOMIZED CLINICAL-TRIAL; DIGESTIVE-TRACT CANCER; EPSTEIN-BARR-VIRUS; TOTAL GASTRECTOMY; BONE-MARROW; ESOPHAGOGASTRIC JUNCTION; STAGING LAPAROSCOPY	The past decade has seen many advances in knowledge about gastric cancer. Notably, tumour biology and lymphatic spread are now better understood, and treatment by surgical and medical oncologists has become more standardised. Since refrigerators have replaced other methods of food conservation, Helicobacter pylori has become a factor in the cause of gastric cancer. Cancers that arise at the oesophagogastric junction might be further examples of wealth-associated disease. To tailor treatment better, the western hemisphere needs to borrow from the East by establishing screening programmes for early diagnosis, through careful surgical resection, and through detailed analysis of tumour spread. In Europe and the USA, most patients reach treatment with cancers already at an advanced stage. For these patients, three important randomised trials are underway that evaluate combined therapy. Cytostatic drugs, especially angiogenesis inhibitors have proved disappointing; however, basic research efforts to detect familial gastric cancers and to assess minimally residual disease look more hopeful.	Humboldt Univ, Max Delbruck Ctr Mol Med, Robert Roessle Hosp, Div Surg & Surg Oncol,Charite, D-13125 Berlin, Germany; Humboldt Univ, Max Delbruck Ctr Mol Med, Tumor Inst, Charite, D-13125 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Hohenberger, P (corresponding author), Humboldt Univ, Max Delbruck Ctr Mol Med, Robert Roessle Hosp, Div Surg & Surg Oncol,Charite, Campus Berlin Buch, D-13125 Berlin, Germany.	hohenberger@rrk-berlin.de						AIKOU T, 1987, LYMPHOLOGY, V20, P145; Ajani JA, 1999, J CLIN ONCOL, V17, P2403, DOI 10.1200/JCO.1999.17.8.2403; AKOH JA, 1992, BRIT J SURG, V79, P293, DOI 10.1002/bjs.1800790404; Allgayer H, 1997, CANCER RES, V57, P1394; ALLUM W, 2003, P AN M AM SOC CLIN, V22, pA998; Allum WH, 2002, GUT, V50, P1; Bamba M, 2001, VIRCHOWS ARCH, V438, P49, DOI 10.1007/s004280000307; BERNDT H, 1965, Z GASTROENTEROL, V3, P317; Bhunchet E, 2002, GASTROINTEST ENDOSC, V55, P562, DOI 10.1067/mge.2002.122031; BOLLSCHWEILER E, 1992, BRIT J SURG, V79, P156, DOI 10.1002/bjs.1800790221; BONENKAMP JJ, 1995, LANCET, V345, P745, DOI 10.1016/S0140-6736(95)90637-1; Bonenkamp JJ, 1999, NEW ENGL J MED, V340, P908, DOI 10.1056/NEJM199903253401202; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; BOTTCHER K, 1994, CHIRURG, V65, P298; Bozzetti F, 1997, ANN SURG, V226, P613, DOI 10.1097/00000658-199711000-00006; Burke EC, 1997, ANN SURG, V225, P262, DOI 10.1097/00000658-199703000-00004; Cascinu S, 1997, J CLIN ONCOL, V15, P3313, DOI 10.1200/JCO.1997.15.11.3313; Catarci M, 1998, ANN SURG ONCOL, V5, P580, DOI 10.1007/BF02303825; Choi HJ, 2002, ANN SURG ONCOL, V9, P13, DOI 10.1245/aso.2002.9.1.13; Chow WH, 1998, CANCER RES, V58, P588; Corley DA, 2001, INT J EPIDEMIOL, V30, P1415, DOI 10.1093/ije/30.6.1415; Correa P, 2000, JNCI-J NATL CANCER I, V92, P1881, DOI 10.1093/jnci/92.23.1881; Corvalan A, 2001, INT J CANCER, V94, P527, DOI 10.1002/ijc.1510; Cuschieri A, 1996, LANCET, V347, P995, DOI 10.1016/S0140-6736(96)90144-0; Cuschieri A, 1999, BRIT J CANCER, V79, P1522, DOI 10.1038/sj.bjc.6690243; de Manzoni G, 2002, ANN THORAC SURG, V73, P1035, DOI 10.1016/S0003-4975(01)03571-8; de Manzoni G, 2001, EUR J SURG, V167, P413; DEDOMBAL FT, 1990, GUT, V31, P115, DOI 10.1136/gut.31.1.115; DENT DM, 1988, BRIT J SURG, V75, P110, DOI 10.1002/bjs.1800750206; Dolan K, 1999, BRIT J CANCER, V80, P834, DOI 10.1038/sj.bjc.6690429; DUgo DM, 1997, SURG ENDOSC, V11, P1159, DOI 10.1007/s004649900560; Earle CC, 1999, EUR J CANCER, V35, P1059, DOI 10.1016/S0959-8049(99)00076-3; ELOMAR EM, 2002, NATURE, P398; Feussner H, 2002, STAGING LAPAROSCOPY, P83; FINK U, 1999, P AN M AM SOC CLIN, V18, P272; FUCHS KH, 1995, WORLD J SURG, V19, P698, DOI 10.1007/BF00295908; Fukayama M, 2001, CURR TOP MICROBIOL, V258, P91; Gallo N, 2003, HELICOBACTER, V8, P21, DOI 10.1046/j.1523-5378.2003.00120.x; Gotoda Takuji, 2000, Gastric Cancer, V3, P219, DOI 10.1007/PL00011720; Guadagni S, 2000, WORLD J SURG, V24, P1550, DOI 10.1007/s002680010276; Hansson LE, 1996, NEW ENGL J MED, V335, P242, DOI 10.1056/NEJM199607253350404; HANSSON LE, 1994, INT J CANCER, V57, P638, DOI 10.1002/ijc.2910570505; HATTORI T, 1986, CANCER, V57, P1528, DOI 10.1002/1097-0142(19860415)57:8<1528::AID-CNCR2820570815>3.0.CO;2-3; HIKI Y, 1991, SURG ENDOSC-ULTRAS, V5, P11, DOI 10.1007/BF00591379; Hiratsuka M, 2001, SURGERY, V129, P335, DOI 10.1067/msy.2001.111699; Hosch S, 2000, CANCER RES, V60, P6836; Hundahl SA, 2002, ANN SURG ONCOL, V9, P278, DOI 10.1007/BF02573066; Hunerbein M, 1998, SURG ENDOSC-ULTRAS, V12, P921, DOI 10.1007/s004649900747; Hunerbein M, 1998, GASTROINTEST ENDOSC, V48, P371, DOI 10.1016/S0016-5107(98)70005-7; Ichikura T, 2002, WORLD J SURG, V26, P318, DOI 10.1007/s00268-001-0226-x; INOUE Y, 1936, ACTA ANAT NIPPON, P35; Jauch KW, 1996, J CLIN ONCOL, V14, P1810, DOI 10.1200/JCO.1996.14.6.1810; KAMPSCHOER GHM, 1989, BRIT J SURG, V76, P905, DOI 10.1002/bjs.1800760910; KANG YK, 1996, P AN M AM SOC CLIN, V15, P215; Kikuchi S, 1998, JPN J CANCER RES, V89, P1109, DOI 10.1111/j.1349-7006.1998.tb00504.x; Kirchner T, 2001, VIRCHOWS ARCH, V439, P512, DOI 10.1007/s004280100477; Kitagawa Y, 2002, BRIT J SURG, V89, P604, DOI 10.1046/j.1365-2168.2002.02065.x; Kitamura K, 1999, BRIT J SURG, V86, P119, DOI 10.1046/j.1365-2168.1999.00967.x; Kocher HM, 2001, BRIT J SURG, V88, P1249, DOI 10.1046/j.0007-1323.2001.01847.x; Kranenbarg EK, 1998, EUR J SURG ONCOL, V24, P384; Krumbiegel P, 2000, INT J HYG ENVIR HEAL, V203, P11, DOI 10.1078/S1438-4639(04)70002-4; Kurosawa M, 2000, J GASTROEN HEPATOL, V15, P1382, DOI 10.1046/j.1440-1746.2000.02360.x; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; LAVECCHIA C, 1994, CANCER EPIDEM BIOMAR, V3, P393; LAVECCHIA C, 1992, CANCER, V70, P50, DOI 10.1002/1097-0142(19920701)70:1<50::AID-CNCR2820700109>3.0.CO;2-I; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; MARSHALL BJ, 1984, LANCET, V1, P1311; MATTANO LA, 1992, CANCER RES, V52, P4701; Meining A, 2001, BEST PRACT RES CL GA, V15, P983, DOI 10.1053/bega.2001.0253; Melcher AA, 1996, BRIT J CANCER, V74, P1651, DOI 10.1038/bjc.1996.604; Miyaji H, 2000, J GASTROEN HEPATOL, V15, P257, DOI 10.1046/j.1440-1746.2000.02070.x; Miyazono F, 2001, ANN SURG, V233, P189, DOI 10.1097/00000658-200102000-00007; MOLINO A, 1991, CANCER, V67, P1033, DOI 10.1002/1097-0142(19910215)67:4<1033::AID-CNCR2820670428>3.0.CO;2-H; Nakajima Toshifusa, 2002, Gastric Cancer, V5, P1, DOI 10.1007/s101200200000; *NCI, SURV EP END RES INC; NOMURA A, 1991, NEW ENGL J MED, V325, P1132, DOI 10.1056/NEJM199110173251604; Ogimoto I, 2000, CANCER CAUSE CONTROL, V11, P9, DOI 10.1023/A:1008927404027; Ohgami M, 1999, WORLD J SURG, V23, P187, DOI 10.1007/PL00013167; Parker SL, 1997, CA-CANCER J CLIN, V47, P5, DOI 10.3322/canjclin.47.1.5; PARSONNET J, 1991, JNCI-J NATL CANCER I, V83, P640, DOI 10.1093/jnci/83.9.640; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Putz E, 1999, CANCER RES, V59, P241; Rosen HR, 1998, J CLIN ONCOL, V16, P2733, DOI 10.1200/JCO.1998.16.8.2733; Schlemper RJ, 2000, GUT, V47, P251, DOI 10.1136/gut.47.2.251; Schlemper RJ, 1997, LANCET, V349, P1725, DOI 10.1016/S0140-6736(96)12249-2; Schwarz A, 1996, WORLD J SURG, V20, P60, DOI 10.1007/s002689900011; Schwarz RE, 2001, J CLIN ONCOL, V19, P1879, DOI 10.1200/JCO.2001.19.6.1879; Shimoyama S, 2002, ANN SURG ONCOL, V9, P625, DOI 10.1245/aso.2002.9.7.625; Siewert JR, 1998, BRIT J SURG, V85, P1457; Siewert JR, 1996, BRIT J SURG, V83, P1144, DOI 10.1002/bjs.1800830836; Siewert JR, 1998, ANN SURG, V228, P449, DOI 10.1097/00000658-199810000-00002; Skoropad VY, 2000, EUR J SURG ONCOL, V26, P773, DOI 10.1053/ejso.2000.1002; SOBALA GM, 1993, GUT, V34, P1038, DOI 10.1136/gut.34.8.1038; Songun I, 1999, EUR J CANCER, V35, P558, DOI 10.1016/S0959-8049(98)00429-8; SPITZER WO, 1981, J CHRON DIS, V34, P585, DOI 10.1016/0021-9681(81)90058-8; Stein HJ, 2000, SURG ONCOL, V9, P35, DOI 10.1016/S0960-7404(00)00021-9; Stell DA, 1996, BRIT J SURG, V83, P1260, DOI 10.1046/j.1365-2168.1996.02262.x; TAKAHASHI T, 1991, SEMIN SURG ONCOL, V7, P378, DOI 10.1002/ssu.2980070610; Tani M, 2001, Gastric Cancer, V4, P122, DOI 10.1007/PL00011734; Terry MB, 2002, SEMIN RADIAT ONCOL, V12, P111, DOI 10.1053/srao.30814; Terry P, 2001, EUR J CANCER PREV, V10, P365, DOI 10.1097/00008469-200108000-00010; TROIDL H, 1987, WORLD J SURG, V11, P699, DOI 10.1007/BF01656592; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; VISICK AH, 1948, LANCET, V254, P505; WANEBO HJ, 1993, ANN SURG, V218, P583, DOI 10.1097/00000658-199321850-00002; WANSIK Y, 1998, ANN SURG, V228, P347; Wayman J, 2001, CANCER CAUSE CONTROL, V12, P943, DOI 10.1023/A:1013756531219; WEINBERG J, 1950, SURG GYNECOL OBSTET, V90, P561; *WHO, 1997, WHO WORLD HLTH REP; Wolf HM, 1999, BRIT J HAEMATOL, V107, P55, DOI 10.1046/j.1365-2141.1999.01686.x; Woodward N, 2001, EUR J GASTROEN HEPAT, V13, P233, DOI 10.1097/00042737-200103000-00003; Wu MS, 1997, GASTROENTEROLOGY, V112, P1457, DOI 10.1016/S0016-5085(97)70071-4; Ye WM, 2001, GASTROENTEROLOGY, V121, P1286, DOI 10.1053/gast.2001.29569; Zambon CF, 2003, J CLIN PATHOL, V56, P287, DOI 10.1136/jcp.56.4.287; Zhang ZX, 1998, INT J RADIAT ONCOL, V42, P929, DOI 10.1016/S0360-3016(98)00280-6; 1997, IARC HDB CANC PREVEN, V1	117	538	569	2	66	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2003	362	9380					305	315		10.1016/S0140-6736(03)13975-X	http://dx.doi.org/10.1016/S0140-6736(03)13975-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705UL	12892963				2022-12-28	WOS:000184413400024
J	Choe, H; Li, WH; Wright, PL; Vasilieva, N; Venturi, M; Huang, CC; Grundner, C; Dorfman, T; Zwick, MB; Wang, LP; Rosenberg, ES; Kwong, PD; Burton, DR; Robinson, JE; Sodroski, JG; Farzan, M				Choe, H; Li, WH; Wright, PL; Vasilieva, N; Venturi, M; Huang, CC; Grundner, C; Dorfman, T; Zwick, MB; Wang, LP; Rosenberg, ES; Kwong, PD; Burton, DR; Robinson, JE; Sodroski, JG; Farzan, M			Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120	CELL			English	Article							HUMAN MONOCLONAL-ANTIBODY; AMINO-TERMINAL DOMAIN; ENVELOPE GLYCOPROTEIN; CHEMOKINE RECEPTORS; CORECEPTOR USAGE; DISTINCT CCR5; N-TERMINUS; ENTRY; NEUTRALIZATION; MACROPHAGE	Sulfated tyrosines at the amino terminus of the principal HIV-1 coreceptor CCR5 play a critical role in its ability to bind the HIV-1 envelope glycoprotein gp120 and mediate HIV-1 infection. Here, we show that a number of human antibodies directed against gp120 are tyrosine sulfated at their antigen binding sites. Like that of CCR5, antibody association with gp120 is dependent on sulfate moieties, enhanced by CD4, and inhibited by sulfated CCR5-derived peptides. Most of these antibodies preferentially associate with gp120 molecules of CCR5-utilizing (R5) isolates and neutralize primary R5 isolates more efficiently than laboratory-adapted isolates. These studies identify a distinct subset of CD4-induced HIV-1 neutralizing antibodies that closely emulate CCR5 and demonstrate that tyrosine sulfation can contribute to the potency and diversity of the human humoral response.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med Microbiol & Mol Genet,Div AIDS, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat, Boston, MA 02115 USA; NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pathol,Div AIDS, Boston, MA 02115 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02115 USA; Tulane Univ, Med Ctr, Dept Pediat, New Orleans, LA 70012 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Scripps Research Institute; Scripps Research Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Tulane University; Harvard University; Harvard T.H. Chan School of Public Health	Farzan, M (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med Microbiol & Mol Genet,Div AIDS, Boston, MA 02115 USA.	farzan@mbcrr.harvard.edu		Li, Wenhui/0000-0003-1305-7404; Farzan, Michael/0000-0002-2990-5319	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI005022, R01AI043891] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI043891] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; ALZARI PM, 1988, ANNU REV IMMUNOL, V6, P555; Atchison RE, 1996, SCIENCE, V274, P1924, DOI 10.1126/science.274.5294.1924; Beisswanger R, 1998, P NATL ACAD SCI USA, V95, P11134, DOI 10.1073/pnas.95.19.11134; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Blanpain C, 1999, J BIOL CHEM, V274, P34719, DOI 10.1074/jbc.274.49.34719; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Cormier EG, 2000, P NATL ACAD SCI USA, V97, P5762, DOI 10.1073/pnas.97.11.5762; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Doranz BJ, 1997, J VIROL, V71, P6305, DOI 10.1128/JVI.71.9.6305-6314.1997; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; EARL PL, 1990, P NATL ACAD SCI USA, V87, P648, DOI 10.1073/pnas.87.2.648; Farzan M, 2000, J BIOL CHEM, V275, P33516, DOI 10.1074/jbc.M007228200; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Farzan M, 2002, J BIOL CHEM, V277, P29484, DOI 10.1074/jbc.M203361200; Farzan M, 2002, J BIOL CHEM, V277, P40397, DOI 10.1074/jbc.M206784200; Farzan M, 1997, J BIOL CHEM, V272, P6854, DOI 10.1074/jbc.272.11.6854; Farzan M, 2001, J EXP MED, V193, P1059, DOI 10.1084/jem.193.9.1059; Farzan M, 1998, J VIROL, V72, P1160, DOI 10.1128/JVI.72.2.1160-1164.1998; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lefranc M-P., 2001, IMMUNOGLOBULIN FACTS; Lu ZH, 1997, P NATL ACAD SCI USA, V94, P6426, DOI 10.1073/pnas.94.12.6426; Montefiori DC, 2001, J VIROL, V75, P10200, DOI 10.1128/JVI.75.21.10200-10207.2001; Moulard M, 2002, P NATL ACAD SCI USA, V99, P6913, DOI 10.1073/pnas.102562599; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Ouyang YB, 1998, P NATL ACAD SCI USA, V95, P2896, DOI 10.1073/pnas.95.6.2896; Parren PWHI, 1998, J VIROL, V72, P10270, DOI 10.1128/JVI.72.12.10270-10274.1998; Picard L, 1997, VIROLOGY, V231, P105, DOI 10.1006/viro.1997.8506; Poignard P, 2001, ANNU REV IMMUNOL, V19, P253, DOI 10.1146/annurev.immunol.19.1.253; POSNER MR, 1993, J ACQ IMMUN DEF SYND, V6, P7; POSNER MR, 1991, J IMMUNOL, V146, P4325; POUYANI T, 1995, CELL, V83, P333, DOI 10.1016/0092-8674(95)90174-4; Preobrazhensky AA, 2000, J IMMUNOL, V165, P5295, DOI 10.4049/jimmunol.165.9.5295; Rabut GEE, 1998, J VIROL, V72, P3464, DOI 10.1128/JVI.72.4.3464-3468.1998; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; ROSENQUIST GL, 1993, PROTEIN SCI, V2, P215; Ross TM, 1998, J VIROL, V72, P1918, DOI 10.1128/JVI.72.3.1918-1924.1998; Rucker J, 1996, CELL, V87, P437, DOI 10.1016/S0092-8674(00)81364-1; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Sullivan N, 1998, J VIROL, V72, P4694, DOI 10.1128/JVI.72.6.4694-4703.1998; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; VUJCIC LK, 1995, AIDS RES HUM RETROV, V11, P783, DOI 10.1089/aid.1995.11.783; Wojtowicz WM, 2002, J BIOL CHEM, V277, P35019, DOI 10.1074/jbc.M203518200; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Xiang SH, 2002, AIDS RES HUM RETROV, V18, P1207, DOI 10.1089/08892220260387959; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	55	160	172	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 25	2003	114	2					161	170		10.1016/S0092-8674(03)00508-7	http://dx.doi.org/10.1016/S0092-8674(03)00508-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887918	Bronze			2022-12-28	WOS:000184378700006
J	Arnqvist, G; Jones, TM; Elgar, MA				Arnqvist, G; Jones, TM; Elgar, MA			Insect behaviour: Reversal of sex roles in nuptial feeding	NATURE			English	Article							MALES		Uppsala Univ, Evolutionary Biol Ctr, Dept Anim Ecol, S-75236 Uppsala, Sweden; Univ Melbourne, Dept Zool, Parkville, Vic 3010, Australia	Uppsala University; University of Melbourne	Arnqvist, G (corresponding author), Uppsala Univ, Evolutionary Biol Ctr, Dept Anim Ecol, S-75236 Uppsala, Sweden.	goran.arnqvist@ebc.uu.se	Jones, Theresa M/B-9124-2009; Arnqvist, Göran/E-6782-2015	Jones, Theresa M/0000-0002-5300-0018; Arnqvist, Göran/0000-0002-3501-3376; Elgar, Mark/0000-0003-0861-6064				Andersen NM, 2001, INVERTEBR TAXON, V15, P217, DOI 10.1071/IT00015; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; GWYNNE DT, 1984, NATURE, V307, P361, DOI 10.1038/307361a0; MARKOW TA, 1984, SCIENCE, V224, P302, DOI 10.1126/science.224.4646.302; PARKER GA, 1989, ETHOLOGY, V82, P3; Polhemus Dan A., 2000, Tijdschrift voor Entomologie, V143, P91; THORNHILL R, 1976, AM NAT, V110, P153, DOI 10.1086/283055; Vahed K, 1998, BIOL REV, V73, P43, DOI 10.1017/S0006323197005112; Vollrath F, 1998, TRENDS ECOL EVOL, V13, P159, DOI 10.1016/S0169-5347(97)01283-4; WEDELL N, 1991, EVOLUTION, V45, P1975, DOI [10.1111/j.1558-5646.1991.tb02704.x, 10.2307/2409847]	10	23	23	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2003	424	6947					387	387		10.1038/424387a	http://dx.doi.org/10.1038/424387a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879056	Bronze			2022-12-28	WOS:000184318400029
J	Fennimore, AM; Yuzvinsky, TD; Han, WQ; Fuhrer, MS; Cumings, J; Zettl, A				Fennimore, AM; Yuzvinsky, TD; Han, WQ; Fuhrer, MS; Cumings, J; Zettl, A			Rotational actuators based on carbon nanotubes	NATURE			English	Article							FABRICATION	Nanostructures are of great interest not only for their basic scientific richness, but also because they have the potential to revolutionize critical technologies. The miniaturization of electronic devices over the past century has profoundly affected human communication, computation, manufacturing and transportation systems. True molecular-scale electronic devices are now emerging that set the stage for future integrated nanoelectronics(1). Recently, there have been dramatic parallel advances in the miniaturization of mechanical and electromechanical devices(2). Commercial microelectromechanical systems now reach the submillimetre to micrometre size scale, and there is intense interest in the creation of next-generation synthetic nanometre-scale electromechanical systems(3,4). We report on the construction and successful operation of a fully synthetic nanoscale electromechanical actuator incorporating a rotatable metal plate, with a multi-walled carbon nanotube serving as the key motion-enabling element.	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zettl, A (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	azettl@physics.berkeley.edu	Han, Wei-Qiang/E-2818-2013; Cumings, John/A-3595-2012; Zettl, Alex K/O-4925-2016; Fuhrer, Michael S/E-7634-2010; Han, Weiqiang/AAJ-7738-2020	Han, Wei-Qiang/0000-0001-5525-8277; Zettl, Alex K/0000-0001-6330-136X; Fuhrer, Michael S/0000-0001-6183-2773; Yuzvinsky, Thomas/0000-0001-5708-2877				Bockrath M, 1997, SCIENCE, V275, P1922, DOI 10.1126/science.275.5308.1922; Carr DW, 1999, APPL PHYS LETT, V75, P920, DOI 10.1063/1.124554; CHARLIER JC, 1993, PHYS REV LETT, V70, P1858, DOI 10.1103/PhysRevLett.70.1858; CHOPRA NG, 1995, SCIENCE, V269, P966, DOI 10.1126/science.269.5226.966; Collins PC, 2001, SCIENCE, V292, P706, DOI 10.1126/science.1058782; Craighead HG, 2000, SCIENCE, V290, P1532, DOI 10.1126/science.290.5496.1532; Cumings J, 2000, NATURE, V406, P586, DOI 10.1038/35020698; Cumings J, 2000, SCIENCE, V289, P602, DOI 10.1126/science.289.5479.602; EBBESEN TW, 1992, NATURE, V358, P220, DOI 10.1038/358220a0; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Judy JW, 2001, SMART MATER STRUCT, V10, P1115, DOI 10.1088/0964-1726/10/6/301; Kolmogorov AN, 2000, PHYS REV LETT, V85, P4727, DOI 10.1103/PhysRevLett.85.4727; Lifshitz R, 2000, PHYS REV B, V61, P5600, DOI 10.1103/PhysRevB.61.5600; Poncharal P, 1999, SCIENCE, V283, P1513, DOI 10.1126/science.283.5407.1513; ROUKES ML, 2000, 2000 SOL STAT SENS A, P367; Tans SJ, 1997, NATURE, V386, P474, DOI 10.1038/386474a0; Tour JM, 1998, ANN NY ACAD SCI, V852, P197, DOI 10.1111/j.1749-6632.1998.tb09873.x; Williams PA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.255502; Williams PA, 2003, APPL PHYS LETT, V82, P805, DOI 10.1063/1.1538346; Yakobson BI, 1996, PHYS REV LETT, V76, P2511, DOI 10.1103/PhysRevLett.76.2511; Yu MF, 2000, J PHYS CHEM B, V104, P8764, DOI 10.1021/jp002828d	21	991	1029	7	248	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2003	424	6947					408	410		10.1038/nature01823	http://dx.doi.org/10.1038/nature01823			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879064				2022-12-28	WOS:000184318400037
J	Hinman, RS; Crossley, KM; McConnell, J; Bennell, KL				Hinman, RS; Crossley, KM; McConnell, J; Bennell, KL			Efficacy of knee tape in the management of osteoarthritis of the knee: blinded randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-TRIAL; THERAPY; HIP; RECOMMENDATIONS; POPULATION; DISORDERS; EXERCISE; JOINT; PAIN	Objectives To test the hypotheses that therapeutic taping of the knee improves pain and disability in patients with osteoarthritis of the knee and that benefits remain after stopping treatment. Design Randomised single blind controlled trial with three intervention arms (therapeutic tape, control tape, and no tape) of three weeks' duration and three week follow tip. Setting Outcome assessment was performed in a university based laboratory. Taping interventions were applied by eight physiotherapists in metropolitan private practice. Participants 87 patients with symptoms of knee osteoarthritis as defined by the American College of Rheumatology. Main outcome measures Primary outcome measure was pain as measured by visual analogue scale and participant perceived rating of change. Secondary measures of pain and disability included the Western Ontario and MacMaster Universities osteoarthritis index, knee pain scale, and the SF-36. Results The therapeutic tape group reported a greater reduction in pain on all primary outcomes than either of the other two groups. A significant association was evident between intervention and change in pain at three weeks (P = 0.000), with 73% (21/29) of the therapeutic tape group reporting improvement compared with 49% (14/29) of the control tape group and 10% (3/29) of the no tape group. Significantly greater improvement in pain and disability was observed on most secondary outcomes in the therapeutic tape group compared with the no tape group. Benefits of therapeutic tape were maintained three weeks after stopping treatment. Conclusions Therapeutic knee taping is an efficacious treatment for the management of pain and disability in patients with knee osteoarthritis.	Univ Melbourne, Ctr Sports Med Res & Educ, Sch Physiotherapy, Melbourne, Vic 3010, Australia	University of Melbourne	Hinman, RS (corresponding author), Univ Melbourne, Ctr Sports Med Res & Educ, Sch Physiotherapy, Melbourne, Vic 3010, Australia.		Crossley, Kay M/G-4436-2010; Bennell, Kim/C-7022-2014	Hinman, Rana/0000-0001-6368-9456; Bennell, Kim/0000-0003-4982-5639; Crossley, Kay/0000-0001-5892-129X				ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905; *ARTHR FDN AUSTR, 2001, PREV COST DIS BURD A; BADLEY EM, 1993, ANN RHEUM DIS, V52, P6, DOI 10.1136/ard.52.1.6; BELLAMY N, 1992, J RHEUMATOL, V19, P451; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Callaghan MJ, 2002, J ATHL TRAINING, V37, P19; Carmona L, 2001, ANN RHEUM DIS, V60, P1040, DOI 10.1136/ard.60.11.1040; Cowan CA, 2002, TRENDS CELL BIOL, V12, P339, DOI 10.1016/S0962-8924(02)02317-6; CUSHNAGHAN J, 1994, BRIT MED J, V308, P753, DOI 10.1136/bmj.308.6931.753; Duri Z A, 1996, Am J Knee Surg, V9, P55; Fransen M, 2001, J RHEUMATOL, V28, P156; Fransen M, 1997, Physiother Res Int, V2, P30, DOI 10.1002/pri.77; Gilleard W, 1998, PHYS THER, V78, P25, DOI 10.1093/ptj/78.1.25; HANDFIELD T, 2000, PHYSIOTHER CAN, V52, P39; Herrington L, 2001, PHYS THER SPORT, V2, P23, DOI DOI 10.1054/PTSP.2000.0034; Huskisson E., 1983, PAIN MEASUREMENT ASS, P33; Kellgren JH, 1963, EPIDEMIOLOGY CHRONIC; McConnell J, 1996, Man Ther, V1, P60, DOI 10.1054/math.1996.0251; Pendleton A, 2000, ANN RHEUM DIS, V59, P936, DOI 10.1136/ard.59.12.936; REJESKI WJ, 1995, J RHEUMATOL, V22, P1124; Van Baar ME, 1998, J RHEUMATOL, V25, P2432; VANSCHAARDENBURG D, 1994, ANN RHEUM DIS, V53, P807, DOI 10.1136/ard.53.12.807; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	24	91	92	0	15	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 19	2003	327	7407					135	138B		10.1136/bmj.327.7407.135	http://dx.doi.org/10.1136/bmj.327.7407.135			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702WJ	12869456	Green Published, Bronze			2022-12-28	WOS:000184247500019
J	Iredale, JP				Iredale, JP			Science, medicine, and the future - Cirrhosis: new research provides a basis for rational and targeted treatments	BMJ-BRITISH MEDICAL JOURNAL			English	Review							GROWTH-FACTOR-BETA; HEPATIC STELLATE CELLS; LIVER FIBROSIS; IN-VIVO; RAT-LIVER; EXPRESSION; INTERLEUKIN-10; THERAPY; MECHANISMS; RESOLUTION		Univ Southampton, Div Infect Inflammat & Repair, Southampton Gen Hosp, Southampton SO16 6YD, Hants, England	University of Southampton	Iredale, JP (corresponding author), Univ Southampton, Div Infect Inflammat & Repair, Southampton Gen Hosp, Southampton SO16 6YD, Hants, England.	jpi@soton.ac.uk		Iredale, John/0000-0003-2174-5127				Bataller R, 2001, SEMIN LIVER DIS, V21, P437, DOI 10.1055/s-2001-17558; Benyon RC, 1996, GASTROENTEROLOGY, V110, P821, DOI 10.1053/gast.1996.v110.pm8608892; Benyon RC, 2001, SEMIN LIVER DIS, V21, P373, DOI 10.1055/s-2001-17552; BORDER WA, 1992, J CLIN INVEST, V90, P1, DOI 10.1172/JCI115821; BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Day CP, 2002, GUT, V50, P585, DOI 10.1136/gut.50.5.585; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; FRIEDMAN SL, 1985, P NATL ACAD SCI USA, V82, P8681, DOI 10.1073/pnas.82.24.8681; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; FRIEDMAN SL, 2002, SCI MED, V8, P194; George J, 1999, P NATL ACAD SCI USA, V96, P12719, DOI 10.1073/pnas.96.22.12719; Iimuro Y, 2003, GASTROENTEROLOGY, V124, P445, DOI 10.1053/gast.2003.50063; Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018; Kweon YO, 2001, J HEPATOL, V35, P749, DOI 10.1016/S0168-8278(01)00218-5; MAHER JJ, 1990, J CLIN INVEST, V86, P1641, DOI 10.1172/JCI114886; *NAT CTR CHRON DIS, US OB TRENDS 1985 20; Nelson DR, 2000, GASTROENTEROLOGY, V118, P655, DOI 10.1016/S0016-5085(00)70134-X; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; Rockey DC, 2001, SEMIN LIVER DIS, V21, P337, DOI 10.1055/s-2001-17551; Rosenberg GA, 2001, STROKE, V32, P183; Thompson K, 1998, HEPATOLOGY, V28, P1597, DOI 10.1002/hep.510280620; Tilg H, 2003, J HEPATOL, V38, P419, DOI 10.1016/S0168-8278(02)00442-7; Wang SC, 1998, J BIOL CHEM, V273, P302, DOI 10.1074/jbc.273.1.302; Wright MC, 2001, GASTROENTEROLOGY, V121, P685, DOI 10.1053/gast.2001.27188; 2001, LIVER CIRRHOSIS STAR	26	138	152	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2003	327	7407					143	147		10.1136/bmj.327.7407.143	http://dx.doi.org/10.1136/bmj.327.7407.143			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702WJ	12869458	Green Submitted, Green Published			2022-12-28	WOS:000184247500021
J	Victora, CG; Wagstaff, A; Schellenberg, JA; Gwatkin, D; Claeson, M; Habicht, JP				Victora, CG; Wagstaff, A; Schellenberg, JA; Gwatkin, D; Claeson, M; Habicht, JP			Applying an equity lens to child health and mortality: more of the same is not enough	LANCET			English	Article							CARE; INDIA; POOR; INEQUITIES; OUTCOMES; WEALTH; AFRICA; INCOME	Gaps in child mortality between rich and poor countries are unacceptably wide and in some areas are becoming wider, as are the gaps between wealthy and poor children within most countries. Poor children are more likely than their better-off peers to be exposed to health risks, and they have less resistance to disease because of undernutrition and other hazards typical in poor communities. These inequities are compounded by reduced access to preventive and curative interventions. Even public subsidies for health frequently benefit rich people more than poor people. Experience and evidence about how to reach poor populations are growing, albeit largely through small-scale case studies. Successful approaches include those that improve geographic access to health interventions in poor communities, subsidised health care and health inputs, and social marketing. Targeting of health Interventions to poor people and ensuring universal coverage are promising approaches for improvement of equity, but both have limitations that necessitate planning for child survival and effective delivery at national level and below. Regular monitoring of inequities and use of the resulting information for education, advocacy, and increased accountability among the general public and decision makers is urgently needed, but will not be sufficient. Equity must be a priority in the design of child survival interventions and delivery strategies, and mechanisms to ensure accountability at national and international levels must be developed.	Univ Fed Pelotas, BR-96001970 Pelotas, RS, Brazil; World Bank, Washington, DC 20433 USA; Univ Sussex, Brighton, E Sussex, England; London Sch Hyg & Trop Med, London WC1, England; Ifakara Hlth Res & Dev Ctr, Ifakara, Tanzania; Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Universidade Federal de Pelotas; The World Bank; University of Sussex; University of London; London School of Hygiene & Tropical Medicine; Ifakara Health Institute; Cornell University	Victora, CG (corresponding author), Univ Fed Pelotas, CP 464, BR-96001970 Pelotas, RS, Brazil.		Victora, Cesar Gomes/Y-2455-2019; Wagstaff, Adam/A-7667-2009; Victora, Cesar G/D-4476-2013	Victora, Cesar Gomes/0000-0002-2465-2180; Victora, Cesar G/0000-0002-2465-2180; Schellenberg, Joanna/0000-0002-0708-3676; Wagstaff, Adam/0000-0003-4442-5070				[Anonymous], 1999, WORLD HLTH REPORT 19; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; Castro-Leal F, 2000, B WORLD HEALTH ORGAN, V78, P66; Chatterjee M, 1990, REPORT INDIAN WOMEN; Claeson M, 2000, B WORLD HEALTH ORGAN, V78, P1192; DASGUPTA M, 1987, POPUL DEV REV, V13, P77; *DAT INT LTD NEP H, 2001, EQ FIN DEL HLTH SERV; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; FILMER D, 1998, 1867 WORLD BANK; Gertler P., 2001, EXPT INCENTIVE BASED; GROSH M, 1994, ADM TARGETED SOCIAL; Gwatkin D. R, 2000, CURRENT STATE KNOWLE; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; HANSON K, 2000, SOCIAL MARKETING INS; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Lavy V, 1996, J HEALTH ECON, V15, P333, DOI 10.1016/0167-6296(95)00021-6; MENZEL P, 1994, MAT WORLD GLOBAL FAM; *MES NUTR PROGR TA, 2002, FOOD NUTR BULL, V23, P162; Morris SS, 2000, J EPIDEMIOL COMMUN H, V54, P381, DOI 10.1136/jech.54.5.381; Mosley WH, 1984, CHILD SURVIVAL; Pande RP, 2002, NATL AVERAGES IMMUNI; PAUL K, 1964, SW J ANTHR, V20, P160; Ravallion, 2001, DOES PIPED WATER RED; *ROCK FDN, EQ GAUG APPR MON EQ; Rogers E., 2003, DIFFUSION INNOVATION, VFifth; Schellenberg JA, 2003, LANCET, V361, P561, DOI 10.1016/S0140-6736(03)12515-9; Skoufias E, 2001, WORLD DEV, V29, P1769, DOI 10.1016/S0305-750X(01)00060-2; Stifel D., 1999, 94 CORN U; Thomas D, 1996, J PUBLIC ECON, V61, P155, DOI 10.1016/0047-2727(95)01530-2; Tipping G, 1996, HEALTH POLICY PLANN, V11, P206, DOI 10.1093/heapol/11.2.206; UK Department for International Development, 1999, BETT HLTH POOR PEOPL; *UNICEF, 2001, PROGR WORLD SUMM CHI; Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0; Wagstaff A, 2000, B WORLD HEALTH ORGAN, V78, P19; Wagstaff A, 2001, 2832 WORLD BANK; WAGSTAFF A, IN PRESS AM J PUBLIC; WHO Europe, 1978, DECL ALM AT; *WHO WORLD BANK, VOIC POOR DYING CHAN; *WHO WORLD BANK WO, 2002, HLTH POV BETT HLTH P; World Bank, 2000, 19920EC WORLD BANK; World Bank, 2002, WORLD DEV IND 2002, DOI [10.1596/0-8213-5088-9, DOI 10.1596/0-8213-5088-9]; *WORLD BANK, 2001, 20488NI WORLD BANK; World Bank, 1997, HLTH NUTR POP SECT S; *WORLD BANK, 2002, 22323IN WORLD BANK; *WORLD BANK GROUP, POV HLTH; Yip W, 2001, HEALTH ECON, V10, P207, DOI 10.1002/hec.589	47	512	532	0	60	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 19	2003	362	9379					233	241		10.1016/S0140-6736(03)13917-7	http://dx.doi.org/10.1016/S0140-6736(03)13917-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	702PJ	12885488				2022-12-28	WOS:000184232000026
J	Robertson, WH; Diken, EG; Johnson, MA				Robertson, WH; Diken, EG; Johnson, MA			Snapshots of water at work	SCIENCE			English	Editorial Material									Yale Univ, Sterling Chem Lab, New Haven, CT 06520 USA	Yale University	Robertson, WH (corresponding author), Yale Univ, Sterling Chem Lab, New Haven, CT 06520 USA.							Ayotte P, 1998, CHEM PHYS, V239, P485, DOI 10.1016/S0301-0104(98)00287-0; Cowin JP, 1999, NATURE, V398, P405, DOI 10.1038/18848; Dhont, 1996, INTRO DYNAMICS COLLO; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; MARCUS Y, 1985, ION SOLVATION; Omta AW, 2003, SCIENCE, V301, P347, DOI 10.1126/science.1084801; ONSAGER L, 1969, SCIENCE, V166, P1359, DOI 10.1126/science.166.3911.1359; Rini M, 2003, SCIENCE, V301, P349, DOI 10.1126/science.1085762; Robertson WH, 2003, SCIENCE, V299, P1367, DOI 10.1126/science.1080695; ROBERTSON WH, IN PRESS J PHYS CH A; Schmitt UW, 1999, J CHEM PHYS, V111, P9361, DOI 10.1063/1.480032	11	14	15	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2003	301	5631					320	321		10.1126/science.1087194	http://dx.doi.org/10.1126/science.1087194			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869746				2022-12-28	WOS:000184207300025
J	Canman, JC; Cameron, LA; Maddox, PS; Straight, A; Tirnauer, JS; Mitchison, TJ; Fang, GW; Kapoor, TM; Salmon, ED				Canman, JC; Cameron, LA; Maddox, PS; Straight, A; Tirnauer, JS; Mitchison, TJ; Fang, GW; Kapoor, TM; Salmon, ED			Determining the position of the cell division plane	NATURE			English	Article							SMALL-MOLECULE INHIBITOR; MAMMALIAN-CELLS; CLEAVAGE FURROW; MICROTUBULES; CYTOKINESIS; SPINDLE; ANAPHASE; MECHANISMS; PROTEIN; MAD2	Proper positioning of the cell division plane during mitosis is essential for determining the size and position of the two daughter cells-a critical step during development and cell differentiation(1). A bipolar microtubule array has been proposed to be a minimum requirement for furrow positioning in mammalian cells, with furrows forming at the site of microtubule plus-end overlap between the spindle poles(2-4). Observations in other species have suggested, however, that this may not be true(5,6). Here we show, by inducing mammalian tissue cells with monopolar spindles to enter anaphase(7,8), that furrow formation in cultured mammalian cells does not require a bipolar spindle. Unexpectedly, cytokinesis occurs at high frequency in monopolar cells. Division always occurs at a cortical position distal to the chromosomes. Analysis of microtubules during cytokinesis in cells with monopolar and bipolar spindles shows that a subpopulation of stable microtubules extends past chromosomes and binds to the cell cortex at the site of furrow formation. Our data are consistent with a model in which chromosomes supply microtubules with factors that promote microtubule stability and furrowing.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27699 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10021 USA	University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard Medical School; Stanford University; Rockefeller University	Salmon, ED (corresponding author), Univ N Carolina, Dept Biol, 607 Fordham Hall,CB 3280, Chapel Hill, NC 27699 USA.		Canman, Julie C/A-3875-2016	Canman, Julie C/0000-0001-8135-2072; Straight, Aaron/0000-0001-5885-7881	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024364] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams RR, 2001, TRENDS CELL BIOL, V11, P49, DOI 10.1016/S0962-8924(00)01880-8; ASNES CF, 1979, EXP CELL RES, V122, P327, DOI 10.1016/0014-4827(79)90309-4; Canman JC, 2000, CURR BIOL, V10, P611, DOI 10.1016/S0960-9822(00)00490-5; Canman JC, 2002, CELL MOTIL CYTOSKEL, V52, P61, DOI 10.1002/cm.10032; Canman JC, 2002, J CELL SCI, V115, P3787, DOI 10.1242/jcs.00057; Dechant R, 2003, DEV CELL, V4, P333, DOI 10.1016/S1534-5807(03)00057-1; Foe VE, 2000, DEVELOPMENT, V127, P1767; Gorbsky GJ, 1998, J CELL BIOL, V141, P1193, DOI 10.1083/jcb.141.5.1193; HARRIS AK, 1989, J CELL BIOL, V109, P2215, DOI 10.1083/jcb.109.5.2215; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; KUBAI DF, 1982, J CELL BIOL, V93, P655, DOI 10.1083/jcb.93.3.655; Kurz T, 2002, SCIENCE, V295, P1294, DOI 10.1126/science.1067765; Mackay AM, 1998, J CELL BIOL, V140, P991, DOI 10.1083/jcb.140.5.991; Mandato CA, 2000, CELL MOTIL CYTOSKEL, V45, P87, DOI 10.1002/(SICI)1097-0169(200002)45:2<87::AID-CM1>3.0.CO;2-0; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Murata-Hori M, 2002, J CELL BIOL, V159, P45, DOI 10.1083/jcb.200207014; RADLEY JM, 1980, BLOOD, V56, P996; RAPPAPORT R, 1961, J EXP ZOOL, V148, P81, DOI 10.1002/jez.1401480107; RAPPAPORT R, 1997, CYTOKINESIS ANIMALS; Shannon KB, 2002, MOL BIOL CELL, V13, P3706, DOI 10.1091/mbc.E02-03-0137; Wheatley SP, 2001, EXP CELL RES, V262, P122, DOI 10.1006/excr.2000.5088; WHITE JG, 1983, J THEOR BIOL, V101, P289, DOI 10.1016/0022-5193(83)90342-9; Wittmann T, 2001, J CELL SCI, V114, P3795; WOLF N, 1978, J ULTRA MOL STRUCT R, V63, P155, DOI 10.1016/S0022-5320(78)80071-9	25	181	184	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 28	2003	424	6952					1074	1078		10.1038/nature01860	http://dx.doi.org/10.1038/nature01860			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715QR	12904818				2022-12-28	WOS:000184984200048
J	Cutforth, T; Moring, L; Mendelsohn, M; Nemes, A; Shah, NM; Kim, MM; Frisen, J; Axel, R				Cutforth, T; Moring, L; Mendelsohn, M; Nemes, A; Shah, NM; Kim, MM; Frisen, J; Axel, R			Axonal ephrin-as and odorant receptors: Coordinate determination of the olfactory sensory map	CELL			English	Article							EXPRESSION PATTERNS; CRYSTAL-STRUCTURE; BRANCH EXTENSION; TOPOGRAPHIC MAP; MULTIPLE ROLES; MESSENGER-RNAS; MICE DEFICIENT; CELL-ADHESION; SYSTEM; LIGANDS	Olfactory sensory neurons expressing a given odorant receptor (OR) project with precision to specific glomeruli in the olfactory bulb, generating a topographic map. In this study, we demonstrate that neurons expressing different ORs express different levels of ephrin-A protein on their axons. Moreover, alterations in the level of ephrin-A alter the glomerular map. Deletion of the ephrin-A5 and ephrin-A3 genes posteriorizes the glomerular locations for neurons expressing either the P2 or SR1 receptor, whereas overexpression of ephrin-A5 in P2 neurons results in an anterior shift in their glomeruli. Thus the ephrin-As are differentially expressed in distinct subpopulations of neurons and are likely to participate, along with the ORs, as one of a complement of guidance receptors governing the targeting of like axons to precise locations in the olfactory bulb.	Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Ctr Neurobiol & Behav, Coll Phys & Surg, New York, NY 10032 USA; Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden	Columbia University; Howard Hughes Medical Institute; Columbia University; Karolinska Institutet	Axel, R (corresponding author), Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA.			Axel, Richard/0000-0002-3141-4076	NATIONAL CANCER INSTITUTE [P01CA023767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004209] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA23767] Funding Source: Medline; NIDCD NIH HHS [R01 DC04209] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Cerretti DP, 1998, GENOMICS, V47, P131, DOI 10.1006/geno.1997.5088; CHEN G, 1994, BIOL CONTROL, V4, P157, DOI 10.1006/bcon.1994.1025; Davy A, 2000, EMBO J, V19, P5396, DOI 10.1093/emboj/19.20.5396; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gogos JA, 2000, CELL, V103, P609, DOI 10.1016/S0092-8674(00)00164-1; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; Hennecke M, 2001, NUCLEIC ACIDS RES, V29, P3327, DOI 10.1093/nar/29.16.3327; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Huai JS, 2001, J BIOL CHEM, V276, P6689, DOI 10.1074/jbc.M008127200; KILLACKEY HP, 1995, TRENDS NEUROSCI, V18, P402, DOI 10.1016/0166-2236(95)93937-S; Knoll B, 2001, DEVELOPMENT, V128, P895; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lane RP, 2001, P NATL ACAD SCI USA, V98, P7390, DOI 10.1073/pnas.131215398; Mann F, 2002, NEURON, V35, P461, DOI 10.1016/S0896-6273(02)00786-9; McLaughlin T, 2003, DEVELOPMENT, V130, P2407, DOI 10.1242/dev.00467; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 2001, NAT NEUROSCI, V4, P1192, DOI 10.1038/nn751; Montag-Sallaz M, 2002, MOL CELL BIOL, V22, P7967, DOI 10.1128/MCB.22.22.7967-7981.2002; O'Leary DDM, 1999, CELL, V96, P255, DOI 10.1016/S0092-8674(00)80565-6; Prakash N, 2000, J NEUROSCI, V20, P5841, DOI 10.1523/JNEUROSCI.20-15-05841.2000; Puche AC, 1996, DEV BIOL, V179, P274, DOI 10.1006/dbio.1996.0257; Renzi MJ, 2000, NEURON, V28, P437, DOI 10.1016/S0896-6273(00)00123-9; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Schaefer ML, 2001, J COMP NEUROL, V436, P351; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schwarting GA, 2000, J NEUROSCI, V20, P7691; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; St John JA, 2002, DEV BRAIN RES, V138, P1, DOI 10.1016/S0165-3806(02)00454-6; St John JA, 2001, DEV BRAIN RES, V126, P43, DOI 10.1016/S0165-3806(00)00136-X; St John JA, 2000, J COMP NEUROL, V416, P540; Tisay KT, 2000, J COMP NEUROL, V428, P656, DOI 10.1002/1096-9861(20001225)428:4<656::AID-CNE6>3.0.CO;2-7; Toth J, 2001, DEV CELL, V1, P83, DOI 10.1016/S1534-5807(01)00002-8; Treloar H, 1997, J NEUROBIOL, V32, P643, DOI 10.1002/(SICI)1097-4695(19970620)32:7<643::AID-NEU1>3.0.CO;2-4; Vanderhaeghen P, 2000, NAT NEUROSCI, V3, P358, DOI 10.1038/73929; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Walz A, 2002, J NEUROSCI, V22, P4025, DOI 10.1523/JNEUROSCI.22-10-04025.2002; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Zhang JH, 1996, J NEUROSCI, V16, P7182; ZHANG JH, 1990, NEUROSCI LETT, V119, P257, DOI 10.1016/0304-3940(90)90847-3; Zhang JH, 1997, MOL BRAIN RES, V47, P202, DOI 10.1016/S0169-328X(97)00051-X; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X	55	175	176	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 8	2003	114	3					311	322		10.1016/S0092-8674(03)00568-3	http://dx.doi.org/10.1016/S0092-8674(03)00568-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914696	Bronze			2022-12-28	WOS:000184679200008
J	Damak, S; Rong, MQ; Yasumatsu, K; Kokrashvili, Z; Varadarajan, V; Zou, SY; Jiang, PH; Ninomiya, Y; Margolskee, RF				Damak, S; Rong, MQ; Yasumatsu, K; Kokrashvili, Z; Varadarajan, V; Zou, SY; Jiang, PH; Ninomiya, Y; Margolskee, RF			Detection of sweet and umami taste in the absence of taste receptor T1r3	SCIENCE			English	Article							SACCHARIN PREFERENCE; GLOSSOPHARYNGEAL NERVES; CHORDA TYMPANI; INBRED STRAINS; MICE; SUBSTANCES; RESPONSES; LOCUS; SAC; IDENTIFICATION	The tastes of sugars ( sweet) and glutamate (umami) are thought to be detected by T1r receptors expressed in taste cells. Molecular genetics and heterologous expression implicate T1r2 plus T1r3 as a sweet-responsive receptor, and T1r1 plus T1r3, as well as a truncated form of the type 4 metabotropic glutamate receptor (taste-mGluR4), as umami-responsive receptors. Here, we show that mice lacking T1r3 showed no preference for artificial sweeteners and had diminished but not abolished behavioral and nerve responses to sugars and umami compounds. These results indicate that T1r3-independent sweet- and umami-responsive receptors and/or pathways exist in taste cells.	CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Howard Hughes Med Inst, New York, NY 10029 USA; Kyushu Univ, Sect Oral Neurosci, Higashi Ku, Fukuoka 8128582, Japan	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Howard Hughes Medical Institute; Icahn School of Medicine at Mount Sinai; Kyushu University	Margolskee, RF (corresponding author), CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, Box 1677,1425 Madison Ave, New York, NY 10029 USA.			Margolskee, Robert/0000-0002-9572-2887				Bachmanov AA, 1997, MAMM GENOME, V8, P545, DOI 10.1007/s003359900500; Bachmanov AA, 2001, CHEM SENSES, V26, P925, DOI 10.1093/chemse/26.7.925; CAPELESS CG, 1995, CHEM SENSES, V20, P291, DOI 10.1093/chemse/20.3.291; CAPRETTA PJ, 1970, PSYCHON SCI, V21, P133; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; FULLER JL, 1974, J HERED, V65, P33, DOI 10.1093/oxfordjournals.jhered.a108452; Kitagawa M, 2001, BIOCHEM BIOPH RES CO, V283, P236, DOI 10.1006/bbrc.2001.4760; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; LUSH IE, 1989, GENET RES, V53, P95, DOI 10.1017/S0016672300027968; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Ninomiya Y, 2000, J NUTR, V130, p950S, DOI 10.1093/jn/130.4.950S; NINOMIYA Y, 1993, NEUROSCI LETT, V163, P197, DOI 10.1016/0304-3940(93)90381-T; PELZ WE, 1973, PHYSIOL BEHAV, V10, P263, DOI 10.1016/0031-9384(73)90308-9; Sainz E, 2001, J NEUROCHEM, V77, P896, DOI 10.1046/j.1471-4159.2001.00292.x; Sako N, 2000, PHYSIOL BEHAV, V71, P193, DOI 10.1016/S0031-9384(00)00342-5; SCHIFFMAN SS, 1995, BRAIN RES BULL, V36, P505, DOI 10.1016/0361-9230(94)00225-P; SHINGAI T, 1985, BRAIN RES, V335, P245, DOI 10.1016/0006-8993(85)90476-7	20	453	498	10	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2003	301	5634					850	853		10.1126/science.1087155	http://dx.doi.org/10.1126/science.1087155			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12869700				2022-12-28	WOS:000184615700050
J	Sullivan, NJ; Geisbert, TW; Geisbert, JB; Xu, L; Yang, ZY; Roederer, M; Koup, RA; Jahrling, PB; Nabel, GJ				Sullivan, NJ; Geisbert, TW; Geisbert, JB; Xu, L; Yang, ZY; Roederer, M; Koup, RA; Jahrling, PB; Nabel, GJ			Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates	NATURE			English	Article							PASSIVE TRANSFER; INFECTION; GLYCOPROTEINS; CYTOTOXICITY; INJURY; GENE	Containment of highly lethal Ebola virus outbreaks poses a serious public health challenge. Although an experimental vaccine has successfully protected non-human primates against disease(1), more than six months was required to complete the immunizations, making it impractical to limit an acute epidemic. Here, we report the development of accelerated vaccination against Ebola virus in non-human primates. The antibody response to immunization with an adenoviral (ADV) vector encoding the Ebola glycoprotein (GP) was induced more rapidly than with DNA priming and ADV boosting, but it was of lower magnitude. To determine whether this earlier immune response could nonetheless protect against disease, cynomolgus macaques were challenged with Ebola virus after vaccination with ADV-GP and nucleoprotein (NP) vectors. Protection was highly effective and correlated with the generation of Ebola-specific CD8(+) T-cell and antibody responses. Even when animals were immunized once with ADV-GP/NP and challenged 28 days later, they remained resistant to challenge with either low or high doses of virus. This accelerated vaccine provides an intervention that may help to limit the epidemic spread of Ebola, and is applicable to other viruses.	NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nabel, GJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, Bldg 40,Room 4502,MSC 3005,40 Convent Dr, Bethesda, MD 20892 USA.	gnabel@nih.gov	Roederer, Mario/G-1887-2011		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI005004, ZIAAI005073, Z01AI005073] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aoki K, 1999, MOL MED, V5, P224, DOI 10.1007/BF03402119; Chan SY, 2000, J GEN VIROL, V81, P2155, DOI 10.1099/0022-1317-81-9-2155; Gupta M, 2001, J VIROL, V75, P4649, DOI 10.1128/JVI.75.10.4649-4654.2001; Jahrling PB, 1999, J INFECT DIS, V179, pS224, DOI 10.1086/514310; Jahrling PB, 1996, ARCH VIROL, P135; KSIAZEK TG, 1992, J CLIN MICROBIOL, V30, P947, DOI 10.1128/JCM.30.4.947-950.1992; OHNO T, 1994, SCIENCE, V265, P781, DOI 10.1126/science.8047883; Parren PWHI, 2002, J VIROL, V76, P6408, DOI 10.1128/JVI.76.12.6408-6412.2002; Sanchez A, 1998, J VIROL, V72, P6442, DOI 10.1128/JVI.72.8.6442-6447.1998; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Takada A, 2000, VIROLOGY, V278, P20, DOI 10.1006/viro.2000.0601; Volchkov VE, 2001, SCIENCE, V291, P1965, DOI 10.1126/science.1057269; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; *WHO, 2003, DIS OUTBR EB HAEM FE; Wilson JA, 2001, J VIROL, V75, P2660, DOI 10.1128/JVI.75.6.2660-2664.2001; Xu L, 1998, NAT MED, V4, P37, DOI 10.1038/nm0198-037; Yang ZY, 2000, NAT MED, V6, P886, DOI 10.1038/78654	17	361	390	0	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2003	424	6949					681	684		10.1038/nature01876	http://dx.doi.org/10.1038/nature01876			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904795	Green Published, Bronze			2022-12-28	WOS:000184578800047
J	Jack, AL; Womack, C				Jack, AL; Womack, C			Why surgical patients do not donate tissue for commercial research: review of records	BRITISH MEDICAL JOURNAL			English	Article									Peterborough Dist Gen Hosp, Dept Cellular Pathol, Peterborough PE3 6DA, England		Womack, C (corresponding author), Peterborough Dist Gen Hosp, Dept Cellular Pathol, Peterborough PE3 6DA, England.							CHATFIELD D, 2001, CLIN RES FOCUS, V12, P1; Gray N, 1999, J CLIN PATHOL, V52, P254, DOI 10.1136/jcp.52.4.254; Medical Research Council and Wellcome Trust, 2001, PUBL PERC COLL HUM B; Start RD, 1996, BRIT MED J, V313, P1366, DOI 10.1136/bmj.313.7069.1366; Womack Christopher, 2002, Cell and Tissue Banking, V3, P203, DOI 10.1023/A:1023628821593	5	54	56	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 2	2003	327	7409					262	262		10.1136/bmj.327.7409.262	http://dx.doi.org/10.1136/bmj.327.7409.262			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708KP	12896938	Bronze, Green Published			2022-12-28	WOS:000184566300019
J	Olliver, JR; Wild, CP; Sahay, P; Dexter, S; Hardie, LJ				Olliver, JR; Wild, CP; Sahay, P; Dexter, S; Hardie, LJ			Chromoendoscopy with methylene blue and associated DNA damage in Barrett's oesophagus	LANCET			English	Article								Chromoendoscopy with methylene blue has been proposed to improve targeting of biopsies to specialised intestinal metaplasia and dysplasia in Barrett's oesophagus. However, methylene blue can induce oxidative damage of DNA when photosensitised by white light. We show that damage to DNA is increased in Barrett's mucosa after chromoendoscopy with methylene blue, an effect apparently dependent on presence of both methylene blue and endoscopic white light. Exposure of Barrett's mucosa to DNA damage during endoscopy warrants caution since it could accelerate carcinogenesis. This risk needs to be carefully balanced against the possible benefit of improved early detection of preneoplastic lesions with methylene blue chromoendoscopy.	Univ Leeds, Mol Epidemiol Unit, Leeds LS2 9JT, W Yorkshire, England; Pontefract Dist Gen Hosp, Dept Gastroenterol, Pontefract, England; Univ Leeds, Sch Med, Dept Surg, Leeds LS2 9JT, W Yorkshire, England	University of Leeds; University of Leeds	Hardie, LJ (corresponding author), Univ Leeds, Mol Epidemiol Unit, Leeds LS2 9JT, W Yorkshire, England.		Hardie, Laura/AAY-6724-2020; Wild, Christopher/ABC-6260-2020	Hardie, Laura/0000-0001-5039-2100; Wild, Christopher/0000-0003-0249-8669					0	190	197	1	20	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 2	2003	362	9381					373	374		10.1016/S0140-6736(03)14026-3	http://dx.doi.org/10.1016/S0140-6736(03)14026-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707FB	12907012				2022-12-28	WOS:000184498700012
J	Gabaldon, T; Huynen, MA				Gabaldon, T; Huynen, MA			Reconstruction of the proto-mitochondrial metabolism	SCIENCE			English	Article									Nijmegen Ctr Mol Life Sci, CMBI, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Huynen, MA (corresponding author), Nijmegen Ctr Mol Life Sci, CMBI, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.		Huijnen, M.A./H-8051-2014; Gabaldón, Toni/A-7336-2008; Huynen, Martijn A/A-1530-2014	Gabaldón, Toni/0000-0003-0019-1735; Huynen, Martijn A/0000-0001-6189-5491				Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Karlberg O, 2000, YEAST, V17, P170, DOI 10.1002/1097-0061(20000930)17:3<170::AID-YEA25>3.0.CO;2-V; Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000; Martin W, 2001, BIOL CHEM, V382, P1521, DOI 10.1515/BC.2001.187; Schnarrenberger C, 2002, EUR J BIOCHEM, V269, P868, DOI 10.1046/j.0014-2956.2001.02722.x; SCHON EA, 2001, METHOD CELL BIOL, V65, P463	7	135	141	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2003	301	5633					609	609		10.1126/science.1085463	http://dx.doi.org/10.1126/science.1085463			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893934				2022-12-28	WOS:000184473600029
J	Neumann, CA; Krause, DS; Carman, CV; Das, S; Dubey, DP; Abraham, JL; Bronson, RT; Fujiwara, Y; Orkin, SH; Van Etten, RA				Neumann, CA; Krause, DS; Carman, CV; Das, S; Dubey, DP; Abraham, JL; Bronson, RT; Fujiwara, Y; Orkin, SH; Van Etten, RA			Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression	NATURE			English	Article							ABL TYROSINE KINASE; PAG GENE-PRODUCT; PHYSIOLOGICAL INHIBITOR; STRESS; CLONING; RESISTANCE; PROTEIN; FAMILY; CELLS; MICE	Reactive oxygen species are involved in many cellular metabolic and signalling processes(1) and are thought to have a role in disease, particularly in carcinogenesis and ageing(2). We have generated mice with targeted inactivation of Prdx1, a member of the peroxiredoxin family of antioxidant enzymes(3). Here we show that mice lacking Prdx1 are viable and fertile but have a shortened lifespan owing to the development beginning at about 9 months of severe haemolytic anaemia and several malignant cancers, both of which are also observed at increased frequency in heterozygotes. The haemolytic anaemia is characterized by an increase in erythrocyte reactive oxygen species, leading to protein oxidation, haemoglobin instability, Heinz body formation and decreased erythrocyte lifespan. The malignancies include lymphomas, sarcomas and carcinomas, and are frequently associated with loss of Prdx1 expression in heterozygotes, which suggests that this protein functions as a tumour suppressor. Prdx1-deficient fibroblasts show decreased proliferation and increased sensitivity to oxidative DNA damage, whereas Prdx1-null mice have abnormalities in numbers, phenotype and function of natural killer cells. Our results implicate Prdx1 as an important defence against oxidants in ageing mice.	Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Tufts Univ, Sch Vet Med, North Grafton, MA 01536 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Tufts University	Van Etten, RA (corresponding author), Tufts Univ New England Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA.	rvanetten@tufts-nemc.org	Carman, Christopher V./AAX-8995-2020; Carman, Christopher/L-8108-2016	Carman, Christopher V./0000-0001-7358-2548; Carman, Christopher/0000-0001-7358-2548; Neumann, Carola/0000-0003-2801-9531	NIEHS NIH HHS [F32 ES011586] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES011586] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Butterfield LH, 1999, ANTIOXID REDOX SIGN, V1, P385, DOI 10.1089/ars.1999.1.4-385; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Chung YM, 2001, ANTICANCER RES, V21, P1129; Dubey DP, 2000, MECH AGEING DEV, V113, P117, DOI 10.1016/S0047-6374(99)00102-5; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Frank J, 2000, HISTOL HISTOPATHOL, V15, P173, DOI 10.14670/HH-15.173; Friedman JS, 2001, J EXP MED, V193, P925, DOI 10.1084/jem.193.8.925; Henderson CJ, 1998, P NATL ACAD SCI USA, V95, P5275, DOI 10.1073/pnas.95.9.5275; HOFFMANNFEZER G, 1993, ANN HEMATOL, V67, P81, DOI 10.1007/BF01788131; ISHII T, 1993, J BIOL CHEM, V268, P18633; IWAHARA S, 1995, BIOCHEMISTRY-US, V34, P13398, DOI 10.1021/bi00041a017; Johnson RM, 2000, BLOOD, V96, P1985, DOI 10.1182/blood.V96.5.1985.h8001985_1985_1988; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Lyu MS, 1999, MAMM GENOME, V10, P1017, DOI 10.1007/s003359901150; Mu ZM, 2002, J BIOL CHEM, V277, P43175, DOI 10.1074/jbc.M206066200; Noh DY, 2001, ANTICANCER RES, V21, P2085; PROSPERI MT, 1993, J BIOL CHEM, V268, P11050; PROSPERI MT, 1994, GENOMICS, V19, P236, DOI 10.1006/geno.1994.1053; Prosperi MT, 1998, FEBS LETT, V423, P39, DOI 10.1016/S0014-5793(98)00057-X; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Sauri H, 1996, J LEUKOCYTE BIOL, V59, P925, DOI 10.1002/jlb.59.6.925; Shau HY, 1997, FREE RADICAL BIO MED, V22, P497, DOI 10.1016/S0891-5849(96)00372-3; SHAU HY, 1993, CELL IMMUNOL, V147, P1, DOI 10.1006/cimm.1993.1043; Struthers L, 1998, ANAL BIOCHEM, V255, P20, DOI 10.1006/abio.1997.2354; Takei F, 1997, IMMUNOL REV, V155, P67, DOI 10.1111/j.1600-065X.1997.tb00940.x; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Westphal GH, 1997, CURR BIOL, V7, P530, DOI 10.1016/S0960-9822(06)00224-7	31	615	645	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 31	2003	424	6948					561	565		10.1038/nature01819	http://dx.doi.org/10.1038/nature01819			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891360	Green Published			2022-12-28	WOS:000184454700045
J	Kaiser, AM; Beart, RW				Kaiser, AM; Beart, RW			Chronic ulcerative colitis with megacolon	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ So Calif, Los Angeles, CA 90033 USA	University of Southern California	Kaiser, AM (corresponding author), Univ So Calif, Los Angeles, CA 90033 USA.								0	0	0	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2003	349	4					358	358		10.1056/NEJMicm020381	http://dx.doi.org/10.1056/NEJMicm020381			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703ZH	12878743				2022-12-28	WOS:000184312800009
J	Nedimovic, MR; Hyndman, RD; Ramachandran, K; Spence, GD				Nedimovic, MR; Hyndman, RD; Ramachandran, K; Spence, GD			Reflection signature of seismic and aseismic slip on the northern Cascadia subduction interface	NATURE			English	Article							SOUTHERN VANCOUVER-ISLAND; DE-FUCA PLATE; ZONE; EARTHQUAKE; MANTLE; CONSTRAINTS; LITHOPROBE; RECORDS; MARGIN; CRUST	At the northern Cascadia margin, the Juan de Fuca plate is underthrusting North America at about 45 mm yr(-1) (ref. 1), resulting in the potential for destructive great earthquakes(2,3). The downdip extent of coupling between the two plates is difficult to determine because the most recent such earthquake (thought to have been in 1700)(4) occurred before instrumental recording. Thermal and deformation studies 5 indicate that, off southern Vancouver Island, the interplate interface is presently fully locked for a distance of approximate to 60 km downdip from the deformation front. Great thrust earthquakes on this section of the interface (with magnitudes of up to 9)(4,5) have been estimated to occur at an average interval of about 590 yr (ref. 3). Further downdip there is a transition from fully locked behaviour to aseismic sliding (where high temperatures allow ductile deformation), with the deep aseismic zone exhibiting slow-slip thrust events(6). Here we show that there is a change in the reflection character on seismic images from a thin sharp reflection where the subduction thrust is inferred to be locked, to a broad reflection band at greater depth where aseismic slip is thought to be occurring. This change in reflection character may provide a new technique to map the landward extent of rupture in great earthquakes and improve the characterization of seismic hazards in subduction zones.	Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Geol Survey Canada, Pacific Geosci Ctr, Sidney, BC V8L 4B2, Canada; Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8W 3P6, Canada	Columbia University; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; University of Victoria	Nedimovic, MR (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, 61 Route 9W,POB 1000, Palisades, NY 10964 USA.	mladen@ldeo.columbia.edu	Nedimovic, Mladen/Q-6865-2019; Nedimovic, Mladen/B-8459-2009	Nedimovic, Mladen/0000-0003-0327-5192				Bostock MG, 2002, NATURE, V417, P536, DOI 10.1038/417536a; Brocher TM, 2003, GEOLOGY, V31, P267, DOI 10.1130/0091-7613(2003)031<0267:SEFWSF>2.0.CO;2; Buske S, 2002, TECTONOPHYSICS, V350, P273, DOI 10.1016/S0040-1951(02)00117-8; Calvert AJ, 1996, CAN J EARTH SCI, V33, P1294, DOI 10.1139/e96-098; CALVERT AJ, 1990, GEOLOGY, V18, P1091, DOI 10.1130/0091-7613(1990)018<1091:DHARFA>2.3.CO;2; CASSIDY JF, 1991, J GEOPHYS RES-SOL EA, V96, P19843, DOI 10.1029/91JB01658; CLOWES RM, 1987, CAN J EARTH SCI, V24, P31, DOI 10.1139/e87-004; CLOWES RM, 2002, 02328 US GEOL SURV; CLOWES RM, 2002, 4350 GEOL SURV CAN; DEMETS C, 1990, GEOPHYS J INT, V101, P425, DOI 10.1111/j.1365-246X.1990.tb06579.x; Dragert H, 2001, SCIENCE, V292, P1525, DOI 10.1126/science.1060152; FISHER MA, 1989, J GEOPHYS RES-SOLID, V94, P4424, DOI 10.1029/JB094iB04p04424; FISHER MA, 1999, EOS T AGU, V80, P16; Goldfinger C, 2003, ANNU REV EARTH PL SC, V31, P555, DOI 10.1146/annurev.earth.31.100901.141246; GRAINDORGE D, IN PRESS J GEOPHYS R; HEATON TH, 1987, SCIENCE, V236, P162, DOI 10.1126/science.236.4798.162; Higgins M.W., 1971, 687 US GEOL SURV; HYNDMAN RD, 1995, J GEOPHYS RES-SOL EA, V100, P22133, DOI 10.1029/95JB01970; HYNDMAN RD, 1988, J GEOPHYS RES-SOLID, V93, P13391, DOI 10.1029/JB093iB11p13391; HYNDMAN RD, 1990, CAN J EARTH SCI, V27, P313, DOI 10.1139/e90-030; JONES TD, 1984, J GEOPHYS RES, V89, P3153, DOI 10.1029/JB089iB05p03153; Kodaira S, 2002, GEOPHYS J INT, V149, P815, DOI 10.1046/j.1365-246X.2002.01691.x; KURTZ RD, 1990, J GEOPHYS RES-SOLID, V95, P10929, DOI 10.1029/JB095iB07p10929; LANGSTON S, 1995, THESIS U VICTORIA; Oncken O, 1999, NATURE, V397, P341, DOI 10.1038/16909; Peacock SM, 1999, GEOPHYS RES LETT, V26, P2517, DOI 10.1029/1999GL900558; RAMACHANDRAN K, 2001, THESIS U VICTORIA, P1; Satake K, 1996, NATURE, V379, P246, DOI 10.1038/379246a0; SPENCE GD, 1985, J GEOPHYS RES-SOLID, V90, P6754, DOI 10.1029/JB090iB08p06754; WANG K, 2003, J GEOPHYS RES, V108, DOI DOI 10.1029/2001JB001703; YORATH CJ, 1985, GEOLOGY, V13, P759, DOI 10.1130/0091-7613(1985)13<759:LSVISR>2.0.CO;2	31	82	83	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2003	424	6947					416	420		10.1038/nature01840	http://dx.doi.org/10.1038/nature01840			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879067				2022-12-28	WOS:000184318400040
J	Hoopengardner, B; Bhalla, T; Staber, C; Reenan, R				Hoopengardner, B; Bhalla, T; Staber, C; Reenan, R			Nervous system targets of RNA editing identified by comparative genomics	SCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; DEPENDENT K+ CHANNEL; POTASSIUM CHANNEL; INACTIVATION GATE; AMINO-ACIDS; MUTATIONS; SYNAPTOTAGMIN; SELECTIVITY; DROSOPHILA; REGION	An unknown number of precursor messenger RNAs undergo genetic recoding by modi. cation of adenosine to inosine, a reaction catalyzed by the adenosine deaminases acting on RNA(ADARs). Discovery of these edited transcripts has always been serendipitous. Using comparative genomics, we identified a phylogenetic signature of RNA editing. We report the identification and experimental veri. cation of 16 previously unknown ADAR target genes in the fruit fly Drosophila and one in humans - more than the sum total previously reported. All of these genes are involved in rapid electrical and chemical neurotransmission, and many of the edited sites recode conserved and functionally important amino acids. These results point to a pivotal role for RNA editing in nervous system function.	Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA	University of Connecticut	Reenan, R (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, 263 Farmington Ave, Farmington, CT 06030 USA.				NIGMS NIH HHS [R01 GM062291] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062291] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aruscavage PJ, 2000, RNA, V6, P257, DOI 10.1017/S1355838200991921; Chapman ER, 1998, J BIOL CHEM, V273, P32966, DOI 10.1074/jbc.273.49.32966; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; EAHOLTZ G, 1994, NEURON, V12, P1041, DOI 10.1016/0896-6273(94)90312-3; Herb A, 1996, P NATL ACAD SCI USA, V93, P1875, DOI 10.1073/pnas.93.5.1875; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; IMOTO K, 1991, FEBS LETT, V289, P193, DOI 10.1016/0014-5793(91)81068-J; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; KONNO T, 1991, P ROY SOC B-BIOL SCI, V244, P69, DOI 10.1098/rspb.1991.0053; Kuryatov A, 1997, J NEUROSCI, V17, P9035; LOPEZ GA, 1991, NEURON, V7, P327, DOI 10.1016/0896-6273(91)90271-Z; Maylie B, 2002, J NEUROSCI, V22, P4786, DOI 10.1523/JNEUROSCI.22-12-04786.2002; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Reenan RA, 2000, NEURON, V25, P139, DOI 10.1016/S0896-6273(00)80878-8; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Schaub M, 2002, BIOCHIMIE, V84, P791, DOI 10.1016/S0300-9084(02)01446-3; Seeburg PH, 2002, NEURON, V35, P17, DOI 10.1016/S0896-6273(02)00760-2; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Tamamizu S, 1999, J MEMBRANE BIOL, V170, P157, DOI 10.1007/s002329900545; Tonkin LA, 2002, EMBO J, V21, P6025, DOI 10.1093/emboj/cdf607; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	27	315	343	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2003	301	5634					832	836		10.1126/science.1086763	http://dx.doi.org/10.1126/science.1086763			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907802				2022-12-28	WOS:000184615700045
J	Gentner, TQ; Margoliash, D				Gentner, TQ; Margoliash, D			Neuronal populations and single cells representing learned auditory objects	NATURE			English	Article							INDIVIDUAL VOCAL RECOGNITION; WHITE-CROWNED SPARROW; EUROPEAN STARLINGS; PREFRONTAL CORTEX; SONG SYSTEM; DISCRIMINATION; PLASTICITY; MONKEYS; SOUNDS; ORGANIZATION	The neural representations associated with learned auditory behaviours, such as recognizing individuals based on their vocalizations, are not well described. Higher vertebrates learn to recognize complex conspecific vocalizations that comprise sequences of easily identified, naturally occurring auditory objects(1,2), which should facilitate the analysis of higher auditory pathways. Here we describe the first example of neurons selective for learned conspecific vocalizations in adult animals-in starlings that have been trained operantly to recognize conspecific songs. The neuronal population is found in a non-primary forebrain auditory region, exhibits increased responses to the set of learned songs compared with novel songs, and shows differential responses to categories of learned songs based on recognition training contingencies. Within the population, many cells respond highly selectively to a subset of specific motifs (acoustic objects) present only in the learned songs. Such neuronal selectivity may contribute to song-recognition behaviour, which in starlings is sensitive to motif identity(3,4). In this system, both top-down and bottom-up processes may modify the tuning properties of neurons during recognition learning, giving rise to plastic representations of behaviourally meaningful auditory objects.	Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	University of Chicago	Gentner, TQ (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1027 E 57th St, Chicago, IL 60637 USA.				NIDCD NIH HHS [F32 DC000389-03, F32 DC000389] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC000389] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BAKIN JS, 1990, BRAIN RES, V536, P271, DOI 10.1016/0006-8993(90)90035-A; EENS M, 1989, ARDEA, V77, P75; Gentner T. Q., 2002, ACOUSTIC COMMUNICATI, P324; Gentner TQ, 1998, ANIM BEHAV, V56, P579, DOI 10.1006/anbe.1998.0810; Gentner TQ, 2000, J NEUROBIOL, V42, P117, DOI 10.1002/(SICI)1097-4695(200001)42:1<117::AID-NEU11>3.0.CO;2-M; Gentner TQ, 2000, J ACOUST SOC AM, V107, P3369, DOI 10.1121/1.429408; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Kilgard MP, 2002, P NATL ACAD SCI USA, V99, P3205, DOI 10.1073/pnas.261705198; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; Kroodsma D.E., 1996, ECOLOGY EVOLUTION AC; KROODSMA DE, 1999, DESIGN ANIMAL COMMUN; LEPPELSACK HJ, 1976, J COMP PHYSIOL, V107, P263, DOI 10.1007/BF00656737; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; MARGOLIASH D, 1986, J NEUROSCI, V6, P1643; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; MULLER CM, 1985, EXP BRAIN RES, V59, P587; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rainer G, 2000, NEURON, V27, P179, DOI 10.1016/S0896-6273(00)00019-2; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; RECANZONE GH, 1993, J NEUROSCI, V13, P87; SCHEICH H, 1979, J COMP PHYSIOL, V132, P257, DOI 10.1007/BF00614497; Sen K, 2001, J NEUROPHYSIOL, V86, P1445, DOI 10.1152/jn.2001.86.3.1445; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; Wang XQ, 2001, J NEUROPHYSIOL, V86, P2616, DOI 10.1152/jn.2001.86.5.2616	27	186	187	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					669	674		10.1038/nature01731	http://dx.doi.org/10.1038/nature01731			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904792	Green Accepted			2022-12-28	WOS:000184578800044
J	Krekelberg, B; Dannenberg, S; Hoffmann, KP; Bremmer, F; Ross, J				Krekelberg, B; Dannenberg, S; Hoffmann, KP; Bremmer, F; Ross, J			Neural correlates of implied motion	NATURE			English	Article							VISUAL AREA MT; TRANSPARENT MOTION; MACAQUE MONKEY; DIRECTION; PERCEPTION; SIGNALS; NEURONS; SELECTIVITY; ORIENTATION; CORTEX	Current views of the visual system assume that the primate brain analyses form and motion along largely independent pathways(1); they provide no insight into why form is sometimes interpreted as motion. In a series of psychophysical and electrophysiological experiments in humans and macaques, here we show that some form information is processed in the prototypical motion areas of the superior temporal sulcus (STS). First, we show that STS cells respond to dynamic Glass patterns(2),which contain no coherent motion but suggest a path of motion(3). Second, we show that when motion signals conflict with form signals suggesting a different path of motion, both humans and monkeys perceive motion in a compromised direction. This compromise also has a correlate in the responses of STS cells, which alter their direction preferences in the presence of conflicting implied motion information. We conclude that cells in the prototypical motion areas in the dorsal visual cortex process form that implies motion. Estimating motion by combining motion cues with form cues may be a strategy to deal with the complexities of motion perception in our natural environment.	Salk Inst Biol Studies, Vis Ctr Lab, La Jolla, CA 92037 USA; Ruhr Univ Bochum, Dept Neurobiol, D-44780 Bochum, Germany; Univ Marburg, Dept Neurophys, Cognit Neurosci Lab, D-35032 Marburg, Germany; Univ Western Australia, Sch Psychol, Nedlands, WA 6907, Australia	Salk Institute; Ruhr University Bochum; Philipps University Marburg; University of Western Australia	Krekelberg, B (corresponding author), Salk Inst Biol Studies, Vis Ctr Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Bremmer, Frank/F-3268-2012; Krekelberg, Bart/N-7938-2019	Bremmer, Frank/0000-0003-1597-7407; Krekelberg, Bart/0000-0003-1083-6103				ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; Batschelet E., 1981, CIRCULAR STAT BIOL; Bremmer F, 1997, J NEUROPHYSIOL, V77, P944, DOI 10.1152/jn.1997.77.2.944; Burr DC, 2002, J NEUROSCI, V22, P8661; Geisler WS, 1999, NATURE, V400, P65, DOI 10.1038/21886; Geisler WS, 2001, VISUAL NEUROSCI, V18, P501, DOI 10.1017/S0952523801184014; GLASS L, 1969, NATURE, V223, P578, DOI 10.1038/223578a0; Jancke D, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-14-j0005.2000; Kourtzi Z, 2000, J COGNITIVE NEUROSCI, V12, P48, DOI 10.1162/08989290051137594; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Pack CC, 2001, NATURE, V409, P1040, DOI 10.1038/35059085; QIAN N, 1994, J NEUROSCI, V14, P7367; Ross J, 2000, CURR BIOL, V10, P679, DOI 10.1016/S0960-9822(00)00524-8; Rudolph K, 1999, CEREB CORTEX, V9, P90, DOI 10.1093/cercor/9.1.90; SCHOPPMANN A, 1976, NEUROSCI LETT, V2, P177, DOI 10.1016/0304-3940(76)90011-2; Smith MA, 2002, J NEUROSCI, V22, P8334, DOI 10.1523/jneurosci.22-18-08334.2002; SNOWDEN RJ, 1991, J NEUROSCI, V11, P2768; Wilson HR, 1997, VISION RES, V37, P2325, DOI 10.1016/S0042-6989(97)00104-1	20	122	125	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					674	677		10.1038/nature01852	http://dx.doi.org/10.1038/nature01852			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904793				2022-12-28	WOS:000184578800045
J	Blackburn, C; Spencer, N; Bonas, S; Coe, C; Dolan, A; Moy, R				Blackburn, C; Spencer, N; Bonas, S; Coe, C; Dolan, A; Moy, R			Effect of strategies to reduce exposure of infants to environmental tobacco smoke in the home: cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article							URINARY COTININE; PARENTAL SMOKING; CHILDREN; ASTHMA	Objective To examine parents' reported knowledge and use of harm reduction strategies to protect their infants from exposure to tobacco smoke in the home, and the relation between reported use of strategies and urinary cotinine to creatinine ratios in the infants. Design Cross sectional survey. Settings Coventry and Birmingham. Main outcome measures Parents' reported knowledge and use of harm reduction strategies and urinary cotinine to creatinine ratios in their infants. Participants 314 smoking households with infants. Results 86% of parents (264/307) believed that environmental tobacco smoke is harmful, 90% (281/314) believed that infants can be protected from it in the home, and 10% (32/314) were either unaware of measures or reported using none. 65% of parents (205/314) reported using two or more measures, but only 18% (58/314) reported not allowing smoking in the home. No difference was found in mean log e transformed urinary cotinine to creatinine ratio in infants from households that used no measures compared with households that used less strict measures. Mean log cotinine to creatinine ratios were significantly different in households banning smoking in the home compared with those using less strict or no measures. Banning smoking in the home was independently associated with a significant reduction in urinary cotinine to creatinine ratio by a factor of 2.6 (1.6 to 4.2) after adjustment for average household cigarette consumption, tenure, and overcrowding. Conclusions Less than a fifth of parents in smoking households ban smoking in the home. Banning smoking was associated with a small but significant reduction in urinary cotinine to creatinine ratio in infants, whereas less strict measures compared with no measures had no effect on the infants' exposure to environmental tobacco smoke.	Univ Warwick, Sch Hlth & Social Studies, Coventry CV4 7AL, W Midlands, England; Univ Leicester, Dept Epidemiol & Publ Hlth, Leicester LE1 6TP, Leics, England; Birmingham Childrens Hosp, Inst Child Hlth, Birmingham, W Midlands, England	University of Warwick; University of Leicester; University of Birmingham	Blackburn, C (corresponding author), Univ Warwick, Sch Hlth & Social Studies, Coventry CV4 7AL, W Midlands, England.							Bakoula CG, 1997, CANCER CAUSE CONTROL, V8, P73, DOI 10.1023/A:1018487222533; Cook DG, 1999, THORAX, V54, P357, DOI 10.1136/thx.54.4.357; GRAHAM H, 1993, WHEN LIFES DRAG WOME; Haufroid V, 1998, INT ARCH OCC ENV HEA, V71, P162, DOI 10.1007/s004200050266; Jarvis MJ, 2000, BRIT MED J, V321, P343, DOI 10.1136/bmj.321.7257.343; Mascola MA, 1998, AM J PUBLIC HEALTH, V88, P893, DOI 10.2105/AJPH.88.6.893; Peterson EL, 1997, J CLIN EPIDEMIOL, V50, P917, DOI 10.1016/S0895-4356(97)00095-4; Wakefield M, 2000, AM J PREV MED, V19, P188, DOI 10.1016/S0749-3797(00)00197-5; Winkelstein ML, 1997, ANN ALLERG ASTHMA IM, V78, P419, DOI 10.1016/S1081-1206(10)63206-1	9	85	90	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 2	2003	327	7409					257	260		10.1136/bmj.327.7409.257	http://dx.doi.org/10.1136/bmj.327.7409.257			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708KP	12896936	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000184566300017
J	Benzi, R				Benzi, R			Getting a grip on turbulence	SCIENCE			English	Editorial Material									Univ Roma Tor Vergata, Dept Phys, I-00173 Rome, Italy	University of Rome Tor Vergata	Benzi, R (corresponding author), Univ Roma Tor Vergata, Dept Phys, Via Ric 1, I-00173 Rome, Italy.			Benzi, Roberto/0000-0002-5335-7068				Arad I, 1999, PHYS REV LETT, V82, P5040, DOI 10.1103/PhysRevLett.82.5040; Benzi R, 1996, PHYSICA D, V96, P162, DOI 10.1016/0167-2789(96)00018-8; BENZI R, 1992, PHYS REP, V222, P145, DOI 10.1016/0370-1573(92)90090-M; Chen HD, 2003, SCIENCE, V301, P633, DOI 10.1126/science.1085048; Falkovich G, 2001, REV MOD PHYS, V73, P913, DOI 10.1103/RevModPhys.73.913; FRISCH U, 1996, TURBULENCE LEGACY AN; Gotlib D., 1977, NUMERICAL ANAL SPECT; Kolmogorov A., 1941, DOKL AKAD NAUK SSSR, V30, P9, DOI DOI 10.1098/RSPA.1991.0075; Smagorinsky J., 1963, MON WEATHER REV, V91, P99, DOI [DOI 10.1175/1520-0493(1963)0912.3.CO;2, 10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.CO;2, 10.1175/1520-0493(1963)0912.3.CO;2, DOI 10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.CO;2]; Succi S., 2001, NUMERICAL MATH SCI C	10	7	8	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2003	301	5633					605	606		10.1126/science.1087141	http://dx.doi.org/10.1126/science.1087141			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893931				2022-12-28	WOS:000184473600026
J	Livingstone, DA				Livingstone, DA			Global climate change strikes a tropical lake	SCIENCE			English	Editorial Material									Duke Univ, Dept Biol, Durham, NC 27708 USA; Duke Univ, Div Earth & Ocean Sci, Durham, NC 27708 USA	Duke University; Duke University	Livingstone, DA (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.							BEADLE LC, 1981, INLAND WATERS AFRICA; Brooks J. L., 1950, Quarterly Review of Biology, V25, P131, DOI 10.1086/397539; Coulter G. W., 1991, LAKE TANGANYIKA ITS; MacIntyre S, 2002, LIMNOL OCEANOGR, V47, P656, DOI 10.4319/lo.2002.47.3.0656; Verburg P, 2003, SCIENCE, V301, P505, DOI 10.1126/science.1084846	5	11	13	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2003	301	5632					468	469		10.1126/science.1088633	http://dx.doi.org/10.1126/science.1088633			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12881557				2022-12-28	WOS:000184340500027
J	Sejvar, JJ; Haddad, MB; Tierney, BC; Campbell, GL; Marfin, AA; Van Gerpen, JA; Fleischauer, A; Leis, AA; Stokic, DS; Petersen, LR				Sejvar, JJ; Haddad, MB; Tierney, BC; Campbell, GL; Marfin, AA; Van Gerpen, JA; Fleischauer, A; Leis, AA; Stokic, DS; Petersen, LR			Neurologic manifestations and outcome of West Nile virus infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEW-YORK; JAPANESE ENCEPHALITIS; MOVEMENT-DISORDERS; CLINICAL-FEATURES; OUTBREAK; POLIOMYELITIS; EPIDEMIC	Context The neurologic manifestations, laboratory findings, and outcome of patients with West Nile virus (WNV) infection have not been prospectively characterized. Objective To describe prospectively the clinical and laboratory features and long-term outcome of patients with neurologic manifestations of WNV infection. Design, Setting, and Participants From August 1 to September 2, 2002, a community-based, prospective case series was conducted in St Tammany Parish, La. Standardized clinical data were collected on patients with suspected WNV infection. Confirmed WNV-seropositive patients were reassessed at 8 months. Main Outcome Measures Clinical, neurologic, and laboratory features at initial presentation, and long-term neurologic outcome. Results Sixteen (37%) of 39 suspected cases had antibodies against WNV; 5 had meningitis, 8 had encephalitis, and 3 had poliomyelitis-like acute flaccid paralysis. Movement disorders, including tremor (15 [94%]), myoclonus (5 [31%]) and parkinsonism (11 [69%]), were common among WNV-seropositive patients. One patient died. At 8-month followup, fatigue, headache, and myalgias were persistent symptoms; gait and movement disorders persisted in 6 patients. Patients with WNV meningitis or encephalitis had favorable outcomes, although patients with acute flaccid paralysis did not recover limb strength. Conclusions Movement disorders, including tremor, myoclonus, and parkinsonism, may be present during acute illness with WNV infection. Some patients with WNV infection and meningitis or encephalitis ultimately may have good long-term outcome, although an irreversible poliomyelitis-like syndrome may result.	CDCP, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; CDCP, Div Vector Borne Infect Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; CDCP, Epidem Intelligence Serv, Epidemiol Program Off, Atlanta, GA 30333 USA; Ochsner Clin & Alton Ochsner Med Fdn, Dept Neurol, New Orleans, LA USA; Methodist Rehabil Ctr, Ctr Neurosci & Neurol Recovery, Jackson, MS USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Ochsner Health System	Sejvar, JJ (corresponding author), CDCP, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, 1600 Clifton Rd,MS A-39, Atlanta, GA 30333 USA.	zea3@cdc.gov		Stokic, Dobrivoje/0000-0002-1891-5730				ALCOCK A, 1985, CMAJ, V130, P1305; Asnis DS, 2000, CLIN INFECT DIS, V30, P413, DOI 10.1086/313737; Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P825; Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P708; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P37; Chowers MY, 2001, EMERG INFECT DIS, V7, P675; Glass JD, 2002, NEW ENGL J MED, V347, P1280, DOI 10.1056/NEJM200210173471616; Goh KJ, 2000, NEW ENGL J MED, V342, P1229, DOI 10.1056/NEJM200004273421701; GORDON B, 1990, ARCH NEUROL-CHICAGO, V47, P646, DOI 10.1001/archneur.1990.00530060054017; Han LL, 1999, J INFECT DIS, V179, P230, DOI 10.1086/314566; Hokkanen L, 2000, NEUROPSYCHOL REV, V10, P151, DOI 10.1023/A:1009079531196; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Leis AA, 2002, NEW ENGL J MED, V347, P1279, DOI 10.1056/NEJM2002c021587; Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000; Martin DA, 2002, CLIN DIAGN LAB IMMUN, V9, P544, DOI 10.1128/CDLI.9.3.544-549.2002; Misra UK, 2002, POSTGRAD MED J, V78, P238, DOI 10.1136/pmj.78.918.238; Misra UK, 1997, J NEUROL, V244, P299, DOI 10.1007/s004150050090; Modlin John F., 1997, P57; MONATH T, 1980, ST LOUIS ENCEPHALITI, P503; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Murgod UA, 2001, NEUROLOGY, V57, P2313, DOI 10.1212/WNL.57.12.2313; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; PETROV V, 2001, MOSCOW VOPROSY VIRUS, V45, P22; Platonov AE, 2001, EMERG INFECT DIS, V7, P128, DOI 10.3201/eid0701.010118; Pradhan S, 1999, NEUROLOGY, V53, P1781, DOI 10.1212/WNL.53.8.1781; Sejvar JJ, 2003, EMERG INFECT DIS, V9, P788, DOI 10.3201/eid0907.030129; Shieh WJ, 2000, EMERG INFECT DIS, V6, P370, DOI 10.3201/eid0604.000407; SHOJI H, 1993, J NEUROL, V240, P59, DOI 10.1007/BF00838449; Solomon T, 2002, CURR TOP MICROBIOL, V267, P171; SOUTHERN PM, 1969, ANN INTERN MED, V71, P681, DOI 10.7326/0003-4819-71-4-681; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; TZENG S, 1989, CHINESE MED J, V43, P208; Wasay M, 2000, ARCH NEUROL-CHICAGO, V57, P114, DOI 10.1001/archneur.57.1.114; Weiss D, 2001, EMERG INFECT DIS, V7, P654, DOI 10.3201/eid0704.010409	35	382	396	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2003	290	4					511	515		10.1001/jama.290.4.511	http://dx.doi.org/10.1001/jama.290.4.511			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703JB	12876094				2022-12-28	WOS:000184275300023
J	Mabey, DCW; Solomon, AW; Foster, A				Mabey, DCW; Solomon, AW; Foster, A			Trachoma	LANCET			English	Review							OCULAR CHLAMYDIAL INFECTION; SINGLE-DOSE AZITHROMYCIN; POLYMERASE-CHAIN-REACTION; SURGICAL COMPLIANCE; CONTROLLED-TRIAL; CLASS-I; TRICHIASIS; SURGERY; PATHOGENESIS; ANTIBODY	Trachoma is the most common infectious cause of blindness. It is caused by ocular serovars of Chlamydia trachomatis. Transmission is favoured in poor communities, where crowding is common and access to water and sanitation inadequate. Repeated reinfection over many years causes dense scarring of the upper eyelid. The resultant inversion of the lashes abrades the eyeball, and the abrasion leads to corneal opacification and visual impairment. The host immune response is probably at least partly the cause of this process. The "SAFE" strategy is used for the control of trachoma: surgery for inturned lashes, antibiotics for active disease, facial cleanliness, and environmental improvement. The demonstration that a single oral dose of the antibiotic azithromycin is as effective as 6 weeks of topical tetracycline was an important advance in trachoma control. By means of the SAFE strategy, WHO and its partners aim to eliminate trachoma as a public-health problem by the year 2020.	Univ London London Sch Hyg & Trop Med, Clin Res Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Mabey, DCW (corresponding author), Univ London London Sch Hyg & Trop Med, Clin Res Unit, Keppel St, London WC1E 7HT, England.	david.mabey@lshtm.ac.uk		Mabey, David/0000-0002-0031-8276; Solomon, Anthony/0000-0001-7101-6649				Abu El-Asrar AM, 1998, EYE, V12, P735; ABUELASRAR AM, 1989, BRIT J OPHTHALMOL, V73, P276, DOI 10.1136/bjo.73.4.276; Bailey R, 1999, EPIDEMIOL INFECT, V123, P479, DOI 10.1017/S0950268899003076; BAILEY RL, 1994, J INFECT DIS, V170, P709, DOI 10.1093/infdis/170.3.709; BAILEY RL, 1993, LANCET, V342, P453, DOI 10.1016/0140-6736(93)91591-9; BAILEY RL, 1993, EPIDEMIOL INFECT, V111, P315, DOI 10.1017/S0950268800057022; BAILEY RL, 1995, INFECT IMMUN, V63, P389, DOI 10.1128/IAI.63.2.389-392.1995; Baral K, 1999, B WORLD HEALTH ORGAN, V77, P461; Barron A. L., 1988, MICROBIOLOGY CHLAMYD; BEATTY WL, 1994, INFECT IMMUN, V62, P3705, DOI 10.1128/IAI.62.9.3705-3711.1994; BEATTY WL, 1994, MICROBIOL REV, V58, P686, DOI 10.1128/MMBR.58.4.686-699.1994; BOBO L, 1991, LANCET, V338, P847, DOI 10.1016/0140-6736(91)91502-L; Bobo LD, 1997, J INFECT DIS, V176, P1524, DOI 10.1086/514151; BOG H, 1993, BRIT J OPHTHALMOL, V77, P81, DOI 10.1136/bjo.77.2.81; Bowman RJC, 2000, TROP MED INT HEALTH, V5, P528, DOI 10.1046/j.1365-3156.2000.00605.x; Bowman RJC, 2000, INVEST OPHTH VIS SCI, V41, P4074; Bryan C.P.t., 1930, PAPYRUS EBERS TRANSL; Chern KC, 1999, BRIT J OPHTHALMOL, V83, P1332, DOI 10.1136/bjo.83.12.1332; COLLIER L H, 1958, Br J Ophthalmol, V42, P705, DOI 10.1136/bjo.42.12.705; Conway DJ, 1997, INFECT IMMUN, V65, P1003, DOI 10.1128/IAI.65.3.1003-1006.1997; Conway DJ, 1996, J INFECT DIS, V174, P643, DOI 10.1093/infdis/174.3.643; COURTRIGHT P, 1994, E AFR MED J, V71, P803; Dawson CR, 1997, CLIN INFECT DIS, V24, P363, DOI 10.1093/clinids/24.3.363; Dawson CR, 1981, GUIDE TRACHOMA CONTR; Duke-Elder W. S., 1937, TXB OPHTHALMOLOGY; Emerson PM, 1999, LANCET, V353, P1401, DOI 10.1016/S0140-6736(98)09158-2; FAAL H, 1989, BRIT J OPHTHALMOL, V73, P82, DOI 10.1136/bjo.73.2.82; Fehlner-Gardiner C, 2002, J BIOL CHEM, V277, P26893, DOI 10.1074/jbc.M203937200; Frick KD, 2001, B WORLD HEALTH ORGAN, V79, P201; GRAYSTON JT, 1985, REV INFECT DIS, V7, P717; Halberstaedter L, 1907, ARBEITEN KAISERLICHE, V26, P44; HOLLAND MJ, 1993, J INFECT DIS, V168, P1528, DOI 10.1093/infdis/168.6.1528; Holm SO, 2001, B WORLD HEALTH ORGAN, V79, P194; JONES BR, 1975, T OPHTHAL SOC UK, V95, P16; Leach AJ, 1997, CLIN INFECT DIS, V24, P356, DOI 10.1093/clinids/24.3.356; Lietman T, 1999, NAT MED, V5, P572, DOI 10.1038/8451; MABEY DCW, 1992, EPIDEMIOL INFECT, V108, P343, DOI 10.1017/S0950268800049815; MALATY R, 1981, J INFECT DIS, V143, P853, DOI 10.1093/infdis/143.6.853; MORRISON RP, 1989, J EXP MED, V169, P663, DOI 10.1084/jem.169.3.663; Oliva MS, 1997, INT OPHTHALMOL, V21, P235, DOI 10.1023/A:1006045824191; PEELING R, 1984, INFECT IMMUN, V46, P484, DOI 10.1128/IAI.46.2.484-488.1984; Peeling RW, 1998, J INFECT DIS, V177, P256, DOI 10.1086/517367; REACHER MH, 1991, OPHTHALMOLOGY, V98, P334; REACHER MH, 1992, ARCH OPHTHALMOL-CHIC, V110, P667, DOI 10.1001/archopht.1992.01080170089030; REACHER MH, 1990, BRIT J OPHTHALMOL, V74, P109, DOI 10.1136/bjo.74.2.109; Schachter J, 1999, LANCET, V354, P630, DOI 10.1016/S0140-6736(98)12387-5; Solomon AW, 2001, B WORLD HEALTH ORGAN, V79, P8; Somani Jyoti, 2000, Journal of Infectious Diseases, V181, P1421, DOI 10.1086/315372; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Tabbara KF, 1996, OPHTHALMOLOGY, V103, P842; TANG F F, 1957, Chin Med J, V75, P429; TAYLOR HR, 1989, ARCH OPHTHALMOL-CHIC, V107, P1821, DOI 10.1001/archopht.1989.01070020903037; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; TREHARNE JD, 1985, REV INFECT DIS, V7, P760; WANG SP, 1967, AM J OPHTHALMOL, V63, P1615, DOI 10.1016/0002-9394(67)94155-4; WARD M, 1990, SCAND J INFECT DIS, P137; WEST S, 1994, INT OPHTHALMOL, V18, P105, DOI 10.1007/BF00919249; WEST S, 1995, LANCET, V345, P155, DOI 10.1016/S0140-6736(95)90167-1; WEST SK, 1991, ARCH OPHTHALMOL-CHIC, V109, P855, DOI 10.1001/archopht.1991.01080060119038; WHITTUMHUDSON JA, 1986, INVEST OPHTH VIS SCI, V27, P64; World Health Organization, 1997, WHOPBL9760; Zhong GM, 2000, J EXP MED, V191, P1525, DOI 10.1084/jem.191.9.1525; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	72	157	161	1	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2003	362	9379					223	229		10.1016/S0140-6736(03)13914-1	http://dx.doi.org/10.1016/S0140-6736(03)13914-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702PJ	12885486				2022-12-28	WOS:000184232000024
J	Wrenger, E; Muller, R; Moesenthin, M; Welte, T; Frolich, JC; Neumann, KH				Wrenger, E; Muller, R; Moesenthin, M; Welte, T; Frolich, JC; Neumann, KH			Lesson of the week - Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases	BRITISH MEDICAL JOURNAL			English	Review							CONGESTIVE-HEART-FAILURE; LIFE-THREATENING HYPERKALEMIA; CONVERTING ENZYME-INHIBITORS; HYPORENINEMIC HYPOALDOSTERONISM; COMBINED THERAPY; RALES		Univ Magdeburg, Div Nephrol, Dept Internal Med, D-39120 Magdeburg, Germany; Univ Magdeburg, Div Cardiol Pulmonol & Angiol, Dept Internal Med, D-39120 Magdeburg, Germany; Hannover Med Sch, Inst Clin Pharmacol, Hannover, Germany	Otto von Guericke University; Otto von Guericke University; Hannover Medical School	Wrenger, E (corresponding author), Univ Magdeburg, Div Nephrol, Dept Internal Med, Leipziger Str 44, D-39120 Magdeburg, Germany.							Bauersachs J, 2000, CIRCULATION, V102, P2325, DOI 10.1161/01.CIR.102.19.2325; Berry C, 2001, Heart, V85, pE8, DOI 10.1136/heart.85.4.e8; Blaustein DA, 2002, AM J CARDIOL, V90, P662, DOI 10.1016/S0002-9149(02)02580-8; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; DEFRONZO RA, 1980, KIDNEY INT, V17, P118, DOI 10.1038/ki.1980.14; Evers S, 1998, J NEUROL NEUROSUR PS, V64, P249, DOI 10.1136/jnnp.64.2.249; Georges B, 2000, LANCET, V355, P1369, DOI 10.1016/S0140-6736(05)72606-4; Greenberg A, 2000, AM J MED SCI, V319, P10, DOI 10.1097/00000441-200001000-00002; Hu YW, 2002, ANESTH ANALG, V95, P39, DOI 10.1097/00000539-200207000-00006; JACKSON EK, 1996, GOODMAN GILMANS PHAR, P733; JOHNSTON RT, 1992, INT J CARDIOL, V34, P213, DOI 10.1016/0167-5273(92)90159-Z; LARGE DM, 1984, POSTGRAD MED J, V60, P370, DOI 10.1136/pgmj.60.703.370; Millane T, 2000, BRIT MED J, V320, P559, DOI 10.1136/bmj.320.7234.559; Obialo CI, 2002, AM J CARDIOL, V90, P663, DOI 10.1016/S0002-9149(02)02581-X; Pitt B, 1996, AM J CARDIOL, V78, P902; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Schepkens H, 2001, AM J MED, V110, P438, DOI 10.1016/S0002-9343(01)00642-8; Vanpee D, 2000, AGING-CLIN EXP RES, V12, P315, DOI 10.1007/BF03339853	18	82	87	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 19	2003	327	7407					147	149		10.1136/bmj.327.7407.147	http://dx.doi.org/10.1136/bmj.327.7407.147			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702WJ	12869459	Green Published			2022-12-28	WOS:000184247500022
J	Rudnick, DL; Boyd, TJ; Brainard, RE; Carter, GS; Egbert, GD; Gregg, MC; Holloway, PE; Klymak, JM; Kunze, E; Lee, CM; Levine, MD; Luther, DS; Martin, JP; Merrifield, MA; Moum, JN; Nash, JD; Pinkel, R; Rainville, L; Sanford, TB				Rudnick, DL; Boyd, TJ; Brainard, RE; Carter, GS; Egbert, GD; Gregg, MC; Holloway, PE; Klymak, JM; Kunze, E; Lee, CM; Levine, MD; Luther, DS; Martin, JP; Merrifield, MA; Moum, JN; Nash, JD; Pinkel, R; Rainville, L; Sanford, TB			From tides to mixing along the Hawaiian ridge	SCIENCE			English	Article							INTERNAL TIDES; ABYSSAL OCEAN; DEEP-OCEAN; DISSIPATION; SEAMOUNT	The cascade from tides to turbulence has been hypothesized to serve as a major energy pathway for ocean mixing. We investigated this cascade along the Hawaiian Ridge using observations and numerical models. A divergence of internal tidal energy flux observed at the ridge agrees with the predictions of internal tide models. Large internal tidal waves with peak-to-peak amplitudes of up to 300 meters occur on the ridge. Internal-wave energy is enhanced, and turbulent dissipation in the region near the ridge is 10 times larger than open-ocean values. Given these major elements in the tides-to-turbulence cascade, an energy budget approaches closure.	Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; NOAA, Natl Marine Fisheries Serv, Pacific Isl Fisheries Sci Ctr, Honolulu Lab, Honolulu, HI 96822 USA; Univ Washington, Appl Phys Lab, Seattle, WA 98105 USA; Univ New S Wales, Sch Geog & Oceanog, Canberra, ACT 2600, Australia; Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Oregon State University; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle; Australian Defense Force Academy; University of New South Wales Sydney; University of Hawaii System	Rudnick, DL (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.		Klymak, Jody M./AAD-7557-2021; Luther, Douglas/ABF-4047-2020; Rudnick, Daniel L/J-8948-2016; Moum, James N/A-1880-2012; Nash, Jonathan/K-8101-2019; Moum, James N/N-1187-2019; Klymak, Jody M/A-3041-2008	Klymak, Jody M./0000-0003-4612-8600; Rudnick, Daniel L/0000-0002-2624-7074; Klymak, Jody M/0000-0003-4612-8600; Egbert, Gary/0000-0003-1276-8538; Nash, Jonathan/0000-0003-4005-9368				BOYD T, 2002, 20021 OR STAT U; Egbert G. D, 2001, J GEOPHYS RES, V106, P22; Egbert GD, 2000, NATURE, V405, P775, DOI 10.1038/35015531; Finnigan TD, 2002, J PHYS OCEANOGR, V32, P2988, DOI 10.1175/1520-0485(2002)032<2988:OOEDMN>2.0.CO;2; GREGG MC, 1989, J GEOPHYS RES-OCEANS, V94, P9686, DOI 10.1029/JC094iC07p09686; Hogg N, 1982, J MAR RES, V40, P231; Kunze E, 1997, J PHYS OCEANOGR, V27, P2663, DOI 10.1175/1520-0485(1997)027<2663:TDVDSA>2.0.CO;2; LEDWELL JR, 1993, NATURE, V364, P701, DOI 10.1038/364701a0; Lueck RG, 1997, SCIENCE, V276, P1831, DOI 10.1126/science.276.5320.1831; Merrifield MA, 2001, GEOPHYS RES LETT, V28, P559, DOI 10.1029/2000GL011749; MERRIFIELD MA, 2002, J GEOPHYS RES, V107; MITCHUM GT, 2000, J GEOPHYS RES, V105, P28; MOROZOV EG, 1995, DEEP-SEA RES PT I, V42, P135, DOI 10.1016/0967-0637(95)92886-C; Moum JN, 2002, J PHYS OCEANOGR, V32, P2113, DOI 10.1175/1520-0485(2002)032<2113:OOBMOT>2.0.CO;2; Munk W, 1998, DEEP-SEA RES PT I, V45, P1977, DOI 10.1016/S0967-0637(98)00070-3; MUNK W., 1966, DEEP SEA RES OCEANOG, V13, P707, DOI [10.1016/0011-7471(66)90602-4, DOI 10.1016/0011-7471(66)90602-4]; Munk W.H., 1981, EVOLUTION PHYS OCEAN, P264, DOI DOI 10.1121/1.3425741; OSBORN TR, 1980, J PHYS OCEANOGR, V10, P83, DOI 10.1175/1520-0485(1980)010<0083:EOTLRO>2.0.CO;2; Polzin KL, 1996, NATURE, V380, P54, DOI 10.1038/380054a0; Polzin KL, 1997, SCIENCE, V276, P93, DOI 10.1126/science.276.5309.93; ROEMMICH D, 1996, J GEOPHYS RES, V101, P14; Sanford T. B., 1985, Journal of Atmospheric and Oceanic Technology, V2, P110, DOI 10.1175/1520-0426(1985)002<0110:AADAEV>2.0.CO;2; St Laurent L, 2002, J PHYS OCEANOGR, V32, P2882, DOI 10.1175/1520-0485(2002)032<2882:TROITI>2.0.CO;2; TOOLE JM, 1994, SCIENCE, V264, P1120, DOI 10.1126/science.264.5162.1120	24	255	259	2	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2003	301	5631					355	357		10.1126/science.1085837	http://dx.doi.org/10.1126/science.1085837			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869758				2022-12-28	WOS:000184207300040
J	Rombough, P				Rombough, P			Communications arising - Development rate - Modelling developmental time and temperature	NATURE			English	Editorial Material									Brandon Univ, Dept Zool, Brandon, MB R7A 6A9, Canada	Brandon University	Rombough, P (corresponding author), Brandon Univ, Dept Zool, Brandon, MB R7A 6A9, Canada.		Rombough, Peter/I-1477-2013					BROWN HA, 1975, COMP BIOCHEM PHYSIOL, V50, P397, DOI 10.1016/0300-9629(75)90033-X; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; Rombought P. J, 1997, GLOBAL WARMING IMPLI, P177, DOI DOI 10.1007/BF02523274; STEPHENS RE, 1972, BIOL BULL, V142, P132, DOI 10.2307/1540251; VELSEN FPJ, 1987, CAN DATA REP FISH AQ, V626, P19	6	11	12	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					268	269		10.1038/424268a	http://dx.doi.org/10.1038/424268a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867969				2022-12-28	WOS:000184183900028
J	Sprung, CL; Cohen, SL; Sjokvist, P; Baras, M; Bulow, HH; Hovilehto, S; Ledoux, D; Lippert, A; Maia, P; Phelan, D; Schobersberger, W; Wennberg, E; Woodcock, T				Sprung, CL; Cohen, SL; Sjokvist, P; Baras, M; Bulow, HH; Hovilehto, S; Ledoux, D; Lippert, A; Maia, P; Phelan, D; Schobersberger, W; Wennberg, E; Woodcock, T		Ethicus Study Grp	End-of-life practices in European intensive care units - The ethicus study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUSTAINING TREATMENT; SUPPORT; WITHDRAWAL; DECISIONS; STATES	Context While the adoption of practice guidelines is standardizing many aspects of patient care, ethical dilemmas are occurring because of forgoing life-sustaining therapies in intensive care and are dealt with in diverse ways between different countries and cultures. Objectives To determine the frequency and types of actual end-of-life practices in European intensive care units (ICUs) and to analyze the similarities and differences. Design and Setting A prospective, observational study of European ICUs. Participants Consecutive patients who died or had any limitation of therapy. Intervention Prospectively defined end-of-life practices in 37 ICUs in 17 European countries were studied from January 1, 1999, to June 30, 2000. Main Outcome Measures Comparison and analysis of the frequencies and patterns of end-of-life care by geographic regions and different patients and professionals. Results Of 31417 patients admitted to ICUs, 4248 patients (13.5%) died or had a limitation of life-sustaining therapy. Of these, 3086 patients (72.6%) had limitations of treatments (10% of admissions). Substantial intercountry variability was found in the limitations and the manner of dying: unsuccessful cardiopulmonary resuscitation in 20% (range, 5%-48%), brain death in 8% (range, 0%-15%), withholding therapy in 38% (range, 16%-70%), withdrawing therapy in 33% (range, 5%-69%), and active shortening of the dying process in 2% (range, 0%-19%). Shortening of the dying process was reported in 7 countries. Doses of opioids and benzodiazepines reported for shortening of the dying process were in the same range as those used for symptom relief in previous studies. Limitation of therapy vs continuation of life-sustaining therapy was associated with patient age, acute and chronic diagnoses, number of days in ICU, region, and religion (P<.001). Conclusion The limiting of life-sustaining treatment in European ICUs is common and variable. Limitations were associated with patient age, diagnoses, ICU stay, and geographic and religious factors. Although shortening of the dying process is rare, clarity between withdrawing therapies and shortening of the dying process and between therapies intended to relieve pain and suffering and those intended to shorten the dying process may be lacking.	Hadassah Hebrew Univ, Med Ctr, Dept Anesthesiol & Crit Care Med, Gen Intens Care Unit, IL-91120 Jerusalem, Israel; UCL, Dept Med, London, England; Orebro Univ Hosp, Dept Anesthesiol, Orebro, Sweden; Hadassah Hebrew Univ, Med Ctr, Dept Social Med, IL-91120 Jerusalem, Israel; Univ Hosp Glostrup, Dept Anesthesiol, Glostrup, Denmark; S Karelia Cent Hosp, Dept Anesthesiol, Lappeenranta, Finland; Univ Liege, Dept Anesthesiol & Intens Care Med, Liege, Belgium; Herlev Univ Hosp, Dept Anesthesiol, DK-2730 Herlev, Denmark; Hosp Geral Santo Antonio, Dept Intens Care, Oporto, Portugal; Mater Hosp Univ Coll, Dept Intens Care, Dublin, Ireland; Univ Innsbruck Hosp, Div Gen & Surg Intens Care Med, A-6020 Innsbruck, Austria; Sahlgrens Univ Hosp, Dept Anesthesia & Intens Care, S-41345 Gothenburg, Sweden; Southampton Univ Hosp NHS Trust, Crit Care Directorate, Southampton, Hants, England	Hebrew University of Jerusalem; Hadassah University Medical Center; University of London; University College London; Orebro University; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Copenhagen; University of Liege; University of Copenhagen; Herlev & Gentofte Hospital; Mater Misericordiae University Hospital; Medical University of Innsbruck; Sahlgrenska University Hospital; University of Southampton; University Hospital Southampton NHS Foundation Trust	Sprung, CL (corresponding author), Hadassah Hebrew Univ, Med Ctr, Dept Anesthesiol & Crit Care Med, Gen Intens Care Unit, POB 12000, IL-91120 Jerusalem, Israel.		Bouza, Carmen/F-4626-2016; Ledoux, Didier/ABA-8401-2021	Bouza, Carmen/0000-0002-8089-9866; Ledoux, Didier/0000-0002-9314-6564; Woodcock, Thomas/0000-0001-5878-4379				[Anonymous], 1991, Am Rev Respir Dis, V144, P726; CHRISTAKIS NA, 1995, AM J PUBLIC HEALTH, V85, P367, DOI 10.2105/AJPH.85.3.367; COOK DJ, 1995, JAMA-J AM MED ASSOC, V273, P703, DOI 10.1001/jama.273.9.703; Cook DJ, 2001, LANCET, V358, P1941, DOI 10.1016/S0140-6736(01)06960-4; Deliens L, 2000, LANCET, V356, P1806, DOI 10.1016/S0140-6736(00)03233-5; Eidelman LA, 1998, INTENS CARE MED, V24, P162, DOI 10.1007/s001340050539; Esteban A, 2001, INTENS CARE MED, V27, P1744, DOI 10.1007/s00134-001-1111-7; Ferrand E, 2001, LANCET, V357, P9, DOI 10.1016/S0140-6736(00)03564-9; Hall RI, 2000, CHEST, V118, P1424, DOI 10.1378/chest.118.5.1424; Keenan SP, 1998, CRIT CARE MED, V26, P245, DOI 10.1097/00003246-199802000-00018; Keenan SP, 1997, CRIT CARE MED, V25, P1324, DOI 10.1097/00003246-199708000-00019; KLESSIG J, 1992, WESTERN J MED, V157, P316; McHaffie HE, 1999, J MED ETHICS, V25, P440, DOI 10.1136/jme.25.6.440; *PC STUD ETH PROBL, 1983, DEC FOR LIF SUST TRE; Prendergast TJ, 1998, AM J RESP CRIT CARE, V158, P1163, DOI 10.1164/ajrccm.158.4.9801108; Prendergast TJ, 1997, AM J RESP CRIT CARE, V155, P15, DOI 10.1164/ajrccm.155.1.9001282; QUILL TE, 1993, NEW ENGL J MED, V329, P1039, DOI 10.1056/NEJM199309303291414; Richter J, 2001, J MED ETHICS, V27, P186, DOI 10.1136/jme.27.3.186; *SOC CRIT CAR MED, 1990, CRIT CARE MED, V18, P1435; SPRUNG CL, 1992, CRIT CARE MED, V20, P320; Sprung CL, 1996, INTENS CARE MED, V22, P1003; Sprung CL, 1997, CRIT CARE MED, V25, P383, DOI 10.1097/00003246-199703000-00002; Sprung CL, 1996, MAYO CLIN PROC, V71, P512, DOI 10.4065/71.5.512; TERES D, 1993, INTENS CARE MED, V19, P316, DOI 10.1007/BF01694704; Truog RD, 2001, CRIT CARE MED, V29, P2332, DOI 10.1097/00003246-200112000-00017; Turner JS, 1996, INTENS CARE MED, V22, P1020, DOI 10.1007/s001340050207; van der Maas PJ, 1996, NEW ENGL J MED, V335, P1699, DOI 10.1056/NEJM199611283352227; VINCENT JL, 1989, CRIT CARE MED, V17, P530, DOI 10.1097/00003246-198906000-00009; Vincent JL, 1999, CRIT CARE MED, V27, P1626, DOI 10.1097/00003246-199908000-00042; WILSON WC, 1992, JAMA-J AM MED ASSOC, V267, P949	30	703	722	2	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2003	290	6					790	797		10.1001/jama.290.6.790	http://dx.doi.org/10.1001/jama.290.6.790			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	709VU	12915432				2022-12-28	WOS:000184647700030
J	Rasaratnam, B; Kaye, D; Jennings, G; Dudley, F; Chin-Dusting, J				Rasaratnam, B; Kaye, D; Jennings, G; Dudley, F; Chin-Dusting, J			The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							SPONTANEOUS BACTERIAL PERITONITIS; NITRIC-OXIDE SYNTHASE; LIVER-CIRRHOSIS; NORFLOXACIN; ASCITES; VASODILATION; ENDOTOXEMIA; EXPRESSION; SEVERITY; DISEASE	Background: Peripheral vasodilatation is central to the pathogenesis of the accompanying hyperkinetic circulatory state and portal hypertension in cirrhotic patients. Selective intestinal decontamination with norfloxacin has been demonstrated to partially correct nitric oxide production in the forearm vasculature of cirrhotic patients. Objective: To examine the effects of selective intestinal decontamination on regional and systemic hemodynamics in cirrhotic patients. Design: Randomized, double-blind, placebo-controlled, crossover study. Setting: Alfred Hospital, Melbourne, Australia. Patients: 14 patients with alcohol-related cirrhosis and 14 matched healthy controls. Intervention: Norfloxacin, 400 mg twice daily, for 4 weeks. Measurements: Venous occlusion plethysmography was used to determine forearm blood flow. Cardiac output and the hepatic venous pressure gradient were determined after cardiac catheterization. Glomerular filtration rate was assessed by measuring inulin clearance. Serum levels of endotoxin were determined by chromogenic Limulus amebocytelysate assay. Results: Norfloxacin significantly diminished serum endotoxin levels (average change, -2.14 EU/mL [95% CI, -3.6 to -0.68 EU/mL]). Derived systemic vascular resistance increased significantly with norfloxacin (2.94 units [CI, 0.74 to 5.11 units]) and was accompanied by an increase in mean arterial pressure (8.70 mm Hg [CI, 2.65 to 14.73]), a trend toward decreased cardiac output (-1.207 L/min [range, 0.05 to -2.37 L/min]), a decrease in forearm blood flow (-0.99 mL/100 mL per min [CI, -1.80 to -0.17 mL/100 mL per min]), and a trend toward reduced hepatic venous pressure gradient (-2.43 mm Hg [CI, -5.2 to 0.34 mm Hg]). Norfloxacin did not significantly alter glomerular filtration rate. Conclusion: Selective intestinal decontamination with norfloxacin partially reverses the hyperdynamic circulatory state in cirrhotic patients without harming splanchnic or renal hemodynamics.	Alfred Hosp, Prahran, Vic 3181, Australia; Baker Med Res Inst, Prahran, Vic 3181, Australia	Florey Institute of Neuroscience & Mental Health; Baker Heart and Diabetes Institute	Chin-Dusting, J (corresponding author), Baker Med Res Inst, POB 6492,St Kilda Rd Cent, Melbourne, Vic 8008, Australia.	j.chin@alfred.org.au	Jennings, Garry/B-3914-2009; Kaye, David/AAF-1202-2021	Kaye, David/0000-0003-4058-0372; Jennings, Garry/0000-0002-7865-5483				ARROYO V, 1992, GASTROENTEROLOGY, V102, P1077, DOI 10.1016/0016-5085(92)90203-B; BELLENTANI S, 1994, HEPATOLOGY, V20, P1442, DOI 10.1002/hep.1840200611; Chang CS, 1998, HEPATOLOGY, V28, P1187, DOI 10.1002/hep.510280504; ChinDusting JPF, 1997, ANN INTERN MED, V127, P985, DOI 10.7326/0003-4819-127-11-199712010-00007; DEITCH EA, 1990, AM J SURG, V159, P79, DOI 10.1016/S0002-9610(05)80610-5; EDLUND C, 1987, SCAND J INFECT DIS, V19, P113, DOI 10.3109/00365548709032386; EPSTEIN M, 1970, AM J MED, V49, P175, DOI 10.1016/S0002-9343(70)80073-0; Garcia-Tsao G, 2001, GASTROENTEROLOGY, V120, P726, DOI 10.1053/gast.2001.22580; GINES P, 1990, HEPATOLOGY, V12, P716, DOI 10.1002/hep.1840120416; GUARNER C, 1993, HEPATOLOGY, V18, P1139; Hori N, 1996, CLIN EXP PHARMACOL P, V23, P30; IWANAGA S, 1978, HAEMOSTASIS, V7, P183; JOHNSON PC, 1986, ANTIMICROB AGENTS CH, V30, P671, DOI 10.1128/AAC.30.5.671; LIN RS, 1995, J HEPATOL, V22, P165, DOI 10.1016/0168-8278(95)80424-2; LLACH J, 1988, GASTROENTEROLOGY, V94, P482, DOI 10.1016/0016-5085(88)90441-6; LUMSDEN AB, 1988, HEPATOLOGY, V8, P232, DOI 10.1002/hep.1840080207; Martin PY, 1996, AM J PHYSIOL-RENAL, V270, pF494, DOI 10.1152/ajprenal.1996.270.3.F494; MoralesRuiz M, 1996, HEPATOLOGY, V24, P1481, DOI 10.1002/hep.510240630; RAIJ L, 1995, KIDNEY INT, V48, P20, DOI 10.1038/ki.1995.262; Sanchez-Rodriguez A, 1998, CLIN SCI, V94, P637, DOI 10.1042/cs0940637; TRIGER DR, 1978, GUT, V19, P935, DOI 10.1136/gut.19.10.935	21	158	160	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2003	139	3					186	193		10.7326/0003-4819-139-3-200308050-00008	http://dx.doi.org/10.7326/0003-4819-139-3-200308050-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707RH	12899586				2022-12-28	WOS:000184523300004
J	Cinatl, J; Morgenstern, B; Bauer, G; Chandra, P; Rabenau, H; Doerr, HW				Cinatl, J; Morgenstern, B; Bauer, G; Chandra, P; Rabenau, H; Doerr, HW			Treatment of SARS with human interferons	LANCET			English	Article							IDENTIFICATION; CORONAVIRUS; VIRUS	Effective antiviral agents are needed to treat severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infection. We assessed the antiviral potential of recombinant interferons against two clinical isolates of SARS-CoV-FFM-1, from Frankfurt patients, and Hong Kong-replicated in Vero and Caco2 cells. Interferon beta was five to ten times more effective in Caco2 cells. Interferon alpha effectively inhibited SARS-CoV replication, but with a selectivity index 50-90 times lower than that for interferon beta. Interferon gamma was slightly better than interferon alpha in Vero cell cultures, but was completely ineffective in Caco2 cell cultures. Interferon beta could be useful alone or in combination with other antiviral drugs for the treatment of SARS.	Univ Frankfurt, Sch Med, Inst Med Virol, D-60596 Frankfurt, Germany	Goethe University Frankfurt	Cinatl, J (corresponding author), Univ Frankfurt, Sch Med, Inst Med Virol, Paul Ehrlich Str 40, D-60596 Frankfurt, Germany.	cinatl@em.uni-frankfurt.de						Cinatl J, 2003, LANCET, V361, P2045, DOI 10.1016/S0140-6736(03)13615-X; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Garcia S, 2001, J CLIN MICROBIOL, V39, P4456, DOI 10.1128/JCM.39.12.4456-4461.2001; Pitkaranta A, 1999, J CLIN VIROL, V14, P199, DOI 10.1016/S1386-6532(99)00056-6	5	317	361	0	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2003	362	9380					293	294		10.1016/S0140-6736(03)13973-6	http://dx.doi.org/10.1016/S0140-6736(03)13973-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705UL	12892961	Bronze, Green Published			2022-12-28	WOS:000184413400013
J	Redinbaugh, EM; Sullivan, AM; Block, SD; Gadmer, NM; Lakoma, M; Mitchell, AM; Seltzer, D; Wolford, J; Arnold, RM				Redinbaugh, EM; Sullivan, AM; Block, SD; Gadmer, NM; Lakoma, M; Mitchell, AM; Seltzer, D; Wolford, J; Arnold, RM			Doctors' emotional reactions to recent death of a patient: cross sectional study of hospital doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Article							STRESS; PHYSICIANS	Objectives To describe doctors' emotional reactions to the recent death of an "average" patient and to explore the effects of level of training on doctors' reactions. Design Cross sectional study using quantitative data. Setting Two academic teaching hospitals in the United States. Participants 188 doctors (attending physicians (equivalent to UK consultants), residents (equivalent to UK senior house officers), and interns (equivalent to UK junior house officers)) who cared for 68 patients who died in the hospital. Main outcome measures Doctors' experiences in providing care, their emotional reactions to the patient's death, and their use of coping and social resources to manage their emotions. Results Most doctors (139/188, 74%) reported satisfying experiences in caring for a dying patient. Doctors reported moderate levels of emotional impact (mean 4.7 (SD 2.4) on a 0-10 scale) from the death. Women and those doctors who had cared for the patient for a longer time experienced stronger emotional reactions. Level of training was not related to emotional reactions, but interns reported needing significantly more emotional support than attending physicians. Although most junior doctors discussed the patient's death with an attending physician, less than a quarter of interns and residents found senior teaching staff (attending physicians) to be the most helpful source of support. Conclusions Doctors who spend a longer time caring for their patients get to know them better but this also makes them more vulnerable to feelings of loss when these patients die. Medical teams may benefit from debriefing within the department to give junior doctors an opportunity to share emotional responses and reflect on the patient's death.	Univ Pittsburgh, Inst Canc, Dept Behav Med & Oncol, Pittsburgh, PA 15232 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Psychosocial Oncol & Palliat Care, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02115 USA; Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Internal Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Redinbaugh, EM (corresponding author), Univ Pittsburgh, Inst Canc, Dept Behav Med & Oncol, 5150 Ctr Ave 445, Pittsburgh, PA 15232 USA.	ellenr@pitt.edu		Sullivan, Amy/0000-0003-1020-3197				BEHNKE M, 1987, DEATH STUD, V11, P169, DOI 10.1080/07481188708252189; Belle D., 1991, STRESS COPING ANTHOL, P258; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Field D, 1998, SOC SCI MED, V46, P1111, DOI 10.1016/S0277-9536(97)10041-7; Firth-Cozens J, 2001, SOC SCI MED, V52, P215, DOI 10.1016/S0277-9536(00)00221-5; FIRTHCOZENS J, 1989, STRESS MEDICINE, V5, P121, DOI 10.1002/smi.2460050210; FIRTHCOZENS J, 1987, BRIT MED J, V295, P533, DOI 10.1136/bmj.295.6597.533; Graham J, 1996, PALLIATIVE MED, V10, P185, DOI 10.1177/026921639601000302; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Jacobs S C, 1986, Hosp J, V2, P21; KRAKOWSKI AJ, 1982, PSYCHOTHER PSYCHOSOM, V38, P11, DOI 10.1159/000287609; LEE ES, 1989, ANAL COMPLEX SURVEY, V71; Meier DE, 2001, JAMA-J AM MED ASSOC, V286, P3007, DOI 10.1001/jama.286.23.3007; MOLASSIOTIS A, 1995, BONE MARROW TRANSPL, V15, P449; Mulder J, 2000, J PALLIATIVE CARE, V16, P25, DOI 10.1177/082585970001600205; Papadatou Danai, 2002, Pediatr Nurs, V28, P345; Purdy R R, 1987, Fam Med, V19, P203; REVICKI DA, 1993, BEHAV MED, V19, P74, DOI 10.1080/08964289.1993.9937568; Shanafelt TD, 2003, AM J MED, V114, P513, DOI 10.1016/S0002-9343(03)00117-7; URBACH J R, 1989, Psychiatric Quarterly (New York), V60, P283, DOI 10.1007/BF01064352; WHIPPEN DA, 1991, J CLIN ONCOL, V9, P1916, DOI 10.1200/JCO.1991.9.10.1916; Whitfield KE, 2002, J CONSULT CLIN PSYCH, V70, P463, DOI 10.1037//0022-006X.70.3.463	22	182	186	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 26	2003	327	7408					185	189		10.1136/bmj.327.7408.185	http://dx.doi.org/10.1136/bmj.327.7408.185			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	706DL	12881257	Bronze, Green Published			2022-12-28	WOS:000184437300013
J	Meili, R; Firtel, RA				Meili, R; Firtel, RA			Two poles and a compass	CELL			English	Review							CHEMOTAXIS; PI3K-GAMMA; POLARITY; ROLES; RHOA	Rho GTPases control fundamental aspects of neutrophil chemotaxis: establishment of front and back and orientation toward the chemoattractant. Two reports in this issue show that activated Cdc42 at the leading edge helps orient the cell's axis in a signaling complex with Gbetagamma, PAK1, and PIXalpha; while Rho, activated via Galpha13, mediates formation of the uropod, which then interacts by mutual negative feedback with the front to reinforce polarization (Li et al., 2003 [this issue of Cell]; Xu et al., 2003 [this issue of Cell]).	Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Firtel, RA (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rafirtel@ucsd.edu						Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Chung CY, 2001, MOL CELL, V7, P937, DOI 10.1016/S1097-2765(01)00247-7; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Firtel RA, 2000, BIOESSAYS, V22, P603, DOI 10.1002/1521-1878(200007)22:7<603::AID-BIES3>3.0.CO;2-#; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Gulli MP, 2001, GENE DEV, V15, P365, DOI 10.1101/gad.876901; IGLESIAS PA, 2002, SCI STKE; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; WESSELS D, 1988, DEV BIOL, V128, P164, DOI 10.1016/0012-1606(88)90279-5; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Worthylake RA, 2003, J BIOL CHEM, V278, P13578, DOI 10.1074/jbc.M211584200; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5	20	67	71	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 25	2003	114	2					153	156		10.1016/S0092-8674(03)00553-1	http://dx.doi.org/10.1016/S0092-8674(03)00553-1			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887916	Bronze			2022-12-28	WOS:000184378700004
J	Kim, M; McCormick, S; Timmermans, M; Sinha, N				Kim, M; McCormick, S; Timmermans, M; Sinha, N			The expression domain of PHANTASTICA determines leaflet placement in compound leaves	NATURE			English	Article								Diverse leaf forms in nature can be categorized as simple or compound. Simple leaves, such as those of petunia, have a single unit of blade, whereas compound leaves, such as those of tomato, have several units of blades called leaflets. Compound leaves can be pinnate, with leaflets arranged in succession on a rachis, or palmate, with leaflets clustered together at the leaf tip. The mechanisms that generate these various leaf forms are largely unknown. The upper (adaxial) surface is usually different from the bottom (abaxial) surface in both simple and compound leaves. In species with simple leaves, the specification of adaxial and abaxial cells is important for formation of the leaf blade(1,2), and the MYB transcription factor gene PHANTASTICA (PHAN) is involved in maintaining the leaf adaxial (upper) domain(3,4). Here we show that downregulation of PHAN is sufficient to reduce the adaxial domain of leaf primordia and to change pinnate compound leaves into palmate compound leaves. Furthermore, this mechanism seems to be shared among compound leaves that arose independently.	Univ Calif Davis, Plant Biol Sect, Davis, CA 95616 USA; USDA ARS, Ctr Plant Gene Express, Albany, CA 94710 USA; Univ Calif Berkeley, Albany, CA 94710 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	University of California System; University of California Davis; United States Department of Agriculture (USDA); University of California System; University of California Berkeley; Cold Spring Harbor Laboratory	Sinha, N (corresponding author), Univ Calif Davis, Plant Biol Sect, 1 Shields Ave, Davis, CA 95616 USA.	nrsinha@ucdavis.edu		Sinha, Neelima/0000-0002-1494-7065; McCormick, Sheila/0000-0001-9106-9385				Averof M, 1997, NATURE, V388, P682, DOI 10.1038/41786; Bharathan G, 2002, SCIENCE, V296, P1858, DOI 10.1126/science.1070343; Byrne ME, 2000, NATURE, V408, P967, DOI 10.1038/35050091; Carroll SB, 2000, CELL, V101, P577, DOI 10.1016/S0092-8674(00)80868-5; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Gellon G, 1998, BIOESSAYS, V20, P116, DOI 10.1002/(SICI)1521-1878(199802)20:2<116::AID-BIES4>3.3.CO;2-N; Gleissberg S, 1999, INT J PLANT SCI, V160, P787, DOI 10.1086/314165; JACKSON D, 1994, DEVELOPMENT, V120, P405; Kessler S, 2001, INT J PLANT SCI, V162, P475, DOI 10.1086/320136; Koltai H, 2000, PLANT J, V22, P455, DOI 10.1046/j.1365-313X.2000.00754.x; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; MCCORMICK S, 1991, PLANT TISSUE CULTU B, V6, P1; Pien S, 2001, PLANT J, V25, P663, DOI 10.1046/j.1365-313x.2001.01002.x; Ruiz-Medrano R, 1999, DEVELOPMENT, V126, P4405; Sun Y, 2002, PLANTA, V214, P694, DOI 10.1007/s004250100673; Timmermans MCP, 1999, SCIENCE, V284, P151, DOI 10.1126/science.284.5411.151; Tsiantis M, 1999, SCIENCE, V284, P154, DOI 10.1126/science.284.5411.154; WAITES R, 1995, DEVELOPMENT, V121, P2143; Waites R, 1998, CELL, V93, P779, DOI 10.1016/S0092-8674(00)81439-7	19	109	116	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2003	424	6947					438	443		10.1038/nature01820	http://dx.doi.org/10.1038/nature01820			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879073				2022-12-28	WOS:000184318400046
J	Meng, Q; Frankel, GS; Colijn, HO; Goss, SH				Meng, Q; Frankel, GS; Colijn, HO; Goss, SH			Metallurgy - Stainless-steel corrosion and MnS inclusions	NATURE			English	Article									Ohio State Univ, Dept Mat Sci & Engn, Fontana Corros Ctr, Columbus, OH 43210 USA; Ohio State Univ, Dept Elect Engn, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Meng, Q (corresponding author), Ohio State Univ, Dept Mat Sci & Engn, Fontana Corros Ctr, 116 W 19th Ave, Columbus, OH 43210 USA.	frankel.10@osu.edu	Frankel, Gerald S/C-3113-2012	Frankel, Gerald S/0000-0003-0573-3548				Frankel GS, 1998, J ELECTROCHEM SOC, V145, P2186, DOI 10.1149/1.1838615; NEWMAN RC, 1982, CORROSION, V38, P261, DOI 10.5006/1.3577348; Ryan MP, 2002, NATURE, V415, P770, DOI 10.1038/415770a; Sedriks A.J., 1996, CORROSION STAINLESS, V2nd; Williams DE, 2000, J ELECTROCHEM SOC, V147, P1763, DOI 10.1149/1.1393431	5	99	103	1	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2003	424	6947					389	390		10.1038/424389b	http://dx.doi.org/10.1038/424389b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879059				2022-12-28	WOS:000184318400032
J	Leteurtre, S; Martinot, A; Duhamel, A; Proulx, F; Grandbastien, B; Cotting, J; Gottesman, R; Joffe, A; Pfenninger, J; Hubert, P; Lacroix, J; Leclerc, F				Leteurtre, S; Martinot, A; Duhamel, A; Proulx, F; Grandbastien, B; Cotting, J; Gottesman, R; Joffe, A; Pfenninger, J; Hubert, P; Lacroix, J; Leclerc, F			Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study	LANCET			English	Article							INTENSIVE-CARE-UNIT; SOFA SCORE; SYSTEM FAILURE; CRITICALLY ILL; HOSPITAL MORTALITY; PRISM-III; RISK; SEPSIS; PREDICTION; DESCRIPTOR	Background Multiple organ dysfunction syndrome is more frequent than death in paediatric intensive care units. Estimation of the severity of this syndrome could be a useful additional outcome measure in clinical trials in such units. We aimed to validate the paediatric logistic organ dysfunction (PELOID) score and estimate its validity when recorded daily (dPELOD). Methods We did a prospective, observational, multicentre cohort study in seven multidisciplinary, tertiary-care paediatric intensive care units of university-affiliated hospitals (two French, three Canadian, and two Swiss). We included 1806 consecutive patients (median age 24 months; IQR 5-90). PELOD score includes six organ dysfunctions and 12 variables and was recorded daily. For each variable, the most abnormal value each day and during the whole stay were used in calculating the dPELOD and PELOD scores, respectively. Outcome was vital status at discharge. We used Hosmer-Lemeshow goodness-of-fit tests to evaluate calibration and areas under receiver operating characteristic curve (AUC) to estimate discrimination. Findings 370 (21%) patients had no organ dysfunction, 471 (26%) had one, 457 (25%) had two, and 508 (28%) had three or more. Case fatality rate was 6.4% (115 deaths). PELOD score was significantly higher in non-survivors (mean 31.0 [SE 1.2]) than survivors (9.4 [0.2]; p<0.0001). Calibration (p=0.54) and discrimination (AUC=0.91, SE=0.01) of PELOD and dPELOD (p&GE;0.39; AUC&GE;0.79) scores were good. Interpretation PELOD and dPELOD scores are valid outcome measures of the severity of multiple organ dysfunction syndrome in paediatric intensive care units; their use should significantly reduce the sample size required to complete clinical trials in critically ill children.	Jeanne de Flandre Univ Hosp, Paediat Intens Care Unit, Lille, France; Univ Med, CERIM, Dept Biostat, Lille, France; Calmette Hosp, Dept Epidemiol & Publ Hlth, Lille, France; Serv Aide Med Urgente, Lille, France; Enfants Malad Hosp, Paediat Intens Care Unit, Paris, France; St Justine Hosp, Paediat Intens Care Unit, Montreal, PQ, Canada; Montreal Childrens Hosp, Paediat Intens Care Unit, Montreal, PQ H3H 1P3, Canada; Childrens Hlth Ctr, Paediat Intens Care Unit, Edmonton, AB, Canada; Ctr Hosp Vaudois, Paediat Intens Care Unit, Lausanne, Switzerland; Inselspital Bern, Paediat Intens Care Unit, CH-3010 Bern, Switzerland	Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; McGill University; University of Bern; University Hospital of Bern	Leclerc, F (corresponding author), Hop Jeanne de Flandre CH, F-59037 Lille, France.		Duhamel, Alain/B-8624-2011; Duhamel, Alain/A-4899-2013; Martinot, Alain/M-6780-2016	Martinot, Alain/0000-0002-2146-8273				Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Ball J, 2002, CRIT CARE, V6, P271, DOI 10.1186/cc1503; Bota DP, 2002, INTENS CARE MED, V28, P1619, DOI 10.1007/s00134-002-1491-3; Cook R, 2001, CRIT CARE MED, V29, P2046, DOI 10.1097/00003246-200111000-00002; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Heard CMB, 1998, CRIT CARE MED, V26, P1593, DOI 10.1097/00003246-199809000-00034; Hutchinson C, 2000, ANAESTHESIA, V55, P1149, DOI 10.1046/j.1365-2044.2000.01608.x; Jacobs S, 1999, CRIT CARE MED, V27, P741, DOI 10.1097/00003246-199904000-00027; Janssens U, 2000, INTENS CARE MED, V26, P1037, DOI 10.1007/s001340051316; Kanter RK, 2000, CRIT CARE MED, V28, P220, DOI 10.1097/00003246-200001000-00036; Kollef M H, 1999, Am J Crit Care, V8, P180; LeGall JR, 1996, JAMA-J AM MED ASSOC, V276, P802, DOI 10.1001/jama.276.10.802; Leteurtre S, 1999, MED DECIS MAKING, V19, P399, DOI 10.1177/0272989X9901900408; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Moreno R, 1999, INTENS CARE MED, V25, P686, DOI 10.1007/s001340050931; Nguyen Trung, 2001, Pediatr Crit Care Med, V2, P187, DOI 10.1097/00130478-200107000-00001; PETROS AJ, 1995, LANCET, V345, P369, DOI 10.1016/S0140-6736(95)90347-X; Pettila V, 2002, CRIT CARE MED, V30, P1705, DOI 10.1097/00003246-200208000-00005; Polderman KH, 1999, LANCET, V353, P380, DOI 10.1016/S0140-6736(05)74953-9; POLLACK MM, 1988, CRIT CARE MED, V16, P1110, DOI 10.1097/00003246-198811000-00006; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Pollack MM, 1997, J PEDIATR-US, V131, P575, DOI 10.1016/S0022-3476(97)70065-9; Proulx F, 1996, CHEST, V109, P1033, DOI 10.1378/chest.109.4.1033; PROULX F, 1994, CRIT CARE MED, V22, P1025, DOI 10.1097/00003246-199406000-00023; RUTTIMANN UE, 1991, CRIT CARE MED, V19, P474, DOI 10.1097/00003246-199104000-00004; Slater A, 2003, INTENS CARE MED, V29, P278, DOI 10.1007/s00134-002-1601-2; Timsit JF, 2001, INTENS CARE MED, V27, P1012, DOI 10.1007/s001340100961; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; WAGNER DP, 1994, CRIT CARE MED, V22, P1359, DOI 10.1097/00003246-199409000-00004; WILKINSON JD, 1986, CRIT CARE MED, V14, P271, DOI 10.1097/00003246-198604000-00002; WILKINSON JD, 1987, J PEDIATR-US, V111, P324, DOI 10.1016/S0022-3476(87)80448-1	31	491	513	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 19	2003	362	9379					192	197		10.1016/S0140-6736(03)13908-6	http://dx.doi.org/10.1016/S0140-6736(03)13908-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702PJ	12885479				2022-12-28	WOS:000184232000008
J	Shibuya, K; Ciecierski, C; Guindon, E; Bettcher, DW; Evans, DB; Murray, CJL				Shibuya, K; Ciecierski, C; Guindon, E; Bettcher, DW; Evans, DB; Murray, CJL			WHO Framework Convention on Tobacco Control: development of an evidence based global public health treaty	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTORS; GLOBALIZATION; COUNTRIES; MORTALITY; BURDEN	Many health problems require international action, but getting governments to agree on strategies for prevention or treatment is difficult. By making use of scientific evidence on the effects of tobacco, the member states of WHO have negotiated their first global health treaty. If the treaty can be implemented effectively, it could act as a possible model for tackling other health issues.	WHO, Global Programme Evidence Hlth Policy, CH-1211 Geneva 27, Switzerland; WHO, Tobacco Free Initiat, Framework Convent Tobacco Control, CH-1211 Geneva 27, Switzerland	World Health Organization; World Health Organization	Shibuya, K (corresponding author), WHO, Global Programme Evidence Hlth Policy, CH-1211 Geneva 27, Switzerland.	shibuyak@who.int		Shibuya, Kenji/0000-0003-2528-7530				Bettcher D, 2001, TOB CONTROL, V10, P65, DOI 10.1136/tc.10.1.65; Brundtland G. H., 1998, 51 WORLD HLTH ASS GE; Chaloupka FJ, 2000, TOBACCO CONTROL DEVE, P237; Chantornvong S, 2000, B WORLD HEALTH ORGAN, V78, P913; Commission on Human Security, 2003, HUM SEC NOW; Corrao MA, 2000, B WORLD HEALTH ORGAN, V78, P884; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ezzati M, 2003, TOB CONTROL, V12, P79, DOI 10.1136/tc.12.1.79; Guindon GE, 2002, TOB CONTROL, V11, P35, DOI 10.1136/tc.11.1.35; Jamison DT, 1998, LANCET, V351, P514, DOI 10.1016/S0140-6736(97)11451-9; Jha P, 2000, BRIT MED J, V321, P358, DOI 10.1136/bmj.321.7257.358; Joossens L, 2000, B WORLD HEALTH ORGAN, V78, P930; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Taylor AL, 2000, B WORLD HEALTH ORGAN, V78, P920; Waxman HA, 2002, NEW ENGL J MED, V346, P936, DOI 10.1056/NEJMsb020030; *WHO, 2003, WHO CONV TOB CONTR A; WHO, 2002, RED RISKS PROM HLTH; World Bank, 1999, CURB EP GOV EC TOB C; World Commission on Environment and Development, 1987, REPORT WORLD COMMISS; World Health Organization, 2001, MACR HLTH INV HLTH E; Yach D, 1998, AM J PUBLIC HEALTH, V88, P735, DOI 10.2105/AJPH.88.5.735; Yach D, 1998, AM J PUBLIC HEALTH, V88, P738, DOI 10.2105/AJPH.88.5.738	24	140	143	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2003	327	7407					154	157		10.1136/bmj.327.7407.154	http://dx.doi.org/10.1136/bmj.327.7407.154			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702WJ	12869461	Green Published			2022-12-28	WOS:000184247500024
J	Keith, DW; Farrell, AE				Keith, DW; Farrell, AE			Rethinking hydrogen cars	SCIENCE			English	Editorial Material							TRANSPORTATION; EMISSIONS; FUTURE		Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA; Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA	Carnegie Mellon University; University of California System; University of California Berkeley	Keith, DW (corresponding author), Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA.		Keith, David W/E-9777-2010	Keith, David W/0000-0002-8224-3780				Azar C, 2003, ENERG POLICY, V31, P961, DOI 10.1016/S0301-4215(02)00139-8; Bishop GA, 2000, ENVIRON SCI TECHNOL, V34, P1110, DOI 10.1021/es9908725; DAVIS SC, 2002, ORNL6976; *EN INF ADM, 2003, DOEEIA03832003; Farrell AE, 2003, ENERG POLICY, V31, P1357, DOI 10.1016/S0301-4215(02)00195-7; HAHN RW, 1995, RAND J ECON, V26, P222, DOI 10.2307/2555914; Harrington W, 2000, TRANSPORT RES D-TR E, V5, P153, DOI 10.1016/S1361-9209(99)00029-2; Herzog H, 2001, ENVIRON SCI TECHNOL, V35, p148A, DOI 10.1021/es012307j; Herzog H, 2000, TECHNOLOGY, V7, P13; HOFFMAN P, 2000, TOMORROWS ENERGY HYD; JOHNSON TL, 2003, IN PRESS ENERGY 0318; Keith DW, 2001, CLIMATIC CHANGE, V49, P1, DOI 10.1023/A:1010617015484; Kennedy RL, 2003, NIOBIUM: HIGH TEMPERATURE APPLICATIONS, PROCEEDINGS, P11; Metz B., 2001, CLIMATE CHANGE 2001; MINTZ M, 2002, COST SOME HYDROGEN F; National Research Council, 2002, EFF IMP CORP AV FUEL; *OFF AIR RAD, 1999, REG IMP AN CONTR AIR; Parson EA, 1998, SCIENCE, V282, P1053, DOI 10.1126/science.282.5391.1053; Weiss M. A., 2000, 00003 MIT EL; WEISS MA, 2000, 2003001 MIT LFEE; Winebrake JJ, 1997, TRANSPORT RES D-TR E, V2, P125, DOI 10.1016/S1361-9209(97)00004-7	21	47	47	2	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2003	301	5631					315	316		10.1126/science.1084294	http://dx.doi.org/10.1126/science.1084294			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869744				2022-12-28	WOS:000184207300022
J	Kmita, M; Duboule, D				Kmita, M; Duboule, D			Organizing axes in time and space; 25 years of colinear tinkering	SCIENCE			English	Review							HOX GENES; HOMEOTIC TRANSFORMATIONS; SEGMENTATION CLOCK; RETINOIC ACID; TARGET GENE; EXPRESSION; DROSOPHILA; COMPLEX; MOUSE; MURINE	During vertebrate development, clustered genes from the Hox family of transcription factors are activated in a precise temporal and spatial sequence that follows their chromosomal order (the "Hox clock"). Recent advances in the knowledge of the underlying mechanisms reveal that the embryo uses a variety of strategies to implement this colinear process, depending on both the type and the evolutionary history of axial structures. The search for a universal mechanism has likely hampered our understanding of this enigmatic phenomenon, which may be caused by various and unrelated regulatory processes, as long as the final distribution of proteins (the HOX code) is preserved.	Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland; Univ Geneva, Natl Ctr Competence Res Frontiers Genet, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Duboule, D (corresponding author), Univ Geneva, Dept Zool & Anim Biol, Quai Ernest Ansermet 30, CH-1211 Geneva 4, Switzerland.		kmita, marie/AAU-9620-2020	duboule, denis/0000-0001-9961-2960; Kmita, Marie/0000-0003-4021-0478				Barna M, 2002, DEV CELL, V3, P499, DOI 10.1016/S1534-5807(02)00289-7; Bel-Vialar S, 2002, DEVELOPMENT, V129, P5103; Brodu V, 2002, DEVELOPMENT, V129, P2957; Deschamps J, 1999, INT J DEV BIOL, V43, P635; DUBOULE D, 1994, TRENDS GENET, V10, P358, DOI 10.1016/0168-9525(94)90132-5; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; Duboule D, 1991, CURR OPIN GENET DEV, V1, P211, DOI 10.1016/S0959-437X(05)80072-3; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; GAUNT SJ, 1988, DEVELOPMENT, V104, P169; GAUNT SJ, 1994, INT J DEV BIOL, V38, P549; Gould A, 1997, CURR OPIN GENET DEV, V7, P488, DOI 10.1016/S0959-437X(97)80075-5; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; Greer JM, 2000, NATURE, V403, P661, DOI 10.1038/35001077; HORAN GSB, 1995, GENE DEV, V9, P1667, DOI 10.1101/gad.9.13.1667; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; Kmita M, 2000, GENE DEV, V14, P198; Kmita M, 2002, NATURE, V420, P145, DOI 10.1038/nature01189; Kondo T, 1999, CELL, V97, P407, DOI 10.1016/S0092-8674(00)80749-7; Kwan CT, 2001, DEV BIOL, V232, P176, DOI 10.1006/dbio.2001.0157; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Lohmann I, 2002, CELL, V110, P457, DOI 10.1016/S0092-8674(02)00871-1; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; MARSHALL H, 1994, NATURE, V370, P567, DOI 10.1038/370567a0; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; Roelen BAJ, 2002, MECH DEVELOP, V119, P81, DOI 10.1016/S0925-4773(02)00329-5; Schock F, 2000, NATURE, V405, P351, DOI 10.1038/35012620; SCOTT MP, 1992, CELL, V71, P551, DOI 10.1016/0092-8674(92)90588-4; Sharpe J, 1998, EMBO J, V17, P1788, DOI 10.1093/emboj/17.6.1788; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; VACHON G, 1992, CELL, V71, P437, DOI 10.1016/0092-8674(92)90513-C; van den Akker E, 2001, DEVELOPMENT, V128, P1911; vanderHoeven F, 1996, CELL, V85, P1025, DOI 10.1016/S0092-8674(00)81303-3; Zakany J, 2001, CELL, V106, P207, DOI 10.1016/S0092-8674(01)00436-6; Zhang F, 1997, MECH DEVELOP, V67, P49, DOI 10.1016/S0925-4773(97)00104-4	37	393	407	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2003	301	5631					331	333		10.1126/science.1085753	http://dx.doi.org/10.1126/science.1085753			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869751				2022-12-28	WOS:000184207300031
J	Omta, AW; Kropman, MF; Woutersen, S; Bakker, HJ				Omta, AW; Kropman, MF; Woutersen, S; Bakker, HJ			Negligible effect of ions on the hydrogen-bond structure in liquid water	SCIENCE			English	Article							MOLECULAR-DYNAMICS SIMULATION; SPIN-LATTICE RELAXATION; X-RAY-DIFFRACTION; HYDRATION STRUCTURE; AQUEOUS-SOLUTION; SPECTROSCOPY; SOLVATION; ENERGY; TIME; NA+	The effects of ions on bulk properties of liquid water, such as viscosity, have suggested that ions alter water's hydrogen-bonding network. We measured the orientational correlation time of water molecules in Mg(ClO4)(2), NaClO4, and Na2SO4 solutions by means of femtosecond pump-probe spectroscopy. The addition of ions had no influence on the rotational dynamics of water molecules outside the first solvation shells of the ions. This result shows that the presence of ions does not lead to an enhancement or a breakdown of the hydrogen-bond network in liquid water.	FOM, Inst Atom & Mol Phys, NL-1098 SJ Amsterdam, Netherlands; Univ Amsterdam, NL-1018 WS Amsterdam, Netherlands	AMOLF; University of Amsterdam	Omta, AW (corresponding author), FOM, Inst Atom & Mol Phys, Kruislaan 407, NL-1098 SJ Amsterdam, Netherlands.							Bockris J.OM., 1970, MODERN ELECTROCHEMIS, P1, DOI DOI 10.1007/B114168; CHANDRASEKHAR J, 1984, J AM CHEM SOC, V106, P903, DOI 10.1021/ja00316a012; CHANDRASEKHAR J, 1982, J CHEM PHYS, V77, P5080, DOI 10.1063/1.443682; Dhont, 1996, INTRO DYNAMICS COLLO; Einstein A, 1926, INVESTIGATIONS THEOR, DOI DOI 10.2307/2298685; Franks F, 1973, WATER COMPREHENSIVE, V3; GRAENER H, 1990, CHEM PHYS LETT, V172, P435, DOI 10.1016/0009-2614(90)80134-Y; Gurney R.W., 1953, IONIC PROCESSES SOLU; HINDMAN JC, 1973, J CHEM PHYS, V59, P1517, DOI 10.1063/1.1680209; Hofmeister F., 1888, N-S ARCH EXP PATH PH, V24, P247; KAMEDA Y, 1993, B CHEM SOC JPN, V66, P1919, DOI 10.1246/bcsj.66.1919; Kindt JT, 1996, J PHYS CHEM-US, V100, P10373, DOI 10.1021/jp960141g; Krestov G. A., 1991, THERMODYNAMICS SOLVA; Kropman MF, 2001, J CHEM PHYS, V115, P8942, DOI 10.1063/1.1412249; Lightstone FC, 2001, CHEM PHYS LETT, V343, P549, DOI 10.1016/S0009-2614(01)00735-7; MARCUS Y, 1985, ION SOLVATION; Obst S, 1996, J PHYS CHEM-US, V100, P15677, DOI 10.1021/jp961384b; OHTAKI H, 1993, CHEM REV, V93, P1157, DOI 10.1021/cr00019a014; Ronne C, 1997, J CHEM PHYS, V107, P5319, DOI 10.1063/1.474242; Schuster P., 1976, RECENT DEV THEORY EX; SMITH DWG, 1966, MOL PHYS, V10, P451, DOI 10.1080/00268976600100571; Tongraar A, 1998, J PHYS CHEM A, V102, P10340, DOI 10.1021/jp982270y; Walser R, 2001, CHEM PHYS LETT, V334, P337, DOI 10.1016/S0009-2614(00)01290-2; White JA, 2000, J CHEM PHYS, V113, P4668, DOI 10.1063/1.1288688; Woutersen S, 1999, NATURE, V402, P507, DOI 10.1038/990058; Woutersen S, 1999, PHYS REV LETT, V83, P2077, DOI 10.1103/PhysRevLett.83.2077; YAMAGUCHI T, 1982, CHEM PHYS LETT, V93, P528, DOI 10.1016/0009-2614(82)83721-4; Yamaguchi T, 1997, CHEM PHYS LETT, V274, P485, DOI 10.1016/S0009-2614(97)00690-8; ZHU SB, 1992, J CHEM PHYS, V97, P4336, DOI 10.1063/1.463903	29	788	799	12	361	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2003	301	5631					347	349		10.1126/science.1084801	http://dx.doi.org/10.1126/science.1084801			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869755				2022-12-28	WOS:000184207300037
J	Pourquie, O				Pourquie, O			The segmentation clock: Converting embryonic time into spatial pattern	SCIENCE			English	Review							LUNATIC-FRINGE EXPRESSION; SOMITE BOUNDARY FORMATION; PRESOMITIC MESODERM; CYCLIC EXPRESSION; ZEBRAFISH SOMITOGENESIS; SIGNALING PATHWAY; GENE-EXPRESSION; OSCILLATOR; HER1; HES1	In most animal species, the anteroposterior body axis is generated by the formation of repeated structures called segments. In vertebrate segmentation, a specialized mesodermal structure called the somite gives rise to skeletal muscles, vertebrae, and some dermis. Formation of the somites is a rhythmic process that involves an oscillator-the segmentation clock-driven by Wnt and Notch signaling. The clock ticks in somite precursors and halts when they reach a specific maturation stage defined as the wavefront, established by fibroblast growth factor and Wnt signaling. This process converts the temporal oscillations into the periodic spatial pattern of somite boundaries. The study of somite development provides insights into the spatiotemporal integration of signaling systems in the vertebrate embryo.	Stowers Inst Med Res, Kansas City, MO 64110 USA	Stowers Institute for Medical Research	Pourquie, O (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.		Pourquié, Olivier/CAJ-5443-2022	Pourquié, Olivier/0000-0001-5189-1227				Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; Cole SE, 2002, DEV CELL, V3, P75, DOI 10.1016/S1534-5807(02)00212-5; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Dale JK, 2003, NATURE, V421, P275, DOI 10.1038/nature01244; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Forsberg H, 1998, CURR BIOL, V8, P1027, DOI 10.1016/S0960-9822(07)00424-1; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Holley SA, 2000, GENE DEV, V14, P1678; Holley SA, 2002, DEVELOPMENT, V129, P1175; Jen WC, 1999, GENE DEV, V13, P1486, DOI 10.1101/gad.13.11.1486; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Jouve C, 2000, DEVELOPMENT, V127, P1421; Jouve C, 2002, DEVELOPMENT, V129, P1107; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Leimeister C, 2000, DEV BIOL, V227, P91, DOI 10.1006/dbio.2000.9884; Li Y, 2003, DIFFERENTIATION, V71, P83, DOI 10.1046/j.1432-0436.2003.700608.x; McGrew MJ, 1998, CURR BIOL, V8, P979, DOI 10.1016/S0960-9822(98)70401-4; Morales AV, 2002, DEV CELL, V3, P63, DOI 10.1016/S1534-5807(02)00211-3; Oates AC, 2002, DEVELOPMENT, V129, P2929; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Pourquie O, 2001, DEV CELL, V1, P619, DOI 10.1016/S1534-5807(01)00082-X; Sawada A, 2000, DEVELOPMENT, V127, P1691; Sawada A, 2001, DEVELOPMENT, V128, P4873; Serth K, 2003, GENE DEV, V17, P912, DOI 10.1101/gad.250603; Takahashi Y, 2000, NAT GENET, V25, P390, DOI 10.1038/78062	26	387	397	3	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2003	301	5631					328	330		10.1126/science.1085887	http://dx.doi.org/10.1126/science.1085887			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869750				2022-12-28	WOS:000184207300030
J	Le Roch, KG; Zhou, YY; Blair, PL; Grainger, M; Moch, JK; Haynes, JD; De la Vega, P; Holder, AA; Batalov, S; Carucci, DJ; Winzeler, EA				Le Roch, KG; Zhou, YY; Blair, PL; Grainger, M; Moch, JK; Haynes, JD; De la Vega, P; Holder, AA; Batalov, S; Carucci, DJ; Winzeler, EA			Discovery of gene function by expression profiling of the malaria parasite life cycle	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM; STABLE TRANSFECTION; ANTIGENIC VARIATION; EBL FAMILY; SEQUENCE; PROTEIN; SPOROZOITE; CHROMOSOME-2; SURFACE; KINASE	The completion of the genome sequence for Plasmodium falciparum, the species responsible for most malaria human deaths, has the potential to reveal hundreds of new drug targets and proteins involved in pathogenesis. However, only similar to35% of the genes code for proteins with an identifiable function. The absence of routine genetic tools for studying Plasmodium parasites suggests that this number is unlikely to change quickly if conventional serial methods are used to characterize encoded proteins. Here, we use a high-density oligonucleotide array to generate expression profiles of human and mosquito stages of the malaria parasite's life cycle. Genes with highly correlated levels and temporal patterns of expression were often involved in similar functions or cellular processes.	Scripps Res Inst, Dept Cell Biol ICND202, La Jolla, CA 92037 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; USN, Med Res Ctr, Malaria Program, Silver Spring, MD 20910 USA; Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; Walter Reed Army Inst Res, Dept Immunol, Silver Spring, MD 20910 USA	Scripps Research Institute; Novartis; United States Department of Defense; United States Navy; MRC National Institute for Medical Research; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Le Roch, KG (corresponding author), Scripps Res Inst, Dept Cell Biol ICND202, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Holder, Anthony A/A-7554-2013; Winzeler, Elizabeth/AAP-6752-2020	Holder, Anthony A/0000-0002-8490-6058; Winzeler, Elizabeth/0000-0002-4049-2113; Batalov, Sergey/0000-0002-0925-0554	Medical Research Council [MC_U117532067] Funding Source: Medline; MRC [MC_U117532067] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adams JH, 2001, TRENDS PARASITOL, V17, P297, DOI 10.1016/S1471-4922(01)01948-1; Bergman LW, 2003, J CELL SCI, V116, P39, DOI 10.1242/jcs.00194; Birago C, 2003, MOL BIOCHEM PARASIT, V126, P209, DOI 10.1016/S0166-6851(02)00275-X; Blair PL, 2002, MOL BIOCHEM PARASIT, V122, P35, DOI 10.1016/S0166-6851(02)00067-1; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; Bozdech Z, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r9; Breman JG, 2001, AM J TROP MED HYG, V64, pIV, DOI 10.4269/ajtmh.2001.64.iv; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Crabb BS, 1996, P NATL ACAD SCI USA, V93, P7289, DOI 10.1073/pnas.93.14.7289; Doerig CM, 1996, GENE, V177, P1, DOI 10.1016/0378-1119(96)00281-8; Dorin D, 1999, J BIOL CHEM, V274, P29912, DOI 10.1074/jbc.274.42.29912; Dorin D, 2001, EUR J BIOCHEM, V268, P2600, DOI 10.1046/j.1432-1327.2001.02151.x; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Fidock DA, 1997, EUR J IMMUNOL, V27, P2502, DOI 10.1002/eji.1830271007; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Gardner MJ, 2002, NATURE, V419, P531, DOI 10.1038/nature01094; Gatton ML, 2003, TRENDS PARASITOL, V19, P202, DOI 10.1016/S1471-4922(03)00067-9; Ghai M, 2002, MOL BIOCHEM PARASIT, V123, P35, DOI 10.1016/S0166-6851(02)00123-8; Hall N, 2002, NATURE, V419, P527, DOI 10.1038/nature01095; Haynes J David, 2002, Methods Mol Med, V72, P489, DOI 10.1385/1-59259-271-6:489; Hyman RW, 2002, NATURE, V419, P534, DOI 10.1038/nature01102; Kappe SHI, 2001, P NATL ACAD SCI USA, V98, P9895, DOI 10.1073/pnas.171185198; Kaviratne M, 2002, EUKARYOT CELL, V1, P926, DOI 10.1128/EC.1.6.926-935.2002; Kyes S, 2001, ANNU REV MICROBIOL, V55, P673, DOI 10.1146/annurev.micro.55.1.673; Kyes SA, 1999, P NATL ACAD SCI USA, V96, P9333, DOI 10.1073/pnas.96.16.9333; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Le Roch KG, 2002, AM J TROP MED HYG, V67, P233, DOI 10.4269/ajtmh.2002.67.233; LEROCH KG, UNPUB; Ling, UNPUB; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Matuschewski K, 2002, J BIOL CHEM, V277, P41948, DOI 10.1074/jbc.M207315200; Rathod PK, 2002, TRENDS PARASITOL, V18, P39, DOI 10.1016/S1471-4922(01)02153-5; SHERMAN IW, 1979, MICROBIOL REV, V43, P453, DOI 10.1128/MMBR.43.4.453-495.1979; Spielmann T, 2003, MOL BIOL CELL, V14, P1529, DOI 10.1091/mbc.E02-04-0240; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Tachibana M, 2001, MOL BIOCHEM PARASIT, V113, P341, DOI 10.1016/S0166-6851(01)00231-6; Trenholme KR, 2000, P NATL ACAD SCI USA, V97, P4029, DOI 10.1073/pnas.040561197; VANDIJK MR, 1995, SCIENCE, V268, P1358, DOI 10.1126/science.7761856; Winter G, 2003, MOL BIOCHEM PARASIT, V127, P179, DOI 10.1016/S0166-6851(03)00004-5; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973; Zhou YY, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-3	44	964	981	1	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 12	2003	301	5639					1503	1508		10.1126/science.1087025	http://dx.doi.org/10.1126/science.1087025			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	720HL	12893887				2022-12-28	WOS:000185255300040
J	Daubin, V; Moran, NA; Ochman, H				Daubin, V; Moran, NA; Ochman, H			Phylogenetics and the cohesion of bacterial genomes	SCIENCE			English	Article							MAXIMUM-LIKELIHOOD METHOD; ESCHERICHIA-COLI; SEQUENCE DATA; GENE-TRANSFER; RECOMBINATION; TOPOLOGIES; EVOLUTION; BLAST	Gene acquisition is an ongoing process in many bacterial genomes, contributing to adaptation and ecological diversification. Lateral gene transfer is considered the primary explanation for discordance among gene phylogenies and as an obstacle to reconstructing the tree of life. We measured the extent of phylogenetic conflict and alien-gene acquisition within quartets of sequenced genomes. Although comparisons of complete gene inventories indicate appreciable gain and loss of genes, orthologs available for phylogenetic reconstruction are consistent with a single tree.	Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA; Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Arizona; University of Arizona	Ochman, H (corresponding author), Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA.	hochman@email.arizona.edu	chen, qi/C-8585-2011; Moran, Nancy A/G-1591-2010	Daubin, Vincent/0000-0001-8269-9430				Adachi J, 1996, MOL PHYLOGENET EVOL, V6, P72, DOI 10.1006/mpev.1996.0059; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Brown JR, 1997, MICROBIOL MOL BIOL R, V61, P456, DOI 10.1128/.61.4.456-502.1997; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Doolittle WF, 1999, TRENDS CELL BIOL, V15, P5, DOI DOI 10.1016/S0168-9525(99)01877-6; DYKHUIZEN DE, 1991, J BACTERIOL, V173, P7257, DOI 10.1128/jb.173.22.7257-7268.1991; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Goldman N, 2000, SYST BIOL, V49, P652, DOI 10.1080/106351500750049752; GRAUR D, 1991, NATURE, V351, P649, DOI 10.1038/351649a0; GUTTMAN DS, 1994, SCIENCE, V266, P1380, DOI 10.1126/science.7973728; Hedges SB, 1999, SCIENCE, V283, P998, DOI 10.1126/science.283.5404.998; Huchon D, 2002, MOL BIOL EVOL, V19, P1053, DOI 10.1093/oxfordjournals.molbev.a004164; Hughes S, 2001, J MOL EVOL, V53, P70, DOI 10.1007/s002390010194; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Millman KL, 2001, J BACTERIOL, V183, P5997, DOI 10.1128/JB.183.20.5997-6008.2001; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Nesbo CL, 2001, J MOL EVOL, V53, P340, DOI 10.1007/s002390010224; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Philippe Herve, 1994, Journal of Mammalian Evolution, V2, P133, DOI 10.1007/BF01464365; Raymond J, 2002, SCIENCE, V298, P1616, DOI 10.1126/science.1075558; Rivera MC, 1998, P NATL ACAD SCI USA, V95, P6239, DOI 10.1073/pnas.95.11.6239; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Zhaxybayeva O, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-4	27	192	203	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2003	301	5634					829	832		10.1126/science.1086568	http://dx.doi.org/10.1126/science.1086568			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907801				2022-12-28	WOS:000184615700044
J	Eichler, EE; Sankoff, D				Eichler, EE; Sankoff, D			Structural dynamics of eukaryotic chromosome evolution	SCIENCE			English	Review							GENOME SEQUENCE; GENETIC DEFINITION; ANOPHELES-GAMBIAE; DUPLICATION; REARRANGEMENTS; INVERSIONS; SEGMENTS; RECOMBINATION; EXPANSION; LESSONS	Large-scale genome sequencing is providing a comprehensive view of the complex evolutionary forces that have shaped the structure of eukaryotic chromosomes. Comparative sequence analyses reveal patterns of apparently random rearrangement interspersed with regions of extraordinarily rapid, localized genome evolution. Numerous subtle rearrangements near centromeres, telomeres, duplications, and interspersed repeats suggest hotspots for eukaryotic chromosome evolution. This localized chromosomal instability may play a role in rapidly evolving lineage-specific gene families and in fostering large-scale changes in gene order. Computational algorithms that take into account these dynamic forces along with traditional models of chromosomal rearrangement show promise for reconstructing the natural history of eukaryotic chromosomes.	Case Western Reserve Univ, Sch Med, Ctr Human Genet, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Ctr Computat Genom, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Univ Ottawa, Dept Math & Stat, Ottawa, ON K1N 6N5, Canada	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; University of Ottawa	Eichler, EE (corresponding author), Case Western Reserve Univ, Sch Med, Ctr Human Genet, Dept Genet, Cleveland, OH 44106 USA.	eee@po.cwru.edu			NHGRI NIH HHS [HG02385] Funding Source: Medline; NICHD NIH HHS [HD43569] Funding Source: Medline; NIGMS NIH HHS [GM58815] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043569] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058815] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amor DJ, 2002, AM J HUM GENET, V71, P695, DOI 10.1086/342730; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Archidiacono N, 1998, CHROMOSOMA, V107, P241, DOI 10.1007/s004120050303; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; BOWERRS JE, 2003, JNATURE, V422, P433; Burt DW, 1999, NATURE, V402, P411, DOI 10.1038/46555; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; CHARLESWORTH B, 1986, GENETICS, V112, P947, DOI 10.1093/genetics/112.4.947; Coghlan A, 2002, GENOME RES, V12, P857, DOI 10.1101/gr.172702; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; Dehal P, 2001, SCIENCE, V293, P104, DOI 10.1126/science.1060310; Devos KM, 2002, GENOME RES, V12, P1075, DOI 10.1101/gr.132102; Ehrlich J, 1997, GENETICS, V147, P289; Eichler EE, 2001, TRENDS GENET, V17, P661, DOI 10.1016/S0168-9525(01)02492-1; ELMABROUK N, 2003, SIAM SOC IND APPL MA, V32, P745; Friedman R, 2003, MOL BIOL EVOL, V20, P154, DOI 10.1093/molbev/msg017; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gaut BS, 2000, P NATL ACAD SCI USA, V97, P7008, DOI 10.1073/pnas.97.13.7008; Glockner G, 2002, NATURE, V418, P79, DOI 10.1038/nature00847; Grutzner F, 2002, GENOME RES, V12, P1316, DOI 10.1101/gr.222402; Gu X, 2002, NAT GENET, V31, P205, DOI 10.1038/ng902; Guy J, 2003, GENOME RES, V13, P159, DOI 10.1101/gr.644503; Hillier LW, 2003, NATURE, V424, P157, DOI 10.1038/nature01782; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Horvath JE, 2001, HUM MOL GENET, V10, P2215, DOI 10.1093/hmg/10.20.2215; HOSKINS RA, 2002, GENOME BIOL, V0003; Huynen MA, 2001, TRENDS GENET, V17, P304, DOI 10.1016/S0168-9525(01)02302-2; Jiang N, 2003, NATURE, V421, P163, DOI 10.1038/nature01214; Kaminker JS, 2002, GENOME BIOL, V3, P0084, DOI DOI 10.1186/GB-2002-3-12-RFESEARCH84; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kumar S, 2001, GENETICS, V157, P1387; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liu G, 2003, GENOME RES, V13, P358, DOI 10.1101/gr.923303; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; Mefford HC, 2002, NAT REV GENET, V3, P91, DOI 10.1038/nrg727; Mural RJ, 2002, SCIENCE, V296, P1661, DOI 10.1126/science.1069193; NADEAU JH, 1984, P NATL ACAD SCI-BIOL, V81, P814, DOI 10.1073/pnas.81.3.814; O'Brien SJ, 1999, SCIENCE, V286, P458, DOI 10.1126/science.286.5439.458; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Pevzner P, 2003, GENOME RES, V13, P37, DOI 10.1101/gr.757503; PEVZNER P, 2003, RECOMB 2003 7 ANN IN; Ramakrishna W, 2002, GENETICS, V162, P1389; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Riethman HC, 2001, NATURE, V409, P948, DOI 10.1038/35057180; Sankoff D, 1999, BIOINFORMATICS, V15, P909, DOI 10.1093/bioinformatics/15.11.909; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; Seoighe C, 2000, P NATL ACAD SCI USA, V97, P14433, DOI 10.1073/pnas.240462997; Sharakhov IV, 2002, SCIENCE, V298, P182, DOI 10.1126/science.1076803; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Trask BJ, 1998, HUM MOL GENET, V7, P13, DOI 10.1093/hmg/7.1.13; Ventura M, 2001, GENOME RES, V11, P595, DOI 10.1101/gr.152101; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; ZHANG L, IN PRESS BIOINFORMAT, V19	60	296	312	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2003	301	5634					793	797		10.1126/science.1086132	http://dx.doi.org/10.1126/science.1086132			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907789				2022-12-28	WOS:000184615700032
J	Manson, JE; Hsia, J; Johnson, KC; Rossouw, JE; Assaf, AR; Lasser, NL; Trevisan, M; Black, HR; Heckbert, SR; Detrano, R; Strickland, OL; Wong, ND; Crouse, JR; Stein, E; Cushman, M; Alving, B; Rossouw, JE; Pottern, L; Ludlam, S; McGowan, JA; Prentice, R; Anderson, G; LaCroix, A; Patterson, R; McTiernan, A; Cochrane, B; Hunt, J; Tinker, L; Kooperberg, C; McIntosh, M; Wang, CY; Chen, C; Bowen, D; Kristal, A; Stanford, J; Urban, N; Weiss, N; White, E; Shumaker, S; Rautaharju, P; Prineas, R; Naughton, M; Stein, E; Laskarzewski, P; Cummings, S; Nevitt, M; Dockrell, M; Harnack, L; Cammarata, F; Lindenfelser, S; Psaty, B; Heckbert, S; Wassertheil-Smoller, S; Frishman, W; Wylie-Rosett, J; Barad, D; Freeman, R; Hays, J; Young, R; Anderson, J; Lithgow, S; Bray, P; Manson, J; Buring, J; Gaziano, JM; Rexrode, K; Chae, C; Assaf, AR; Carleton, R; Wheeler, C; Eaton, C; Cyr, M; Phillips, L; Pedersen, M; Strickland, O; Huber, M; Porter, V; Beresford, SAA; Taylor, VM; Woods, NF; Henderson, M; Kestin, M; Hsia, J; Gaba, N; Ascensao, J; Laowattana, S; Chlebowski, R; Detrano, R; Nelson, A; Heiner, J; Marshall, J; Ritenbaugh, C; Valanis, B; Elmer, P; Stevens, V; Karanja, N; Caan, B; Sidney, S; Bailey, G; Hirata, J; Kotchen, JM; Barnabei, V; Kotchen, TA; Gilligan, MAC; Neuner, J; Howard, BV; Adams-Campbell, L; Passaro, M; Rainford, M; Agurs-Collins, T; Van Horn, L; Greenland, P; Khandekar, J; Liu, K; Rosenberg, C; Black, H; Powell, L; Mason, E; Stefanick, ML; Hlatky, MA; Chen, B; Stafford, RS; Giudice, LC; Lane, D; Granek, I; Lawson, W; San Roman, G; Messina, C; Jackson, R; Harris, R; Frid, D; Mysiw, WJ; Blumenfeld, M; Lewis, CE; Oberman, A; Fouad, MN; Shikany, JM; West, DS; Bassford, T; Mattox, J; Ko, M; Lohman, T; Trevisan, M; Wactawski-Wende, J; Graham, S; Chang, J; Smit, E; Robbins, J; Yasmeen, S; Lindfors, K; Stern, J; Hubbell, A; Frank, G; Wong, N; Greep, N; MoOnk, B; Judd, H; Heber, D; Elashoff, R; Langer, RD; Criqui, MH; Talavera, GT; Garland, CF; Hanson, RE; Gass, M; Wernke, S; Watts, N; Limacher, M; Perri, M; Kaunitz, A; Williams, RS; Brinson, Y; Curb, D; Petrovitch, H; Rodriguez, B; Masaki, K; Sharma, S; Wallace, R; Torner, J; Johnson, S; Snetselaar, L; VanVoorhis, B; Ockene, I; Yood, R; Aronson, P; Lasser, N; Hymowitz, N; Lasser, V; Safford, M; Kostis, J; O'Sullivan, MJ; Parker, L; Estape, R; Fernandez, D; Margolis, KL; Grimm, RH; Hunninghake, DB; LaValleur, J; Hall, KM; Brunner, R; St Jeor, S; Graettinger, W; Oujevolk, V; Heiss, G; Haines, P; Ontjes, D; Sueta, C; Wells, E; Kuller, L; Caggiula, A; Cauley, J; Berga, S; Milas, NC; Johnson, KC; Satterfield, S; Ke, TW; Vile, J; Tylavsky, F; Brzyski, R; Schenken, R; Trabal, J; Rodriguez-Sifuentes, M; Mouton, C; Allen, C; Laube, D; McBride, P; Mares-Perlman, J; Loevinger, B; Burke, G; Crouse, R; Parsons, L; Vitolins, M; Hendrix, S; Simon, M; McNeeley, G; Gordon, P; Makela, P				Manson, JE; Hsia, J; Johnson, KC; Rossouw, JE; Assaf, AR; Lasser, NL; Trevisan, M; Black, HR; Heckbert, SR; Detrano, R; Strickland, OL; Wong, ND; Crouse, JR; Stein, E; Cushman, M; Alving, B; Rossouw, JE; Pottern, L; Ludlam, S; McGowan, JA; Prentice, R; Anderson, G; LaCroix, A; Patterson, R; McTiernan, A; Cochrane, B; Hunt, J; Tinker, L; Kooperberg, C; McIntosh, M; Wang, CY; Chen, C; Bowen, D; Kristal, A; Stanford, J; Urban, N; Weiss, N; White, E; Shumaker, S; Rautaharju, P; Prineas, R; Naughton, M; Stein, E; Laskarzewski, P; Cummings, S; Nevitt, M; Dockrell, M; Harnack, L; Cammarata, F; Lindenfelser, S; Psaty, B; Heckbert, S; Wassertheil-Smoller, S; Frishman, W; Wylie-Rosett, J; Barad, D; Freeman, R; Hays, J; Young, R; Anderson, J; Lithgow, S; Bray, P; Manson, J; Buring, J; Gaziano, JM; Rexrode, K; Chae, C; Assaf, AR; Carleton, R; Wheeler, C; Eaton, C; Cyr, M; Phillips, L; Pedersen, M; Strickland, O; Huber, M; Porter, V; Beresford, SAA; Taylor, VM; Woods, NF; Henderson, M; Kestin, M; Hsia, J; Gaba, N; Ascensao, J; Laowattana, S; Chlebowski, R; Detrano, R; Nelson, A; Heiner, J; Marshall, J; Ritenbaugh, C; Valanis, B; Elmer, P; Stevens, V; Karanja, N; Caan, B; Sidney, S; Bailey, G; Hirata, J; Kotchen, JM; Barnabei, V; Kotchen, TA; Gilligan, MAC; Neuner, J; Howard, BV; Adams-Campbell, L; Passaro, M; Rainford, M; Agurs-Collins, T; Van Horn, L; Greenland, P; Khandekar, J; Liu, K; Rosenberg, C; Black, H; Powell, L; Mason, E; Stefanick, ML; Hlatky, MA; Chen, B; Stafford, RS; Giudice, LC; Lane, D; Granek, I; Lawson, W; San Roman, G; Messina, C; Jackson, R; Harris, R; Frid, D; Mysiw, WJ; Blumenfeld, M; Lewis, CE; Oberman, A; Fouad, MN; Shikany, JM; West, DS; Bassford, T; Mattox, J; Ko, M; Lohman, T; Trevisan, M; Wactawski-Wende, J; Graham, S; Chang, J; Smit, E; Robbins, J; Yasmeen, S; Lindfors, K; Stern, J; Hubbell, A; Frank, G; Wong, N; Greep, N; MoOnk, B; Judd, H; Heber, D; Elashoff, R; Langer, RD; Criqui, MH; Talavera, GT; Garland, CF; Hanson, RE; Gass, M; Wernke, S; Watts, N; Limacher, M; Perri, M; Kaunitz, A; Williams, RS; Brinson, Y; Curb, D; Petrovitch, H; Rodriguez, B; Masaki, K; Sharma, S; Wallace, R; Torner, J; Johnson, S; Snetselaar, L; VanVoorhis, B; Ockene, I; Yood, R; Aronson, P; Lasser, N; Hymowitz, N; Lasser, V; Safford, M; Kostis, J; O'Sullivan, MJ; Parker, L; Estape, R; Fernandez, D; Margolis, KL; Grimm, RH; Hunninghake, DB; LaValleur, J; Hall, KM; Brunner, R; St Jeor, S; Graettinger, W; Oujevolk, V; Heiss, G; Haines, P; Ontjes, D; Sueta, C; Wells, E; Kuller, L; Caggiula, A; Cauley, J; Berga, S; Milas, NC; Johnson, KC; Satterfield, S; Ke, TW; Vile, J; Tylavsky, F; Brzyski, R; Schenken, R; Trabal, J; Rodriguez-Sifuentes, M; Mouton, C; Allen, C; Laube, D; McBride, P; Mares-Perlman, J; Loevinger, B; Burke, G; Crouse, R; Parsons, L; Vitolins, M; Hendrix, S; Simon, M; McNeeley, G; Gordon, P; Makela, P		Women's Hlth Initiative Investigat	Estrogen plus progestin and the risk of coronary heart disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HORMONE-REPLACEMENT THERAPY; ESTROGEN/PROGESTIN INTERVENTIONS PEPI; RANDOMIZED CONTROLLED TRIAL; POSTMENOPAUSAL WOMEN; CARDIOVASCULAR-DISEASE; CLINICAL-TRIAL; ATHEROSCLEROSIS; PREVENTION; INFLAMMATION; PROGRESSION	BACKGROUND: Recent randomized clinical trials have suggested that estrogen plus progestin does not confer cardiac protection and may increase the risk of coronary heart disease (CHD). In this report, we provide the final results with regard to estrogen plus progestin and CHD from the Women's Health Initiative (WHI). METHODS: The WHI included a randomized primary-prevention trial of estrogen plus progestin in 16,608 postmenopausal women who were 50 to 79 years of age at base line. Participants were randomly assigned to receive conjugated equine estrogens (0.625 mg per day) plus medroxyprogesterone acetate (2.5 mg per day) or placebo. The primary efficacy outcome of the trial was CHD (nonfatal myocardial infarction or death due to CHD). RESULTS: After a mean follow-up of 5.2 years (planned duration, 8.5 years), the data and safety monitoring board recommended terminating the estrogen-plus-progestin trial because the overall risks exceeded the benefits. Combined hormone therapy was associated with a hazard ratio for CHD of 1.24 (nominal 95 percent confidence interval, 1.00 to 1.54; 95 percent confidence interval after adjustment for sequential monitoring, 0.97 to 1.60). The elevation in risk was most apparent at one year (hazard ratio, 1.81 [95 percent confidence interval, 1.09 to 3.01]). Although higher base-line levels of low-density lipoprotein cholesterol were associated with an excess risk of CHD among women who received hormone therapy, higher base-line levels of C-reactive protein, other biomarkers, and other clinical characteristics did not significantly modify the treatment-related risk of CHD. CONCLUSIONS: Estrogen plus progestin does not confer cardiac protection and may increase the risk of CHD among generally healthy postmenopausal women, especially during the first year after the initiation of hormone use. This treatment should not be prescribed for the prevention of cardiovascular disease.	Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; George Washington Univ, Dept Med, Washington, DC USA; Univ Tennessee, Hlth Sci Ctr, Dept Prevent Med, Memphis, TN USA; NHLBI, Program Off, Bethesda, MD 20892 USA; Brown Univ, Mem Hosp, Sch Med, Pawtucket, RI USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Prevent Cardiol Program, Newark, NJ 07103 USA; Univ Buffalo, Dept Social & Prevent Med, Buffalo, NY USA; Rush Presbyterian St Lukes Med Ctr, Dept Prevent Med, Chicago, IL 60612 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Calif Los Angeles, Div Cardiol, Harbor Res & Educ Inst, Torrance, CA USA; Emory Univ, Woodruff Sch Nursing, Atlanta, GA 30322 USA; Univ Calif Irvine, Heart Dis Prevent Program, Irvine, CA 92717 USA; Wake Forest Univ, Dept Med, Winston Salem, NC 27109 USA; Med Res Labs Int, Highland Hts, KY USA; Univ Vermont, Coll Med, Dept Med, Burlington, VT 05405 USA; Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; George Washington University; University of Tennessee System; University of Tennessee Health Science Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Brown University; Rutgers State University New Brunswick; Rutgers State University Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Rush University; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Emory University; University of California System; University of California Irvine; Wake Forest University; University of Vermont; University of Vermont; Harvard University; Harvard Medical School	Manson, JE (corresponding author), Brigham & Womens Hosp, Div Prevent Med, 900 Commonwealth Ave, Boston, MA 02215 USA.		Cauley, Jane A/N-4836-2015; West, Delia Smith/GWV-5839-2022; Sueta, Carla/AAH-8100-2021; Rexrode, Kathryn M/I-1177-2018; Barad, David/AAF-4332-2021; Wactawski-Wende, Jean/AGH-5457-2022; Greenland, Philip/ABD-5528-2021; Kaunitz, Andrew/AAL-8448-2020; Mysiw, Walter/E-3724-2011; Kristal, Alan/A-8779-2008; Stafford, Randall/F-3974-2017	Cauley, Jane A/0000-0003-0752-4408; West, Delia Smith/0000-0002-4375-2785; Wactawski-Wende, Jean/0000-0003-3096-9595; Stafford, Randall/0000-0003-1805-1271				Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Berg AO, 2002, ANN INTERN MED, V137, P834, DOI 10.7326/0003-4819-137-10-200211190-00013; CHAE CU, 1999, CLIN TRIALS CARDIOVA, P399; Cherry N, 2002, LANCET, V360, P2001; Clarke SC, 2002, BJOG-INT J OBSTET GY, V109, P1056, DOI 10.1111/j.1471-0528.2002.01544.x; COX DR, 1972, J R STAT SOC B, V34, P187; Cushman M, 1999, ARTERIOSCL THROM VAS, V19, P893, DOI 10.1161/01.ATV.19.4.893; Cushman M, 1999, CIRCULATION, V100, P717, DOI 10.1161/01.CIR.100.7.717; *ESTR PROG INT PEP, 1995, JAMA-J AM MED ASSOC, V274, P1676; Furberg CD, 2002, CIRCULATION, V105, P917, DOI 10.1161/hc0802.104280; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; GRADY D, 2002, JAMA-J AM MED ASSOC, V288, P1064; GRODSTEIN F, 1995, PROG CARDIOVASC DIS, V38, P199, DOI 10.1016/S0033-0620(95)80012-3; Grodstein F, 2003, NEW ENGL J MED, V348, P645, DOI 10.1056/NEJMsb022365; Hemminki E, 1997, BRIT MED J, V315, P149, DOI 10.1136/bmj.315.7101.149; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Manson JE, 2001, NEW ENGL J MED, V345, P34, DOI 10.1056/NEJM200107053450106; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; Mosca L, 2001, CIRCULATION, V104, P499, DOI 10.1161/hc2901.092200; *N AM MEN SOC NAMS, 2002, REP NAMS ADV PAN POS; Pilon D, 2001, OBSTET GYNECOL, V97, P97, DOI 10.1016/S0029-7844(00)01104-2; Psaty BM, 2001, JAMA-J AM MED ASSOC, V285, P906, DOI 10.1001/jama.285.7.906; Rautaharju PM, 1998, J ELECTROCARDIOL, V31, P157, DOI 10.1016/S0022-0736(98)90132-7; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Shlipak MG, 2000, JAMA-J AM MED ASSOC, V283, P1845, DOI 10.1001/jama.283.14.1845; Viscoli CM, 2001, NEW ENGL J MED, V345, P1243, DOI 10.1056/NEJMoa010534; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673; Waters DD, 2002, JAMA-J AM MED ASSOC, V288, P2432, DOI 10.1001/jama.288.19.2432; 2002, JAMA, V288, P2819	34	1511	1555	1	73	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2003	349	6					523	534		10.1056/NEJMoa030808	http://dx.doi.org/10.1056/NEJMoa030808			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708JL	12904517				2022-12-28	WOS:000184563500003
J	Shimizu, T; Takeda, T				Shimizu, T; Takeda, T			Massive calcification in pseudohypoparathyroidism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Shinshu Univ, Sch Med, Matsumoto, Nagano 3908621, Japan	Shinshu University	Shimizu, T (corresponding author), Shinshu Univ, Sch Med, Matsumoto, Nagano 3908621, Japan.								0	1	1	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2003	349	5					464	464		10.1056/NEJMicm010730	http://dx.doi.org/10.1056/NEJMicm010730			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706FV	12890845				2022-12-28	WOS:000184443700008
J	Wiedemann, N; Kozjak, V; Chacinska, A; Schonfisch, B; Rospert, S; Ryan, MT; Pfanner, N; Meisinger, C				Wiedemann, N; Kozjak, V; Chacinska, A; Schonfisch, B; Rospert, S; Ryan, MT; Pfanner, N; Meisinger, C			Machinery for protein sorting and assembly in the mitochondrial outer membrane	NATURE			English	Article							GENERAL IMPORT PORE; TOM COMPLEX; RECEPTORS; PREPROTEINS; BIOGENESIS; CHANNEL; TRANSLOCATION	Mitochondria contain translocases for the transport of precursor proteins across their outer and inner membranes(1-5). It has been assumed that the translocases also mediate the sorting of proteins to their submitochondrial destination(1,2,5-10). Here we show that the mitochondrial outer membrane contains a separate sorting and assembly machinery (SAM) that operates after the translocase of the outer membrane (TOM). Mas37 forms a constituent of the SAM complex. The central role of the SAM complex in the sorting and assembly pathway of outer membrane proteins explains the various pleiotropic functions that have been ascribed to Mas37 (refs 4, 11-15). These results suggest that the TOM complex, which can transport all kinds of mitochondrial precursor proteins, is not sufficient for the correct integration of outer membrane proteins with a complicated topology, and instead transfers precursor proteins to the SAM complex.	Univ Freiburg, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle Saale, Germany	University of Freiburg; University of Freiburg; Max Planck Society	Pfanner, N (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, Hermann Herder Str 7, D-79104 Freiburg, Germany.		Pfanner, Nikolaus/AAV-7878-2021; Kozjak-Pavlovic, Vera/E-1494-2013; Ryan, Michael/X-2152-2019; Meisinger, Chris/J-1110-2014; Ryan, Michael T/C-6673-2011	Kozjak-Pavlovic, Vera/0000-0001-9658-7018; Ryan, Michael/0000-0003-2586-8829; Meisinger, Chris/0000-0002-8326-3548; Ryan, Michael T/0000-0003-2586-8829; Wiedemann, Nils/0000-0001-8305-6728; Chacinska, Agnieszka/0000-0002-2832-2568; Rospert, Sabine/0000-0002-3089-9614				Abdul KM, 2000, BIOCHEM BIOPH RES CO, V276, P1028, DOI 10.1006/bbrc.2000.3589; Dekker PJT, 1997, EMBO J, V16, P5408, DOI 10.1093/emboj/16.17.5408; Dietmeier K, 1997, NATURE, V388, P195, DOI 10.1038/40663; Endo T, 2002, BBA-MOL CELL RES, V1592, P3, DOI 10.1016/S0167-4889(02)00259-8; GRATZER S, 1995, J CELL BIOL, V129, P25, DOI 10.1083/jcb.129.1.25; HACHIYA N, 1995, NATURE, V376, P705, DOI 10.1038/376705a0; Herrmann JM, 2000, CURR OPIN MICROBIOL, V3, P210, DOI 10.1016/S1369-5274(00)00077-1; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Jensen RE, 2001, NAT STRUCT BIOL, V8, P1008, DOI 10.1038/nsb1201-1008; Koehler CM, 1999, TRENDS BIOCHEM SCI, V24, P428, DOI 10.1016/S0968-0004(99)01462-0; Krimmer T, 2001, J CELL BIOL, V152, P289, DOI 10.1083/jcb.152.2.289; LITHGOW T, 1994, P NATL ACAD SCI USA, V91, P11973, DOI 10.1073/pnas.91.25.11973; Martelli Pier Luigi, 2002, Bioinformatics, V18 Suppl 1, pS46; Matouschek A, 2001, NAT STRUCT BIOL, V8, P284, DOI 10.1038/86140; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Rapaport D, 1999, J CELL BIOL, V146, P321, DOI 10.1083/jcb.146.2.321; Rapaport D, 2002, TRENDS BIOCHEM SCI, V27, P191, DOI 10.1016/S0968-0004(02)02065-0; Ryan MT, 1999, J BIOL CHEM, V274, P20619, DOI 10.1074/jbc.274.29.20619; Sesaki H, 2001, J CELL BIOL, V152, P1123, DOI 10.1083/jcb.152.6.1123; SOGO LF, 1994, J CELL BIOL, V126, P1361, DOI 10.1083/jcb.126.6.1361; Taylor RD, 2003, J BIOL CHEM, V278, P765, DOI 10.1074/jbc.M208083200; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802	24	288	302	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					565	571		10.1038/nature01753	http://dx.doi.org/10.1038/nature01753			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891361				2022-12-28	WOS:000184454700046
J	Rees, E; Hardy, J				Rees, E; Hardy, J			Novel consent process for research in dying patients unable to give consent	BRITISH MEDICAL JOURNAL			English	Article							INFORMED CONSENT; PALLIATIVE CARE; EMERGENCY RESEARCH; TRIALS	Objectives To develop a process of advance consent to enable research to be undertaken in patients in the terminal phase. Design Feasibility study of an advance consent process to support a randomised controlled trial of two antimuscarinic drugs (hyoscine hydrobromide and glycopyrronium bromide) in the management of noisy respirations associated with retained secretions ("death rattle"). Setting Palliative care wards in a major cancer centre. Participants Patients admitted to a palliative care ward who may develop "death rattle" and thus be eligible for randomisation. Main outcome measures Patient accrual; acceptability of the consent process. Results Of the 107 patients approached to date, 58 patients gave advance consent to participate in the study. Of these, 15 patients developed death rattle and were randomised to receive either hyoscine or glycopyrronium; 16 patients died elsewhere; 15 patients died on the palliative care wards but were not randomised; 12 patients are still alive. Conclusions Initial assessment suggests that this is a workable consent process allowing research to be undertaken in patients who are unable to give consent at the time of randomisation. Patient accrual rates to date are lower than needed to recruit adequate numbers in the time allotted to answer the research question.	Royal Marsden Hosp, Dept Palliat Med, Sutton SM2 5PT, Surrey, England	Royal Marsden NHS Foundation Trust	Hardy, J (corresponding author), Royal Marsden Hosp, Dept Palliat Med, Downs Rd, Sutton SM2 5PT, Surrey, England.		Hardy, Janet/F-2501-2012					Adams JG, 1999, ANN EMERG MED, V33, P218, DOI 10.1016/S0196-0644(99)70398-7; Bennett M, 2002, PALLIATIVE MED, V16, P369, DOI 10.1191/0269216302pm584oa; BIROS MH, 1995, JAMA-J AM MED ASSOC, V273, P1283, DOI 10.1001/jama.273.16.1283; *BMA, 1995, ASS MENT CAP GUID DO; Doyal L, 1998, BRIT MED J, V316, P1000, DOI 10.1136/bmj.316.7136.1000; Grande GE, 2000, PALLIATIVE MED, V14, P69, DOI 10.1191/026921600677940614; Hardy J, 2000, LANCET, V356, pS44, DOI 10.1016/S0140-6736(00)92030-0; Hardy JR, 1997, PALLIATIVE MED, V11, P415, DOI 10.1177/026921639701100514; Hermet R, 2002, EUR J PALLIAT CARE, V9, P104; LIKAR R, 2001, 7 EUR ASS PALL CAR C; Ling J, 2000, EUR J CANCER, V36, P621, DOI 10.1016/S0959-8049(99)00330-5; OLSON CM, 1994, JAMA-J AM MED ASSOC, V271, P1445, DOI 10.1001/jama.271.18.1445; Smith R, 1997, BRIT MED J, V314, P1059, DOI 10.1136/bmj.314.7087.1059; WARREN JW, 1986, NEW ENGL J MED, V315, P1124, DOI 10.1056/NEJM198610303151804; Worthington R, 2002, J MED ETHICS, V28, P377, DOI 10.1136/jme.28.6.377	15	32	32	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2003	327	7408					198	200B		10.1136/bmj.327.7408.198	http://dx.doi.org/10.1136/bmj.327.7408.198			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706DL	12881261	Green Published, Bronze			2022-12-28	WOS:000184437300017
J	Engelberg-Kulka, H; Hazan, R				Engelberg-Kulka, H; Hazan, R			Cannibals defy starvation and avoid sporulation	SCIENCE			English	Editorial Material							PROGRAMMED CELL-DEATH; BACTERIAL-POPULATIONS; BACILLUS-SUBTILIS		Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Biol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Engelberg-Kulka, H (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Biol, IL-91120 Jerusalem, Israel.		Hazan, Ronen/ABI-1067-2020; Hazan, Ronen/R-8384-2016	Hazan, Ronen/0000-0001-9967-730X; Hazan, Ronen/0000-0001-9967-730X				BURBULYS D, 1991, CELL, V64, P545, DOI 10.1016/0092-8674(91)90238-T; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; Fawcett P, 2000, P NATL ACAD SCI USA, V97, P8063, DOI 10.1073/pnas.140209597; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; KAISER D, 1993, CELL, V73, P873, DOI 10.1016/0092-8674(93)90268-U; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Piggot P. J., 2002, BACILLUS SUBTILIS IT, P473; Sat B, 2003, J BACTERIOL, V185, P1803, DOI 10.1128/JB.185.6.1803-1807.2003; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; Sonenshein AL, 2000, BACTERIAL STRESS RESPONSES, P199; YARMOLINSKY MB, 1995, SCIENCE, V267, P836, DOI 10.1126/science.7846528	11	42	43	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2003	301	5632					467	468		10.1126/science.1088051	http://dx.doi.org/10.1126/science.1088051			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12881556				2022-12-28	WOS:000184340500026
J	Dickersin, K; Rennie, D				Dickersin, K; Rennie, D			Registering clinical trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED TRIAL; ACUTE MYOCARDIAL-INFARCTION; UP HERS-II; PUBLICATION BIAS; FOLLOW-UP; ESTROGEN/PROGESTIN REPLACEMENT; BIOMEDICAL-RESEARCH; DISEASE OUTCOMES; HORMONE-THERAPY; HEALTH-CARE	That it is not possible to find information about all initiated clinical trials is of international concern. This is a particular worry because scientists tend to publish their positive findings more often than their negative findings (publication bias). A comprehensive register of initiated clinical trials, with each trial assigned a unique identifier, would inform reviewers, physicians, and others (eg, consumers) about which trials had been started and directly address the problem of publication bias. Patients and their clinicians could also know which trials are open for enrollment, thus speeding medical advances. Individuals who participate in clinical trials typically provide consent in the belief that they are contributing to medical knowledge. But if the knowledge gained is never reported, the trust between patients and investigators and that between patients and research ethics review boards are both damaged. Ethical issues are of particular concern if industry is gaining financially from public involvement in trials, but refusing to reciprocate by making information from industry-sponsored trials generally available. All stakeholders-investigators, research organizations and institutions, journal editors, lawmakers, consumers, and others-must act now, together and in their own domains, to ensure comprehensive registration of clinical trials.	Brown Univ, Sch Med, Ctr Clin Trials & Evidence Based Healthcare, Providence, RI 02912 USA; US Cochrane Ctr, San Francisco, CA USA	Brown University	Dickersin, K (corresponding author), Brown Univ, Sch Med, Ctr Clin Trials & Evidence Based Healthcare, 169 Angell St,Box G-S2, Providence, RI 02912 USA.	kay_dickersin@brown.edu	Dickersin, Kay/A-4576-2008					Andersen B, 2001, ENDOCR REV, V22, P2, DOI 10.1210/er.22.1.2; [Anonymous], 1948, BMJ-BRIT MED J, V2, P769; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Benson DA, 2002, NUCLEIC ACIDS RES, V30, P17, DOI 10.1093/nar/30.1.17; *BIOM CENTR, INF AUTH PUBL YOUR S; Blum J, 1998, BRIT MED J, V316, P312, DOI 10.1136/bmj.316.7127.312; BRAZIER H, 1999, P 2 S SYST REV BAS J; *CENT, CLIN TRIALS LIST SER; CHALMERS I, 1986, CONTROL CLIN TRIALS, V7, P306, DOI 10.1016/0197-2456(86)90038-3; CHALMERS I, 1990, JAMA-J AM MED ASSOC, V263, P1405, DOI 10.1001/jama.263.10.1405; Chalmers I, 1998, BMJ-BRIT MED J, V317, P1167, DOI 10.1136/bmj.317.7167.1167; Chalmers I., 2001, SYSTEMATIC REV HLTH, P429, DOI DOI 10.1002/9780470693926.CH24; Chalmers Iain, 2000, Curr Control Trials Cardiovasc Med, V1, P3, DOI 10.1186/CVM-1-1-003; CHALMERS TC, 1977, NEW ENGL J MED, V296, P107; COWLEY AJ, 1993, INT J CARDIOL, V40, P161, DOI 10.1016/0167-5273(93)90279-P; DEMARINIS AD, 2002, RES PRACTITIONER, V3, P105; DERBIS J, 2003, 9 ANN FDA SCI FOR AP; DICKERSIN K, 1988, CONTROL CLIN TRIALS, V9, P76; Dickersin K, 2002, EVAL HEALTH PROF, V25, P38, DOI 10.1177/0163278702025001004; DICKERSIN K, 1992, CONTROL CLIN TRIALS, V13, P507, DOI 10.1016/0197-2456(92)90207-G; Dickersin K, 1997, AIDS EDUC PREV, V9, P15; Dickersin K, 2002, JAMA-J AM MED ASSOC, V287, P2772, DOI 10.1001/jama.287.21.2772; DICKERSIN K, 1987, CONTROL CLIN TRIALS, V8, P343, DOI 10.1016/0197-2456(87)90155-3; DICKERSIN K, 1992, CONTROL CLIN TRIALS, V13, P170, DOI 10.1016/0197-2456(92)90022-R; Dickersin K., 1993, ONLINE J CURR CLIN T, pDoc No 50; FLANAGIN A, 2002, JAMA-J AM MED ASSOC, V2887, P3166; FURBERG CD, 1983, AM J CARDIOL, V52, pC32, DOI 10.1016/0002-9149(83)90629-X; GIBBS TG, 2000, INT J PHARM MED, V14, P203; GOTZSCHE PC, 1989, EUR J CLIN PHARMACOL, V36, P429, DOI 10.1007/BF00558064; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; HARLAN WR, 1994, JAMA-J AM MED ASSOC, V271, P1729, DOI 10.1001/jama.271.22.1729; Hayward S., 1997, P 2 INT C SCI BAS HL; HETHERINGTON J, 1989, PEDIATRICS, V84, P374; Hopewell S, 2002, STAT MED, V21, P1625, DOI 10.1002/sim.1191; Horton R, 1997, LANCET, V349, P6, DOI 10.1016/S0140-6736(05)62158-7; Horton R, 1999, LANCET, V354, P1138, DOI 10.1016/S0140-6736(99)00328-1; Horton R, 1999, BRIT MED J, V319, P865, DOI 10.1136/bmj.319.7214.865; HUBBARD S, 1987, IMPORTANT ADV ONCOLO; Hulley S, 2002, JAMA-J AM MED ASSOC, V288, P58, DOI 10.1001/jama.288.1.58; Huston P, 1996, LANCET, V347, P1024, DOI 10.1016/S0140-6736(96)90153-1; *I MED COMM ASS SY, 2002, RESP RES SYST APPR P; *I MED COMM ROUT P, 2000, EXT MED REIMB CLIN T; *INT COLL GROUP CL, 1993, CLIN TRIALS METAANAL, V28, P199; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Johansen HK, 1999, JAMA-J AM MED ASSOC, V282, P1752, DOI 10.1001/jama.282.18.1752; Jull Andrew, 2002, N Z Med J, V115, pU269; Kmietowicz Z, 2000, BRIT MED J, V321, P850; LEVINE J, 1974, PSYCHOPHARMACOLOGICA; MacLean CH, 2003, J CLIN EPIDEMIOL, V56, P44, DOI 10.1016/S0895-4356(02)00520-6; Manheimer E, 2002, BRIT MED J, V325, P528, DOI 10.1136/bmj.325.7363.528; McCray AT, 2000, ANN INTERN MED, V133, P609, DOI 10.7326/0003-4819-133-8-200010170-00013; McManus RJ, 1998, BMJ-BRIT MED J, V317, P1562, DOI 10.1136/bmj.317.7172.1562; MEINERT CL, 1988, CONTROL CLIN TRIALS, V9, P1, DOI 10.1016/0197-2456(88)90002-5; Moore T., 1995, DEADLY MED WHY 10S 1; Moses H, 2001, JAMA-J AM MED ASSOC, V285, P933, DOI 10.1001/jama.285.7.933; Petitti DB, 2002, JAMA-J AM MED ASSOC, V288, P99, DOI 10.1001/jama.288.1.99; *PHARM RES MAN AM, 2003 IND PROF DRAM G; *PHARM RES MAN AM, 2002, 2002 IND PROF RES DE; *PHRMA, 2002, PUBL DISCL CLIN TRIA; Pich J, 2003, LANCET, V361, P1015, DOI 10.1016/S0140-6736(03)12799-7; Rennie D, 1999, JAMA-J AM MED ASSOC, V282, P1766, DOI 10.1001/jama.282.18.1766; *RES AM, MUCH IS REALL SPENT; Reynolds T, 2003, J NATL CANCER I, V95, P772, DOI 10.1093/jnci/95.11.772; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rowland D, 2002, BRIT MED J, V325, P998, DOI 10.1136/bmj.325.7371.998; Savulescu J, 1996, BMJ-BRIT MED J, V313, P1390, DOI 10.1136/bmj.313.7069.1390; SCHERER RW, 2003, COCHRANE LIB; SCHIFF H, 1998, MAMM             OCT, P86; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; STERLING TD, 1959, J AM STAT ASSOC, V54, P30, DOI 10.2307/2282137; Sykes R, 1998, BRIT MED J, V317, P1172, DOI 10.1136/bmj.317.7167.1172; TEO KK, 1993, JAMA-J AM MED ASSOC, V270, P1589, DOI 10.1001/jama.270.13.1589; THORN J, 2001, TOTAL BASEBALL OFFIC; Tonks A, 2002, BRIT MED J, V325, P1314, DOI 10.1136/bmj.325.7376.1314; Tramer MR, 1997, BMJ-BRIT MED J, V315, P635, DOI 10.1136/bmj.315.7109.635; VALE CL, 2001, P 9 INT COCHR C LYON; VERSTRAETE M, 1975, THROMB DIATH HAEMOST, V33, P655, DOI 10.1055/s-0038-1647862; Wager E, 2003, CURR MED RES OPIN, V19, P149, DOI 10.1185/030079903125001767; 1996, BASEBALL ENCY COMPLE; 1995, ANN INTERN MED, V123, P1	80	320	323	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2003	290	4					516	523		10.1001/jama.290.4.516	http://dx.doi.org/10.1001/jama.290.4.516			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703JB	12876095				2022-12-28	WOS:000184275300024
J	Johansson, L; Rytkonen, A; Bergman, P; Albiger, B; Kallstrom, H; Hokfelt, T; Agerberth, B; Cattaneo, R; Jonsson, AB				Johansson, L; Rytkonen, A; Bergman, P; Albiger, B; Kallstrom, H; Hokfelt, T; Agerberth, B; Cattaneo, R; Jonsson, AB			CD46 in meningococcal disease	SCIENCE			English	Article							MEMBRANE COFACTOR PROTEIN; MEASLES-VIRUS; PATHOGENIC NEISSERIA; MULTIPLE ISOFORMS; CELLULAR RECEPTOR; EXPRESSION; COMPLEMENT; MCP; MENINGITIDIS; CELLS	The human-specific bacterial pathogen Neisseria meningitidis is a major cause of sepsis and/or meningitis. The pili of N. meningitidis interact with CD46, a human cell-surface protein involved in regulation of complement activation. Transgenic mice expressing human CD46 were susceptible to meningococcal disease, because bacteria crossed the blood-brain barrier in these mice. Development of disease was more efficient with piliated bacteria after intranasal, but not intraperitoneal, challenge of CD46 transgenic mice, suggesting that human CD46 facilitates pilus-dependent interactions at the epithelial mucosa. Hence, the human CD46 transgenic mice model is a potentially useful tool for studying pathogenesis and for vaccine development against meningococcal disease.	Ctr Microbiol & Tumor Biol, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Neurosci, SE-17177 Stockholm, Sweden; Swedish Inst Infect Dis Control, SE-17182 Solna, Sweden; Mayo Clin & Mayo Fdn, Program Mol Med, Rochester, MN 55905 USA	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Swedish Institute for Infectious Disease Control; Mayo Clinic	Jonsson, AB (corresponding author), Ctr Microbiol & Tumor Biol, Nobels Vag 16,Box 280, SE-17177 Stockholm, Sweden.			Bergman, Peter/0000-0003-3306-3713				ADAMS JC, 1992, J HISTOCHEM CYTOCHEM, V40, P1457, DOI 10.1177/40.10.1527370; Albiger B, 2003, INFECT IMMUN, V71, P155, DOI 10.1128/IAI.71.1.155-162.2003; Ayala BP, 2001, CELL MICROBIOL, V3, P265, DOI 10.1046/j.1462-5822.2001.00112.x; Brumovsky PR, 2002, EXP NEUROL, V174, P1, DOI 10.1006/exnr.2001.7845; Danielii J.F., 1958, GENERAL CYTOCHEMICAL, P399; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; DYER DW, 1987, MICROB PATHOGENESIS, V3, P351, DOI 10.1016/0882-4010(87)90005-2; JOHANSSON LS, UNPUB; JONSSON AB, 1991, EMBO J, V10, P477, DOI 10.1002/j.1460-2075.1991.tb07970.x; Kallstrom H, 1997, MOL MICROBIOL, V25, P639, DOI 10.1046/j.1365-2958.1997.4841857.x; Kallstrom H, 1998, J BIOL CHEM, V273, P21777, DOI 10.1074/jbc.273.34.21777; Kemper C, 2001, CLIN EXP IMMUNOL, V124, P180, DOI 10.1046/j.1365-2249.2001.01458.x; Lee SW, 2002, J CELL BIOL, V156, P951, DOI 10.1083/jcb.200109005; Liszewski MK, 1996, J IMMUNOL, V156, P4415; MANCHESTER M, 1994, P NATL ACAD SCI USA, V91, P2161, DOI 10.1073/pnas.91.6.2161; Marie JC, 2002, NAT IMMUNOL, V3, P659, DOI 10.1038/ni810; Merz AJ, 2000, ANNU REV CELL DEV BI, V16, P423, DOI 10.1146/annurev.cellbio.16.1.423; Mrkic B, 1998, J VIROL, V72, P7420, DOI 10.1128/JVI.72.9.7420-7427.1998; NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993; Nassif X, 1999, MOL MICROBIOL, V32, P1124, DOI 10.1046/j.1365-2958.1999.01416.x; OKADA N, 1995, P NATL ACAD SCI USA, V92, P2489, DOI 10.1073/pnas.92.7.2489; POST TW, 1991, J EXP MED, V174, P93, DOI 10.1084/jem.174.1.93; PURCELL DFJ, 1991, IMMUNOGENETICS, V33, P335, DOI 10.1007/BF00216692; Rahman M, 1997, MOL MICROBIOL, V25, P11, DOI 10.1046/j.1365-2958.1997.4601823.x; Santoro F, 1999, CELL, V99, P817, DOI 10.1016/S0092-8674(00)81678-5; Shusta EV, 2002, J NEUROPATH EXP NEUR, V61, P597, DOI 10.1093/jnen/61.7.597; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2	27	131	140	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2003	301	5631					373	375		10.1126/science.1086476	http://dx.doi.org/10.1126/science.1086476			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869763				2022-12-28	WOS:000184207300046
J	McIntosh, AR; Lobaugh, NJ				McIntosh, AR; Lobaugh, NJ			When is a word not a word?	SCIENCE			English	Editorial Material							PREFRONTAL CORTEX		Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON M6A 2E1, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada	University of Toronto; University Toronto Affiliates; Baycrest; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	McIntosh, AR (corresponding author), Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON M6A 2E1, Canada.	rmcintosh@rotman-baycrest.on.ca; nlobaugh@sten.sunnybrook.utoronto.ca	McIntosh, Anthony R/G-4955-2011	McIntosh, Anthony/0000-0002-1784-5662				Buchel C, 1999, SCIENCE, V283, P1538, DOI 10.1126/science.283.5407.1538; Finger S., 1994, ORIGINS NEUROSCIENCE; McIntosh AR, 2000, NEURAL NETWORKS, V13, P861, DOI 10.1016/S0893-6080(00)00059-9; McIntosh AR, 1999, SCIENCE, V284, P1531, DOI 10.1126/science.284.5419.1531; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Rinne T, 1999, NEUROREPORT, V10, P1113, DOI 10.1097/00001756-199904060-00038; Sanders LD, 2003, COGNITIVE BRAIN RES, V15, P228, DOI 10.1016/S0926-6410(02)00195-7; Stephan KE, 2003, SCIENCE, V301, P384, DOI 10.1126/science.1086025; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x	9	3	3	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2003	301	5631					322	323		10.1126/science.1087853	http://dx.doi.org/10.1126/science.1087853			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869747				2022-12-28	WOS:000184207300027
J	Kelley, SP; Dunlop, JI; Kirkness, EF; Lambert, JJ; Peters, JA				Kelley, SP; Dunlop, JI; Kirkness, EF; Lambert, JJ; Peters, JA			A cytoplasmic region determines single-channel conductance in 5-HT3 receptors	NATURE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; STRUCTURAL BASIS; GATING KINETICS; ION PERMEATION; SUBUNIT; SELECTIVITY; EXPRESSION; PORE	5-Hydroxytryptamine type 3 (5-HT3) receptors are cation-selective transmitter-gated ion channels of the Cys-loop superfamily(1-9). The single-channel conductance of human recombinant 5-HT3 receptors assembled as homomers of 5-HT3A subunits, or heteromers of 5-HT3A and 5-HT3B subunits, are markedly different, being 0.4 pS (refs 6, 9) and 16 pS (ref. 7), respectively. Paradoxically, the channel-lining M2 domain of the 5-HT3A subunit would be predicted to promote cation conduction, whereas that of the 5-HT3B subunit would not(7). Here we describe a determinant of single-channel conductance that can explain these observations. By constructing chimaeric 5-HT3A and 5-HT3B subunits we identified a region (the 'HA-stretch')(10) within the large cytoplasmic loop of the receptor that markedly influences channel conductance. Replacement of three arginine residues unique to the HA-stretch of the 5-HT3A subunit by their 5-HT3B subunit counterparts increased single-channel conductance 28-fold. Significantly, ultrastructural studies of the Torpedo nicotinic acetylcholine receptor(11) indicate that the key residues might frame narrow openings that contribute to the permeation pathway. Our findings solve the conundrum of the anomalously low conductance of homomeric 5-HT3A receptors and indicate an important function for the HA-stretch in Cys-loop transmitter-gated ion channels.	Univ Dundee, Ninewells Hosp & Med Sch, Inst Neurosci, Dept Pharmacol & Neurosci, Dundee DD1 9SY, Scotland; Inst Genom Res, Rockville, MD 20850 USA	University of Dundee; J. Craig Venter Institute	Peters, JA (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Inst Neurosci, Dept Pharmacol & Neurosci, Dundee DD1 9SY, Scotland.	j.a.peters@dundee.ac.uk						Akk G, 2000, J PHYSIOL-LONDON, V527, P405, DOI 10.1111/j.1469-7793.2000.t01-2-00405.x; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; BOUZAT C, 1994, NEURON, V13, P1395, DOI 10.1016/0896-6273(94)90424-3; Boyd GW, 2002, MOL CELL NEUROSCI, V21, P38, DOI 10.1006/mcne.2002.1160; Brown AM, 1998, J PHYSIOL-LONDON, V507, P653, DOI 10.1111/j.1469-7793.1998.653bs.x; Davies PA, 2003, J BIOL CHEM, V278, P712, DOI 10.1074/jbc.M208814200; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; DERKACH V, 1989, NATURE, V339, P706, DOI 10.1038/339706a0; Dubin AE, 1999, J BIOL CHEM, V274, P30799, DOI 10.1074/jbc.274.43.30799; FINERMOORE J, 1984, P NATL ACAD SCI-BIOL, V81, P155, DOI 10.1073/pnas.81.1.155; GILL CH, 1995, BRIT J PHARMACOL, V114, P1211, DOI 10.1111/j.1476-5381.1995.tb13335.x; Gunthorpe MJ, 2001, J BIOL CHEM, V276, P10977, DOI 10.1074/jbc.M009575200; Hanna MC, 2000, J NEUROCHEM, V75, P240, DOI 10.1046/j.1471-4159.2000.0750240.x; Higgins MK, 2002, EMBO J, V21, P2087, DOI 10.1093/emboj/21.9.2087; HUSSY N, 1994, J PHYSIOL-LONDON, V481, P311, DOI 10.1113/jphysiol.1994.sp020441; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Kobertz WR, 2000, BIOCHEMISTRY-US, V39, P10347, DOI 10.1021/bi001292j; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; Panicker S, 2002, J NEUROSCI, V22, P1629, DOI 10.1523/JNEUROSCI.22-05-01629.2002; Reeves DC, 2001, J BIOL CHEM, V276, P42035, DOI 10.1074/jbc.M106066200; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sato C, 2001, NATURE, V409, P1047, DOI 10.1038/35059098; Sokolova O, 2001, STRUCTURE, V9, P215, DOI 10.1016/S0969-2126(01)00578-0; Unwin N, 2000, PHILOS T R SOC B, V355, P1813, DOI 10.1098/rstb.2000.0737; YAKEL JL, 1988, NEURON, V1, P615, DOI 10.1016/0896-6273(88)90111-0; YAKEL JL, 1990, BRAIN RES, V533, P46, DOI 10.1016/0006-8993(90)91793-G; YANG J, 1990, J GEN PHYSIOL, V96, P1177, DOI 10.1085/jgp.96.6.1177; YU XM, 1994, NEURON, V13, P247, DOI 10.1016/0896-6273(94)90473-1	29	227	238	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2003	424	6946					321	324		10.1038/nature01788	http://dx.doi.org/10.1038/nature01788			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867984	Green Accepted			2022-12-28	WOS:000184183900044
J	Opalka, N; Chlenov, M; Chacon, P; Rice, WJ; Wriggers, W; Darst, SA				Opalka, N; Chlenov, M; Chacon, P; Rice, WJ; Wriggers, W; Darst, SA			Structure and function of the transcription elongation factor GreB bound to bacterial RNA polymerase	CELL			English	Article							CLEAVAGE FACTORS GREA; CRYSTAL-STRUCTURE; FACTOR TFIIS; II ELONGATION; NASCENT TRANSCRIPT; IN-VIVO; SUBUNIT; BINDING; DOMAIN; MECHANISM	Bacterial GreA and GreB promote transcription elongation by stimulating an endogenous, endonucleolytic transcript cleavage activity of the RNA polymerase. The structure of Escherichia coli core RNA polymerase bound to GreB was determined by cryo-electron microscopy and image processing of helical crystals to a nominal resolution of 15 Angstrom, allowing fitting of high-resolution RNA polymerase and GreB structures. In the resulting model, the GreB N-terminal coiled-coil domain extends 45 Angstrom through a channel directly to the RNA polymerase active site. The model leads to detailed insights into the mechanism of Gre factor activity that explains a wide range of experimental observations and points to a key role for conserved acidic residues at the tip of the Gre factor coiled coil in modifying the RNA polymerase active site to catalyze the cleavage reaction. Mutational studies confirm that these positions are critical for Gre factor function.	Rockefeller Univ, New York, NY 10021 USA; Scripps Res Inst, Dept Biol Mol, La Jolla, CA 92037 USA; NYU, Med Ctr, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Med Ctr, Dept Cell Biol, New York, NY 10016 USA	Rockefeller University; Scripps Research Institute; New York University; New York University	Darst, SA (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	darst@rockefeller.edu	Chacon, Pablo/B-4211-2014	Chacon, Pablo/0000-0002-3168-4826; Wriggers, Willy/0000-0001-5326-3152; Rice, William/0000-0002-5187-255X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062968, R01GM058020, R01GM061898] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGARWAL K, 1991, BIOCHEMISTRY-US, V30, P7842, DOI 10.1021/bi00245a026; ARCHAMBAULT J, 1992, MOL CELL BIOL, V12, P4142, DOI 10.1128/MCB.12.9.4142; ARCHAMBAULT J, 1993, MICROBIOL REV, V57, P703, DOI 10.1128/MMBR.57.3.703-724.1993; Awrey DE, 1997, J BIOL CHEM, V272, P14747, DOI 10.1074/jbc.272.23.14747; Awrey DE, 1998, J BIOL CHEM, V273, P22595, DOI 10.1074/jbc.273.35.22595; BORUKHOV S, 1991, J BIOL CHEM, V266, P23921; Borukhov S, 1996, METHOD ENZYMOL, V274, P315; BORUKHOV S, 1992, P NATL ACAD SCI USA, V89, P8899, DOI 10.1073/pnas.89.19.8899; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; BORUKHOV S, 1991, J BIOL CHEM, V266, P23932; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; CIPRESPALACIN G, 1995, BIOCHEMISTRY-US, V34, P15375, DOI 10.1021/bi00046a046; Cramer P, 2001, SCIENCE, V292, P1863, DOI 10.1126/science.1059493; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Darst SA, 2002, P NATL ACAD SCI USA, V99, P4296, DOI 10.1073/pnas.052054099; Darst SA, 2001, CURR OPIN STRUC BIOL, V11, P155; DeRosier D, 1999, J MOL BIOL, V289, P159, DOI 10.1006/jmbi.1999.2677; Epshtein V, 2002, MOL CELL, V10, P623, DOI 10.1016/S1097-2765(02)00640-8; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; FENG GH, 1994, J BIOL CHEM, V269, P22282; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Fu JH, 1999, CELL, V98, P799, DOI 10.1016/S0092-8674(00)81514-7; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Hogan BP, 2002, J BIOL CHEM, V277, P967, DOI 10.1074/jbc.M108737200; HSU LM, 1995, P NATL ACAD SCI USA, V92, P11588, DOI 10.1073/pnas.92.25.11588; IZBAN MG, 1992, GENE DEV, V6, P1342, DOI 10.1101/gad.6.7.1342; JEON CJ, 1994, P NATL ACAD SCI USA, V91, P9106, DOI 10.1073/pnas.91.19.9106; Juo ZS, 2003, NATURE, V422, P534, DOI 10.1038/nature01534; Kamada K, 2001, P NATL ACAD SCI USA, V98, P3115, DOI 10.1073/pnas.051631098; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Kornberg Roger D., 1999, Trends in Cell Biology, V9, pM46, DOI 10.1016/S0962-8924(99)01679-7; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Koulich D, 1998, J MOL BIOL, V276, P379, DOI 10.1006/jmbi.1997.1545; Koulich D, 1997, J BIOL CHEM, V272, P7201, DOI 10.1074/jbc.272.11.7201; Kulish D, 2000, J BIOL CHEM, V275, P12789, DOI 10.1074/jbc.275.17.12789; Loizos N, 1999, J BIOL CHEM, V274, P23378, DOI 10.1074/jbc.274.33.23378; Malhotra A, 1996, CELL, V87, P127, DOI 10.1016/S0092-8674(00)81329-X; Markovtsov V, 1996, P NATL ACAD SCI USA, V93, P3221, DOI 10.1073/pnas.93.8.3221; Marr MT, 2000, MOL CELL, V6, P1275, DOI 10.1016/S1097-2765(00)00126-X; Minakhin L, 2001, P NATL ACAD SCI USA, V98, P892, DOI 10.1073/pnas.98.3.892; Morin PE, 1996, P NATL ACAD SCI USA, V93, P10604, DOI 10.1073/pnas.93.20.10604; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Mustaev A, 1997, P NATL ACAD SCI USA, V94, P6641, DOI 10.1073/pnas.94.13.6641; NAKANISHI T, 1995, J BIOL CHEM, V270, P8991, DOI 10.1074/jbc.270.15.8991; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; NIKOLOV DB, 1992, NATURE, V360, P40, DOI 10.1038/360040a0; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Olmsted VK, 1998, J BIOL CHEM, V273, P22589, DOI 10.1074/jbc.273.35.22589; Opalka N, 2000, P NATL ACAD SCI USA, V97, P617, DOI 10.1073/pnas.97.2.617; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; POLYAKOV A, 1995, CELL, V83, P365, DOI 10.1016/0092-8674(95)90114-0; Polyakov A, 1998, J MOL BIOL, V281, P465, DOI 10.1006/jmbi.1998.1958; QIAN XQ, 1993, NATURE, V365, P277, DOI 10.1038/365277a0; Reeder TC, 1996, CELL, V87, P767, DOI 10.1016/S0092-8674(00)81395-1; REINES D, 1992, J BIOL CHEM, V267, P3795; REINES D, 1989, J BIOL CHEM, V264, P10799; Rice WJ, 2001, BIOPHYS J, V80, P2187, DOI 10.1016/S0006-3495(01)76191-7; RUDD MD, 1994, P NATL ACAD SCI USA, V91, P8057, DOI 10.1073/pnas.91.17.8057; SEVERINOV K, 1994, J BIOL CHEM, V269, P14254; SLUDER AE, 1989, J BIOL CHEM, V264, P8963; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; STEBBINS CE, 1995, NATURE, V373, P636, DOI 10.1038/373636a0; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; SURRATT CK, 1991, P NATL ACAD SCI USA, V88, P7983, DOI 10.1073/pnas.88.18.7983; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Toulme F, 2000, EMBO J, V19, P6853, DOI 10.1093/emboj/19.24.6853; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; WANG DG, 1993, P NATL ACAD SCI USA, V90, P843, DOI 10.1073/pnas.90.3.843; Wriggers W, 2001, STRUCTURE, V9, P779, DOI 10.1016/S0969-2126(01)00648-7; Wu JS, 1996, P NATL ACAD SCI USA, V93, P11552, DOI 10.1073/pnas.93.21.11552; YEE D, 1979, BIOCHEMISTRY-US, V18, P4116, DOI 10.1021/bi00586a009; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; Zhang GY, 1998, SCIENCE, V281, P262, DOI 10.1126/science.281.5374.262	81	165	173	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 8	2003	114	3					335	345		10.1016/S0092-8674(03)00600-7	http://dx.doi.org/10.1016/S0092-8674(03)00600-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914698	Bronze			2022-12-28	WOS:000184679200010
J	Korbling, M; Estrov, Z				Korbling, M; Estrov, Z			Adult stem cells for tissue repair - A new therapeutic concept?	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BONE-MARROW-CELLS; MUSCLE PROGENITOR CELLS; HEMATOPOIETIC STEM; PERIPHERAL-BLOOD; ISCHEMIC MYOCARDIUM; EPITHELIAL-CELLS; IN-VIVO; TRANSPLANTATION; DIFFERENTIATION; REGENERATION		Univ Texas, MD Anderson Canc Ctr, Dept Blood & Marrow Transplant, Unit 423, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Bioimmunotherapy, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Korbling, M (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Blood & Marrow Transplant, Unit 423, 1515 Holcombe Blvd, Houston, TX 77030 USA.	mkorblin@mdanderson.org						Alison MR, 2000, NATURE, V406, P257, DOI 10.1038/35018642; Anderson DJ, 2001, NAT MED, V7, P393, DOI 10.1038/86439; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Blau H, 2002, SCIENCE, V298, P361; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; Blau HM, 2002, NATURE, V419, P437, DOI 10.1038/419437a; BODINE DM, 1994, BLOOD, V84, P1482; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Castro RF, 2002, SCIENCE, V297, P1299, DOI 10.1126/science.297.5585.1299; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Edelberg JM, 2002, CIRC RES, V90, pE89, DOI 10.1161/01.RES.0000020861.20064.7E; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; ESCHBACH JW, 1965, NEW ENGL J MED, V273, P998; Eto T, 1999, NAT MED, V5, P577, DOI 10.1038/8462; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Frisen J, 2002, NEURON, V35, P415, DOI 10.1016/S0896-6273(02)00798-5; Fu XB, 2001, LANCET, V358, P1067, DOI 10.1016/S0140-6736(01)06202-X; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Grompe M, 2002, MOL THER, V6, P303, DOI 10.1006/mthe.2002.0687; Gussoni E, 2002, J CLIN INVEST, V110, P807, DOI 10.1172/JCI200216098; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Hatch Heather M., 2002, Cloning and Stem Cells, V4, P339, DOI 10.1089/153623002321025014; Hematti P, 2002, EXP HEMATOL, V30, P943, DOI 10.1016/S0301-472X(02)00873-1; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Huss R, 2000, STEM CELLS, V18, P252, DOI 10.1634/stemcells.18-4-252; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kleeberger W, 2002, HEPATOLOGY, V35, P110, DOI 10.1053/jhep.2002.30275; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Korbling M, 2002, NEW ENGL J MED, V346, P738, DOI 10.1056/NEJMoa3461002; Korbling M, 2001, BLOOD, V98, P2900, DOI 10.1182/blood.V98.10.2900; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Kuznetsov SA, 2001, J CELL BIOL, V153, P1133, DOI 10.1083/jcb.153.5.1133; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lagaaij EL, 2001, LANCET, V357, P33, DOI 10.1016/S0140-6736(00)03569-8; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Masuda H, 2000, Hum Cell, V13, P153; Masuya M, 2003, BLOOD, V101, P2215, DOI 10.1182/blood-2002-04-1076; Medvinsky A, 2003, NATURE, V422, P823, DOI 10.1038/422823a; Mezey E, 2003, SCIENCE, V299; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Mezey E, 2003, P NATL ACAD SCI USA, V100, P1364, DOI 10.1073/pnas.0336479100; Muller P, 2002, CIRCULATION, V106, P31, DOI 10.1161/01.CIR.0000022405.68464.CA; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; Okamoto R, 2002, NAT MED, V8, P1011, DOI 10.1038/nm755; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Orlic D, 2002, BLOOD, V100, p28A; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Otani A, 2002, NAT MED, V8, P1004, DOI 10.1038/nm744; Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Quesenberry PJ, 2002, BLOOD, V100, P4266, DOI 10.1182/blood-2002-04-1246; Saiura A, 2001, NAT MED, V7, P382, DOI 10.1038/86394; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; Simper D, 2002, CIRCULATION, V106, P1199, DOI 10.1161/01.CIR.0000031525.61826.A8; Slack JMW, 2000, SCIENCE, V287, P1431, DOI 10.1126/science.287.5457.1431; Srivatsa B, 2001, LANCET, V358, P2034, DOI 10.1016/S0140-6736(01)07099-4; Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Taylor DA, 2002, CIRCULATION, V106, P2, DOI 10.1161/01.CIR.0000024386.99599.4A; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124; Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135; Theise ND, 2003, SCIENCE, V299, p1317A, DOI 10.1126/science.1078412; Tran SD, 2003, LANCET, V361, P1084, DOI 10.1016/S0140-6736(03)12894-2; Tse HF, 2003, LANCET, V361, P47, DOI 10.1016/S0140-6736(03)12111-3; Ueki T, 1999, NAT MED, V5, P226, DOI 10.1038/5593; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Wang XL, 2003, BLOOD, V101, P4201, DOI 10.1182/blood-2002-05-1338; Weimann JM, 2003, P NATL ACAD SCI USA, V100, P2088, DOI 10.1073/pnas.0337659100; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	84	561	626	0	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2003	349	6					570	582		10.1056/NEJMra022361	http://dx.doi.org/10.1056/NEJMra022361			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708JL	12904523				2022-12-28	WOS:000184563500010
J	Stern, SA				Stern, SA			The evolution of comets in the Oort cloud and Kuiper belt	NATURE			English	Article							EROSION	Comets are remnants from the time when the outer planets formed, similar to4-4.5 billion years ago. They have been in storage since then in the Oort cloud and Kuiper belt-distant regions that are so cold and sparsely populated that it was long thought that comets approaching the Sun were pristine samples from the time of Solar System formation. It is now recognized, however, that a variety of subtle but important evolutionary mechanisms operate on comets during their long storage, so they can no longer be regarded as wholly pristine.	SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA		Stern, SA (corresponding author), SW Res Inst, Dept Space Studies, 1050 Walnut St,Suite 400, Boulder, CO 80302 USA.	astern@swri.edu						Asphaug E, 1996, ICARUS, V121, P225, DOI 10.1006/icar.1996.0083; BELTON M, 2002, NEW FRONTIERS SOLAR, P457; DELSEMME AH, 1977, COMETS ASTEROIDS MET, P3; DONES L, UNPUB ICARUS; DUNCAN M, 1988, ASTROPHYS J, V328, pL69, DOI 10.1086/185162; Durda DD, 2000, ICARUS, V145, P220, DOI 10.1006/icar.1999.6333; FARINELLA P, 2000, PROTOSTARS PLANETS, V4, P125; Gerakines PA, 2001, J GEOPHYS RES-PLANET, V106, P33381, DOI 10.1029/2000JE001320; GERAKINES PA, 2001, J GEOPHYS RES, V106, P33275; Greenberg J., 1982, COMETS, P131; JEWITT D, 1993, NATURE, V362, P730, DOI 10.1038/362730a0; Johnson R. E., 1990, ENERGETIC CHARGED PA, P232; KLINGER J, 1985, ICES SOLAR SYSTEM, P407; KOUCHI A, 1992, ASTROPHYS J, V388, pL73, DOI 10.1086/186333; Kuiper G.P., 1951, ASTROPHYSICS TOPICAL, P357; LEVISON HF, 1994, ICARUS, V108, P18, DOI 10.1006/icar.1994.1039; LISSAUER JJ, 1989, ASTROPHYS J, V340, P468, DOI 10.1086/167409; Mumma M. J., 1997, Astronomical Society of the Pacific Conference Series, V122, P369; Mumma M. J., 1993, PROTOSTARS PLANETS, P1177; ODELL CR, 1973, ICARUS, V19, P137; Oort J. H., 1950, B ASTRON I NETH, V11, P91; Prialnik D, 1999, SPACE SCI REV, V90, P169, DOI 10.1023/A:1005202215579; SAFRONOV VS, 1987, EVOLUTION SMALL BODI, P217; Schwadron NA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015829; STERN SA, 1988, ICARUS, V73, P499, DOI 10.1016/0019-1035(88)90059-0; STERN SA, 1990, ICARUS, V84, P447, DOI 10.1016/0019-1035(90)90048-E; STERN SA, 1986, ICARUS, V68, P276, DOI 10.1016/0019-1035(86)90024-2; Stern SA, 2001, NATURE, V409, P589, DOI 10.1038/35054508; STERN SA, 1988, NATURE, V332, P407, DOI 10.1038/332407a0; STRAZZULA G, 1999, COMPOSITION ORIGIN C, P269; THOMPSON WR, 1987, J GEOPHYS RES, V92, P14933, DOI 10.1029/JA092iA13p14933; THROOP HB, 2000, THESIS U COLORADO, P1; Weaver HA, 2002, ASTROPHYS J, V576, pL95, DOI 10.1086/343087; WEISSMAN PR, 1990, NATURE, V344, P825, DOI 10.1038/344825a0; Weissman PR, 1996, ASTR SOC P, V107, P265; WEISSMAN PR, IN PRESS COMETS, V2; WHIPPLE FL, 1950, ASTROPHYS J, V111, P375, DOI 10.1086/145272; WHIPPLE FL, 1964, P NATL ACAD SCI USA, V51, P711, DOI 10.1073/pnas.51.5.711; WHIPPLE FL, 1977, COMETS ASTEROIDS MET, P25; Wilkening L. L, 1982, IAU C 61 COMET DISCO, P85; [No title captured]	41	83	86	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2003	424	6949					639	642		10.1038/nature01725	http://dx.doi.org/10.1038/nature01725			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904784				2022-12-28	WOS:000184578800036
J	Veronesi, U; Paganelli, G; Viale, G; Luini, A; Zurrida, S; Galimberti, V; Intra, M; Veronesi, P; Robertson, C; Maisonneuve, P; Renne, G; De Cicco, C; De Lucia, F; Gennari, R				Veronesi, U; Paganelli, G; Viale, G; Luini, A; Zurrida, S; Galimberti, V; Intra, M; Veronesi, P; Robertson, C; Maisonneuve, P; Renne, G; De Cicco, C; De Lucia, F; Gennari, R			A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TERM FOLLOW-UP; LYMPH-NODES; INVOLVEMENT; CARCINOMA	BACKGROUND: Although numerous studies have shown that the status of the sentinel node is an accurate predictor of the status of the axillary nodes in breast cancer, the efficacy and safety of sentinel-node biopsy require validation. METHODS: From March 1998 to December 1999, we randomly assigned 516 patients with primary breast cancer in whom the tumor was less than or equal to 2 cm in diameter either to sentinel-node biopsy and total axillary dissection (the axillary-dissection group) or to sentinel-node biopsy followed by axillary dissection only if the sentinel node contained metastases (the sentinel-node group). RESULTS: The number of sentinel nodes found was the same in the two groups. A sentinel node was positive in 83 of the 257 patients in the axillary-dissection group (32.3 percent), and in 92 of the 259 patients in the sentinel-node group (35.5 percent). In the axillary-dissection group, the overall accuracy of the sentinel-node status was 96.9 percent, the sensitivity 91.2 percent, and the specificity 100 percent. There was less pain and better arm mobility in the patients who underwent sentinel-node biopsy only than in those who also underwent axillary dissection. There were 15 events associated with breast cancer in the axillary-dissection group and 10 such events in the sentinel-node group. Among the 167 patients who did not undergo axillary dissection, there were no cases of overt axillary metastasis during follow-up. CONCLUSIONS: Sentinel-node biopsy is a safe and accurate method of screening the axillary nodes for metastasis in women with a small breast cancer.	Ist Europeo Oncol, Div Senol, I-20141 Milan, Italy; Ist Europeo Oncol, Div Nucl Med, I-20141 Milan, Italy; Ist Europeo Oncol, Div Pathol, I-20141 Milan, Italy; Ist Europeo Oncol, Div Epidemiol, I-20141 Milan, Italy; Ist Europeo Oncol, Div Anaesthesiol, I-20141 Milan, Italy; Univ Milan, Sch Med, Milan, Italy	IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); University of Milan	Veronesi, U (corresponding author), Ist Europeo Oncol, Div Senol, Via G Ripamonti 435, I-20141 Milan, Italy.		Intra, Mattia/AAQ-8852-2020; paganelli, giovanni/AAC-5267-2022; Viale, Giuseppe/AAE-8921-2019; GALIMBERTI, Viviana Enrica/AAS-3963-2020; Maisonneuve, Patrick/U-9789-2018	GALIMBERTI, Viviana Enrica/0000-0002-5036-7439; Maisonneuve, Patrick/0000-0002-5309-4704; VERONESI, PAOLO/0000-0001-8926-4106; Paganelli, Giovanni/0000-0002-2631-4652; GENNARI, Roberto/0000-0001-8327-7985				Albertini JJ, 1996, JAMA-J AM MED ASSOC, V276, P1818, DOI 10.1001/jama.276.22.1818; BERG JW, 1955, CANCER, V8, P776, DOI 10.1002/1097-0142(1955)8:4<776::AID-CNCR2820080421>3.0.CO;2-B; De Cicco C, 1998, J NUCL MED, V39, P2080; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; GIULIANO AE, 1994, ANN SURG, V220, P391, DOI 10.1097/00000658-199409000-00015; GOULD AL, 1993, STAT MED, V12, P2009, DOI 10.1002/sim.4780122105; Krag D, 1998, NEW ENGL J MED, V339, P941, DOI 10.1056/NEJM199810013391401; Mansi JL, 1999, LANCET, V354, P197, DOI 10.1016/S0140-6736(98)10175-7; *MATHS, 2000, S PLUS 2000 S PLUS P; McMasters KM, 1998, NEW ENGL J MED, V339, P990, DOI 10.1056/NEJM199810013391410; MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392; VERONESI U, 1990, EUR J SURG ONCOL, V16, P127; Veronesi U, 1999, JNCI-J NATL CANCER I, V91, P368, DOI 10.1093/jnci/91.4.368; Veronesi U, 2001, EUR J CANCER, V37, P454, DOI 10.1016/S0959-8049(00)00410-X; Veronesi U, 1997, LANCET, V349, P1864, DOI 10.1016/S0140-6736(97)01004-0; Viale G, 1999, CANCER, V85, P2433, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2433::AID-CNCR18>3.3.CO;2-V; Zurrida S, 1999, INT J ONCOL, V15, P475; Zurrida S, 2001, Int J Surg Investig, V2, P423	18	1530	1599	1	32	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2003	349	6					546	553		10.1056/NEJMoa012782	http://dx.doi.org/10.1056/NEJMoa012782			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708JL	12904519	Bronze			2022-12-28	WOS:000184563500005
J	Winston, FK; Kassam-Adams, N; Garcia-Espana, F; Ittenbach, R; Cnaan, A				Winston, FK; Kassam-Adams, N; Garcia-Espana, F; Ittenbach, R; Cnaan, A			Screening for risk of persistent posttraumatic stress in injured children and their parents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICAL INJURY; SEVERITY SCORE; DISORDER; SYMPTOMS; EPIDEMIOLOGY; DISASTER; TRAUMA; IMPACT; ADOLESCENTS; PREDICTORS	Context Injury, a leading health threat to children, is also a common cause of posttraumatic stress disorder (PTSD) in childhood. Most injured children with PTSD are not diagnosed or treated. Objective To develop a stand-alone screening tool for use by clinicians during acute trauma care to identify injured children and their parents who are at risk of significant, persistent posttraumatic stress symptoms. Design The Screening Tool for Early Predictors of PTSD (STEPP) was derived from a 50-item risk factor survey administered within 1 month of injury as part of a prospective cohort study of posttraumatic stress in injured children and their parents. Symptoms of PTSD were assessed at least 3 months after injury. Setting Urban, pediatric level I trauma center. Participants A sample of 269 children aged 8 to 17 years admitted for treatment of traffic-related injuries between July 1999 and October 2001, and one parent per child, completed a risk factor survey assessing potential predictors of PTSD outcome. One hundred seventy-one families (63%) completed a follow-up assessment. Main Outcome Measures The Clinician-Administered PTSD Scale for Children and Adolescents and the PTSD Checklist served as criterion standards for child and parent outcomes, respectively. Positive cases were defined as those meeting criteria for at least subsyndromal PTSD with continuing impairment ("persistent traumatic stress"). Results The STEPP contains 4 dichotomous questions asked of the child, 4 asked of one parent, and 4 items obtained easily from the emergency medical record. STEPP sensitivity in predicting posttraumatic stress was 0.88 for children and 0.96 for parents, with negative predictive values of 0.95 for children and 0.99 for parents. The odds ratio for prediction of persistent traumatic stress was 6.5 (95% confidence interval [CI], 1.8-22.8) in children and 26.6 (95% CI, 3.5-202.1) in parents. Conclusions The STEPP represents a new method to guide clinicians in making evidence-based decisions for the allocation of scarce mental health resources for traumatic stress. Its brevity and simple scoring rule suggest that it can be easily administered in the acute care setting.	Childrens Hosp Philadelphia, Traumalink Pediat Interdisciplinary Injury Contro, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Div Gen Pediat, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Ctr Pediat Traumat Stress, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Biostat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Winston, FK (corresponding author), Childrens Hosp Philadelphia, Traumalink Pediat Interdisciplinary Injury Contro, 34th St & Civic Ctr Blvd,3535 TraumaLink,10th Flo, Philadelphia, PA 19104 USA.	flaura@mail.med.upenn.edu	Kassam-Adams, Nancy/C-4091-2009; Ittenbach, Richard F/Q-1806-2015	Kassam-Adams, Nancy/0000-0001-7412-1428	PHS HHS [R40 MC 00138] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aaron J, 1999, J PEDIATR PSYCHOL, V24, P335, DOI 10.1093/jpepsy/24.4.335; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Athey JL, 1997, PROF PSYCHOL-RES PR, V28, P464, DOI 10.1037/0735-7028.28.5.464; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Baker SP, 1992, THE INJURY FACT BOOK, V2nd; Breslau N, 2001, J CLIN PSYCHIAT, V62, P16; BRETON JJ, 1993, J AM ACAD CHILD PSY, V32, P438, DOI 10.1097/00004583-199303000-00028; BULL JP, 1975, ACCIDENT ANAL PREV, V7, P249, DOI 10.1016/0001-4575(75)90026-3; Daviss WB, 2000, J AM ACAD CHILD PSY, V39, P576, DOI 10.1097/00004583-200005000-00011; de Vries APJ, 1999, PEDIATRICS, V104, P1293, DOI 10.1542/peds.104.6.1293; DiGallo A, 1997, BRIT J PSYCHIAT, V170, P358, DOI 10.1192/bjp.170.4.358; Fletcher Kenneth E., 1996, P242; Foy D., 1994, J SCH PSYCHOL, V34, P133; Gavin LA, 1997, PEDIATR EMERG CARE, V13, P222, DOI 10.1097/00006565-199706000-00013; GREEN BL, 1991, J AM ACAD CHILD PSY, V30, P945, DOI 10.1097/00004583-199111000-00012; HAINES C, 1995, J ADV NURS, V21, P350, DOI 10.1111/j.1365-2648.1995.tb02533.x; *I MED, 1999, RED BURD INJ ADV PRE; KOCH WJ, 1995, COGN BEHAV PRACT, V2, P327, DOI 10.1016/S1077-7229(95)80016-6; KOOPMAN C, 1994, AM J PSYCHIAT, V151, P888; Kovacs M., 1992, CHILDRENS DEPRESSION; Kuch K, 1996, CAN J PSYCHIAT, V41, P429, DOI 10.1177/070674379604100707; Litz BT, 2002, CLIN PSYCHOL-SCI PR, V9, P112, DOI 10.1093/clipsy/9.2.112; March JS, 1998, J AM ACAD CHILD PSY, V37, P585, DOI 10.1097/00004583-199806000-00008; March JS., 2013, MULTIDIMENSIONAL ANX, V2nd; Marshall RD, 2001, AM J PSYCHIAT, V158, P1467, DOI 10.1176/appi.ajp.158.9.1467; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; Michaels AJ, 1999, J TRAUMA, V47, P460, DOI 10.1097/00005373-199909000-00005; Mirza KAH, 1998, BRIT J PSYCHIAT, V172, P443, DOI 10.1192/bjp.172.5.443; National Institute of Mental Health, 1998, NIH PUBL, V98-4321; NEWMAN E, 1996, MEASUREMENT STRESS T, P108; NORRIS FH, 1992, J CONSULT CLIN PSYCH, V60, P409, DOI 10.1037/0022-006X.60.3.409; Pfefferbaum B, 2000, PSYCHIATRY, V63, P358, DOI 10.1080/00332747.2000.11024929; PTACEK JT, 1995, J PAIN SYMPTOM MANAG, V10, P446, DOI 10.1016/0885-3924(95)00083-B; PYNOOS RS, 1991, POSTTRAUMATIC STRESS, P65; Richmond TS, 1998, J TRAUMA, V44, P635, DOI 10.1097/00005373-199804000-00012; SAXE G, 1998, J BURN CARE REHABIL, V19, pS206; SCHREIBER S, 1993, PAIN, V54, P107, DOI 10.1016/0304-3959(93)90105-X; SHANNON MP, 1994, J AM ACAD CHILD PSY, V33, P80, DOI 10.1097/00004583-199401000-00012; Stallard P, 1998, BRIT MED J, V317, P1619, DOI 10.1136/bmj.317.7173.1619; Stuber J, 2002, PSYCHIAT SERV, V53, P815, DOI 10.1176/appi.ps.53.7.815; U.S. Public Health Service, 2000, SURG GEN C CHILDR ME; Vernberg EM, 1996, J ABNORM PSYCHOL, V105, P237, DOI 10.1037/0021-843X.105.2.237; Weathers F.W., 1996, MEASUREMENT STRESS T, P250; Winje D, 1996, J CONSULT CLIN PSYCH, V64, P1037, DOI 10.1037/0022-006X.64.5.1037; Winston FK, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e90; Yehuda R, 1998, BIOL PSYCHIAT, V44, P1305, DOI 10.1016/S0006-3223(98)00276-5; 1997, INT CLASSIFICATION D	48	128	130	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2003	290	5					643	649		10.1001/jama.290.5.643	http://dx.doi.org/10.1001/jama.290.5.643			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	708GH	12902368	Bronze			2022-12-28	WOS:000184558500019
J	Devereux, RB; Dahlof, B; Kjeldsen, SE; Julius, S; Aurup, P; Beevers, G; Edelman, JM; de Faire, U; Fyhrquist, F; Berg, SH; Ibsen, H; Kristianson, K; Lederballe-Pedersen, O; Lindholm, LH; Nieminen, MS; Omvik, P; Oparil, S; Snapinn, S; Wedel, H				Devereux, RB; Dahlof, B; Kjeldsen, SE; Julius, S; Aurup, P; Beevers, G; Edelman, JM; de Faire, U; Fyhrquist, F; Berg, SH; Ibsen, H; Kristianson, K; Lederballe-Pedersen, O; Lindholm, LH; Nieminen, MS; Omvik, P; Oparil, S; Snapinn, S; Wedel, H		LIFE Study Grp	Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: A substudy of the LIFE randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; END-POINT REDUCTION; CONVERTING-ENZYME-INHIBITOR; CARDIOVASCULAR MORBIDITY; ELECTROCARDIOGRAPHIC IDENTIFICATION; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; SWEDISH TRIAL; OLD PATIENTS; MORTALITY	Background: Cardiovascular morbidity and mortality are reduced by treatment with the angiotensin II AT(1)-receptor antagonist losartan compared with conventional treatment with the beta-blocker atenolol in patients with hypertension and electrocardiogram-defined left ventricular hypertrophy, many of whom had known vascular disease. Objective: To determine whether losartan reduces cardiovascular event rates in lower-risk hypertensive patients without clinically evident vascular disease. Design: Subgroup analysis of a randomized trial. Setting: The Losartan Intervention for Endpoint reduction in hypertension (LIFE) study. Patients: 6886 men and women (57% women) 55 to 80 years of age (average, 66 years) with essential hypertension (sitting blood pressure, 160 to 200/95 to 115 mm Hg [average, 174/98 mm Hg]) and electrocardiogram-defined left ventricular hypertrophy who did not have clinically evident vascular disease. Intervention: Patients were randomly assigned to once-daily double-blind treatment with losartan or atenolol. Measurements: An end point committee ascertained end points (cardiovascular death, stroke, or myocardial infarction). Results: Blood pressure was reduced similarly by losartan and atenolol. The primary composite end point occurred in 282 losartan-treated patients (17.5 per 1000 patient-years) and 355 atenolol-treated patients (21.8 per 1000 patient-years; relative risk, 0.81 [95% CI, 0.69 to 0.95]; P = 0.008). Cardiovascular death occurred in 103 losartan-treated patients and 132 atenolol-treated patients (relative risk, 0.80 [CI, 0.62 to 1.04]; P = 0.092), stroke (nonfatal and fatal) occurred in 125 losartan-treated patients and 193 atenolol-treated patients (relative risk, 0.66 [CI, 0.53 to 0.82]; P < 0.001), and myocardial infarction (nonfatal and fatal) occurred in 110 losartan-treated patients and 100 atenolol-treated patients (relative risk, 1.14 [CI, 0.87 to 1.49]; P > 0.2). New-onset diabetes occurred less often in patients treated with losartan (n = 173) than in patients treated with atenolol (n = 254) (relative risk, 0.69 [CI, 0.57 to 0.84]; P < 0.001). Benefits of losartan treatment were numerically smaller, but not significantly so, in patients with preexisting vascular disease. Conclusion: In hypertensive patients without clinically evident vascular disease, losartan was more effective than atenolol in preventing cardiovascular morbidity and death, predominantly stroke, independent of blood pressure reduction.	Cornell Univ, Weill Med Coll, New York, NY USA; Sahlgrenska Ostra Univ Hosp, Gothenburg, Sweden; Nord Sch Publ Hlth, Gothenburg, Sweden; Ullevaal Univ Hosp, Oslo, Norway; Univ Michigan, Ann Arbor, MI 48109 USA; Merck & Co Inc, Whitehouse Stn, NJ USA; City Hosp, Birmingham, W Midlands, England; Karolinska Univ Hosp, Stockholm, Sweden; Univ Helsinki, Cent Hosp, FIN-00014 Helsinki, Finland; Glostrup Univ Hosp, Glostrup, Denmark; Viborg Hosp, Viborg, Denmark; Umea Univ, S-90187 Umea, Sweden; Haukeland Hosp, N-5021 Bergen, Norway; Univ Alabama Birmingham, Birmingham, AL USA	Cornell University; Sahlgrenska University Hospital; University of Oslo; University of Michigan System; University of Michigan; Merck & Company; University of Birmingham; Karolinska Institutet; Karolinska University Hospital; University of Helsinki; Helsinki University Central Hospital; University of Copenhagen; Aarhus University; Umea University; University of Alabama System; University of Alabama Birmingham	Devereux, RB (corresponding author), New York Presbyterian Hosp, Div Cardiol, 525 E 68th St, New York, NY 10021 USA.	rbdevere@med.cornell.edu						ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; [Anonymous], 1986, LANCET, V2, P57; CASALE PN, 1987, CIRCULATION, V75, P565, DOI 10.1161/01.CIR.75.3.565; DAHLOF B, 1991, LANCET, V338, P1281, DOI 10.1016/0140-6736(91)92589-T; Dahlof B, 1997, AM J HYPERTENS, V10, P705; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Dahlof B, 1998, HYPERTENSION, V32, P989, DOI 10.1161/01.HYP.32.6.989; Devereux RB, 2001, BLOOD PRESSURE, V10, P74, DOI 10.1080/08037050152112050; Devereux Richard B., 2002, American Journal of Hypertension, V15, p167A, DOI 10.1016/S0895-7061(02)02727-9; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; Hansson L, 1999, LANCET, V354, P1751, DOI 10.1016/S0140-6736(99)10327-1; KJEKSHUS JK, 1986, AM J CARDIOL, V57, pF43, DOI 10.1016/0002-9149(86)90888-X; Kjeldsen SE, 2002, JAMA-J AM MED ASSOC, V288, P1491, DOI 10.1001/jama.288.12.1491; Kjeldsen SE, 2001, BLOOD PRESSURE, V10, P190, DOI 10.1080/08037050152669684; Kjeldsen SE, 2000, AM J HYPERTENS, V13, P899, DOI 10.1016/S0895-7061(00)00280-6; Lindholm LH, 2002, LANCET, V359, P1004, DOI 10.1016/S0140-6736(02)08090-X; Mathew J, 2001, CIRCULATION, V104, P1615, DOI 10.1161/hc3901.096700; MULROW C, 2001, COCHRANE LIBR; Neal B, 2000, LANCET, V356, P1955; NELSON RR, 1974, CIRCULATION, V50, P1179, DOI 10.1161/01.CIR.50.6.1179; OKIN PM, 1995, J AM COLL CARDIOL, V25, P417, DOI 10.1016/0735-1097(94)00371-V; Okin PM, 1996, J AM COLL CARDIOL, V27, P124, DOI 10.1016/0735-1097(95)00421-1; PEDERSEN TR, 1981, NEW ENGL J MED, V304, P801; TOBIAN L, 1984, J HYPERTENS        S, V2, P363; Verdecchia P, 1998, CIRCULATION, V97, P48, DOI 10.1161/01.CIR.97.1.48; VOLPE M, 1990, HYPERTENSION, V15, P318, DOI 10.1161/01.HYP.15.3.318; WHO Expert Committee on Diabetes Mellitus, 1980, WHO EXP COMM DIAB ME, V646; Yusuf S, 2000, NEW ENGL J MED, V342, P145	28	47	52	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2003	139	3					169	177		10.7326/0003-4819-139-3-200308050-00006	http://dx.doi.org/10.7326/0003-4819-139-3-200308050-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707RH	12899584				2022-12-28	WOS:000184523300002
J	Wills, CJ; Scott, A; Swift, PGF; Davies, MJ; Mackie, ADR; Mansell, P				Wills, CJ; Scott, A; Swift, PGF; Davies, MJ; Mackie, ADR; Mansell, P			Retrospective review of care and outcomes in young adults with type 1 diabetes	BRITISH MEDICAL JOURNAL			English	Article								The national service framework for diabetes includes standards to improve care and outcomes for young people.(1) Good glycaemic control delays the onset and progression of microvascular complications, but control can be difficult to achieve, particularly in young people(2).	Queens Med Ctr, Nottingham NG7 2UH, England; Derbyshire Royal Infirm, Derby DE1 2QY, England; Leicester Royal Infirm, Leicester LE1 5WW, Leics, England; No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England	University of Nottingham; University of Leicester; Northern General Hospital	Wills, CJ (corresponding author), Queens Med Ctr, Nottingham NG7 2UH, England.	catherinewills1@hotmail.com		Davies, Melanie/0000-0002-9987-9371				Amiel S, 2002, BRIT MED J, V325, P746, DOI 10.1136/bmj.325.7367.746; Bryden KS, 2001, DIABETES CARE, V24, P1536, DOI 10.2337/diacare.24.9.1536; Department of Health, 2001, NAT SERV FRAM DIAB S; DORCHY H, 1993, DIABETES CARE, V16, P1311, DOI 10.2337/diacare.16.9.1311b; GRAHAM H, 1993, WHEN LIFES DRAG WOME; Haufroid V, 1998, INT ARCH OCC ENV HEA, V71, P162, DOI 10.1007/s004200050266; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401	7	50	50	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 2	2003	327	7409					260	261		10.1136/bmj.327.7409.260	http://dx.doi.org/10.1136/bmj.327.7409.260			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708KP	12896937	Bronze, Green Published			2022-12-28	WOS:000184566300018
J	Burrows, M				Burrows, M			Biomechanics: Froghopper insects leap to new heights - An innovative leaping action propels these bugs to the top of the insect athletic league.	NATURE			English	Editorial Material							JUMP; ENERGETICS; MECHANISM		Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Burrows, M (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.							ALEXANDER RM, 1995, PHILOS T R SOC B, V347, P235, DOI 10.1098/rstb.1995.0024; Bennet-Clark H.C., 1976, P467; BENNETCLARK HC, 1967, J EXP BIOL, V47, P59; BENNETCLARK HC, 1975, J EXP BIOL, V63, P53; Burrows M, 2003, J EXP BIOL, V206, P1035, DOI 10.1242/jeb.00214; DOWLING JJ, 1993, J APPL BIOMECH, V9, P95, DOI 10.1123/jab.9.2.95; EVANS MEG, 1973, J ZOOL, V169, P181; ROTHSCHILD M, 1975, PHILOS T ROY SOC B, V271, P499, DOI 10.1098/rstb.1975.0064; Sander K., 1956, Zoologische Jahrbuecher Jena Anatomie, V75, P383; WEISFOGH T, 1956, J EXP BIOL, V33, P668	10	169	176	11	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					509	509		10.1038/424509a	http://dx.doi.org/10.1038/424509a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891345	Bronze			2022-12-28	WOS:000184454700029
J	Custers, J; Gegenwart, P; Wilhelm, H; Neumaier, K; Tokiwa, Y; Trovarelli, O; Geibel, C; Steglich, F; Pepin, C; Coleman, P				Custers, J; Gegenwart, P; Wilhelm, H; Neumaier, K; Tokiwa, Y; Trovarelli, O; Geibel, C; Steglich, F; Pepin, C; Coleman, P			The break-up of heavy electrons at a quantum critical point	NATURE			English	Article								The point at absolute zero where matter becomes unstable to new forms of order is called a quantum critical point (QCP). The quantum fluctuations between order and disorder(1-5) that develop at this point induce profound transformations in the finite temperature electronic properties of the material. Magnetic fields are ideal for tuning a material as close as possible to a QCP, where the most intense effects of criticality can be studied. A previous study(6) on the heavy-electron material YbRh2Si2 found that near a field-induced QCP electrons move ever more slowly and scatter off one another with ever increasing probability, as indicated by a divergence to infinity of the electron effective mass and scattering cross-section. But these studies could not shed light on whether these properties were an artefact of the applied field(7,8), or a more general feature of field-free QCPs. Here we report that, when germanium-doped YbRh2Si2 is tuned away from a chemically induced QCP by magnetic fields, there is a universal behaviour in the temperature dependence of the specific heat and resistivity: the characteristic kinetic energy of electrons is directly proportional to the strength of the applied field. We infer that all ballistic motion of electrons vanishes at a QCP, forming a new class of conductor in which individual electrons decay into collective current-carrying motions of the electron fluid.	Rutgers State Univ, Dept Phys & Astron, CMT, Piscataway, NJ 08854 USA; Max Planck Inst Chem Phys Solids, D-01187 Dresden, Germany; Bavarian Acad Sci, Walther Meissner Inst Low Temp Res, D-85748 Garching, Germany; CEA Saclay, SPhT, F-91190 Gif Sur Yvette, France	Rutgers State University New Brunswick; Max Planck Society; CEA; UDICE-French Research Universities; Universite Paris Saclay	Coleman, P (corresponding author), Rutgers State Univ, Dept Phys & Astron, CMT, POB 849, Piscataway, NJ 08854 USA.	coleman@physics.rutgers.edu	Custers, Jeroen/D-8011-2016; Wilhelm, Heribert/C-6871-2017; Gegenwart, Philipp/A-7291-2017; Tokiwa, Yoshifumi/P-6593-2015	Custers, Jeroen/0000-0001-6974-1489; Wilhelm, Heribert/0000-0002-9890-7895; Gegenwart, Philipp/0000-0003-4180-3785; Tokiwa, Yoshifumi/0000-0002-6294-7879				CARTER GC, 1977, PROGR MAT SCI, V20, P123; Coleman P, 2002, PHYSICA B, V312, P383, DOI 10.1016/S0921-4526(01)01342-4; CONTINENTINO MA, 1994, PHYS REP, V239, P179, DOI 10.1016/0370-1573(94)90112-0; FRANCOIS M, 1985, J LESS-COMMON MET, V113, P231, DOI 10.1016/0022-5088(85)90281-4; Gegenwart P, 2003, ACTA PHYS POL B, V34, P323; Gegenwart P, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.056402; GIAMARCHI T, 1993, PHYS REV LETT, V70, P3967, DOI 10.1103/PhysRevLett.70.3967; HERTZ JA, 1976, PHYS REV B, V14, P1165, DOI 10.1103/PhysRevB.14.1165; Heuser K, 1998, PHYS REV B, V57, pR4198, DOI 10.1103/PhysRevB.57.R4198; KADOWAKI K, 1986, SOLID STATE COMMUN, V58, P507, DOI 10.1016/0038-1098(86)90785-4; LANDAU LD, 1957, ZH EKSP TEOR FIZ, V3, P920; Mederle S, 2002, J PHYS-CONDENS MAT, V14, P10731, DOI 10.1088/0953-8984/14/44/367; MILLIS AJ, 1993, PHYS REV B, V48, P7183, DOI 10.1103/PhysRevB.48.7183; Paul I, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.184414; Plessel J, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.180403; Schroder A, 2000, NATURE, V407, P351, DOI 10.1038/35030039; Si QM, 2001, NATURE, V413, P804, DOI 10.1038/35101507; Stockert O, 2002, PHYSICA B, V312, P458, DOI 10.1016/S0921-4526(01)01142-5; Trovarelli O, 2000, PHYS REV LETT, V85, P626, DOI 10.1103/PhysRevLett.85.626	19	558	564	4	171	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 31	2003	424	6948					524	527		10.1038/nature01774	http://dx.doi.org/10.1038/nature01774			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891349	Green Submitted			2022-12-28	WOS:000184454700034
J	Lee, WM				Lee, WM			Medical progress: Drug-induced hepatotoxicity	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACUTE LIVER-FAILURE; ACUTE CHOLESTATIC HEPATITIS; CAUSALITY ASSESSMENT; ADVERSE REACTIONS; ACETAMINOPHEN; PATIENT; INJURY; DISEASE; ASSOCIATION; PROTEINS		Univ Texas, SW Med Ctr, Dept Internal Med, Div Digest & Liver Dis, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Lee, WM (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, Div Digest & Liver Dis, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	william.lee@utsouthwestern.edu	Manfredini, Roberto/A-3471-2008; Manfredini, Roberto/N-3859-2019	Manfredini, Roberto/0000-0002-8364-2601; Manfredini, Roberto/0000-0002-8364-2601				Adedoyin A, 1998, CLIN PHARMACOL THER, V64, P8, DOI 10.1016/S0009-9236(98)90017-0; Aithal GP, 2000, GASTROENTEROLOGY, V118, pA977, DOI 10.1016/S0016-5085(00)86050-3; Al-Salman J, 2000, ANN INTERN MED, V132, P121, DOI 10.7326/0003-4819-132-2-200001180-00006; Angell M, 1998, NEW ENGL J MED, V339, P839, DOI 10.1056/NEJM199809173391210; Meadows M, 2001, FDA Consum, V35, P8; Aranda-Michel J, 1999, ANN INTERN MED, V130, P285, DOI 10.7326/0003-4819-130-4-199902160-00013; Babich MM, 1998, AM J MED, V104, P490, DOI 10.1016/S0002-9343(98)00088-6; BANKS AT, 1995, HEPATOLOGY, V22, P820, DOI 10.1016/0270-9139(95)90303-8; Baylor P, 1999, CLIN INFECT DIS, V29, P1350, DOI 10.1086/313475; BEAUNE P, 1987, P NATL ACAD SCI USA, V84, P551, DOI 10.1073/pnas.84.2.551; Benazzi F, 1998, PHARMACOPSYCHIATRY, V31, P241, DOI 10.1055/s-2007-979337; Benbow SJ, 1997, BRIT MED J, V314, P1387; BENICHOU C, 1993, J CLIN EPIDEMIOL, V46, P1331, DOI 10.1016/0895-4356(93)90102-7; Benninger J, 1999, GASTROENTEROLOGY, V117, P1234, DOI 10.1016/S0016-5085(99)70410-5; Bernal W, 1998, J HEPATOL, V29, P53, DOI 10.1016/S0168-8278(98)80178-5; Bissell DM, 2001, HEPATOLOGY, V33, P1009, DOI 10.1053/jhep.2001.23505; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; Bosch X, 1997, JAMA-J AM MED ASSOC, V278, P1572, DOI 10.1001/jama.278.19.1572; BROSENS I, 1986, BRIT MED J, V292, P1667, DOI 10.1136/bmj.292.6536.1667-a; Burckart GJ, 1998, CLIN PHARMACOL THER, V63, P296, DOI 10.1016/S0009-9236(98)90161-8; Cai HL, 2001, CHEM RES TOXICOL, V14, P54, DOI 10.1021/tx000185n; Campo JV, 2002, J AM ACAD CHILD PSY, V41, P631, DOI 10.1097/00004583-200206000-00001; Capella D, 1999, EUR J CLIN PHARMACOL, V55, P545, DOI 10.1007/s002280050671; Cardona X, 2000, ANN INTERN MED, V132, P417, DOI 10.7326/0003-4819-132-5-200003070-00016; Carrillo-Jimenez R, 2000, ARCH INTERN MED, V160, P553, DOI 10.1001/archinte.160.4.553; Chitturi S, 2000, J GASTROEN HEPATOL, V15, P1093, DOI 10.1046/j.1440-1746.2000.02349.x; Chitturi S, 2002, SEMIN LIVER DIS, V22, P169, DOI 10.1055/s-2002-30102; Chitturi S, 2001, Semin Gastrointest Dis, V12, P113; Clark SJ, 2002, J HEPATOL, V36, P295, DOI 10.1016/S0168-8278(01)00291-4; *CTR DRUG EV RES, DRUG IND LIV TOX; DANAN G, 1993, J CLIN EPIDEMIOL, V46, P1323, DOI 10.1016/0895-4356(93)90101-6; de la Puente MAG, 2001, ANN PHARMACOTHER, V35, P1492, DOI 10.1345/aph.1A055; DeLeve LD, 2002, SEMIN LIVER DIS, V22, P27, DOI 10.1055/s-2002-23204; Deltenre P, 1999, GUT, V44, P886, DOI 10.1136/gut.44.6.886; Favreau JT, 2002, ANN INTERN MED, V136, P590, DOI 10.7326/0003-4819-136-8-200204160-00008; Fernandes NF, 2000, AM J GASTROENTEROL, V95, P532; Fontana RJ, 1999, LIVER TRANSPLANT SUR, V5, P480, DOI 10.1002/lt.500050607; Forman LM, 2000, ANN INTERN MED, V132, P118, DOI 10.7326/0003-4819-132-2-200001180-00005; Froomes PRA, 1999, GASTROENTEROLOGY, V116, P915, DOI 10.1016/S0016-5085(99)70075-2; GARIBALDI RA, 1972, AM REV RESPIR DIS, V106, P357, DOI 10.1164/arrd.1972.106.3.357; GEORGE J, 1995, HEPATOLOGY, V21, P120, DOI 10.1002/hep.1840210121; Gitlin N, 1998, ANN INTERN MED, V129, P36, DOI 10.7326/0003-4819-129-1-199807010-00008; Graham DJ, 2002, HEPATOLOGY, V36, p168A; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Gupta AK, 1998, CLIN EXP DERMATOL, V23, P64, DOI 10.1046/j.1365-2230.1998.00321.x; Hartleb M, 1999, AM J GASTROENTEROL, V94, P1388, DOI 10.1016/S0002-9270(99)00147-1; Hautekeete ML, 1999, GASTROENTEROLOGY, V117, P1181, DOI 10.1016/S0016-5085(99)70404-X; Heubi JE, 1998, J PEDIATR-US, V132, P22, DOI 10.1016/S0022-3476(98)70479-2; Huang YS, 2002, HEPATOLOGY, V35, P883, DOI 10.1053/jhep.2002.32102; HUNT CM, 1992, BIOCHEM PHARMACOL, V44, P275, DOI 10.1016/0006-2952(92)90010-G; Hwang I, 2002, MIL MED, V167, P155, DOI 10.1093/milmed/167.2.155; IKEMOTO S, 1992, BIOCHEM PHARMACOL, V43, P2407, DOI 10.1016/0006-2952(92)90320-I; Iqbal M, 1998, DIGEST DIS SCI, V43, P2223, DOI 10.1023/A:1026658320577; Jaeschke H, 2002, TOXICOL SCI, V65, P166, DOI 10.1093/toxsci/65.2.166; Jonsson JR, 2000, J HEPATOL, V32, P392, DOI 10.1016/S0168-8278(00)80388-8; Kaplowitz N, 2001, HEPATOLOGY, V33, P308, DOI 10.1053/jhep.2001.21083; Kaufman KR, 1999, SEIZURE-EUR J EPILEP, V8, P250, DOI 10.1053/seiz.1999.0281; Kenna J. Gerald, 1997, Journal of Hepatology, V26, P5; KLECKNER HB, 1975, ANN INTERN MED, V83, P522, DOI 10.7326/0003-4819-83-4-522; Konig SA, 1999, EPILEPSIA, V40, P1036, DOI 10.1111/j.1528-1157.1999.tb00814.x; Kraus I, 2001, INT J CLIN PHARM TH, V39, P395; Lasser KE, 2002, JAMA-J AM MED ASSOC, V287, P2215, DOI 10.1001/jama.287.17.2215; Lasso-de-la-Vega MC, 2001, AM J GASTROENTEROL, V96, P3460; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Lucena MA, 2001, HEPATOLOGY, V33, P123, DOI 10.1053/jhep.2001.20645; Lucena MI, 2000, CLIN INFECT DIS, V30, P400, DOI 10.1086/313680; Malik AH, 2000, DIGEST DIS SCI, V45, P210, DOI 10.1023/A:1005450519498; May LD, 2002, ANN INTERN MED, V136, P449, DOI 10.7326/0003-4819-136-6-200203190-00008; Moss AJ, 1999, DRUG SAFETY, V21, P5, DOI 10.2165/00002018-199921001-00002; Moynihan R, 2002, BRIT MED J, V325, P678, DOI 10.1136/bmj.325.7366.678; Murphy EJ, 2000, DIGEST DIS SCI, V45, P549, DOI 10.1023/A:1005405526283; Neuschwander-Tetri BA, 1998, ANN INTERN MED, V129, P38, DOI 10.7326/0003-4819-129-1-199807010-00009; Nolan CM, 1999, JAMA-J AM MED ASSOC, V281, P1014, DOI 10.1001/jama.281.11.1014; Olanow CW, 2000, ARCH NEUROL-CHICAGO, V57, P263, DOI 10.1001/archneur.57.2.263; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; Pessayre D, 2001, SEMIN LIVER DIS, V21, P57, DOI 10.1055/s-2001-12929; Phillips KA, 2001, JAMA-J AM MED ASSOC, V286, P2270, DOI 10.1001/jama.286.18.2270; Piliero P J, 2001, AIDS Read, V11, P379; Pol S, 2002, J VIRAL HEPATITIS, V9, P1, DOI 10.1046/j.1365-2893.2002.00326.x; Reed JC, 2001, TRENDS MOL MED, V7, P314, DOI 10.1016/S1471-4914(01)02026-3; Ribeiro JM, 2000, AM J GASTROENTEROL, V95, P559; Robins C, 2001, AM BOOK REV, V23, P30; Romero-Gomez M, 1999, AM J GASTROENTEROL, V94, P2324, DOI 10.1111/j.1572-0241.1999.02324.x; Rosh JR, 1998, PEDIATRICS, V101, P921, DOI 10.1542/peds.101.5.921; Schenker S, 1999, J HEPATOL, V31, P1098, DOI 10.1016/S0168-8278(99)80325-0; Schiodt FV, 1997, NEW ENGL J MED, V337, P1112, DOI 10.1056/NEJM199710163371602; Schmidt LE, 2002, HEPATOLOGY, V35, P876, DOI 10.1053/jhep.2002.32148; Sgro C, 2002, HEPATOLOGY, V36, P451, DOI 10.1053/jhep.2002.34857; Spahr L, 2001, J HEPATOL, V35, P308, DOI 10.1016/S0168-8278(01)00082-4; Sreenarasimhaiah J, 2002, AM J MED, V113, P348, DOI 10.1016/S0002-9343(02)01178-6; Stedman C, 2002, SEMIN LIVER DIS, V22, P195, DOI 10.1055/s-2002-30104; Strasser SI, 1999, HEPATOLOGY, V29, P1893, DOI 10.1002/hep.510290609; Thummel KE, 2000, CLIN PHARMACOL THER, V67, P591, DOI 10.1067/mcp.2000.106574; Trauner M, 1998, NEW ENGL J MED, V339, P1217, DOI 10.1056/NEJM199810223391707; Vergis E, 1998, INT J STD AIDS, V9, P53, DOI 10.1258/0956462981920883; Wang K, 1999, Zhonghua Yi Xue Za Zhi (Taipei), V62, P369; WATKINS PB, 1992, GASTROENTEROL CLIN N, V21, P511; Weinshilboum R, 2003, NEW ENGL J MED, V348, P529, DOI 10.1056/NEJMra020021; Weltman MD, 1998, HEPATOLOGY, V27, P128, DOI 10.1002/hep.510270121; WHITCOMB DC, 1994, JAMA-J AM MED ASSOC, V272, P1845, DOI 10.1001/jama.272.23.1845; YUN CH, 1993, DRUG METAB DISPOS, V21, P403; Zhang J, 2002, SCIENCE, V298, P422, DOI 10.1126/science.1073502; Zimmerman H. J., 1978, HEPATOTOXICITY ADVER	103	855	947	1	122	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2003	349	5					474	485		10.1056/NEJMra021844	http://dx.doi.org/10.1056/NEJMra021844			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706FV	12890847				2022-12-28	WOS:000184443700010
J	Matsushita, T; Mochizuki, N; Nagatani, A				Matsushita, T; Mochizuki, N; Nagatani, A			Dimers of the N-terminal domain of phytochrome B are functional in the nucleus	NATURE			English	Article							SIGNAL-TRANSDUCTION; LIGHT; PROTEIN; REVEALS; ENCODES; REGION; PIF3	A plant modulates its developmental processes in response to light by several informational photoreceptors such as phytochrome. Phytochrome is a dimeric chromoprotein which regulates various aspects of plant development from seed germination to flowering(1). Upon absorption of red light, phytochrome translocates from the cytoplasm to the nucleus(2-4), and regulates gene expression through interaction with transcription factors such as PIF3 (refs 5-7). The phytochrome polypeptide has two domains(1,8) : the amino-terminal photosensory domain with a chromophore and the carboxy-terminal domain which contains signalling motifs such as a kinase domain(9). The latter is widely believed to transduce the signal to downstream components(1,5,810). Here we show that the C-terminal domain of Arabidopsis phytochrome B (phyB), which is known as the most important member of the phytochrome family(1), is not directly involved in signal transduction. The N-terminal domain isolated from phyB, when dimerized and localized in the nucleus, triggered full phyB responses with much higher photosensitivity than the full-length phyB. These findings indicate that the C-terminal domain attenuates the activity of phyB rather than positively transducing the signal.	Kyoto Univ, Grad Sch Sci, Dept Bot, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Nagatani, A (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Bot, Sakyo Ku, Kyoto 6068502, Japan.	nagatani@physiol.bot.kyoto-u.ac.jp						CHERRY JR, 1993, PLANT CELL, V5, P565, DOI 10.1105/tpc.5.5.565; Clough RC, 1999, PLANT J, V17, P155, DOI 10.1046/j.1365-313X.1999.00360.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Fankhauser C, 1999, SCIENCE, V284, P1539, DOI 10.1126/science.284.5419.1539; Grebenok RJ, 1997, PLANT J, V11, P573, DOI 10.1046/j.1365-313X.1997.11030573.x; Jarillo JA, 2001, NATURE, V410, P487, DOI 10.1038/35068589; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kato A, 1999, PLANT CELL PHYSIOL, V40, P586, DOI 10.1093/oxfordjournals.pcp.a029581; Kircher S, 2002, PLANT CELL, V14, P1541, DOI 10.1105/tpc.001156; Liu XL, 2001, PLANT CELL, V13, P1293, DOI 10.1105/tpc.13.6.1293; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Nagy F, 2000, SEMIN CELL DEV BIOL, V11, P505, DOI 10.1006/scdb.2000.0202; Ni M, 1998, CELL, V95, P657, DOI 10.1016/S0092-8674(00)81636-0; Ni M, 1999, NATURE, V400, P781, DOI 10.1038/23500; Park CM, 2000, SEMIN CELL DEV BIOL, V11, P449, DOI 10.1006/scdb.2000.0200; REED JW, 1993, PLANT CELL, V5, P147, DOI 10.1105/tpc.5.2.147; Sakamoto K, 1996, PLANT J, V10, P859, DOI 10.1046/j.1365-313X.1996.10050859.x; SHACKLOCK PS, 1992, NATURE, V358, P753, DOI 10.1038/358753a0; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Shinomura T, 1996, P NATL ACAD SCI USA, V93, P8129, DOI 10.1073/pnas.93.15.8129; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; STOCKHAUS J, 1992, GENE DEV, V6, P2364, DOI 10.1101/gad.6.12a.2364; Wagner D, 1996, P NATL ACAD SCI USA, V93, P4011, DOI 10.1073/pnas.93.9.4011; Wagner D, 1996, PLANT CELL, V8, P859, DOI 10.1105/tpc.8.5.859; WAGNER D, 1995, P NATL ACAD SCI USA, V92, P8596, DOI 10.1073/pnas.92.19.8596; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Yamaguchi R, 1999, J CELL BIOL, V145, P437, DOI 10.1083/jcb.145.3.437; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976	30	227	245	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 31	2003	424	6948					571	574		10.1038/nature01837	http://dx.doi.org/10.1038/nature01837			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891362				2022-12-28	WOS:000184454700047
J	Santarius, T; Menon, DK				Santarius, T; Menon, DK			Carotid-artery thrombosis secondary to basal skull fracture	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Addenbrookes Hosp, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Santarius, T (corresponding author), Addenbrookes Hosp, Hills Rd, Cambridge CB2 2QQ, England.			Santarius, Thomas/0000-0002-1416-9566					0	6	6	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2003	349	5					E5	E5		10.1056/ENEJMicm020664	http://dx.doi.org/10.1056/ENEJMicm020664			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706FV	12890856				2022-12-28	WOS:000184443700031
J	Mitchell, K; Owens, RG				Mitchell, K; Owens, RG			National survey of medical decisions at end of life made by New Zealand general practitioners	BRITISH MEDICAL JOURNAL			English	Article									Univ Auckland, Dept Psychol, Auckland, New Zealand; Univ Wales, Bangor LL57 2AS, Gwynedd, Wales	University of Auckland; Bangor University	Mitchell, K (corresponding author), Univ Auckland, Dept Psychol, Private Bag 92019, Auckland, New Zealand.							Deliens L, 2000, LANCET, V356, P1806, DOI 10.1016/S0140-6736(00)03233-5; GILLETT GR, 1991, NZ LAW J         APR; Kuhse H, 1997, MED J AUSTRALIA, V166, P191, DOI 10.5694/j.1326-5377.1997.tb140074.x; van der Maas PJ, 1992, HEALTH POLICY, V22, P1; Zylicz Z, 2000, PATIENT EDUC COUNS, V41, P47, DOI 10.1016/S0738-3991(00)00114-2	5	32	32	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2003	327	7408					202	203		10.1136/bmj.327.7408.202	http://dx.doi.org/10.1136/bmj.327.7408.202			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	706DL	12881263	Bronze, Green Published			2022-12-28	WOS:000184437300019
J	McKnight, S				McKnight, S			Gene switching by metabolic enzymes - How did you get on the invitation list?	CELL			English	Editorial Material							COMPLEX; NPAS2; LIVER		Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	McKnight, S (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.							Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Freije JMP, 1998, BIOCHEM SOC SYMP, P261; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Luo Y, 1999, COLD SPRING HARB SYM, V64, P119, DOI 10.1101/sqb.1999.64.119; Perrimon N, 1996, GENETICS, V144, P1681; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; WISTOW G, 1987, SCIENCE, V236, P1554, DOI 10.1126/science.3589669; Zhang QH, 2002, SCIENCE, V295, P1895; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	11	21	22	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 25	2003	114	2					150	152		10.1016/S0092-8674(03)00563-4	http://dx.doi.org/10.1016/S0092-8674(03)00563-4			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887915	Bronze			2022-12-28	WOS:000184378700003
J	Feldman, MW; Lewontin, RC; King, MC				Feldman, MW; Lewontin, RC; King, MC			A genetic melting-pot	NATURE			English	Editorial Material									Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA	Stanford University; Harvard University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Feldman, MW (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.			King, Mary-Claire/0000-0001-9426-1743				Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311	5	53	56	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2003	424	6947					374	374		10.1038/424374a	http://dx.doi.org/10.1038/424374a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879045	Bronze			2022-12-28	WOS:000184318400020
J	Gutmann, S; Haebel, PW; Metzinger, L; Sutter, M; Felden, B; Ban, N				Gutmann, S; Haebel, PW; Metzinger, L; Sutter, M; Felden, B; Ban, N			Crystal structure of the transfer-RNA domain of transfer-messenger RNA in complex with SmpB	NATURE			English	Article							PHENYLALANINE TRANSFER-RNA; ESCHERICHIA-COLI; ANGSTROM RESOLUTION; RIBOSOME RESCUE; BINDING PROTEIN; TAGGING SYSTEM; 10SA RNA; TMRNA; DEGRADATION; IDENTITY	Accurate translation of genetic information into protein sequence depends on complete messenger RNA molecules. Truncated mRNAs cause synthesis of defective proteins, and arrest ribosomes at the end of their incomplete message. In bacteria, a hybrid RNA molecule that combines the functions of both transfer and messenger RNAs (called tmRNA) rescues stalled ribosomes, and targets aberrant, partially synthesized, proteins for proteolytic degradation(1,2). Here we report the 3.2-Angstrom-resolution structure of the tRNA-like domain of tmRNA (tmRNA(Delta)) in complex with small protein B (SmpB), a protein essential for biological functions of tmRNA. We find that the flexible RNA molecule adopts an open L-shaped conformation and SmpB binds to its elbow region, stabilizing the single-stranded D-loop in an extended conformation. The most striking feature of the structure of tmRNA(Delta) is a 90degrees rotation of the TPsiC-arm around the helical axis. Owing to this unusual conformation, the SmpB-tmRNA(Delta) complex positioned into the A-site of the ribosome orients SmpB towards the small ribosomal subunit, and directs tmRNA towards the elongation-factor binding region of the ribosome. On the basis of this structure, we propose a model for the binding of tmRNA on the ribosome.	ETH, Inst Mol Biol & Biophys, HPK Gebaude, CH-8093 Zurich, Switzerland; Univ Rennes 1, UPRES JE2311, F-35043 Rennes, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; Universite de Rennes	Ban, N (corresponding author), ETH, Inst Mol Biol & Biophys, HPK Gebaude, CH-8093 Zurich, Switzerland.		Metzinger, Laurent/B-1426-2016; metzinger, laurent/AAY-4634-2021; felden, brice/L-4825-2015	Metzinger, Laurent/0000-0002-7636-8480; metzinger, laurent/0000-0002-7636-8480; Gutmann, Sascha/0000-0002-4242-8510; Sutter, Markus/0000-0001-6290-4820				Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Barends S, 2001, J MOL BIOL, V314, P9, DOI 10.1006/jmbi.2001.5114; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Corvaisier S, 2003, J BIOL CHEM, V278, P14788, DOI 10.1074/jbc.M212830200; DeLano W.L, PYMOL MOL GRAPHICS S; Dong G, 2002, EMBO J, V21, P1845, DOI 10.1093/emboj/21.7.1845; Felden B, 1997, RNA, V3, P89; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Hanawa-Suetsugu K, 2001, NUCLEIC ACIDS RES, V29, P4663, DOI 10.1093/nar/29.22.4663; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Keiler KC, 2000, P NATL ACAD SCI USA, V97, P7778, DOI 10.1073/pnas.97.14.7778; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; KIM SH, 1973, SCIENCE, V179, P285, DOI 10.1126/science.179.4070.285; Komine Y, 1996, J BIOCHEM-TOKYO, V119, P463; MCCLAIN WH, 1991, P NATL ACAD SCI USA, V88, P9272, DOI 10.1073/pnas.88.20.9272; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PRICE SR, 1995, J MOL BIOL, V249, P398, DOI 10.1006/jmbi.1995.0305; Rudinger-Thirion J, 1999, RNA, V5, P989, DOI 10.1017/S135583829999101X; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; Someya T, 2003, FEBS LETT, V535, P94, DOI 10.1016/S0014-5793(02)03880-2; Stagg SM, 2001, J MOL BIOL, V309, P727, DOI 10.1006/jmbi.2001.4632; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; USHIDA C, 1994, NUCLEIC ACIDS RES, V22, P3392, DOI 10.1093/nar/22.16.3392; Valle M, 2003, SCIENCE, V300, P127, DOI 10.1126/science.1081798; Williams KP, 1996, RNA, V2, P1306; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	30	100	103	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					699	703		10.1038/nature01831	http://dx.doi.org/10.1038/nature01831			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904796				2022-12-28	WOS:000184578800051
J	Thompson, MR; Heath, I; Ellis, BG; Swarbrick, ET; Wood, LF; Atkin, WS				Thompson, MR; Heath, I; Ellis, BG; Swarbrick, ET; Wood, LF; Atkin, WS			Identifying and managing patients at low-risk of bowel cancer in general practice	BMJ-BRITISH MEDICAL JOURNAL			English	Article							UNITED-STATES; INFORMATION; DIAGNOSIS; DELAY		Queen Alexandra Hosp, Dept Surg, Portsmouth PO6 3LY, Hants, England; Queen Alexandra Hosp, Postgrad Med Sch, Portsmouth PO6 3LY, Hants, England; Kaversham Grp Practice, London, England; New Cross Hosp, Wolverhampton, England; Bowel Canc Campaign, Twickenham TW1 1QS, England; St Marks Hosp, Colorectal Canc Unit, Harrow, Middx, England	Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital; Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital; New Cross Hospital; Imperial College London	Thompson, MR (corresponding author), Queen Alexandra Hosp, Dept Surg, Portsmouth PO6 3LY, Hants, England.	michael.thompson@porthosp.nhs.uk						BART JT, 1994, FEASIBLE SOCIALISM N; *BOW CANC CAMP, 2003, PAT INF LEAFL; CARRUTHERS SG, 1993, CAN MED ASSOC J, V149, P289; Cochrane AL, 1972, ROCK CARLING FELLOWS; COOK DJ, 1995, CHEST, V108, pS227, DOI 10.1378/chest.108.4_Supplement.227S; CROSLAND A, 1995, BRIT MED J, V311, P486, DOI 10.1136/bmj.311.7003.486; Edwards A, 2001, J HEALTH COMMUN, V6, P61, DOI 10.1080/10810730150501413; Edwards A, 2001, BRIT J GEN PRACT, V51, P259; ELLIS BG, 1999, COLORECTAL DIS, V1, P23; EVERHART JE, 1989, DIGEST DIS SCI, V34, P1153, DOI 10.1007/BF01537261; Fitzmaurice DA, 2001, BRIT MED J, V322, P1193, DOI 10.1136/bmj.322.7296.1193; GOODMAN D, 1993, BRIT J SURG, V80, P1327, DOI 10.1002/bjs.1800801037; Hannay DR., 1979, SYMPTOM ICEBERG STUD; HAYWARD RSA, 1993, CAN MED ASSOC J, V148, P507; HOLLIDAY HW, 1979, LANCET, V1, P309; JONES R, 2001, BMJ-BRIT MED J, V320, P596; Knottnerus J A, 1989, Theor Med, V10, P67, DOI 10.1007/BF00625761; MELTZER S, 1998, CMAJ S8, V150, P51; Morrell D C, 1976, J R Coll Gen Pract, V26, P398; MOWLAM M, 2001, STAKEHOLDER, V5, P13; SANDLER RS, 1990, GASTROENTEROLOGY, V99, P409, DOI 10.1016/0016-5085(90)91023-Y; Slaney G, 1971, Mod Trends Surg, V3, P69; Thompson JA, 2000, COLORECTAL DIS J ASS, V2, P288; THOMPSON MR, EFFECTIVE MANAGEMENT, P173; 2002, COLORECTAL DIS, V4, P287	25	36	36	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 2	2003	327	7409					263	265		10.1136/bmj.327.7409.263	http://dx.doi.org/10.1136/bmj.327.7409.263			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708KP	12896939	Bronze, Green Published			2022-12-28	WOS:000184566300020
J	Abramson, J; Smirnova, I; Kasho, V; Verner, G; Kaback, HR; Iwata, S				Abramson, J; Smirnova, I; Kasho, V; Verner, G; Kaback, HR; Iwata, S			Structure and mechanism of the lactose permease of Escherichia coli	SCIENCE			English	Article								Membrane transport proteins that transduce free energy stored in electrochemical ion gradients into a concentration gradient are a major class of membrane proteins. We report the crystal structure at 3.5 angstroms of the Escherichia coli lactose permease, an intensively studied member of the major facilitator superfamily of transporters. The molecule is composed of N- and C-terminal domains, each with six transmembrane helices, symmetrically positioned within the permease. A large internal hydrophilic cavity open to the cytoplasmic side represents the inward-facing conformation of the transporter. The structure with a bound lactose homolog, beta-D-galactopyranosyl-1-thio-beta-D-galactopyranoside, reveals the sugar-binding site in the cavity, and residues that play major roles in substrate recognition and proton translocation are identified. We propose a possible mechanism for lactose/proton symport (cotransport) consistent with both the structure and a large body of experimental data.	Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England; Univ London Imperial Coll Sci Technol & Med, Div Biomed Sci, London SW7 2AZ, England; Univ Calif Los Angeles, Inst Mol Biol, Howard Hughes Med Inst, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Howard Hughes Med Inst, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA	Imperial College London; Imperial College London; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Kaback, HR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England.	ronaldk@hhmi.ucla.edu; s.iwata@imperial.ac.uk			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051131] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK51131: 08] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CALAMIA J, 1990, P NATL ACAD SCI USA, V87, P4937, DOI 10.1073/pnas.87.13.4937; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; FOSTER DL, 1983, J BIOL CHEM, V258, P31; FRANCO PJ, 1994, J BIOL CHEM, V269, P7379; Frillingos S, 1997, PROTEIN SCI, V6, P438; Frillingos S, 1998, FASEB J, V12, P1281, DOI 10.1096/fasebj.12.13.1281; Guan L, 2003, BIOCHEMISTRY-US, V42, P1377, DOI 10.1021/bi027152m; Guan L, 2002, P NATL ACAD SCI USA, V99, P3475, DOI 10.1073/pnas.052703699; Guan L, 2002, P NATL ACAD SCI USA, V99, P6613, DOI 10.1073/pnas.102178299; HENDERSON PJF, 1990, J BIOENERG BIOMEMBR, V22, P525, DOI 10.1007/BF00762961; Hirai T, 2003, J BACTERIOL, V185, P1712, DOI 10.1128/JB.185.5.1712-1718.2003; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; JUNG K, 1995, BIOCHEMISTRY-US, V34, P6272, DOI 10.1021/bi00019a003; JUNG K, 1993, BIOCHEMISTRY-US, V32, P12273, DOI 10.1021/bi00097a001; Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077; le Coutre J, 1998, P NATL ACAD SCI USA, V95, P6114, DOI 10.1073/pnas.95.11.6114; M_uller-Hill B., 1996, LAC OPERON SHORT HIS; Merritt EA, 1997, STRUCTURE, V5, P1485, DOI 10.1016/S0969-2126(97)00298-0; Miller C, 2000, CURR OPIN CHEM BIOL, V4, P148, DOI 10.1016/S1367-5931(99)00068-X; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Patzlaff JS, 1998, BIOCHEMISTRY-US, V37, P15363, DOI 10.1021/bi981142x; ROEPE PD, 1989, BIOCHEMISTRY-US, V28, P6127, DOI 10.1021/bi00440a060; Sahin-Toth M, 2000, BIOCHEMISTRY-US, V39, P5097, DOI 10.1021/bi0000263; Sahin-Toth M, 2001, BIOCHEMISTRY-US, V40, P13015, DOI 10.1021/bi011233l; Sahin-Toth M, 2001, P NATL ACAD SCI USA, V98, P6068, DOI 10.1073/pnas.111139698; SAHINTOTH M, 1992, P NATL ACAD SCI USA, V89, P10547, DOI 10.1073/pnas.89.21.10547; Saier MH, 2000, MOL MICROBIOL, V35, P699, DOI 10.1046/j.1365-2958.2000.01759.x; Smirnova IN, 2003, BIOCHEMISTRY-US, V42, P3025, DOI 10.1021/bi027329c; Sorgen PL, 2002, P NATL ACAD SCI USA, V99, P14037, DOI 10.1073/pnas.182552199; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; UJWAL ML, 1994, MOL MEMBR BIOL, V11, P9, DOI 10.3109/09687689409161024; Venkatesan P, 1998, P NATL ACAD SCI USA, V95, P9802, DOI 10.1073/pnas.95.17.9802; Weinglass AB, 2002, J MOL BIOL, V315, P561, DOI 10.1006/jmbi.2001.5289; WIDDAS WF, 1952, J PHYSIOL-LONDON, V118, P23, DOI 10.1113/jphysiol.1952.sp004770; Wolin CD, 2000, BIOCHEMISTRY-US, V39, P6130, DOI 10.1021/bi0001269; Wolin CD, 2001, BIOCHEMISTRY-US, V40, P1996, DOI 10.1021/bi0025767; Zhao M, 1999, BIOCHEMISTRY-US, V38, P7407, DOI 10.1021/bi9906524	37	1180	1205	1	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2003	301	5633					610	615		10.1126/science.1088196	http://dx.doi.org/10.1126/science.1088196			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893935				2022-12-28	WOS:000184473600030
J	Thomson, RE; Mihaly, SF; Rabinovich, AB; McDuff, RE; Veirs, SR; Stahr, FR				Thomson, RE; Mihaly, SF; Rabinovich, AB; McDuff, RE; Veirs, SR; Stahr, FR			Constrained circulation at Endeavour ridge facilitates colonization by vent larvae	NATURE			English	Article							DE-FUCA RIDGE; MID-ATLANTIC RIDGE; HYDROTHERMAL PLUMES; NORTHEAST PACIFIC; HEAT-FLUX; BIOLOGY; EVOLUTION; OCEAN	Understanding how larvae from extant hydrothermal vent fields colonize neighbouring regions of the mid-ocean ridge system remains a major challenge in oceanic research(1,2). Among the factors considered important in the recruitment of deep-sea larvae are metabolic lifespan, the connectivity of the seafloor topography, and the characteristics of the currents(3). Here we use current velocity measurements from Endeavour ridge to examine the role of topographically constrained circulation on larval transport along-ridge. We show that the dominant tidal and wind-generated currents in the region are strongly attenuated within the rift valley that splits the ridge crest, and that hydrothermal plumes rising from vent fields in the valley drive a steady near-bottom inflow within the valley. Extrapolation of these findings suggests that the suppression of oscillatory currents within rift valleys of mid-ocean ridges shields larvae from cross-axis dispersal into the inhospitable deep ocean. This effect, augmented by plume-driven circulation within rift valleys having active hydrothermal venting, helps retain larvae near their source. Larvae are then exported preferentially down-ridge during regional flow events that intermittently over-ride the currents within the valley.	Inst Ocean Sci, Sidney, BC V8L 4B2, Canada; PP Shirshov Oceanol Inst, Moscow 117851, Russia; Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	Russian Academy of Sciences; Shirshov Institute of Oceanology; University of Washington; University of Washington Seattle	Thomson, RE (corresponding author), Inst Ocean Sci, 9860 W Saanich Rd, Sidney, BC V8L 4B2, Canada.		Rabinovich, Alexander/ABD-5745-2020	Veirs, Scott/0000-0001-7395-9085				BAKER ET, 1987, EARTH PLANET SC LETT, V85, P59, DOI 10.1016/0012-821X(87)90021-5; BEMIS KG, 1993, J GEOPHYS RES-SOL EA, V98, P6351, DOI 10.1029/92JB02273; Cannon GA, 1996, GEOPHYS RES LETT, V23, P1613, DOI 10.1029/96GL01370; GERMAN CR, 1993, EARTH PLANET SC LETT, V116, P129, DOI 10.1016/0012-821X(93)90049-F; GINSTER U, 1994, J GEOPHYS RES-SOL EA, V99, P4937, DOI 10.1029/93JB02800; Kelley D. S., 2001, EOS T AGU, V82, pF612; Lavelle JW, 2001, J GEOPHYS RES-OCEANS, V106, P31099, DOI 10.1029/2001JC000865; LUPTON JE, 1985, NATURE, V316, P621, DOI 10.1038/316621a0; Marsh AG, 2001, NATURE, V411, P77, DOI 10.1038/35075063; Mcduff R.E., 1995, PHYSICAL CHEM BIOL G, P357; Mihaly SF, 1998, GEOPHYS RES LETT, V25, P1205, DOI 10.1029/98GL00722; Murton BJ, 1999, EARTH PLANET SC LETT, V171, P301, DOI 10.1016/S0012-821X(99)00157-0; ROSENBERG ND, 1988, NATURE, V334, P604, DOI 10.1038/334604a0; STAHR FR, 2000, EOS T AGU S, V81; THOMSON RE, 1992, EARTH PLANET SC LETT, V111, P141, DOI 10.1016/0012-821X(92)90175-U; Thurnherr AM, 2002, J PHYS OCEANOGR, V32, P1763, DOI 10.1175/1520-0485(2002)032<1763:FAMITR>2.0.CO;2; TUNNICLIFFE V, 1991, OCEANOGR MAR BIOL, V29, P319; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; VEIRS SR, 2003, THESIS U WASHINGTON	19	81	83	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					545	549		10.1038/nature01824	http://dx.doi.org/10.1038/nature01824			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891356				2022-12-28	WOS:000184454700041
J	Webster, AJ; Payne, RJH; Pagel, M				Webster, AJ; Payne, RJH; Pagel, M			Molecular Phylogenies link rates of evolution and speciation	SCIENCE			English	Article							DIVERSITY		Univ Reading, Sch Anim & Microbial Sci, Reading RG6 2AH, Berks, England	University of Reading	Pagel, M (corresponding author), Univ Reading, Sch Anim & Microbial Sci, Reading RG6 2AH, Berks, England.							Barraclough TG, 2001, EVOLUTION, V55, P677, DOI 10.1554/0014-3820(2001)055[0677:ERASDI]2.0.CO;2; GOULD SJ, 1993, NATURE, V366, P223, DOI 10.1038/366223a0; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Mayr E., 1954, EVOLUTION PROCESS, P157; MINDELL DP, 1990, J EVOLUTION BIOL, V3, P125, DOI 10.1046/j.1420-9101.1990.3010125.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Weller SG, 1996, EVOLUTION, V50, P23, DOI 10.1111/j.1558-5646.1996.tb04469.x	7	122	125	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2003	301	5632					478	478		10.1126/science.1083202	http://dx.doi.org/10.1126/science.1083202			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12881561				2022-12-28	WOS:000184340500031
J	Petersen, LR; Marfin, AA; Gubler, DJ				Petersen, LR; Marfin, AA; Gubler, DJ			West Nile virus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NEW-YORK; FEVER OUTBREAK; ENCEPHALITIS; INFECTION; POLIOMYELITIS; EPIDEMIC; ANTIBODY; ISRAEL		CDCP, Div Vector Borne Infect Dis, Natl Ctr Infect Dis, US PHS,US Dept HHS, Ft Collins, CO 80522 USA	Centers for Disease Control & Prevention - USA; United States Public Health Service	Petersen, LR (corresponding author), CDCP, Div Vector Borne Infect Dis, Natl Ctr Infect Dis, US PHS,US Dept HHS, POB 2087,Foothills Campus, Ft Collins, CO 80522 USA.	LRPetersen@CDC.GOV						Ahmed S, 2000, NEUROLOGY, V55, P144, DOI 10.1212/WNL.55.1.144; Asnis DS, 2000, CLIN INFECT DIS, V30, P413, DOI 10.1086/313737; Bains HS, 2003, ARCH OPHTHALMOL-CHIC, V121, P205, DOI 10.1001/archopht.121.2.205; Beasley DWC, 2002, VIROLOGY, V296, P17, DOI 10.1006/viro.2002.1372; BIGGERSTAFF B, 2002, IN PRESS TRANSFUSION; Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P31; Ceausu Em., 1997, Romanian Journal of Virology, V48, P3; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1135; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P877; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1133; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1129; Chowers MY, 2001, EMERG INFECT DIS, V7, P675; Deubel V, 2001, ANN NY ACAD SCI, V951, P195; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Drebot Michael A, 2003, Can J Infect Dis, V14, P105; Gilad R, 2003, INFECTION, V31, P55, DOI 10.1007/s15010-002-3039-4; Glass JD, 2002, NEW ENGL J MED, V347, P1280, DOI 10.1056/NEJM200210173471616; Hubalek Z, 2001, LANCET, V358, P254, DOI 10.1016/S0140-6736(01)05491-5; Hubalek Z, 1999, EMERG INFECT DIS, V5, P594, DOI 10.3201/eid0504.990430; Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987; Kelley TW, 2003, NEW ENGL J MED, V348, P564, DOI 10.1056/NEJM200302063480618; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Leis AA, 2002, NEW ENGL J MED, V347, P1279, DOI 10.1056/NEJM2002c021587; MARBERG K, 1956, AM J HYG, V64, P259, DOI 10.1093/oxfordjournals.aje.a119838; MONATH TP, 1980, ST LOUIS ENCEPHALITI, P239; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; *NEW YORK CIT DEP, 2001, W NIL VIR SURV CONTR; Ohry A, 2001, SPINAL CORD, V39, P662, DOI 10.1038/sj.sc.3101228; Pepperell C, 2003, CAN MED ASSOC J, V168, P1399; Petersen LR, 2002, ANN INTERN MED, V137, P173, DOI 10.7326/0003-4819-137-3-200208060-00009; Platonov AE, 2001, EMERG INFECT DIS, V7, P128, DOI 10.3201/eid0701.010118; Roehrig JT, 2003, EMERG INFECT DIS, V9, P376, DOI 10.3201/eid0903.020531; Sampson BA, 2001, ANN NY ACAD SCI, V951, P172; Sejvar JJ, 2003, JAMA-J AM MED ASSOC, V290, P511, DOI 10.1001/jama.290.4.511; Sejvar JJ, 2003, EMERG INFECT DIS, V9, P788, DOI 10.3201/eid0907.030129; SOUTHAM CM, 1954, AM J TROP MED HYG, V3, P19, DOI 10.4269/ajtmh.1954.3.19; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; Vandenbelt S, 2003, RETINA-J RET VIT DIS, V23, P97, DOI 10.1097/00006982-200302000-00016; Weinberger M, 2001, EMERG INFECT DIS, V7, P686, DOI 10.3201/eid0704.010416	41	155	161	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2003	290	4					524	528		10.1001/jama.290.4.524	http://dx.doi.org/10.1001/jama.290.4.524			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703JB	12876096				2022-12-28	WOS:000184275300025
J	Cobb, KM; Charles, CD; Cheng, H; Edwards, RL				Cobb, KM; Charles, CD; Cheng, H; Edwards, RL			El Nino/Southern Oscillation and tropical Pacific climate during the last millennium	NATURE			English	Article							SOUTHERN-OSCILLATION; SOLAR IRRADIANCE; NINO; VARIABILITY; ENSO; CORAL; DROUGHT; MODEL; STABILITY; FREQUENCY	Any assessment of future climate change requires knowledge of the full range of natural variability in the El Nino/Southern Oscillation (ENSO) phenomenon. Here we splice together fossil-coral oxygen isotopic records from Palmyra Island in the tropical Pacific Ocean to provide 30-150-year windows of tropical Pacific climate variability within the last 1,100 years. The records indicate mean climate conditions in the central tropical Pacific ranging from relatively cool and dry during the tenth century to increasingly warmer and wetter climate in the twentieth century. But the corals also document a broad range of ENSO behaviour that correlates poorly with these estimates of mean climate. The most intense ENSO activity within the reconstruction occurred during the mid-seventeenth century. Taken together, the coral data imply that the majority of ENSO variability over the last millennium may have arisen from dynamics internal to the ENSO system itself.	Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Univ Minnesota, Dept Geol & Geophys, Minnesota Isotope Lab, Minneapolis, MN 55455 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Minnesota System; University of Minnesota Twin Cities	Cobb, KM (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	kcobb@gps.caltech.edu	CHENG, HAI/H-3413-2017; Edwards, R. Lawrence/I-3124-2014	CHENG, HAI/0000-0002-5305-9458; Edwards, R. Lawrence/0000-0002-7027-5881; Cobb, Kim/0000-0002-2125-9164				Bard E, 2000, TELLUS B, V52, P985, DOI 10.1034/j.1600-0889.2000.d01-7.x; Black DE, 1999, SCIENCE, V286, P1709, DOI 10.1126/science.286.5445.1709; Cane M. A., 1995, NATURAL CLIMATE VARI, P442; Cobb KM, 2003, EARTH PLANET SC LETT, V210, P91, DOI 10.1016/S0012-821X(03)00138-9; Cobb KM, 2001, GEOPHYS RES LETT, V28, P2209, DOI 10.1029/2001GL012919; COLE JE, 1993, SCIENCE, V260, P1790, DOI 10.1126/science.260.5115.1790; Correge T, 2001, GEOPHYS RES LETT, V28, P3477, DOI 10.1029/2001GL013216; Crowley TJ, 2000, SCIENCE, V289, P270, DOI 10.1126/science.289.5477.270; Dai A, 2000, GEOPHYS RES LETT, V27, P1283, DOI 10.1029/1999GL011140; Evans M., 2001, INTERHEMISPHERIC CLI, DOI [10.1016/b978-012472670-3/50007-0, DOI 10.1016/B978-012472670-3/50007-0]; Evans MN, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000590; Evans MN, 1999, J GEOPHYS RES-OCEANS, V104, P13409, DOI 10.1029/1999JC900001; Fedorov AV, 2001, J CLIMATE, V14, P3086, DOI 10.1175/1520-0442(2001)014<3086:ASAOTO>2.0.CO;2; GRAHAM NE, 1988, SCIENCE, V240, P1293, DOI 10.1126/science.240.4857.1293; Gu DF, 1997, SCIENCE, V275, P805, DOI 10.1126/science.275.5301.805; Harrison DE, 1997, GEOPHYS RES LETT, V24, P1779, DOI 10.1029/97GL01789; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Hendy EJ, 2002, SCIENCE, V295, P1511, DOI 10.1126/science.1067693; Hodell DA, 2001, SCIENCE, V292, P1367, DOI 10.1126/science.1057759; HODELL DA, 1995, NATURE, V375, P391, DOI 10.1038/375391a0; Hughen KA, 1999, GEOPHYS RES LETT, V26, P3129, DOI 10.1029/1999GL006062; JIN FF, 1994, SCIENCE, V264, P70, DOI 10.1126/science.264.5155.70; Jin FF, 1997, J ATMOS SCI, V54, P811, DOI 10.1175/1520-0469(1997)054<0811:AEORPF>2.0.CO;2; JONES PD, 1986, J CLIM APPL METEOROL, V25, P161, DOI 10.1175/1520-0450(1986)025<0161:NHSATV>2.0.CO;2; Kaplan A, 1998, J GEOPHYS RES-OCEANS, V103, P18567, DOI 10.1029/97JC01734; KEEMAN R, 1994, TELLUS A, V46, P529, DOI 10.1034/j.1600-0870.1994.00014.x; Knutson TR, 1997, J CLIMATE, V10, P138, DOI 10.1175/1520-0442(1997)010<0138:SEIAGC>2.0.CO;2; Latif M, 1997, J CLIMATE, V10, P2221, DOI 10.1175/1520-0442(1997)010<2221:GWDVOE>2.0.CO;2; LEAN J, 1995, GEOPHYS RES LETT, V22, P3195, DOI 10.1029/95GL03093; Linsley BK, 1999, CORAL REEFS, V18, P13, DOI 10.1007/s003380050148; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; Mann ME, 2000, EL NINO SO OSCILLATI, P357, DOI 10.1017/CBO9780511573125.011; McCulloch M, 1996, EARTH PLANET SC LETT, V138, P169, DOI 10.1016/0012-821X(95)00230-A; McPhaden MJ, 2002, NATURE, V415, P603, DOI 10.1038/415603a; Neelin JD, 1998, J GEOPHYS RES-OCEANS, V103, P14261, DOI 10.1029/97JC03424; Parker DE, 1995, CLIMATIC CHANGE, V31, P559, DOI 10.1007/BF01095162; Rajagopalan B, 1997, J CLIMATE, V10, P2351, DOI 10.1175/1520-0442(1997)010<2351:AEOAAV>2.0.CO;2; Robock A, 2000, REV GEOPHYS, V38, P191, DOI 10.1029/1998RG000054; SCOFFIN TP, 1993, CORAL REEFS, V12, P203, DOI 10.1007/BF00334480; STINE S, 1994, NATURE, V369, P546, DOI 10.1038/369546a0; TETT S, 1995, J CLIMATE, V8, P1473, DOI 10.1175/1520-0442(1995)008<1473:SOENSO>2.0.CO;2; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505; Timmermann A, 2001, GEOPHYS RES LETT, V28, P2061, DOI 10.1029/2001GL012879; Trenberth KE, 1996, GEOPHYS RES LETT, V23, P57, DOI 10.1029/95GL03602; Tudhope AW, 2001, SCIENCE, V291, P1511, DOI 10.1126/science.1057969; TZIPERMAN E, 1994, SCIENCE, V264, P72, DOI 10.1126/science.264.5155.72; Urban FE, 2000, NATURE, V407, P989, DOI 10.1038/35039597; Verschuren D, 2000, NATURE, V403, P410, DOI 10.1038/35000179; Xie PP, 1997, B AM METEOROL SOC, V78, P2539, DOI 10.1175/1520-0477(1997)078<2539:GPAYMA>2.0.CO;2; Zhang Y, 1997, J CLIMATE, V10, P1004, DOI 10.1175/1520-0442(1997)010<1004:ELIV>2.0.CO;2	50	649	676	6	232	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2003	424	6946					271	276		10.1038/nature01779	http://dx.doi.org/10.1038/nature01779			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867972				2022-12-28	WOS:000184183900031
J	Han, Y; Grier, DG				Han, Y; Grier, DG			Fluid dynamics: Vortex rings in a constant electric field	NATURE			English	Editorial Material							COLLOIDAL CRYSTALS		Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; Univ Chicago, Dept Phys, Chicago, IL 60637 USA; Univ Penn, Phys Dept, Philadelphia, PA 19104 USA	University of Chicago; University of Chicago; University of Pennsylvania	Han, Y (corresponding author), Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA.	d-grier@uchicago.edu	Grier, David G/C-5761-2008	Grier, David G/0000-0002-4382-5139				Behrens SH, 2001, J CHEM PHYS, V115, P6716, DOI 10.1063/1.1404988; MURRAY CA, 1995, AM SCI, V83, P238; RICHETTI P, 1984, J PHYS LETT-PARIS, V45, P1137, DOI 10.1051/jphyslet:0198400450230113700; Shariff K, 1992, ANNU REV FLUID MECH, V24, P235, DOI DOI 10.1146/ANNUREV.FL.24.010192.001315; Squires TM, 2001, J FLUID MECH, V443, P403, DOI 10.1017/S0022112001005432; Trau M, 1997, LANGMUIR, V13, P6375, DOI 10.1021/la970568u	6	100	102	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					267	268		10.1038/424267b	http://dx.doi.org/10.1038/424267b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867968				2022-12-28	WOS:000184183900027
J	Jiang, GY; Giannone, G; Critchley, DR; Fukumoto, E; Sheetz, MP				Jiang, GY; Giannone, G; Critchley, DR; Fukumoto, E; Sheetz, MP			Two-piconewton slip bond between fibronectin and the cytoskeleton depends on talin	NATURE			English	Article								Mechanical forces on matrix-integrin-cytoskeleton linkages are crucial for cell viability, morphology and organ function(1). The production of force depends on the molecular connections from extracellular-matrix-integrin complexes to the cytoskeleton(2,3). The minimal matrix complex causing integrin-cytoskeleton connections is a trimer of fibronectin's integrin-binding domain FNIII7-10 (ref. 4). Here we report a specific, molecular slip bond that was broken repeatedly by a force of 2 pN at the cellular loading rate of 60 nm s(-1); this occurred with single trimer beads but not with monomer. Talin1, which binds to both integrins and actin filaments in vitro, is required for the 2-pN slip bond and rapid cytoskeleton binding. Further, inhibition of fibronectin binding to alpha(v)beta(3) and deletion of beta(3) markedly decreases the 2-pN force peak. We suggest that talin1 initially forms a molecular slip bond between closely packed fibronectin-integrin complexes and the actin cytoskeleton, which can apply a low level of force to fibronectin until many bonds form or a signal is received to activate a force response.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; NIH, Natl Inst Dent & Craniofacial Res, Bethesda, MD 20892 USA	Columbia University; University of Leicester; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Sheetz, MP (corresponding author), Columbia Univ, Dept Biol Sci, 1212 Amsterdam Ave, New York, NY 10027 USA.			Giannone, Gregory/0000-0002-0932-1690	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000524] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Coussen F, 2002, J CELL SCI, V115, P2581; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Felsenfeld DP, 1996, NATURE, V383, P438, DOI 10.1038/383438a0; FINER JT, 1995, BIOPHYS J, V68, P291; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; GIANNONE G, UNPUB J CELL BIOL; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Litvinov RI, 2002, P NATL ACAD SCI USA, V99, P7426, DOI 10.1073/pnas.112194999; NISHIZAKA T, 1995, NATURE, V377, P251, DOI 10.1038/377251a0; Nishizaka T, 2000, P NATL ACAD SCI USA, V97, P692, DOI 10.1073/pnas.97.2.692; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294; Priddle H, 1998, J CELL BIOL, V142, P1121, DOI 10.1083/jcb.142.4.1121; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Sheetz MP, 1998, TRENDS CELL BIOL, V8, P51, DOI 10.1016/S0962-8924(98)80005-6; Sonnenberg A, 1993, Curr Top Microbiol Immunol, V184, P7; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; Suzuki K, 2001, BIOPHYS J, V81, P2181, DOI 10.1016/S0006-3495(01)75866-3; Thoumine O, 2000, EUR BIOPHYS J BIOPHY, V29, P398, DOI 10.1007/s002490000087; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Watanabe K, 2002, J BIOL CHEM, V277, P11549, DOI 10.1074/jbc.M200356200; Xing BD, 2001, J BIOL CHEM, V276, P44373, DOI 10.1074/jbc.M108587200	30	348	368	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					334	337		10.1038/nature01805	http://dx.doi.org/10.1038/nature01805			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867986				2022-12-28	WOS:000184183900047
J	Slabbekoorn, H; Peet, M				Slabbekoorn, H; Peet, M			Ecology: Birds sing at a higher pitch in urban noise - Great tits hit the high notes to ensure that their mating calls are heard above the city's din.	NATURE			English	Editorial Material							PARUS-MAJOR; SONG; HYPOTHESIS; SELECTION; ROADS		Leiden Univ, Inst Biol Leiden, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Slabbekoorn, H (corresponding author), Leiden Univ, Inst Biol Leiden, NL-2300 RA Leiden, Netherlands.							Catterall CP, 1998, BIOL CONSERV, V84, P65, DOI 10.1016/S0006-3207(97)00076-1; Clergeau P, 1998, CONDOR, V100, P413, DOI 10.2307/1369707; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; HANSEN P, 1979, ANIM BEHAV, V27, P1270, DOI 10.1016/0003-3472(79)90073-3; HUNTER ML, 1979, J ANIM ECOL, V48, P759, DOI 10.2307/4194; Junker-Bornholdt R, 1998, J ORNITHOL, V139, P131, DOI 10.1007/BF01651222; Klump Georg M., 1996, P321; MCGREGOR PK, 1989, BEHAVIOUR, V108, P139, DOI 10.1163/156853989X00105; Rabin LA, 2002, J COMP PSYCHOL, V116, P137, DOI 10.1037//0735-7036.116.2.137; REIJNEN R, 1995, J APPL ECOL, V32, P187, DOI 10.2307/2404428; Skiba R, 2000, J ORNITHOL, V141, P160, DOI 10.1046/j.1439-0361.2000.00071.x; Slabbekoorn H, 2002, PHILOS T R SOC B, V357, P493, DOI 10.1098/rstb.2001.1056; Slabbekoorn H, 2002, EVOLUTION, V56, P1849	13	673	710	10	459	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					267	267		10.1038/424267a	http://dx.doi.org/10.1038/424267a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867967				2022-12-28	WOS:000184183900026
J	Amanullah, A; Azam, N; Balliet, A; Hollander, C; Hoffman, B; Fornace, A; Liebermann, D				Amanullah, A; Azam, N; Balliet, A; Hollander, C; Hoffman, B; Fornace, A; Liebermann, D			Cell signalling (communication arising) - Cell survival and a Gadd45-factor deficiency	NATURE			English	Editorial Material							NF-KAPPA-B; TRANSDUCTION; ACTIVATION; LIFE		Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; NCI, Gene Response Sect, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Amanullah, A (corresponding author), GlaxoSmithKline, HTB Integrat Biol Initiat, King Of Prussia, PA 19406 USA.	lieberma@unix.temple.edu	Fornace, Albert J/A-7407-2008	Fornace, Albert J/0000-0001-9695-085X				Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; FORNACE AJ, 1992, ANN NY ACAD SCI, V663, P139, DOI 10.1111/j.1749-6632.1992.tb38657.x; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kyriakis JM, 2001, NATURE, V414, P265, DOI 10.1038/35104735; Liebermann DA, 2002, LEUKEMIA, V16, P527, DOI 10.1038/sj.leu.2402477; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568	10	79	84	0	5	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 14	2003	424	6950					741	742		10.1038/424741b	http://dx.doi.org/10.1038/424741b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711HQ	12917673	Bronze			2022-12-28	WOS:000184733900028
J	Mann, NH; Cook, A; Millard, A; Bailey, S; Clokie, M				Mann, NH; Cook, A; Millard, A; Bailey, S; Clokie, M			Marine ecosystems: Bacterial photosynthesis genes in a virus	NATURE			English	Editorial Material									Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Mann, NH (corresponding author), Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.	n.h.mann@warwick.ac.uk	millard, andrew D/B-3893-2011; chen, qi/C-8585-2011	Clokie, Martha/0000-0002-6069-8936; Millard, Andrew/0000-0002-3895-2854				ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Deshpande NN, 1997, RNA, V3, P37; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Hambly E, 2001, P NATL ACAD SCI USA, V98, P11411, DOI 10.1073/pnas.191174498; Partensky F., 1999, B I OCEANOGRAPHIQUE, V19, P457; Piazena H, 2002, DEEP-SEA RES PT II, V49, P3513, DOI 10.1016/S0967-0645(02)00093-0; Seaton GGR, 1996, FEBS LETT, V389, P319, DOI 10.1016/0014-5793(96)00615-1; WILSON WH, 1993, APPL ENVIRON MICROB, V59, P3736, DOI 10.1128/AEM.59.11.3736-3743.1993	8	303	335	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2003	424	6950					741	741		10.1038/424741a	http://dx.doi.org/10.1038/424741a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711HQ	12917674	Bronze			2022-12-28	WOS:000184733900027
J	Kaspar, BK; Llado, J; Sherkat, N; Rothstein, JD; Gage, FH				Kaspar, BK; Llado, J; Sherkat, N; Rothstein, JD; Gage, FH			Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model	SCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DEGENERATION; SUSTAINED EXPRESSION; SUPEROXIDE-DISMUTASE; DISEASE PROGRESSION; LENTIVIRAL VECTORS; NERVOUS-SYSTEM; GENE DELIVERY; MICE; GDNF	Amyotrophic lateral sclerosis (ALS) is a progressive, lethal neuromuscular disease that is associated with the degeneration of spinal and brainstem motor neurons, leading to atrophy of limb, axial, and respiratory muscles. The cause of ALS is unknown, and there is no effective therapy. Neurotrophic factors are candidates for therapeutic evaluation in ALS. Although chronic delivery of molecules to the central nervous system has proven difficult, we recently discovered that adeno-associated virus can be retrogradely transported efficiently from muscle to motor neurons of the spinal cord. We report that insulin-like growth factor 1 prolongs life and delays disease progression, even when delivered at the time of overt disease symptoms.	Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21287 USA	Salk Institute; Johns Hopkins University; Johns Hopkins University	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Kaspar, Brian/E-6490-2010; Lladó, Jerònia/A-2633-2011; rothstein, jeffrey d/C-9470-2013; Kaspar, Brian/E-3349-2011	Lladó, Jerònia/0000-0002-8489-427X; 	NIA NIH HHS [AG21876, AG12992] Funding Source: Medline; NINDS NIH HHS [NS33958] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021876, P01AG012992] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Acsadi G, 2002, HUM GENE THER, V13, P1047, DOI 10.1089/104303402753812458; Azzouz M, 2000, HUM MOL GENET, V9, P803, DOI 10.1093/hmg/9.5.803; Bilak MM, 2001, AMYOTROPH LATERAL SC, V2, P83; Boulis NM, 2003, NEUROSURGERY, V52, P381, DOI 10.1227/01.NEU.0000044459.24519.3E; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Corse AM, 1999, NEUROBIOL DIS, V6, P335, DOI 10.1006/nbdi.1999.0253; Davidson BL, 2000, P NATL ACAD SCI USA, V97, P3428, DOI 10.1073/pnas.050581197; Drachman DB, 2000, ANN NEUROL, V48, P792, DOI 10.1002/1531-8249(200011)48:5<792::AID-ANA14>3.3.CO;2-X; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Kafri T, 1997, NAT GENET, V17, P314, DOI 10.1038/ng1197-314; Kaspar BK, 2002, MOL THER, V5, P50, DOI 10.1006/mthe.2001.0520; KASPAR BK, UNPUB; Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559; Kriz J, 2002, NEUROBIOL DIS, V10, P268, DOI 10.1006/nbdi.2002.0487; Levine JB, 1999, GLIA, V28, P215; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Lu YY, 2003, NEUROSCI RES, V45, P33, DOI 10.1016/S0168-0102(02)00195-5; Manabe Y, 2003, NEUROL RES, V25, P195, DOI 10.1179/016164103101201193; Manabe Y, 2002, APOPTOSIS, V7, P329, DOI 10.1023/A:1016123413038; Mazarakis ND, 2001, HUM MOL GENET, V10, P2109, DOI 10.1093/hmg/10.19.2109; MILLER RG, 2001, COCHRANE DB SYST REV, V4, P1447; MITCHELL JD, 2002, COCHRANE DB SYST REV, V3; Mohajeri MH, 1999, HUM GENE THER, V10, P1853, DOI 10.1089/10430349950017536; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; Vincent AM, 2002, GROWTH HORM IGF RES, V12, P193, DOI 10.1016/S1096-6374(02)00017-5; Wang LJ, 2002, J NEUROSCI, V22, P6920; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; Yoshihara T, 2002, J NEUROCHEM, V80, P158, DOI 10.1046/j.0022-3042.2001.00683.x; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	33	672	761	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2003	301	5634					839	842		10.1126/science.1086137	http://dx.doi.org/10.1126/science.1086137			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907804				2022-12-28	WOS:000184615700047
J	Bailar, J				Bailar, J			Hormone-replacement therapy and cardiovascular diseases	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Illinois, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bailar, J (corresponding author), Univ Illinois, Chicago, IL 60607 USA.							BAILAR JC, 1985, NEW ENGL J MED, V313, P1080, DOI 10.1056/NEJM198510243131709; Grodstein F, 2003, NEW ENGL J MED, V348, P645, DOI 10.1056/NEJMsb022365; STAMPFER MJ, 1985, NEW ENGL J MED, V313, P1044, DOI 10.1056/NEJM198510243131703; Ware JH, 2003, NEW ENGL J MED, V348, P2136, DOI 10.1056/NEJMe030054; Ware JH, 2003, NEW ENGL J MED, V348, P2055, DOI 10.1056/NEJMp030068; WILSON PWF, 1985, NEW ENGL J MED, V313, P1038, DOI 10.1056/NEJM198510243131702	6	19	19	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2003	349	6					521	522		10.1056/NEJMp038110	http://dx.doi.org/10.1056/NEJMp038110			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708JL	12904516				2022-12-28	WOS:000184563500002
J	DeRenzo, C; Reese, KJ; Seydoux, G				DeRenzo, C; Reese, KJ; Seydoux, G			Exclusion of germ plasm proteins from somatic lineages by cullin-dependent degradation	NATURE			English	Article							CAENORHABDITIS-ELEGANS EMBRYOS; ZINC-FINGER PROTEINS; C-ELEGANS; GENE-EXPRESSION; PIE-1 PROTEIN; SOCS-BOX; LOCALIZATION; RNA; UBIQUITINATION; SPECIFICATION	In many animals, establishment of the germ line depends on segregation of a specialized cytoplasm, or 'germplasm', to a small number of germline precursor cells during early embryogenesis(1). Germ plasm asymmetry involves targeting of RNAs and proteins to a specific region of the oocyte and/or embryo(2). Here we demonstrate that germ plasm asymmetry also depends on degradation of germline proteins in non-germline (somatic) cells. We show that five CCCH finger proteins, components of the Caenorhabditis elegans germ plasm, are targeted for degradation by the novel CCCH-finger-binding protein ZIF-1. ZIF-1 is a SOCS-box protein that interacts with the E3 ubiquitin ligase subunit elongin C. Elongin C, the cullin CUL-2, the ring finger protein RBX-1 and the E2 ubiquitin conjugation enzyme UBC5 (also known as LET-70) are all required in vivo for CCCH finger protein degradation. Degradation is activated in somatic cells by the redundant CCCH finger proteins MEX-5 and MEX-6, which are counteracted in the germ line by the PAR-1 kinase. We propose that segregation of the germ plasm involves both stabilization of germline proteins in the germ line and cullin-dependent degradation in the soma.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Johns Hopkins University	Seydoux, G (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.		SEYDOUX, Geraldine/AAA-2005-2020	Seydoux, Geraldine/0000-0001-8257-0493	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037047] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD037047] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; Detwiler MR, 2001, DEV CELL, V1, P187, DOI 10.1016/S1534-5807(01)00026-0; Feng H, 1999, NAT CELL BIOL, V1, P486, DOI 10.1038/70272; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Guedes S, 1997, DEVELOPMENT, V124, P731; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hird SN, 1996, DEVELOPMENT, V122, P1303; Houston DW, 2000, CURR TOP DEV BIOL, V50, P155, DOI 10.1016/S0070-2153(00)50008-8; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Kloc M, 2001, INT REV CYTOL, V203, P63; Mello CC, 1996, NATURE, V382, P710, DOI 10.1038/382710a0; Reese KJ, 2000, MOL CELL, V6, P445, DOI 10.1016/S1097-2765(00)00043-5; Riechmann V, 2002, NAT CELL BIOL, V4, P337, DOI 10.1038/ncb782; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; Seydoux G, 1995, METHOD CELL BIOL, V48, P323; Strome S, 2001, MOL BIOL CELL, V12, P1751, DOI 10.1091/mbc.12.6.1751; Styhler S, 2002, DEV CELL, V3, P865, DOI 10.1016/S1534-5807(02)00361-1; Tabara H, 1999, DEVELOPMENT, V126, P1; Tenenhaus C, 1998, DEV BIOL, V200, P212, DOI 10.1006/dbio.1998.8940; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Wirbelauer C, 2000, EMBO J, V19, P5362, DOI 10.1093/emboj/19.20.5362; Wolke U, 2002, CURR BIOL, V12, P289, DOI 10.1016/S0960-9822(02)00679-6; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2	28	135	149	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					685	689		10.1038/nature01887	http://dx.doi.org/10.1038/nature01887			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12894212	Green Accepted			2022-12-28	WOS:000184578800048
J	Stover, E; Haglund, WD; Samuels, M				Stover, E; Haglund, WD; Samuels, M			Exhumation of mass graves in Iraq - Considerations for forensic investigations, humanitarian needs, and the demands of justice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Calif Berkeley, Human Rights Ctr, Sch Publ Hlth, Berkeley, CA 94702 USA; Int Forens Program, Boston, MA USA; Yale Univ, Sch Med, Ctr Child Study, Natl Ctr Children Exposed Violence, New Haven, CT 06510 USA	University of California System; University of California Berkeley; Yale University	Stover, E (corresponding author), Univ Calif Berkeley, Human Rights Ctr, Sch Publ Hlth, 460 Stephens Hall 2300, Berkeley, CA 94702 USA.	hrc@globetrotter.berkeley.edu						Abrahams Fred, 2001, VILLAGE DESTROYED MA; *AMN INT, 1981, DIS WORKB, P109; [Anonymous], 1991, WITNESSES GRAVE STOR; BASSIOUNI C, 2003, IRAQ POST CONFLICT J; BLACK G, 1995, IRAQS CRIME GENOCIDE; Boss P, 1999, AMBIGUOUS LOSS LEARN; BOUCKAERT P, 2003, MASS GRAVES MAHAWIL; Davenport GC, 2001, HIST ARCHAEOL, V35, P87, DOI 10.1007/BF03374530; DORRETI M, 2001, ARCHAEOLOGIES CONT P, P138; FRIEDMAN T, 2003, NY TIMES        0122, pA21; GEIGER HJ, 1993, JAMA-J AM MED ASSOC, V270, P616; HAGLUND WD, 2002, ADV FORENSIC TAPHONO, P245; HARVEY M, 2002, ADV FORENSIC TAPHONO, P473; HERMAN J, 1992, TRAUMA RECOVERY AFTE, P237; Keough M E, 2000, Health Hum Rights, V5, P68, DOI 10.2307/4065223; LINDHEIM R, 1983, ANNU REV PUBL HEALTH, V4, P335, DOI 10.1146/annurev.pu.04.050183.002003; QUIRK GJ, 1994, SOC SCI MED, V39, P1675, DOI 10.1016/0277-9536(94)90082-5; Stover E, 2001, HIST ARCHAEOL, V35, P7, DOI 10.1007/BF03374523; Stover E, 1992, UNQUIET GRAVES SEARC; Stover E., 1998, GRAVES SREBRENICA VU; Stover E., 2002, INT REV RED CROSS, V84, P845, DOI DOI 10.1017/S1560775500104201; SUMMERFIELD D, 1995, TRAUMA CULTURAL SOC, P19; *US OFF REC HUM AS, 2003, MASS GRAV ACT PLAN; VANZYL P, 2003, TRANSITIONAL JUSTICE	24	29	29	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2003	290	5					663	666		10.1001/jama.290.5.663	http://dx.doi.org/10.1001/jama.290.5.663			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	708GH	12902372				2022-12-28	WOS:000184558500023
J	Ault, A				Ault, A			McClellan's FDA: boon to industry, consumers, or both?	LANCET			English	News Item																			0	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 2	2003	362	9381					379	380		10.1016/S0140-6736(03)14063-9	http://dx.doi.org/10.1016/S0140-6736(03)14063-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707FB	12911016				2022-12-28	WOS:000184498700019
J	Oransky, I				Oransky, I			Limits imposed on residents' work hours	LANCET			English	News Item																			0	6	6	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 2	2003	362	9381					378	379		10.1016/S0140-6736(03)14062-7	http://dx.doi.org/10.1016/S0140-6736(03)14062-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707FB	12907033				2022-12-28	WOS:000184498700018
J	Shaughnessy, AF; Slawson, DC				Shaughnessy, AF; Slawson, DC			What happened to the valid POEMs? A survey of review articles on the treatment of type 2 diabetes	BRITISH MEDICAL JOURNAL			English	Article							BLOOD-GLUCOSE CONTROL; MICROVASCULAR COMPLICATIONS; CARDIOVASCULAR-DISEASE; INFORMATION MASTER; MELLITUS; RISK; MANAGEMENT; TRIALS; AGENTS	Objective To evaluate systematically the review literature on type 2 diabetes to assess transmission of the findings of the United Kingdom prospective diabetes study (UKPDS), an important source of recent valid patient oriented evidence that matters (POEMs). Design Inception cohort analysis of the recent medical literature. Studies reviewed Thirty five reviews on treatment of type 2 diabetes. Main outcome measures Presentation of three types of information from UKPDS in review articles: recommendations based on patient oriented outcomes of study; recommendations contradicted by patient oriented outcomes of study; and recommendations based on disease oriented outcomes for which no patient oriented evidence exists. Results Only six of the reviews included the POEM that tight blood glucose control had no effect on diabetes related or overall mortality. Just seven mentioned that metformin treatment was associated with decreased mortality. Most (30) of the reviews did not report that diabetic patients with hypertension benefit more from good blood pressure control than good blood glucose control. No review pointed out that treatment of overweight patients with type 2 diabetes with insulin or sulphonylurea drugs had no effect on microvascular or macrovascular outcomes. Thirteen reviews recommended drugs as first line treatment for which we do not have patient oriented outcomes data. The average validity assessment score was 1.3 out of a possible score of 15 (95% confidence interval 0.9 to 1.8). Conclusions Review articles on the treatment of type 2 diabetes have not accurately transmitted the valid POEM results of the UKPDS to clinicians. Clinicians relying on review articles written by experts as a source of valid POEMs may be misled.	Harrisburg Family Practice Residency, Harrisburg, PA USA; Univ Virginia, Dept Family Med, Charlottesville, VA USA	University of Virginia	Shaughnessy, AF (corresponding author), Pinnaclehlth Syst, POB 8700, Harrisburg, PA 17105 USA.							Cook RJ, 1995, CAN J STAT, V23, P333, DOI 10.2307/3315378; Cruickshank JK, 2001, BRIT MED J, V322, P1246; Ewart RM, 2001, BMJ-BRIT MED J, V323, P854, DOI 10.1136/bmj.323.7317.854; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; HAYNES RB, 1992, BRIT MED J, V304, P330, DOI 10.1136/bmj.304.6823.330; Huang ES, 2001, AM J MED, V111, P633, DOI 10.1016/S0002-9343(01)00978-0; Luna B, 2001, AM FAM PHYSICIAN, V63, P1747; McAlister FA, 1999, ANN INTERN MED, V131, P947, DOI 10.7326/0003-4819-131-12-199912210-00007; McCormack J, 2000, BMJ-BRIT MED J, V320, P1720, DOI 10.1136/bmj.320.7251.1720; *OXF CTR EV BAS ME, LEV EV GRAD REC; OXMAN AD, 1994, JAMA-J AM MED ASSOC, V272, P1367, DOI 10.1001/jama.272.17.1367; SHAUGHNESSY AF, 1994, J FAM PRACTICE, V39, P489; Siwek J, 2002, AM FAM PHYSICIAN, V65, P251; SLAWSON DC, 1994, J FAM PRACTICE, V38, P505; Smith R, 1996, BRIT MED J, V313, P1062; Stearne MR, 1998, BRIT MED J, V317, P713; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Temple R, 1999, JAMA-J AM MED ASSOC, V282, P790, DOI 10.1001/jama.282.8.790; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Weldy DL, 2002, J FAM PRACTICE, V51, P984; Wilson SH, 2001, DRUG AGING, V18, P325, DOI 10.2165/00002512-200118050-00003	23	56	58	0	10	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 2	2003	327	7409					266	269		10.1136/bmj.327.7409.266	http://dx.doi.org/10.1136/bmj.327.7409.266			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708KP	12896940	Green Published, Bronze			2022-12-28	WOS:000184566300021
J	Yang, JC; Haworth, L; Sherry, RM; Hwu, P; Schwartzentruber, DJ; Topalian, SL; Steinberg, SM; Chen, HX; Rosenberg, SA				Yang, JC; Haworth, L; Sherry, RM; Hwu, P; Schwartzentruber, DJ; Topalian, SL; Steinberg, SM; Chen, HX; Rosenberg, SA			A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TUMOR-SUPPRESSOR GENE; HYPOXIA-INDUCIBLE FACTORS; EMBRYONIC LETHALITY; ANGIOGENESIS; CARCINOMA; EXPRESSION; INHIBITION; PRODUCT; PROTEIN; THERAPY	BACKGROUND: Mutations in the tumor-suppressor gene VHL cause oversecretion of vascular endothelial growth factor by clear-cell renal carcinomas. We conducted a clinical trial to evaluate bevacizumab, a neutralizing antibody against vascular endothelial growth factor, in patients with metastatic renal-cell carcinoma. METHODS: A randomized, double-blind, phase 2 trial was conducted comparing placebo with bevacizumab at doses of 3 and 10 mg per kilogram of body weight, given every two weeks; the time to progression of disease and the response rate were primary end points. Crossover from placebo to antibody treatment was allowed, and survival was a secondary end point. RESULTS: Minimal toxic effects were seen, with hypertension and asymptomatic proteinuria predominating. The trial was stopped after the interim analysis met the criteria for early stopping. With 116 patients randomly assigned to treatment groups (40 to placebo, 37 to low-dose antibody, and 39 to high-dose antibody), there was a significant prolongation of the time to progression of disease in the high-dose-antibody group as compared with the placebo group (hazard ratio, 2.55; P<0.001). There was a small difference, of borderline significance, between the time to progression of disease in the low-dose-antibody group and that in the placebo group (hazard ratio, 1.26; P=0.053). The probability of being progression-free for patients given high-dose antibody, low-dose-antibody, and placebo was 64 percent, 39 percent, and 20 percent, respectively, at four months and 30 percent, 14 percent, and 5 percent at eight months. At the last analysis, there were no significant differences in overall survival between groups (P>0.20 for all comparisons). CONCLUSIONS: Bevacizumab can significantly prolong the time to progression of disease in patients with metastatic renal-cell cancer.	NCI, Surg Branch, NIH, Bethesda, MD 20892 USA; NCI, Biostat & Data Management Sect, NIH, Bethesda, MD 20892 USA; NCI, Canc Therapy Evaluat Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yang, JC (corresponding author), NCI, Surg Branch, NIH, Rm 2B-37,Bldg 10,9000 Rockville Pike, Bethesda, MD 20892 USA.	james_yang@nih.gov	Toon, Christopher W/G-3610-2012		Intramural NIH HHS [Z01 SC003811-32] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01SC003811] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Borgstrom P, 1998, PROSTATE, V35, P1; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; Gnarra JR, 1996, BBA-REV CANCER, V1242, P201, DOI 10.1016/0304-419X(95)00012-5; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Gnarra JR, 1997, P NATL ACAD SCI USA, V94, P9102, DOI 10.1073/pnas.94.17.9102; Gnarra JR, 1996, P NATL ACAD SCI USA, V93, P10589, DOI 10.1073/pnas.93.20.10589; Gordon MS, 2001, J CLIN ONCOL, V19, P843, DOI 10.1200/JCO.2001.19.3.843; Haigh JJ, 2000, DEVELOPMENT, V127, P1445; Hanada K, 2001, CANCER RES, V61, P5511; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mukhopadhyay D, 1997, MOL CELL BIOL, V17, P5629, DOI 10.1128/MCB.17.9.5629; Mundhenke C, 2001, CLIN CANCER RES, V7, P3366; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Presta LG, 1997, CANCER RES, V57, P4593; Stadler WM, 1999, J CLIN ONCOL, V17, P2541, DOI 10.1200/JCO.1999.17.8.2541; Turner KJ, 2002, CANCER RES, V62, P2957	19	2185	2305	2	138	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2003	349	5					427	434		10.1056/NEJMoa021491	http://dx.doi.org/10.1056/NEJMoa021491			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706FV	12890841	Green Accepted			2022-12-28	WOS:000184443700004
J	Taylor, HR; Dax, EM				Taylor, HR; Dax, EM			New precision in measuring trachoma infection	LANCET			English	Editorial Material									Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic 3002, Australia; Natl Serol Reference Lab, Fitzroy, Vic, Australia	Centre for Eye Research Australia; University of Melbourne	Taylor, HR (corresponding author), Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic 3002, Australia.			Taylor, Hugh/0000-0002-9437-784X				BOBO L, 1991, LANCET, V338, P847, DOI 10.1016/0140-6736(91)91502-L; BOLT J, 2004, TRACHOMA; GRAYSTON JT, 1985, REV INFECT DIS, V7, P717; Halberstaedter L., 1907, DTSCH MED WECHENSCHR, V33, P1285; T'ang F- F, 1957, NATL MED J CHINA, V43, P81; TAYLOR HR, 1989, INVEST OPHTH VIS SCI, V30, P1823; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P447; WHO, 1997, FUT APPR TRACH CONTR	8	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 19	2003	362	9379					181	182		10.1016/S0140-6736(03)13949-9	http://dx.doi.org/10.1016/S0140-6736(03)13949-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702PJ	12885474				2022-12-28	WOS:000184232000003
J	Li, Y; Brown, JH; Reshetnikova, L; Blazsek, A; Farkas, L; Nyitray, L; Cohen, C				Li, Y; Brown, JH; Reshetnikova, L; Blazsek, A; Farkas, L; Nyitray, L; Cohen, C			Visualization of an unstable coiled coil from the scallop myosin rod	NATURE			English	Article							SMOOTH-MUSCLE MYOSIN; JUNCTION; DESIGN; STABILITY; FEATURES; CALCIUM; BINDING; DOMAIN; MODEL	alpha-Helical coiled coils in muscle exemplify simplicity and economy of protein design: small variations in sequence lead to remarkable diversity in cellular functions(1,2). Myosin II is the key protein in muscle contraction, and the molecule's two-chain alpha-helical coiled-coil rod region-towards the carboxy terminus of the heavy chain-has unusual structural and dynamic features. The amino-terminal subfragment-2 (S2) domains of the rods can swing out from the thick filament backbone at a hinge in the coiled coil, allowing the two myosin 'heads' and their motor domains to interact with actin and generate tension(3). Most of the S2 rod appears to be a flexible coiled coil, but studies suggest that the structure at the N-terminal region is unstable(4-6), and unwinding or bending of the alpha-helices near the head-rod junction seems necessary for many of myosin's functional properties(7,8). Here we show the physical basis of a particularly weak coiled-coil segment by determining the 2.5-Angstrom-resolution crystal structure of a leucine-zipper-stabilized fragment of the scallop striated-muscle myosin rod adjacent to the head-rod junction. The N-terminal 14 residues are poorly ordered; the rest of the S2 segment forms a flexible coiled coil with poorly packed core residues. The unusual absence of inter-helical salt bridges here exposes apolar core atoms to solvent.	Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; Brandeis Univ, Biophys & Struct Biol Program, Waltham, MA 02454 USA; Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary	Brandeis University; Brandeis University; Eotvos Lorand University	Cohen, C (corresponding author), Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA.	ccohen@brandeis.edu	Nyitray, László/AAE-5910-2020	Nyitray, László/0000-0003-4717-5994				ADELSTEIN RS, 1980, ANNU REV BIOCHEM, V49, P921, DOI 10.1146/annurev.bi.49.070180.004421; Arndt KM, 2002, STRUCTURE, V10, P1235, DOI 10.1016/S0969-2126(02)00838-9; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brown JH, 2001, P NATL ACAD SCI USA, V98, P8496, DOI 10.1073/pnas.131219198; Burgess S, 2002, BIOPHYS J, V82, p356A; Burkhard P, 2000, STRUCTURE, V8, P223, DOI 10.1016/S0969-2126(00)00100-3; Burkhard P, 2002, J MOL BIOL, V318, P901, DOI 10.1016/S0022-2836(02)00114-6; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Buss F, 2001, FEBS LETT, V508, P295, DOI 10.1016/S0014-5793(01)03065-4; Chakrabarty T, 2002, P NATL ACAD SCI USA, V99, P6011, DOI 10.1073/pnas.082024299; COHEN C, 1990, PROTEINS, V7, P1, DOI 10.1002/prot.340070102; CONWAY JF, 1990, INT J BIOL MACROMOL, V12, P328, DOI 10.1016/0141-8130(90)90023-4; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; Kammerer RA, 1998, P NATL ACAD SCI USA, V95, P13419, DOI 10.1073/pnas.95.23.13419; Knight PJ, 1996, J MOL BIOL, V255, P269, DOI 10.1006/jmbi.1996.0022; Lauzon AM, 2001, BIOPHYS J, V80, P1900, DOI 10.1016/S0006-3495(01)76159-0; Li Y, 2002, P NATL ACAD SCI USA, V99, P7378, DOI 10.1073/pnas.102179999; Liu J, 2003, J MOL BIOL, V329, P963, DOI 10.1016/S0022-2836(03)00516-3; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Malnasi-Csizmadia A, 1998, BIOCHEM BIOPH RES CO, V252, P595, DOI 10.1006/bbrc.1998.9603; MCLACHLAN AD, 1975, J MOL BIOL, V98, P293, DOI 10.1016/S0022-2836(75)80119-7; MCLACHLAN AD, 1983, J MOL BIOL, V164, P605, DOI 10.1016/0022-2836(83)90053-0; Meier M, 2002, J STRUCT BIOL, V137, P65, DOI 10.1006/jsbi.2002.4467; Nyitrai M, 2002, BIOCHEM J, V365, P19, DOI 10.1042/BJ20020099; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Stafford WF, 2001, J MOL BIOL, V307, P137, DOI 10.1006/jmbi.2000.4490; Tomishige M, 2000, J CELL BIOL, V151, P1081, DOI 10.1083/jcb.151.5.1081; TRYBUS KM, 1994, J BIOL CHEM, V269, P20819; WOOLFSON DN, 1995, PROTEIN SCI, V4, P1596, DOI 10.1002/pro.5560040818	31	72	72	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2003	424	6946					341	345		10.1038/nature01801	http://dx.doi.org/10.1038/nature01801			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867988				2022-12-28	WOS:000184183900049
J	Yoshida, T; Jones, LE; Ellner, SP; Fussmann, GF; Hairston, NG				Yoshida, T; Jones, LE; Ellner, SP; Fussmann, GF; Hairston, NG			Rapid evolution drives ecological dynamics in a predator-prey system	NATURE			English	Article							CYCLES	Ecological and evolutionary dynamics can occur on similar timescales(1-7). However, theoretical predictions of how rapid evolution can affect ecological dynamics(8) are inconclusive and often depend on untested model assumptions(8). Here we report that rapid prey evolution in response to oscillating predator density affects predator-prey (rotifer-algal) cycles in laboratory microcosms. Our experiments tested explicit predictions from a model for our system that allows prey evolution(9). We verified the predicted existence of an evolutionary tradeoff between algal competitive ability and defence against consumption, and examined its effects on cycle dynamics by manipulating the evolutionary potential of the prey population. Single-clone algal cultures (lacking genetic variability) produced short cycle periods and typical quarter-period phase lags between prey and predator densities, whereas multi-clonal (genetically variable) algal cultures produced long cycles with prey and predator densities nearly out of phase, exactly as predicted. These results confirm that prey evolution can substantially alter predator-prey dynamics, and therefore that attempts to understand population oscillations in nature(10,11) cannot neglect potential effects from ongoing rapid evolution.	Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA	Cornell University	Hairston, NG (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.	NGH1@cornell.edu	Yoshida, Takehito/ABB-2490-2020; Yoshida, Takehito/O-9983-2014	Yoshida, Takehito/0000-0001-9178-3634; Yoshida, Takehito/0000-0001-9178-3634; Fussmann, Gregor/0000-0001-9576-0122				Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Berryman, 2002, POPULATION CYCLES CA, DOI 10.1093/oso/9780195140989.001.0001; Bohannan BJM, 2000, ECOL LETT, V3, P362, DOI 10.1046/j.1461-0248.2000.00161.x; Fussmann GF, 2000, SCIENCE, V290, P1358, DOI 10.1126/science.290.5495.1358; Hairston NG, 1999, NATURE, V401, P446, DOI 10.1038/46731; HALBACH U, 1974, ARCH HYDROBIOL, V73, P273; Hendry AP, 2000, SCIENCE, V290, P516, DOI 10.1126/science.290.5491.516; Hillborn R., 1997, ECOLOGICAL DETECTIVE; Huey RB, 2000, SCIENCE, V287, P308, DOI 10.1126/science.287.5451.308; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Kendall BE, 1999, ECOLOGY, V80, P1789, DOI 10.1890/0012-9658(1999)080[1789:WDPCAS]2.0.CO;2; Lambin X, 2002, POPULATION CYCLES: THE CASE FOR TROPHIC INTERACTIONS, P155; McCauley E, 1999, NATURE, V402, P653, DOI 10.1038/45223; MONOD J, 1950, ANN I PASTEUR PARIS, V79, P390; Palumbi Stephen R., 2001, EVOLUTION EXPLOSION; Pickett-Heaps J. D., 1975, GREEN ALGAE STRUCTUR; Rothhaupt KO, 1995, LIMNOL OCEANOGR, V40, P1201, DOI 10.4319/lo.1995.40.7.1201; Shertzer KW, 2002, J ANIM ECOL, V71, P802, DOI 10.1046/j.1365-2656.2002.00645.x; Sinervo B, 2000, NATURE, V406, P985, DOI 10.1038/35023149; Thompson JN, 2001, BIOSCIENCE, V51, P15, DOI 10.1641/0006-3568(2001)051[0015:FOE]2.0.CO;2; Tollrian R, 1999, ECOLOGY EVOLUTION IN; TURCHIN P, IN PRESS ECOLOGY; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; Vermeij G.J., 1987, EVOLUTION ESCALATION; VERMEIJ GJ, 1994, ANNU REV ECOL SYST, V25, P219, DOI 10.1146/annurev.es.25.110194.001251	25	740	749	7	406	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 17	2003	424	6946					303	306		10.1038/nature01767	http://dx.doi.org/10.1038/nature01767			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867979				2022-12-28	WOS:000184183900039
J	Periana, RA; Mironov, O; Taube, D; Bhalla, G; Jones, CJ				Periana, RA; Mironov, O; Taube, D; Bhalla, G; Jones, CJ			Catalytic, oxidative condensation of CH4 to CH3COOH in one step via CH activation	SCIENCE			English	Article							ACETIC-ACID; CARBON-HYDROGEN; METHANESULFONIC-ACID; METHANE; CONVERSION; CO; FUNCTIONALIZATION; SULFONATION; ETHANE	Acetic acid is an important petrochemical that is currently produced from methane ( or coal) in a three-step process based on carbonylation of methanol. We report a direct, selective, oxidative condensation of two methane molecules to acetic acid at 180 degreesC in liquid sulfuric acid. Carbon-13 isotopic labeling studies show that both carbons of acetic acid originate from methane. The reaction is catalyzed by palladium, and the results are consistent with the reaction occurring by tandem catalysis, involving methane C-H activation to generate Pd-CH3 species, followed by efficient oxidative carbonylation with methanol, generated in situ from methane, to produce acetic acid.	Univ So Calif, Dept Chem, Loker Hydrocarbon Inst, Los Angeles, CA 90089 USA	University of Southern California	Periana, RA (corresponding author), Univ So Calif, Dept Chem, Loker Hydrocarbon Inst, Los Angeles, CA 90089 USA.	rperiana@usc.edu						Arakawa H, 2001, CHEM REV, V101, P953, DOI 10.1021/cr000018s; ARNDTSEN BA, 1995, ACCOUNTS CHEM RES, V28, P154, DOI 10.1021/ar00051a009; CRABTREE RH, 1995, CHEM REV, V95, P987, DOI 10.1021/cr00036a005; de Rege PJE, 2002, ADV SYNTH CATAL, V344, P1059, DOI 10.1002/1615-4169(200212)344:10<1059::AID-ADSC1059>3.0.CO;2-O; DEROUANE EG, 1997, NATO ASI SERIES; Hill C. L., 1989, ACTIVATION FUNCTIONA; Jia CG, 2001, ACCOUNTS CHEM RES, V34, P633, DOI 10.1021/ar000209h; Jones WD, 2000, SCIENCE, V287, P1942, DOI 10.1126/science.287.5460.1942; Kakiuchi F., 1999, TOPICS ORGANOMETALLI, V3, P47, DOI DOI 10.1007/3-540-68525-1-3; Labinger JA, 2002, NATURE, V417, P507, DOI 10.1038/417507a; LIN M, 1994, NATURE, V368, P613, DOI 10.1038/368613a0; Linke D, 2002, J CATAL, V205, P32, DOI 10.1006/jcat.2001.3368; Lunsford JH, 2000, CATAL TODAY, V63, P165, DOI 10.1016/S0920-5861(00)00456-9; Muehlhofer M, 2002, ANGEW CHEM INT EDIT, V41, P1745, DOI 10.1002/1521-3773(20020517)41:10<1745::AID-ANIE1745>3.0.CO;2-E; Mukhopadhyay S, 2003, J AM CHEM SOC, V125, P4406, DOI 10.1021/ja0281737; Mukhopadhyay S, 2003, CHEM COMMUN, P1590, DOI 10.1039/b303561a; Mukhopadhyay S, 2003, ANGEW CHEM INT EDIT, V42, P1019, DOI 10.1002/anie.200390260; Nizova GV, 1998, CHEM COMMUN, P1885, DOI 10.1039/a804699i; Olah G.A., 1995, HYDROCARBON CHEM; Periana RA, 2002, CHEM COMMUN, P2376, DOI 10.1039/b205366g; Periana RA, 1998, SCIENCE, V280, P560, DOI 10.1126/science.280.5363.560; PERIANA RA, 1993, SCIENCE, V259, P340, DOI 10.1126/science.259.5093.340; Reis PM, 2003, ANGEW CHEM INT EDIT, V42, P821, DOI 10.1002/anie.200390219; Sen A, 1998, ACCOUNTS CHEM RES, V31, P550, DOI 10.1021/ar970290x; Shibamoto A, 2002, TETRAHEDRON LETT, V43, P8859, DOI 10.1016/S0040-4039(02)02208-6; Shilov AE, 1997, CHEM REV, V97, P2879, DOI 10.1021/cr9411886; Wolf E. E., 1992, METHANE CONVERSION O	27	322	341	11	336	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2003	301	5634					814	818		10.1126/science.1086466	http://dx.doi.org/10.1126/science.1086466			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	709FT	12907796				2022-12-28	WOS:000184615700039
J	Clayton, EW				Clayton, EW			Ethical, legal, and social implications of genomic medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HEALTH-INSURANCE PORTABILITY; GENETIC DISCRIMINATION; ACCOUNTABILITY ACT; INFORMATION; PRIVACY		Vanderbilt Univ, Ctr Genet & Hlth Policy, Nashville, TN 37232 USA	Vanderbilt University	Clayton, EW (corresponding author), Vanderbilt Univ, Ctr Genet & Hlth Policy, 507A Light Hall, Nashville, TN 37232 USA.			Clayton, Ellen/0000-0002-0308-4110	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001974] Funding Source: NIH RePORTER; NHGRI NIH HHS [5R01 HG 01974-02] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Bernstein T, 1994, RADON RENTAL HOUSING; CALVO C, 2001, NAT C STAT LEG SEPT; *CDCP, TRANSL ADV HUM GEN P; Chance PF, 1999, ANN NY ACAD SCI, V883, P14, DOI 10.1111/j.1749-6632.1999.tb08562.x; Clayton E W, 1998, J Health Care Law Policy, V1, P373; Fleisher LD, 2001, GENET MED, V3, P286, DOI 10.1097/00125817-200107000-00003; Gostin LO, 2001, JAMA-J AM MED ASSOC, V285, P3015, DOI 10.1001/jama.285.23.3015; Hall MA, 2000, GENET MED, V2, P214, DOI 10.1097/00125817-200007000-00003; *HLTH PRIV PROJ, STAT HLTH PRIV UN TE; Holtzman NA., 1998, PROMOTING SAFE EFFEC; HUDSON KL, 1995, SCIENCE, V270, P391, DOI 10.1126/science.270.5235.391; Khoury MJ, 2003, NEW ENGL J MED, V348, P50, DOI 10.1056/NEJMra013182; Knoppers BM, 1998, AM J HUM GENET, V62, P474; Lapham EV, 1996, SCIENCE, V274, P621, DOI 10.1126/science.274.5287.621; LEWIN T, 2001, NY TIMES        0210, pA7; Pokorski RJ, 1997, AM J HUM GENET, V60, P205; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1983, SCREEN COUNS GEN CON; Rothstein MA, 2001, GENET MED, V3, P354, DOI 10.1097/00125817-200109000-00005; *SECR ADV COMM GEN, ENH OV GEN TESTS REC; Silvers A, 2002, VANDERBILT LAW REV, V55, P1341; Welch CA, 2001, NEW ENGL J MED, V345, P371, DOI 10.1056/NEJM200108023450512; 2002, GENETIC INFORMATION; 2001, NY TIMES        0419, pC4; 1998, WALL STREET J   0312, pB8	24	201	206	2	19	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2003	349	6					562	569		10.1056/NEJMra012577	http://dx.doi.org/10.1056/NEJMra012577			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708JL	12904522				2022-12-28	WOS:000184563500009
J	Galli, C; Lagutina, I; Crotti, G; Colleoni, S; Turini, P; Ponderato, N; Duchi, R; Lazzari, G				Galli, C; Lagutina, I; Crotti, G; Colleoni, S; Turini, P; Ponderato, N; Duchi, R; Lazzari, G			A cloned horse born to its dam twin - A birth announcement calls for a rethink on the immunological demands of pregnancy.	NATURE			English	Editorial Material									CIZ Srl, Ist Sperimentale Italiano Lazzaro Spallanzani, Lab Tecnol Riproduz, I-26100 Cremona, Italy	IRCCS Lazzaro Spallanzani	Galli, C (corresponding author), CIZ Srl, Ist Sperimentale Italiano Lazzaro Spallanzani, Lab Tecnol Riproduz, I-26100 Cremona, Italy.		王, 士勇/B-5170-2012					[Anonymous], 2003, CLONING STEM CELLS, V5, P1, DOI 10.1089/153623003321512102; Galli C, 2002, THERIOGENOLOGY, V58, P705; Lagutina I., 2003, Theriogenology, V59, P269; Lazzari G, 2002, J REPROD FERTIL ABST, V28, P73; Szekeres-Bartho Julia, 2002, Int Rev Immunol, V21, P471, DOI 10.1080/08830180215017; WOODS GL, 2003, SCIENCE	6	312	370	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					635	635		10.1038/424635a	http://dx.doi.org/10.1038/424635a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904778				2022-12-28	WOS:000184578800030
J	Hodis, HN; Mack, WJ; Azen, SP; Lobo, RA; Shoupe, D; Mahrer, PR; Faxon, DP; Cashin-Hemphill, L; Sanmarco, ME; French, WJ; Shook, TL; Gaarder, TD; Mehra, AO; Rabbani, R; Sevanian, A; Shil, AB; Torres, M; Vogelbach, KH; Selzer, RH; Hodis, HN; Azen, SP; Faxon, DP; Lobo, RA; Mack, WJ; Charlson, M; Gesselman, C; Morales, T; Torres, M; Watcher, F; Zurbrugg, L; Faxon, DP; Mehra, AO; Rabbani, R; Agra, B; Coria, I; Ee, J; Johnson, S; Reyes, L; Stolicky, C; Mahrer, PR; Aharonian, VJ; Browning, RA; Jackimowicz, P; Scutella, PJ; Velasco, A; Williams, C; French, WJ; Shook, TL; Matthews, RV; Vogelbach, KH; Ujiiye, DL; Selzer, RH; Shil, AB; Shircore, A; Mack, WJ; Azen, SP; Ying-Lai, M; Morales, O; Xiang, M; Sevanian, A; Hwang, J; Bolusan, O; Ramirez, A; Cashin-Hemphill, L; Sanmarco, ME; Faxon, DP; French, WJ; Gaarder, TD; Mahrer, PR; Mehra, AO; Rabbani, R; Shook, TL; Mezrow, G; Shoupe, D; Stanczyk, FZ; Felix, JC; Parisky, Y; Brown, BG; Chaudhuri, G; Malloy, M; Odom-Maryon, T; Wilson-Ross, J; Gordon, DJ				Hodis, HN; Mack, WJ; Azen, SP; Lobo, RA; Shoupe, D; Mahrer, PR; Faxon, DP; Cashin-Hemphill, L; Sanmarco, ME; French, WJ; Shook, TL; Gaarder, TD; Mehra, AO; Rabbani, R; Sevanian, A; Shil, AB; Torres, M; Vogelbach, KH; Selzer, RH; Hodis, HN; Azen, SP; Faxon, DP; Lobo, RA; Mack, WJ; Charlson, M; Gesselman, C; Morales, T; Torres, M; Watcher, F; Zurbrugg, L; Faxon, DP; Mehra, AO; Rabbani, R; Agra, B; Coria, I; Ee, J; Johnson, S; Reyes, L; Stolicky, C; Mahrer, PR; Aharonian, VJ; Browning, RA; Jackimowicz, P; Scutella, PJ; Velasco, A; Williams, C; French, WJ; Shook, TL; Matthews, RV; Vogelbach, KH; Ujiiye, DL; Selzer, RH; Shil, AB; Shircore, A; Mack, WJ; Azen, SP; Ying-Lai, M; Morales, O; Xiang, M; Sevanian, A; Hwang, J; Bolusan, O; Ramirez, A; Cashin-Hemphill, L; Sanmarco, ME; Faxon, DP; French, WJ; Gaarder, TD; Mahrer, PR; Mehra, AO; Rabbani, R; Shook, TL; Mezrow, G; Shoupe, D; Stanczyk, FZ; Felix, JC; Parisky, Y; Brown, BG; Chaudhuri, G; Malloy, M; Odom-Maryon, T; Wilson-Ross, J; Gordon, DJ		WELL-HART Res Grp	Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ESTROGEN PLUS PROGESTIN; CONJUGATED EQUINE ESTROGENS; COLESTIPOL-NIACIN THERAPY; REPLACEMENT THERAPY; HEART-DISEASE; PREVENTION; REGRESSION; RECEPTOR; EVENTS; STATIN	BACKGROUND: In postmenopausal women with coronary artery disease, conjugated equine estrogen with or without continuous administration of medroxyprogesterone acetate has failed to slow the progression of atherosclerosis. Whether 17(beta)-estradiol (the endogenous estrogen molecule) alone or administered sequentially with medroxyprogesterone acetate can slow the progression of atherosclerosis is unknown. METHODS: We conducted a double-blind, placebo-controlled trial in 226 postmenopausal women (mean age, 63.5 years) who had at least one coronary-artery lesion. Participants were randomly assigned to usual care (control group), estrogen therapy with micronized 17(beta)-estradiol alone (estrogen group), or 17(beta)-estradiol plus sequentially administered medroxyprogesterone acetate (estrogen-progestin group). In all patients the low-density lipoprotein (LDL) cholesterol level was reduced to a target of less than 130 mg per deciliter. The primary outcome was the average per-participant change between base-line and follow-up coronary angiograms in the percent stenosis measured by quantitative coronary angiography. RESULTS: After a median of 3.3 years of follow-up, the mean (+/-SE) change in the percent stenosis in the 169 participants who had a pair of matched angiograms was 1.89+/-0.78 percentage points in the control group, 2.18+/-0.76 in the estrogen group, and 1.24+/-0.80 in the estrogen-progestin group (P=0.66 for the comparison among the three groups). The mean difference in the percent stenosis between the estrogen group and the control group was 0.29 percentage point (95 percent confidence interval, -1.88 to 2.46), and the mean difference between the estrogen-progestin group and the control group was -0.65 (95 percent confidence interval, -2.87 to 1.57). CONCLUSIONS: In older postmenopausal women with established coronary-artery atherosclerosis, 17(beta)-estradiol either alone or with sequentially administered medroxyprogesterone acetate had no significant effect on the progression of atherosclerosis.	Univ So Calif, Keck Sch Med, Atherosclerosis Res Unit, Los Angeles, CA 90033 USA; Univ So Calif, Dept Prevent Med, Los Angeles, CA 90033 USA; Univ So Calif, Dept Mol Pharmacol & Toxicol, Sch Pharm, Los Angeles, CA 90033 USA; Univ So Calif, Dept Obstet & Gynecol, Los Angeles, CA 90033 USA; Univ So Calif, Div Cardiovasc Med, Los Angeles, CA 90033 USA; Columbia Univ Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10032 USA; Kaiser Permanente Med Ctr, Los Angeles, CA 90034 USA; Univ Chicago, Div Cardiol, Chicago, IL USA; Boston Heart Fdn, Boston, MA USA; Lakewood Reg Med Ctr, Lakewood, CA USA; Univ Calif Los Angeles, Harbor Med Ctr, Div Cardiol, Torrance, CA 90509 USA; Good Samaritan Hosp, Los Angeles, CA USA; Presbyterian Intercommunity Hosp, Whittier, CA USA; So Calif Heart Specialits, Pasadena, CA USA; CALTECH, Jet Prop Lab, Pasadena, CA USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; Columbia University; Kaiser Permanente; University of Chicago; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Hodis, HN (corresponding author), Univ So Calif, Keck Sch Med, Atherosclerosis Res Unit, 2250 Alcazar St,CSC132, Los Angeles, CA 90033 USA.	watcher@usc.edu			NHLBI NIH HHS [U01-HL-49298] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL049298] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams MR, 1997, ARTERIOSCL THROM VAS, V17, P217, DOI 10.1161/01.ATV.17.1.217; Angerer P, 2001, ARTERIOSCL THROM VAS, V21, P262, DOI 10.1161/01.ATV.21.2.262; AZEN SP, 1991, ARTERIOSCLER THROMB, V11, P385, DOI 10.1161/01.ATV.11.2.385; Azen SP, 1996, CIRCULATION, V93, P34, DOI 10.1161/01.CIR.93.1.34; BLANKENHORN DH, 1993, ANN INTERN MED, V119, P969, DOI 10.7326/0003-4819-119-10-199311150-00002; BLANKENHORN DH, 1992, CIRCULATION, V86, P1701, DOI 10.1161/01.CIR.86.6.1701; BLANKENHORN DH, 1987, JAMA-J AM MED ASSOC, V257, P3233, DOI 10.1001/jama.257.23.3233; BLANKENHORN DH, 1987, CONTROL CLIN TRIALS, V8, P354, DOI 10.1016/0197-2456(87)90156-5; BLANKENHORN DH, 1988, JAMA-J AM MED ASSOC, V259, P2698; Byington RP, 2002, ARTERIOSCL THROM VAS, V22, P1692, DOI 10.1161/01.ATV.0000033514.79653.04; Campisi R, 2002, CIRCULATION, V105, P425, DOI 10.1161/hc0402.102860; CASHINHEMPHILL L, 1992, ONLINE J CURR C 1023; CASHINHEMPHILL L, 1992, ONLINE J CURR C 1114; Cherry N, 2002, LANCET, V360, P2001; Clarke SC, 2002, BJOG-INT J OBSTET GY, V109, P1056, DOI 10.1111/j.1471-0528.2002.01544.x; Clarkson TB, 1998, J CLIN ENDOCR METAB, V83, P721, DOI 10.1210/jc.83.3.721; Clarkson TB, 2001, J CLIN ENDOCR METAB, V86, P41, DOI 10.1210/jc.86.1.41; ESPELAND MA, 1995, AM J EPIDEMIOL, V142, P1011, DOI 10.1093/oxfordjournals.aje.a117553; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; GRODSTEIN F, 1995, PROG CARDIOVASC DIS, V38, P199, DOI 10.1016/S0033-0620(95)80012-3; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; Herrington DM, 2002, CIRCULATION, V105, P2962, DOI 10.1161/01.CIR.0000019406.74017.B2; Hodis HN, 2001, ANN INTERN MED, V135, P939, DOI 10.7326/0003-4819-135-11-200112040-00005; Hodis Howard N, 2003, Curr Atheroscler Rep, V5, P56, DOI 10.1007/s11883-003-0069-z; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; *LIP RES CLIN PROG, 1974, DHEW PUBL NIH; LOSORDO DW, 1994, CIRCULATION, V89, P1501, DOI 10.1161/01.CIR.89.4.1501; Luan ZX, 2003, ARTERIOSCL THROM VAS, V23, P769, DOI 10.1161/01.ATV.0000068646.76823.AE; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; Post WS, 1999, CARDIOVASC RES, V43, P985, DOI 10.1016/S0008-6363(99)00153-4; Rosenfeld ME, 2002, ATHEROSCLEROSIS, V164, P251, DOI 10.1016/S0021-9150(02)00178-8; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; SELZER RH, 1989, J CLIN INVEST, V83, P520, DOI 10.1172/JCI113913; Son JW, 2003, INT J CARDIOL, V88, P77, DOI 10.1016/S0167-5273(02)00368-6; Viscoli CM, 2001, NEW ENGL J MED, V345, P1243, DOI 10.1056/NEJMoa010534; Waters DD, 2002, JAMA-J AM MED ASSOC, V288, P2432, DOI 10.1001/jama.288.19.2432; WEI LJ, 1977, J AM STAT ASSOC, V72, P382, DOI 10.2307/2286803; WILLIAMS JK, 1995, ARTERIOSCL THROM VAS, V15, P827, DOI 10.1161/01.ATV.15.7.827; *WRIT GROUP PEPI T, 1995, JAMA-J AM MED ASSOC, V274, P1676; Zanger D, 2000, J AM COLL CARDIOL, V36, P1797, DOI 10.1016/S0735-1097(00)00952-9	40	282	288	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2003	349	6					535	545		10.1056/NEJMoa030830	http://dx.doi.org/10.1056/NEJMoa030830			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708JL	12904518				2022-12-28	WOS:000184563500004
J	Ono, M; Terabe, H; Hori, H; Sasaki, M				Ono, M; Terabe, H; Hori, H; Sasaki, M			Components of giant hornet alarm pheromone	NATURE			English	Editorial Material							VOLATILES		Tamagawa Univ, Res Inst, Ctr Excellence Integrat Human Sci Program, Tokyo 1948610, Japan; Tamagawa Univ, Grad Sch Agr, Tokyo 1948610, Japan; Tamagawa Univ, Dept Appl Biol Chem, Tokyo 1948610, Japan		Ono, M (corresponding author), Tamagawa Univ, Res Inst, Ctr Excellence Integrat Human Sci Program, Tokyo 1948610, Japan.							Dani FR, 2000, PHYSIOL ENTOMOL, V25, P363, DOI 10.1046/j.1365-3032.2000.00205.x; HEATH RR, 1988, EXPERIENTIA, V44, P82, DOI 10.1007/BF01960257; ONO M, 1995, NATURE, V377, P334, DOI 10.1038/377334a0; Ono M., 1997, SCI JAPANESE HORNETS; Rossiter K. J., 1996, PERFUM FLAVOR, V21, P33; SHIOTA H, 1993, J AGR FOOD CHEM, V41, P2056, DOI 10.1021/jf00035a046; VEITH HJ, 1984, NATURWISSENSCHAFTEN, V71, P328, DOI 10.1007/BF00396622	7	68	71	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					637	638		10.1038/424637a	http://dx.doi.org/10.1038/424637a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904781				2022-12-28	WOS:000184578800033
J	Brenton, JD; Caldas, C				Brenton, JD; Caldas, C			Predictive cancer genomics - what do we need?	LANCET			English	Editorial Material							BREAST-CANCER; NEOADJUVANT CHEMOTHERAPY		Univ Cambridge, Dept Oncol, Canc Genom Program, Hutchison MRC Res Ctr, Cambridge CB2 2XZ, England	University of Cambridge	Brenton, JD (corresponding author), Univ Cambridge, Dept Oncol, Canc Genom Program, Hutchison MRC Res Ctr, Cambridge CB2 2XZ, England.		Caldas, Carlos/U-7250-2019; Brenton, James D/B-3174-2008; Caldas, Carlos/A-7543-2008	Caldas, Carlos/0000-0003-3547-1489; Brenton, James D/0000-0002-5738-6683; 				Ball CA, 2002, LANCET, V360, P1019, DOI 10.1016/S0140-6736(02)11100-7; BONADONNA G, 1990, J NATL CANCER I, V82, P1539, DOI 10.1093/jnci/82.19.1539; Chollet P, 2002, BRIT J CANCER, V86, P1041, DOI 10.1038/sj/bjc/6600210; Cocquyt VF, 2003, EUR J SURG ONCOL, V29, P361, DOI 10.1053/ejso.2002.1404; Faneyte IF, 2003, BRIT J CANCER, V88, P406, DOI 10.1038/sj.bjc.6600749; Kuerer HM, 1999, J CLIN ONCOL, V17, P460, DOI 10.1200/JCO.1999.17.2.460; *NAT CANC I, CACORE NCICB CANC IN; *NCBI, GEN EXP OMN; Petricoin EF, 2002, NAT GENET, V32, P474, DOI 10.1038/ng1029; SMITH IE, 1993, EUR J CANCER, V29A, P1796, DOI 10.1016/0959-8049(93)90133-Z	10	17	17	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 2	2003	362	9381					340	341		10.1016/S0140-6736(03)14053-6	http://dx.doi.org/10.1016/S0140-6736(03)14053-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707FB	12907001				2022-12-28	WOS:000184498700002
J	Onwuteaka-Philipsen, BD; van der Heide, A; Koper, D; Keij-Deerenberg, I; Rietjens, JAC; Rurup, ML; Vrakking, AM; Georges, JJ; Muller, MT; van der Wal, G; van der Maas, PJ				Onwuteaka-Philipsen, BD; van der Heide, A; Koper, D; Keij-Deerenberg, I; Rietjens, JAC; Rurup, ML; Vrakking, AM; Georges, JJ; Muller, MT; van der Wal, G; van der Maas, PJ			Euthanasia and other end-of-life decisions in the Netherlands in 1990, 1995, and 2001	LANCET			English	Article							PHYSICIAN-ASSISTED SUICIDE	Empirical data on the rate of euthanasia, physician-assisted suicide, and other end-of-life decisions have greatly contributed to the debate about the role of such practices in modern health care. In the Netherlands, the continuing debate about whether and when physician-assisted dying is acceptable seems to be resulting in a gradual stabilisation of end-of-life practices. We replicated interview and death-certificate studies done in 1990 and 1995 to investigate whether end-of-life practices had altered between 1995 and 2001. Since 1995, the demand for physician-assisted death has not risen among patients and physicians, who seem to have become somewhat more reluctant in their attitude towards this practice.	Free Univ Amsterdam, Med Ctr, Dept Social Med, NL-1081 BT Amsterdam, Netherlands; Free Univ Amsterdam, Med Ctr, Inst Res Extramural Med, NL-1081 BT Amsterdam, Netherlands; Univ Med Ctr Rotterdam, Erasmus Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; Stat Netherlands, Voorburg, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC	Onwuteaka-Philipsen, BD (corresponding author), Free Univ Amsterdam, Med Ctr, Dept Social Med, van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.							Asch DA, 1999, AM J MED, V107, P153, DOI 10.1016/S0002-9343(99)00198-9; Groenewoud JH, 2000, NEW ENGL J MED, V342, P551, DOI 10.1056/NEJM200002243420805; Groenewoud JH, 2000, ARCH INTERN MED, V160, P357, DOI 10.1001/archinte.160.3.357; Hofmann JC, 1997, ANN INTERN MED, V127, P1, DOI 10.7326/0003-4819-127-1-199707010-00001; Morita T, 2001, J PAIN SYMPTOM MANAG, V21, P282, DOI 10.1016/S0885-3924(01)00258-5; OnwuteakaPhilipsen BD, 1997, J AM GERIATR SOC, V45, P1208, DOI 10.1111/j.1532-5415.1997.tb03771.x; *ROYAL DUTCH MED A, 1995, VIS EUTH; Sepulveda C, 2002, J PAIN SYMPTOM MANAG, V24, P91, DOI 10.1016/S0885-3924(02)00440-2; Teno J, 1997, J AM GERIATR SOC, V45, P500, DOI 10.1111/j.1532-5415.1997.tb05178.x; TENO J, 2001, CLIN EPIDEMIOLOGICAL; Thorns A, 2000, LANCET, V356, P398, DOI 10.1016/S0140-6736(00)02534-4; van der Maas PJ, 1991, LANCET, V338, P669, DOI 10.1016/0140-6736(91)91241-L; van der Maas PJ, 1996, NEW ENGL J MED, V335, P1699, DOI 10.1056/NEJM199611283352227; Van Der Maas PJ, 1996, EUTHANASIA OTHER MED; VANDERMAAS PJ, 1992, HLTH POLICY, V21, P1; vanderWal G, 1996, NEW ENGL J MED, V335, P1706; VANDERWAL G, 1992, FAM PRACT, V9, P130, DOI 10.1093/fampra/9.2.130; Weiss SC, 2001, LANCET, V357, P1311, DOI 10.1016/S0140-6736(00)04515-3	18	168	169	0	12	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 2	2003	362	9381					395	399		10.1016/S0140-6736(03)14029-9	http://dx.doi.org/10.1016/S0140-6736(03)14029-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707FB	12907015				2022-12-28	WOS:000184498700023
J	Sramek, A; Kriek, M; Rosendaal, FR				Sramek, A; Kriek, M; Rosendaal, FR			Decreased mortality of ischaemic heart disease among carriers of haemophilia	LANCET			English	Article							MYOCARDIAL-INFARCTION; VENOUS THROMBOSIS; FACTOR-V; RISK; MUTATION; STROKE; GENE; WOMEN	Background Coagulation plays an important part in ischaemic cardiovascular disease. Results of studies have shown that extremes in hypocoagulability protect against ischaemic cardiovascular disease. We have investigated overall mortality and death from cardiovascular causes in carriers of haemophilia, who in most cases have mildly decreased coagulability without clinical signs. Methods We followed-up a cohort of 1012 mothers of all known people with haemophilia in the Netherlands from birth to death, or the end-of-study date (41 984 person years of follow-up). We obtained vital status and causes of death, if deceased, and compared overall and cause-specific mortality in our cohort with that in the general Dutch female population adjusted for age and calendar period by calculating the standardised mortality ratio (SMR). Findings Overall mortality was reduced by 22% (261 observed deaths, 333.74 expected; SMR 0.78 [95% CI 0.69-0.88]). Deaths from ischaemic heart disease were reduced by 36% (39 observed deaths, 60.53 expected; SMR 0.64 [0.47-0.88]). We did not note decreased mortality for cerebral stroke (ischaemic and haemorrhagic combined) (28 observed deaths, 36.82 expected; SMR 0.76 [0.53-1.10]). A separate analysis of these two types of stroke was not possible. Women in our cohort had an increased risk of death from extracranial haemorrhage (5 observed deaths, 0.18 expected; SMR 27.78 [8.49-58.18]); however, the number of deaths from this cause was much lower than that for ischaemic heart disease. Conclusion The results show that a mild decrease in coagulability has a protective effect against fatal ischaemic heart disease.	Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Haemostasis & Thrombosis Res Ctr, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Rosendaal, FR (corresponding author), Leiden Univ, Med Ctr, Dept Clin Epidemiol, C9-P,POB 9600, NL-2300 RC Leiden, Netherlands.	F.R.Rosendaal@lumc.nl	Rosendaal, Frits/Q-3842-2017	Rosendaal, Frits/0000-0003-2558-7496				ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Breslow NE., 1987, STATISTICAL METHODS, P48; BUNSCHOTEN EPM, 1988, THROMB HAEMOSTASIS, V59, P349; Doggen CJM, 1998, CIRCULATION, V97, P1037, DOI 10.1161/01.CIR.97.11.1037; HILLE ET, 1998, THESIS LEIDEN; Kadir RA, 2000, HAEMOPHILIA, V6, P33; Knobe KE, 1999, HAEMOPHILIA, V5, P238; KOSTER T, 1995, LANCET, V345, P152, DOI 10.1016/S0140-6736(95)90166-3; LUND E, 1990, J EPIDEMIOL COMMUN H, V44, P237, DOI 10.1136/jech.44.3.237; LYON MF, 1962, AM J HUM GENET, V14, P135; MEADE TW, 1986, LANCET, V2, P533, DOI 10.1016/S0140-6736(86)90111-X; MEDALIE JH, 1971, NEW ENGL J MED, V285, P1348, DOI 10.1056/NEJM197112092852404; NICHOLS TC, 1991, CIRCULATION, V83, P56; RAPAPORT SI, 1960, J CLIN INVEST, V39, P1619, DOI 10.1172/JCI104184; RIDKER PM, 1995, NEW ENGL J MED, V332, P912, DOI 10.1056/NEJM199504063321403; Ridker PM, 1999, CIRCULATION, V99, P999, DOI 10.1161/01.CIR.99.8.999; RIZZA CR, 1975, BRIT J HAEMATOL, V30, P447, DOI 10.1111/j.1365-2141.1975.tb01859.x; ROSENDAAL FR, 1990, BRIT J HAEMATOL, V75, P525, DOI 10.1111/j.1365-2141.1990.tb07793.x; ROSENDAAL FR, 1990, HUM GENET, V86, P139, DOI 10.1007/BF00197695; SMIT C, 1989, BRIT MED J, V298, P235, DOI 10.1136/bmj.298.6668.235; SMITH P, 1990, NEW ENGL J MED, V323, P147, DOI 10.1056/NEJM199007193230302; TRIEMSTRA AHM, 1995, HAEMOPHILIA, V1, P165, DOI 10.1111/j.1365-2516.1995.tb00061.x; TRIEMSTRA M, 1995, ANN INTERN MED, V123, P823, DOI 10.7326/0003-4819-123-11-199512010-00002; *WHO, 1940, MAN INT STAT CLASS D; *WHO, 1948, MAN INT STAT CLASS D; WHO (World Health Organization), 1977, MAN INT STAT CLASS D; WILHELMSEN L, 1984, NEW ENGL J MED, V311, P501, DOI 10.1056/NEJM198408233110804; World Health Organization, 1957, MAN INT STAT CLASS D; World Health Organization (WHO), 1968, MAN INT STAT CLASS D; World Health Organization (WHO), 1992, ICD10 INT STAT CLASS	30	101	105	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2003	362	9381					351	354		10.1016/S0140-6736(03)14021-4	http://dx.doi.org/10.1016/S0140-6736(03)14021-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707FB	12907007	Green Submitted			2022-12-28	WOS:000184498700007
J	Tei, S; Kitajima, N; Takahashi, K; Mishiro, S				Tei, S; Kitajima, N; Takahashi, K; Mishiro, S			Zoonotic transmission of hepatitis E virus from deer to human beings	LANCET			English	Article								Zoonosis has been suggested for hepatitis E virus (HEV) infection, but so far is based only on indirect evidence. We experienced a series of cases of HEV infection among people who had eaten uncooked deer meat 6-7 weeks before. On testing, a left over portion of the deer meat, kept frozen to eat in the future, was positive for HEV RNA, whose nucleotide sequence was identical to those from the patients. Patients' family members who ate none or very little of the deer meat remained uninfected. These findings provide direct evidence for HEV infection to be a zoonosis.	Toshiba Gen Hosp, Dept Med Sci, Shinagawa Ku, Tokyo 1408522, Japan; Kasai City Hosp, Dept Internal Med, Kasai, Hyogo, Japan	Toshiba Corporation	Mishiro, S (corresponding author), Toshiba Gen Hosp, Dept Med Sci, Shinagawa Ku, 6-3-22 Higashi Oh I, Tokyo 1408522, Japan.	shunji.mishiro@po.toshiba.co.jp		Mishiro, Shunji/0000-0001-9618-6468				MENG XJ, 2000, INFECT DIS REV, V2, P35; Schlauder GG, 1998, J GEN VIROL, V79, P447, DOI 10.1099/0022-1317-79-3-447; Schlauder GG, 1999, J MED VIROL, V57, P243, DOI 10.1002/(SICI)1096-9071(199903)57:3&lt;243::AID-JMV6&gt;3.0.CO;2-R; Takahashi K, 2002, J INFECT DIS, V185, P1342, DOI 10.1086/340023; Takahashi K, 2001, VIROLOGY, V287, P9, DOI 10.1006/viro.2001.1017	5	728	771	4	44	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2003	362	9381					371	373		10.1016/S0140-6736(03)14025-1	http://dx.doi.org/10.1016/S0140-6736(03)14025-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707FB	12907011				2022-12-28	WOS:000184498700011
J	Neuberger, J				Neuberger, J			A healthy view of dying	BRITISH MEDICAL JOURNAL			English	Article									Kings Fund, London W1G 0AN, England		Neuberger, J (corresponding author), Kings Fund, London W1G 0AN, England.							*COUNS CAR, 1995, LAST RIGHTS STUD DEA; Ellershaw J, 2003, BRIT MED J, V326, P30, DOI 10.1136/bmj.326.7379.30; Finlay I, 2003, CLIN MED, V3, P102, DOI 10.7861/clinmedicine.3-2-102; HIGGINSON IJ, 2002, PALLIATIVE CARE PROG; Kafetz K, 2002, J ROY SOC MED, V95, P536, DOI 10.1258/jrsm.95.11.536; *NAT COUNC HOSP SP, 2001, PALL CAR SERV DIFF E; SHIPMAN C, 2002, PSYCHOSOCIAL SUPPORT	7	7	9	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2003	327	7408					207	208		10.1136/bmj.327.7408.207	http://dx.doi.org/10.1136/bmj.327.7408.207			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706DL	12881266	Green Published			2022-12-28	WOS:000184437300022
J	Walter, T				Walter, T			Historical and cultural variants on the good death	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Reading, Dept Sociol, Reading RG6 6AA, Berks, England	University of Reading	Walter, T (corresponding author), Univ Reading, Dept Sociol, Reading RG6 6AA, Berks, England.	j.a.walter@reading.ac.uk						Aries P., 1981, HOUR OUR DEATH, P10; BAYLEY J, 2000, IRIS FRIENDS YEAR ME; CLEMENTJONES V, 1985, BRIT MED J, V219, P1021; Diamond J., 1998, C BECAUSE COWARDS GE; Durkheim Emile, 1915, ELEMENTARY FORMS REL; FIRTH S, 1993, DEATH DYING BEREAVEM; Gittings C., 1984, DEATH BURIAL INDIVID; Macfarlane A., 1978, ORIGINS ENGLISH INDI; Paton L, 1996, Am J Hosp Palliat Care, V13, P26; PELLEGRINO ED, 1992, JAMA-J AM MED ASSOC, V268, P1734, DOI 10.1001/jama.268.13.1734; SEALE C, 1995, SOCIOLOGY, V29, P597, DOI 10.1177/0038038595029004003; Stannard David, 1977, PURITAN WAY DEATH; Walter T, 1997, PALLIATIVE MED, V11, P21, DOI 10.1177/026921639701100103; WALTER T, 1996, ECLIPSE ETERNITY SOC, P32; Walter T, 1994, REVIVAL DEATH	15	69	70	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 26	2003	327	7408					218	220		10.1136/bmj.327.7408.218	http://dx.doi.org/10.1136/bmj.327.7408.218			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	706DL	12881270	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000184437300026
J	Goebel, T; Waters, MR; Dikova, M				Goebel, T; Waters, MR; Dikova, M			The archaeology of Ushki Lake, Kamchatka, and the Pleistocene peopling of the Americas	SCIENCE			English	Article							CENTRAL ALASKA; NEW-WORLD; COLONIZATION; SETTLEMENT; BERINGIA; SIBERIA; DATES; SITE	The Ushki Paleolithic sites of Kamchatka, Russia, have long been thought to contain information critical to the peopling of the Americas, especially the origins of Clovis. New radiocarbon dates indicate that human occupation of Ushki began only 13,000 calendar years ago-nearly 4000 years later than previously thought. Although biface industries were widespread across Beringia contemporaneous to the time of Clovis in western North America, these data suggest that late-glacial Siberians did not spread into Beringia until the end of the Pleistocene, perhaps too recently to have been ancestral to proposed pre-Clovis populations in the Americas.	Univ Nevada, Dept Anthropol 096, Reno, NV 89557 USA; Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA; Russian Acad Sci, Lab Archaeol, NE Asian Interdisciplinary Res Ctr, Magadan, Russia	Nevada System of Higher Education (NSHE); University of Nevada Reno; Texas A&M University System; Texas A&M University College Station; Russian Academy of Sciences	Goebel, T (corresponding author), Univ Nevada, Dept Anthropol 096, Reno, NV 89557 USA.		Waters, Michael/ABI-2377-2020; Waters, Michael R/A-9430-2009; Goebel, Ted/A-7051-2009	Waters, Michael/0000-0003-2660-3355; 				ADOVASLO JM, 2002, 1 AM PURSUIT ARCHAEO; Ames KM, 2003, EVOL ANTHROPOL, V12, P19, DOI 10.1002/evan.10102; Bland RL, 1979, DREVNIE KULTURY SEVE; Dikov N.N., 1977, ARKHEOLOGICHESKIE PA; DIKOV NN, 1984, ARCTIC ANTHROPOL, V21, P69; DIKOV NN, 1993, AZIIA STYKE AMERIKOI; Dillehay T. D., 1997, ARCHAEOLOGICAL CONTE, VII; Elston R.G., 2008, ARCHAEOLOGICAL PAPER, V12, P103; FERRING CR, 1995, ANCIENT PEOPLES LAND; Fiedel SJ, 1999, AM ANTIQUITY, V64, P95, DOI 10.2307/2694348; Goebel T, 1999, EVOL ANTHROPOL, V8, P208; Goebel T., 1999, ICE AGE PEOPLES N AM, P104; Goebel T., 2002, ARCHAEOLOGICAL PAPER, V12, P117, DOI 10.1525/ap3a.2002.12.1.117; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; Hamilton T.D., 1999, ICE AGE PEOPLES N AM, P156; HAYNES CV, 1992, RADIOCARBON 4 DECADE; HAYNES G, 2002, EARLY SETTLEMTN N AM; HOFFECKER JF, 1993, SCIENCE, V259, P46, DOI 10.1126/science.259.5091.46; Ivanov V. F., 1990, DREVNIE PAMIATNIKI S, P161; King ML, 1996, SCIENCE, V273, P634, DOI 10.1126/science.273.5275.634; Kiryak Margarita A., 1996, P228; Lell JT, 2002, AM J HUM GENET, V70, P192, DOI 10.1086/338457; LONG A, 1974, AM ANTIQUITY, V39, P205, DOI 10.2307/279583; Mandryk CAS, 2001, QUATERNARY SCI REV, V20, P301, DOI 10.1016/S0277-3791(00)00115-3; Mason OK, 2001, QUATERNARY SCI REV, V20, P525, DOI 10.1016/S0277-3791(00)00100-1; MOCHANOV IA, 1982, PROBLEMY ARKHEOLOGII, P36; MULLERBECK H, 1966, SCIENCE, V152, P1192; Pearson GA, 1999, ARCTIC, V52, P332; POWERS WR, 1989, AM ANTIQUITY, V54, P263, DOI 10.2307/281707; POWERS WR, 1990, PREHIST MONGOLOID DI, V7, P53; Schurr TG, 2000, AM SCI, V88, P246; Scott G.R., 1997, ANTHR MODERN HUMAN T, DOI 10.1017/CBO9781316529843; SHILO NA, 1984, ARCT ANTHR, V21, P69; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; Yesner DR, 2001, QUATERNARY SCI REV, V20, P315, DOI 10.1016/S0277-3791(00)00114-1	35	94	102	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2003	301	5632					501	505		10.1126/science.1086555	http://dx.doi.org/10.1126/science.1086555			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	704LE	12881567				2022-12-28	WOS:000184340500038
J	Kanold, PO; Kara, P; Reid, RC; Shatz, CJ				Kanold, PO; Kara, P; Reid, RC; Shatz, CJ			Role of subplate neurons in functional maturation of visual cortical columns	SCIENCE			English	Article							OCULAR DOMINANCE COLUMNS; LATERAL GENICULATE-NUCLEUS; THALAMOCORTICAL SYNAPSES; CORTEX; CONNECTIONS; EXPRESSION; PLASTICITY; ABSENCE; SYSTEM; INPUT	The subplate forms a transient circuit required for development of connections between the thalamus and the cerebral cortex. When subplate neurons are ablated, ocular dominance columns do not form in the visual cortex despite the robust presence of thalamic axons in layer 4. We show that subplate ablation also prevents formation of orientation columns. Visual responses are weak and poorly tuned to orientation. Furthermore, thalamocortical synaptic transmission fails to strengthen, whereas intracortical synapses are unaffected. Thus, subplate circuits are essential not only for the anatomical segregation of thalamic inputs but also for key steps in synaptic remodeling and maturation needed to establish the functional architecture of visual cortex.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Shatz, CJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.			Kanold, Patrick/0000-0002-7529-5435	NEI NIH HHS [P30 EY12196, R01 EY02858, F32 EY013526, R01 EY10115, F32 EY013526-01, F32 EY1352] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010115, R01EY002858, P30EY012196, F32EY013526] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLENDOERFER KL, 1994, ANNU REV NEUROSCI, V17, P185, DOI 10.1146/annurev.neuro.17.1.185; ANTONINI A, 1993, J NEUROSCI, V13, P3549; Cai DQ, 1997, J NEUROPHYSIOL, V78, P1045, DOI 10.1152/jn.1997.78.2.1045; Chapman B, 1996, J NEUROSCI, V16, P6443; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crair MC, 2001, J COMP NEUROL, V430, P235, DOI 10.1002/1096-9861(20010205)430:2<235::AID-CNE1028>3.0.CO;2-P; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Feldman DE, 1998, NEURON, V21, P347, DOI 10.1016/S0896-6273(00)80544-9; Fine A, 1997, NEUROSCIENCE, V81, P331, DOI 10.1016/S0306-4522(97)00208-X; Finney EM, 1998, J COMP NEUROL, V398, P105; FRIAUF E, 1991, J NEUROPHYSIOL, V66, P2059, DOI 10.1152/jn.1991.66.6.2059; GHOSH A, 1992, SCIENCE, V255, P1441, DOI 10.1126/science.1542795; GHOSH A, 1990, NATURE, V347, P179, DOI 10.1038/347179a0; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; KANOLD PO, UNPUB; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Lein ES, 1999, P NATL ACAD SCI USA, V96, P13491, DOI 10.1073/pnas.96.23.13491; Lein ES, 2000, J COMP NEUROL, V420, P1, DOI 10.1002/(SICI)1096-9861(20000424)420:1<1::AID-CNE1>3.0.CO;2-H; Mrzljak L, 1998, J COMP NEUROL, V390, P112; PIORO EP, 1990, NEUROSCIENCE, V34, P57, DOI 10.1016/0306-4522(90)90304-M; SHATZ CJ, 1986, J NEUROSCI, V6, P3655; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599	26	222	225	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2003	301	5632					521	525		10.1126/science.1084152	http://dx.doi.org/10.1126/science.1084152			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12881571				2022-12-28	WOS:000184340500044
J	Wang, X; Huong, SM; Chiu, ML; Raab-Traub, N; Huang, ES				Wang, X; Huong, SM; Chiu, ML; Raab-Traub, N; Huang, ES			Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus	NATURE			English	Article								Human cytomegalovirus (HCMV) is a widespread opportunistic herpesvirus that causes severe and fatal diseases in immune-compromised individuals, including organ transplant recipients and individuals with AIDS(1). It is also a leading cause of virus-associated birth defects and is associated with atherosclerosis and letters to nature and coronary restenosis(1-3). HCMV initiates infection and intracellular signalling by binding to its cognate cellular receptors 4,5 and by activating several signalling pathways including those mediated by mitogen-activated protein kinase(5-7), phosphatidylinositol-3-OH kinase(8), interferons(5,9), and G proteins(10). But a cellular receptor responsible for viral entry and HCMV-induced signalling has yet to be identified. Here we show that HCMV infects cells by interacting with epidermal growth factor receptor (EGFR) and inducing signalling. Transfecting EGFR-negative cells with an EGFR complementary DNA renders non-susceptible cells susceptible to HCMV. Ligand displacement and crosslinking analyses show that HCMV interacts with EGFR through gB, its principal envelope glycoprotein. gB preferentially binds EGFR and EGFR-ErbB3 oligomeric molecules in Chinese hamster ovary cells transfected with erbB family cDNAs. Taken together, these data indicate that EGFR is a necessary component for HCMV-triggered signalling and viral entry.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Huang, ES (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	eshuang@med.unc.edu						Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; Baulida J, 1996, J BIOL CHEM, V271, P5251; Boyle KA, 1999, MOL CELL BIOL, V19, P3607; COMPTON T, 1992, VIROLOGY, V191, P387, DOI 10.1016/0042-6822(92)90200-9; EARP HS, 1995, BREAST CANCER RES TR, V35, P115, DOI 10.1007/BF00694752; Fairley JA, 2002, J GEN VIROL, V83, P2803, DOI 10.1099/0022-1317-83-11-2803; Huang ES, 1993, MOL ASPECTS HUMAN CY, P1; Johnson RA, 2000, J VIROL, V74, P1158, DOI 10.1128/JVI.74.3.1158-1167.2000; Johnson RA, 2001, J VIROL, V75, P6022, DOI 10.1128/JVI.75.13.6022-6032.2001; Johnson RA, 2001, J GEN VIROL, V82, P493, DOI 10.1099/0022-1317-82-3-493; Kanda S, 1997, J BIOL CHEM, V272, P23347, DOI 10.1074/jbc.272.37.23347; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; MELNICK JL, 1993, EUR HEART J, V14, P30; Miyazawa N, 1999, J VIROL, V73, P6056, DOI 10.1128/JVI.73.7.6056-6065.1999; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; PELES E, 1993, BIOESSAYS, V15, P815, DOI 10.1002/bies.950151207; Pietropaolo RL, 1997, J VIROL, V71, P9803, DOI 10.1128/JVI.71.12.9803-9807.1997; Prenzel N, 2001, ENDOCR-RELAT CANCER, V8, P11, DOI 10.1677/erc.0.0080011; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sexl V, 1997, J BIOL CHEM, V272, P5792, DOI 10.1074/jbc.272.9.5792; Shibutani T, 1997, J CLIN INVEST, V100, P2054, DOI 10.1172/JCI119738; Simmen KA, 2001, P NATL ACAD SCI USA, V98, P7140, DOI 10.1073/pnas.121177598; SPEIR E, 1994, SCIENCE, V265, P391, DOI 10.1126/science.8023160; Tvorogov D, 2002, EXP CELL RES, V277, P86, DOI 10.1006/excr.2002.5545; Tzahar E, 1998, EMBO J, V17, P5948, DOI 10.1093/emboj/17.20.5948; Tzahar E, 1997, EMBO J, V16, P4938, DOI 10.1093/emboj/16.16.4938; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; Yurochko AD, 1997, J VIROL, V71, P5051, DOI 10.1128/JVI.71.7.5051-5059.1997	30	309	336	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2003	424	6947					456	461		10.1038/nature01818	http://dx.doi.org/10.1038/nature01818			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879076				2022-12-28	WOS:000184318400050
J	Watanabe, H; Vriens, J; Prenen, J; Droogmans, G; Voets, T; Nilius, B				Watanabe, H; Vriens, J; Prenen, J; Droogmans, G; Voets, T; Nilius, B			Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels	NATURE			English	Article								TRPV4 is a widely expressed cation channel of the 'transient receptor potential' (TRP) family(1) that is related to the vanilloid receptor VR1 (TRPV1). It functions as a Ca2+ entry channel(2) and displays remarkable gating promiscuity by responding to both physical stimuli (cell swelling, innoxious heat(2-7)) and the synthetic ligand 4alphaPDD(8). An endogenous ligand for this channel has not yet been identified. Here we show that the endocannabinoid anandamide and its metabolite arachidonic acid activate TRPV4 in an indirect way involving the cytochrome P450 epoxygenase-dependent formation of epoxyeicosatrienoic acids. Application of 5',6'-epoxyeicosatrienoic acid at submicromolar concentrations activates TRPV4 in a membrane-delimited manner and causes Ca2+ influx through TRPV4- like channels in vascular endothelial cells. Activation of TRPV4 in vascular endothelial cells might therefore contribute to the relaxant effects of endocannabinoids and their P450 epoxygenase-dependent metabolites on vascular tone(9-12).	Katholieke Univ Leuven, Dept Physiol, B-3000 Louvain, Belgium	KU Leuven	Nilius, B (corresponding author), Katholieke Univ Leuven, Dept Physiol, Campus Gasthuisberg, B-3000 Louvain, Belgium.	bernd.nilius@med.kuleuven.ac.be	Voets, Thomas/AAD-4389-2019; Voets, Thomas/E-2466-2012; Vriens, Joris/G-9966-2018	Voets, Thomas/0000-0001-5526-5821; Voets, Thomas/0000-0001-5526-5821; Vriens, Joris/0000-0002-2502-0409				Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Fleming I, 2001, CIRC RES, V89, P753, DOI 10.1161/hh2101.099268; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Fuloria M, 2002, AM J PHYSIOL-LUNG C, V283, pL383, DOI 10.1152/ajplung.00444.2001; GRAIER WF, 1995, J PHYSIOL-LONDON, V482, P259, DOI 10.1113/jphysiol.1995.sp020515; Grainger J, 2001, BRIT J PHARMACOL, V134, P1003, DOI 10.1038/sj.bjp.0704340; Guler AD, 2002, J NEUROSCI, V22, P6408; Jarai Z, 1999, P NATL ACAD SCI USA, V96, P14136, DOI 10.1073/pnas.96.24.14136; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Nilius B, 2001, PFLUG ARCH EUR J PHY, V443, P227, DOI 10.1007/s004240100676; Randall MD, 1998, EUR J PHARMACOL, V346, P51, DOI 10.1016/S0014-2999(98)00003-X; Randall MD, 1998, TRENDS PHARMACOL SCI, V19, P55, DOI 10.1016/S0165-6147(97)01161-9; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; Rzigalinski BA, 1999, J BIOL CHEM, V274, P175, DOI 10.1074/jbc.274.1.175; Seegers HC, 2002, J PHARMACOL EXP THER, V302, P918, DOI 10.1124/jpet.302.3.918; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suh SH, 1999, PFLUG ARCH EUR J PHY, V438, P612, DOI 10.1007/s004240051084; Tan JZ, 1997, ADV EXP MED BIOL, V407, P561; Ueda N, 2002, PROSTAG OTH LIPID M, V68-9, P521, DOI 10.1016/S0090-6980(02)00053-9; Voets T, 2002, J BIOL CHEM, V277, P33704, DOI 10.1074/jbc.M204828200; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; WILLAN RL, 1990, MULTIPURPOSE TREE SP, V2, P11; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; Xie Q, 2002, J BIOL CHEM, V277, P16559, DOI 10.1074/jbc.M109518200; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	27	731	767	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2003	424	6947					434	438		10.1038/nature01807	http://dx.doi.org/10.1038/nature01807			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879072				2022-12-28	WOS:000184318400045
J	Yamazaki, D; Suetsugu, S; Miki, H; Kataoka, Y; Nishikawa, SI; Fujiwara, T; Yoshida, N; Takenawa, T				Yamazaki, D; Suetsugu, S; Miki, H; Kataoka, Y; Nishikawa, SI; Fujiwara, T; Yoshida, N; Takenawa, T			WAVE2 is required for directed cell migration and cardiovascular development	NATURE			English	Article								WAVE2, a protein related to Wiskott-Aldrich syndrome protein, is crucial for Rac-induced membrane ruffling, which is important in cell motility(1-4). Cell movement is essential for morphogenesis, but it is unclear how cell movement is regulated or related to morphogenesis. Here we show the physiological functions of WAVE2 by disruption of the WAVE2 gene in mice. WAVE2 was expressed predominantly in vascular endothelial cells during embryogenesis. WAVE2(-/-) embryos showed haemorrhages and died at about embryonic day 10. Deficiency in WAVE2 had no significant effect on vasculogenesis, but it decreased sprouting and branching of endothelial cells from existing vessels during angiogenesis. In WAVE2(-/-) endothelial cells, cell polarity formed in response to vascular endothelial growth factor, but the formation of lamellipodia at leading edges and capillaries was severely impaired. These findings indicate that WAVE2-regulated actin reorganization might be required for proper cell movement and that a lack of functional WAVE2 impairs angiogenesis in vivo.	Univ Tokyo, Dept Biochem, Mianato Ku, Tokyo 1088639, Japan; Univ Tokyo, Div Canc Genom, Mianato Ku, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Div Gene Express & Regulat, Mianato Ku, Tokyo 1088639, Japan; Japan Sci & Technol Corp, CREST, Tokyo, Japan; Japan Sci & Technol Corp, PRESTO, Kawaguchi, Japan; Kyoto Univ, Grad Sch Med, Dept Mol Genet, Sakyo Ku, Kyoto 6068509, Japan; Ehime Univ, Sch Med, Lab Anim Ctr, Shigenobu, Ehime 7910295, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Kyoto University; Ehime University	Takenawa, T (corresponding author), Univ Tokyo, Dept Biochem, Mianato Ku, 4-6-1 Shirokanedai, Mianato ku, Tokyo 1088639, Japan.	takenawa@ims.u-tokyo.ac.jp	Suetsugu, Shiro/B-3300-2010; Suetsugu, Shiro/AAF-4427-2019; Suetsugu, Shiro/ABB-6033-2020	Suetsugu, Shiro/0000-0002-4612-0628; Suetsugu, Shiro/0000-0002-4612-0628; 				Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X; Connolly JO, 2002, MOL BIOL CELL, V13, P2474, DOI 10.1091/mbc.E02-01-0006; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Hashi H, 2001, J IMMUNOL, V166, P3702, DOI 10.4049/jimmunol.166.6.3702; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Miki H, 2002, BIOCHEM BIOPH RES CO, V293, P93, DOI 10.1016/S0006-291X(02)00218-8; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; SHIMADA T, 1983, J ELECTRON MICROSC, V32, P187; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Suetsugu S, 1999, BIOCHEM BIOPH RES CO, V260, P296, DOI 10.1006/bbrc.1999.0894; Takakura N, 1998, IMMUNITY, V9, P677, DOI 10.1016/S1074-7613(00)80665-2; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; Takenawa T, 2001, J CELL SCI, V114, P1801; Yamaguchi H, 2002, CANCER RES, V62, P2503	16	182	184	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2003	424	6947					452	456		10.1038/nature01770	http://dx.doi.org/10.1038/nature01770			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879075				2022-12-28	WOS:000184318400049
J	Fleury, HJ; Pinson, P; Faure, M; Masquelier, B; Dupon, M				Fleury, HJ; Pinson, P; Faure, M; Masquelier, B; Dupon, M			HIV-1 transmission during scintigraphy	LANCET			English	Editorial Material									Hop Pellegrin, Dept Virol, F-33076 Bordeaux, France; Hop Pellegrin, Dept Infect Dis, F-33076 Bordeaux, France	CHU Bordeaux; CHU Bordeaux	Fleury, HJ (corresponding author), Hop Pellegrin, Dept Virol, F-33076 Bordeaux, France.							ALLAIN JP, 1987, NEW ENGL J MED, V317, P114; Fleury H, 2003, AIDS RES HUM RETROV, V19, P41, DOI 10.1089/08892220360473952	2	9	9	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 19	2003	362	9379					210	210		10.1016/S0140-6736(03)13911-6	http://dx.doi.org/10.1016/S0140-6736(03)13911-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702PJ	12885483				2022-12-28	WOS:000184232000012
J	Poethig, RS				Poethig, RS			Phase change and the regulation of developmental timing in plants	SCIENCE			English	Review							ARABIDOPSIS-THALIANA; VEGETATIVE-PHASE; FLOWERING TIME; LEAF; MORPHOGENESIS; MAIZE; IDENTITY; MUTANTS; PATHWAY; LEAVES	Plants produce different types of organs at different times in shoot development. Along with the major changes in organ morphology that take place during developmental transitions, more gradual patterns of variation occur. The identity of organs produced at a particular position on the shoot is determined by interactions between several independently regulated, temporally coordinated processes. Two of these processes are organ production and the specification of organ identity. Coordination of these processes is accomplished in part by a thermal clock and by signal transduction pathways that mediate the response of plants to light.	Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA	University of Pennsylvania	Poethig, RS (corresponding author), Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA.		Poethig, R. Scott/J-7009-2015	Poethig, R. Scott/0000-0001-6592-5862	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051893] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allsopp A, 1967, Adv Morphog, V6, P127; Asai K, 2002, DEVELOPMENT, V129, P265; BATTEY NH, 1988, ANN BOT-LONDON, V61, P9, DOI 10.1093/oxfordjournals.aob.a087531; Berardini TZ, 2001, SCIENCE, V291, P2405, DOI 10.1126/science.1057144; BERNIER G, 1988, ANNU REV PLANT PHYS, V39, P175, DOI 10.1146/annurev.arplant.39.1.175; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Bollman KM, 2003, DEVELOPMENT, V130, P1493, DOI 10.1242/dev.00362; Bonhomme R, 2000, EUR J AGRON, V13, P1, DOI 10.1016/S1161-0301(00)00058-7; Chien JC, 1996, PLANT PHYSIOL, V111, P1321, DOI 10.1104/pp.111.4.1321; Cockcroft CE, 2000, NATURE, V405, P575, DOI 10.1038/35014621; Conway LJ, 1997, P NATL ACAD SCI USA, V94, P10209, DOI 10.1073/pnas.94.19.10209; Fernandez DE, 1997, DEVELOPMENT, V124, P1149; Granier C, 1998, PLANT PHYSIOL, V116, P991, DOI 10.1104/pp.116.3.991; Granier C, 2002, ANN BOT-LONDON, V89, P595, DOI 10.1093/aob/mcf085; Hackett W. P., 1987, MANIPULATION FLOWERI, P93; HACKETT WP, 1992, ACTA HORTIC, V314, P195; Halliday KJ, 2003, PLANT J, V33, P875, DOI 10.1046/j.1365-313X.2003.01674.x; Irish EE, 1998, INT J PLANT SCI, V159, P695, DOI 10.1086/297587; Itoh JI, 1998, PLANT CELL, V10, P1511, DOI 10.1105/tpc.10.9.1511; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Melzer S, 1999, PLANT J, V18, P395, DOI 10.1046/j.1365-313X.1999.00461.x; Moose SP, 1996, GENE DEV, V10, P3018, DOI 10.1101/gad.10.23.3018; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Orkwiszewski JAJ, 2000, P NATL ACAD SCI USA, V97, P10631, DOI 10.1073/pnas.180301597; POETHIG RS, 1990, SCIENCE, V250, P923, DOI 10.1126/science.250.4983.923; RICKMAN RW, 1995, CROP SCI, V35, P44, DOI 10.2135/cropsci1995.0011183X003500010008x; Schultz TF, 2003, SCIENCE, V301, P326, DOI 10.1126/science.1085935; Scott DB, 1999, PLANT PHYSIOL, V120, P675, DOI 10.1104/pp.120.3.675; Soppe WJJ, 1999, DEVELOPMENT, V126, P4763; STEBBINS GL, 1967, DEVELOP BIOL       S, V1, P113; Telfer A, 1997, DEVELOPMENT, V124, P645; VOLK T, 1991, CROP SCI, V31, P1218, DOI 10.2135/cropsci1991.0011183X003100050028x; WILLIAMS R. F., 1975, SHOOT APEX LEAF GROW; WILTSHIRE RJE, 1994, J EVOLUTION BIOL, V7, P447, DOI 10.1046/j.1420-9101.1994.7040447.x	34	250	274	3	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2003	301	5631					334	336		10.1126/science.1085328	http://dx.doi.org/10.1126/science.1085328			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869752				2022-12-28	WOS:000184207300032
J	Jasmin, L; Rabkin, SD; Granato, A; Boudah, A; Ohara, PT				Jasmin, L; Rabkin, SD; Granato, A; Boudah, A; Ohara, PT			Analgesia and hyperalgesia from GABA-mediated modulation of the cerebral cortex	NATURE			English	Article								It is known that pain perception can be altered by mood, attention and cognition, or by direct stimulation of the cerebral cortex(1), but we know little of the neural mechanisms underlying the cortical modulation of pain. One of the few cortical areas consistently activated by painful stimuli is the rostral agranular insular cortex (RAIC) where, as in other parts of the cortex, the neurotransmitter gamma-aminobutyric acid (GABA) robustly inhibits neuronal activity. Here we show that changes in GABA neurotransmission in the RAIC can raise or lower the pain threshold-producing analgesia or hyperalgesia, respectively-in freely moving rats. Locally increasing GABA, by using an enzyme inhibitor or gene transfer mediated by a viral vector, produces lasting analgesia by enhancing the descending inhibition of spinal nociceptive neurons. Selectively activating GABA(B)-receptor-bearing RAIC neurons produces hyperalgesia through projections to the amygdala, an area involved in pain and fear. Whereas most studies focus on the role of the cerebral cortex as the end point of nociceptive processing, we suggest that cerebral cortex activity can change the set-point of pain threshold in a top-down manner.	Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurosurg, Boston, MA 02129 USA; Catholic Univ, Dept Psychol, I-20123 Milan, Italy	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Massachusetts General Hospital; Catholic University of the Sacred Heart	Jasmin, L (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.		rabkin, samuel/C-2443-2012	rabkin, samuel/0000-0003-2344-2795; GRANATO, Alberto/0000-0003-3755-1036				BERENDSE HW, 1992, J COMP NEUROL, V316, P314, DOI 10.1002/cne.903160305; BERTHIER M, 1988, ANN NEUROL, V24, P41, DOI 10.1002/ana.410240109; BROG JS, 1993, J COMP NEUROL, V338, P255, DOI 10.1002/cne.903380209; Burkey AR, 1999, J NEUROSCI, V19, P4169; Calejesan AA, 2000, EUR J PAIN, V4, P83, DOI 10.1053/eujp.1999.0158; EVERITT B J, 1992, P401; Fields HL, 2000, PROG BRAIN RES, V122, P245; GREENSPAN JD, 1992, PAIN, V50, P29, DOI 10.1016/0304-3959(92)90109-O; Helmstetter FJ, 1998, BRAIN RES, V779, P104, DOI 10.1016/S0006-8993(97)01104-9; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Jasmin L, 2003, J COMP NEUROL, V460, P38, DOI 10.1002/cne.10633; Jasmin L, 2001, J NEUROSCI METH, V110, P81, DOI 10.1016/S0165-0270(01)00420-4; JUNG MJ, 1977, J NEUROCHEM, V29, P797, DOI 10.1111/j.1471-4159.1977.tb10721.x; Killcross S, 1997, NATURE, V388, P377, DOI 10.1038/41097; LeDoux JE., 2000, AMYGDALA FUNCTIONAL, P289; Lopantsev V, 1999, J NEUROPHYSIOL, V82, P1218, DOI 10.1152/jn.1999.82.3.1218; Manning BH, 1998, J NEUROSCI, V18, P9453; Margeta-Mitrovic M, 1999, J COMP NEUROL, V405, P299, DOI 10.1002/(SICI)1096-9861(19990315)405:3<299::AID-CNE2>3.0.CO;2-6; Nandigama P, 2003, BRAIN RES, V959, P343, DOI 10.1016/S0006-8993(02)03884-2; New KC, 1996, MOL BRAIN RES, V37, P317, DOI 10.1016/0169-328X(95)00262-Q; New KC, 1998, MOL BRAIN RES, V61, P121, DOI 10.1016/S0169-328X(98)00203-4; New KC, 1998, J NEUROCHEM, V71, P2304; Ostrowsky K, 2002, CEREB CORTEX, V12, P376, DOI 10.1093/cercor/12.4.376; Pitkanen A., 2000, AMYGDALA FUNCTIONAL, V2; PROUDFIT HK, 1991, PROG BRAIN RES, V88, P123; SAGEN J, 1984, BRAIN RES, V310, P295, DOI 10.1016/0006-8993(84)90152-5; Somogyi J, 2001, EUR J NEUROSCI, V14, P219, DOI 10.1046/j.0953-816x.2001.01638.x; Suzuki R, 2002, NAT NEUROSCI, V5, P1319, DOI 10.1038/nn966; Watkins LR, 1998, BEHAV NEUROSCI, V112, P360; Zhang S, 1997, NEUROSCI LETT, V224, P142, DOI 10.1016/S0304-3940(97)13478-4	30	255	264	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					316	320		10.1038/nature01808	http://dx.doi.org/10.1038/nature01808			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867983				2022-12-28	WOS:000184183900043
J	Tadin, D; Lappin, JS; Gilroy, LA; Blake, R				Tadin, D; Lappin, JS; Gilroy, LA; Blake, R			Perceptual consequences of centre-surround antagonism in visual motion processing	NATURE			English	Article								Centre-surround receptive field organization is a ubiquitous property in mammalian visual systems, presumably tailored for extracting image features that are differentially distributed over space(1). In visual motion, this is evident as antagonistic interactions between centre and surround regions of the receptive fields of many direction-selective neurons in visual cortex(2-6). In a series of psychophysical experiments we make the counterintuitive observation that increasing the size of a high-contrast moving pattern renders its direction of motion more difficult to perceive and reduces its effectiveness as an adaptation stimulus. We propose that this is a perceptual correlate of centre-surround antagonism, possibly within a population of neurons in the middle temporal visual area. The spatial antagonism of motion signals observed at high contrast gives way to spatial summation as contrast decreases. Evidently, integration of motion signals over space depends crucially on the visibility of those signals, thereby allowing the visual system to register motion information efficiently and adaptively.	Vanderbilt Univ, Vanderbilt Vis Res Ctr, Nashville, TN 37203 USA	Vanderbilt University	Tadin, D (corresponding author), Vanderbilt Univ, Vanderbilt Vis Res Ctr, 111 21st Ave S, Nashville, TN 37203 USA.			Tadin, Duje/0000-0003-1571-5589				ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; ANDERSON SJ, 1991, J OPT SOC AM A, V8, P1330, DOI 10.1364/JOSAA.8.001330; Born RT, 2000, NEURON, V26, P725, DOI 10.1016/S0896-6273(00)81208-8; BORN RT, 1992, NATURE, V357, P497, DOI 10.1038/357497a0; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Buracas GT, 1996, VISION RES, V36, P869, DOI 10.1016/0042-6989(95)00192-1; CAVANAGH P, 1987, J OPT SOC AM A, V4, P1428, DOI 10.1364/JOSAA.4.001428; DERRINGTON AM, 1989, VISION RES, V29, P1767, DOI 10.1016/0042-6989(89)90159-4; Dobkins K., 1998, HIGH LEVEL MOTION PR, P53; Eifuku S, 1998, J NEUROPHYSIOL, V80, P282, DOI 10.1152/jn.1998.80.1.282; Gautama T, 2001, VISION RES, V41, P3917, DOI 10.1016/S0042-6989(01)00246-2; GEGENFURTNER KR, 1994, VISUAL NEUROSCI, V11, P455, DOI 10.1017/S095252380000239X; Huk AC, 2001, NEURON, V32, P161, DOI 10.1016/S0896-6273(01)00452-4; Jones HE, 2001, J NEUROPHYSIOL, V86, P2011, DOI 10.1152/jn.2001.86.4.2011; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; Kastner S, 2001, J NEUROPHYSIOL, V86, P1398, DOI 10.1152/jn.2001.86.3.1398; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; MURAKAMI I, 1995, VISION RES, V35, P1835, DOI 10.1016/0042-6989(94)00269-R; NAKAYAMA K, 1985, J OPT SOC AM A, V2, P267, DOI 10.1364/JOSAA.2.000267; NAKAYAMA K, 1974, PERCEPTION, V3, P63, DOI 10.1068/p030063; RAIGUEL S, 1995, EUR J NEUROSCI, V7, P2064, DOI 10.1111/j.1460-9568.1995.tb00629.x; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; SACHTLER WL, 1993, J OPT SOC AM A, V10, P1433, DOI 10.1364/JOSAA.10.001433; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; Verghese P, 1996, NATURE, V381, P161, DOI 10.1038/381161a0; WATSON AB, 1995, VISION RES, V35, P325, DOI 10.1016/0042-6989(94)00182-L; WESTHEIMER G, 1967, J PHYSIOL-LONDON, V190, P139, DOI 10.1113/jphysiol.1967.sp008198	30	232	232	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					312	315		10.1038/nature01800	http://dx.doi.org/10.1038/nature01800			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867982				2022-12-28	WOS:000184183900042
J	Gonzalez, MM; Dingus, BL; Kaneko, Y; Preece, RD; Dermer, CD; Briggs, MS				Gonzalez, MM; Dingus, BL; Kaneko, Y; Preece, RD; Dermer, CD; Briggs, MS			A gamma-ray burst with a high-energy spectral component inconsistent with the synchrotron shock model	NATURE			English	Article							CALIBRATION; EMISSION; CATALOG; EGRET	Gamma-ray bursts are among the most powerful events in nature. These events release most of their energy as photons with energies in the range from 30 keV to a few MeV, with a smaller fraction of the energy radiated in radio, optical, and soft X-ray afterglows(1). The data are in general agreement with a relativistic shock model(2), where the prompt and afterglow emissions 3 correspond to synchrotron radiation from shock-accelerated electrons. Here we report an observation of a high-energy (multi-MeV) spectral component in the burst of 17 October 1994 that is distinct from the previously observed lower-energy gamma-ray component. The flux of the high-energy component decays more slowly and its fluence is greater than the lower-energy component; it is described by a power law of differential photon number index approximately 21 up to about 200 MeV. This observation is difficult to explain with the standard synchrotron shock model(2), suggesting the presence of new phenomena such as a different non-thermal electron process, or the interaction of relativistic protons with photons at the source.	Univ Wisconsin, Dept Phys, Madison, WI 53706 USA; Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Univ Alabama, Dept Phys, Natl Space Sci & Technol Ctr, Huntsville, AL 35899 USA; USN, Res Lab, Washington, DC 20375 USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Alabama System; University of Alabama Huntsville; United States Department of Defense; United States Navy; Naval Research Laboratory	Gonzalez, MM (corresponding author), Univ Wisconsin, Dept Phys, 1150 Univ Ave, Madison, WI 53706 USA.	magda@whopper.lanl.gov	Kaneko, Yuki/V-2908-2019	Kaneko, Yuki/0000-0002-1861-5703; Dingus, Brenda/0000-0001-8451-7450; Preece, Robert/0000-0003-1626-7335				Alvarez-Muniz J, 2000, PHYS REV D, V62, DOI 10.1103/PhysRevD.62.093015; Atkins R, 2000, ASTROPHYS J, V533, pL119, DOI 10.1086/312629; BAND D, 1993, ASTROPHYS J, V413, P281, DOI 10.1086/172995; Bottcher M, 1998, ASTROPHYS J, V499, pL131, DOI 10.1086/311366; Briggs MS, 1998, AIP CONF PROC, P299; Catelli JR, 1998, AIP CONF PROC, P309; *COMPTEL, 1997, COMPTEL BURST IM TIM; Costa E, 1997, NATURE, V387, P783, DOI 10.1038/42885; Dermer CD, 2000, ASTROPHYS J, V537, P785, DOI 10.1086/309061; Dingus BL, 2001, AIP CONF PROC, V558, P383, DOI 10.1063/1.1370806; Esposito JA, 1999, ASTROPHYS J SUPPL S, V123, P203, DOI 10.1086/313227; FISHMAN GJ, 1995, ANNU REV ASTRON ASTR, V33, P415, DOI 10.1146/annurev.astro.33.1.415; Gonzalez MM, 2003, AIP CONF PROC, V662, P267; Harris MJ, 1998, ASTROPHYS J, V494, P724, DOI 10.1086/305227; HURLEY K, 1994, NATURE, V372, P652, DOI 10.1038/372652a0; Inoue S, 2003, ASTROPHYS J, V583, P379, DOI 10.1086/345080; KATZ JI, 1994, ASTROPHYS J, V432, pL27, DOI 10.1086/187503; Liang E, 1996, NATURE, V381, P49, DOI 10.1038/381049a0; Meszaros P, 2002, ANNU REV ASTRON ASTR, V40, P137, DOI 10.1146/annurev.astro.40.060401.093821; Paciesas WS, 1999, ASTROPHYS J SUPPL S, V122, P465, DOI 10.1086/313224; Preece RD, 2000, ASTROPHYS J SUPPL S, V126, P19, DOI 10.1086/313289; THOMPSON DJ, 1993, ASTROPHYS J SUPPL S, V86, P629, DOI 10.1086/191793; van Paradijs J, 2000, ANNU REV ASTRON ASTR, V38, P379, DOI 10.1146/annurev.astro.38.1.379; VIETRI M, 1995, ASTROPHYS J, V453, P883, DOI 10.1086/176448; WAXMAN E, 1995, PHYS REV LETT, V75, P386, DOI 10.1103/PhysRevLett.75.386; Zhang B, 2002, ASTROPHYS J, V581, P1236, DOI 10.1086/344338; Zhang B, 2001, ASTROPHYS J, V559, P110, DOI 10.1086/322400	27	231	235	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2003	424	6950					749	751		10.1038/nature01869	http://dx.doi.org/10.1038/nature01869			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711HQ	12917676				2022-12-28	WOS:000184733900031
J	Schulman, S				Schulman, S			Care of patients receiving long-term anticoagulant therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERNATIONAL NORMALIZED RATIO; ACUTE MYOCARDIAL-INFARCTION; INTENSITY WARFARIN THERAPY; ASSOCIATION TASK-FORCE; VENOUS THROMBOEMBOLISM; ANTITHROMBOTIC THERAPY; ORAL ANTICOAGULATION; ATRIAL-FIBRILLATION; VITAMIN-K; BLEEDING COMPLICATIONS		Karolinska Hosp, Coagulat Unit, Dept Hematol, S-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Schulman, S (corresponding author), Karolinska Hosp, Coagulat Unit, Dept Hematol, S-17176 Stockholm, Sweden.	sam.schulman@ks.se	Greiver, Michelle/N-8764-2015; Schulman, Sam/I-7559-2019; Miranda, Fausto/N-9780-2018	Greiver, Michelle/0000-0001-8957-0285; Schulman, Sam/0000-0002-8512-9043; Miranda, Fausto/0000-0003-2954-8638				Ageno W, 1998, THROMB RES, V91, P237, DOI 10.1016/S0049-3848(98)00092-9; Aillaud MF, 2000, BLOOD COAGUL FIBRIN, V11, P511; Albers GW, 2001, CHEST, V119, p194S, DOI 10.1378/chest.119.1_suppl.194S; Allen EV, 1942, J AMER MED ASSOC, V120, P1009, DOI 10.1001/jama.1942.02830480013004; [Anonymous], 1994, ARCH INTERN MED, V154, P2254; Ascani A, 1999, BLOOD COAGUL FIBRIN, V10, P291, DOI 10.1097/00001721-199907000-00011; Becker RC, 2002, NEW ENGL J MED, V347, P1019, DOI 10.1056/NEJMe020097; Cairns, 2001, CHEST, V120, P1427; Cairns JA, 2001, CHEST, V119, p228S, DOI 10.1378/chest.119.1_suppl.228S; CANNEGIETER SC, 1994, CIRCULATION, V89, P635, DOI 10.1161/01.CIR.89.2.635; CHENELLA FC, 1983, AM J HOSP PHARM, V40, P1642, DOI 10.1093/ajhp/40.10.1642; Chiquette E, 1998, ARCH INTERN MED, V158, P1641, DOI 10.1001/archinte.158.15.1641; COULSHED N, 1970, BRIT HEART J, V32, P26; Crowther MA, 2000, LANCET, V356, P1551, DOI 10.1016/S0140-6736(00)03125-1; De Stefano V, 1999, NEW ENGL J MED, V341, P801, DOI 10.1056/NEJM199909093411104; DOECKE CJ, 1991, AUST NZ J MED, V21, P319, DOI 10.1111/j.1445-5994.1991.tb04697.x; Eisen GM, 2002, GASTROINTEST ENDOSC, V55, P775, DOI 10.1016/S0016-5107(02)70402-1; Fitzmaurice DA, 2001, BRIT MED J, V323, P985, DOI 10.1136/bmj.323.7319.985; Fuster V, 2001, J AM COLL CARDIOL, V38, P1231, DOI 10.1016/S0735-1097(01)01587-X; GALLUS A, 1986, LANCET, V2, P1293; GOHLKEBARWOLF C, 1995, EUR HEART J, V16, P1320; Harrison L, 1997, ANN INTERN MED, V126, P133, DOI 10.7326/0003-4819-126-2-199701150-00006; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; HERAS M, 1995, J AM COLL CARDIOL, V25, P1111, DOI 10.1016/0735-1097(94)00563-6; Hurlen M, 2002, NEW ENGL J MED, V347, P969, DOI 10.1056/NEJMoa020496; Hutten BA, 2000, J CLIN ONCOL, V18, P3078, DOI 10.1200/JCO.2000.18.17.3078; Hyers TM, 2001, CHEST, V119, p176S, DOI 10.1378/chest.119.1_suppl.176S; Izzo AA, 2001, DRUGS, V61, P2163, DOI 10.2165/00003495-200161150-00002; Jillella AP, 1996, AM J HEMATOL, V52, P117, DOI 10.1002/(SICI)1096-8652(199606)52:2<117::AID-AJH9>3.3.CO;2-Z; KARLSON B, 1986, ACTA MED SCAND, V220, P347; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Kearon C, 1997, NEW ENGL J MED, V336, P1506, DOI 10.1056/NEJM199705223362107; KHAMASHTA MA, 1995, NEW ENGL J MED, V332, P993, DOI 10.1056/NEJM199504133321504; Koefoed BG, 1999, J INTERN MED, V245, P375, DOI 10.1046/j.1365-2796.1999.00461.x; Kortke H, 2001, ANN THORAC SURG, V72, P44, DOI 10.1016/S0003-4975(01)02656-X; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; Kretschmer G, 1999, J INTERN MED, V245, P389, DOI 10.1046/j.1365-2796.1999.00463.x; Kyrle PA, 2000, NEW ENGL J MED, V343, P457, DOI 10.1056/NEJM200008173430702; LAGERSTEDT CI, 1985, LANCET, V2, P515; LANDEFELD CS, 1989, AM J MED, V87, P144; Lane DA, 1996, THROMB HAEMOSTASIS, V76, P651; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; Levine MN, 2001, CHEST, V119, p108S, DOI 10.1378/chest.119.1_suppl.108S; Lindmarker P, 1999, THROMB HAEMOSTASIS, V81, P684; Lip GY, 2001, COCHRANE DB SYST REV, V4; Lyrer P., 2000, COCHRANE DB SYST REV, V4, P255, DOI 10.1002/14651858.cd000255; Makris M, 1997, THROMB HAEMOSTASIS, V77, P477; Massel D, 2001, J AM COLL CARDIOL, V37, P569, DOI 10.1016/S0735-1097(00)01135-9; Meyer G, 2002, ARCH INTERN MED, V162, P1729, DOI 10.1001/archinte.162.15.1729; Milligan PE, 2002, ANN PHARMACOTHER, V36, P764, DOI 10.1345/aph.1A327; MOK CK, 1985, CIRCULATION, V72, P1059, DOI 10.1161/01.CIR.72.5.1059; Nee R, 1999, AM J CARDIOL, V83, P286, DOI 10.1016/S0002-9149(98)00842-X; PEDERSEN FM, 1991, J INTERN MED, V229, P517, DOI 10.1111/j.1365-2796.1991.tb00388.x; Pinede L, 2000, J INTERN MED, V247, P553, DOI 10.1046/j.1365-2796.2000.00631.x; Poller L, 1998, LANCET, V352, P1505, DOI 10.1016/S0140-6736(98)04147-6; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; RAMSTROM G, 1993, J ORAL MAXIL SURG, V51, P1211, DOI 10.1016/S0278-2391(10)80291-5; Reimold SC, 2003, NEW ENGL J MED, V349, P52, DOI 10.1056/NEJMcp021265; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; ROSENBECK-HANSEN J V, 1968, Nordisk Medicin, V80, P1305; Ryan TJ, 1999, CIRCULATION, V100, P1016, DOI 10.1161/01.CIR.100.9.1016; Salem DN, 2001, CHEST, V119, p207S, DOI 10.1378/chest.119.1_suppl.207S; Schnyder G, 2001, NEW ENGL J MED, V345, P1593, DOI 10.1056/NEJMoa011364; Schulman S, 1999, Wien Med Wochenschr, V149, P66; Schulman S, 1997, NEW ENGL J MED, V336, P393, DOI 10.1056/NEJM199702063360601; SCHULMAN S, 1984, THROMB HAEMOSTASIS, V52, P276; SCHULMAN S, 2001, WILLIAMS HEMATOLOGY, P1777; Smith P, 1999, J INTERN MED, V245, P383, DOI 10.1046/j.1365-2796.1999.00462.x; Stein PD, 2001, CHEST, V119, p220S, DOI 10.1378/chest.119.1_suppl.220S; Stein PD, 2001, CHEST, V120, P1044; SZEKELY P, 1964, BMJ-BRIT MED J, V1, P1209, DOI 10.1136/bmj.1.5392.1209; vandenBelt AGM, 1997, ARCH INTERN MED, V157, P2227, DOI 10.1001/archinte.157.19.2227; Vigano'D'Angelo S, 1998, THROMB RES, V91, pS100	73	159	173	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2003	349	7					675	683		10.1056/NEJMcp025373	http://dx.doi.org/10.1056/NEJMcp025373			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711FL	12917305				2022-12-28	WOS:000184728900010
J	Wang, YJ; Wang, J; Sun, HQ; Martinez, M; Sun, YX; Macia, E; Kirchhausen, T; Albanesi, JP; Roth, MG; Yin, HL				Wang, YJ; Wang, J; Sun, HQ; Martinez, M; Sun, YX; Macia, E; Kirchhausen, T; Albanesi, JP; Roth, MG; Yin, HL			Phosphatidylinositol 4 phosphate regulates targeting of clathrin adaptor AP-1 complexes to the golgi	CELL			English	Article							PLASMA-MEMBRANE; SORTING SIGNALS; 4,5-BISPHOSPHATE; 4-KINASE; PROTEIN; DOMAIN; YEAST; PHOSPHOINOSITIDES; RECRUITMENT; SECRETION	Phosphatidylinositol 4 phosphate [PI(4)P] is essential for secretion in yeast, but its role in mammalian cells is unclear. Current paradigms propose that PI(4)P acts primarily as a precursor to phosphatidylinositol 4,5 bisphosphate (PIP2), an important plasma membrane regulator. We found that PI(4)P is enriched in the mammalian Golgi, and used RNA interference (RNAi) of PI4KIIalpha, a Golgi resident phosphatidylinositol 4 kinase, to determine whether PI(4)P directly regulates the Golgi. PI4KIIalpha RNAi decreases Golgi PI(4)P, blocks the recruitment of clathrin adaptor AP-1 complexes to the Golgi, and inhibits AP-1-dependent functions. This AP-1 binding defect is rescued by adding back PI(4)P. In addition, purified AP-1 binds PI(4)P, and anti-PI(4)P inhibits the in vitro recruitment of cytosolic AP-1 to normal cellular membranes. We propose that PI4KIIalpha establishes the Golgi's unique lipid-defined organelle identity by generating PI(4)P-rich domains that specify the docking of the AP-1 coat machinery.	Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Yin, HL (corresponding author), Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA.	helen.yin@utsouthwestern.edu	Macia, Eric/AAW-2964-2021	Roth, Michael/0000-0002-9056-332X; macia, eric/0000-0003-3686-2000	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM021681, R01GM051112, R01GM036548, R01GM055562, R01GM037547] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM55562, R01 GM51112, GM37547, GM36548, GM21681] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Balla A, 2002, J BIOL CHEM, V277, P20041, DOI 10.1074/jbc.M111807200; Barylko B, 2001, J BIOL CHEM, V276, P7705, DOI 10.1074/jbc.C000861200; Barylko B, 2002, J BIOL CHEM, V277, P44366, DOI 10.1074/jbc.M203241200; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Cockcroft S, 2001, J MEMBRANE BIOL, V180, P187, DOI 10.1007/s002320010069; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Cremona O, 2001, J CELL SCI, V114, P1041; Crottet P, 2002, MOL BIOL CELL, V13, P3672, DOI 10.1091/mbc.E02-05-0309; De Matteis MA, 2002, CURR OPIN CELL BIOL, V14, P434, DOI 10.1016/S0955-0674(02)00357-5; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gaidarov I, 1999, J CELL BIOL, V146, P755, DOI 10.1083/jcb.146.4.755; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Guo J, 2003, P NATL ACAD SCI USA, V100, P3995, DOI 10.1073/pnas.0230488100; Hama H, 1999, J BIOL CHEM, V274, P34294, DOI 10.1074/jbc.274.48.34294; Han P, 2002, CYTOTHERAPY, V4, P277, DOI 10.1080/146532402320219790; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Krugmann S, 2002, MOL CELL, V9, P95, DOI 10.1016/S1097-2765(02)00434-3; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Lin S, 1997, J BIOL CHEM, V272, P26300, DOI 10.1074/jbc.272.42.26300; Lin SS, 1998, J CELL BIOL, V142, P51, DOI 10.1083/jcb.142.1.51; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Meyer C, 2001, J CELL SCI, V114, P4469; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Minogue S, 2001, J BIOL CHEM, V276, P16635, DOI 10.1074/jbc.M100982200; Munro S, 2002, CURR OPIN CELL BIOL, V14, P506, DOI 10.1016/S0955-0674(02)00350-2; Ozaki S, 2000, P NATL ACAD SCI USA, V97, P11286, DOI 10.1073/pnas.210197897; Panaretou C, 2002, BIOCHEM J, V363, P289, DOI 10.1042/0264-6021:3630289; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; Rohde G, 2002, J CELL BIOL, V158, P209, DOI 10.1083/jcb.200203103; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Shelton SN, 2003, BIOCHEM J, V371, P533, DOI 10.1042/BJ20021407; Siddhanta A, 2000, J BIOL CHEM, V275, P12023, DOI 10.1074/jbc.275.16.12023; Skippen A, 2002, J BIOL CHEM, V277, P5823, DOI 10.1074/jbc.M110274200; Tran D, 1999, J HISTOCHEM CYTOCHEM, V47, P601, DOI 10.1177/002215549904700503; TRAUB LM, 1993, J CELL BIOL, V123, P561, DOI 10.1083/jcb.123.3.561; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Wei YJ, 2002, J BIOL CHEM, V277, P46586, DOI 10.1074/jbc.M206860200; Wong K, 1997, J BIOL CHEM, V272, P13236, DOI 10.1074/jbc.272.20.13236; Yamamoto M, 2001, J CELL BIOL, V152, P867, DOI 10.1083/jcb.152.5.867; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zhu Y.-P., 1998, J SURFACTANTS DETERG, V1, P1; Zhu YX, 1999, P NATL ACAD SCI USA, V96, P5013, DOI 10.1073/pnas.96.9.5013	51	390	400	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 8	2003	114	3					299	310		10.1016/S0092-8674(03)00603-2	http://dx.doi.org/10.1016/S0092-8674(03)00603-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914695	Bronze			2022-12-28	WOS:000184679200007
J	Lyss, SB; Kamb, ML; Peterman, TA; Moran, JS; Newman, DR; Bolan, G; Douglas, JM; Iatesta, M; Malotte, CK; Zenilman, JM; Ehret, J; Gaydos, C; Newhall, WJ				Lyss, SB; Kamb, ML; Peterman, TA; Moran, JS; Newman, DR; Bolan, G; Douglas, JM; Iatesta, M; Malotte, CK; Zenilman, JM; Ehret, J; Gaydos, C; Newhall, WJ		RESPECT Study Grp	Chlamydia trachomatis among patients infected with and treated for Neisseria gonorrhoeae in sexually transmitted disease clinics in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							NONGONOCOCCAL URETHRITIS; GENITAL INFECTIONS; ADOLESCENT WOMEN; VENEREAL-DISEASE; PREVALENCE; MEN; COINFECTION; URINE; TRACT; INTERVENTION	Background: For two decades, treatment guidelines for sexually transmitted diseases (STDs) have recommended empirical co-treatment for chlamydia when patients are treated for gonorrhea. Because the epidemiology of and diagnostic testing for STDs have changed over time, co-treatment may no longer be needed as a clinical or public health strategy. Objective: To assess the prevalence of chlamydia among patients at STD clinics who are infected with and treated for Neisseria gonorrhoeae and to determine whether co-treatment recommendations are still justified. Design: Cross-sectional analysis of data from a multisite study. Setting: Five public STD clinics (Baltimore, Maryland; Denver, Colorado; Long Beach, California; Newark, New Jersey; and San Francisco, California), July 1993 through October 1995. Patients: 3885 heterosexual patients (2184 men and 1701 women) who agreed to participate in a trial of counseling interventions and had conclusive results from diagnostic tests for gonorrhea and chlamydia performed routinely as part of the trial. Measurements: infection with Chlamydia trachomatis as determined by polymerase chain reaction. Results: Chlamydia trachomatis was detected in 20% (95% CI, 16% to 24%) of 411 men and 42% (CI, 35% to 50%) of 151 women with laboratory-confirmed N. gonorrhoeae. Chlamydia trachomatis was detected in 19% (CI, 15% to 22%) of 410 men and 35% (CI, 28% to 43%) of 154 women with treatment indications for gonorrhea who would not otherwise have been treated for chlamydia: chlamydia prevalence among these patients was significantly higher than among patients without treatment indications for either gonorrhea or chlamydia: 7% in men and 9% in women (relative risk, 2.58 [CI, 1.92 to 3.47] and 4.12 [CI, 3.05 to 5.57], respectively). Conclusion: The frequent presence of chlamydia among patients at STD clinics who received treatment for gonorrhea, including sex partners of gonorrhea-infected patients, supports continuing current recommendations for co-treatment.	Ctr Dis Control & Prevent, Off Commun, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA; San Francisco Hlth Dept, San Francisco, CA USA; Denver Publ Hlth, Denver, CO USA; New Jersey State Dept Hlth, Newark, NJ USA; Calif State Univ Long Beach, Long Beach, CA 90840 USA; Baltimore City Dept Hlth, Baltimore, MD USA; Johns Hopkins Univ, Baltimore, MD 21218 USA	Centers for Disease Control & Prevention - USA; New Jersey Department of Health & Senior Services; California State University System; California State University Long Beach; Johns Hopkins University	Lyss, SB (corresponding author), Ctr Dis Control & Prevent, Off Commun, Natl Ctr HIV STD & TB Prevent, 1600 Clifton Rd NE,Mailstop E-07, Atlanta, GA 30333 USA.		Gaydos, Charlotte A./E-9937-2010					ALANI MD, 1977, BRIT J VENER DIS, V53, P88; [Anonymous], 2002, MMWR MORB MORTAL WKL, V51; ARYA OP, 1981, BRIT J VENER DIS, V57, P118; BIRO FM, 1995, CLIN PEDIATR, V34, P419, DOI 10.1177/000992289503400804; Black CM, 1997, CLIN MICROBIOL REV, V10, P160, DOI 10.1128/CMR.10.1.160; BOWIE WR, 1981, CAN MED ASSOC J, V124, P1477; BRUNHAM R, 1981, CLIN RES, V29, pA47; BURNS DCM, 1975, BRIT J VENER DIS, V51, P314; Carroll KC, 1998, J CLIN MICROBIOL, V36, P1630, DOI 10.1128/JCM.36.6.1630-1633.1998; *CDCP, 2000, TRACK HIDD EP TRENDS; *CDCP, 2002, SEX TRANS DIS SURV 2; Chernesky M, 1999, SEX TRANSM DIS, V26, pS8, DOI 10.1097/00007435-199904001-00003; CHOW JM, 2001, INT C SEX TRANSM INF; CHRISTMAS JT, 1989, OBSTET GYNECOL, V74, P295; Ciemins EL, 2000, SEX TRANSM DIS, V27, P249, DOI 10.1097/00007435-200005000-00002; Creighton S, 2003, INT J STD AIDS, V14, P109, DOI 10.1258/095646203321156872; David LM, 1997, INT J STD AIDS, V8, P311, DOI 10.1258/0956462971920154; DEVORE JL, 1991, PROBABILITY STAT ENG, P266; Dicker LW, 2003, SEX TRANSM DIS, V30, P472, DOI 10.1097/00007435-200305000-00016; Embling ML, 2000, ANN EMERG MED, V36, P28, DOI 10.1067/mem.2000.105930; GREYDANUS DE, 1980, J FAM PRACTICE, V10, P611; HANDSFIELD HH, 1997, INT C SEX TRANSM DIS; Hijazi L, 2002, SEX TRANSM INFECT, V78, P387, DOI 10.1136/sti.78.5.387; HILTON AL, 1974, BRIT J VENER DIS, V50, P1; HOLMES KK, 1975, NEW ENGL J MED, V292, P1199, DOI 10.1056/NEJM197506052922301; Hook Er., 1999, SEX TRANSM DIS; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Laumann EO, 1999, SEX TRANSM DIS, V26, P250, DOI 10.1097/00007435-199905000-00003; Lin JSL, 1998, J INFECT DIS, V178, P1707, DOI 10.1086/314485; LYCKE E, 1980, SEX TRANSM DIS, V7, P6, DOI 10.1097/00007435-198001000-00002; MARDH PA, 1980, BRIT J VENER DIS, V56, P327; Mehta SD, 2001, SEX TRANSM DIS, V28, P33, DOI 10.1097/00007435-200101000-00008; Mertz KJ, 1997, SEX TRANSM DIS, V24, P169, DOI 10.1097/00007435-199703000-00009; METCALF CA, 2002, 14 INT AIDS C BARC S; NAYYAR KC, 1976, BRIT J VENER DIS, V52, P396; Oh MK, 1998, ARCH PEDIAT ADOL MED, V152, P52; ORIEL JD, 1974, BRIT J VENER DIS, V50, P11; ORIEL JD, 1976, J INFECT DIS, V133, P568, DOI 10.1093/infdis/133.5.568; ORIEL JD, 1975, J INFECT DIS, V131, P376, DOI 10.1093/infdis/131.4.376; PERROUD HM, 1978, BRIT J VENER DIS, V54, P45; RICHMOND SJ, 1972, BRIT J VENER DIS, V48, P437; RUDEN AK, 1986, ACTA DERM-VENEREOL, V66, P453; SCHACHTER J, 1975, JAMA-J AM MED ASSOC, V231, P1252, DOI 10.1001/jama.231.12.1252; SMITH TF, 1978, AM J CLIN PATHOL, V70, P333; STAMM WE, 1984, NEW ENGL J MED, V310, P545, DOI 10.1056/NEJM198403013100901; SVENSSON L, 1981, BRIT J VENER DIS, V57, P259; TERHO P, 1978, BRIT J VENER DIS, V54, P326; WONG JL, 1977, SEX TRANSM DIS, V4, P4, DOI 10.1097/00007435-197701000-00002; WOOLFITT JMG, 1977, BRIT J VENER DIS, V53, P93; Xu KY, 1998, SEX TRANSM DIS, V25, P533, DOI 10.1097/00007435-199811000-00007; 2002, MMWR MORB MORTAL WKL, V51, P36; 1985, MMWR MORB MORTAL S3, V34, pS53; 1982, MMWR MORB MORTAL  S2, V31, pS33	53	58	63	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2003	139	3					178	185		10.7326/0003-4819-139-3-200308050-00007	http://dx.doi.org/10.7326/0003-4819-139-3-200308050-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707RH	12899585				2022-12-28	WOS:000184523300003
J	Crow, JF				Crow, JF			There's something curious about paternal-age effects	SCIENCE			English	Editorial Material							MUTATIONS; CELLS		Univ Wisconsin, Dept Genet, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Crow, JF (corresponding author), Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.	jfcrow@facstaff.wisc.edu						ABRAHAMSON S, 1966, GENETICS, V54, P687; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; GLASER R, IN PRESS AM J HUM GE; Goriely A, 2003, SCIENCE, V301, P643, DOI 10.1126/science.1085710; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; Luria SE, 1943, GENETICS, V28, P491; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Moloney DM, 1996, NAT GENET, V13, P48, DOI 10.1038/ng0596-48; PENROSE LS, 1955, LANCET, V2, P312; Potten CS, 2002, J CELL SCI, V115, P2381; RISCH N, 1987, AM J HUM GENET, V41, P218; Tiemann-Boege I, 2002, P NATL ACAD SCI USA, V99, P14952, DOI 10.1073/pnas.232568699; VOGEL F, 1997, HUM GENET, P402; Weinberg W., 1912, ARCH RASSEN U GESEL, V9, P710	14	53	55	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2003	301	5633					606	607		10.1126/science.1088552	http://dx.doi.org/10.1126/science.1088552			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893932				2022-12-28	WOS:000184473600027
J	Locher, KP; Bass, RB; Rees, DC				Locher, KP; Bass, RB; Rees, DC			Breaching the barrier	SCIENCE			English	Editorial Material									Swiss Fed Inst Technol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; California Institute of Technology	Locher, KP (corresponding author), Swiss Fed Inst Technol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	dcrees@caltech.edu						Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Busch W, 2002, CRIT REV BIOCHEM MOL, V37, P287, DOI 10.1080/10409230290771528; Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; Hirai T, 2002, NAT STRUCT BIOL, V9, P597, DOI 10.1038/nsb821; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Sorgen PL, 2002, P NATL ACAD SCI USA, V99, P14037, DOI 10.1073/pnas.182552199; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; WIDDAS WF, 1952, J PHYSIOL-LONDON, V118, P23, DOI 10.1113/jphysiol.1952.sp004770	18	28	28	2	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2003	301	5633					603	604		10.1126/science.1088621	http://dx.doi.org/10.1126/science.1088621			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893929				2022-12-28	WOS:000184473600024
J	Liou, YC; Sun, A; Ryo, A; Zhou, XZ; Yu, ZX; Huang, HK; Uchida, T; Bronson, R; Bing, GY; Li, XJ; Hunter, T; Lu, KP				Liou, YC; Sun, A; Ryo, A; Zhou, XZ; Yu, ZX; Huang, HK; Uchida, T; Bronson, R; Bing, GY; Li, XJ; Hunter, T; Lu, KP			Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration	NATURE			English	Article							PAIRED HELICAL FILAMENTS; PROLINE-DIRECTED PHOSPHORYLATION; ALZHEIMERS-DISEASE; TRANSGENIC MICE; TAU-PROTEIN; NEUROFIBRILLARY TANGLES; P301L TAU; ISOMERIZATION; HYPERPHOSPHORYLATION; DEPHOSPHORYLATION	The neuropathological hallmarks of Alzheimer's disease and other tauopathies include senile plaques and/or neurofibrillary tangles(1-4). Although mouse models have been created by overexpressing specific proteins including beta-amyloid precursor protein, presenilin and tau(1-10), no model has been generated by gene knockout. Phosphorylation of tau and other proteins on serine or threonine residues preceding proline seems to precede tangle formation and neurodegeneration in Alzheimer's disease(11-14). Notably, these phospho(Ser/Thr)-Pro motifs exist in two distinct conformations, whose conversion in some proteins is catalysed by the Pin1 prolyl isomerase(15-17). Pin1 activity can directly restore the conformation and function of phosphorylated tau or it can do so indirectly by promoting its dephosphorylation, which suggests that Pin1 is involved in neurodegeneration(14,18,19); however, genetic evidence is lacking. Here we show that Pin1 expression is inversely correlated with predicted neuronal vulnerability and actual neurofibrillary degeneration in Alzheimer's disease. Pin1 knockout in mice causes progressive age-dependent neuropathy characterized by motor and behavioural deficits, tau hyperphosphorylation, tau filament formation and neuronal degeneration. Thus, Pin1 is pivotal in protecting against age-dependent neurodegeneration, providing insight into the pathogenesis and treatment of Alzheimer's disease and other tauopathies.	Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Canc Biol Program, Boston, MA 02215 USA; Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA; Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; Tohoku Univ, Dept Pathol, Sendai, Miyagi 9808575, Japan; Tufts Univ, Sch Vet Med, North Grafton, MA 01536 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Kentucky; Emory University; Salk Institute; Tohoku University; Tufts University	Lu, KP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Canc Biol Program, Boston, MA 02215 USA.		bing, guoying/F-7084-2012	Uchida, Takafumi/0000-0003-3665-4906; Bing, Guoying/0000-0003-0609-8152				Allen B, 2002, J NEUROSCI, V22, P9340; BANCHER C, 1989, BRAIN RES, V477, P90, DOI 10.1016/0006-8993(89)91396-6; DAVIES DC, 1992, ACTA NEUROPATHOL, V83, P510, DOI 10.1007/BF00310028; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Gordon-Krajcer W, 2000, BRAIN RES, V856, P163, DOI 10.1016/S0006-8993(99)02391-4; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; Holzer M, 2002, ACTA NEUROPATHOL, V104, P471, DOI 10.1007/s00401-002-0581-1; Husseman JW, 2000, NEUROBIOL AGING, V21, P815, DOI 10.1016/S0197-4580(00)00221-9; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Kins S, 2001, J BIOL CHEM, V276, P38193; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Lu KP, 2003, BIOESSAYS, V25, P174, DOI 10.1002/bies.10223; Lu PJ, 1999, NATURE, V399, P784; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Mandelkow EM, 1998, TRENDS CELL BIOL, V8, P425, DOI 10.1016/S0962-8924(98)01368-3; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Preuss U, 1998, EUR J CELL BIOL, V76, P176, DOI 10.1016/S0171-9335(98)80032-0; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Vincent I, 1998, NEUROBIOL AGING, V19, P287, DOI 10.1016/S0197-4580(98)00071-2; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509; Wong PC, 2002, NAT NEUROSCI, V5, P633, DOI 10.1038/nn0702-633; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	30	354	373	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					556	561		10.1038/nature01832	http://dx.doi.org/10.1038/nature01832			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891359				2022-12-28	WOS:000184454700044
J	Okada, Y; Higuchi, H; Hirokawa, N				Okada, Y; Higuchi, H; Hirokawa, N			Processivity of the single-headed kinesin KIF1A through biased binding to tubulin	NATURE			English	Article							SUPERFAMILY PROTEIN KIF1A; MOTOR PROTEIN; MECHANISM; MOLECULES; MICROTUBULES; TRANSPORT; MOVEMENT; ATPASE; MUTANT; STEPS	Conventional isoforms of the motor protein kinesin behave functionally not as 'single molecules' but as 'two molecules' paired. This dimeric structure poses a barrier to solving its mechanism(1-4). To overcome this problem, we used an unconventional kinesin KIF1A (refs 5, 6) as a model molecule. KIF1A moves processively as an independent monomer(7,8), and can also work synergistically as a functional dimer(9). Here we show, by measuring its movement with an optical trapping system(10), that a single ATP hydrolysis triggers a single stepping movement of a single KIF1A monomer. The step size is distributed stochastically around multiples of 8 nm with a gaussian-like envelope and a standard deviation of 15 nm. On average, the step is directional to the microtubule's plus-end against a load force of up to 0.15 pN. As the source for this directional movement, we show that KIF1A moves to the microtubule's plus-end by similar to3 nm on average on binding to the microtubule, presumably by preferential binding to tubulin on the plus-end side. We propose a simple physical formulation to explain the movement of KIF1A.	Univ Tokyo, Dept Cell Biol & Anat, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; Tohoku Univ, Grad Sch Engn, Dept Met, Sendai, Miyagi 9808579, Japan; Tohoku Univ, Interdisciplinary Res Ctr, Sendai, Miyagi 9808579, Japan	University of Tokyo; Tohoku University; Tohoku University	Hirokawa, N (corresponding author), Univ Tokyo, Dept Cell Biol & Anat, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan.		Okada, Yasushi/N-5067-2015	Okada, Yasushi/0000-0003-2601-3689				Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; BERLINER E, 1995, NATURE, V373, P718, DOI 10.1038/373718a0; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; deCastro MJ, 2000, NAT CELL BIOL, V2, P724, DOI 10.1038/35036357; Endow SA, 2000, NATURE, V406, P913, DOI 10.1038/35022617; Farrell CM, 2002, J BIOL CHEM, V277, P17079, DOI 10.1074/jbc.M108793200; Gilbert SP, 1998, BIOCHEMISTRY-US, V37, P792, DOI 10.1021/bi971117b; Hackney DD, 2002, BIOCHEMISTRY-US, V41, P4437, DOI 10.1021/bi0159229; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; HOWARD J, 1993, METHOD CELL BIOL, V39, P105, DOI 10.1016/S0091-679X(08)60164-8; Hua W, 2002, SCIENCE, V295, P844, DOI 10.1126/science.1063089; Inoue Y, 1997, P NATL ACAD SCI USA, V94, P7275, DOI 10.1073/pnas.94.14.7275; Julicher F, 1997, REV MOD PHYS, V69, P1269, DOI 10.1103/RevModPhys.69.1269; Kaseda K, 2002, P NATL ACAD SCI USA, V99, P16058, DOI 10.1073/pnas.252409199; Kikkawa M, 2000, CELL, V100, P241, DOI 10.1016/S0092-8674(00)81562-7; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Nishiyama M, 2002, NAT CELL BIOL, V4, P790, DOI 10.1038/ncb857; Nishiyama M, 2001, NAT CELL BIOL, V3, P425, DOI 10.1038/35070116; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Tomishige M, 2002, SCIENCE, V297, P2263, DOI 10.1126/science.1073386; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104	25	137	142	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 31	2003	424	6948					574	577		10.1038/nature01804	http://dx.doi.org/10.1038/nature01804			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891363				2022-12-28	WOS:000184454700048
J	Reeves, WH; Skryabin, DV; Biancalana, F; Knight, JC; Russell, PS; Omenetto, FG; Efimov, A; Taylor, AJ				Reeves, WH; Skryabin, DV; Biancalana, F; Knight, JC; Russell, PS; Omenetto, FG; Efimov, A; Taylor, AJ			Transformation and control of ultra-short pulses in dispersion-engineered photonic crystal fibres	NATURE			English	Article							STIMULATED RAMAN-SCATTERING; SUPERCONTINUUM GENERATION; CONTINUUM GENERATION; SOLITONS; PROPAGATION	Photonic crystal fibres (PCFs) offer greatly enhanced design freedom compared to standard optical fibres. For example, they allow precise control of the chromatic dispersion (CD) profile-the frequency dependence of propagation speed-over a broad wavelength range. This permits studies of nonlinear pulse propagation in previously inaccessible parameter regimes. Here we report on spectral broadening of 100-fs pulses in PCFs with anomalously flat CD profiles. Maps of the spectral and spatio-temporal behaviour as a function of power show that dramatic conversion (to both longer and shorter wavelengths) can occur in remarkably short lengths of fibre, depending on the magnitude and shape of the CD profile. Because the PCFs used are single-mode at all wavelengths, the light always emerges in a fundamental guided mode. Excellent agreement is obtained between the experimental results and numerical solutions of the nonlinear wave equation, indicating that the underlying processes can be reliably modelled. These results show how, through appropriate choice of CD, nonlinearities can be efficiently harnessed to generate laser light at new wavelengths.	Univ Bath, Dept Phys, Optoelect Grp, Bath BA2 7AY, Avon, England; Los Alamos Natl Lab, Div Phys, Los Alamos, NM 87545 USA; Los Alamos Natl Lab, Div Mat Sci & Technol, Los Alamos, NM 87545 USA	University of Bath; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Knight, JC (corresponding author), Univ Bath, Dept Phys, Optoelect Grp, Bath BA2 7AY, Avon, England.	j.c.knight@bath.ac.uk	Skryabin, Dmitry V/F-3589-2011; Skryabin, Dmitry/AAB-4224-2021; Knight, Jonathan C/D-3879-2011; Biancalana, Fabio/C-2377-2008; Russell, Philip St.J./G-5132-2012	Skryabin, Dmitry V/0000-0001-5038-2500; Skryabin, Dmitry/0000-0001-5038-2500; Knight, Jonathan C/0000-0002-0802-8804; Russell, Philip St.J./0000-0002-8972-2477; Biancalana, Fabio/0000-0002-4093-7688				Agrawal G. P., 2001, NONLINEAR FIBER OPTI; AKHMEDIEV N, 1995, PHYS REV A, V51, P2602, DOI 10.1103/PhysRevA.51.2602; Benabid F, 2002, SCIENCE, V298, P399, DOI 10.1126/science.1076408; Coen S, 2002, J OPT SOC AM B, V19, P753, DOI 10.1364/JOSAB.19.000753; Dudley JM, 2002, J OPT SOC AM B, V19, P765, DOI 10.1364/JOSAB.19.000765; Gaeta AL, 2002, OPT LETT, V27, P924, DOI 10.1364/OL.27.000924; Hansryd J, 2001, IEEE PHOTONIC TECH L, V13, P194, DOI 10.1109/68.914318; Hartl I, 2001, OPT LETT, V26, P608, DOI 10.1364/OL.26.000608; HASEGAWA A, 1973, APPL PHYS LETT, V23, P142, DOI 10.1063/1.1654836; Herrmann J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.173901; Holzwarth R, 2000, PHYS REV LETT, V85, P2264, DOI 10.1103/PhysRevLett.85.2264; Jones DJ, 2000, SCIENCE, V288, P635, DOI 10.1126/science.288.5466.635; Knight JC, 1997, OPT LETT, V22, P484, DOI 10.1364/OL.22.000484; Kumar VVRK, 2002, OPT EXPRESS, V10, P1520, DOI 10.1364/OE.10.001520; Lee J, 2001, IEEE PHOTONIC TECH L, V13, P317, DOI 10.1109/68.917837; LUNDIN R, 1994, APPL OPTICS, V33, P1011, DOI 10.1364/AO.33.001011; MOLLENAUER LF, 1980, PHYS REV LETT, V45, P1095, DOI 10.1103/PhysRevLett.45.1095; Omenetto FG, 2001, OPT LETT, V26, P938, DOI 10.1364/OL.26.000938; Ortigosa-Blanch A, 2002, J OPT SOC AM B, V19, P2567, DOI 10.1364/JOSAB.19.002567; Parker AR, 2000, J OPT A-PURE APPL OP, V2, pR15, DOI 10.1088/1464-4258/2/6/201; Reeves WH, 2002, OPT EXPRESS, V10, P609, DOI 10.1364/OE.10.000609; RUSSELL JS, 1845, 14 M BRIT ASS ADV SC, P311; Russell P, 2003, SCIENCE, V299, P358, DOI 10.1126/science.1079280; Smith NJ, 1996, ELECTRON LETT, V32, P54, DOI 10.1049/el:19960062; Takushima Y, 1999, IEEE PHOTONIC TECH L, V11, P322, DOI 10.1109/68.748222; TATEDA M, 1981, IEEE J QUANTUM ELECT, V17, P404, DOI 10.1109/JQE.1981.1071115; Wadsworth WJ, 2002, J OPT SOC AM B, V19, P2148, DOI 10.1364/JOSAB.19.002148; Weiner AM, 2000, REV SCI INSTRUM, V71, P1929, DOI 10.1063/1.1150614; ZAKHAROV VE, 1972, SOV PHYS JETP-USSR, V34, P62	29	343	364	6	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 31	2003	424	6948					511	515		10.1038/nature01798	http://dx.doi.org/10.1038/nature01798			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891348				2022-12-28	WOS:000184454700032
J	Hoskins, BJ				Hoskins, BJ			Climate change at cruising altitude?	SCIENCE			English	Editorial Material							TROPOSPHERE; TROPOPAUSE; HEIGHT		Univ Reading, Dept Meteorol, Reading RG6 6BB, Berks, England	University of Reading	Hoskins, BJ (corresponding author), Univ Reading, Dept Meteorol, Reading RG6 6BB, Berks, England.							APPENZELLER C, 1992, NATURE, V358, P570, DOI 10.1038/358570a0; Bethan S, 1996, Q J ROY METEOR SOC, V122, P929, DOI 10.1002/qj.49712253207; DAVIES HC, 1994, J ATMOS SCI, V51, P1930, DOI 10.1175/1520-0469(1994)051<1930:EEWARD>2.0.CO;2; HELD IM, 1982, J ATMOS SCI, V39, P412, DOI 10.1175/1520-0469(1982)039<0412:OTHOTT>2.0.CO;2; HOLTON JR, 1995, REV GEOPHYS, V33, P403, DOI 10.1029/95RG02097; HOSKINS BJ, 1985, Q J ROY METEOR SOC, V111, P877, DOI 10.1256/smsqj.47001; Jackson DR, 2001, J ATMOS SCI, V58, P173, DOI 10.1175/1520-0469(2001)058<0173:TITLLT>2.0.CO;2; KEYSER D, 1986, MON WEATHER REV, V114, P452, DOI 10.1175/1520-0493(1986)114<0452:AROTSA>2.0.CO;2; Santer BD, 2003, SCIENCE, V301, P479, DOI 10.1126/science.1084123; Thuburn J, 2000, J ATMOS SCI, V57, P17, DOI 10.1175/1520-0469(2000)057<0017:SIOTHT>2.0.CO;2	10	4	7	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2003	301	5632					469	470		10.1126/science.1086051	http://dx.doi.org/10.1126/science.1086051			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12881558				2022-12-28	WOS:000184340500028
J	Richardson, JP				Richardson, JP			Loading rho to terminate transcription	CELL			English	Review							ESCHERICHIA-COLI; DEPENDENT TERMINATION; BINDING DOMAIN; RNA; ANTITERMINATION; RECOGNITION; PROTECTION; MECHANISM; LAMBDA; SITE	In bacteria, one of the major transcriptional termination mechanisms requires a hexameric RNA/DNA helicase known as Rho. One question that has remained unanswered is how the helicase loads onto a nascent transcript so that it can initiate actions on the transcript to cause termination. Recent structures of Rho bound to nucleic acid by Skordalakes and Berger (2003) show how the individual RNA-binding domains of the 6 subunits are organized and that the ring is split open. The opening is wide enough to accommodate single-stranded RNA and suggests that this conformation is poised to load onto mRNA.	Indiana Univ, Dept Chem, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Richardson, JP (corresponding author), Indiana Univ, Dept Chem, 800 E Kirkwood Ave, Bloomington, IN 47405 USA.							Allison TJ, 1998, NAT STRUCT BIOL, V5, P352, DOI 10.1038/nsb0598-352; BEAR DG, 1988, J MOL BIOL, V199, P623, DOI 10.1016/0022-2836(88)90306-3; Bogden CE, 1999, MOL CELL, V3, P487, DOI 10.1016/S1097-2765(00)80476-1; CONDON C, 1995, MICROBIOL REV, V59, P623, DOI 10.1128/MMBR.59.4.623-645.1995; COURT D, 1980, J MOL BIOL, V138, P231, DOI 10.1016/0022-2836(80)90285-5; GALLUPPI GR, 1980, J MOL BIOL, V138, P513, DOI 10.1016/S0022-2836(80)80016-7; GOGOL EP, 1991, J MOL BIOL, V221, P1127, DOI 10.1016/0022-2836(91)80116-C; HART CM, 1994, J MOL BIOL, V237, P255, DOI 10.1006/jmbi.1994.1229; LI J, 1993, GENE DEV, V7, P161, DOI 10.1101/gad.7.1.161; Nudler E, 2002, GENES CELLS, V7, P755, DOI 10.1046/j.1365-2443.2002.00563.x; RICHARDSON JP, 1991, CELL, V64, P1047, DOI 10.1016/0092-8674(91)90257-Y; Richardson JP, 2002, BBA-GENE STRUCT EXPR, V1577, P251, DOI 10.1016/S0167-4781(02)00456-6; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; von Hippel PH, 2001, CELL, V104, P177, DOI 10.1016/S0092-8674(01)00203-3; Wei RR, 2001, J BIOL CHEM, V276, P28380, DOI 10.1074/jbc.M102444200; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611	16	58	59	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 25	2003	114	2					157	159		10.1016/S0092-8674(03)00554-3	http://dx.doi.org/10.1016/S0092-8674(03)00554-3			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887917	Bronze			2022-12-28	WOS:000184378700005
J	Schmitz, C; Perraud, AL; Johnson, CO; Inabe, K; Smith, MK; Penner, R; Kurosaki, T; Fleig, A; Scharenberg, AM				Schmitz, C; Perraud, AL; Johnson, CO; Inabe, K; Smith, MK; Penner, R; Kurosaki, T; Fleig, A; Scharenberg, AM			Regulation of vertebrate cellular Mg2+ Homeostasis by TRPM7	CELL			English	Article							MAGNESIUM TRANSPORT; ADP-RIBOSE; CHANNEL; PROTEIN; ION; MEMBRANE; LTRPC2; FAMILY; KINASE; YEAST	TRPM7 is a polypeptide with intrinsic ion channel and protein kinase domains whose targeted deletion causes cells to experience growth arrest within 24 hr and eventually die. Here, we show that while TRPM7's kinase domain is not essential for activation of its channel, a functional coupling exists such that structural alterations of the kinase domain alter the sensitivity of channel activation to Mg2+. Investigation of the relationship between Mg2+ and the cell biological role of TRPM7 revealed that TRPM7-deficient cells become Mg2+ deficient, that both the viability and proliferation of TRPM7-deficient cells are rescued by supplementation of extracellular Mg2+, and that the capacity of heterologously expressed TRPM7 mutants to complement TRPM7 deficiency correlates with their sensitivity to Mg2+. Overall, our results indicate that TRPM7 has a central role in Mg2+ homeostasis as a Mg2+ uptake pathway regulated through a functional coupling between its channel and kinase domains.	Univ Washington, Dept Immunol, Dept Pediat, Seattle, WA 98195 USA; Childrens Hosp & Reg Med Ctr, Seattle, WA 98195 USA; Natl Jewish Med & Res Ctr, Dept Immunol, Denver, CO 80206 USA; Kansai Med Univ, Inst Liver Res, Dept Mol Genet, Osaka 5708506, Japan; RIKEN, Res Ctr Allergy & Immunol, Lab Lymphocyte Differentiat, Osaka, Japan; Univ Hawaii, Queens Med Ctr, Ctr Biomed Res, Lab Cell & Mol Signaling, Honolulu, HI 96813 USA; Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96813 USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; National Jewish Health; Kansai Medical University; RIKEN; The Queen's Medical Center; University of Hawaii System; University of Hawaii System	Scharenberg, AM (corresponding author), Univ Washington, Dept Immunol, Dept Pediat, Seattle, WA 98195 USA.		Kurosaki, Tomohiro/D-1306-2009	Kurosaki, Tomohiro/0000-0002-6352-304X; Fleig, Andrea/0000-0001-8396-7249; Penner, Reinhold/0000-0002-5366-1537	NIAID NIH HHS [R01-AI64316] Funding Source: Medline; NIGMS NIH HHS [R01-GM065360] Funding Source: Medline; NINDS NIH HHS [R01-NS040927] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040927] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bui DM, 1999, J BIOL CHEM, V274, P20438, DOI 10.1074/jbc.274.29.20438; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Elliott AC, 2001, CELL CALCIUM, V30, P73, DOI 10.1054/ceca.2001.0215; Graschopf A, 2001, J BIOL CHEM, V276, P16216, DOI 10.1074/jbc.M101504200; Gregan J, 2001, MOL GEN GENET, V264, P773, DOI 10.1007/s004380000366; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hermosura MC, 2002, J PHYSIOL-LONDON, V539, P445, DOI 10.1113/jphysiol.2001.013361; Hofmann T, 2000, J MOL MED, V78, P14, DOI 10.1007/s001090050378; Li LG, 2001, PLANT CELL, V13, P2761, DOI 10.1105/tpc.13.12.2761; MacDiarmid CW, 1998, J BIOL CHEM, V273, P1727, DOI 10.1074/jbc.273.3.1727; MONTEILHZOLLER MK, 2003, J PHYSL, V121, P1; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; PERRAUD AL, 2003, CELL CALCIUM, V382, P1; Romani AMP, 2000, FRONT BIOSCI, V5, pD720, DOI 10.2741/Romani; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Ryazanov AG, 2002, FEBS LETT, V514, P26, DOI 10.1016/S0014-5793(02)02299-8; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Smith RL, 1998, MOL MICROBIOL, V28, P217, DOI 10.1046/j.1365-2958.1998.00810.x; Vennekens R, 2002, CELL CALCIUM, V31, P253, DOI 10.1016/S0143-4160(02)00055-6; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8; Zhang Y, 1998, EMBO J, V17, P7304, DOI 10.1093/emboj/17.24.7304	26	571	595	1	36	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 25	2003	114	2					191	200		10.1016/S0092-8674(03)00556-7	http://dx.doi.org/10.1016/S0092-8674(03)00556-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887921	Bronze			2022-12-28	WOS:000184378700009
J	Walter, F; Bertoldi, F; Carilli, C; Cox, P; Lo, KY; Neri, R; Fan, XH; Omont, A; Strauss, MA; Menten, KM				Walter, F; Bertoldi, F; Carilli, C; Cox, P; Lo, KY; Neri, R; Fan, XH; Omont, A; Strauss, MA; Menten, KM			Molecular gas in the host galaxy of a quasar at redshift z=6.42	NATURE			English	Article							LINE EMISSION	Observations of molecular hydrogen in quasar host galaxies at high redshifts provide fundamental constraints on galaxy evolution, because it is out of this molecular gas that stars form. Molecular hydrogen is traced by emission from the carbon monoxide molecule, CO; cold H-2 itself is generally not observable. Carbon monoxide has been detected in about ten quasar host galaxies with redshifts z > 2; the record- holder is at z = 4.69 (refs 1- 3). Here we report CO emission from the quasar SDSS J114816.64 + 525150.3 (refs 5, 6) at z = 6.42. At that redshift, the Universe was only 1/16 of its present age, and the era of cosmic reionization was just ending. The presence of about 2 x 10(10) M-. of H-2 in an object at this time demonstrates that molecular gas enriched with heavy elements can be generated rapidly in the youngest galaxies.	Natl Radio Astron Observ, Socorro, NM 87801 USA; Max Planck Inst Radioastron, D-53121 Bonn, Germany; Univ Paris 11, Inst Astrophys Spatiale, F-91405 Orsay, France; Inst Radio Astron Millimetr, F-38406 St Martin Dheres, France; Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; Princeton Univ Observ, Princeton, NJ 08544 USA	National Radio Astronomy Observatory (NRAO); Max Planck Society; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; University of Arizona; Princeton University	Walter, F (corresponding author), Natl Radio Astron Observ, POB 0, Socorro, NM 87801 USA.	fwalter@nrao.edu		Walter, Fabian/0000-0003-4793-7880				ARNETT D, 1991, ASTROPHYS J, V383, P295, DOI 10.1086/170786; BERTOLDI F, IN PRESS ASTRON ASTR; Carilli CL, 2002, ASTROPHYS J, V569, P605, DOI 10.1086/339361; Carilli CL, 2002, ASTRON J, V123, P1838, DOI 10.1086/339306; CEN R, UNPUB ASTROPHYS J LE; Downes D, 1998, ASTROPHYS J, V507, P615, DOI 10.1086/306339; ELVIS M, 1994, ASTROPHYS J SUPPL S, V95, P1, DOI 10.1086/192093; Fan XH, 2003, ASTRON J, V125, P1649, DOI 10.1086/368246; Ferrarese L, 2000, ASTROPHYS J, V539, pL9, DOI 10.1086/312838; Gebhardt K, 2000, ASTROPHYS J, V539, pL13, DOI 10.1086/312840; Haiman Z, 2002, ASTROPHYS J, V578, P702, DOI 10.1086/342610; Heger A, 2002, ASTROPHYS J, V567, P532, DOI 10.1086/338487; Hu EM, 2002, ASTROPHYS J, V568, pL75, DOI 10.1086/340424; KOGUT A, UNPUB ASTROPHYS J; Loeb A, 2001, ANNU REV ASTRON ASTR, V39, P19, DOI 10.1146/annurev.astro.39.1.19; Ohta K, 1996, NATURE, V382, P426, DOI 10.1038/382426a0; Omont A, 1996, NATURE, V382, P428, DOI 10.1038/382428a0; Pentericci L, 2002, ASTRON J, V123, P2151, DOI 10.1086/340077; Richards GT, 2002, ASTRON J, V124, P1, DOI 10.1086/341167; SOLOMON PM, 1992, NATURE, V356, P318, DOI 10.1038/356318a0; Solomon PM, 1997, ASTROPHYS J, V478, P144, DOI 10.1086/303765; SPERGEL DN, UNPUB ASTROPHYS J; STRONG AW, 1994, ASTRON ASTROPHYS, V292, P82; Telfer RC, 2002, ASTROPHYS J, V565, P773, DOI 10.1086/324689; Weiss A, 2001, ASTRON ASTROPHYS, V365, P571, DOI 10.1051/0004-6361:20000145; WHITE RL, IN PRESS ASTRON J; Willott CJ, 2003, ASTROPHYS J, V587, pL15, DOI 10.1086/375126	27	258	259	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2003	424	6947					406	408		10.1038/nature01821	http://dx.doi.org/10.1038/nature01821			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879063	Green Submitted			2022-12-28	WOS:000184318400036
J	Etminan, M; Gill, S; Samii, A				Etminan, M; Gill, S; Samii, A			Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VASCULAR DEMENTIA; CACHE COUNTY; HETEROGENEITY; HEALTH; AD; ANTAGONISTS; TESTS; NSAID		Royal Victoria Hosp, Dept Clin Epidemiol, Montreal, PQ H3A 1A1, Canada; Univ Toronto, Appl Res Unit, Baycrest Ctr Geriatr Care, Dept Hlth Policy Management & Evaluat, Toronto, ON M6A 2E1, Canada; Univ Washington, Dept Neurol, Seattle, WA 98195 USA	McGill University; Royal Victoria Hospital; University of Toronto; University Toronto Affiliates; Baycrest; University of Washington; University of Washington Seattle	Etminan, M (corresponding author), Royal Victoria Hosp, Dept Clin Epidemiol, Montreal, PQ H3A 1A1, Canada.	mahyar.etminan@mail.mcgill.ca						Aisen PS, 2002, J PAIN SYMPTOM MANAG, V23, pS35, DOI 10.1016/S0885-3924(02)00374-3; Aisen PS, 2002, NEUROLOGY, V58, P1050, DOI 10.1212/WNL.58.7.1050; Amar K, 1996, BMJ-BRIT MED J, V312, P227; ANDERSEN K, 1995, NEUROLOGY, V45, P1441, DOI 10.1212/WNL.45.8.1441; Anthony JC, 2000, NEUROLOGY, V54, P2066, DOI 10.1212/WNL.54.11.2066; Beard CM, 1998, MAYO CLIN PROC, V73, P951, DOI 10.4065/73.10.951; Breitner JCS, 2001, NEW ENGL J MED, V345, P1567, DOI 10.1056/NEJM200111223452110; BREITNER JCS, 1995, NEUROBIOL AGING, V16, P523, DOI 10.1016/0197-4580(95)00049-K; BREITNER JCS, 1994, NEUROLOGY, V44, P227, DOI 10.1212/WNL.44.2.227; Chen P, 2000, NEUROLOGY, V55, P1847, DOI 10.1212/WNL.55.12.1847; Costa-Bouzas J, 2001, COMPUT METH PROG BIO, V64, P101, DOI 10.1016/S0169-2607(00)00087-0; Cryer B, 1998, AM J MED, V104, P413, DOI 10.1016/S0002-9343(98)00091-6; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger E, 1997, LANCET, V350, P326, DOI 10.1016/S0140-6736(97)02419-7; Fourrier A, 1996, J CLIN EPIDEMIOL, V49, P1201, DOI 10.1016/0895-4356(96)00202-8; Hardy RJ, 1998, STAT MED, V17, P841, DOI 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D; Hebert R, 2000, STROKE, V31, P1487, DOI 10.1161/01.STR.31.7.1487; Henderson AS, 1997, INT J GERIATR PSYCH, V12, P926, DOI 10.1002/(SICI)1099-1166(199709)12:9<926::AID-GPS665>3.3.CO;2-P; Ho L, 2001, ARCH NEUROL-CHICAGO, V58, P487, DOI 10.1001/archneur.58.3.487; Huston P, 1996, LANCET, V347, P1024, DOI 10.1016/S0140-6736(96)90153-1; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; MCDOWELL I, 1994, NEUROLOGY, V44, P2073; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Scharf S, 1999, NEUROLOGY, V53, P197, DOI 10.1212/WNL.53.1.197; Stewart WF, 1997, NEUROLOGY, V48, P626, DOI 10.1212/WNL.48.3.626; Takkouche B, 1999, AM J EPIDEMIOL, V150, P206; Veld BAI, 1998, NEUROBIOL AGING, V19, P607, DOI 10.1016/S0197-4580(98)00096-7; WALKER AM, 1988, AM J PUBLIC HEALTH, V78, P961, DOI 10.2105/AJPH.78.8.961; Wolfson C, 2002, NEUROEPIDEMIOLOGY, V21, P81, DOI 10.1159/000048621; Zandi PP, 2002, NEUROLOGY, V59, P880, DOI 10.1212/WNL.59.6.880	32	345	370	1	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2003	327	7407					128	+		10.1136/bmj.327.7407.128	http://dx.doi.org/10.1136/bmj.327.7407.128			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702WJ	12869452	Green Published, Bronze			2022-12-28	WOS:000184247500015
J	Gandhi, D; Shanbag, P; Vaidya, M				Gandhi, D; Shanbag, P; Vaidya, M			Clinical picture - Lead lines	LANCET			English	Editorial Material									Lokmanya Tilak Municipal Med Coll & Gen Hosp, Paediat Intens Care Unit, Bombay 400022, Maharashtra, India		Gandhi, D (corresponding author), Lokmanya Tilak Municipal Med Coll & Gen Hosp, Paediat Intens Care Unit, Bombay 400022, Maharashtra, India.		Shanbag, Preeti/F-4572-2014	Shanbag, Preeti/0000-0001-6162-5950					0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 19	2003	362	9379					197	197		10.1016/S0140-6736(03)13946-3	http://dx.doi.org/10.1016/S0140-6736(03)13946-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702PJ	12885480				2022-12-28	WOS:000184232000009
J	Spiro, D				Spiro, D			A little bit longer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2003	290	6					716	716		10.1001/jama.290.6.716	http://dx.doi.org/10.1001/jama.290.6.716			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	709VU	12915408				2022-12-28	WOS:000184647700001
J	Woolhandler, S; Himmelstein, DU; Angell, M; Young, QD				Woolhandler, S; Himmelstein, DU; Angell, M; Young, QD		Physicians Working Grp Single-Payer	Proposal of the physicians' working group for single-payer National Health Insurance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-CARE; FOR-PROFIT; EMPLOYER MANDATES; OWNERSHIP; HOSPITALS; COST; OUTCOMES; LESSONS; SYSTEM; REFORM	The United States spends more than twice as much on health care as the average of other developed nations, all of which boast universal coverage. Yet more than 41 million Americans have no health insurance. Many more are underinsured. Confronted by the rising costs and capabilities of modern medicine, other nations have chosen national health insurance (NHI). The United States alone treats health care as a commodity distributed according to the ability to pay, rather than as a social service to be distributed according to medical need. In this market-driven system, insurers and providers compete not so much by increasing quality or lowering costs, but by avoiding unprofitable patients and shifting costs back to patients or to other payers. This creates the paradox of a health care system based on avoiding the sick. It generates huge administrative costs that, along with profits, divert resources from clinical care to the demands of business. In addition, burgeoning satellite businesses, such as consulting firms and marketing companies, consume an increasing fraction of the health care dollar. We endorse a fundamental change in US health care-the creation of an NHI program. Such a program, which in essence would be an expanded and improved version of traditional Medicare, would cover every American for all necessary medical care. An NHI program would save at least $200 billion annually (more than enough to cover all of the uninsured) by eliminating the high overhead and profits of the private, investor-owned insurance industry and reducing spending for marketing and other satellite services. Physicians and hospitals would be freed from the concomitant burdens and expenses of paperwork created by having to deal with multiple insurers with different rules, often designed to avoid payment. National health insurance would make it possible to set and enforce overall spending limits for the health care system, slowing cost growth over the long run. An NHI program is the only affordable option for universal, comprehensive coverage.	Harvard Univ, Sch Med, Cambridge Hosp, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Social Med, Boston, MA 02115 USA; Physicians Natl Hlth Program, Chicago, IL USA	Harvard University; Cambridge Health Alliance; Cambridge Hospital; Harvard University; Harvard Medical School	Himmelstein, DU (corresponding author), Harvard Univ, Sch Med, Cambridge Hosp, 1493 Cambridge St, Cambridge, MA 02139 USA.	Dhimmelstein@challiance.org						AYANIAN JZ, 1993, NEW ENGL J MED, V329, P326, DOI 10.1056/NEJM199307293290507; Barer ML, 1996, HEALTH AFFAIR, V15, P216, DOI 10.1377/hlthaff.15.2.216; Bodenheimer T, 1997, NEW ENGL J MED, V337, P651, DOI 10.1056/NEJM199708283370923; Bodenheimer T, 1997, NEW ENGL J MED, V337, P720, DOI 10.1056/NEJM199709043371021; BRAND R, 1998, UNIVERSAL COMPREHENS; *C BUDG OFF, 1993, SINGL PAYER ALLP HLT; Chan L, 1997, NEW ENGL J MED, V337, P978, DOI 10.1056/NEJM199710023371406; Charatan F, 2001, BRIT MED J, V323, P772, DOI 10.1136/bmj.323.7316.772a; *CTR MED MED SERV, 1996, TABL 3 NAT HLTH EXP; DICK AW, 1994, HEALTH AFFAIR, V13, P343, DOI 10.1377/hlthaff.13.1.343; Dickinson CJ, 1996, BRIT MED J, V312, P1617; Galblum T W, 1982, Health Care Financ Rev, V3, P1; Garg PP, 1999, NEW ENGL J MED, V341, P1653, DOI 10.1056/NEJM199911253412205; Geraedts M, 2000, MILBANK Q, V78, P375, DOI 10.1111/1468-0009.00178; GLASER W, 1994, HEALTH AFFAIR, V13, P229, DOI 10.1377/hlthaff.13.4.229; GOTTLIEB M, 1995, NY TIMES        1002, pA14; GOTTLIEB M, 1995, NY TIMES        1004, pA1; GRAY BH, 1986, NEW ENGL J MED, V314, P1523, DOI 10.1056/NEJM198606053142335; Gray BH., 1986, FOR PROFIT ENTERPRIS; Gruber J, 2000, HEALTH AFFAIR, V19, P72, DOI 10.1377/hlthaff.19.1.72; GRUMBACH K, 1991, JAMA-J AM MED ASSOC, V265, P2549, DOI 10.1001/jama.265.19.2549; Harrington C, 2001, AM J PUBLIC HEALTH, V91, P1452, DOI 10.2105/AJPH.91.9.1452; HARTZ AJ, 1989, NEW ENGL J MED, V321, P1720, DOI 10.1056/NEJM198912213212506; Hibbard JH, 1998, HEALTH AFFAIR, V17, P181, DOI 10.1377/hlthaff.17.6.181; Himmelstein DU, 1999, JAMA-J AM MED ASSOC, V282, P159, DOI 10.1001/jama.282.2.159; Himmelstein DU, 2001, BLEEDING PATIENT CON; IGLEHART JK, 1994, NEW ENGL J MED, V330, P75, DOI 10.1056/NEJM199401063300128; Institute of Medicine, 2002, CAR COV TOO LITTL TO; Kane R L, 1992, Health Econ, V1, P105, DOI 10.1002/hec.4730010204; KELLERMANN AL, 1994, NEW ENGL J MED, V330, P1426; Kovner C, 1998, Image J Nurs Sch, V30, P315, DOI 10.1111/j.1547-5069.1998.tb01326.x; Liu K, 1985, Health Care Financ Rev, V7, P51; MARTIN A, TRENDS STATE HLTH CA; MERLIS M, 2003, FEDERAL EMPLOYEES HL; MIRVIS DM, 1995, JAMA-J AM MED ASSOC, V274, P1235, DOI 10.1001/jama.274.15.1235; PATTISON RV, 1983, NEW ENGL J MED, V309, P347, DOI 10.1056/NEJM198308113090606; *PHYS PAYM REV COM, 1996, ANN REP C, pCH15; RASELL ME, 1995, NEW ENGL J MED, V332, P1164, DOI 10.1056/NEJM199504273321711; Relman AS, 2002, NEW REPUBLIC, V227, P27; Schneeweiss S, 2002, NEW ENGL J MED, V346, P822, DOI 10.1056/NEJMsa003087; SCHULTE F, 1994, FT LAUDERDALE S 1211, P1; SHEILS JF, 2001, ANAL COSTS IMPACT UN; Silverman EM, 1999, NEW ENGL J MED, V341, P420, DOI 10.1056/NEJM199908053410606; Taylor DH, 1999, NEW ENGL J MED, V340, P293, DOI 10.1056/NEJM199901283400408; *US BUR CENS, 2001, HLTH INS COV; *US BUR CENS, HIST HLTH INS TABL H; *US GEN ACC OFF, 1992, HRD92110 US GEN ACC; *US GEN ACC OFF, 1997, GAOHEHS9760 US GEN A; *US GOV ACC OFF, 1991, GAOHRD9190 US GOV AC; WATT JM, 1986, NEW ENGL J MED, V314, P89, DOI 10.1056/NEJM198601093140206; WEILER PC, 1995, RUTGERS LAW REV, V47, P1157; Woolhandler S, 1997, NEW ENGL J MED, V336, P769, DOI 10.1056/NEJM199703133361106; WOOLHANDLER S, 1991, NEW ENGL J MED, V324, P1253, DOI 10.1056/NEJM199105023241805; Woolhandler S, 2002, HEALTH AFFAIR, V21, P88, DOI 10.1377/hlthaff.21.4.88; WOOLHANDLER S, IN PRESS N ENGL J ME	55	95	95	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2003	290	6					798	805						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	709VU	12915433				2022-12-28	WOS:000184647700031
J	Houghton, T; Kaye, GC				Houghton, T; Kaye, GC			ABC of interventional cardiology - Implantable devices for treating tachyarrhythmias	BRITISH MEDICAL JOURNAL			English	Review									Castle Hill Hosp, Hull & E Yorkshire Trust, Kingston Upon Hull, N Humberside, England	University of Hull	Houghton, T (corresponding author), Castle Hill Hosp, Hull & E Yorkshire Trust, Kingston Upon Hull, N Humberside, England.		Kaye, Gerald/T-8056-2019; Kaye, Gerald/F-6182-2012	Kaye, Gerald/0000-0002-0702-3681				Connolly SJ, 2000, EUR HEART J, V21, P2071, DOI 10.1053/euhj.2000.2476; Cooper Randolph A. S., 1997, P3; JOSEPHSON ME, 1993, CLIN CARDIAC ELECTRO, P181; MIROWSKI M, 1973, ANN INTERN MED, V129, P773; OKEEFE DB, 1988, CLIN ASPECTS CARDIAC, P337	5	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 9	2003	327	7410					333	336		10.1136/bmj.327.7410.333	http://dx.doi.org/10.1136/bmj.327.7410.333			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	710JE	12907492	Green Published			2022-12-28	WOS:000184676400027
J	MacQueen, KM; Karim, QA; Sugarman, J				MacQueen, KM; Karim, QA; Sugarman, J		Ethics Working Grp HIV Prevention	Ethics guidance for HIV prevention trials	BRITISH MEDICAL JOURNAL			English	Article									Family Hlth Int, Res Triangle Pk, NC 27709 USA; Univ Natal, Ctr AIDS Program Res S Africa, ZA-4001 Durban, South Africa; Duke Univ, Ctr Study Med Eth & Humanities, Durham, NC USA	University of Kwazulu Natal; Duke University	MacQueen, KM (corresponding author), Family Hlth Int, POB 13950, Res Triangle Pk, NC 27709 USA.		Abdool Karim, Quarraisha/GVS-1160-2022	Abdool Karim, Quarraisha/0000-0002-0985-477X; Sugarman, Jeremy/0000-0001-7022-8332	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068619] Funding Source: NIH RePORTER; NIAID NIH HHS [UM1 AI068619] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		*HIV PREV TRIALS N, ETH GUID RES; MacQueen Kathleen M, 2003, IRB, V25, P11, DOI 10.2307/3563635	2	6	6	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 9	2003	327	7410					340	340		10.1136/bmj.327.7410.340	http://dx.doi.org/10.1136/bmj.327.7410.340			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	710JE	12907494	Green Published			2022-12-28	WOS:000184676400030
J	Bailey, WB; Chaitman, BR				Bailey, WB; Chaitman, BR			Electrocardiographic changes in intracranial hemorrhage mimicking myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									St Louis Univ, Sch Med, St Louis, MO 63110 USA	Saint Louis University	Bailey, WB (corresponding author), St Louis Univ, Sch Med, St Louis, MO 63110 USA.								0	8	8	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2003	349	6					561	561		10.1056/NEJMicm020416	http://dx.doi.org/10.1056/NEJMicm020416			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708JL	12904521				2022-12-28	WOS:000184563500007
J	Hu, DL; Chan, B; Bush, JWM				Hu, DL; Chan, B; Bush, JWM			The hydrodynamics of water strider locomotion	NATURE			English	Article							GERRIS-REMIGIS; SURFACE; FLIGHT	Water striders Gerridae are insects of characteristic length 1 cm and weight 10 dynes that reside on the surface of ponds, rivers, and the open ocean(1-4). Their weight is supported by the surface tension force generated by curvature of the free surface(5,6), and they propel themselves by driving their central pair of hydrophobic legs in a sculling motion(7,8). Previous investigators have assumed that the hydrodynamic propulsion of the water strider relies on momentum transfer by surface waves(1,9,10). This assumption leads to Denny's paradox(11): infant water striders, whose legs are too slow to generate waves, should be incapable of propelling themselves along the surface. We here resolve this paradox through reporting the results of high-speed video and particle-tracking studies. Experiments reveal that the strider transfers momentum to the underlying fluid not primarily through capillary waves, but rather through hemispherical vortices shed by its driving legs. This insight guided us in constructing a self-contained mechanical water strider whose means of propulsion is analogous to that of its natural counterpart.	MIT, Dept Math, Cambridge, MA 02139 USA; MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Bush, JWM (corresponding author), MIT, Dept Math, Cambridge, MA 02139 USA.							Andersen N.M., 1976, Videnskabelige Meddr dansk naturh Foren, V139, P337; Andersen NM, 1982, SEMIAQUATIC BUGS HEM; Baudoin R, 1955, B BIOL FR BELG, V89, P16; BOWDAN E, 1978, J COMP PHYSIOL, V123, P43, DOI 10.1007/BF00657342; Brinkhurst R. O., 1960, Proceedings of the Zoological Society of London, V133, P531; Chen Y Y, 2010, HYDRODYNAMICS, V42, P1; Childress S., 1981, MECH SWIMMING FLYING; COBBEN RH, 1960, STUD FAUNA CURACAO, V11, P1; Darnhofer-Demar, 1969, ZOOL ANZ S, V32, P430; DEGENNES PG, 2002, GOUTTES BOULES PERLE; DENNY MW, 1993, AIR WATER BIOL PHYSI; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; ELLINGTON CP, 1990, NATURE, V347, P472, DOI 10.1038/347472a0; Glasheen JW, 1996, NATURE, V380, P340, DOI 10.1038/380340a0; Henry T. J., 1998, CATALOG HETEROPTERA; HUNGERFORD HB, 1960, KANS U SCI B, V41; Keller JB, 1998, PHYS FLUIDS, V10, P3009, DOI 10.1063/1.869820; MATSUDA K, 1985, APPL OPTICS, V24, P4443, DOI 10.1364/AO.24.004443; MURPHEY RK, 1971, Z VERGL PHYSIOL, V72, P150, DOI 10.1007/BF00297819; RAYNER JMV, 1986, NATURE, V321, P162, DOI 10.1038/321162a0; SCHOOLEY AH, 1958, J MAR RES, V16, P100; SCRIVEN LE, 1960, NATURE, V187, P186, DOI 10.1038/187186a0; STARR VP, 1947, J MAR RES, V6, P175; Sun SM, 2001, PHYS FLUIDS, V13, P2146, DOI 10.1063/1.1384889; Suter RB, 1997, J EXP BIOL, V200, P2523; Suter RB, 1999, J EXP BIOL, V202, P2771; Tseng M, 1999, CAN J ZOOL, V77, P923, DOI 10.1139/cjz-77-6-923; Vogel S, 1994, LIFE MOVING FLUIDS; VOGEL S, 1988, LIFES DEVICES; WILCOX RS, 1979, SCIENCE, V206, P1325, DOI 10.1126/science.206.4424.1325	30	510	536	17	346	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					663	666		10.1038/nature01793	http://dx.doi.org/10.1038/nature01793			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904790				2022-12-28	WOS:000184578800042
J	Nanayama, F; Satake, K; Furukawa, R; Shimokawa, K; Atwater, BF; Shigeno, K; Yamaki, S				Nanayama, F; Satake, K; Furukawa, R; Shimokawa, K; Atwater, BF; Shigeno, K; Yamaki, S			Unusually large earthquakes inferred from tsunami deposits along the Kuril trench	NATURE			English	Article							SUBDUCTION ZONE; JAPAN; RECURRENCE; HOKKAIDO; KAMCHATKA	The Pacific plate converges with northeastern Eurasia at a rate of 8-9 m per century along the Kamchatka, Kuril and Japan trenches(1). Along the southern Kuril trench, which faces the Japanese island of Hokkaido, this fast subduction has recurrently generated earthquakes with magnitudes of up to similar to8 over the past two centuries(2-6). These historical events, on rupture segments 100-200 km long, have been considered characteristic of Hokkaido's plate-boundary earthquakes(7,8). But here we use deposits of prehistoric tsunamis to infer the infrequent occurrence of larger earthquakes generated from longer ruptures. Many of these tsunami deposits form sheets of sand that extend kilometres inland from the deposits of historical tsunamis. Stratigraphic series of extensive sand sheets, intercalated with dated volcanic-ash layers, show that such unusually large tsunamis occurred about every 500 years on average over the past 2,000-7,000 years, most recently similar to350 years ago. Numerical simulations of these tsunamis are best explained by earthquakes that individually rupture multiple segments along the southern Kuril trench. We infer that such multi-segment earthquakes persistently recur among a larger number of single-segment events.	Geol Survey Japan, Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058567, Japan; Univ Washington, US Geol Survey, Seattle, WA 98195 USA; Meiji Consultant Co Ltd, Chuo Ku, Sapporo, Hokkaido 0640807, Japan; Seamus Ltd, Niigata 9503304, Japan	National Institute of Advanced Industrial Science & Technology (AIST); United States Department of the Interior; United States Geological Survey; University of Washington; University of Washington Seattle	Satake, K (corresponding author), Geol Survey Japan, Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058567, Japan.		Furukawa, Ryuta/AAF-1365-2020; Satake, Kenji/E-2312-2011; Nanayama, Futoshi/L-4453-2018; Nanayama, Futoshi/K-2190-2019; Satake, Kenji/GMX-4217-2022	Furukawa, Ryuta/0000-0001-5722-4521; Satake, Kenji/0000-0002-3368-3085; Nanayama, Futoshi/0000-0001-8693-4784; Nanayama, Futoshi/0000-0001-8693-4784; Satake, Kenji/0000-0002-3368-3085; Atwater, Brian/0000-0003-1155-2815				Abe K., 1999, ZISIN J SEISM SOC JA, V52, P369; Aida I., 1978, Journal of Physics of the Earth, V26, P57, DOI 10.4294/jpe1952.26.57; ANDO M, 1975, TECTONOPHYSICS, V27, P119, DOI 10.1016/0040-1951(75)90102-X; BECK SL, 1987, J GEOPHYS RES-SOLID, V92, P14123, DOI 10.1029/JB092iB13p14123; Central Meteorological Observatory, 1953, Q J SEISMOLOGY, V17, P1; Chikita K., 1997, GEOPHYS B HOKKAIDO U, V60, P13; Clague JJ, 2000, QUATERNARY SCI REV, V19, P849, DOI 10.1016/S0277-3791(99)00101-8; DEMETS C, 1992, J GEOPHYS RES-SOL EA, V97, P17615, DOI 10.1029/92JB01306; FUKAO Y, 1979, GEOPHYS J ROY ASTR S, V57, P23, DOI 10.1111/j.1365-246X.1979.tb03769.x; FURUKAWA R, 1997, KAZAN, V42, P269; HATORI T, 1984, B EARTHQ RES I TOKYO, V59, P423; HATORI T, 1974, SPEC B EARTHQUAKE RE, V13, P67; Hirakawa K., 2000, CHIKYU MONTHLY, V31, P92; HIRATA K, 2003, J GEOPHYS RES, V108; Imamura F., 1996, LONG WAVE RUNUP MODE, P25, DOI DOI 10.1142/3327; Iwasaki T., 1979, P 26 C COAST ENG JSC, P70; Kanamori H., 1972, PHYS EARTH PLANET IN, V6, P246, DOI DOI 10.1016/0031-9201(72)90058-1; MANSINHA L, 1971, B SEISMOL SOC AM, V61, P1433; NISHENKO SP, 1991, PURE APPL GEOPHYS, V135, P169, DOI 10.1007/BF00880240; Nishimura Y., 2000, DAIYONKI KENKYU, V39, P451; Okal EA, 2001, PHYS EARTH PLANET IN, V124, P45, DOI 10.1016/S0031-9201(01)00187-X; Pinegina TK, 2003, QUATERNARY RES, V59, P36, DOI 10.1016/S0033-5894(02)00009-1; SATAKE K, 1995, PURE APPL GEOPHYS, V144, P455, DOI 10.1007/BF00874378; Sawai Y, 2002, J QUATERNARY SCI, V17, P607, DOI 10.1002/jqs.708; Sawai Y, 2002, J ASIAN EARTH SCI, V20, P903, DOI 10.1016/S1367-9120(01)00077-3; Schwartz SY, 1999, J GEOPHYS RES-SOL EA, V104, P23111, DOI 10.1029/1999JB900226; SHIMAZAKI K, 1974, PHYS EARTH PLANET IN, V9, P314; Tanioka Y, 1996, GEOPHYS RES LETT, V23, P1549, DOI 10.1029/96GL01479; THATCHER W, 1989, NATURE, V341, P432, DOI 10.1038/341432a0; Watanabe H., 1998, COMPLIHENSIVE LIST T, Vsecond, P238	30	285	304	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					660	663		10.1038/nature01864	http://dx.doi.org/10.1038/nature01864			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904789				2022-12-28	WOS:000184578800041
J	Walther, TC; Askjaer, P; Gentzel, M; Habermann, A; Griffiths, G; Wilm, M; Mattaj, IW; Hetzer, M				Walther, TC; Askjaer, P; Gentzel, M; Habermann, A; Griffiths, G; Wilm, M; Mattaj, IW; Hetzer, M			RanGTP mediates nuclear pore complex assembly	NATURE			English	Article							IMPORTIN-BETA; GTPASE CYCLE; CHROMATIN; SUBCOMPLEX; PROTEINS; YEAST	In metazoa, the nuclear envelope breaks down and reforms during each cell cycle. Nuclear pore complexes (NPCs), which serve as channels for transport between the nucleus and cytoplasm(1), assemble into the reforming nuclear envelope in a sequential process involving association of a subset of NPC proteins, nucleoporins, with chromatin followed by the formation of a closed nuclear envelope fenestrated by NPCs2-7. How chromatin recruitment of nucleoporins and NPC assembly are regulated is unknown. Here we demonstrate that RanGTP production is required to dissociate nucleoporins Nup107, Nup153 and Nup358 from Importin beta, to target them to chromatin and to induce association between separate NPC subcomplexes. Additionally, either an excess of RanGTP or removal of Importin beta induces formation of NPC-containing membrane structures-annulate lamellae-both in vitro in the absence of chromatin and in vivo. Annulate lamellae formation is strongly and specifically inhibited by an excess of Importin beta. The data demonstrate that RanGTP triggers distinct steps of NPC assembly, and suggest a mechanism for the spatial restriction of NPC assembly to the surface of chromatin.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Mattaj, IW (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Askjaer, Peter/I-3316-2012	Askjaer, Peter/0000-0003-3192-4428; Mattaj, Iain/0000-0002-5537-8284; Habermann, Anja/0000-0003-3686-9050; Walther, Tobias/0000-0003-1442-1327; Gentzel, Marc/0000-0002-4482-6010; Wilm, Matthias/0000-0002-5461-6834				Askjaer P, 2002, MOL BIOL CELL, V13, P4355, DOI 10.1091/mbc.E02-06-0346; Bamba C, 2002, CURR BIOL, V12, P503, DOI 10.1016/S0960-9822(02)00741-8; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Bodoor K, 1999, J CELL SCI, V112, P2253; DABAUVALLE MC, 1991, J CELL BIOL, V112, P1073, DOI 10.1083/jcb.112.6.1073; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; DEMETER J, 1995, P NATL ACAD SCI USA, V92, P1436, DOI 10.1073/pnas.92.5.1436; Dreier L, 2000, J CELL BIOL, V148, P883, DOI 10.1083/jcb.148.5.883; GRIFFITHS G, 1993, FINE STRUCTURE IMMUN, P137; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Hinkle B, 2002, J CELL SCI, V115, P4685, DOI 10.1242/jcs.00136; KESSEL RG, 1992, INT REV CYTOL, V133, P43, DOI 10.1016/S0074-7696(08)61858-6; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Lusk CP, 2002, J CELL BIOL, V159, P267, DOI 10.1083/jcb.200203079; MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254; MURRAY AW, 1991, CELL CYCLE EXTRACTS, P581; Rout MP, 2001, J BIOL CHEM, V276, P16593, DOI 10.1074/jbc.R100015200; Ryan KJ, 2003, J CELL BIOL, V160, P1041, DOI 10.1083/jcb.200209116; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Vasu SK, 2001, CURR OPIN CELL BIOL, V13, P363, DOI 10.1016/S0955-0674(00)00221-0; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Zhang CM, 2000, SCIENCE, V288, P1429, DOI 10.1126/science.288.5470.1429; Zhang CM, 2002, EUR J CELL BIOL, V81, P623, DOI 10.1078/0171-9335-00288; Zhang CM, 2002, CURR BIOL, V12, P498, DOI 10.1016/S0960-9822(02)00714-5	30	166	173	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					689	694		10.1038/nature01898	http://dx.doi.org/10.1038/nature01898			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12894213				2022-12-28	WOS:000184578800049
J	Kimmel, PL; Barisoni, L; Kopp, JB				Kimmel, PL; Barisoni, L; Kopp, JB			Pathogenesis and treatment of HIV-associated renal diseases: Lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; ACTIVE ANTIRETROVIRAL THERAPY; SOLID-ORGAN TRANSPLANTATION; CONVERTING-ENZYME GENE; TUBULAR EPITHELIAL-CELLS; CHEMOKINE RECEPTOR CCR5; HEPATITIS-C VIRUS; INFECTED PATIENTS; NEPHROTIC SYNDROME	HIV infection is associated with several renal syndromes, including acute renal failure. Chronic renal failure directly linked to HIV infection includes thrombotic microangiopathic renal diseases, immune-mediated glomerulonephritides, and HIV-associated nephropathy. A renal biopsy may be necessary for diagnosis. The development of HIV-associated nephropathy has been definitively linked to renal cellular infection, but the disease affects only a minority of patients, typically men of African descent. Therefore, factors determining disease expression in infected patients must now be emphasized. The pathogenic mechanisms involved in HIV-associated renal disease remain obscure. Genetic factors, as well as renal cellular responses, mediated by HIV proteins (including an immune-activated microenvironment) capable of presenting antigen in susceptible hosts probably explain most cases. HIV-associated nephropathy has a characteristic pathologic phenotype, including glomerular, tubular, and interstitial changes, and ultrastructural findings. Infection of the glomerular epithelial cell, or podocyte, and consequent structural and biochemical changes may be pivotal in pathogenesis. The HIV-1 transgenic mouse is an important model for understanding disease pathogenesis, particularly the role of HIV proteins in mediating renal tissue injury. Rigorously controlled randomized trials have not evaluated treatment, but corticosteroids and angiotensin-converting enzyme inhibitors have been used. Highly active antiretroviral therapy seems to have decreased the incidence of end-stage renal disease related to HIV infection and, in case reports, to have improved renal functional and pathologic outcomes of HIV-associated nephropathy. Outcomes in patients undergoing hemodialysis and peritoneal dialysis have improved, and current research focuses on renal transplantation for treatment of HIV-infected patients.	George Washington Univ, Med Ctr, Dept Med, Div Renal Dis & Hypertens, Washington, DC 20037 USA; NIDDKD, NIH, Bethesda, MD 20892 USA	George Washington University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Kimmel, PL (corresponding author), George Washington Univ, Med Ctr, Dept Med, Div Renal Dis & Hypertens, 2150 Penn Ave NW, Washington, DC 20037 USA.		Kopp, Jeffrey B/O-2681-2015	Kopp, Jeffrey B/0000-0001-9052-186X	NIDDK NIH HHS [R01-DK-40811] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040811, Z01DK043308] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahuja TS, 2002, J AM SOC NEPHROL, V13, P1889, DOI 10.1097/01.ASN.0000019773.43765.BF; Ahuja TS, 2000, AM J KIDNEY DIS, V36, P574, DOI 10.1053/ajkd.2000.16196; Alarcon-Zurita A, 2000, NEPHROL DIAL TRANSPL, V15, P1097, DOI 10.1093/ndt/15.7.1097; Alpers CE, 1997, AIDS RES HUM RETROV, V13, P413, DOI 10.1089/aid.1997.13.413; ALPERS CE, 1992, AM J KIDNEY DIS, V19, P126, DOI 10.1016/S0272-6386(12)70120-8; Alpers CE, 2003, KIDNEY INT, V63, P385, DOI 10.1046/j.1523-1755.2003.00743.x; Bariety J, 1998, KIDNEY INT, V53, P918, DOI 10.1111/j.1523-1755.1998.00845.x; Barisoni L, 2002, MICROSC RES TECHNIQ, V57, P254, DOI 10.1002/jemt.10084; Barisoni L, 1999, J AM SOC NEPHROL, V10, P51; Barisoni L, 2000, KIDNEY INT, V58, P137, DOI 10.1046/j.1523-1755.2000.00149.x; Barisoni L, 2000, KIDNEY INT, V58, P173, DOI 10.1046/j.1523-1755.2000.00152.x; BAUER FA, 1991, HUM PATHOL, V22, P63, DOI 10.1016/0046-8177(91)90063-U; BEAUFILS H, 1995, NEPHROL DIAL TRANSPL, V10, P35; Bird JE, 1998, J AM SOC NEPHROL, V9, P1441; Bloem LJ, 1996, HYPERTENSION, V27, P62, DOI 10.1161/01.HYP.27.1.62; Bodi I, 1997, KIDNEY INT, V51, P1568, DOI 10.1038/ki.1997.215; BODI I, 1995, AM J KIDNEY DIS, V26, P286, DOI 10.1016/0272-6386(95)90648-7; BODI I, 1994, AM J KIDNEY DIS, V24, P762, DOI 10.1016/S0272-6386(12)80669-X; Boix E, 2000, NEPHROL DIAL TRANSPL, V15, P412, DOI 10.1093/ndt/15.3.412; Bottieau E, 2000, J INFECTION, V41, P108, DOI 10.1053/jinf.2000.0659; BOURGOIGNIE JJ, 1990, KIDNEY INT, V37, P1571, DOI 10.1038/ki.1990.151; Briggs WA, 1996, AM J KIDNEY DIS, V28, P618, DOI 10.1016/S0272-6386(96)90477-1; Bruggeman LA, 2000, J AM SOC NEPHROL, V11, P2079, DOI 10.1681/ASN.V11112079; Bruggeman LA, 1997, J CLIN INVEST, V100, P84, DOI 10.1172/JCI119525; Burns GC, 1997, J AM SOC NEPHROL, V8, P1140; Carrington M, 1999, HUM MOL GENET, V8, P1939, DOI 10.1093/hmg/8.10.1939; CASANOVA S, 1995, AM J KIDNEY DIS, V26, P446, DOI 10.1016/0272-6386(95)90490-5; Castro JG, 2002, AM J MED, V112, P505, DOI 10.1016/S0002-9343(01)01135-4; Cheng CH, 2002, AM J HEALTH-SYST PH, V59, P728, DOI 10.1093/ajhp/59.8.728; Cheng JT, 1999, J AM SOC NEPHROL, V10, P1566; Chidambaram M, 2002, CLIN NEPHROL, V57, P154; Coca S, 2002, AM J MED SCI, V324, P342, DOI 10.1097/00000441-200212000-00011; COHEN AH, 1988, MODERN PATHOL, V1, P87; COHEN AH, 1989, MODERN PATHOL, V2, P125; Conaldi PG, 1998, J CLIN INVEST, V102, P2041, DOI 10.1172/JCI3480; CONNOLLY JO, 1995, QJM-MON J ASSOC PHYS, V88, P627; Cosgrove CJ, 2002, AM J MED SCI, V323, P102, DOI 10.1097/00000441-200202000-00009; D'Agati V, 1998, SEMIN NEPHROL, V18, P406; DAGATI V, 1994, KIDNEY INT, V46, P1223, DOI 10.1038/ki.1994.388; DAgati V, 1997, J AM SOC NEPHROL, V8, P138; DICKIE P, 1991, VIROLOGY, V185, P109, DOI 10.1016/0042-6822(91)90759-5; Dieleman JP, 2003, JAIDS-J ACQ IMM DEF, V32, P135, DOI 10.1097/00126334-200302010-00004; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; Dybul M, 2002, ANN INTERN MED, V137, P381, DOI 10.7326/0003-4819-137-5_Part_2-200209031-00001; Eggers PW, 2002, J AM SOC NEPHROL, V13, p38A; Eitner F, 2000, J AM SOC NEPHROL, V11, P856, DOI 10.1681/ASN.V115856; Eitner F, 1999, AM J PATHOL, V155, P649, DOI 10.1016/S0002-9440(10)65161-9; Engeler DS, 2002, J UROLOGY, V167, P1384, DOI 10.1016/S0022-5347(05)65307-4; Eustace JA, 2000, KIDNEY INT, V58, P1253, DOI 10.1046/j.1523-1755.2000.00280.x; Freedman BI, 1999, AM J KIDNEY DIS, V34, P254, DOI 10.1016/S0272-6386(99)70352-5; GARDENSWARTZ MH, 1984, CLIN NEPHROL, V21, P197; Gardner LI, 2003, JAIDS-J ACQ IMM DEF, V32, P203, DOI 10.1097/00126334-200302010-00013; Gorriz JL, 1997, NEPHROL DIAL TRANSPL, V12, P2796, DOI 10.1093/ndt/12.12.2796; Gow PJ, 2001, TRANSPLANTATION, V72, P177, DOI 10.1097/00007890-200107270-00001; GREEN DF, 1992, KIDNEY INT, V41, P956, DOI 10.1038/ki.1992.146; GUERRA IL, 1987, AM J KIDNEY DIS, V10, P385, DOI 10.1016/S0272-6386(87)80107-5; Haas M, 2000, NEPHROL DIAL TRANSPL, V15, P1679, DOI 10.1093/ndt/15.10.1679; Hailemariam S, 2001, SWISS MED WKLY, V131, P412; Halpern SD, 2002, NEW ENGL J MED, V347, P284, DOI 10.1056/NEJMsb020632; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Hare CB, 2002, CLIN INFECT DIS, V35, pE111, DOI 10.1086/344179; Hori C, 2001, NEPHRON, V88, P313, DOI 10.1159/000046014; Huber TB, 2002, J IMMUNOL, V168, P6244, DOI 10.4049/jimmunol.168.12.6244; Hymes KB, 1997, SEMIN HEMATOL, V34, P117; Joshi MK, 2000, AIDS PATIENT CARE ST, V14, P541, DOI 10.1089/108729100750018308; KAJIYAMA W, 1995, AIDS RES HUM RETROV, V11, pS153; KATZ A, 1992, CLIN NEPHROL, V38, P61; Kimmel PL, 1998, SEMIN NEPHROL, V18, P446; Kimmel PL, 1996, AM J KIDNEY DIS, V28, P202, DOI 10.1016/S0272-6386(96)90302-9; KIMMEL PL, 1993, KIDNEY INT, V44, P1327, DOI 10.1038/ki.1993.386; KIMMEL PL, 1992, NEW ENGL J MED, V327, P702, DOI 10.1056/NEJM199209033271006; Kimmel PL, 1996, J INVEST MED, V44, pA321; Kimmel PL, 2003, NEPHROL DIAL TRANSPL, V18, P285, DOI 10.1093/ndt/18.2.285; KIMMEL PL, 1993, KIDNEY INT, V43, P1347, DOI 10.1038/ki.1993.189; KIMMEL PL, 1993, CLIN NEPHROL, V39, P17; Kimmel PL, 2000, CURR OPIN NEPHROL HY, V9, P117, DOI 10.1097/00041552-200003000-00004; Kimmel PL, 1995, RENAL UROLOGIC ASPEC, P77; Kinter A, 2000, IMMUNOL REV, V177, P88, DOI 10.1034/j.1600-065X.2000.17708.x; Kirchner Jeffrey T, 2002, AIDS Read, V12, P103; Klotman Paul, 2002, AIDS Read, V12, P273; Klotman PE, 1999, KIDNEY INT, V56, P1161, DOI 10.1046/j.1523-1755.1999.00748.x; Kopp JB, 2003, KIDNEY INT, V63, P43, DOI 10.1046/j.1523-1755.63.s83.39.x; KOPP JB, 1992, P NATL ACAD SCI USA, V89, P1577, DOI 10.1073/pnas.89.5.1577; Kopp JB, 1997, ANN INTERN MED, V127, P119, DOI 10.7326/0003-4819-127-2-199707150-00004; KOPP JB, 1998, J AM SOC NEPHROL, V9, pA1997; Kopp Jeffrey B., 2002, Curr Infect Dis Rep, V4, P449, DOI 10.1007/s11908-002-0013-3; KORBET SM, 1992, AM J KIDNEY DIS, V20, P97, DOI 10.1016/S0272-6386(12)80326-X; Krishnan M, 2000, AM J KIDNEY DIS, V36, P1075, DOI 10.1053/ajkd.2000.19114; Kuo PC, 2001, AM J TRANSPLANT, V1, P13, DOI 10.1034/j.1600-6143.2001.010104.x; Lee DY, 1997, NEPHRON, V77, P471, DOI 10.1159/000190326; Levin ML, 2001, AM J KIDNEY DIS, V37, part. no.; Li RM, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000028249.06596.CF; Lista FS, 2001, CLIN NEPHROL, V55, P404; Marras D, 2002, NAT MED, V8, P522, DOI 10.1038/nm0502-522; Marre M, 1997, J CLIN INVEST, V99, P1585, DOI 10.1172/JCI119321; Mastroianni CM, 2001, AIDS, V15, P820, DOI 10.1097/00002030-200104130-00029; Mattana J, 1997, AM J KIDNEY DIS, V30, P116, DOI 10.1016/S0272-6386(97)90573-4; Mitra D, 1998, AM J HEMATOL, V59, P279, DOI 10.1002/(SICI)1096-8652(199812)59:4<279::AID-AJH3>3.0.CO;2-J; Monga G, 1997, MODERN PATHOL, V10, P159; Murphy B, 2002, J AM SOC NEPHROL, V13, p11A; NOCHY D, 1993, NEPHROL DIAL TRANSPL, V8, P11, DOI 10.1093/oxfordjournals.ndt.a092263; Olyaei AJ, 2000, CURR OPIN NEPHROL HY, V9, P473, DOI 10.1097/00041552-200009000-00003; PARDO V, 1984, ANN INTERN MED, V101, P429, DOI 10.7326/0003-4819-101-4-429; Park IW, 2001, J IMMUNOL, V167, P2766, DOI 10.4049/jimmunol.167.5.2766; Peraldi MN, 1999, NEPHROL DIAL TRANSPL, V14, P1578, DOI 10.1093/ndt/14.6.1578; Perazella MA, 2000, AM J MED SCI, V319, P385, DOI 10.1097/00000441-200006000-00008; Perazella MA, 1999, AM J MED, V106, P459, DOI 10.1016/S0002-9343(99)00041-8; Praditpornsilpa K, 1999, AM J KIDNEY DIS, V33, P282, DOI 10.1016/S0272-6386(99)70301-X; Rao TKS, 1998, SEMIN NEPHROL, V18, P378; RAO TKS, 1987, NEW ENGL J MED, V316, P1062, DOI 10.1056/NEJM198704233161705; RAO TKS, 1984, NEW ENGL J MED, V310, P669, DOI 10.1056/NEJM198403153101101; Ray PE, 1998, KIDNEY INT, V53, P1217, DOI 10.1046/j.1523-1755.1998.00900.x; Reid W, 2001, P NATL ACAD SCI USA, V98, P9271, DOI 10.1073/pnas.161290298; Reilly RF, 2001, AM J KIDNEY DIS, V38, part. no.; Roland ME, 2003, TRANSPLANTATION, V75, P425, DOI 10.1097/01.TP.0000046943.35335.18; Ross MJ, 2002, J AM SOC NEPHROL, V13, P2997, DOI 10.1097/01.ASN.0000040750.40907.99; Ross MJ, 2001, J AM SOC NEPHROL, V12, P2645, DOI 10.1681/ASN.V12122645; Sahud MA, 2002, BRIT J HAEMATOL, V116, P909, DOI 10.1046/j.0007-1048.2002.03349.x; SCHWARTZ MM, 1995, AM J KIDNEY DIS, V25, P845, DOI 10.1016/0272-6386(95)90566-9; Schwimmer JA, 2003, SEMIN NEPHROL, V23, P209, DOI 10.1053/snep.2003.50019; Segerer S, 2000, J AM SOC NEPHROL, V11, P152, DOI 10.1681/ASN.V111152; Shankland SJ, 2000, KIDNEY INT, V58, P674, DOI 10.1046/j.1523-1755.2000.00213.x; Smith MC, 1996, AM J MED, V101, P41, DOI 10.1016/S0002-9343(96)00065-4; Sothinathan R, 2001, AIDS PATIENT CARE ST, V15, P363, DOI 10.1089/108729101750301915; Stephens EB, 2000, AIDS RES HUM RETROV, V16, P1295, DOI 10.1089/08892220050117050; Stokes MB, 1997, AM J KIDNEY DIS, V29, P514, DOI 10.1016/S0272-6386(97)90332-2; STRAUSS J, 1989, NEW ENGL J MED, V321, P625, DOI 10.1056/NEJM198909073211001; Szczech A, 2002, CLIN NEPHROL, V57, P336; Szczech LA, 2002, KIDNEY INT, V61, P195, DOI 10.1046/j.1523-1755.2002.00094.x; Szczech LA, 2001, CLIN INFECT DIS, V33, P115, DOI 10.1086/320893; Tokars JI, 2002, SEMIN DIALYSIS, V15, P162, DOI 10.1046/j.1525-139X.2002.00051.x; Tokizawa S, 2000, KIDNEY INT, V58, P607, DOI 10.1046/j.1523-1755.2000.00207.x; Valeri A, 1996, KIDNEY INT, V50, P1734, DOI 10.1038/ki.1996.493; Verhelst D, 2002, AM J KIDNEY DIS, V40, P1331, DOI 10.1053/ajkd.2002.36924; Wali RK, 1998, LANCET, V352, P783, DOI 10.1016/S0140-6736(98)24037-2; Weiner NJ, 2003, KIDNEY INT, V63, P1618, DOI 10.1046/j.1523-1755.2003.00901.x; Williams DI, 1998, SEX TRANSM INFECT, V74, P179, DOI 10.1136/sti.74.3.179; Winston JA, 2000, SEMIN NEPHROL, V20, P293; Winston JA, 1999, KIDNEY INT, V55, P1036, DOI 10.1046/j.1523-1755.1999.0550031036.x; Winston JA, 1996, J AM SOC NEPHROL, V7, P1; Winston JA, 2001, NEW ENGL J MED, V344, P1979, DOI 10.1056/NEJM200106283442604; Yamamoto T, 1996, KIDNEY INT, V49, P461, DOI 10.1038/ki.1996.65; YOSHIDA H, 1995, J CLIN INVEST, V96, P2162, DOI 10.1172/JCI118270	143	113	119	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2003	139	3					214	226		10.7326/0003-4819-139-3-200308050-00011	http://dx.doi.org/10.7326/0003-4819-139-3-200308050-00011			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707RH	12899589				2022-12-28	WOS:000184523300007
J	McCarthy, M				McCarthy, M			US doctors press for malpractice reform	LANCET			English	News Item																			0	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 2	2003	362	9381					377	377		10.1016/S0140-6736(03)14061-5	http://dx.doi.org/10.1016/S0140-6736(03)14061-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707FB	12907027				2022-12-28	WOS:000184498700017
J	Dowsett, M; Ashworth, A				Dowsett, M; Ashworth, A			New biology of the oestrogen receptor	LANCET			English	Editorial Material							BREAST-CANCER		Royal Marsden Hosp, Dept Biochem, London SW3 6JJ, England; Inst Canc Res, Breakthrough Breast Canc Ctr, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Dowsett, M (corresponding author), Royal Marsden Hosp, Dept Biochem, London SW3 6JJ, England.	mitch@icr.ac.uk						CLARK JH, 1979, FEMALE SEX STEROIDS, P70; Gruvberger S, 2001, CANCER RES, V61, P5979; McDonnell DP, 2002, RECENT PROG HORM RES, V57, P295, DOI 10.1210/rp.57.1.295; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Peto R, 2000, LANCET, V356, P593, DOI 10.1016/S0140-6736(05)73970-2; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Smith IE, 2003, NEW ENGL J MED, V348, P2431, DOI 10.1056/NEJMra023246; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998	10	14	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2003	362	9380					260	262		10.1016/S0140-6736(03)14005-6	http://dx.doi.org/10.1016/S0140-6736(03)14005-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705UL	12892953				2022-12-28	WOS:000184413400005
J	Bingham, SA; Luben, R; Welch, A; Wareham, N; Khaw, KT; Day, N				Bingham, SA; Luben, R; Welch, A; Wareham, N; Khaw, KT; Day, N			Are imprecise methods obscuring a relation between fat and breast cancer?	LANCET			English	Article							NORFOLK; COHORT	Pooled analyses of cohort studies show no relation between fat intake and breast-cancer risk. However, food-frequency questionnaire (FFQ) methods used in these studies are prone to measurement error. We assessed diet with an FFQ and a detailed 7-day food diary in 13 070 women between 1993 and 1997. We compared 168 breast-cancer cases incident by 2000 with four matched controls. Risk of breast cancer was associated with saturated-fat intake measured with the food diary (hazard ratio 1.22 [95% CI 1.06-1.40], p=0.005, per quintile increase in energy-adjusted fat intake), but not with saturated fat measured with the FFQ (1.10 [0.94-1.29], p=0.23). Dietary measurement error might explain the absence of a significant association between dietary fat and breast-cancer risk in cohort studies.	MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England; Univ Cambridge, Sch Clin Med, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Cambridge	Bingham, SA (corresponding author), MRC, Dunn Human Nutr Unit, Welcome Trust MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.		Khaw, Kay-Tee/AAZ-3209-2021; Luben, Robert N/H-5519-2015; Welch, Ailsa Ann/A-4850-2008	Luben, Robert N/0000-0002-5088-6343; Welch, Ailsa Ann/0000-0002-6702-3704				Bingham SA, 2001, PUBLIC HEALTH NUTR, V4, P847, DOI 10.1079/PHN2000102; Day N, 1999, BRIT J CANCER, V80, P95; Day NE, 2001, INT J EPIDEMIOL, V30, P309, DOI 10.1093/ije/30.2.309; HOWE GR, 1990, JNCI-J NATL CANCER I, V82, P561, DOI 10.1093/jnci/82.7.561; Smith-Warner SA, 2001, INT J CANCER, V92, P767, DOI 10.1002/1097-0215(20010601)92:5&lt;767::AID-IJC1247&gt;3.0.CO;2-0	5	301	309	0	20	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 19	2003	362	9379					212	214		10.1016/S0140-6736(03)13913-X	http://dx.doi.org/10.1016/S0140-6736(03)13913-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702PJ	12885485				2022-12-28	WOS:000184232000014
J	McManus, IC; Smithers, E; Partridge, P; Keeling, A; Fleming, PR				McManus, IC; Smithers, E; Partridge, P; Keeling, A; Fleming, PR			A levels and intelligence as predictors of medical careers in UK doctors: 20 year prospective study	BRITISH MEDICAL JOURNAL			English	Article							PERFORMANCE; STUDENTS; UNHAPPY	Objective To assess whether A level grades (achievement) and intelligence (ability) predict doctors' careers. Design Prospective cohort study with follow up after 20 years by postal questionnaire. Setting A UK medical school in London. Participants 511 doctors who had entered Westminster Medical School as clinical students between 1975 and 1982 were followed up in January 2002. Main outcome measures Time taken to reach different career grades in hospital or general practice, postgraduate qualifications obtained (mernbership/fellowships, diplomas, higher academic degrees), number of research publications, and measures of stress mid burnout related to A level grades and intelligence (result of AH5 intelligence test) at entry to clinical school. General health questionnaire, Maslach burnout inventory, and questionnaire on satisfaction with career at follow up. Results 47 (9%) doctors were no longer on the Medical Register. They had lower A level grades than those who were still on the register (P < 0.001). A levels also predicted performance in undergraduate training, performance in postregistration house officer posts, and time to achieve membership qualifications (Cox regression, P < 0.001; b = 0.376, SE = 0.098, exp(b) = 1.457). Intelligence did not independently predict dropping off the register, career outcome, or other measures. A levels did not predict diploma or higher academic qualifications, research publications, or stress or burnout. Diplomas, higher academic degrees, and research publications did, however, significantly correlate with personality measures. Conclusions Results of achievement tests, in this case A level grades, which are particularly used for selection of students in the United Kingdom, have long term predictive validity for undergraduate and postgraduate careers. In contrast, a test of ability or aptitude (AH5) was of little predictive validity for subsequent medical careers.	UCL, Dept Psychol, London WC1E 6BT, England; Westminster Med Sch & Hosp, London, England	University of London; University College London; Imperial College London	McManus, IC (corresponding author), UCL, Dept Psychol, Mortimer St, London WC1E 6BT, England.	i.mcmanus@ucl.ac.uk		McManus, Ian/0000-0003-3510-4814				Bekhradnia B, 2002, WHO DOES BEST U; Costa PT., 1992, REVISED NEO PERSONAL; Deary IJ, 1998, BRIT MED J, V317, P1701, DOI 10.1136/bmj.317.7174.1701; Ferguson E, 2002, BMJ-BRIT MED J, V324, P952, DOI 10.1136/bmj.324.7343.952; Heim AW, 1968, AH5 GROUP TEST HIGH; Matthews G, 1998, PERSONALITY TRAITS; McDonald A. S., 2000, APTITUDE TESTING U E; MCDONALD AS, 2000, PILOT APTITUDE TESTI; McManus IC, 1998, BRIT MED J, V316, P345, DOI 10.1136/bmj.316.7128.345; McManus IC, 2002, LANCET, V359, P2089, DOI 10.1016/S0140-6736(02)08915-8; McManus IC, 1998, BRIT MED J, V317, P1111; McManus IC, 1999, BRIT MED J, V319, P542, DOI 10.1136/bmj.319.7209.542; MCMANUS IC, 1990, MED EDUC, V24, P181; PEERS IS, 1994, BRIT J EDUC PSYCHOL, V64, P1, DOI 10.1111/j.2044-8279.1994.tb01081.x; Schmidt FL, 1998, PSYCHOL BULL, V124, P262, DOI 10.1037/0033-2909.124.2.262; Smith R, 2001, BMJ-BRIT MED J, V322, P1073, DOI 10.1136/bmj.322.7294.1073; *U UK, 2003, FAIR EN WID ACC U ID; West PA, 2001, BRIT MED J, V322, P1361, DOI 10.1136/bmj.322.7298.1361	18	194	195	0	29	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 19	2003	327	7407					139	142		10.1136/bmj.327.7407.139	http://dx.doi.org/10.1136/bmj.327.7407.139			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702WJ	12869457	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000184247500020
J	Pearson, GA				Pearson, GA			Mathematical morbidity in paediatric intensive care	LANCET			English	Editorial Material							MORTALITY; SEPSIS		Birmingham Childrens Hosp, Birmingham B4 6NH, W Midlands, England	University of Birmingham	Pearson, GA (corresponding author), Birmingham Childrens Hosp, Birmingham B4 6NH, W Midlands, England.							Angus DC, 1997, CRIT CARE CLIN, V13, P389, DOI 10.1016/S0749-0704(05)70317-1; Bucher HC, 1999, JAMA-J AM MED ASSOC, V282, P771, DOI 10.1001/jama.282.8.771; LECLERC F, 1996, UPD INT CAR, V25, P229; Levy Mitchell M, 2003, Intensive Care Med, V29, P530; Parry G, 2002, ARCH DIS CHILD, V86, P65, DOI 10.1136/adc.86.1.65; Pearson G, 2001, INTENS CARE MED, V27, P1670, DOI 10.1007/s001340101072; Pearson G, 1997, LANCET, V349, P1213, DOI 10.1016/S0140-6736(96)12396-5; Shann F, 2002, INTENS CARE MED, V28, P105, DOI 10.1007/s00134-001-1186-1; WILKINSON JD, 1987, J PEDIATR-US, V111, P324, DOI 10.1016/S0022-3476(87)80448-1	9	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 19	2003	362	9379					180	181		10.1016/S0140-6736(03)13948-7	http://dx.doi.org/10.1016/S0140-6736(03)13948-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702PJ	12885473				2022-12-28	WOS:000184232000002
J	Sharp, D				Sharp, D			Dam medicine	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							Hunter JM, 2003, SOC SCI MED, V56, P219, DOI 10.1016/S0277-9536(02)00021-7; *INT FIN CORP, 2003, EQ PRINC IND APPR FI; Poda Jean-Noel, 2003, Sante, V13, P49; Sleigh AC, 2001, LANCET, V357, P570, DOI 10.1016/S0140-6736(00)04072-1	4	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2003	362	9379					184	184		10.1016/S0140-6736(03)13952-9	http://dx.doi.org/10.1016/S0140-6736(03)13952-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	702PJ	12885477				2022-12-28	WOS:000184232000006
J	Stephan, KE; Marshall, JC; Friston, KJ; Rowe, JB; Ritzl, A; Zilles, K; Fink, GR				Stephan, KE; Marshall, JC; Friston, KJ; Rowe, JB; Ritzl, A; Zilles, K; Fink, GR			Lateralized cognitive processes and lateralized task control in the human brain	SCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; HEMISPHERIC-SPECIALIZATION; VISUAL-ATTENTION; WORKING-MEMORY; RHESUS-MONKEY; DISSOCIATION; CONNECTIONS; ASYMMETRY; CONFLICT; PATHWAYS	The principles underlying human hemispheric specialization are poorly understood. We used functional magnetic resonance imaging of letter and visuospatial decision tasks with identical word stimuli to address two unresolved problems. First, hemispheric specialization depended on the nature of the task rather than on the nature of the stimulus. Second, analysis of frontal candidate regions for cognitive control showed increased coupling between left anterior cingulate cortex (ACC) and left inferior frontal gyrus during letter decisions, whereas right ACC showed enhanced coupling with right parietal areas during visuospatial decisions. Cognitive control is thus localized in the same hemisphere as task execution.	Res Ctr Julich, Inst Med, D-52425 Julich, Germany; Univ Aachen, Dept Neurol, D-52074 Aachen, Germany; UCL, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; UCL, Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; Univ Oxford, Radcliffe Infirm, Dept Clin Neurol, Neuropsychol Unit, Oxford OX2 6HE, England; Univ Dusseldorf, C&O Vogt Brain Res Inst, D-40225 Dusseldorf, Germany	Helmholtz Association; Research Center Julich; RWTH Aachen University; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Radcliffe Infirmary; University of Oxford; Heinrich Heine University Dusseldorf	Fink, GR (corresponding author), Res Ctr Julich, Inst Med, D-52425 Julich, Germany.	g.fink@fz-juelich.de	Friston, Karl/D-9230-2011; rowe, james B/C-3661-2013; Zilles, Karl/Y-3784-2019; Fink, Gereon R./AFW-9377-2022; Zilles, Karl/J-9704-2013; Fink, Gereon R./E-1616-2012; Tick, Beata/ABA-1728-2020	Friston, Karl/0000-0001-7984-8909; rowe, james B/0000-0001-7216-8679; Zilles, Karl/0000-0002-4705-4175; Fink, Gereon R./0000-0002-8230-1856; Zilles, Karl/0000-0001-9296-9959; Fink, Gereon R./0000-0002-8230-1856; Stephan, Klaas Enno/0000-0002-8594-9092	Wellcome Trust [077029] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BRADSHAW JL, 1981, BEHAV BRAIN SCI, V4, P51, DOI 10.1017/S0140525X00007548; Buchel C, 1997, CEREB CORTEX, V7, P768, DOI 10.1093/cercor/7.8.768; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Casey BJ, 2000, P NATL ACAD SCI USA, V97, P8728, DOI 10.1073/pnas.97.15.8728; CAVADA C, 1989, J COMP NEUROL, V287, P393, DOI 10.1002/cne.902870402; CHIARELLO C, 1986, NEUROPSYCHOLOGIA, V24, P521, DOI 10.1016/0028-3932(86)90096-5; Corballis PM, 1999, NEUROREPORT, V10, P2183, DOI 10.1097/00001756-199907130-00033; Courtney SM, 1996, CEREB CORTEX, V6, P39, DOI 10.1093/cercor/6.1.39; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fink GR, 1996, NATURE, V382, P626, DOI 10.1038/382626a0; Fink GR, 1999, BRAIN, V122, P497, DOI 10.1093/brain/122.3.497; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; HELLIGE JB, 1990, ANNU REV PSYCHOL, V41, P55, DOI 10.1146/annurev.ps.41.020190.000415; HUGDAHL K, 2003, ASYMMETRICAL BRAIN; LEVY J, 1976, J EXP PSYCHOL HUMAN, V2, P299, DOI 10.1037/0096-1523.2.3.299; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MARSHALL JC, 1981, BEHAV BRAIN SCI, V4, P72, DOI 10.1017/S0140525X00007664; MCINTOSH AR, 1994, J NEUROSCI, V14, P655; Nystrom LE, 2000, NEUROIMAGE, V11, P424, DOI 10.1006/nimg.2000.0572; PANDYA DN, 1981, EXP BRAIN RES, V42, P319, DOI 10.1007/BF00237497; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Price CJ, 1996, CEREB CORTEX, V6, P62, DOI 10.1093/cercor/6.1.62; SERGENT J, 1983, PSYCHOL BULL, V93, P481, DOI 10.1037/0033-2909.93.3.481; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45	27	223	229	3	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2003	301	5631					384	386		10.1126/science.1086025	http://dx.doi.org/10.1126/science.1086025			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869765				2022-12-28	WOS:000184207300049
J	Agrawal, A; Lingappa, J; Leppla, SH; Agrawal, S; Jabbar, A; Quinn, C; Pulendran, B				Agrawal, A; Lingappa, J; Leppla, SH; Agrawal, S; Jabbar, A; Quinn, C; Pulendran, B			Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin	NATURE			English	Article								Anthrax poses a clear and present danger as an agent of biological terrorism(1-3). Infection with Bacillus anthracis, the causative agent of anthrax, if untreated can result in rampant bacteraemia, multisystem dysfunction and death(4-8). Anthrax lethal toxin (LT) is a critical virulence factor of B. anthracis, which occurs as a complex of protective antigen and lethal factor. Here we demonstrate that LT severely impairs the function of dendritic cells-which are pivotal to the establishment of immunity against pathogens- and host immune responses by disrupting the mitogen-activated protein (MAP) kinase intracellular signalling network. Dendritic cells exposed to LT and then stimulated with lipopolysaccharide do not upregulate co-stimulatory molecules, secrete greatly diminished amounts of proinflammatory cytokines, and do not effectively stimulate antigen-specific T cells in vivo. Furthermore, injections of LT induce a profound impairment of antigen-specific T- and B-cell immunity. These data suggest a role for LT in suppressing host immunity during B. anthracis infections, and represent an immune evasion strategy, where a microbe targets MAP kinases in dendritic cells to disarm the immune response.	Emory Vaccine Res Ctr, Atlanta, GA 30329 USA; CDCP, Meningitis & Special Pathogens Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; NIAID, Microbial Pathogenesis Sect, Bethesda, MD 20892 USA	Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Pulendran, B (corresponding author), Emory Vaccine Res Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.		Lingappa, Jairam/N-7760-2017; Pulendran, Bali/AAW-9550-2021	Pulendran, Bali/0000-0001-6517-4333	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000929, ZIAAI000929] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Brossier F, 2001, TOXICON, V39, P1747, DOI 10.1016/S0041-0101(01)00161-1; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; HANNA PC, 1993, P NATL ACAD SCI USA, V90, P10198, DOI 10.1073/pnas.90.21.10198; Hanna PC, 1999, TRENDS MICROBIOL, V7, P180, DOI 10.1016/S0966-842X(99)01507-3; HASKINS K, 1983, J EXP MED, V157, P1149, DOI 10.1084/jem.157.4.1149; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Lane HC, 2001, NAT MED, V7, P1271, DOI 10.1038/nm1201-1271; Little SF, 1999, MICROBES INFECT, V1, P131, DOI 10.1016/S1286-4579(99)80004-5; Liu LZ, 2002, NAT MED, V8, P185, DOI 10.1038/nm0202-185; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Mourez M, 2002, TRENDS MICROBIOL, V10, P287, DOI 10.1016/S0966-842X(02)02369-7; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Pulendran B, 1997, J IMMUNOL, V159, P2222; Pulendran B, 2001, SCIENCE, V293, P253, DOI 10.1126/science.1062060; Sailaja G, 2003, J IMMUNOL, V170, P2496, DOI 10.4049/jimmunol.170.5.2496; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Smith H, 2000, TRENDS MICROBIOL, V8, P199, DOI 10.1016/S0966-842X(00)01755-8; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Yi AK, 2001, INT IMMUNOL, V13, P1391, DOI 10.1093/intimm/13.11.1391; Yi AK, 2002, J IMMUNOL, V168, P4711, DOI 10.4049/jimmunol.168.9.4711	30	238	250	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					329	334		10.1038/nature01794	http://dx.doi.org/10.1038/nature01794			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867985				2022-12-28	WOS:000184183900046
J	Hochedlinger, K; Jaenisch, R				Hochedlinger, K; Jaenisch, R			Mechanisms of disease: Nuclear transplantation, embryonic stem cells, and the potential for cell therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SOMATIC-CELLS; CLONED MICE; ES CELLS; ENUCLEATED OOCYTES; NEURAL PRECURSORS; TELOMERE LENGTH; MOUSE EMBRYOS; GENE-THERAPY; DONOR CELLS; CLONING		Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu			NCI NIH HHS [R37-CA84198] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA084198] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Assady S, 2001, DIABETES, V50, P1691, DOI 10.2337/diabetes.50.8.1691; Betts DH, 2001, P NATL ACAD SCI USA, V98, P1077, DOI 10.1073/pnas.031559298; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Buehr M, 2003, BIOL REPROD, V68, P222, DOI 10.1095/biolreprod.102.006197; Byrne JA, 2002, P NATL ACAD SCI USA, V99, P6059, DOI 10.1073/pnas.082112099; Carpenter MK, 2001, EXP NEUROL, V172, P383, DOI 10.1006/exnr.2001.7832; Check E, 2003, NATURE, V421, P305, DOI 10.1038/421305a; CHEONG HT, 1993, BIOL REPROD, V48, P958, DOI 10.1095/biolreprod48.5.958; Cibelli JB, 2002, NAT BIOTECHNOL, V20, P13, DOI 10.1038/nbt0102-13; Colman A, 2000, TRENDS BIOTECHNOL, V18, P192, DOI 10.1016/S0167-7799(00)01434-7; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Eggan K, 2000, SCIENCE, V290, P1578, DOI 10.1126/science.290.5496.1578; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; GAO S, IN PRESS BIOL REPROD; GURDON JB, 1975, J EMBRYOL EXP MORPH, V34, P93; Hill JR, 2000, BIOL REPROD, V63, P1787, DOI 10.1095/biolreprod63.6.1787; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hochedlinger K, 2002, CURR OPIN CELL BIOL, V14, P741, DOI 10.1016/S0955-0674(02)00380-0; HUBER K, 2003, SCIENCE, V300, P1251; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Humphreys D, 2002, P NATL ACAD SCI USA, V99, P12889, DOI 10.1073/pnas.192433399; Jaenisch Rudolf, 2002, Cloning and Stem Cells, V4, P389, DOI 10.1089/153623002321025069; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Joshi CV, 2002, CURR OPIN CELL BIOL, V14, P749, DOI 10.1016/S0955-0674(02)00392-7; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Kang YK, 2002, EMBO J, V21, P1092, DOI 10.1093/emboj/21.5.1092; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665; Li M, 1998, CURR BIOL, V8, P971, DOI 10.1016/S0960-9822(98)70399-9; Liu L, 2001, NAT BIOTECHNOL, V19, P406, DOI 10.1038/88052; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Moorehead RA, 2003, ONCOGENE, V22, P853, DOI 10.1038/sj.onc.1206188; Morshead CM, 2002, NAT MED, V8, P268, DOI 10.1038/nm0302-268; Munsie MJ, 2000, CURR BIOL, V10, P989, DOI 10.1016/S0960-9822(00)00648-5; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Oback Bjorn, 2002, Cloning and Stem Cells, V4, P147, DOI 10.1089/153623002320253328; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; Ogonuki N, 2002, NAT GENET, V30, P253, DOI 10.1038/ng841; Reik W, 1997, TRENDS GENET, V13, P330, DOI 10.1016/S0168-9525(97)01200-6; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Rideout WM, 2000, NAT GENET, V24, P109, DOI 10.1038/72753; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Schuldiner M, 2001, BRAIN RES, V913, P201, DOI 10.1016/S0006-8993(01)02776-7; Solter D, 2000, NAT REV GENET, V1, P199, DOI 10.1038/35042066; Soria B, 2000, DIABETES, V49, P157, DOI 10.2337/diabetes.49.2.157; Tamashiro KLK, 2002, NAT MED, V8, P262, DOI 10.1038/nm0302-262; Tanaka S, 2001, BIOL REPROD, V65, P1813, DOI 10.1095/biolreprod65.6.1813; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Tian XC, 2000, NAT GENET, V26, P272, DOI 10.1038/81559; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Vogelstein B, 2002, SCIENCE, V295, P1237, DOI 10.1126/science.1070247; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Wakayama T, 2000, NATURE, V407, P318, DOI 10.1038/35030301; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 2001, MOL REPROD DEV, V58, P376, DOI 10.1002/1098-2795(20010401)58:4<376::AID-MRD4>3.0.CO;2-L; Wakayama T, 1999, NAT GENET, V22, P127, DOI 10.1038/9632; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wells DN, 1999, BIOL REPROD, V60, P996, DOI 10.1095/biolreprod60.4.996; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wilmut I, 1997, NATURE, V386, P200, DOI 10.1038/386200a0; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/revreprod/3.3.155; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	72	213	251	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2003	349	3					275	286		10.1056/NEJMra035397	http://dx.doi.org/10.1056/NEJMra035397			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701KA	12867612				2022-12-28	WOS:000184165700013
J	Taneike, M; Abe, F; Sawada, K				Taneike, M; Abe, F; Sawada, K			Creep-strengthening of steel at high temperatures using nano-sized carbonitride dispersions	NATURE			English	Article								Creep is a time-dependent mechanism of plastic deformation, which takes place in a range of materials under low stress-that is, under stresses lower than the yield stress(1). Metals and alloys can be designed to withstand creep at high temperatures, usually by a process called dispersion strengthening(2), in which fine particles are evenly distributed throughout the matrix. For example, high-temperature creep-resistant ferritic steels achieve optimal creep strength (at 923 K) through the dispersion of yttrium oxide nanoparticles(3). However, the oxide particles are introduced by complicated mechanical alloying techniques and, as a result, the production of large-scale industrial components is economically unfeasible. Here we report the production of a 9 per cent Cr martensitic steel dispersed with nanometre-scale carbonitride particles using conventional processing techniques. At 923 K, our dispersion-strengthened material exhibits a time-to-rupture that is increased by two orders of magnitude relative to the current strongest creep-resistant steels(4). This improvement in creep resistance is attributed to a mechanism of boundary pinning by the thermally stable carbonitride precipitates. The material also demonstrates enough fracture toughness. Our results should lead to improved grades of creep-resistant steels and to the economical manufacture of large-scale steel components for high-temperature applications.	Natl Inst Mat Sci, Steel Res Ctr, Tsukuba, Ibaraki 3050047, Japan; Natl Inst Mat Sci, Mat Informat Technol Stn, Tsukuba, Ibaraki 3050047, Japan	National Institute for Materials Science; National Institute for Materials Science	Abe, F (corresponding author), Natl Inst Mat Sci, Steel Res Ctr, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.		ABE, Fujio/H-2677-2011; SAWADA, Kota/H-2586-2011; Abe, Fujio/R-7753-2017	Abe, Fujio/0000-0001-8053-0885				ABE F, 1992, METALL TRANS A, V23, P469, DOI 10.1007/BF02801164; Abe F, 2003, METALL MATER TRANS A, V34A, P913, DOI 10.1007/s11661-003-0222-x; *ASTM, 1977, ASTME23; BAKKER WT, 2001, P 3 EPRI C ADV MAT T, P1; Evans R. W., 1985, CREEP METALS ALLOYS, P1; Goecmen A, 1996, ISIJ INT, V36, P768, DOI 10.2355/isijinternational.36.768; GOLDHOFF RT, 1960, T ASME D, V82, P848; *INT STAND, 1997, 204 ISO; *JAP IND STAND, 1999, 2271 JISZ; *NAT RES I MET, 1996, 43 NAT RES I MET NAT; *NAT RES I MET, 2002, 48 NAT RES I MET NAT; Sawada K, 2001, MAT SCI ENG A-STRUCT, V319, P784, DOI 10.1016/S0921-5093(01)00973-X; Strang A, 1996, MATER SCI TECH SER, V12, P552, DOI 10.1179/026708396790165993; STRUDEL JL, 1983, PHYS METALLURGY, P1412; Ukai S, 1998, J NUCL MATER, V258, P1745, DOI 10.1016/S0022-3115(98)00241-4; UKAI S, 1993, J NUCL MATER, V204, P74, DOI 10.1016/0022-3115(93)90201-9; WEY MY, 1981, T JPN I MET, V22, P733, DOI 10.2320/matertrans1960.22.733	17	319	344	10	191	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					294	296		10.1038/nature01740	http://dx.doi.org/10.1038/nature01740			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867976				2022-12-28	WOS:000184183900036
J	Whitaker, RJ; Grogan, DW; Taylor, JW				Whitaker, RJ; Grogan, DW; Taylor, JW			Geographic barriers isolate endemic populations of hyperthermophilic archaea	SCIENCE			English	Article							DIFFERENT OCEANIC PROVINCES; BACTERIA; SULFOLOBUS; DIVERSITY; BIOGEOGRAPHY; TEMPERATURE; VIRUSES; SOIL; SEA	Barriers to dispersal between populations allow them to diverge through local adaptation or random genetic drift. High-resolution multilocus sequence analysis revealed that, on a global scale, populations of hyperthermophilic microorganisms are isolated from one another by geographic barriers and have diverged over the course of their recent evolutionary history. The identification of a biogeographic pattern in the archaeon Sulfolobus challenges the current model of microbial biodiversity in which unrestricted dispersal constrains the development of global species richness.	Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA	University of California System; University of California Berkeley; University System of Ohio; University of Cincinnati	Whitaker, RJ (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, 111 Koshland Hall, Berkeley, CA 94720 USA.							Beja O, 2002, APPL ENVIRON MICROB, V68, P335, DOI 10.1128/AEM.68.1.335-345.2002; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; Casamayor EO, 2002, APPL ENVIRON MICROB, V68, P1706, DOI 10.1128/AEM.68.4.1706-1714.2002; Castenholz R. W., 1996, NOVA HEDWIGIA, V112, P33; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Fulthorpe RR, 1998, APPL ENVIRON MICROB, V64, P1620; Glockner FO, 2000, APPL ENVIRON MICROB, V66, P5053, DOI 10.1128/AEM.66.11.5053-5065.2000; Hjort K, 1999, J BACTERIOL, V181, P5669, DOI 10.1128/JB.181.18.5669-5675.1999; Massana R, 2000, APPL ENVIRON MICROB, V66, P1777, DOI 10.1128/AEM.66.5.1777-1787.2000; MUSSER JM, 1990, REV INFECT DIS, V12, P75; Oda Y, 2002, APPL ENVIRON MICROB, V68, P3467, DOI 10.1128/AEM.68.7.3467-3477.2002; Palys T, 1997, INT J SYST BACTERIOL, V47, P1145, DOI 10.1099/00207713-47-4-1145; Papke RT, 2003, ENVIRON MICROBIOL, V5, P650, DOI 10.1046/j.1462-2920.2003.00460.x; Petursdottir SK, 2000, EXTREMOPHILES, V4, P267, DOI 10.1007/s007920070012; Rice G, 2001, P NATL ACAD SCI USA, V98, P13341, DOI 10.1073/pnas.231170198; Roberts MS, 1995, EVOLUTION, V49, P1081, DOI 10.1111/j.1558-5646.1995.tb04435.x; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; SMITH JM, 1991, NATURE, V349, P29, DOI 10.1038/349029a0; Staley JT, 1999, ANNU REV MICROBIOL, V53, P189, DOI 10.1146/annurev.micro.53.1.189; STETTER KO, 1993, NATURE, V365, P743, DOI 10.1038/365743a0; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; ZILLIG W, 1994, SYST APPL MICROBIOL, V16, P609	25	605	637	6	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 15	2003	301	5635					976	978		10.1126/science.1086909	http://dx.doi.org/10.1126/science.1086909			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711RY	12881573				2022-12-28	WOS:000184755900043
J	Smith, GCS; Pell, JP; Dobbie, R				Smith, GCS; Pell, JP; Dobbie, R			Interpregnancy interval and risk of preterm birth and neonatal death: retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							PERINATAL OUTCOMES; PREGNANCY INTERVAL; GESTATIONAL-AGE; BLACK-WOMEN; WEIGHT; ASSOCIATION; DELIVERY; LABOR; WHITE	Objective To determine whether a short interval between pregnancies is an independent risk factor for adverse obstetric outcome. Design Retrospective cohort study. Setting Scotland. Subjects 89 143 women having second births in 1992-8 who conceived within five years of their first birth. Main outcome measures Intrauterine growth restriction (birth weight less than the 5th centile for gestational acre), extremely preterm birth (24-32 weeks), moderately preterm birth (33-36 weeks), and perinatal death. Results Women whose subsequent interpregnancy interval was less than six months were more likely than other women to have had a first birth complicated by 4-itrauterine growth restriction (odds ratio 1.3, 95% confidence interval 1.1 to 1.5), extremely preterm birth (4.1, 3.2 to 5.3), moderately preterm birth (1.5, 1.3 to 1.7), or perinatal death (24.4, 18.9 to 31.5). They were also shorter, less likely to be married, mid more likely to be aged less than 20 years at the time of the second birth, to smoke, and to live in an area of high socioeconomic deprivation. When the outcome of die second birth was analysed in relation to the preceding interpregnancy interval and the analysis confined to women whose first birth was a term live birth (n = 69 055), no significant association occurred (adjusted for age, marital status, height, socioeconomic deprivation, smoking, previous birth weight vigesimal, and previous caesarean delivery) between interpregnancy interval and intrauterine growth restriction or stillbirth. However, a short interpregnancy interval (< 6 months) was an independent risk factor for extremely preterm birth (adjusted odds ratio 2.2, 1.3 to 3.6), moderately preterm birth (1.6,1.3 to 2.0), and neonatal death unrelated to congenital abnormality (3.6, 1.2 to 10.7). The adjusted attributable fractions for these associations were 6.1%,3.9%, and 13.8%. The associations were very similar when the analysis was confined to married non-smokers aged 25 and above. Conclusions A short interpregnancy interval is an independent risk factor for preterm delivery and neonatal death in the second birth.	Univ Cambridge, Rosie Hosp, Dept Obstet & Gynaecol, Cambridge CB2 2QQ, England; Greater Glasgow NHS Board, Dept Publ Hlth, Glasgow, Lanark, Scotland; Common Serv Agcy, Informat & Stat Div, Edinburgh, Midlothian, Scotland	University of Cambridge	Smith, GCS (corresponding author), Univ Cambridge, Rosie Hosp, Dept Obstet & Gynaecol, Box 223, Cambridge CB2 2QQ, England.		Smith, Gordon/A-8070-2008	Smith, Gordon/0000-0003-2124-0997; Pell, Jill/0000-0002-8898-7035				Adams MM, 1997, PAEDIATR PERINAT EP, V11, P48, DOI 10.1046/j.1365-3016.11.s1.8.x; Adams MM, 1997, PAEDIATR PERINAT EP, V11, P1; Basso O, 1998, AM J OBSTET GYNECOL, V178, P259, DOI 10.1016/S0002-9378(98)80010-0; BRODY DJ, 1987, AM J PERINAT, V4, P50, DOI 10.1055/s-2007-999736; Campbell S., 1993, ULTRASOUND OBSTET GY, P1432; COLE SK, 1986, BRIT J OBSTET GYNAEC, V93, P1204, DOI 10.1111/j.1471-0528.1986.tb07853.x; COLE SK, 1980, PERINATAL AUDIT SURV, P39; ERICKSON JD, 1978, J EPIDEMIOL COMMUN H, V32, P124, DOI 10.1136/jech.32.2.124; Fuentes-Afflick E, 2000, OBSTET GYNECOL, V95, P383, DOI 10.1016/S0029-7844(99)00583-9; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; HOSMER DW, 1989, APPL LOGISTIC REGRES; *INF STAT DIV NHS, 2002, SCOTT PER INF MORT M; Kaharuza FM, 2001, ACTA OBSTET GYN SCAN, V80, P532, DOI 10.1034/j.1600-0412.2001.080006532.x; Kendrick Stephen, 1993, Health Bulletin (Edinburgh), V51, P72; Khoshnood B, 1998, AM J EPIDEMIOL, V148, P798; KLEBANOFF MA, 1988, AM J PUBLIC HEALTH, V78, P667, DOI 10.2105/AJPH.78.6.667; LIEBERMAN E, 1989, OBSTET GYNECOL, V74, P1; MCILWAINE GM, 1985, BRIT J OBSTET GYNAEC, V92, P9, DOI 10.1111/j.1471-0528.1985.tb01041.x; Norwitz ER, 1999, NEW ENGL J MED, V341, P660, DOI 10.1056/NEJM199908263410906; RAWLINGS JS, 1995, NEW ENGL J MED, V332, P69, DOI 10.1056/NEJM199501123320201; Shults RA, 1999, EPIDEMIOLOGY, V10, P250, DOI 10.1097/00001648-199905000-00010; Smith GCS, 2002, JAMA-J AM MED ASSOC, V287, P2684, DOI 10.1001/jama.287.20.2684; Smith GCS, 2001, BRIT MED J, V323, P476, DOI 10.1136/bmj.323.7311.476; Zhu BP, 2001, AM J OBSTET GYNECOL, V185, P1403, DOI 10.1067/mob.2001.118307; Zhu BP, 1999, NEW ENGL J MED, V340, P589, DOI 10.1056/NEJM199902253400801	25	184	191	0	13	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 9	2003	327	7410					313	316		10.1136/bmj.327.7410.313	http://dx.doi.org/10.1136/bmj.327.7410.313			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	710JE	12907483	Bronze, Green Published			2022-12-28	WOS:000184676400015
J	Hacker, J; Hentschel, U; Dobrindt, U				Hacker, J; Hentschel, U; Dobrindt, U			Prokaryotic chromosomes and disease	SCIENCE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; BACTERIAL PATHOGENICITY; HORIZONTAL TRANSFER; GENOME SEQUENCE; MISMATCH REPAIR; YERSINIA-PESTIS; HIGH-FREQUENCY; VIRULENCE; RESISTANCE; EVOLUTION	Recent insights into bacterial genome organization and function have improved our understanding of the nature of pathogenic bacteria and their ability to cause disease. It is becoming increasingly clear that the bacterial chromosome constantly undergoes structural changes due to gene acquisition and loss, recombination, and mutational events that have an impact on the pathogenic potential of the bacterium. Even though the bacterial genome includes additional genetic elements, the chromosome represents the most important entity in this context. Here, we will show that various processes of genomic instability have an influence on the many manifestations of infectious disease.	Univ Wurzburg, Inst Mol Infekt Biol, D-97070 Wurzburg, Germany	University of Wurzburg	Hacker, J (corresponding author), Univ Wurzburg, Inst Mol Infekt Biol, Rontgenring 11, D-97070 Wurzburg, Germany.	j.hacker@mail.uni-wuerzburg.de	Hentschel, Ute/ABD-6624-2021; Hentschel, Ute/H-8343-2013; Dobrindt, Ulrich/AEU-2378-2022	Hentschel, Ute/0000-0003-0596-790X; Hentschel, Ute/0000-0003-0596-790X; Dobrindt, Ulrich/0000-0001-9949-1898				Boddicker JD, 2002, MOL MICROBIOL, V45, P1255, DOI 10.1046/j.1365-2958.2002.03121.x; Boyd EF, 2002, TRENDS MICROBIOL, V10, P521, DOI 10.1016/S0966-842X(02)02459-9; Brown EW, 2001, J BACTERIOL, V183, P1631, DOI 10.1128/JB.183.5.1631-1644.2001; Brumell JH, 2003, TRAFFIC, V4, P36, DOI 10.1034/j.1600-0854.2003.40106.x; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; de Boer P, 2002, MOL MICROBIOL, V44, P351, DOI 10.1046/j.1365-2958.2002.02930.x; Denamur E, 2000, CELL, V103, P711, DOI 10.1016/S0092-8674(00)00175-6; Dobrindt U, 2003, J BACTERIOL, V185, P1831, DOI 10.1128/JB.185.6.1831-1840.2003; Dobrindt U, 2002, MOL GENET GENOMICS, V267, P370, DOI 10.1007/s00438-002-0668-3; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Gross Roy, 2003, Molecular Microbiology, V47, P1749, DOI 10.1046/j.1365-2958.2003.03443.x; Gunther NW, 2001, INFECT IMMUN, V69, P2838, DOI 10.1128/IAI.69.5.2838-2846.2001; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Hakenbeck R, 2001, INFECT IMMUN, V69, P2477, DOI 10.1128/IAI.69.4.2477-2486.2001; Hentschel U, 2000, TRENDS MICROBIOL, V8, P226, DOI 10.1016/S0966-842X(00)01758-3; Hinnebusch BJ, 2002, MOL MICROBIOL, V46, P349, DOI 10.1046/j.1365-2958.2002.03159.x; Ho TD, 2002, J BACTERIOL, V184, P5234, DOI 10.1128/JB.184.19.5234-5239.2002; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Loessner I, 2002, J BACTERIOL, V184, P4709, DOI 10.1128/JB.184.17.4709-4714.2002; Maurelli AT, 1998, P NATL ACAD SCI USA, V95, P3943, DOI 10.1073/pnas.95.7.3943; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Oelschlaeger TA, 2003, J BACTERIOL, V185, P1107, DOI 10.1128/JB.185.3.1107-1111.2003; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Picard B, 2001, INFECT IMMUN, V69, P9, DOI 10.1128/IAI.69.1.9-14.2001; Prunier AL, 2003, J INFECT DIS, V187, P1709, DOI 10.1086/374937; Richardson AR, 2001, MOL MICROBIOL, V40, P645, DOI 10.1046/j.1365-2958.2001.02408.x; Rowe-Magnus DA, 2003, GENOME RES, V13, P428, DOI 10.1101/gr.617103; Saunders NJ, 2000, MOL MICROBIOL, V37, P207, DOI 10.1046/j.1365-2958.2000.02000.x; Shankar N, 2002, NATURE, V417, P746, DOI 10.1038/nature00802; Umeda A, 2002, J ANTIMICROB CHEMOTH, V50, P253, DOI 10.1093/jac/dkf105; Weissman SJ, 2003, TRENDS MICROBIOL, V11, P115, DOI 10.1016/S0966-842X(03)00010-6	35	87	92	2	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2003	301	5634					790	793		10.1126/science.1086802	http://dx.doi.org/10.1126/science.1086802			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907788				2022-12-28	WOS:000184615700031
J	Lamb, J; Ramaswamy, S; Ford, HL; Contreras, B; Martinez, RV; Kittrell, FS; Zahnow, CA; Patterson, N; Golub, TR; Ewen, ME				Lamb, J; Ramaswamy, S; Ford, HL; Contreras, B; Martinez, RV; Kittrell, FS; Zahnow, CA; Patterson, N; Golub, TR; Ewen, ME			A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer	CELL			English	Article							BINDING-PROTEIN-BETA; MESSENGER-RNA; TRANSCRIPTION FACTOR; ESTROGEN-RECEPTOR; BREAST-CANCER; MOLECULAR CLASSIFICATION; RETINOBLASTOMA PROTEIN; INHIBITORY PROTEIN; CDK INHIBITORS; IN-SITU	Here we describe how patterns of gene expression in human tumors have been deconvoluted to reveal a mechanism of action for the cyclin D1 oncogene. Computational analysis of the expression patterns of thousands of genes across hundreds of tumor specimens suggested that a transcription factor, C/EBPbeta/Nf-II6, participates in the consequences of cyclin Di overexpression. Functional analyses confirmed the involvement of C/EBPbeta in the regulation of genes affected by cyclin D1 and established this protein as an indispensable effector of a potentially important facet of cyclin D1 biology. This work demonstrates that tumor gene expression databases can be used to study the function of a human oncogene in situ.	Harvard Univ, Sch Med, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biochem, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; MIT, Whitehead Inst, Ctr Genome Res, Cambridge, MA 02139 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD 21231 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Baylor College of Medicine; Johns Hopkins University; Johns Hopkins Medicine	Ewen, ME (corresponding author), Harvard Univ, Sch Med, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.		Villena, Rodolfo/HDM-2742-2022		NCI NIH HHS [CA88843, F32-CA79197, P01-CA80111, R01-CA61253, R01-CA65842] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA079197, R01CA065842, P50CA088843, P01CA080111] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bienvenu F, 2001, J BIOL CHEM, V276, P16840, DOI 10.1074/jbc.M100795200; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Desprez Pierre-Yves, 1993, Molecular and Cellular Differentiation, V1, P99; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; GAUGITSCH HW, 1992, J BIOL CHEM, V267, P11267; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hall M, 1996, ADV CANCER RES, V68, P67, DOI 10.1016/S0065-230X(08)60352-8; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HINDS PW, 1994, P NATL ACAD SCI USA, V91, P709, DOI 10.1073/pnas.91.2.709; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Inoue K, 1998, MOL CELL BIOL, V18, P1590, DOI 10.1128/MCB.18.3.1590; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; Kamano H, 1997, ONCOGENE, V14, P1223, DOI 10.1038/sj.onc.1200945; KITTRELL FS, 1992, CANCER RES, V52, P1924; Knudsen KE, 1999, CANCER RES, V59, P2297; Lamb J, 2000, MOL CELL BIOL, V20, P8667, DOI 10.1128/MCB.20.23.8667-8675.2000; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Neuman E, 1997, MOL CELL BIOL, V17, P5338, DOI 10.1128/MCB.17.9.5338; Oyama T, 1998, CANCER RES, V58, P2876; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Ratineau C, 2002, J BIOL CHEM, V277, P8847, DOI 10.1074/jbc.M110747200; RAUGHT B, 1995, MOL ENDOCRINOL, V9, P1223, DOI 10.1210/me.9.9.1223; Raught B, 1996, CANCER RES, V56, P4382; ROSENBERG CL, 1991, P NATL ACAD SCI USA, V88, P9638, DOI 10.1073/pnas.88.21.9638; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Siu F, 2001, J BIOL CHEM, V276, P48100, DOI 10.1074/jbc.M109533200; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Su AI, 2001, CANCER RES, V61, P7388; TSUKADA J, 1994, MOL CELL BIOL, V14, P7285, DOI 10.1128/MCB.14.11.7285; Ubeda M, 1999, BIOCHEM BIOPH RES CO, V262, P31, DOI 10.1006/bbrc.1999.1140; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vos CBJ, 1999, J PATHOL, V187, P279; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WEINSTATSASLOW D, 1995, NAT MED, V1, P1257, DOI 10.1038/nm1295-1257; Zahnow CA, 1997, J NATL CANCER I, V89, P1887, DOI 10.1093/jnci/89.24.1887; Zahnow CA, 2001, CANCER RES, V61, P261; ZUKERBERG LR, 1995, MODERN PATHOL, V8, P560; Zukerberg LR, 1996, BLOOD, V88, P268, DOI 10.1182/blood.V88.1.268.bloodjournal881268; Zwijsen RML, 1997, CELL, V88, P405, DOI 10.1016/S0092-8674(00)81879-6	48	337	352	0	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 8	2003	114	3					323	334		10.1016/S0092-8674(03)00570-1	http://dx.doi.org/10.1016/S0092-8674(03)00570-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914697	Bronze			2022-12-28	WOS:000184679200009
J	Glastonbury, CM; Kennedy, AM				Glastonbury, CM; Kennedy, AM			A fetus with hypogenesis of the corpus callosum	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Utah, Hlth Sci Ctr, Salt Lake City, UT 84103 USA	Utah System of Higher Education; University of Utah	Glastonbury, CM (corresponding author), Univ Utah, Hlth Sci Ctr, Salt Lake City, UT 84103 USA.								0	0	0	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2003	349	6					E6	E6		10.1056/ENEJMicm010394	http://dx.doi.org/10.1056/ENEJMicm010394			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708JL	12904533				2022-12-28	WOS:000184563500008
J	Winful, HG				Winful, HG			Mechanism for 'superluminal' tunnelling	NATURE			English	Editorial Material							PULSES		Univ Michigan, Dept Elect Engn & Comp Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Winful, HG (corresponding author), Univ Michigan, Dept Elect Engn & Comp Sci, Ann Arbor, MI 48109 USA.	winful@eecs.umich.edu	, Herbert/ABG-7860-2020					Buttiker M, 2003, NATURE, V422, P271, DOI 10.1038/422271a; HARTMAN TE, 1962, J APPL PHYS, V33, P3427, DOI 10.1063/1.1702424; Japha Y, 1996, PHYS REV A, V53, P586, DOI 10.1103/PhysRevA.53.586; Longhi S, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.055602; NIMTZ G, 1994, J PHYS I, V4, P565, DOI 10.1051/jp1:1994160; SPIELMANN C, 1994, PHYS REV LETT, V73, P2308, DOI 10.1103/PhysRevLett.73.2308; STEINBERG AM, 1993, PHYS REV LETT, V71, P708, DOI 10.1103/PhysRevLett.71.708; Winful HG, 2003, IEEE J SEL TOP QUANT, V9, P17, DOI 10.1109/JSTQE.2002.807972; Winful HG, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.023901; Winful HG, 2002, OPT EXPRESS, V10, P1491, DOI 10.1364/OE.10.001491	10	38	38	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2003	424	6949					638	638		10.1038/424638a	http://dx.doi.org/10.1038/424638a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904782	Bronze, Green Published			2022-12-28	WOS:000184578800034
J	Pfisterer, M				Pfisterer, M			Right ventricular involvement in myocardial infarction and cardiogenic shock	LANCET			English	Review							EARLY REVASCULARIZATION; DYSFUNCTION; REPERFUSION; MANAGEMENT; SURVIVAL; LOCATION; TRIAL; HEART	Context Right ventricular involvement in acute myocardial, infarction and cardiogenic shock has received, little attention by clinicians band, researchers although its pathophysiology, clinical presentation, and natural history are distinctly different from those of left ventricular infarction and associated cardiogenic shock. Right ventricular shock has important, therapeutic implications for the management of patients, which need to be recognised. Starting point Investigators at the SHOCK Registry (Alice Jacobs and colleagues, J Am Coll Cardiol 2003; 341: 1273-79), evaluated 49 patients with cardiogenic shock predominantly due to right ventricular infarction and compared them with 884 patients with cardiogenic shock and predominantly left ventricular failure. Perhaps surprisingly, these investigators found that the in-hospital mortality of patients with right ventricular shock Was not significantly lower than that of patients with left ventricular shock (53%, vs 61%, p=0.296), despite, the fact, that patients with right ventricular shock were younger, with a lower prevalance of previous infarctions, fewer anterior infarct locations, and less multivessel disease. There was a shorter median time between index infarction, and diagnosis of shock in patients with right ventricular shock. In multivariate analysis, right ventricular shock was not an independent predictor of lower in-hospital mortality. Where next? The unexpectedly high mortality of patients with cardiogenic shock due to predominantly right ventricular infarction challenges the general notion that right ventricular involvement in myocardial infarction has only little relevance for patient's outcome. Therefore more attention should-be given to the detection of right ventricular involvement in acute myocardial infarction and particularly in cardiogenic shock. If right ventricular shock is diagnosed, urgent reperfusion of the infarct related artery and appropriate circulatory support are required.	Univ Basel Hosp, Div Cardiol, CH-4031 Basel, Switzerland	University of Basel	Pfisterer, M (corresponding author), Univ Basel Hosp, Div Cardiol, CH-4031 Basel, Switzerland.	pfisterer@email.ch						[Anonymous], 1990, LANCET, V336, P65; [Anonymous], 1988, LANCET, V2, P349; BERGER PB, 1993, AM J CARDIOL, V71, P1148, DOI 10.1016/0002-9149(93)90637-R; BERISHA S, 1990, BRIT HEART J, V63, P98; Bowers TR, 1998, NEW ENGL J MED, V338, P933, DOI 10.1056/NEJM199804023381401; DELLITALIA LJ, 1984, J AM COLL CARDIOL, V4, P931, DOI 10.1016/S0735-1097(84)80053-4; Goldstein JA, 2003, J AM COLL CARDIOL, V41, P1280, DOI 10.1016/S0735-1097(03)00127-X; Goldstein JA, 2002, J AM COLL CARDIOL, V40, P841, DOI 10.1016/S0735-1097(02)02048-X; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Hochman JS, 2001, JAMA-J AM MED ASSOC, V285, P190, DOI 10.1001/jama.285.2.190; Hochman JS, 2000, J AM COLL CARDIOL, V36, P1063, DOI 10.1016/S0735-1097(00)00879-2; Jacobs AK, 2003, J AM COLL CARDIOL, V41, P1273, DOI 10.1016/S0735-1097(03)00120-7; KINCH JW, 1994, NEW ENGL J MED, V330, P1211, DOI 10.1056/NEJM199404283301707; KINN JW, 1995, J AM COLL CARDIOL, V26, P1230, DOI 10.1016/0735-1097(95)00311-8; PFISTERER M, 1990, INT J CARDIOL, V28, P325, DOI 10.1016/0167-5273(90)90315-V; PFISTERER M, 1986, EUR HEART J, V7, P289, DOI 10.1093/oxfordjournals.eurheartj.a062066; SANBORN TA, 2003, IN PRESS J AM COLL C; Urban P, 1999, EUR HEART J, V20, P1030, DOI 10.1053/euhj.1998.1353; YASUDA T, 1990, AM HEART J, V119, P816, DOI 10.1016/S0002-8703(05)80317-5; ZEHENDER M, 1993, NEW ENGL J MED, V328, P981, DOI 10.1056/NEJM199304083281401	20	50	63	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2003	362	9381					392	394		10.1016/S0140-6736(03)14028-7	http://dx.doi.org/10.1016/S0140-6736(03)14028-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707FB	12907014				2022-12-28	WOS:000184498700022
J	Dioumaev, VK; Bullock, RM				Dioumaev, VK; Bullock, RM			A recyclable catalyst that precipitates at the end of the reaction	NATURE			English	Article							LIQUID/SOLID PHASE-SEPARATION; FLUOROUS CATALYSIS; HOMOGENEOUS CATALYSIS; RECOVERABLE CATALYSTS; GREEN CHEMISTRY; SOLVENTS; COMPLEXES; TEMPERATURE; MOLYBDENUM; ALUMINUM	Homogeneous catalysts-which exist in the same (usually liquid) phase as reactants and products- are usually more selective than heterogeneous catalysts and far less affected by limitations due to slow transport of reactants and products, but their separation from reaction products can be costly and inefficient. This has stimulated the development of strategies that facilitate the recycling of homogeneous catalysts(1-4). Some of these methods exploit the preference of a catalyst for one of two solvents with thermoregulated miscibility(5,6); others exploit a dramatic decrease in catalyst solubility as one reagent is consumed(7,8) or temperature changed after completion of the reaction(9-14). Here we describe a tungsten catalyst for the solvent-free hydrosilylation of ketones that retains its activity until essentially all of the liquid substrate is converted to liquid products, which we can then simply decant to separate the catalyst that precipitates from the products of the reaction. We attribute the ability of the catalyst to retain its solubility and hence activity until completion of the reaction to the transient formation of liquid clathrate(15,16) that contains a few molecules of the substrate per molecule of the otherwise solid catalyst. Insights into the fundamental processes controlling the formation of this liquid clathrate might help to tailor other catalysts and substrates, so as to develop efficient and solvent-free schemes for reactions of practical interest.	Brookhaven Natl Lab, Dept Chem, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory	Bullock, RM (corresponding author), Brookhaven Natl Lab, Dept Chem, Upton, NY 11973 USA.	bullock@bnl.gov	Bullock, R. Morris/L-6802-2016	Bullock, R. Morris/0000-0001-6306-4851				Anastas PT, 2002, ACCOUNTS CHEM RES, V35, P686, DOI 10.1021/ar010065m; Anastas PT, 2003, ENVIRON SCI TECHNOL, V37, p94A, DOI 10.1021/es032373g; ATWOOD JL, 1993, COORDINATION CHEM AL, P197; Borovik AS, 2002, J AM CHEM SOC, V124, P3743, DOI 10.1021/ja012029o; Bullock RM, 2000, J AM CHEM SOC, V122, P12594, DOI 10.1021/ja0010599; Cole-Hamilton DJ, 2003, SCIENCE, V299, P1702, DOI 10.1126/science.1081881; DeSimone JM, 2002, SCIENCE, V297, P799, DOI 10.1126/science.1069622; Dioumaev VK, 2003, CHEM COMMUN, P1670, DOI 10.1039/b303762b; Gladysz JA, 2002, CHEM REV, V102, P3215, DOI 10.1021/cr020068s; Gladysz JA, 2002, TETRAHEDRON, V58, P3823, DOI 10.1016/S0040-4020(02)00222-3; Gladysz JA, 2001, PURE APPL CHEM, V73, P1319, DOI 10.1351/pac200173081319; Holbrey JD, 2003, CHEM COMMUN, P476, DOI 10.1039/b212726a; Horvath IT, 1998, ACCOUNTS CHEM RES, V31, P641, DOI 10.1021/ar970342i; Hourdin GL, 2002, J CATAL, V209, P217, DOI 10.1006/jcat.2002.3608; Ishihara K, 2002, SYNLETT, P1299; Ishihara K, 2001, SYNLETT, P1371; Korolev AV, 2001, J AM CHEM SOC, V123, P8291, DOI 10.1021/ja010242e; Kragl U, 2001, TRENDS BIOTECHNOL, V19, P442, DOI 10.1016/S0167-7799(01)01766-8; Lambert JB, 1999, J AM CHEM SOC, V121, P5001, DOI 10.1021/ja990389u; Ojima I, 1998, CHEM FUNCT, V2, P1687, DOI 10.1002/0470857250.ch29; Ojima I., 1989, CHEM ORGANIC SILICON, P1479; STEED JW, 2002, SUPRAMOL CHEM, P707; Voges MH, 2002, J CHEM SOC DALTON, P759, DOI 10.1039/b107754f; Wang YH, 2000, J MOL CATAL A-CHEM, V157, P111, DOI 10.1016/S1381-1169(00)00045-5; Wende M, 2003, J AM CHEM SOC, V125, P5861, DOI 10.1021/ja029241s; Wende M, 2001, J AM CHEM SOC, V123, P11490, DOI 10.1021/ja011444d; Xiang JN, 2002, ADV SYNTH CATAL, V344, P84, DOI 10.1002/1615-4169(200201)344:1<84::AID-ADSC84>3.0.CO;2-C; Zuwei X, 2001, Science, V292, P1139, DOI 10.1126/science.292.5519.1139	28	160	165	6	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 31	2003	424	6948					530	532		10.1038/nature01856	http://dx.doi.org/10.1038/nature01856			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	706LG	12891351				2022-12-28	WOS:000184454700036
J	Fruh-Green, GL; Kelley, DS; Bernasconi, SM; Karson, JA; Ludwig, KA; Butterfield, DA; Boschi, C; Proskurowski, G				Fruh-Green, GL; Kelley, DS; Bernasconi, SM; Karson, JA; Ludwig, KA; Butterfield, DA; Boschi, C; Proskurowski, G			30,000 years of hydrothermal activity at the Lost City vent field	SCIENCE			English	Article							MID-ATLANTIC RIDGE; CORE COMPLEXES; SERPENTINIZATION; ORIGIN	Strontium, carbon, and oxygen isotope data and radiocarbon ages document at least 30,000 years of hydrothermal activity driven by serpentinization reactions at Lost City. Serpentinization beneath this off-axis field is estimated to occur at a minimum rate of 1.2x10(-4) cubic kilometers per year. The access of seawater to relatively cool, fresh peridotite, coupled with faulting, volumetric expansion, and mass wasting processes, are crucial to sustain such systems. The amount of heat produced by serpentinization of peridotite massifs, typical of slow and ultraslow spreading environments, has the potential to drive Lost City-type systems for hundreds of thousands, possibly millions, of years.	ETH, Dept Earth Sci, CH-8092 Zurich, Switzerland; Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; Duke Univ, Div Earth & Ocean Sci, Durham, NC 27708 USA; Univ Washington, Seattle, WA 98195 USA; NOAA, Pacific Marine Environm Lab, Seattle, WA 98195 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Washington; University of Washington Seattle; Duke University; University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA	Fruh-Green, GL (corresponding author), ETH, Dept Earth Sci, CH-8092 Zurich, Switzerland.		Butterfield, David/H-3815-2016; Bernasconi, Stefano M/E-5394-2010; Proskurowski, Giora/B-3862-2013	Butterfield, David/0000-0002-1595-9279; Bernasconi, Stefano M/0000-0001-7672-8856; Boschi, Chiara/0000-0001-8972-4432; Ludwig, Kristin/0000-0002-0935-9410				Berndt ME, 1996, GEOLOGY, V24, P351, DOI 10.1130/0091-7613(1996)024<0351:ROCDSO>2.3.CO;2; Blackman DK, 1998, J GEOPHYS RES-SOL EA, V103, P21315, DOI 10.1029/98JB01756; BLACKMAN DK, 2001, INTERRIDGE NEWS, P33; Cann JR, 1997, NATURE, V385, P329, DOI 10.1038/385329a0; Detrick R.S, 1998, EOS T AGUFALL M S, V79, pF800; FRUHGREEN GL, IN PRESS SUBSEAFLOOR; Fyfe W., 1981, SEA, V7, P589; Kelley DS, 2001, NATURE, V412, P145, DOI 10.1038/35084000; KELLEY DS, 2002, EOS, V83, pF222; LOWELL RP, 2002, GEOPHYS RES LETT, V29; MACDONALD AH, 1985, TECTONOPHYSICS, V116, P123, DOI 10.1016/0040-1951(85)90225-2; MACLEOD G, 1994, ORIGINS LIFE EVOL B, V24, P19, DOI 10.1007/BF01582037; MARTIN B, 1970, CHEM GEOL, V6, P185, DOI 10.1016/0009-2541(70)90018-5; Nooner SL, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017126; PARKHURST DL, 1980, 8096 US GEOL SURV; Schrag DP, 2002, QUATERNARY SCI REV, V21, P331, DOI 10.1016/S0277-3791(01)00110-X; SCHRENK MO, 2002, EOS, V83, pF2301; Shock EL, 1998, J GEOPHYS RES-PLANET, V103, P28513, DOI 10.1029/98JE02142; Stott LD, 1996, PALEOCEANOGRAPHY, V11, P37, DOI 10.1029/95PA03344	19	281	290	4	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2003	301	5632					495	498		10.1126/science.1085582	http://dx.doi.org/10.1126/science.1085582			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12881565				2022-12-28	WOS:000184340500036
J	Chittka, L; Dyer, AG; Bock, F; Dornhaus, A				Chittka, L; Dyer, AG; Bock, F; Dornhaus, A			Psychophysics - Bees trade off foraging speed for accuracy	NATURE			English	Article									Univ Wurzburg, Biozentrum, D-97074 Wurzburg, Germany; Univ London, Queen Mary, London E1 4NS, England; La Trobe Univ, Fac Hlth Sci, Sch Orthopt, Bundoora, Vic 3086, Australia; Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England	University of Wurzburg; University of London; La Trobe University; University of Bristol	Chittka, L (corresponding author), Univ Wurzburg, Biozentrum, Hubland, D-97074 Wurzburg, Germany.	l.chittka@qmul.ac.uk	Chittka, Lars/C-3110-2012	Chittka, Lars/0000-0001-8153-1732				CHITTKA L, 1995, ANIM BEHAV, V49, P159, DOI 10.1016/0003-3472(95)80163-4; DUKAS R, 1994, ANIM BEHAV, V48, P1001, DOI 10.1006/anbe.1994.1332; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; Maleszka R, 2000, BEHAV BRAIN RES, V115, P49, DOI 10.1016/S0166-4328(00)00235-7; Menzel R., 1990, NEUROBIOLOGY COMP CO, P237; Rival C, 2003, NEUROSCI LETT, V336, P65, DOI 10.1016/S0304-3940(02)01246-6; SMITH BH, 1991, J COMP PSYCHOL, V105, P345, DOI 10.1037/0735-7036.105.4.345; Thomson JD, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P191, DOI 10.1017/CBO9780511542268.011; Zenger B, 1997, J EXP PSYCHOL HUMAN, V23, P1783, DOI 10.1037/0096-1523.23.6.1783	9	277	278	4	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2003	424	6947					388	388		10.1038/424388a	http://dx.doi.org/10.1038/424388a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879057				2022-12-28	WOS:000184318400030
J	Baldwin, MP; Thompson, DWJ; Shuckburgh, EF; Norton, WA; Gillett, NP				Baldwin, MP; Thompson, DWJ; Shuckburgh, EF; Norton, WA; Gillett, NP			Weather from the stratosphere?	SCIENCE			English	Editorial Material									NW Res Associates Inc, Bellevue, WA 98007 USA; Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA; Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England; Univ Oxford, Dept Atmospher Ocean & Planetary Phys, Oxford OX1 3PU, England; Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8W 3P6, Canada	NorthWest Research Associates; Colorado State University; University of Cambridge; University of Oxford; University of Victoria	Baldwin, MP (corresponding author), NW Res Associates Inc, Bellevue, WA 98007 USA.		Thompson, David W J/F-9627-2012; Baldwin, Mark/J-6720-2012	Thompson, David W J/0000-0002-5413-4376; Shuckburgh, Emily/0000-0001-9206-3444				Baldwin MP, 2001, SCIENCE, V294, P581, DOI 10.1126/science.1063315; HAYNES PH, 1989, Q J ROY METEOR SOC, V115, P1181, DOI 10.1002/qj.49711549002; HAYNES PH, 1991, J ATMOS SCI, V48, P651, DOI 10.1175/1520-0469(1991)048<0651:OTCOED>2.0.CO;2; HURRELL JW, 2003, GEOPHYSICS MONOGRAPH, V134; Lorenz DJ, 2003, J CLIMATE, V16, P1212, DOI 10.1175/1520-0442(2003)16<1212:EFFITN>2.0.CO;2; MCINTYRE ME, 1983, NATURE, V305, P593, DOI 10.1038/305593a0; Moritz RE, 2002, SCIENCE, V297, P1497, DOI 10.1126/science.1076522; Robock A, 2002, SCIENCE, V295, P1242, DOI 10.1126/science.1069903; Thompson DWJ, 2000, J CLIMATE, V13, P1000, DOI 10.1175/1520-0442(2000)013<1018:AMITEC>2.0.CO;2; Thompson DWJ, 1998, GEOPHYS RES LETT, V25, P1297, DOI 10.1029/98GL00950; 2003, ROLE STRATOSPHERE TR	11	82	109	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2003	301	5631					317	+		10.1126/science.1085688	http://dx.doi.org/10.1126/science.1085688			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869745				2022-12-28	WOS:000184207300023
J	Bauch, D; Darling, K; Simstich, J; Bauch, HA; Erlenkeuser, H; Kroon, D				Bauch, D; Darling, K; Simstich, J; Bauch, HA; Erlenkeuser, H; Kroon, D			Palaeoceanographic implications of genetic variation in living North Atlantic Neogloboquadrina pachyderma	NATURE			English	Article								The shells of the planktonic foraminifer Neogloboquadrina pachyderma have become a classical tool for reconstructing glacial-interglacial climate conditions in the North Atlantic Ocean(1-3). Palaeoceanographers utilize its left- and right-coiling variants, which exhibit a distinctive reciprocal temperature and water mass related shift in faunal abundance both at present and in late Quaternary sediments(1,2,4,5). Recently discovered cryptic genetic diversity in planktonic foraminifers(6-8) now poses significant questions for these studies. Here we report genetic evidence demonstrating that the apparent 'single species' shell-based records of right-coiling N. pachyderma used in palaeoceanographic reconstructions contain an alternation in species as environmental factors change. This is reflected in a species-dependent incremental shift in right-coiling N. pachyderma shell calcite delta(18)O between the Last Glacial Maximum and full Holocene conditions. Guided by the percentage dextral coiling ratio, our findings enhance the use of delta(18)O records of right-coiling N. pachyderma for future study. They also highlight the need to genetically investigate other important morphospecies to refine their accuracy and reliability as palaeoceanographic proxies.	GEOMAR, D-24148 Kiel, Germany; Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JG, Midlothian, Scotland; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JG, Midlothian, Scotland; Mainz Acad Sci Human & Lit, D-55131 Mainz, Germany; Univ Kiel, Leibniz Lab, D-24118 Kiel, Germany; Vrije Univ Amsterdam, NL-1081 HV Amsterdam, Netherlands	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Edinburgh; University of Edinburgh; University of Kiel; Vrije Universiteit Amsterdam	Bauch, D (corresponding author), GEOMAR, Wischhofstr 1-3, D-24148 Kiel, Germany.			Bauch, Dorothea/0000-0002-1419-9714	Natural Environment Research Council [NER/J/S/2000/00860] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		BANDY O L, 1972, Micropaleontology (New York), V18, P294, DOI 10.2307/1485010; Bauch D, 2002, MAR MICROPALEONTOL, V45, P83, DOI 10.1016/S0377-8398(02)00038-5; Bauch H. A., 1999, LAND OCEAN SYSTEMS S, DOI [10.1007/978- 3, DOI 10.1007/978-3-642-60134-7_46, 10.1007/978-3-642-60134-7_46]; Bauch HA, 2001, QUATERNARY SCI REV, V20, P659, DOI 10.1016/S0277-3791(00)00098-6; Be A.W.H., 1971, MICROPALEONTOLOGY OC, P105; Bemis BE, 2002, MAR MICROPALEONTOL, V46, P405, DOI 10.1016/S0377-8398(02)00083-X; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; CIFELLI R, 1973, Journal of Foraminiferal Research, V3, P157; CLIMAP PM, 1976, SCIENCE, V191, P1131, DOI DOI 10.1126/SCIENCE.191.4232.1131; Darling KF, 2000, NATURE, V405, P43, DOI 10.1038/35011002; Darling KF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2001PA000723; de Vargas C, 2001, PALEOBIOLOGY, V27, P104, DOI 10.1666/0094-8373(2001)027<0104:PARIGT>2.0.CO;2; de Vargas C, 1999, P NATL ACAD SCI USA, V96, P2864, DOI 10.1073/pnas.96.6.2864; EMILIANI C, 1955, J GEOL, V63, P538, DOI 10.1086/626295; ERICSON DB, 1959, SCIENCE, V130, P219, DOI 10.1126/science.130.3369.219; HEALYWILLIAMS N, 1984, ANTARCT J US, V18, P138; Huber R, 2000, PALAEOGEOGR PALAEOCL, V160, P193, DOI 10.1016/S0031-0182(00)00066-3; Jansen E., 1989, Quaternary International, V1, P151, DOI 10.1016/1040-6182(89)90013-X; Kandiano ES, 2002, J FORAMIN RES, V32, P245, DOI 10.2113/32.3.245; KELLOGG TB, 1978, BOREAS, V7, P61, DOI 10.1111/j.1502-3885.1978.tb00051.x; KIPP NG, 1976, GEOL SOC AM MEM, V145, P3, DOI DOI 10.1130/MEM145-P3; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Oppo DW, 1998, SCIENCE, V279, P1335, DOI 10.1126/science.279.5355.1335; Oppo DW, 2001, PALEOCEANOGRAPHY, V16, P280, DOI 10.1029/2000PA000527; Pflaumann U, 1996, PALEOCEANOGRAPHY, V11, P15, DOI 10.1029/95PA01743; SIMSTICH J, 1999, BER REP I GEOWISS U, V2, P1; Spero HJ, 1997, NATURE, V390, P497, DOI 10.1038/37333; Stewart IA, 2001, MAR MICROPALEONTOL, V43, P143, DOI 10.1016/S0377-8398(01)00024-X; WILLIAMS DF, 1988, PALAEOGEOGR PALAEOCL, V64, P153, DOI 10.1016/0031-0182(88)90004-1	29	65	70	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					299	302		10.1038/nature01778	http://dx.doi.org/10.1038/nature01778			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867978	Green Published			2022-12-28	WOS:000184183900038
J	Hannan, EL; Racz, MJ; Walford, G; Ryan, TJ; Isom, OW; Bennett, E; Jones, RH				Hannan, EL; Racz, MJ; Walford, G; Ryan, TJ; Isom, OW; Bennett, E; Jones, RH			Predictors of readmission for complications of coronary artery bypass graft surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEW-YORK-STATE; HOSPITAL READMISSION; OUTCOMES; QUALITY; MORTALITY; CHOICE; RATES; CARE	Context Risk factors for perioperative mortality after coronary artery bypass graft (CABG) surgery have been extensively studied. However, which factors are associated with early readmissions following CABG surgery are less clear. Objective To identify significant predictors of readmission within 30 days following CABG surgery. Design, Setting, and Patients Causes for readmission within 30 days were investigated for all patients discharged after CABG surgery in the state of New York from January 1, 1999, through December 31, 1999. A variety of patient demographics, preoperative risk factors, complications, operative and postoperative factors, and provider characteristics were considered as potential predictors of readmissions. Main Outcome Measure Hospital readmissions within 30 days of discharge following CABG surgery. Results Of 16325 total patients, 2111 (12.9%) were readmitted within 30 days for reasons related to CABG surgery. The most common causes of readmission were postsurgical infection (n=598 [28%]) and heart failure (n=331 [16%]). Eleven risk factors were found to be independently associated with higher readmission rates: older age, female sex, African American race, greater body surface area, previous myocardial infarction within 1 week, and 6 comorbidities. After controlling for these preoperative patient-level risk factors, 2 provider characteristics (annual surgeon CABG volume <100, hospital risk-adjusted mortality rate in the highest decile) and 2 postoperative factors (discharge to nursing home or rehabilitation/acute care facility, length of stay during index CABG admission of &GE;5 days) were also related to higher readmission rates. Conclusions Readmission within 30 days following discharge is an important adverse outcome of CABG surgery. Continued attempts should be made to explore the potential of readmission as a supplement to mortality in assessing provider quality.	SUNY Albany, Sch Publ Hlth, Dept Hlth Policy Management & Behav, Rensselaer, NY 12144 USA; St Josephs Hosp, Cardiac Catheterizat Lab, Syracuse, NY USA; Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; New York Hosp Cornell, Dept Cardiothorac Surg, New York, NY USA; St Peters Hosp, Dept Cardiac Surg, Albany, NY USA; Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; Boston University; NewYork-Presbyterian Hospital; Duke University	Hannan, EL (corresponding author), SUNY Albany, Sch Publ Hlth, Dept Hlth Policy Management & Behav, 1 Univ Pl, Rensselaer, NY 12144 USA.							*AM HEART ASS, 2002, 2002 HEART STROK STA; Cowper PA, 1997, J AM COLL CARDIOL, V30, P908, DOI 10.1016/S0735-1097(97)00243-X; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HANNAN EL, 1990, JAMA-J AM MED ASSOC, V264, P2768, DOI 10.1001/jama.264.21.2768; HANNAN EL, 1995, JAMA-J AM MED ASSOC, V273, P209, DOI 10.1001/jama.273.3.209; HANNAN EL, 1994, ANN THORAC SURG, V58, P1852, DOI 10.1016/0003-4975(94)91726-4; HANNAN EL, 1994, JAMA-J AM MED ASSOC, V271, P761, DOI 10.1001/jama.271.10.761; HOSMER DW, 1989, APPL LOGISTIC REGRES; Kiefe C, 1999, MED CARE, V37, P621, DOI 10.1097/00005650-199907000-00001; *NJ DEP HLTH SEN S, 1997, COR ART BYP GRAFT SU; *NY STAT DEP HLTH, 2002, COR ART BYP SURG NEW; OCONNOR GT, 1992, CIRCULATION, V85, P2110, DOI 10.1161/01.CIR.85.6.2110; *PA HLTH CAR COST, 2002, PENNS GUID COR ART B; *PAC BUS GROUP HLT, 2001, CAL REP COR ART BYP; *PENNS HLTH CAR CO, 2001, HOSP READM FOLL COR; RILEY G, 1993, MED CARE, V31, P921, DOI 10.1097/00005650-199310000-00005; ROSENTHAL GE, 1994, JOINT COMM J QUAL IM, V20, P425, DOI 10.1016/S1070-3241(16)30088-8; Silber JH, 1997, INT J QUAL HEALTH C, V9, P193, DOI 10.1093/intqhc/9.3.193; SILBER JH, 1995, JAMA-J AM MED ASSOC, V274, P317, DOI 10.1001/jama.274.4.317; STANTON BA, 1985, JAMA-J AM MED ASSOC, V253, P3568; Steuer J, 2002, ANN THORAC SURG, V73, P1380, DOI 10.1016/S0003-4975(02)03467-7; Stewart RD, 2000, ANN THORAC SURG, V70, P169, DOI 10.1016/S0003-4975(00)01386-2; Thomas JW, 1996, INQUIRY-J HEALTH CAR, V33, P258; Tu JV, 1998, CAN MED ASSOC J, V159, P221; *US DEP HHS, 1998, INT CLASS DIS; Zitser-Gurevich Y, 1999, MED CARE, V37, P625, DOI 10.1097/00005650-199907000-00002	26	190	193	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2003	290	6					773	780		10.1001/jama.290.6.773	http://dx.doi.org/10.1001/jama.290.6.773			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	709VU	12915430	Bronze			2022-12-28	WOS:000184647700028
J	Grewal, SIS; Moazed, D				Grewal, SIS; Moazed, D			Heterochromatin and epigenetic control of gene expression	SCIENCE			English	Review							H3 LYSINE-9 METHYLATION; HISTONE METHYLTRANSFERASE ACTIVITY; X-CHROMOSOME INACTIVATION; FISSION YEAST; DNA METHYLATION; RNA INTERFERENCE; DROSOPHILA; CHROMATIN; BINDING; COMPLEX	Eukaryotic DNA is organized into structurally distinct domains that regulate gene expression and chromosome behavior. Epigenetically heritable domains of heterochromatin control the structure and expression of large chromosome domains and are required for proper chromosome segregation. Recent studies have identified many of the enzymes and structural proteins that work together to assemble heterochromatin. The assembly process appears to occur in a stepwise manner involving sequential rounds of histone modi. cation by silencing complexes that spread along the chromatin fiber by self-oligomerization, as well as by association with specifically modified histone amino-terminal tails. Finally, an unexpected role for noncoding RNAs and RNA interference in the formation of epigenetic chromatin domains has been uncovered.	NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard Medical School	Grewal, SIS (corresponding author), NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA.							Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carmen AA, 2002, J BIOL CHEM, V277, P4778, DOI 10.1074/jbc.M110532200; Cavalli G, 2002, CURR OPIN CELL BIOL, V14, P269, DOI 10.1016/S0955-0674(02)00324-1; Cohen DE, 2002, CURR OPIN GENET DEV, V12, P219, DOI 10.1016/S0959-437X(02)00289-7; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dhillon N, 2002, CURR OPIN GENET DEV, V12, P188, DOI 10.1016/S0959-437X(02)00285-X; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; GREWAL SI, UNPUB; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Grewal SIS, 1997, GENETICS, V146, P1221; Guarente L, 2000, GENE DEV, V14, P1021; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Henikoff S., 2000, BIOCHIM BIOPHYS ACTA, V1470, P01; Hoppe GJ, 2002, MOL CELL BIOL, V22, P4167, DOI 10.1128/MCB.22.12.4167-4180.2002; Hsieh J, 2000, ANNU REV GENET, V34, P187, DOI 10.1146/annurev.genet.34.1.187; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Labrador M, 2002, CELL, V111, P151, DOI 10.1016/S0092-8674(02)01004-8; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Luo KH, 2002, GENE DEV, V16, P1528, DOI 10.1101/gad.988802; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Muchardt C, 2002, EMBO REP, V3, P975, DOI 10.1093/embo-reports/kvf194; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nakayama J, 2000, CELL, V101, P307, DOI 10.1016/S0092-8674(00)80840-5; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Park Y, 2001, SCIENCE, V293, P1083, DOI 10.1126/science.1063073; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Rusche LN, 2002, MOL BIOL CELL, V13, P2207, DOI 10.1091/mbc.E02-03-0175; Saurin AJ, 2001, NATURE, V412, P655, DOI 10.1038/35088096; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Selker EU, 1999, CELL, V97, P157, DOI 10.1016/S0092-8674(00)80725-4; Shankaranarayana GD, 2003, CURR BIOL, V13, P1240, DOI 10.1016/S0960-9822(03)00489-5; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Sun FL, 2000, P NATL ACAD SCI USA, V97, P5340, DOI 10.1073/pnas.090530797; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; van Leeuwen F, 2002, CURR OPIN CELL BIOL, V14, P756, DOI 10.1016/S0955-0674(02)00393-9; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	65	757	812	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2003	301	5634					798	802		10.1126/science.1086887	http://dx.doi.org/10.1126/science.1086887			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907790				2022-12-28	WOS:000184615700033
J	Seidenbecher, T; Laxmi, TR; Stork, O; Pape, HC				Seidenbecher, T; Laxmi, TR; Stork, O; Pape, HC			Amygdalar and hippocampal theta rhythm synchronization during fear memory retrieval	SCIENCE			English	Article							LONG-TERM POTENTIATION; BASOLATERAL AMYGDALA; IN-VIVO; SYNAPTIC PLASTICITY; PERIRHINAL CORTEX; LATERAL AMYGDALA; CONSCIOUS CATS; DENTATE GYRUS; STIMULATION; OSCILLATIONS	The amygdalohippocampal circuit plays a pivotal role in Pavlovian fear memory. We simultaneously recorded electrical activity in the lateral amygdala (LA) and the CA1 area of the hippocampus in freely behaving fear-conditioned mice. Patterns of activity were related to fear behavior evoked by conditioned and indifferent sensory stimuli and contexts. Rhythmically synchronized activity at theta frequencies increased between the LA and the CA1 after fear conditioning and became significant during confrontation with conditioned fear stimuli and expression of freezing behavior. Synchronization of theta activities in the amygdalohippocampal network represents a neuronal correlate of conditioned fear, apt to improve neuronal communication during memory retrieval.	Otto Von Guericke Univ, Inst Physiol, D-39120 Magdeburg, Germany	Otto von Guericke University	Pape, HC (corresponding author), Otto Von Guericke Univ, Inst Physiol, Leipziger Str 44, D-39120 Magdeburg, Germany.		Laxmi, T. R./T-9769-2019	Laxmi, T. R./0000-0001-8147-9559; Stork, Oliver/0000-0003-4285-7507				Akirav I, 1999, J NEUROSCI, V19, P10530; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; Cahill L, 2000, PROG BRAIN RES, V126, P29; CAHILL L, 2001, AMYGDALA FUNCTIONAL, P425; Collins DR, 1999, NEUROSCIENCE, V89, P1025, DOI 10.1016/S0306-4522(98)00396-0; Frey S, 2001, J NEUROSCI, V21, P3697, DOI 10.1523/JNEUROSCI.21-10-03697.2001; Heinbockel T, 2000, J NEUROSCI, V20; IKEGAYA Y, 1994, BRAIN RES, V656, P157, DOI 10.1016/0006-8993(94)91377-3; IKEGAYA Y, 1995, J NEUROPHYSIOL, V74, P2201, DOI 10.1152/jn.1995.74.5.2201; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Maren S, 1999, TRENDS NEUROSCI, V22, P561, DOI 10.1016/S0166-2236(99)01465-4; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; MAREN S, 1995, J NEUROSCI, V15, P7548; Maren S, 2001, NEUROBIOL LEARN MEM, V76, P268, DOI 10.1006/nlme.2001.4042; PACKARD MG, 1994, P NATL ACAD SCI USA, V91, P8477, DOI 10.1073/pnas.91.18.8477; Pape HC, 1998, J NEUROPHYSIOL, V79, P205, DOI 10.1152/jn.1998.79.1.205; PARE D, 1995, J NEUROPHYSIOL, V74, P1179, DOI 10.1152/jn.1995.74.3.1179; Pare D, 1996, J NEUROSCI, V16, P3334; Pare D, 2000, J NEUROSCI, V20, P2701; Pare D, 2002, TRENDS COGN SCI, V6, P306, DOI 10.1016/S1364-6613(02)01924-1; PHILLIPS RG, 1994, LEARN MEMORY, V1, P34; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; Vertes RP, 2001, NEUROSCIENCE, V104, P619, DOI 10.1016/S0306-4522(01)00131-2; Vertes RP, 1997, NEUROSCIENCE, V81, P893; Willingham DB, 1997, NEURON, V18, P5, DOI 10.1016/S0896-6273(01)80040-4	28	525	534	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2003	301	5634					846	850		10.1126/science.1085818	http://dx.doi.org/10.1126/science.1085818			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907806				2022-12-28	WOS:000184615700049
J	Tagaya, A; Ohkita, H; Mukoh, M; Sakaguchi, R; Koike, Y				Tagaya, A; Ohkita, H; Mukoh, M; Sakaguchi, R; Koike, Y			Compensation of the birefringence of a polymer by a birefringent crystal	SCIENCE			English	Article							ZERO-BIREFRINGENCE; ORIENTED POLYMERS	We report a method for compensating the birefringence of optical polymers by doping them with inorganic birefringent crystals. In this method, an inorganic birefringent material is chosen that has the opposite birefringence to that of the polymer and has rod-shaped crystals that are oriented when the polymer chains are oriented. The birefringence of the polymer is thus compensated by the opposing birefringence of the crystal. Birefringence is minimized in various polymer optical devices by adjusting process conditions, because it degrades the performance of devices. This method minimizes it, independent of process conditions, which potentially improves the productivity of devices.	Keio Univ, Fac Sci & Technol, Kohoku Ku, Yokohama, Kanagawa 2230061, Japan; Japan Sci & Technol Corp, Koike Photon Polymer Project, Exploratory Res Adv Technol, Saiwai Ku, Kawasaki, Kanagawa 2120054, Japan	Keio University; Japan Science & Technology Agency (JST)	Tagaya, A (corresponding author), Keio Univ, Fac Sci & Technol, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2230061, Japan.		Koike, Yasuhiro/G-2104-2014					Chen YC, 1996, POLYM INT, V40, P251, DOI 10.1002/(SICI)1097-0126(199608)40:4<251::AID-PI547>3.0.CO;2-L; HAHN BR, 1985, POLYMER, V26, P1619, DOI 10.1016/0032-3861(85)90273-3; Iwata S, 1997, APPL OPTICS, V36, P4549, DOI 10.1364/AO.36.004549; Iwata S, 1996, JPN J APPL PHYS 1, V35, P3896, DOI 10.1143/JJAP.35.3896; MURAYAMA M, 1988, P SOC PHOTO-OPT INS, V896, P123; Tagaya A, 2001, P SOC PHOTO-OPT INS, V4594, P348, DOI 10.1117/12.446564; Tagaya A, 2001, JPN J APPL PHYS 1, V40, P6117, DOI 10.1143/JJAP.40.6117; Tagaya A, 2001, APPL OPTICS, V40, P3677, DOI 10.1364/AO.40.003677	8	93	97	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2003	301	5634					812	814		10.1126/science.1086966	http://dx.doi.org/10.1126/science.1086966			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907795				2022-12-28	WOS:000184615700038
J	Merlini, G; Bellotti, V				Merlini, G; Bellotti, V			Molecular mechanisms of amyloidosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HEREDITARY SYSTEMIC AMYLOIDOSIS; IMMUNOGLOBULIN LIGHT-CHAINS; CENTRAL-NERVOUS-SYSTEM; GELSOLIN DOMAIN 2; ALZHEIMERS-DISEASE; AL AMYLOIDOSIS; FIBRIL FORMATION; HUMAN LYSOZYME; P-COMPONENT; IN-VITRO		Policlin San Matteo, Amyloid Ctr, Biotechnol Res Lab, Univ Hosp,IRCCS, I-27100 Pavia, Italy; Univ Pavia, Dept Biochem, I-27100 Pavia, Italy	IRCCS Fondazione San Matteo; University of Pavia; University of Pavia	Merlini, G (corresponding author), Policlin San Matteo, Amyloid Ctr, Biotechnol Res Lab, Univ Hosp,IRCCS, Piazzale Golgi 2, I-27100 Pavia, Italy.		Merlini, Giampaolo/A-3817-2008; Bellotti, Vittorio/A-6201-2014	Merlini, Giampaolo/0000-0001-7680-3254; Bellotti, Vittorio/0000-0001-8678-662X				ABRAHAMSON M, 1994, P NATL ACAD SCI USA, V91, P1416, DOI 10.1073/pnas.91.4.1416; Almeida MR, 2000, BIOCHEM BIOPH RES CO, V270, P1024, DOI 10.1006/bbrc.2000.2554; Andersson K, 2002, BIOCHEM BIOPH RES CO, V294, P309, DOI 10.1016/S0006-291X(02)00465-5; Andreola A, 2003, J BIOL CHEM, V278, P2444, DOI 10.1074/jbc.M204801200; Arbustini E, 1997, AMYLOID, V4, P157, DOI 10.3109/13506129709014380; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bellotti V, 2000, J STRUCT BIOL, V130, P280, DOI 10.1006/jsbi.2000.4248; Benson MD, 2001, GENOMICS, V72, P272, DOI 10.1006/geno.2000.6499; Booth D R, 2000, Hum Mutat, V16, P180, DOI 10.1002/1098-1004(200008)16:2<180::AID-HUMU20>3.0.CO;2-#; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Buxbaum JN, 2000, ANNU REV MED, V51, P543, DOI 10.1146/annurev.med.51.1.543; Canet D, 2002, NAT STRUCT BIOL, V9, P308, DOI 10.1038/nsb768; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Chen CD, 2001, EMBO J, V20, P6277, DOI 10.1093/emboj/20.22.6277; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Chiti F, 2002, P NATL ACAD SCI USA, V99, P16419, DOI 10.1073/pnas.212527999; Citron M, 2002, NAT NEUROSCI, V5, P1055, DOI 10.1038/nn940; Comenzo RL, 2001, BLOOD, V98, P714, DOI 10.1182/blood.V98.3.714; Comenzo RL, 1996, BLOOD, V88, P2801, DOI 10.1182/blood.V88.7.2801.bloodjournal8872801; Davis DP, 2000, IMMUNITY, V13, P433, DOI 10.1016/S1074-7613(00)00043-1; Dember LM, 2001, ANN INTERN MED, V134, P746, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00011; Demetriades AK, 2002, J NEUROL SCI, V203, P247, DOI 10.1016/S0022-510X(02)00299-X; Dobson Christopher M., 1999, Current Opinion in Structural Biology, V9, P92, DOI 10.1016/S0959-440X(99)80012-8; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dobson CM, 2002, NATURE, V418, P729, DOI 10.1038/418729a; Drenth JPH, 2001, NEW ENGL J MED, V345, P1748, DOI 10.1056/NEJMra010200; Drewe E, 2000, NEW ENGL J MED, V343, P1044, DOI 10.1056/NEJM200010053431412; Drueke TB, 2000, NEPHROL DIAL TRANSPL, V15, P17, DOI 10.1093/oxfordjournals.ndt.a027958; Elliott-Bryant R, 1998, CLIN IMMUNOL IMMUNOP, V88, P65, DOI 10.1006/clin.1998.4555; ESPOSITO G, IN PRESS J BIOL CHEM; Falk RH, 1997, NEW ENGL J MED, V337, P898, DOI 10.1056/NEJM199709253371306; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Findeis Mark A., 2002, Current Topics in Medicinal Chemistry, V2, P417, DOI 10.2174/1568026024607508; Frangione B, 1996, CIBA F SYMP, V199, P132; GALLO G, 1994, AM J PATHOL, V145, P526; Gertz MA, 2002, AMYLOID, V9, P24, DOI 10.3109/13506120209072441; GIANNI L, 1995, BLOOD, V86, P855; Gillmore JD, 2001, TRANSPLANTATION, V71, P986, DOI 10.1097/00007890-200104150-00026; GLENNER GG, 1971, SCIENCE, V172, P1150, DOI 10.1126/science.172.3988.1150; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harris DL, 2000, J MOL RECOGNIT, V13, P198, DOI 10.1002/1099-1352(200007/08)13:4<198::AID-JMR499>3.0.CO;2-D; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; HAWKINS PN, 1988, LANCET, V1, P1413; Higuchi K, 1999, METHOD ENZYMOL, V309, P674; Hrncic R, 2000, AM J PATHOL, V157, P1239, DOI 10.1016/S0002-9440(10)64639-1; HURLE MR, 1994, P NATL ACAD SCI USA, V91, P5446, DOI 10.1073/pnas.91.12.5446; Isaacson RL, 1999, P NATL ACAD SCI USA, V96, P11247, DOI 10.1073/pnas.96.20.11247; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jick H, 2001, LANCET, V357, P562; Kazmirski SL, 2000, P NATL ACAD SCI USA, V97, P10706, DOI 10.1073/pnas.180310097; Khurana R, 2001, BIOCHEMISTRY-US, V40, P3525, DOI 10.1021/bi001782b; Kim SH, 1999, NAT NEUROSCI, V2, P984, DOI 10.1038/14783; Kim YS, 2001, J BIOL CHEM, V276, P1626, DOI 10.1074/jbc.M007766200; KISILEVSKY R, 1995, NAT MED, V1, P143, DOI 10.1038/nm0295-143; Kisilevsky R, 2000, J STRUCT BIOL, V130, P99, DOI 10.1006/jsbi.2000.4222; Klabunde T, 2000, NAT STRUCT BIOL, V7, P312; KYLE RA, 1992, BLOOD, V79, P1817; Lachmann HJ, 2002, NEW ENGL J MED, V346, P1786, DOI 10.1056/NEJMoa013354; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Livneh A, 2000, BEST PRACT RES CL RH, V14, P477, DOI 10.1053/berh.2000.0089; Lundmark K, 2002, P NATL ACAD SCI USA, V99, P6979, DOI 10.1073/pnas.092205999; MCCUTCHEN SL, 1995, BIOCHEMISTRY-US, V34, P13527, DOI 10.1021/bi00041a032; McDermott MF, 2002, TRENDS MOL MED, V8, P550, DOI 10.1016/S1471-4914(02)02425-5; McLaurin J, 2000, J STRUCT BIOL, V130, P259, DOI 10.1006/jsbi.2000.4289; MERLINI G, 1995, SEMIN HEMATOL, V32, P60; MERLINI G, 1995, P NATL ACAD SCI USA, V92, P2959, DOI 10.1073/pnas.92.7.2959; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Morozova-Roche LA, 2000, J STRUCT BIOL, V130, P339, DOI 10.1006/jsbi.2000.4264; Murphy CL, 2001, AM J CLIN PATHOL, V116, P135; Naiki H, 1997, AMYLOID, V4, P223, DOI 10.3109/13506129709003833; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; Ohno S, 2002, J IMMUNOL, V169, P4039, DOI 10.4049/jimmunol.169.7.4039; Olofsson BO, 2002, TRANSPLANTATION, V73, P745, DOI 10.1097/00007890-200203150-00015; OZAKI S, 1994, CLIN IMMUNOL IMMUNOP, V71, P183, DOI 10.1006/clin.1994.1070; Palha JA, 2000, AM J PATHOL, V156, P1919, DOI 10.1016/S0002-9440(10)65065-1; Palladini G, 2001, BRIT J HAEMATOL, V113, P1044, DOI 10.1046/j.1365-2141.2001.02859.x; Pepys MB, 2002, NATURE, V417, P254, DOI 10.1038/417254a; PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0; Pepys MB, 1997, AMYLOID, V4, P274, DOI 10.3109/13506129709003838; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Perfetti V, 2002, BLOOD, V100, P948, DOI 10.1182/blood-2002-01-0114; Perfetti V, 1998, BLOOD, V91, P2948, DOI 10.1182/blood.V91.8.2948.2948_2948_2954; Permanne B, 2002, FASEB J, V16, P860, DOI 10.1096/fj.01-0841fje; Perutz MF, 1997, NATURE, V385, P773, DOI 10.1038/385773a0; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; Rogers J, 1996, NEUROBIOL AGING, V17, P681, DOI 10.1016/0197-4580(96)00115-7; Saraiva MJM, 2002, NEW ENGL J MED, V346, P1818, DOI 10.1056/NEJM200206063462312; Saraiva MJM, 2001, FEBS LETT, V498, P201, DOI 10.1016/S0014-5793(01)02480-2; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schenk D, 2002, NAT REV NEUROSCI, V3, P824, DOI 10.1038/nrn938; Schultz CP, 2000, NAT STRUCT BIOL, V7, P7, DOI 10.1038/71197; Sebastiao MP, 2000, BIOCHEM J, V351, P273, DOI 10.1042/0264-6021:3510273; SNOW AD, 1987, LAB INVEST, V56, P665; Sousa MM, 2001, AM J PATHOL, V159, P1993; Sousa MM, 2001, J NEUROSCI, V21, P7576, DOI 10.1523/JNEUROSCI.21-19-07576.2001; Stevens FJ, 2000, AMYLOID, V7, P200, DOI 10.3109/13506120009146835; Stevens FJ, 2000, CELL MOL LIFE SCI, V57, P441, DOI 10.1007/PL00000706; Stix B, 2001, AM J PATHOL, V159, P561, DOI 10.1016/S0002-9440(10)61727-0; Suhr OB, 2002, LIVER TRANSPLANT, V8, P787, DOI 10.1053/jlts.2002.34386; Sunde M, 1998, Q REV BIOPHYS, V31, P1, DOI 10.1017/S0033583598003400; TENNENT GA, 1995, P NATL ACAD SCI USA, V92, P4299, DOI 10.1073/pnas.92.10.4299; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Valleix S, 2002, KIDNEY INT, V61, P907, DOI 10.1046/j.1523-1755.2002.00205.x; Verdone G, 2002, PROTEIN SCI, V11, P487, DOI 10.1110/ps.29002; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Westermark P, 2002, AMYLOID, V9, P197; Wetzel R, 1997, ADV PROTEIN CHEM, V50, P183, DOI 10.1016/S0065-3233(08)60322-8; Wolfe MS, 2001, J MED CHEM, V44, P2039, DOI 10.1021/jm0004897; Xia HB, 2002, NAT BIOTECHNOL, V20, P1006, DOI 10.1038/nbt739; YAKAR S, 1995, SEMIN ARTHRITIS RHEU, V24, P255, DOI 10.1016/S0049-0172(95)80035-2; Yan SD, 2000, NAT MED, V6, P643, DOI 10.1038/76216; Yazaki M, 2000, BIOCHEM BIOPH RES CO, V274, P702, DOI 10.1006/bbrc.2000.3203	114	1257	1346	1	109	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2003	349	6					583	596		10.1056/NEJMra023144	http://dx.doi.org/10.1056/NEJMra023144			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708JL	12904524				2022-12-28	WOS:000184563500011
J	Lee, EC				Lee, EC			Clinical manifestations of sarin nerve gas exposure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHEMICAL WARFARE; ACETYLCHOLINESTERASE ACTIVITY; DISASTER MANAGEMENT; HIPPOCAMPAL SLICES; AGENTS; ATTACK; LEVEL		Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard Medical School								Agency for Toxic Substances and Disease Registry Centers for Disease Control and Prevention, MED MAN GUID NERV AG; Brown MA, 1998, J APPL TOXICOL, V18, P393, DOI 10.1002/(SICI)1099-1263(199811/12)18:6<393::AID-JAT528>3.0.CO;2-0; Chebabo SR, 1999, NEUROTOXICOLOGY, V20, P871; *DEP DEF, 2001, ARM MED NBC BATTL; Devereaux A, 2002, POSTGRAD MED, V112, P90, DOI 10.3810/pgm.2002.10.1334; GRAY AP, 1984, DRUG METAB REV, V15, P557, DOI 10.3109/03602538409029973; GUNDERSON CH, 1992, NEUROLOGY, V42, P946, DOI 10.1212/WNL.42.5.946; Holstege CP, 1997, CRIT CARE CLIN, V13, P923, DOI 10.1016/S0749-0704(05)70374-2; INST. OF MED, 2000, GULF WAR HLTH; Lotti M., 2000, EXPT CLIN NEUROTOXIC; Nozaki H, 1997, INTENS CARE MED, V23, P1005, DOI 10.1007/s001340050447; Okudera H, 1997, AM J EMERG MED, V15, P527, DOI 10.1016/S0735-6757(97)90201-1; Okumura T, 1998, ACAD EMERG MED, V5, P625, DOI 10.1111/j.1553-2712.1998.tb02472.x; Okumura T, 1998, ACAD EMERG MED, V5, P618, DOI 10.1111/j.1553-2712.1998.tb02471.x; Rocha ES, 1998, DRUG CHEM TOXICOL, V21, P191, DOI 10.3109/01480549809007411; SIDELL F, 1995, P SEM RESP CONS CHEM, P232; SIDELL FR, 1992, ANN EMERG MED, V21, P865, DOI 10.1016/S0196-0644(05)81036-4; Somani SM, 1992, CHEM WARFARE AGENTS; SOMANI SM, 1987, TOXICOL LETT, V36, P243; Spencer P, 2000, EXPT CLIN NEUROTOXIC; Stewart C, 1992, HAZARDOUS MAT TOXICO; TRIPATHI HL, 1989, J TOXICOL ENV HEALTH, V26, P437, DOI 10.1080/15287398909531267; Urbanetti J. S., 1997, MED ASPECTS CHEM BIO, P247; *USAMRICO, 2000, MED MAN CHEM CAS HDB; Woodall J, 1997, LANCET, V350, P296, DOI 10.1016/S0140-6736(05)62271-4; Yokoyama K, 1998, J OCCUP ENVIRON MED, V40, P17, DOI 10.1097/00043764-199801000-00006; 2002, MED LETT DRUGS THER, V44, P1	27	75	79	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2003	290	5					659	662		10.1001/jama.290.5.659	http://dx.doi.org/10.1001/jama.290.5.659			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708GH	12902371				2022-12-28	WOS:000184558500022
J	Bhargava, B; Karthikeyan, G; Abizaid, AS; Mehran, R				Bhargava, B; Karthikeyan, G; Abizaid, AS; Mehran, R			New approaches to preventing restenosis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							IN-STENT RESTENOSIS; INTRACORONARY GAMMA-RADIATION; PACLITAXEL-ELUTING STENT; DIRECTIONAL CORONARY ATHERECTOMY; CUTTING BALLOON ANGIOPLASTY; BETA-RADIATION; FOLLOW-UP; INHIBITS RECURRENCE; CONVERTING-ENZYME; THERAPY	For over a quarter of a century percutaneous coronary interventions have been used to treat patients with coronary artery disease, yet restenosis continues to be a problem. This review discusses the advances being made to overcome restenosis, particularly the development of drug eluting stents	All India Inst Med Sci, Dept Cardiol, Cardiothorac Sci Ctr, New Delhi 110029, India; Danta Pazzanese Inst Cardiol, Sao Paulo, Brazil; Cardiovasc Res Fdn, New York, NY USA	All India Institute of Medical Sciences (AIIMS) New Delhi; Cardiovascular Research Foundation (CRF)	Bhargava, B (corresponding author), All India Inst Med Sci, Dept Cardiol, Cardiothorac Sci Ctr, New Delhi 110029, India.	balrambhargava@yahoo.com	Abizaid, Alexandre Antônio Cunha/H-6955-2012; Karthikeyan, Ganesan/D-5767-2012	Karthikeyan, Ganesan/0000-0002-2073-2917				Abizaid A, 1998, J AM COLL CARDIOL, V32, P584, DOI 10.1016/S0735-1097(98)00286-1; ADELMAN AG, 1993, NEW ENGL J MED, V329, P228, DOI 10.1056/NEJM199307223290402; ALANIZCAMINO F, 1982, OPHTHALMIC SURG LAS, V13, P1022; Albiero R, 2000, CATHETER CARDIO INTE, V50, P452, DOI 10.1002/1522-726X(200008)50:4<452::AID-CCD19>3.0.CO;2-W; Alfonso F, 2000, AM J CARDIOL, V85, P327, DOI 10.1016/S0002-9149(99)00741-9; Aronson D, 1996, J AM COLL CARDIOL, V27, P528, DOI 10.1016/0735-1097(95)00496-3; Baim DS, 1998, CIRCULATION, V97, P322; Bhargava B, 2002, LANCET, V359, P543, DOI 10.1016/S0140-6736(02)07720-6; Bonan R, 1999, J INVASIVE CARDIOL, V11, P749; COLOMBO A, 2003, TAXUS 2 12 MONTH RES; Condado JA, 1997, CIRCULATION, V96, P727; Dauerman HL, 1998, AM J CARDIOL, V82, P277, DOI 10.1016/S0002-9149(98)00311-7; Di Mario C, 2000, HEART, V84, P471, DOI 10.1136/heart.84.5.471; ELLIOTT JM, 1995, CIRCULATION, V91, P2158, DOI 10.1161/01.CIR.91.8.2158; Eltchaninoff H, 1998, J AM COLL CARDIOL, V32, P980, DOI 10.1016/S0735-1097(98)00333-7; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; FOLEY DP, 1994, CIRCULATION, V90, P1239, DOI 10.1161/01.CIR.90.3.1239; Grube E, 2003, CIRCULATION, V107, P38, DOI 10.1161/01.CIR.0000047700.58683.A1; Grube Eberhard, 2002, J Interv Cardiol, V15, P471, DOI 10.1111/j.1540-8183.2002.tb01091.x; GRUNTZIG A, 1978, LANCET, V1, P263, DOI 10.1016/s0140-6736(78)90500-7; HIRSHFELD JW, 1991, J AM COLL CARDIOL, V18, P647, DOI 10.1016/0735-1097(91)90783-6; HOLMES DR, 1984, AM J CARDIOL, V53, pC77, DOI 10.1016/0002-9149(84)90752-5; Hopp HW, 2000, J AM COLL CARDIOL, V36, P1853, DOI 10.1016/S0735-1097(00)00967-0; Izumi M, 2001, AM HEART J, V142, P782, DOI 10.1067/mhj.2001.119129; Kastrati A, 1998, CIRCULATION, V97, P2396, DOI 10.1161/01.CIR.97.24.2396; Kastrati A, 1999, CIRCULATION, V99, P1005, DOI 10.1161/01.CIR.99.8.1005; Kim HS, 2001, J AM COLL CARDIOL, V37, P1026, DOI 10.1016/S0735-1097(01)01112-3; Kipshidze NN, 2002, J AM COLL CARDIOL, V39, P1686, DOI 10.1016/S0735-1097(02)01830-2; KUNTZ R, 2001, BREAK TRIAL 50 ANN S; KUNTZ RE, 1993, J AM COLL CARDIOL, V21, P15, DOI 10.1016/0735-1097(93)90712-A; Kurbaan AS, 2000, CATHETER CARDIO INTE, V50, P480, DOI 10.1002/1522-726X(200008)50:4<480::AID-CCD24>3.0.CO;2-2; Leon MB, 2001, NEW ENGL J MED, V344, P250, DOI 10.1056/NEJM200101253440402; Liistro F, 2001, HEART, V86, P262, DOI 10.1136/heart.86.3.262; MARX SO, 1995, CIRC RES, V76, P412, DOI 10.1161/01.RES.76.3.412; Mehran R, 1996, AM J CARDIOL, V78, P618, DOI 10.1016/S0002-9149(96)00381-5; Mehran R, 1999, CIRCULATION, V100, P1872, DOI 10.1161/01.CIR.100.18.1872; Mintz GS, 1996, CIRCULATION, V94, P35, DOI 10.1161/01.CIR.94.1.35; Moliterno DJ, 2002, LANCET, V360, P355, DOI 10.1016/S0140-6736(02)09605-8; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; MOSES JW, 2002, SIRIUS 1 CLIN ANGIOG; Moussa I, 1999, AM J CARDIOL, V83, P1012, DOI 10.1016/S0002-9149(99)00006-5; Moussa I, 1998, CIRCULATION, V98, P1604, DOI 10.1161/01.CIR.98.16.1604; NOBUYOSHI M, 1988, J AM COLL CARDIOL, V12, P616, DOI 10.1016/S0735-1097(88)80046-9; Park SJ, 2003, NEW ENGL J MED, V348, P1537, DOI 10.1056/NEJMoa021007; Poon M, 1996, J CLIN INVEST, V98, P2277, DOI 10.1172/JCI119038; Radke PW, 2003, EUR HEART J, V24, P266, DOI 10.1016/S0195-668X(02)00202-6; Raizner AE, 2000, CIRCULATION, V102, P951, DOI 10.1161/01.CIR.102.9.951; Ribichini F, 1998, CIRCULATION, V97, P147, DOI 10.1161/01.CIR.97.2.147; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; ROSS R, 1990, ANN NY ACAD SCI, V598, P102, DOI 10.1111/j.1749-6632.1990.tb42282.x; Sapirstein W, 2001, NEW ENGL J MED, V344, P297, DOI 10.1056/NEJM200101253440410; Saunders RN, 2001, KIDNEY INT, V59, P3, DOI 10.1046/j.1523-1755.2001.00460.x; Schomig A, 1997, CIRCULATION, V96, P3880; SEHGAL SN, 1995, THER DRUG MONIT, V17, P660, DOI 10.1097/00007691-199512000-00019; Serruys PW, 2002, EUR HEART J, V23, P757, DOI 10.1053/euhj.2001.3020; Serruys PW, 2002, EUR HEART J, V23, P1351, DOI 10.1053/euhj.2001.3153; SERRUYS PW, 1988, CIRCULATION, V77, P361, DOI 10.1161/01.CIR.77.2.361; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; SHARMA SK, 1999, EUR HEART J, V20, pA281; Simonton CA, 1998, CIRCULATION, V97, P332; Smith SC, 2001, J AM COLL CARDIOL, V37, P2215, DOI 10.1016/S0735-1097(01)01344-4; Sousa JE, 2001, CIRCULATION, V104, P2007, DOI 10.1161/hc4201.098056; Sousa JE, 2001, CIRCULATION, V103, P192; Tamai H, 2000, CIRCULATION, V102, P399; Tanabe K, 2003, CIRCULATION, V107, P559, DOI 10.1161/01.CIR.0000048184.96491.8A; Tardif JC, 1997, NEW ENGL J MED, V337, P365, DOI 10.1056/NEJM199708073370601; Teirstein PS, 1997, NEW ENGL J MED, V336, P1697, DOI 10.1056/NEJM199706123362402; VANBOCKXMEER FM, 1995, CIRCULATION, V92, P2066, DOI 10.1161/01.CIR.92.8.2066; Verin V, 2001, NEW ENGL J MED, V344, P243, DOI 10.1056/NEJM200101253440401; Versaci F, 2002, J AM COLL CARDIOL, V40, P1935, DOI 10.1016/S0735-1097(02)02562-7; vom Dahl J, 2002, CIRCULATION, V105, P583, DOI 10.1161/hc0502.103347; Waksman R, 2001, CIRCULATION, V103, P2332; Waksman R, 2000, CIRCULATION, V101, P2165, DOI 10.1161/01.CIR.101.18.2165; Waksman R, 2000, J AM COLL CARDIOL, V36, P65, DOI 10.1016/S0735-1097(00)00681-1; Waksman R, 2000, CIRCULATION, V101, P1895, DOI 10.1161/01.CIR.101.16.1895; Waksman R, 2002, LANCET, V359, P551, DOI 10.1016/S0140-6736(02)07741-3; Yla-Herttuala S, 2000, LANCET, V355, P213, DOI 10.1016/S0140-6736(99)04180-X	77	60	70	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 2	2003	327	7409					274	279		10.1136/bmj.327.7409.274	http://dx.doi.org/10.1136/bmj.327.7409.274			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708KP	12896943	Green Published			2022-12-28	WOS:000184566300024
J	Goriely, A; McVean, GAT; Rojmyr, M; Ingemarsson, B; Wilkie, AOM				Goriely, A; McVean, GAT; Rojmyr, M; Ingemarsson, B; Wilkie, AOM			Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line	SCIENCE			English	Article								Observed mutation rates in humans appear higher in male than female gametes and often increase with paternal age. This bias, usually attributed to the accumulation of replication errors or inefficient repair processes, has been difficult to study directly. Here, we describe a sensitive method to quantify substitutions at nucleotide 755 of the fibroblast growth factor receptor 2 (FGFR2) gene in sperm. Although substitution levels increase with age, we show that even high levels originate from infrequent mutational events. We propose that these FGFR2 mutations, although harmful to embryonic development, are paradoxically enriched because they confer a selective advantage to the spermatogonial cells in which they arise.	Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DS, England; Univ Oxford, Dept Stat, Oxford OX1 3TG, England; Pyrosequencing AB, SE-75228 Uppsala, Sweden	University of Oxford; University of Oxford; University of Oxford	Wilkie, AOM (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England.		Wilkie, Andrew/AAC-3820-2020; Goriely, Anne/AAR-1133-2020	Wilkie, Andrew/0000-0002-2972-5481; Goriely, Anne/0000-0001-9229-7216				Anderson J, 1998, HUM MOL GENET, V7, P1475, DOI 10.1093/hmg/7.9.1475; COHEN MM, 1992, AM J MED GENET, V42, P655, DOI 10.1002/ajmg.1320420505; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Ibrahimi OA, 2001, P NATL ACAD SCI USA, V98, P7182, DOI 10.1073/pnas.121183798; Jang JH, 2001, CANCER RES, V61, P3541; Kan S, 2002, AM J HUM GENET, V70, P472, DOI 10.1086/338758; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Lajeunie E, 1999, J NEUROSURG, V90, P443, DOI 10.3171/jns.1999.90.3.0443; Li WH, 2002, CURR OPIN GENET DEV, V12, P650, DOI 10.1016/S0959-437X(02)00354-4; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Moloney DM, 1996, NAT GENET, V13, P48, DOI 10.1038/ng0596-48; MUENKE M, 2001, METABOLIC MOL BASES, P6117; Nachman MW, 2000, GENETICS, V156, P297; Oldridge M, 1997, HUM MOL GENET, V6, P137, DOI 10.1093/hmg/6.1.137; OROURKE AW, UNPUB; Otto SP, 1998, GENETICA, V102-3, P507, DOI 10.1023/A:1017074823337; RISCH N, 1987, AM J HUM GENET, V41, P218; Tiemann-Boege I, 2002, P NATL ACAD SCI USA, V99, P14952, DOI 10.1073/pnas.232568699; Tolarova MM, 1997, AM J MED GENET, V72, P394, DOI 10.1002/(SICI)1096-8628(19971112)72:4<394::AID-AJMG4>3.0.CO;2-R; Tomlinson IPM, 1996, P NATL ACAD SCI USA, V93, P14800, DOI 10.1073/pnas.93.25.14800; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165; Wilkie AOM, 2002, AM J MED GENET, V112, P266, DOI 10.1002/ajmg.10775; Yu K, 2000, P NATL ACAD SCI USA, V97, P14536, DOI 10.1073/pnas.97.26.14536	24	203	215	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2003	301	5633					643	646		10.1126/science.1085710	http://dx.doi.org/10.1126/science.1085710			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893942				2022-12-28	WOS:000184473600039
J	Gu, C; Jan, YN; Jan, LY				Gu, C; Jan, YN; Jan, LY			A conserved domain in axonal targeting of Kv1 (shaker) voltage-gated potassium channels	SCIENCE			English	Article							BETA-SUBUNIT; K+ CHANNEL; SURFACE; RELEASE; MICE; GENE	Axonal voltage-gated potassium (Kv1) channels regulate action-potential invasion and hence transmitter release. Although evolutionarily conserved, what mediates their axonal targeting is not known. We found that Kv1 axonal targeting required its T1 tetramerization domain. When fused to unpolarized CD4 or dendritic transferrin receptor, T1 promoted their axonal surface expression. Moreover, T1 mutations eliminating Kvbeta association compromised axonal targeting, but not surface expression, of CD4-T1 fusion proteins. Thus, proper association of Kvbeta with the Kv1 T1 domain is essential for axonal targeting.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, LY (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.		Gu, Chen/E-3163-2011	Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498				Baccus SA, 2000, J NEUROPHYSIOL, V83, P1693, DOI 10.1152/jn.2000.83.3.1693; Brody DL, 2000, J NEUROSCI, V20, P2480; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Campomanes CR, 2002, J BIOL CHEM, V277, P8298, DOI 10.1074/jbc.M110276200; Debanne D, 1997, NATURE, V390, P536, DOI 10.1038/37406; Fili O, 2001, J NEUROSCI, V21, P1964, DOI 10.1523/JNEUROSCI.21-06-01964.2001; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Hattan D, 2002, J BIOL CHEM, V277, P38596, DOI 10.1074/jbc.M205005200; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P449, DOI 10.1113/jphysiol.1952.sp004717; Kosolapov A, 2003, J BIOL CHEM, V278, P4305, DOI 10.1074/jbc.M209422200; Lambe EK, 2001, J NEUROSCI, V21, P9955, DOI 10.1523/JNEUROSCI.21-24-09955.2001; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Manganas LN, 2000, J BIOL CHEM, V275, P29685, DOI 10.1074/jbc.M005010200; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Monaghan MM, 2001, J NEUROSCI, V21, P5973, DOI 10.1523/JNEUROSCI.21-16-05973.2001; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; Rivera JF, 2003, NAT NEUROSCI, V6, P243, DOI 10.1038/nn1020; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Schulteis CT, 1998, J BIOL CHEM, V273, P26210, DOI 10.1074/jbc.273.40.26210; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; Zhou L, 1998, J NEUROSCI, V18, P7200	23	126	130	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2003	301	5633					646	649		10.1126/science.1086998	http://dx.doi.org/10.1126/science.1086998			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893943				2022-12-28	WOS:000184473600040
J	de Lemos, JA; McGuire, DK; Drazner, MH				de Lemos, JA; McGuire, DK; Drazner, MH			B-type natriuretic peptide in cardiovascular disease	LANCET			English	Review							CHRONIC HEART-FAILURE; N-TERMINAL PROATRIAL; LEFT-VENTRICULAR DYSFUNCTION; BETA-BLOCKER THERAPY; NEUROHORMONAL ACTIVATION; DIASTOLIC DYSFUNCTION; PROGNOSTIC VALUE; GENE-EXPRESSION; PLASMA-LEVELS; DOUBLE-BLIND	Natriuretic peptide hormones, a family of vasoactive peptides with many favourable physiological properties, have emerged as important candidates for development of diagnostic tools and therapeutic agents in cardiovascular disease. The rapid incorporation into clinical practice of bioassays to measure natriuretic peptide concentrations, and drugs that augment the biological actions of this system, show the potential for translational research to improve patient care. Here, we focus on the physiology of the natriuretic peptide system, measurement of circulating concentrations of B-type natriuretic peptide (BNP) and the N-terminal fragment of its prohormone (N-terminal SNP) to diagnose heart failure and left ventricular dysfunction, measurement of BNP and N-terminal BNP to assess prognosis in patients with cardiac abnormalities, and use of recombinant human BNP (nesiritide) and vasopeptidase inhibitors to treat heart failure.	Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	de Lemos, JA (corresponding author), Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA.	james.delemos@utsouthwestern.edu	de Lemos, James/ABD-6669-2021					Abraham W T, 1998, J Card Fail, V4, P37, DOI 10.1016/S1071-9164(98)90506-1; ATARASHI K, 1985, J CLIN INVEST, V76, P1807, DOI 10.1172/JCI112172; Bando M, 1999, RESP MED, V93, P507, DOI 10.1016/S0954-6111(99)90094-X; Berger R, 2002, CIRCULATION, V105, P2392, DOI 10.1161/01.CIR.0000016642.15031.34; Bolger AP, 2002, CIRCULATION, V106, P92, DOI 10.1161/01.CIR.0000020009.30736.3F; Bruneau BG, 1997, AM J PHYSIOL-HEART C, V273, pH2678, DOI 10.1152/ajpheart.1997.273.6.H2678; Brunner-La Rocca HP, 2001, J AM COLL CARDIOL, V37, P1221, DOI 10.1016/S0735-1097(01)01172-X; Burger AJ, 2001, AM J CARDIOL, V88, P35, DOI 10.1016/S0002-9149(01)01581-8; BURNETT JC, 1984, AM J PHYSIOL, V247, pF863, DOI 10.1152/ajprenal.1984.247.5.F863; CAO L, 1995, HYPERTENSION, V25, P227, DOI 10.1161/01.HYP.25.2.227; CHARLES CJ, 1995, PEPTIDES, V16, P129, DOI 10.1016/0196-9781(94)00160-8; Cheng V, 2001, J AM COLL CARDIOL, V37, P386, DOI 10.1016/S0735-1097(00)01157-8; CHRISTENSEN G, 1991, CIRC RES, V68, P638, DOI 10.1161/01.RES.68.3.638; Cirillo W, 2000, CIRCULATION, V101, P378, DOI 10.1161/01.CIR.101.4.378; CLARKSON PBM, 1995, CLIN SCI, V88, P159, DOI 10.1042/cs0880159; Colucci WS, 2000, NEW ENGL J MED, V343, P246, DOI 10.1056/NEJM200007273430403; Corti R, 2001, CIRCULATION, V104, P1856, DOI 10.1161/hc4001.097191; Cowie MR, 1997, LANCET, V350, P1349, DOI 10.1016/S0140-6736(97)06031-5; Dao Q, 2001, J AM COLL CARDIOL, V37, P379, DOI 10.1016/S0735-1097(00)01156-6; DAVIS M, 1994, LANCET, V343, P440, DOI 10.1016/S0140-6736(94)92690-5; de Lemos JA, 2001, NEW ENGL J MED, V345, P1014, DOI 10.1056/NEJMoa011053; DEBOLD AJ, 1981, LIFE SCI, V28, P89, DOI 10.1016/0024-3205(81)90370-2; Doyama K, 1998, J AM COLL CARDIOL, V32, P1832, DOI 10.1016/S0735-1097(98)00494-X; EDWARDS BS, 1988, CIRC RES, V62, P191, DOI 10.1161/01.RES.62.2.191; FLORAS JS, 1990, CIRCULATION, V81, P1860, DOI 10.1161/01.CIR.81.6.1860; HAMA N, 1995, CIRCULATION, V92, P1558, DOI 10.1161/01.CIR.92.6.1558; Hammerer-Lercher A, 2001, CLIN CHIM ACTA, V310, P193, DOI 10.1016/S0009-8981(01)00578-2; Harrison A, 2002, ANN EMERG MED, V39, P131, DOI 10.1067/mem.2002.121483; HENRY JP, 1956, J PHYSIOL-LONDON, V131, P572, DOI 10.1113/jphysiol.1956.sp005483; Hobbs RE, 1996, AM J CARDIOL, V78, P896, DOI 10.1016/S0002-9149(96)00464-X; HOLMES SJ, 1993, J CLIN ENDOCR METAB, V76, P91, DOI 10.1210/jc.76.1.91; HOSODA K, 1991, HYPERTENSION, V17, P1152, DOI 10.1161/01.HYP.17.6.1152; HUNT PJ, 1994, J CLIN ENDOCR METAB, V78, P1428, DOI 10.1210/jc.78.6.1428; Ishii J, 2000, CLIN CHIM ACTA, V301, P19, DOI 10.1016/S0009-8981(00)00312-0; Isnard R, 2000, AM J CARDIOL, V86, P417, DOI 10.1016/S0002-9149(00)00957-7; ITOH H, 1990, J CLIN INVEST, V86, P1690, DOI 10.1172/JCI114893; Jernberg T, 2002, J AM COLL CARDIOL, V40, P437, DOI 10.1016/S0735-1097(02)01986-1; Johnson W, 2002, J AM COLL CARDIOL, V39, P1623, DOI 10.1016/S0735-1097(02)01814-4; KANGAWA K, 1984, BIOCHEM BIOPH RES CO, V119, P933, DOI 10.1016/0006-291X(84)90863-5; Kawai K, 2001, AM HEART J, V141, P925, DOI 10.1067/mhj.2001.115435; Kazanegra R, 2001, J CARD FAIL, V7, P21, DOI 10.1054/jcaf.2001.23355; KISCH B, 1956, Exp Med Surg, V14, P99; Klapholz M, 2001, AM J CARDIOL, V88, P657, DOI 10.1016/S0002-9149(01)01809-4; Koglin J, 2001, J AM COLL CARDIOL, V38, P1934, DOI 10.1016/S0735-1097(01)01672-2; LADENSON PW, 1988, ENDOCRINOLOGY, V123, P652, DOI 10.1210/endo-123-1-652; Lainchbury JG, 1997, HYPERTENSION, V30, P398, DOI 10.1161/01.HYP.30.3.398; Latini R, 2002, CIRCULATION, V106, P2454, DOI 10.1161/01.CIR.0000036747.68104.AC; Lubien E, 2002, CIRCULATION, V105, P595, DOI 10.1161/hc0502.103010; Luchner A, 2000, J HYPERTENS, V18, P1121, DOI 10.1097/00004872-200018080-00018; Maeda K, 2000, J AM COLL CARDIOL, V36, P1587, DOI 10.1016/S0735-1097(00)00912-8; Maisel AS, 2001, AM HEART J, V141, P367, DOI 10.1067/mhj.2001.113215; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Mallamaci F, 2001, KIDNEY INT, V59, P1559, DOI 10.1046/j.1523-1755.2001.0590041559.x; Marcus LS, 1996, CIRCULATION, V94, P3184, DOI 10.1161/01.CIR.94.12.3184; MARGULIES KB, 1995, CIRCULATION, V91, P2036, DOI 10.1161/01.CIR.91.7.2036; MARINGREZ M, 1986, NATURE, V324, P473, DOI 10.1038/324473a0; Matsuo K, 1998, CIRCULATION, V98, P2433, DOI 10.1161/01.CIR.98.22.2433; McClean DR, 2000, J AM COLL CARDIOL, V36, P479, DOI 10.1016/S0735-1097(00)00741-5; McCullough PA, 2002, CIRCULATION, V106, P416, DOI 10.1161/01.CIR.0000025242.79963.4C; McDonagh TA, 2001, HEART, V86, P21, DOI 10.1136/heart.86.1.21; Messerli FH, 2000, LANCET, V356, P608, DOI 10.1016/S0140-6736(00)02596-4; MINAMINO N, 1991, BIOCHEM BIOPH RES CO, V179, P535, DOI 10.1016/0006-291X(91)91404-Z; Mitchell GF, 2002, CIRCULATION, V105, P2955, DOI 10.1161/01.CIR.0000020500.77568.3C; Mizuno Y, 2000, AM J CARDIOL, V86, P1036, DOI 10.1016/S0002-9149(00)01147-4; Morrison LK, 2002, J AM COLL CARDIOL, V39, P202, DOI 10.1016/S0735-1097(01)01744-2; MOTWANI JG, 1993, LANCET, V341, P1109, DOI 10.1016/0140-6736(93)93126-L; MUKOYAMA M, 1991, J CLIN INVEST, V87, P1402, DOI 10.1172/JCI115146; Murdoch DR, 1999, AM HEART J, V138, P1126, DOI 10.1016/S0002-8703(99)70079-7; Nagaya N, 1998, AM HEART J, V135, P21, DOI 10.1016/S0002-8703(98)70338-2; Nagaya N, 1998, J AM COLL CARDIOL, V31, P202, DOI 10.1016/S0735-1097(97)00452-X; Nagaya N, 2000, CIRCULATION, V102, P865; NAKAMURA S, 1991, AM J HYPERTENS, V4, P909, DOI 10.1093/ajh/4.11.909; NAKAO K, 1991, CAN J PHYSIOL PHARM, V69, P1500, DOI 10.1139/y91-225; Nishimori T, 1997, J MOL CELL CARDIOL, V29, P2125, DOI 10.1006/jmcc.1997.0460; Okumura H, 2000, ACTA HAEMATOL-BASEL, V104, P158, DOI 10.1159/000046508; Omland T, 1996, CIRCULATION, V93, P1963, DOI 10.1161/01.CIR.93.11.1963; Omland T, 1996, HEART, V76, P232, DOI 10.1136/hrt.76.3.232; Omland T, 2002, AM J CARDIOL, V89, P463, DOI 10.1016/S0002-9149(01)02271-8; Onuoha GN, 1998, NEUROPEPTIDES, V32, P319, DOI 10.1016/S0143-4179(98)90054-3; Osca JQ, 2001, CIRCULATION, V104, P501; Packer M, 2002, CIRCULATION, V106, P920, DOI 10.1161/01.CIR.0000029801.86489.50; PUCCI A, 1992, INT J CARDIOL, V34, P237, DOI 10.1016/0167-5273(92)90020-4; Qi W, 2001, AM HEART J, V142, P725, DOI 10.1067/mhj.2001.117131; Rame JE, 2001, AM HEART J, V142, P714, DOI 10.1067/mhj.2001.118473; Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4; RICHARDS AM, 1988, J CLIN ENDOCR METAB, V67, P1134, DOI 10.1210/jcem-67-6-1134; Richards AM, 1998, CIRCULATION, V97, P1921, DOI 10.1161/01.CIR.97.19.1921; Richards AM, 1999, HEART, V81, P114, DOI 10.1136/hrt.81.2.114; Richards AM, 1999, CIRCULATION, V99, P786, DOI 10.1161/01.CIR.99.6.786; Richards AM, 2001, J AM COLL CARDIOL, V37, P1781, DOI 10.1016/S0735-1097(01)01269-4; RICHARDS AM, 1993, BRIT HEART J, V69, P414; RIDDERVOLD F, 1991, AM J PHYSIOL, V260, pH1953, DOI 10.1152/ajpheart.1991.260.6.H1953; Rouleau JL, 2000, LANCET, V356, P615, DOI 10.1016/S0140-6736(00)02602-7; SANDERSON JE, 1995, BRIT HEART J, V74, P502; SONNENBERG JL, 1988, PEPTIDES, V9, P173, DOI 10.1016/0196-9781(88)90024-1; Stanek B, 2001, J AM COLL CARDIOL, V38, P436, DOI 10.1016/S0735-1097(01)01383-3; Struthers AD, 2002, LANCET, V359, P1430, DOI 10.1016/S0140-6736(02)08358-7; SUDOH T, 1990, BIOCHEM BIOPH RES CO, V168, P863, DOI 10.1016/0006-291X(90)92401-K; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; SUGA S, 1992, J CLIN INVEST, V90, P1145, DOI 10.1172/JCI115933; SUGA SI, 1992, ENDOCRINOLOGY, V130, P229, DOI 10.1210/en.130.1.229; SUMIDA H, 1995, J AM COLL CARDIOL, V25, P1105, DOI 10.1016/0735-1097(94)00525-U; Takemura G, 1998, J AM COLL CARDIOL, V31, P754, DOI 10.1016/S0735-1097(98)00045-X; TONOLO G, 1989, CIRCULATION, V80, P893, DOI 10.1161/01.CIR.80.4.893; Troughton RW, 2000, LANCET, V355, P1126, DOI 10.1016/S0140-6736(00)02060-2; Tsutamoto T, 2001, J AM COLL CARDIOL, V37, P1228, DOI 10.1016/S0735-1097(01)01116-0; *UMAC INV, 2002, JAMA-J AM MED ASSOC, V287, P1531; van Veldhuisen DJ, 1998, J AM COLL CARDIOL, V32, P1811, DOI 10.1016/S0735-1097(98)00464-1; Vasan RS, 2002, JAMA-J AM MED ASSOC, V288, P1252, DOI 10.1001/jama.288.10.1252; Wallen T, 1997, HEART, V77, P264, DOI 10.1136/hrt.77.3.264; Wang TJ, 2002, AM J CARDIOL, V90, P254, DOI 10.1016/S0002-9149(02)02464-5; Wiese S, 2000, CIRCULATION, V102, P3074; Williams ES, 2002, J AM COLL CARDIOL, V40, P1; Yamamoto K, 1996, HYPERTENSION, V28, P988, DOI 10.1161/01.HYP.28.6.988; YASUE H, 1994, CIRCULATION, V90, P195, DOI 10.1161/01.CIR.90.1.195; YOSHIMURA M, 1993, CIRCULATION, V87, P464, DOI 10.1161/01.CIR.87.2.464; Yu CM, 1996, EUR HEART J, V17, P1694	117	793	811	0	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2003	362	9380					316	322		10.1016/S0140-6736(03)13976-1	http://dx.doi.org/10.1016/S0140-6736(03)13976-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705UL	12892964				2022-12-28	WOS:000184413400025
J	Glare, P; Virik, K; Jones, M; Hudson, M; Eychmuller, S; Simes, J; Christakis, N				Glare, P; Virik, K; Jones, M; Hudson, M; Eychmuller, S; Simes, J; Christakis, N			A systematic review of physicians' survival predictions in terminally ill cancer patients	BRITISH MEDICAL JOURNAL			English	Review							PALLIATIVE PROGNOSTIC SCORE; CLINICAL SYMPTOMS; LIFE-SPAN; ACCURACY; CARE; HOSPICE	Objective To systematically review the accuracy of physicians clinical predictions of survival in terminally ill cancer patients. Data sources Cochrane Library, Medline (1996-2000), Embase, Current Contents, and Cancerlit databases as well as hand searching. Study selection Studies were included if a physician's temporal clinical prediction of survival (CPS) and the actual survival (AS) for terminally ill cancer patients were available for statistical analysis. Study quality was assessed by using a critical appraisal tool produced by the local health authority. Data synthesis Raw data were pooled and analysed with regression and other multivariate techniques. Results 17 published Studies were identified; 12 met the inclusion criteria, and 8 were evaluable, providing 1563 individual prediction-survival dyads. CPS was generally overoptimistic (median CPS 42 days, median AS 29 days); it was correct to within one week in 25% of cases and overestimated survival by at least four weeks in 27%. The longer the CPS the greater the variability in AS. Although agreement between CPS and AS was poor (weighted K 0.36), the two were highly significantly associated after log transformation (Spearman rank correlation 0.60, P < 0.001). Consideration of performance status, symptoms, and use of steroids improved the accuracy of the CPS, although the additional value was small. Heterogeneity of the studies results precluded a comprehensive meta-analysis. Conclusions Although clinicians consistently overestimate survival, their predictions are highly correlated with actual Survival; die predictions have discriminatory ability even if they are miscalibrated. Clinicians caring for patients with terminal cancer 0 need to be aware of their tendency to overestimate survival. as it may affect patients prospects for achieving, a good death. Accurate prognostication 0 0 models incorporating clinical prediction of survival are needed.	Royal Prince Alfred Hosp, Dept Palliat Care, Camperdown, NSW 2050, Australia; Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia; Macquarie Univ, Dept Stat, Sydney, NSW 2109, Australia; Kantonsspital, Dept Palliat Care, St Gallen, Switzerland; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA USA	University of Sydney; University of Sydney; Macquarie University; Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; Harvard University; Harvard Medical School	Glare, P (corresponding author), Royal Prince Alfred Hosp, Dept Palliat Care, Camperdown, NSW 2050, Australia.		Christakis, Nicholas A/C-3205-2009; Glare, Paul Andrew/AAE-8468-2021; Christakis, Nicholas A/B-6690-2008; Jones, Mark/I-2720-2016	Jones, Mark/0000-0001-6858-9710; Hudson, Harold/0000-0002-4209-6915; Glare, Paul/0000-0001-6850-7025				BRUERA E, 1992, J PAIN SYMPTOM MANAG, V7, P82, DOI 10.1016/0885-3924(92)90118-2; Christakis NA, 1997, SOC SCI MED, V44, P301, DOI 10.1016/S0277-9536(96)00100-1; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Christakis NicholasA., 1999, DEATH FORETOLD; EVANS C, 1985, LANCET, V1, P1204; FORSTER LE, 1988, ARCH INTERN MED, V148, P2540, DOI 10.1001/archinte.148.12.2540; Heyse-Moore LH., 1987, PALLIATIVE MED, V1, P165, DOI DOI 10.1177/026921638700100213; Liddel J, 1996, METHOD EVALUATING RE; Llobera J, 2000, EUR J CANCER, V36, P2036, DOI 10.1016/S0959-8049(00)00291-4; Mackillop WJ, 1997, J CLIN EPIDEMIOL, V50, P21, DOI 10.1016/S0895-4356(96)00316-2; Maltoni M, 1999, J PAIN SYMPTOM MANAG, V17, P240, DOI 10.1016/S0885-3924(98)00146-8; MALTONI M, 1994, EUR J CANCER, V30A, P764, DOI 10.1016/0959-8049(94)90289-5; MALTONI M, 1995, CANCER-AM CANCER SOC, V75, P2613, DOI 10.1002/1097-0142(19950515)75:10<2613::AID-CNCR2820751032>3.0.CO;2-1; MCKILLOP WJ, 2001, PROGNOSTIC FACTORS C; Morishita Ryuichi, 2000, Current Drug Targets, V1, P15, DOI 10.2174/1389450003349344; Morita T, 2001, PALLIATIVE MED, V15, P419, DOI 10.1191/026921601680419474; Morita T, 1999, JPN J CLIN ONCOL, V29, P156, DOI 10.1093/jjco/29.3.156; Muers MF, 1996, THORAX, V51, P894, DOI 10.1136/thx.51.9.894; Oxenham D, 1998, PALLIATIVE MED, V12, P117, DOI 10.1191/026921698672034203; PARKES CM, 1972, BRIT MED J, V2, P29, DOI 10.1136/bmj.2.5804.29; Pirovano M, 1999, J PAIN SYMPTOM MANAG, V17, P231, DOI 10.1016/S0885-3924(98)00145-6; REUBEN DB, 1988, ARCH INTERN MED, V148, P1586, DOI 10.1001/archinte.148.7.1586; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Vigano A, 2000, PALLIATIVE MED, V14, P363, DOI 10.1191/026921600701536192; VIGNANO A, 1999, CANCER, V86, P170	25	668	679	2	27	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2003	327	7408					195	198		10.1136/bmj.327.7408.195	http://dx.doi.org/10.1136/bmj.327.7408.195			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706DL	12881260	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000184437300016
J	Kikule, E				Kikule, E			A good death in Uganda: survey of needs for palliative care for terminally ill people in urban areas	BRITISH MEDICAL JOURNAL			English	Article								Objective To identify the palliative care needs of terminally ill people in Uganda. Design Descriptive cross sectional study. Setting Home care programmes in and around Kampala that look after terminally ill people in their homes. Participants 173 terminally ill patients registered with the home care programmes. Results Most of the participants had either HIV/AIDS or cancer or both; 145 were aged under 50 years, and 107 were women. Three main needs were identified: the control or relief of pain and other symptoms; counselling; and financial assistance for basic needs such as food, shelter, and school fees for their children. The preferred site of care was the home, though all these people lived in urban areas with access to healthcare services within 5 kin of their homes. Conclusion A "good death" in a developing country occurs when the dying person is being cared for at home, is free from pain or other distressing symptoms, feels no stigma, is at peace, and has their basic needs met without feeling dependent on others.	Hospice Africa Uganda, Kampala, Uganda		Kikule, E (corresponding author), Hospice Africa Uganda, POB 7757, Kampala, Uganda.							KATABIRA E, 1998, WORLD HLTH, P16; Kish L, 1965, SURVEY SAMPLING; *MIN ENV, 1999, POLL CHECK RES 98 EV, P10; Murray SA, 2003, BRIT MED J, V326, P368, DOI 10.1136/bmj.326.7385.368; OKUONZI SA, 2003, UGANDA HLTH B J  JAN, P9; REGNARD FBC, 1998, GUIDE SYMPTOM RELIEF; SIMS R, 1995, TERMINAL CARE PEOPLE, P1; *UN DEV PROGR, 2000, UG HUM DEV REP; *UNAIDS WHO, 1998, AIDS EP UPD DEC, P1; 1990, WHO TECH REP SER, V804, P1	10	72	73	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2003	327	7408					192	194		10.1136/bmj.327.7408.192	http://dx.doi.org/10.1136/bmj.327.7408.192			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706DL	12881259	Green Published, Bronze			2022-12-28	WOS:000184437300015
J	Lin, G; Hoxie, JA				Lin, G; Hoxie, JA			CCR5 mimicry by sulfated human Anti-HIV-1 antibodies	CELL			English	Editorial Material							HIV-1 ENTRY; NEUTRALIZATION; TERMINUS		Univ Penn, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania	Lin, G (corresponding author), Biol Mimet Inc, 124 Byte Dr, Frederick, MD 21702 USA.							Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Choe H, 2003, CELL, V114, P161, DOI 10.1016/S0092-8674(03)00508-7; Dragic T, 2001, J GEN VIROL, V82, P1807, DOI 10.1099/0022-1317-82-8-1807; Farzan M, 2000, J BIOL CHEM, V275, P33516, DOI 10.1074/jbc.M007228200; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Farzan M, 2002, J BIOL CHEM, V277, P40397, DOI 10.1074/jbc.M206784200; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Sharon M, 2003, STRUCTURE, V11, P225, DOI 10.1016/S0969-2126(03)00011-X; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884	11	6	6	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 25	2003	114	2					147	148		10.1016/S0092-8674(03)00564-6	http://dx.doi.org/10.1016/S0092-8674(03)00564-6			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887913	Bronze			2022-12-28	WOS:000184378700001
J	Voelker, R				Voelker, R			Medical students, reach out to rural communities in "WWAMI Land"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2003	290	4					452	453		10.1001/jama.290.4.452	http://dx.doi.org/10.1001/jama.290.4.452			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703JB	12876078				2022-12-28	WOS:000184275300003
J	Solomon, AW; Holland, MJ; Burton, MJ; West, SK; Alexander, NDE; Aguirre, A; Massae, PA; Mkocha, H; Munoz, B; Johnson, GJ; Peeling, RW; Bailey, RL; Foster, A; Mabey, DCW				Solomon, AW; Holland, MJ; Burton, MJ; West, SK; Alexander, NDE; Aguirre, A; Massae, PA; Mkocha, H; Munoz, B; Johnson, GJ; Peeling, RW; Bailey, RL; Foster, A; Mabey, DCW			Strategies for control of trachoma: observational study with quantitative PCR	LANCET			English	Article							SINGLE-DOSE AZITHROMYCIN; CHLAMYDIA-TRACHOMATIS; MASS TREATMENT; ORAL AZITHROMYCIN; CHILDREN; BLINDNESS; IMPACT; NEPAL	Background Antibiotics are an important part of WHO's strategy to eliminate trachoma as a blinding disease by 2020. At present, who needs to be treated is unclear. We aimed to establish the burden of ocular Chlamydia trachomatis in three trachoma-endemic communities in Tanzania and The Gambia with real-time quantitative PCR. Methods Conjunctival swabs were obtained at examination from 3146 individuals. Swabs were first tested by the qualitative Amplicor PCR, which is known to be highly sensitive. In positive samples, the number of copies of omp1 (a single-copy C trachomatis gene) was measured by quantitative PCR. Findings Children had the highest ocular loads of C trachomatis, although the amount of pooling in young age groups was less striking at the site with the lowest trachoma frequency. Individuals with intense inflammatory trachoma had higher loads than did those with other conjunctival signs. At the site with the highest prevalence of trachoma, 48 of 93 (52%) individuals with conjunctival scarring but no sign of active disease were positive for ocular chlamydiae. Interpretation Children younger than 10 years old, and those with intense inflammatory trachoma, probably represent the major source of ocular C trachomatis infection in endemic communities. Success of antibiotic distribution programmes could depend on these groups receiving effective treatment.	Univ London London Sch Hyg & Trop Med, Clin Res Unit, London WC1E 7HT, England; Tumaini Univ, Kilimanjaro Christian Med Coll, Moshi, Tanzania; Huruma Hosp, Rombo Dist, Tanzania; MRC Labs, Fajara, Gambia; Johns Hopkins Univ, Dana Ctr Prevent Ophthalmol, Baltimore, MD USA; Kongwa Trachoma Project, Kongwa, Tanzania; WHO, Special Programme Res & Training Trop Dis, CH-1211 Geneva, Switzerland; Hlth Canada, Natl Microbiol Lab, Winnipeg, MB, Canada	University of London; London School of Hygiene & Tropical Medicine; MRC Laboratory Molecular Biology; Johns Hopkins University; World Health Organization; Health Canada	Mabey, DCW (corresponding author), Univ London London Sch Hyg & Trop Med, Clin Res Unit, Keppel St, London WC1E 7HT, England.		Holland, Martin J/K-6502-2012	Holland, Martin J/0000-0002-5828-6318; Burton, Matthew/0000-0003-1872-9169; Andreasen, Aura/0000-0003-0664-7342; Foster, Allen/0000-0003-2368-4436; Solomon, Anthony/0000-0001-7101-6649; Mabey, David/0000-0002-0031-8276				BAILEY RL, 1993, LANCET, V342, P453, DOI 10.1016/0140-6736(93)91591-9; BOBO L, 1991, LANCET, V338, P847, DOI 10.1016/0140-6736(91)91502-L; Bowman RJC, 2000, INVEST OPHTH VIS SCI, V41, P4074; Chern KC, 1999, BRIT J OPHTHALMOL, V83, P1332, DOI 10.1136/bjo.83.12.1332; Dawson CR, 1997, CLIN INFECT DIS, V24, P363, DOI 10.1093/clinids/24.3.363; Dawson CR, 1981, GUIDE TRACHOMA CONTR; Frick KD, 2001, B WORLD HEALTH ORGAN, V79, P201; Fry AM, 2002, CLIN INFECT DIS, V35, P395, DOI 10.1086/341414; Holm SO, 2001, B WORLD HEALTH ORGAN, V79, P194; Laming AC, 2000, MED J AUSTRALIA, V172, P163, DOI 10.5694/j.1326-5377.2000.tb125541.x; Leach AJ, 1997, CLIN INFECT DIS, V24, P356, DOI 10.1093/clinids/24.3.356; Lietman T, 1999, NAT MED, V5, P572, DOI 10.1038/8451; Munoz B, 1999, INT J EPIDEMIOL, V28, P1167, DOI 10.1093/ije/28.6.1167; PICKETT MA, 2000, P 4 M EUR SOC CHLAM, P45; Schachter J, 1999, LANCET, V354, P630, DOI 10.1016/S0140-6736(98)12387-5; SMITH IW, 1993, J CLIN PATHOL, V46, P822, DOI 10.1136/jcp.46.9.822; STEPHENS RS, 1982, J CLIN MICROBIOL, V16, P4, DOI 10.1128/JCM.16.1.4-7.1982; Tabbara KF, 1996, OPHTHALMOLOGY, V103, P842; Taylor K, 1999, BRIT J OPHTHALMOL, V83, P134, DOI 10.1136/bjo.83.2.134; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; Verkooyen RP, 1996, J CLIN MICROBIOL, V34, P3072, DOI 10.1128/JCM.34.12.3072-3074.1996; Whitty CJM, 1999, PEDIATR INFECT DIS J, V18, P955, DOI 10.1097/00006454-199911000-00003; *WORLD HLTH ASS, 1998, 51 WORLD HLTH ASS RE; *WORLD MED ASS, 2000, DECL HELS ETH PRINC	25	175	175	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 19	2003	362	9379					198	204		10.1016/S0140-6736(03)13909-8	http://dx.doi.org/10.1016/S0140-6736(03)13909-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702PJ	12885481				2022-12-28	WOS:000184232000010
J	Carrington, JC; Ambros, V				Carrington, JC; Ambros, V			Role of microRNAs in plant and animal development	SCIENCE			English	Review							SMALL RNAS; CAENORHABDITIS-ELEGANS; ARABIDOPSIS; IDENTIFICATION; DICER-LIKE1; EXPRESSION; HOMOLOG; ENCODES; PROTEIN; LIN-28	Small RNAs, including microRNAs (miRNAs) and short interfering RNAs (siRNAs), are key components of an evolutionarily conserved system of RNA-based gene regulation in eukaryotes. They are involved in many molecular interactions, including defense against viruses and regulation of gene expression during development. miRNAs interfere with expression of messenger RNAs encoding factors that control developmental timing, stem cell maintenance, and other developmental and physiological processes in plants and animals. miRNAs are negative regulators that function as specificity determinants, or guides, within complexes that inhibit protein synthesis (animals) or promote degradation (plants) of mRNA targets.	Oregon State Univ, Ctr Gene Res & Biotechnol, Corvallis, OR 97331 USA; Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; Dartmouth Coll, Sch Med, Dept Genet, Hanover, NH 03755 USA	Oregon State University; Oregon State University; Dartmouth College	Carrington, JC (corresponding author), Oregon State Univ, Ctr Gene Res & Biotechnol, Corvallis, OR 97331 USA.	carrington@orst.edu	Carrington, James C/A-4656-2012	Carrington, James C/0000-0003-3572-129X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI043288, R21AI043288, R01AI043288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034028] Funding Source: NIH RePORTER; NIAID NIH HHS [AI43288] Funding Source: Medline; NIGMS NIH HHS [GM34028] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrahante JE, 2003, DEV CELL, V4, P625, DOI 10.1016/S1534-5807(03)00127-8; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Bashirullah A, 2003, DEV BIOL, V259, P1, DOI 10.1016/S0012-1606(03)00063-0; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Denli AM, 2003, TRENDS BIOCHEM SCI, V28, P196, DOI 10.1016/S0968-0004(03)00058-6; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kawasaki H, 2003, NATURE, V423, P838, DOI 10.1038/nature01730; Kidner CA, 2003, TRENDS GENET, V19, P13, DOI 10.1016/S0168-9525(02)00011-2; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lin SY, 2003, DEV CELL, V4, P639, DOI 10.1016/S1534-5807(03)00124-2; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Pasquinelli AE, 2002, ANNU REV CELL DEV BI, V18, P495, DOI 10.1146/annurev.cellbio.18.012502.105832; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	40	1390	1571	6	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 18	2003	301	5631					336	338		10.1126/science.1085242	http://dx.doi.org/10.1126/science.1085242			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869753				2022-12-28	WOS:000184207300033
J	Dunne, L; Eales, S; Ivison, R; Morgan, H; Edmunds, M				Dunne, L; Eales, S; Ivison, R; Morgan, H; Edmunds, M			Type II supernovae as a significant source of interstellar dust	NATURE			English	Article							REMNANT CASSIOPEIA; FLUX-DENSITY; SUBMILLIMETER SURVEY; INFRARED-EMISSION; STAR-FORMATION; 16.5 GHZ; EVOLUTION; REDSHIFT; GRAINS; SHELL	Large amounts of dust (>10(8) M-circle dot) have recently been discovered in high-redshift quasars(1,2) and galaxies(3-5) corresponding to a time when the Universe was less than one-tenth of its present age. The stellar winds produced by stars in the late stages of their evolution (on the asymptotic giant branch of the Hertzsprung-Russell diagram) are thought to be the main source of dust in galaxies, but they cannot produce that dust on a short enough timescale(6) (<1 Gyr) to explain the results in the high-redshift galaxies. Supernova explosions of massive stars (type II) are also a potential source, with models predicting 0.2-4M(circle dot) of dust(7-10). As massive stars evolve rapidly, on timescales of a few Myr, these supernovae could be responsible for the high-redshift dust. Observations(11-13) of supernova remnants in the Milky Way, however, have hitherto revealed only 10(-7)-10(23) M-circle dot each, which is insufficient to explain the high-redshift data. Here we report the detection of similar to 2-M-circle dot of cold dust in the youngest known Galactic supernova remnant, Cassiopeia A. This observation implies that supernovae are at least as important as stellar winds in producing dust in our Galaxy and would have been the dominant source of dust at high redshifts.	Cardiff Univ, Dept Phys & Astron, Cardiff CF24 3YB, S Glam, Wales; Royal Observ, Astron Technol Ctr, Edinburgh EH9 3HJ, Midlothian, Scotland	Cardiff University; University of Edinburgh	Dunne, L (corresponding author), Cardiff Univ, Dept Phys & Astron, 5 Parade, Cardiff CF24 3YB, S Glam, Wales.	L.Dunne@astro.cf.ac.uk	Gomez, Haley/C-2800-2009; Ivison, R. J./G-4450-2011	Ivison, R. J./0000-0001-5118-1313; Gomez, Haley/0000-0003-3398-0052				Agueros MA, 1999, MON NOT R ASTRON SOC, V305, P957, DOI 10.1046/j.1365-8711.1999.02504.x; Archibald EN, 2001, MON NOT R ASTRON SOC, V323, P417, DOI 10.1046/j.1365-8711.2001.04188.x; BAARS JWM, 1977, ASTRON ASTROPHYS, V61, P99; BERTOLDI F, 2003, IN PRESS ASTRON ASTR; Borkowski KJ, 1996, ASTROPHYS J, V466, P866, DOI 10.1086/177560; Clayton DD, 1999, SCIENCE, V283, P1290, DOI 10.1126/science.283.5406.1290; Douvion T, 2001, ASTRON ASTROPHYS, V373, P281, DOI 10.1051/0004-6361:20010447; Dunne L, 2003, MON NOT R ASTRON SOC, V341, P589, DOI 10.1046/j.1365-8711.2003.06440.x; DWEK E, 1987, ASTROPHYS J, V315, P571, DOI 10.1086/165160; GarciaSegura G, 1996, ASTRON ASTROPHYS, V316, P133; Gotthelf EV, 2001, ASTROPHYS J, V552, pL39, DOI 10.1086/320250; Holland WS, 1999, MON NOT R ASTRON SOC, V303, P659, DOI 10.1046/j.1365-8711.1999.02111.x; Hughes DH, 1998, NATURE, V394, P241, DOI 10.1038/28328; KOZASA T, 1991, ASTRON ASTROPHYS, V249, P474; Lagage PO, 1996, ASTRON ASTROPHYS, V315, pL273; Li AG, 2001, ASTROPHYS J, V554, P778, DOI 10.1086/323147; Liszt H, 1999, ASTRON ASTROPHYS, V347, P258; LUCY LB, 1991, SUPERNOVAE //, P82; Mason BS, 1999, ASTRON J, V118, P2908, DOI 10.1086/301121; MEZGER PG, 1986, ASTRON ASTROPHYS, V167, P145; MORGAN HL, IN PRESS MON NOT R A; O'Sullivan C, 1999, MON NOT R ASTRON SOC, V303, P575, DOI 10.1046/j.1365-8711.1999.02259.x; REED JE, 1995, ASTROPHYS J, V440, P706, DOI 10.1086/175308; Reichart DE, 2000, ASTROPHYS J, V537, P904, DOI 10.1086/309073; SAKEN JM, 1992, ASTROPHYS J SUPPL S, V81, P715, DOI 10.1086/191703; Smail I, 1997, ASTROPHYS J, V490, pL5, DOI 10.1086/311017; Todini P, 2001, MON NOT R ASTRON SOC, V325, P726, DOI 10.1046/j.1365-8711.2001.04486.x; Tuffs RJ, 1999, ESA SP PUBL, V427, P241; WOOSLEY SE, 1995, ASTROPHYS J SUPPL SE, V101, P101; Wright M, 1999, ASTROPHYS J, V518, P284, DOI 10.1086/307270	30	215	217	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2003	424	6946					285	287		10.1038/nature01792	http://dx.doi.org/10.1038/nature01792			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867973	Green Submitted			2022-12-28	WOS:000184183900033
J	Forbes, DA; Beasley, MA; Bekki, K; Brodie, JP; Strader, J				Forbes, DA; Beasley, MA; Bekki, K; Brodie, JP; Strader, J			Galaxy disruption in a halo of dark matter	SCIENCE			English	Article							DWARF ELLIPTIC GALAXIES; GLOBULAR-CLUSTERS; ADVANCED CAMERA; EVOLUTION	The relics of disrupted satellite galaxies have been found around the Milky Way and Andromeda, but direct evidence of a satellite galaxy in the early stages of disruption has remained elusive. We have discovered a dwarf satellite galaxy in the process of being torn apart by gravitational tidal forces as it merges with a larger galaxy's dark matter halo. Our results illustrate the morphological transformation of dwarf galaxies by tidal interaction and the continued buildup of galaxy halos.	Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic 3122, Australia; Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia; Univ Calif Santa Cruz, Lick Observ, Santa Cruz, CA 95064 USA	Swinburne University of Technology; University of New South Wales Sydney; University of California System; University of California Santa Cruz	Forbes, DA (corresponding author), Swinburne Univ Technol, Ctr Astrophys & Supercomp, POB 218, Hawthorn, Vic 3122, Australia.	dforbes@swin.edu.au	Bekki, Kenji/H-8821-2014; Forbes, Duncan/AAG-8594-2019	Bekki, Kenji/0000-0001-6163-4726				Bekki K, 2001, ASTROPHYS J, V557, pL39, DOI 10.1086/323075; BRODIE JP, 1991, ASTROPHYS J, V379, P157, DOI 10.1086/170492; Colpi M, 1999, ASTROPHYS J, V525, P720, DOI 10.1086/307952; de Grijs R, 2003, NEW ASTRON, V8, P155, DOI 10.1016/S1384-1076(02)00224-5; Ghigna S, 1998, MON NOT R ASTRON SOC, V300, P146, DOI 10.1046/j.1365-8711.1998.01918.x; Girardi L, 2002, ASTRON ASTROPHYS, V391, P195, DOI 10.1051/0004-6361:20020612; GRAHAM A, UNPUB; Graham AW, 2003, ASTRON J, V125, P2936, DOI 10.1086/374992; Grebel EK, 2003, ASTRON J, V125, P1926, DOI 10.1086/368363; Grebel EK, 1999, IAU SYMP, P17; Harris WE, 2001, ASTRON J, V122, P3065, DOI 10.1086/323928; Helmi A, 2001, NATURE, V412, P25, DOI 10.1038/35083656; Ibata R, 2001, NATURE, V412, P49, DOI 10.1038/35083506; IBATA RA, 1994, NATURE, V370, P194, DOI 10.1038/370194a0; KAUFFMANN G, 1993, MON NOT R ASTRON SOC, V264, P201, DOI 10.1093/mnras/264.1.201; LYNDENBELL D, 1995, MON NOT R ASTRON SOC, V275, P429, DOI 10.1093/mnras/275.2.429; Mayer L, 2001, ASTROPHYS J, V559, P754, DOI 10.1086/322356; SERSIC JL, 1968, ATLAS GALAXES AUSTRA; Strader J, 2003, ASTRON J, V125, P1291, DOI 10.1086/367599; Tran HD, 2003, ASTROPHYS J, V585, P750, DOI 10.1086/346125	23	34	35	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2003	301	5637					1217	1219		10.1126/science.1089237	http://dx.doi.org/10.1126/science.1089237			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZC	12907809				2022-12-28	WOS:000185003500034
J	Ouyang, M; Awschalom, DD				Ouyang, M; Awschalom, DD			Coherent spin transfer between molecularly bridged quantum dots	SCIENCE			English	Article							TRANSPORT; RESONANCE	Femtosecond time-resolved Faraday rotation spectroscopy reveals the instantaneous transfer of spin coherence through conjugated molecular bridges spanning quantum dots of different size over a broad range of temperature. The room-temperature spin-transfer efficiency is similar to20%, showing that conjugated molecules can be used not only as interconnections for the hierarchical assembly of functional networks but also as efficient spin channels. The results suggest that this class of structures may be useful as two-spin quantum devices operating at ambient temperatures and may offer promising opportunities for future versatile molecule-based spintronic technologies.	Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Ctr Spintron & Quantum Comp, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Awschalom, DD (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	awsch@physics.ucsb.edu						Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; AVIRAM A, 1998, ANN NY ACAD SCI, V852; Brown KR, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.012307; Burkard G, 2002, NANOSCI TECHNOL, P229; Chen J, 2002, CHEM PHYS, V281, P127, DOI 10.1016/S0301-0104(02)00616-X; Crooker SA, 1997, PHYS REV B, V56, P7574, DOI 10.1103/PhysRevB.56.7574; Greenham NC, 1996, PHYS REV B, V54, P17628, DOI 10.1103/PhysRevB.54.17628; Gupta JA, 1999, PHYS REV B, V59, P10421, DOI 10.1103/PhysRevB.59.R10421; Hikmet RAM, 2003, J APPL PHYS, V93, P3509, DOI 10.1063/1.1542940; Hu XD, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.062301; Imamoglu A, 1999, PHYS REV LETT, V83, P4204, DOI 10.1103/PhysRevLett.83.4204; Janes DB, 2000, SUPERLATTICE MICROST, V27, P555, DOI 10.1006/spmi.2000.0882; Kagan CR, 1996, PHYS REV B, V54, P8633, DOI 10.1103/PhysRevB.54.8633; Kornilovitch PE, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.195413; Leatherdale CA, 2000, PHYS REV B, V62, P2669, DOI 10.1103/PhysRevB.62.2669; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Malajovich I, 2001, NATURE, V411, P770, DOI 10.1038/35081014; Norris DJ, 1996, PHYS REV B, V53, P16338, DOI 10.1103/PhysRevB.53.16338; OUYANG M, UNPUB; Peng XG, 1997, ANGEW CHEM INT EDIT, V36, P145, DOI 10.1002/anie.199701451; Sanders GD, 1999, PHYS REV A, V60, P4146, DOI 10.1103/PhysRevA.60.4146; TOTH C, 2001, PHYS REV A, V63; van der Wiel WG, 2003, REV MOD PHYS, V75, P1, DOI 10.1103/RevModPhys.75.1; Vossmeyer T, 1998, J APPL PHYS, V84, P3664, DOI 10.1063/1.368542	24	218	222	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2003	301	5636					1074	1078		10.1126/science.1086963	http://dx.doi.org/10.1126/science.1086963			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	713RP	12893886				2022-12-28	WOS:000184872400033
J	Schramke, V; Allshire, R				Schramke, V; Allshire, R			RETRACTED: Hairpin RNAs and retrotransposon LTRs effect RNAi and chromatin-based gene silencing (Retracted Article. See vol 301, pg 1069, 2003)	SCIENCE			English	Article; Retracted Publication							DISRUPT CHROMOSOME SEGREGATION; H3 LYSINE-9 METHYLATION; FISSION YEAST; HISTONE H3; SEQUENCE-ANALYSIS; DNA METHYLATION; CENTROMERE IDENTITY; HETEROCHROMATIN; INTERFERENCE; ARABIDOPSIS	The expression of short hairpin RNAs in several organisms silences gene expression by targeted mRNA degradation. This RNA interference (RNAi) pathway can also affect the genome, as DNA methylation arises at loci homologous to the target RNA in plants. We demonstrate in fission yeast that expression of a synthetic hairpin RNA is sufficient to silence the homologous locus in trans and causes the assembly of a patch of silent Swi6 chromatin with cohesin. This requires components of the RNAi machinery and Clr4 histone methyltransferase for small interfering RNA generation. A similar process represses several meiotic genes through nearby retrotransposon long terminal repeats (LTRs). These analyses directly implicate interspersed LTRs in regulating gene expression during cellular differentiation.	Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Allshire, R (corresponding author), Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Ctr Cell Biol, Kings Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.	robin.allshire@ed.ac.uk		Allshire, Robin/0000-0002-8005-3625				ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Baulcombe D, 2002, SCIENCE, V297, P2002, DOI 10.1126/science.1077906; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; BOWEN NJ, IN PRESS GENOME RES; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Comfort NC, 2001, TRENDS GENET, V17, P475, DOI 10.1016/S0168-9525(01)02383-6; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; Dawe RK, 2003, PLANT CELL, V15, P297, DOI 10.1105/tpc.150230; Dernburg AF, 2002, CELL, V111, P159, DOI 10.1016/S0092-8674(02)01039-5; Ekwall K, 1999, GENETICS, V153, P1153; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fournier C, 2002, EMBO J, V21, P6560, DOI 10.1093/emboj/cdf655; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Hakimi MA, 2002, NATURE, V418, P994, DOI 10.1038/nature01024; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Jeddeloh JA, 1998, GENE DEV, V12, P1714, DOI 10.1101/gad.12.11.1714; Jones L, 1999, PLANT CELL, V11, P2291, DOI 10.1105/tpc.11.12.2291; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; Kashkush K, 2003, NAT GENET, V33, P102, DOI 10.1038/ng1063; Kidner CA, 2003, TRENDS GENET, V19, P13, DOI 10.1016/S0168-9525(02)00011-2; Kondo Y, 2003, J BIOL CHEM, V278, P27658, DOI 10.1074/jbc.M304072200; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Nakagawa H, 2002, GENE DEV, V16, P1766, DOI 10.1101/gad.997702; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Partridge JF, 2000, GENE DEV, V14, P783; Partridge JF, 2002, CURR BIOL, V12, P1652, DOI 10.1016/S0960-9822(02)01177-6; Provost P, 2002, P NATL ACAD SCI USA, V99, P16648, DOI 10.1073/pnas.212633199; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; SCHRAMKE V, UNPUB; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Speek M, 2001, MOL CELL BIOL, V21, P1973, DOI 10.1128/MCB.21.6.1973-1985.2001; Sullivan BA, 2001, NAT REV GENET, V2, P584, DOI 10.1038/35084512; Sun XP, 2003, GENOME RES, V13, P182, DOI 10.1101/gr.681703; TUFARELLI C, 2003, NATURE GENET; Volpe T, 2003, CHROMOSOME RES, V11, P137, DOI 10.1023/A:1022815931524; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Watanabe T, 2001, NUCLEIC ACIDS RES, V29, P2327, DOI 10.1093/nar/29.11.2327; WEAVER DC, 1993, GENE, V131, P135, DOI 10.1016/0378-1119(93)90682-S; Weiner AM, 2002, CURR OPIN CELL BIOL, V14, P343, DOI 10.1016/S0955-0674(02)00338-1; Zhong CX, 2002, PLANT CELL, V14, P2825, DOI 10.1105/tpc.006106; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	53	253	278	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 22	2003	301	5636					1069	1074		10.1126/science.1086870	http://dx.doi.org/10.1126/science.1086870			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	713RP	12869699	Green Submitted			2022-12-28	WOS:000184872400032
J	Holbrook, WS; Paramo, P; Pearse, S; Schmitt, RW				Holbrook, WS; Paramo, P; Pearse, S; Schmitt, RW			Thermohaline fine structure in an oceanographic front from seismic reflection profiling	SCIENCE			English	Article							SMALL-SCALE STRUCTURE; NORTH-ATLANTIC; INTERNAL WAVES; WATER MASS; TEMPERATURE; SALINITY; OCEAN	We present acoustic images of oceanic thermohaline structure created from marine seismic reflection profiles across the major oceanographic front between the Labrador Current and the North Atlantic Current. The images show that distinct water masses can be mapped, and their internal structure imaged, using low frequency acoustic reflections from sound speed contrasts at interfaces across which temperature changes. The warm/cold front is characterized by east-dipping reflections generated by thermohaline intrusions in the uppermost 1000 meters of the ocean. Our results imply that marine seismic reflection techniques can provide excellent spatial resolution of important oceanic phenomena, including thermohaline intrusions, internal waves, and eddies.	Univ Wyoming, Dept Geol & Geophys, Laramie, WY 82071 USA; Woods Hole Oceanog Inst, Dept Phys Oceanog, Woods Hole, MA 02543 USA	University of Wyoming; Woods Hole Oceanographic Institution	Holbrook, WS (corresponding author), Univ Wyoming, Dept Geol & Geophys, Laramie, WY 82071 USA.		Schmitt, Raymond W/B-7451-2011; Holbrook, Steven/G-9800-2011	Holbrook, Steven/0000-0003-0065-8841				GARRETT C, 1979, ANNU REV FLUID MECH, V11, P339, DOI 10.1146/annurev.fl.11.010179.002011; GEORGI DT, 1983, J PHYS OCEANOGR, V13, P632, DOI 10.1175/1520-0485(1983)013<0632:FAMOOA>2.0.CO;2; GONELLA J, 1988, CR ACAD SCI II, V306, P781; HAURY LR, 1979, NATURE, V278, P312, DOI 10.1038/278312a0; JOYCE TM, 1976, DEEP-SEA RES, V23, P1175, DOI 10.1016/0011-7471(76)90893-7; JOYCE TM, 1977, J PHYS OCEANOGR, V7, P626, DOI 10.1175/1520-0485(1977)007<0626:ANOTLM>2.0.CO;2; JOYCE TM, 1978, J GEOPHYS RES-OCEANS, V83, P6093, DOI 10.1029/JC083iC12p06093; PHILLIPS JD, 1991, OCEAN VARIABILITY & ACOUSTIC PROPAGATION, P199; Pickart RS, 1996, J GEOPHYS RES-OCEANS, V101, P20711, DOI 10.1029/96JC01453; PICKART RS, 1992, DEEP-SEA RES, V39, P1553, DOI 10.1016/0198-0149(92)90047-W; PINGREE RD, 1969, DEEP-SEA RES, V16, P275, DOI 10.1016/0011-7471(69)90019-9; Ruddick B, 2003, PROG OCEANOGR, V56, P499, DOI 10.1016/S0079-6611(03)00028-4; Rudnick DL, 1999, SCIENCE, V283, P526, DOI 10.1126/science.283.5401.526; Schmitt RW, 1982, J MAR RES, V40, P659; SCHMITT RW, 1987, DEEP-SEA RES, V34, P1655, DOI 10.1016/0198-0149(87)90014-8; STOMMEL H, 1967, TELLUS, V19, P306, DOI 10.1111/j.2153-3490.1967.tb01484.x; WARNER M, 1990, TECTONOPHYSICS, V173, P15, DOI 10.1016/0040-1951(90)90199-I; Wessel P, 1991, EOS T AM GEOPHYS UN, V72, P445, DOI [10.1029/90EO00319, DOI 10.1029/90EO00319, DOI 10.1029/90E000319]; Wiebe PH, 1997, IEEE J OCEANIC ENG, V22, P445, DOI 10.1109/48.611135	19	176	203	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2003	301	5634					821	824		10.1126/science.1085116	http://dx.doi.org/10.1126/science.1085116			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907798				2022-12-28	WOS:000184615700041
J	Li, XQ; Wu, YW; Steel, D; Gammon, D; Stievater, TH; Katzer, DS; Park, D; Piermarocchi, C; Sham, LJ				Li, XQ; Wu, YW; Steel, D; Gammon, D; Stievater, TH; Katzer, DS; Park, D; Piermarocchi, C; Sham, LJ			An all-optical quantum gate in a semiconductor quantum dot	SCIENCE			English	Article								We report coherent optical control of a biexciton ( two electron-hole pairs), confined in a single quantum dot, that shows coherent oscillations similar to the excited-state Rabi flopping in an isolated atom. The pulse control of the biexciton dynamics, combined with previously demonstrated control of the single-exciton Rabi rotation, serves as the physical basis for a two-bit conditional quantum logic gate. The truth table of the gate shows the features of an all-optical quantum gate with interacting yet distinguishable excitons as qubits. Evaluation of the fidelity yields a value of 0.7 for the gate operation. Such experimental capability is essential to a scheme for scalable quantum computation by means of the optical control of spin qubits in dots.	Univ Michigan, Harrison M Randall Lab Phys, FOCUS, Ann Arbor, MI 48109 USA; USN, Res Lab, Washington, DC 20375 USA; Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA; Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA	University of Michigan System; University of Michigan; United States Department of Defense; United States Navy; Naval Research Laboratory; Michigan State University; University of California System; University of California San Diego	Steel, D (corresponding author), Univ Michigan, Harrison M Randall Lab Phys, FOCUS, Ann Arbor, MI 48109 USA.	dst@umich.edu	Piermarocchi, Carlo/AAH-2162-2019; Piermarocchi, Carlo/A-2427-2008; Katzer, D. Scott/N-7841-2013	Piermarocchi, Carlo/0000-0003-2762-8562; Piermarocchi, Carlo/0000-0003-2762-8562; Wu, Yanwen/0000-0001-7782-4153; Sham, Lu/0000-0001-5718-2077				BARENCO A, 1995, PHYS REV LETT, V74, P4083, DOI 10.1103/PhysRevLett.74.4083; Bayer M, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.041308; Biolatti E, 2000, PHYS REV LETT, V85, P5647, DOI 10.1103/PhysRevLett.85.5647; Birkedal D, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.227401; Borri P, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.157401; BROWN KR, 2001, PHYS REV A, V65; BRUNNER K, 1994, PHYS REV LETT, V73, P1138, DOI 10.1103/PhysRevLett.73.1138; Burkard G, 1999, PHYS REV B, V59, P2070, DOI 10.1103/PhysRevB.59.2070; Chen G, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.117901; Chen PC, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.067401; De Martini F, 2002, NATURE, V419, P815, DOI 10.1038/nature01093; Gammon D, 1996, SCIENCE, V273, P87, DOI 10.1126/science.273.5271.87; Gammon D, 1996, PHYS REV LETT, V76, P3005, DOI 10.1103/PhysRevLett.76.3005; Guest JR, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.241310; Htoon H, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.087401; Imamoglu A, 1999, PHYS REV LETT, V83, P4204, DOI 10.1103/PhysRevLett.83.4204; Kamada H, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.246401; Kikkawa JM, 1998, PHYS REV LETT, V80, P4313, DOI 10.1103/PhysRevLett.80.4313; Piermarocchi C, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.167402; Stievater TH, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.205319; Stievater TH, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.133603; Troiani F, 2000, PHYS REV B, V62, pR2263, DOI 10.1103/PhysRevB.62.R2263; Zrenner A, 2002, NATURE, V418, P612, DOI 10.1038/nature00912	24	799	811	2	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2003	301	5634					809	811		10.1126/science.1083800	http://dx.doi.org/10.1126/science.1083800			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907794				2022-12-28	WOS:000184615700037
J	Fitzmaurice, DA				Fitzmaurice, DA			Commentary: The faults of expert reviews are already well known	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Birmingham, Sch Med, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Fitzmaurice, DA (corresponding author), Univ Birmingham, Sch Med, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England.								0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 2	2003	327	7409					269	269		10.1136/bmj.327.7409.269	http://dx.doi.org/10.1136/bmj.327.7409.269			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708KP	12896941	Green Published			2022-12-28	WOS:000184566300022
J	McCarthy, M				McCarthy, M			US health-care system faces cost and insurance crises	LANCET			English	News Item																		McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; 2003, HLTH AFF, V22, P154	2	6	6	0	38	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 2	2003	362	9381					375	375		10.1016/S0140-6736(03)14057-3	http://dx.doi.org/10.1016/S0140-6736(03)14057-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707FB	12907006	Bronze			2022-12-28	WOS:000184498700013
J	Swarte, NB; van der Lee, ML; van der Bom, JG; van den Bout, J; Heintz, APM				Swarte, NB; van der Lee, ML; van der Bom, JG; van den Bout, J; Heintz, APM			Effects of euthanasia on the bereaved family and friends: a cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PHYSICIAN-ASSISTED SUICIDE; NATIONWIDE; LIFE; END	Objective To assess how euthanasia in terminally ill cancer patients affects the grief response of bereaved family and friends. Design Cross sectional study Setting Tertiary referral centre for oncology patients in Utrecht, the Netherlands. Participants 189 bereaved family members and close friends of terminally ill cancer patients who died by euthanasia and 316 bereaved family members and close friends of comparable cancer patients who died a natural death between 1992 and 1999. Main outcome measures Symptoms of traumatic grief assessed by the inventory of traumatic grief, current feelings of grief assessed by the Texas revised inventory of grief, and post-traumatic stress reactions assessed by the impact of event scale. Results The bereaved family and friends of cancer patients who died by euthanasia had less traumatic grief symptoms (adjusted difference - 5.29 (95% confidence interval - 8.44 to - 2.15)), less current feeling of grief (adjusted difference 2.93 (0.85 to 5.01)); and less post-traumatic stress reactions (adjusted difference - 2.79 (- 5.33 to - 0.25)) than the family and friends of patients who died of natural causes. These differences were independent of other risk factors. Conclusions The bereaved family and friends of cancer patients who died by euthanasia coped better with respect to grief symptoms and post-traumatic stress reactions than the bereaved of comparable cancer patients who died a natural death. These results should not be interpreted as a plea for euthanasia, but as a plea for the same level of care and openness in all patients who are terminally ill.	Univ Med Ctr Utrecht, Dept Gynaecol, NL-3508 GA Utrecht, Netherlands; Univ Utrecht, Dept Clin Psychol, NL-3508 TC Utrecht, Netherlands; Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University; Utrecht University Medical Center	Swarte, NB (corresponding author), Univ Med Ctr Utrecht, Dept Gynaecol, F05-829,POB 85500, NL-3508 GA Utrecht, Netherlands.	n.swarte@azu.nl	van der Bom, Johanna G./G-1965-2018	van der Bom, Johanna G./0000-0001-9095-2475				Arrindell WA, 1986, SCL 90 MANUAL MULTID; Boelen PA, 2003, DEATH STUD, V27, P227, DOI 10.1080/07481180302889; BrintzenhofeSzoc KM, 1999, CANCER PRACT, V7, P233, DOI 10.1046/j.1523-5394.1999.75006.x; Chochinov HM, 2000, PSYCHOSOMATICS, V41, P500, DOI 10.1176/appi.psy.41.6.500; Emanuel EJ, 2002, ARCH INTERN MED, V162, P142, DOI 10.1001/archinte.162.2.142; FASCHINGBAUER RRZ, 1987, BIOPSYCHOSOCIAL ASPE, P127; Goldstein H., 1998, USERS GUIDE MLWIN; Groenewoud JH, 2000, NEW ENGL J MED, V342, P551, DOI 10.1056/NEJM200002243420805; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Jacobs S, 2000, DEATH STUD, V24, P185, DOI 10.1080/074811800200531; Kelly BJ, 1996, AUST NZ J PSYCHIAT, V30, P3, DOI 10.3109/00048679609076068; Koop P M, 1997, Can J Nurs Res, V29, P33; LUBIN B, 1965, ARCH GEN PSYCHIAT, V12, P57; PIJNENBORG L, 1994, BMJ-BRIT MED J, V309, P1209, DOI 10.1136/bmj.309.6963.1209; SANDERMAN R, 1995, EYSENCK PERSONALITY; STROEBE MS, 1989, OMEGA-J DEATH DYING, V20, P1, DOI 10.2190/C3JE-C9L1-5R91-DWDU; STROEBE W, 2001, HDB BEREAVEMENT RES, P613; Swarte NB, 2001, BEST PRACT RES CL OB, V15, P313, DOI 10.1053/beog.2000.0171; Swarte NB, 1999, ANN MED, V31, P364, DOI 10.3109/07853899908998793; SWARTE NB, 2000, BAILLIERE CLIN OB GY, V15, P313; Valdimarsdottir U, 2002, BRIT J CANCER, V86, P1540, DOI 10.1038/sj.bjc.6600271; van der Maas PJ, 1996, NEW ENGL J MED, V335, P1699, DOI 10.1056/NEJM199611283352227; vandenBoom F, 1995, AIDS CARE, V7, pS175; VANDERWAL G, 1994, BRIT MED J, V308, P1346, DOI 10.1136/bmj.308.6940.1346; WEGNER M, 1993, MEASUREMENT PERCEIVE	25	64	64	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 26	2003	327	7408					189	192		10.1136/bmj.327.7408.189	http://dx.doi.org/10.1136/bmj.327.7408.189			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	706DL	12881258	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000184437300014
J	Katoh, H; Negishi, M				Katoh, H; Negishi, M			RhoG activates Rac1 by direct interaction with the Dock180-binding protein Elmo	NATURE			English	Article								The small GTPase Rac has a central role in regulating the actin cytoskeleton during cell migration and axon guidance(1). Elmo has been identified as an upstream regulator of Rac1 that binds to and functionally cooperates with Dock180 (refs 2-4). Dock180 does not contain a conventional catalytic domain for guanine nucleotide exchange on Rac, but possesses a domain that directly binds to and specifically activates Rac1 (refs 5, 6). The small GTPase RhoG mediates several cellular morphological processes, such as neurite outgrowth in neuronal cells, through a signalling cascade that activates Rac1 (refs 7-12); however, the downstream target of RhoG and the mechanism by which RhoG regulates Rac1 activity remain unclear. Here we show that RhoG interacts directly with Elmo in a GTP-dependent manner and forms a ternary complex with Dock180 to induce activation of Rac1. The RhoG-Elmo-Dock180 pathway is required for activation of Rac1 and cell spreading mediated by integrin, as well as for neurite outgrowth induced by nerve growth factor. We conclude that RhoG activates Rac1 through Elmo and Dock180 to control cell morphology.	Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Katoh, H (corresponding author), Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068502, Japan.	hirokato@pharm.kyoto-u.ac.jp		Katoh, Hironori/0000-0002-8191-8117				Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Blangy A, 2000, J CELL SCI, V113, P729; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gauthier-Rouviere C, 1998, MOL BIOL CELL, V9, P1379, DOI 10.1091/mbc.9.6.1379; Gu JG, 2001, J BIOL CHEM, V276, P27090, DOI 10.1074/jbc.M102284200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Katoh H, 2000, MOL CELL BIOL, V20, P7378, DOI 10.1128/MCB.20.19.7378-7387.2000; Katoh H, 2002, MOL CELL BIOL, V22, P2952, DOI 10.1128/MCB.22.9.2952-2964.2002; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; May V, 2002, J NEUROSCI, V22, P6980; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Vigorito E, 2003, ONCOGENE, V22, P330, DOI 10.1038/sj.onc.1206116; Wu YC, 2002, DEV BIOL, V250, P145, DOI 10.1006/dbio.2002.0785; Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9; Zhou WS, 2001, J VIS COMMUN IMAGE R, V12, P1, DOI 10.1006/jvci.2000.0459	25	272	276	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2003	424	6947					461	464		10.1038/nature01817	http://dx.doi.org/10.1038/nature01817			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879077				2022-12-28	WOS:000184318400051
J	Prentice, RL				Prentice, RL			Dietary assessment and the reliability of nutritional epidemiology reports	LANCET			English	Editorial Material							FOOD FREQUENCY QUESTIONNAIRE; BREAST-CANCER; FAT; INDIVIDUALS; CAUSATION; VALIDITY; NITROGEN		Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Prentice, RL (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA.							[Anonymous], 1996, CA Cancer J Clin, V46, P325; BINGHAM SA, 1985, AM J CLIN NUTR, V42, P1276, DOI 10.1093/ajcn/42.6.1276; Day NE, 2001, INT J EPIDEMIOL, V30, P309, DOI 10.1093/ije/30.2.309; Greenwald P, 1999, CANCER EPIDEM BIOMAR, V8, P3; HEBERT JR, 1995, INT J EPIDEMIOL, V24, P389, DOI 10.1093/ije/24.2.389; HEITMANN BL, 1995, BRIT MED J, V311, P986; Hunter DJ, 1999, CANCER EPIDEM BIOMAR, V8, P9; Prentice RL, 2000, BREAST CANCER RES, V2, P268, DOI 10.1186/bcr68; Schoeller DA, 1999, J NUTR, V129, P1765, DOI 10.1093/jn/129.10.1765; *US DEP HHS, 1999, HLTH PEOPL 2010 OBJ; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086	11	76	79	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 19	2003	362	9379					182	183		10.1016/S0140-6736(03)13950-5	http://dx.doi.org/10.1016/S0140-6736(03)13950-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702PJ	12885475				2022-12-28	WOS:000184232000004
J	Kearon, C; Ginsberg, JS; Kovacs, MJ; Anderson, DR; Wells, P; Julian, JA; MacKinnon, B; Weitz, JI; Crowther, MA; Dolan, S; Turpie, AG; Geerts, W; Solymoss, S; van Nguyen, P; Demers, C; Kahn, SR; Kassis, J; Rodger, M; Hambleton, J; Gent, M				Kearon, C; Ginsberg, JS; Kovacs, MJ; Anderson, DR; Wells, P; Julian, JA; MacKinnon, B; Weitz, JI; Crowther, MA; Dolan, S; Turpie, AG; Geerts, W; Solymoss, S; van Nguyen, P; Demers, C; Kahn, SR; Kassis, J; Rodger, M; Hambleton, J; Gent, M		Extended Low-Intens Anticoagulat Thr	Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROTHROMBIN GENE; EPISODE; RISK	BACKGROUND Warfarin is very effective in preventing recurrent venous thromboembolism but is also associated with a substantial risk of bleeding. After three months of conventional warfarin therapy, a lower dose of anticoagulant medication may result in less bleeding and still prevent recurrent venous thromboembolism. METHODS We conducted a randomized, double-blind study, in which 738 patients who had completed three or more months of warfarin therapy for unprovoked venous thromboembolism were randomly assigned to continue warfarin therapy with a target international normalized ratio (INR) of 2.0 to 3.0 (conventional intensity) or a target INR of 1.5 to 1.9 (low intensity). Patients were followed for an average of 2.4 years. RESULTS Of 369 patients assigned to low-intensity therapy, 16 had recurrent venous thromboembolism (1.9 per 100 person-years), as compared with 6 of 369 assigned to conventional-intensity therapy (0.7 per 100 person-years; hazard ratio, 2.8; 95 percent confidence interval, 1.1 to 7.0). A major bleeding episode occurred in nine patients assigned to low-intensity therapy (1.1 events per 100 person-years) and eight patients assigned to conventional-intensity therapy (0.9 event per 100 person-years; hazard ratio, 1.2; 95 percent confidence interval, 0.4 to 3.0). There was no significant difference in the frequency of overall bleeding between the two groups (hazard ratio, 1.3; 95 percent confidence interval, 0.8 to 2.1). CONCLUSIONS Conventional-intensity warfarin therapy is more effective than low-intensity warfarin therapy for the long-term prevention of recurrent venous thromboembolism. The low-intensity warfarin regimen does not reduce the risk of clinically important bleeding.	McMaster Univ, Hamilton, ON, Canada; Henderson Res Ctr, Hamilton, ON, Canada; Univ Western Ontario, London, ON, Canada; Dalhousie Univ, Halifax, NS, Canada; Univ Ottawa, Ottawa, ON, Canada; Univ New Brunswick, St John, NB E2L 4L5, Canada; Univ Toronto, Toronto, ON, Canada; McGill Univ, Montreal, PQ, Canada; Univ Montreal, Montreal, PQ, Canada; Univ Laval, Quebec City, PQ, Canada; Univ Calif San Francisco, San Francisco, CA 94143 USA	McMaster University; Western University (University of Western Ontario); Dalhousie University; University of Ottawa; University of New Brunswick; University of Toronto; McGill University; Universite de Montreal; Laval University; University of California System; University of California San Francisco	Kearon, C (corresponding author), McMaster Univ, Hamilton, ON, Canada.		ginsberg, jeffrey s/ABC-1065-2020; Kovacs, Michael/G-3315-2011; Weitz, Jeffrey/AAD-1929-2019	Weitz, Jeffrey/0000-0002-1092-7550; Anderson, David/0000-0003-0845-1722; Crowther, Mark/0000-0003-4986-4873; Rodger, Marc/0000-0001-8166-3487				BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Beyth RJ, 1998, AM J MED, V105, P91, DOI 10.1016/S0002-9343(98)00198-3; Hirsh J, 2001, CHEST, V119, p8S, DOI 10.1378/chest.119.1_suppl.8S; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kearon C, 1999, NEW ENGL J MED, V341, P298; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; KEARON C, 2003, CIRCULATION S1, V107, P2; Lindmarker P, 1999, THROMB HAEMOSTASIS, V81, P684; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; Schulman S, 1997, NEW ENGL J MED, V336, P393, DOI 10.1056/NEJM199702063360601	12	598	621	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2003	349	7					631	639		10.1056/NEJMoa035422	http://dx.doi.org/10.1056/NEJMoa035422			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711FL	12917299	Bronze			2022-12-28	WOS:000184728900003
J	Strang, J; Sheridan, S				Strang, J; Sheridan, S			Effect of national guidelines on prescription of methadone: analysis of NHS prescription data, England 1990-2001	BRITISH MEDICAL JOURNAL			English	Article							DEPENDENCE		Maudsley Inst Psychiat, Natl Addict Ctr, London SE5 8AF, England	University of London; King's College London	Strang, J (corresponding author), Maudsley Inst Psychiat, Natl Addict Ctr, London SE5 8AF, England.		Strang, John/H-5460-2011	Strang, John/0000-0002-5413-2725; Sheridan, Janie/0000-0002-0312-3095				Gabbay MB, 2000, BRIT J GEN PRACT, V50, P92; Keen J, 1999, BMJ-BRIT MED J, V318, P1503, DOI 10.1136/bmj.318.7197.1503; Strang J, 1996, BMJ-BRIT MED J, V313, P270, DOI 10.1136/bmj.313.7052.270; Strang J, 1998, BRIT MED J, V317, P1489, DOI 10.1136/bmj.317.7171.1489; Ward J, 1999, LANCET, V353, P221, DOI 10.1016/S0140-6736(98)05356-2	5	14	14	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 9	2003	327	7410					321	322		10.1136/bmj.327.7410.321	http://dx.doi.org/10.1136/bmj.327.7410.321			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	710JE	12907486	Bronze, Green Published			2022-12-28	WOS:000184676400018
J	Goff, SP				Goff, SP			Death by deamination: A novel host restriction system for HIV-1	CELL			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; RNA EDITING ENZYME; VIRAL VIF PROTEIN; DNA; AID; HYPERMUTATION; EXPRESSION; INFECTION; APOBEC3G	A human gene with potent antiretroviral activity has recently been found to encode a new member of the family of cytidine deaminases, previously known to be involved in mRNA editing, immunoglobulin gene class switching, and immunoglobulin gene hypermutation. The enzyme attacks viral DNA as it is synthesized in infected cells and prevents the formation of functional proviruses. The Vif gene of HIV-1 blocks this host restriction and so allows virus replication.	Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Goff, SP (corresponding author), Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, 701 W 168th St, New York, NY 10032 USA.		Goff, Stephen P/K-6337-2014	Goff, Stephen P/0000-0003-0693-5547				Fouchier RAM, 1996, J VIROL, V70, P8263, DOI 10.1128/JVI.70.12.8263-8269.1996; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Hatziioannou T, 2003, EMBO J, V22, P385, DOI 10.1093/emboj/cdg042; Klarmann GJ, 2003, J BIOL CHEM, V278, P7902, DOI 10.1074/jbc.M207223200; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Madani N, 1998, J VIROL, V72, P10251, DOI 10.1128/JVI.72.12.10251-10255.1998; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon JHM, 1998, NAT MED, V4, P1397, DOI 10.1038/3987; Simon JHM, 1998, EMBO J, V17, P1259, DOI 10.1093/emboj/17.5.1259; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	20	56	66	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 8	2003	114	3					281	283		10.1016/S0092-8674(03)00602-0	http://dx.doi.org/10.1016/S0092-8674(03)00602-0			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	710KK	12914693	Bronze			2022-12-28	WOS:000184679200005
J	Kohiyama, M; Hiraga, S; Matic, I; Radman, M				Kohiyama, M; Hiraga, S; Matic, I; Radman, M			Bacterial sex: Playing voyeurs 50 years later	SCIENCE			English	Article							REPLICATION; CHROMOSOME; COLI	The concept of chromosomes with a ring structure was born during the early studies of bacterial sexuality, and the discovery of fertility factors - episomes or plasmids - provided much later the key tools for gene cloning and biotechnology. But the plasmid- mediated transfer of antibiotic and other resistances, as well as pathogenicity, has served bacteria well in their own adaptive evolution.	Univ Paris 05, Fac Necker Enfants Malad, INSERM, U571, F-75730 Paris 15, France; Univ Paris 06, Inst Jacques Monod, F-75251 Paris, France; Univ Paris 07, Inst Jacques Monod, F-75251 Paris 05, France; Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Kyoto 6068501, Japan	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Kyoto University	Matic, I (corresponding author), Univ Paris 05, Fac Necker Enfants Malad, INSERM, U571, 156 Rue Vaugirard, F-75730 Paris 15, France.		, KohiyamaM123456K/U-6104-2019; Radman, Miroslav/HDM-5955-2022	Radman, Miroslav/0000-0003-0216-3148; Radman, Miroslav/0000-0002-7034-4365				CAIRNS J, 1963, J MOL BIOL, V6, P208, DOI 10.1016/S0022-2836(63)80070-4; CAVALLI LL, 1953, J GEN MICROBIOL, V8, P89, DOI 10.1099/00221287-8-1-89; Hacker J, 2003, SCIENCE, V301, P790, DOI 10.1126/science.1086802; HAYES W, 1953, J GEN MICROBIOL, V8, P72, DOI 10.1099/00221287-8-1-72; HAYES W, 1952, NATURE, V169, P118, DOI 10.1038/169118b0; Hiraga S, 1998, MOL CELL, V1, P381, DOI 10.1016/S1097-2765(00)80038-6; JACOB F, 1963, COLD SPRING HARB SYM, V28, P329, DOI 10.1101/SQB.1963.028.01.048; Jacob F., 1961, SEXUALITY GENETICS B; KOHIYAMA M, 1963, CR HEBD ACAD SCI, V257, P1979; LEDERBERG J, 1946, NATURE, V158, P558, DOI 10.1038/158558a0; Sherratt DJ, 2003, SCIENCE, V301, P780, DOI 10.1126/science.1084780	11	16	17	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2003	301	5634					802	803		10.1126/science.1085154	http://dx.doi.org/10.1126/science.1085154			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907791				2022-12-28	WOS:000184615700034
J	Harley, HE; Putman, EA; Roitblat, HL				Harley, HE; Putman, EA; Roitblat, HL			Bottlenose dolphins perceive object features through echolocation	NATURE			English	Article							TURSIOPS-TRUNCATUS; RECOGNITION; INFORMATION; INTEGRATION	How organisms (including people) recognize distant objects is a fundamental question(1). The correspondence between object characteristics (distal stimuli), like visual shape, and sensory characteristics (proximal stimuli), like retinal projection, is ambiguous. The view that sensory systems are 'designed' to 'pick up' ecologically useful information is vague about how such mechanisms might work(2). In echolocating dolphins, which are studied as models for object recognition sonar systems, the correspondence between echo characteristics and object characteristics is less clear(3). Many cognitive scientists assume that object characteristics are extracted from proximal stimuli, but evidence for this remains ambiguous. For example, a dolphin may store 'sound templates' in its brain and identify whole objects by listening for a particular sound. Alternatively, a dolphin's brain may contain algorithms, derived through natural endowments or experience or both, which allow it to identify object characteristics based on sounds. The standard method used to address this question in many species(4-7) is indirect and has led to equivocal results with dolphins(8-10). Here we outline an appropriate method and test it to show that dolphins extract object characteristics directly from echoes.	New Coll Florida, Div Social Sci, Sarasota, FL 34243 USA; Walt Disney World Resort, Anim Programs, Epcots Living Seas, Lake Buena Vista, FL 32830 USA; DolphinSearch Inc, Ventura, CA 93001 USA	State University System of Florida; New College Florida; Walt Disney Company	Harley, HE (corresponding author), New Coll Florida, Div Social Sci, 5700 N Tamiami Trail, Sarasota, FL 34243 USA.							Au W. W., 1993, SONAR DOLPHINS; AU WWL, 1980, ANIMAL SONAR SYSTEMS, P859; AU WWL, 1992, J COMP PHYSIOL A, V172, P41; DAVENPORT RK, 1976, ANN NY ACAD SCI, V280, P143, DOI 10.1111/j.1749-6632.1976.tb25482.x; EVANS WE, 1973, J ACOUST SOC AM, V54, P191, DOI 10.1121/1.1913562; GARBIN CP, 1988, J EXP PSYCHOL HUMAN, V14, P547, DOI 10.1037/0096-1523.14.4.547; Gibson J.J., 1986, ECOLOGICAL APPROACH; GOLDSTEIN EB, 2001, BLACKWELL HDB PERCEP; GUNDERSON VM, 1990, DEV PSYCHOL, V26, P576, DOI 10.1037/0012-1649.26.4.576; Harley HE, 1996, J EXP PSYCHOL ANIM B, V22, P164, DOI 10.1037/0097-7403.22.2.164; Herman LM, 1998, J COMP PSYCHOL, V112, P292, DOI 10.1037/0735-7036.112.3.292; Nachtigall PE., 1980, ANIMAL SONAR SYSTEMS, P945, DOI [10.1007/978-1-4684-7254-7_64, DOI 10.1007/978-1-4684-7254-7_64]; PACK AA, 1995, J ACOUST SOC AM, V98, P722, DOI 10.1121/1.413566; ROITBLAT HL, 1990, J EXP PSYCHOL ANIM B, V16, P85, DOI 10.1037/0097-7403.16.1.85; WEISKRANTZ L, 1975, NEUROPSYCHOLOGIA, V13, P257, DOI 10.1016/0028-3932(75)90001-9; Xitco MJ, 1996, ANIM LEARN BEHAV, V24, P355, DOI 10.3758/BF03199007	16	57	58	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					667	669		10.1038/nature01846	http://dx.doi.org/10.1038/nature01846			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	708QE	12904791				2022-12-28	WOS:000184578800043
J	Smith, CM; Venkataraman, N; Gallagher, MT; Muller, D; West, JA; Borrelli, NF; Allan, DC; Koch, KW				Smith, CM; Venkataraman, N; Gallagher, MT; Muller, D; West, JA; Borrelli, NF; Allan, DC; Koch, KW			Low-loss hollow-core silica/air photonic bandgap fibre	NATURE			English	Article							CRYSTALS	Photonic bandgap structures use the principle of interference to reflect radiation. Reflection from photonic bandgap structures has been demonstrated in one, two and three dimensions and various applications have been proposed(1-4). Early work in hollow-core photonic bandgap fibre technology(5) used a hexagonal structure surrounding the air core; this fibre was the first demonstration of light guided inside an air core of a photonic bandgap fibre. The potential benefits of guiding light in air derive from lower Rayleigh scattering, lower nonlinearity and lower transmission loss compared to conventional waveguides. In addition, these fibres offer a new platform for studying nonlinear optics in gases(6). Owing largely to challenges in fabrication, the early air-core fibres were only available in short lengths, and so systematic studies of loss were not possible. More recently, longer lengths of fibre have become available(7,8) with reported losses of 1,000 dB km(-1). We report here the fabrication and characterization of long lengths of low attenuation photonic bandgap fibre. Attenuation of less than 30 dB km(-1) over a wide transmission window is observed with minimum loss of 13 dB km(-1) at 1,500 nm, measured on 100 m of fibre. Coupling between surface and core modes of the structure is identified as an important contributor to transmission loss in hollow-core photonic bandgap fibres.	Corning Inc, Corning, NY 14831 USA	Corning Inc; State University of New York (SUNY) System; SUNY Community College	Koch, KW (corresponding author), Corning Inc, Sullivan Pk, Corning, NY 14831 USA.	kochkw@corning.com						Allan DC, 2001, NATO SCI SER II-MATH, V563, P305; Benabid F, 2002, SCIENCE, V298, P399, DOI 10.1126/science.1076408; Cregan RF, 1999, SCIENCE, V285, P1537, DOI 10.1126/science.285.5433.1537; Joannopoulos J. D., 1995, PHOTONIC CRYSTALS MO; Joannopoulos JD, 1997, SOLID STATE COMMUN, V102, P165, DOI 10.1016/S0038-1098(96)00716-8; Johnson SG, 2001, OPT EXPRESS, V8, P173, DOI 10.1364/OE.8.000173; Krauss TF, 1999, PROG QUANT ELECTRON, V23, P51, DOI 10.1016/S0079-6727(99)00004-X; Krauss TF, 2002, IEEE J QUANTUM ELECT, V38, P724, DOI 10.1109/JQE.2002.1017581; SKOUKOULIS CM, 2001, PHOTONIC CRYSTALS LI; WEST JA, 2001, ECOC 2001 EUR C OPT	10	382	404	2	153	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					657	659		10.1038/nature01849	http://dx.doi.org/10.1038/nature01849			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904788				2022-12-28	WOS:000184578800040
J	Bleich, A; Gelkopf, M; Solomon, Z				Bleich, A; Gelkopf, M; Solomon, Z			Exposure to terrorism, stress-related mental health symptoms, and coping behaviors among a nationally representative sample in Israel	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PSYCHOLOGICAL REACTIONS; SEPTEMBER 11; DISORDER; ATTACKS; WAR; RESPONSES; CHILDREN; TRAUMA; EVENTS	Context The terrorist attacks on Israeli society have been ongoing since September 2000. However, few studies have examined the impact of terrorism on nationally representative population samples, and no study has examined the psychological impact of ongoing terrorism in Israel. Objectives To determine the level of exposure to terrorist attacks and the prevalence of traumatic stress-related (TSR) symptoms, symptoms of posttraumatic stress disorder (PTSD), and sense of safety after 19 months of terrorism in Israel, and to identify correlates of the psychological sequelae and the modes of coping with the terrorism. Design, Setting, and Participants Telephone survey conducted April-May 2002, using a strata sampling method, of 902 eligible households and a representative sample of 742 Israeli residents older than 18 years (82% contact rate) and a final participation of 512 (57%). Main Outcome Measures Number of TSR symptoms, rates of those with symptom criteria for PTSD and acute stress disorder assessed by the Stanford Acute Stress Reaction Questionnaire, self-reported feelings of depression, optimism, sense of safety, help-seeking, and modes of coping. Results Of 512 survey participants, 84 (16.4%) had been directly exposed to a terrorist attack and 191 (37.3%) had a family member or friend who had been exposed. Of 510 participants who responded to questions about TSR symptoms, 391 (76.7%) had at least 1 TSR symptom (mean, 4.0 [SD, 4.5]; range, 0-23; mean intensity, 0.8; range, 0-4). Symptom criteria for PTSD were met by 48 participants (9.4%) and criteria for acute stress disorder, by 1 participant; 299 (58.6%) reported feeling depressed. The majority of respondents expressed optimism about their personal future (421/512 [82.2%]) and the future of Israel (307/509 [66.8%]), and expressed self-efficacy with regard to their ability to function in a terrorist attack (322/431 [74.6%]). Most expressed a low sense of safety with respect to themselves (307/509 [60.4%]) and their relatives (345/507 [67.9%]). Few reported a need for professional help (27/506 [5.3%]). Female sex, sense of safety, and use of tranquilizers, alcohol, and cigarettes to cope were associated with TSR symptoms and symptom criteria for PTSD; level of exposure and objective risk were not. The most prevalent coping mechanisms were active information search about loved ones and social support. Conclusions Considering the nature and length of the Israeli traumatic experience, the psychological impact may be considered moderate. Although the survey participants showed distress and lowered sense of safety, they did not develop high levels of psychiatric distress, which may be related to a habituation process and to coping mechanisms.	Tel Aviv Univ, Sackler Sch Med, Lev Hasharon Mental Hlth Ctr, IL-69978 Tel Aviv, Israel; Tel Aviv Sackler Sch Med, Dept Psychiat, Tel Aviv, Israel; Tel Aviv Univ, Shappel Sch Social Work, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Adler Res Ctr, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv University	Gelkopf, M (corresponding author), Lev Hasharon Mental Hlth Ctr, POB 90000, IL-42100 Netanya, Israel.							BLEICH A, 1992, JAMA-J AM MED ASSOC, V268, P613, DOI 10.1001/jama.268.5.613; Cardena E, 2000, J TRAUMA STRESS, V13, P719, DOI 10.1023/A:1007822603186; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; Dyregrov A, 2000, J TRAUMA STRESS, V13, P3, DOI 10.1023/A:1007759112499; Fullerton CS, 2001, AM J PSYCHIAT, V158, P1486, DOI 10.1176/appi.ajp.158.9.1486; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Lazarus RS., 1984, STRESS APPRAISAL COP; Rachman Stanley, 1990, FEAR AND COURAGE; Rosner R, 2003, J CLIN PSYCHOL, V59, P41, DOI 10.1002/jclp.10116; Saigh P.A., 1997, ANN M INT SOC TRAUM; Schlenger WE, 2002, JAMA-J AM MED ASSOC, V288, P581, DOI 10.1001/jama.288.5.581; Schuster MA, 2001, NEW ENGL J MED, V345, P1507, DOI 10.1056/NEJM200111153452024; Silver RC, 2002, JAMA-J AM MED ASSOC, V288, P1235, DOI 10.1001/jama.288.10.1235; SOLOMON SD, 1996, INDIVIDUAL COMMUNITY, P179; SOLOMON Z, 1995, PSYCHOL MED, V25, P1289, DOI 10.1017/S0033291700033250; SOLOMON Z, 1988, J ABNORM PSYCHOL, V97, P302, DOI 10.1037/0021-843X.97.3.302; Solomon Z., 1995, COPING WAR INDUCED S; Thabet AAM, 2002, LANCET, V359, P1801, DOI 10.1016/S0140-6736(02)08709-3	20	412	417	0	51	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2003	290	5					612	620		10.1001/jama.290.5.612	http://dx.doi.org/10.1001/jama.290.5.612			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	708GH	12902364	Bronze			2022-12-28	WOS:000184558500015
J	Rahmathullah, L; Tielsch, JM; Thulasiraj, RD; Katz, J; Coles, C; Devi, S; John, R; Prakash, K; Sadanand, AV; Edwin, N; Kamaraj, C				Rahmathullah, L; Tielsch, JM; Thulasiraj, RD; Katz, J; Coles, C; Devi, S; John, R; Prakash, K; Sadanand, AV; Edwin, N; Kamaraj, C			Impact of supplementing newborn infants with vitamin A on early infant mortality: community based randomised trial in southern India	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BETA-CAROTENE SUPPLEMENTATION; CHILDHOOD MORTALITY; CHILDREN; PROTEIN; MOTHERS; AGE	Objective To assess the impact of supplementing newborn infants with vitamin A on mortality at age 6 months. Design Community based, randomised, double blind, placebo controlled trial. Setting Two rural districts of Tamil Nadu, southern India. Participants 11619 newborn infants allocated 24 000 IU oral vitamin A or placebo on days 1 and 2 after delivery. Main outcome measure Primary outcome measure was mortality at age 6 months. Results Infants in the vitamin A group had a 22% reduction in total mortality (95% confidence interval 4% to 37%) compared with those in the placebo group. Vitamin A had an impact on mortality between two weeks and three months after treatment, with no additional impact after three months. Conclusion Supplementing newborn infants with vitamin A can significantly reduce early infant mortality.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; Aravind Ctr Women Children & Community Hlth, Madurai, Tamil Nadu, India; Lions Aravind Inst Community Ophthalmol, Madurai, Tamil Nadu, India; Madurai Med Coll, Dept Pediat, Madurai, Tamil Nadu, India	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Madurai Medical College	Tielsch, JM (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	jtielsch@jhsph.edu	KAMARAJ, CHINNAPERUMAL/D-6771-2012	KAMARAJ, CHINNAPERUMAL/0000-0003-0639-8518; Tielsch, James/0000-0002-1151-060X; KAMARAJ, CHINNAPERUMAL/0000-0001-9955-9397; Katz, Joanne/0000-0002-5997-7823				BEATON GH, 1993, 13 ADM COMM COORD SU; CANTORNA MT, 1994, J IMMUNOL, V152, P1515; DAULAIRE NMP, 1992, BMJ-BRIT MED J, V304, P207, DOI 10.1136/bmj.304.6821.207; DE LUCA LM, 1991, FASEB J, V5, P2924; Humphrey JH, 1996, J PEDIATR-US, V128, P489, DOI 10.1016/S0022-3476(96)70359-1; Katz J, 2000, AM J CLIN NUTR, V71, P1570; MUHILAL, 1988, AM J CLIN NUTR, V48, P1271, DOI 10.1093/ajcn/48.5.1271; OLSON JA, 1979, ARCH LATINOAM NUTR, V29, P521; OLSON JA, 1984, AM J CLIN NUTR, V39, P903, DOI 10.1093/ajcn/39.6.903; PASATIEMPO AMG, 1990, FASEB J, V4, P2518, DOI 10.1096/fasebj.4.8.2110538; RAHMATHULLAH L, 1990, NEW ENGL J MED, V323, P929, DOI 10.1056/NEJM199010043231401; Rice AL, 1999, J NUTR, V129, P356, DOI 10.1093/jn/129.2.356; Ross CA, 1996, VITAMIN A DEFICIENCY, P251; ROSS DA, 1993, LANCET, V342, P7, DOI 10.1016/0140-6736(93)91879-Q; SEMBA RD, 1993, LANCET, V341, P5, DOI 10.1016/0140-6736(93)92478-C; SHENAI JP, 1981, J PEDIATR-US, V99, P302, DOI 10.1016/S0022-3476(81)80484-2; SHENAI JP, 1987, J PEDIATR-US, V111, P269, DOI 10.1016/S0022-3476(87)80086-0; SOMMER A, 1986, LANCET, V1, P1169; Sommer A., 1996, VITAMIN A DEFICIENCY, P19; STOLTZFUS RJ, 1993, J NUTR, V123, P666, DOI 10.1093/jn/123.4.666; Wallingford JC, 1986, VITAMIN A DEFICIENCY, P101; WEST KP, 1991, LANCET, V338, P67, DOI 10.1016/0140-6736(91)90070-6; WEST KP, 1995, AM J CLIN NUTR, V62, P143, DOI 10.1093/ajcn/62.1.143; *WHO CHD IMM LINK, 1998, LANCET, V353, P1257	24	161	163	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 2	2003	327	7409					254	257		10.1136/bmj.327.7409.254	http://dx.doi.org/10.1136/bmj.327.7409.254			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708KP	12896935	Bronze, Green Published			2022-12-28	WOS:000184566300016
J	George, DJ; Kaelin, WG				George, DJ; Kaelin, WG			The von Hippel-Lindau protein, vascular endothelial growth factor, and kidney cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute	George, DJ (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.							COMINGS DE, 1973, P NATL ACAD SCI USA, V70, P3324, DOI 10.1073/pnas.70.12.3324; KNUDSON AG, 1973, PROG MED GENET, V9, P113; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189	3	114	121	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2003	349	5					419	421		10.1056/NEJMp030061	http://dx.doi.org/10.1056/NEJMp030061			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706FV	12890838				2022-12-28	WOS:000184443700001
J	Vocadlo, L; Alfe, D; Gillan, MJ; Wood, IG; Brodholt, JP; Price, GD				Vocadlo, L; Alfe, D; Gillan, MJ; Wood, IG; Brodholt, JP; Price, GD			Possible thermal and chemical stabilization of body-centred-cubic iron in the Earth's core	NATURE			English	Article							AB-INITIO CALCULATIONS; INNER-CORE; HIGH-PRESSURE; ENERGY CALCULATIONS; PHASE; CONSTRAINTS; BCC; TEMPERATURE; TRANSITION	The nature of the stable phase of iron in the Earth's solid inner core is still highly controversial. Laboratory experiments 1 suggest the possibility of an uncharacterized phase transformation in iron at core conditions and seismological observations(2-4) have indicated the possible presence of complex, inner-core layering. Theoretical studies(5,6) currently suggest that the hexagonal close packed (h. c. p.) phase of iron is stable at core pressures and that the body centred cubic (b. c. c.) phase of iron becomes elastically unstable at high pressure. In other h. c. p. metals, however, a high-pressure b. c. c. form has been found to become stabilized at high temperature. We report here a quantum mechanical study of b.c.c.-iron able to model its behaviour at core temperatures as well as pressures, using ab initio molecular dynamics free-energy calculations. We find that b.c.c.-iron indeed becomes entropically stabilized at core temperatures, but in its pure state h.c.p.-iron still remains thermodynamically more favourable. The inner core, however, is not pure iron, and our calculations indicate that the b. c. c. phase will be stabilized with respect to the h. c. p. phase by sulphur or silicon impurities in the core. Consequently, a b.c.c.-structured alloy may be a strong candidate for explaining the observed seismic complexity of the inner core(2-4).	Univ London Birkbeck Coll, Res Sch Earth Sci, London WC1E 7HX, England; UCL, Dept Phys & Astron, London WC1E 6BT, England	University of London; Birkbeck University London; University of London; University College London	Vocadlo, L (corresponding author), Univ London Birkbeck Coll, Res Sch Earth Sci, London WC1E 7HX, England.	l.vocadlo@ucl.ac.uk	Vocadlo, Lidunka/C-4197-2008; Alfe`, Dario/C-1521-2008; Price, Geoffrey D/C-1545-2008; Brodholt, John P/B-7136-2011; Gillan, Michael J/C-2130-2008	Alfe`, Dario/0000-0002-9741-8678; Price, Geoffrey D/0000-0001-8232-6853; Brodholt, John P/0000-0001-7395-5834; Vocadlo, Lidunka/0000-0002-2577-0277	Natural Environment Research Council [NER/O/S/2001/01227] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Alfe D, 2000, PHYS REV B, V61, P132, DOI 10.1103/PhysRevB.61.132; Alfe D, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.165118; Alfe D, 2002, J CHEM PHYS, V116, P7127, DOI 10.1063/1.1464121; Alfe D, 2002, EARTH PLANET SC LETT, V195, P91, DOI 10.1016/S0012-821X(01)00568-4; Alfe D, 1999, NATURE, V401, P462, DOI 10.1038/46758; Alfe D, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.045123; Alfe D, 2000, NATURE, V405, P172, DOI 10.1038/35012056; Beghein C, 2003, SCIENCE, V299, P552, DOI 10.1126/science.1078159; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Brown JM, 2001, GEOPHYS RES LETT, V28, P4339, DOI 10.1029/2001GL013759; Dobson DP, 2002, AM MINERAL, V87, P784; Grad GB, 2000, PHYS REV B, V62, P12743, DOI 10.1103/PhysRevB.62.12743; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Ishii M, 2002, P NATL ACAD SCI USA, V99, P14026, DOI 10.1073/pnas.172508499; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Lin JF, 2002, SCIENCE, V295, P313, DOI 10.1126/science.1066932; Mao HK, 2001, SCIENCE, V292, P914, DOI 10.1126/science.1057670; Matsui M, 1997, PHYS EARTH PLANET IN, V103, P55, DOI 10.1016/S0031-9201(97)00020-4; MORIARTY JA, 1994, HIGH-PRESSURE SCIENCE AND TECHNOLOGY - 1993, PTS 1 AND 2, P233; PETRY W, 1995, J PHYS IV, V5, P15, DOI 10.1051/jp4:1995202; ROSS M, 1990, J GEOPHYS RES-SOLID, V95, P21713, DOI 10.1029/JB095iB13p21713; Shen GY, 1998, GEOPHYS RES LETT, V25, P373, DOI 10.1029/97GL03776; Soderlind P, 1996, PHYS REV B, V53, P14063, DOI 10.1103/PhysRevB.53.14063; Song XD, 1998, SCIENCE, V282, P924, DOI 10.1126/science.282.5390.924; Steinle-Neumann G, 2001, NATURE, V413, P57, DOI 10.1038/35092536; STIXRUDE L, 1995, GEOPHYS RES LETT, V22, P125, DOI 10.1029/94GL02742; TRAMPENAU J, 1991, PHYS REV B, V43, P10963, DOI 10.1103/PhysRevB.43.10963; Vocadlo L, 2000, PHYS EARTH PLANET IN, V117, P123, DOI 10.1016/S0031-9201(99)00092-8; Vocadlo L, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.214105; WANG Y, 1991, PHYS REV B, V44, P13298, DOI 10.1103/PhysRevB.44.13298	30	198	205	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 31	2003	424	6948					536	539		10.1038/nature01829	http://dx.doi.org/10.1038/nature01829			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891353				2022-12-28	WOS:000184454700038
J	Glantz, SA				Glantz, SA			Smoking in movies: a major problem and a real solution	LANCET			English	Editorial Material							TOBACCO; ADOLESCENTS		Univ Calif San Francisco, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Glantz, SA (corresponding author), Univ Calif San Francisco, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA.	glantz@medicine.ucsf.edu			NCI NIH HHS [CA-61021] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA061021] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*BRFSS COORD, 1996, MMWR-MORBID MORTAL W, V45, P971; Distefan JM, 1999, PREV MED, V28, P1, DOI 10.1006/pmed.1998.0409; Fichtenberg CM, 2002, PEDIATRICS, V109, P1088, DOI 10.1542/peds.109.6.1088; GLANTZ S, IN PRESS AM J PUBLIC; GLANTZ S, 2003, SMOKE FREE MOVIES SO; Glantz Stanton A, 2002, Eff Clin Pract, V5, P31; Kacirk K, 2001, TOB CONTROL, V10, P397; Ling PM, 2002, TOB CONTROL, V11, P3, DOI 10.1136/tc.11.1.3; Mekemson C, 2002, TOB CONTROL, V11, pI81, DOI 10.1136/tc.11.suppl_1.i81; Pechmann C, 1999, J MARKETING, V63, P1, DOI 10.2307/1251772; Pierce JP, 2002, AM J PREV MED, V23, P73, DOI 10.1016/S0749-3797(02)00459-2; Pierce JP, 1998, JAMA-J AM MED ASSOC, V279, P511, DOI 10.1001/jama.279.7.511; Sargent JD, 2002, AM J PREV MED, V22, P137, DOI 10.1016/S0749-3797(01)00434-2	13	28	29	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2003	362	9380					258	259		10.1016/S0140-6736(03)14001-9	http://dx.doi.org/10.1016/S0140-6736(03)14001-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	705UL	12892950				2022-12-28	WOS:000184413400002
J	Fukami, T; Morin, PJ				Fukami, T; Morin, PJ			Productivity-biodiversity relationships depend on the history of community assembly	NATURE			English	Article							SPECIES-DIVERSITY; GRADIENTS; RICHNESS; PATTERNS	Identification of the causes of productivity-species diversity relationships remains a central topic of ecological research(1,2). Different relations have been attributed to the influence of disturbance(3,4), consumers(5,6), niche specialization 7 and spatial scale(8-14). One unexplored cause is the history of community assembly, the partly stochastic sequential arrival of species from a regional pool of potential community members. The sequence of species arrival can greatly affect community structure(15-19). If assembly sequence interacts with productivity to influence diversity, different sequences can contribute to variation in productivity-diversity relationships. Here we report a test of this hypothesis by assembling aquatic microbial communities at five productivity levels using four assembly sequences. About 30 generations after assembly, productivity-diversity relationships took various forms, including a positive, a hump-shaped, a U-shaped and a non-significant pattern, depending on assembly sequence. This variation resulted from idiosyncratic joint effects of assembly sequence, productivity and species identity on species abundances. We suggest that the history of community assembly should be added to the growing list of factors that influence productivity-biodiversity patterns.	Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA	University of Tennessee System; University of Tennessee Knoxville; Rutgers State University New Brunswick	Fukami, T (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	tfukami@utk.edu	Fukami, Tadashi/A-2934-2010	Fukami, Tadashi/0000-0001-5654-4785				ABRAMS PA, 1995, ECOLOGY, V76, P2019, DOI 10.2307/1941677; Chase JM, 1999, AM NAT, V154, P559, DOI 10.1086/303260; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; CONNELL JH, 1964, AM NAT, V98, P399, DOI 10.1086/282335; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; DRAKE JA, 1991, AM NAT, V137, P1, DOI 10.1086/285143; GILPIN ME, 1976, NATURE, V261, P40, DOI 10.1038/261040a0; Gross KL, 2000, OIKOS, V89, P417, DOI 10.1034/j.1600-0706.2000.890301.x; Holt RD, 1997, AM NAT, V149, P745, DOI 10.1086/286018; Huston M. A., 1994, BIOL DIVERSITY; Kassen R, 2000, NATURE, V406, P508, DOI 10.1038/35020060; Kondoh M, 2001, P ROY SOC B-BIOL SCI, V268, P269, DOI 10.1098/rspb.2000.1384; Leibold MA, 1997, ANNU REV ECOL SYST, V28, P467, DOI 10.1146/annurev.ecolsys.28.1.467; LEIGH EG, 1965, P NATL ACAD SCI USA, V53, P777, DOI 10.1073/pnas.53.4.777; MITCHELLOLDS T, 1987, EVOLUTION, V41, P1149, DOI [10.2307/2409084, 10.1111/j.1558-5646.1987.tb02457.x]; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Morin PJ, 2000, NATURE, V406, P463, DOI 10.1038/35020160; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; ROSENZWEIG ML, 1992, J MAMMAL, V73, P715, DOI 10.2307/1382191; Scheiner SM, 2000, EVOL ECOL RES, V2, P791; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Tilman David, 1993, P13; vandeKoppel J, 1996, ECOLOGY, V77, P736, DOI 10.2307/2265498; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; WILSON DS, 1992, ECOLOGY, V73, P1984, DOI 10.2307/1941449; Worm B, 2002, NATURE, V417, P848, DOI 10.1038/nature00830; Wright David H., 1993, P66	30	193	202	7	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2003	424	6947					423	426		10.1038/nature01785	http://dx.doi.org/10.1038/nature01785			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879069				2022-12-28	WOS:000184318400042
J	Keppler, H; Wiedenbeck, M; Shcheka, SS				Keppler, H; Wiedenbeck, M; Shcheka, SS			Carbon solubility in olivine and the mode of carbon storage in the Earth's mantle	NATURE			English	Article							CO2	The total amount of carbon in the atmosphere, oceans and other near-surface reservoirs is thought to be negligible compared to that stored in the Earth's mantle(1-3). Although the mode of carbon storage in the mantle is largely unknown, observations of microbubbles on dislocations in minerals from mantle xenoliths has led to the suggestion that carbon may be soluble in silicates at high pressure(4,5). Here we report measurements of carbon solubility in olivine, the major constituent of the upper mantle, at pressures up to 3.5 GPa. We have found that, contrary to previous expectations, carbon solubility in olivine is exceedingly low- of the order of 0.1 to 1 parts per million by weight. Together with similar data for pyroxenes, garnet and spinel, we interpret this to imply that most carbon must be present as a separate phase in the deeper parts of the upper mantle, probably as a carbonate phase(6,7). Large-scale volcanic eruptions tapping such a carbonate-bearing mantle reservoir might therefore rapidly transfer large amounts of carbon dioxide into the atmosphere, consistent with models that link global mass extinctions to flood basalt eruptions via a sudden increase in atmospheric carbon dioxide levels(8-11)	Univ Tubingen, Inst Geowissensch, D-72074 Tubingen, Germany; Geoforschungszentrum Potsdam, Projektbereich 4 2, D-14473 Potsdam, Germany	Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences	Keppler, H (corresponding author), Univ Tubingen, Inst Geowissensch, Wilhelmstr 56, D-72074 Tubingen, Germany.	Hans.Keppler@uni-tuebingen.de		Shcheka, Svyatoslav/0000-0003-0865-0828				Beerling D, 2002, NATURE, V415, P386, DOI 10.1038/415386a; BELL DR, 1992, SCIENCE, V255, P1391, DOI 10.1126/science.255.5050.1391; FREUND F, 1980, GEOCHIM COSMOCHIM AC, V44, P1319, DOI 10.1016/0016-7037(80)90092-7; GREEN HW, 1972, NATURE-PHYS SCI, V238, P2, DOI 10.1038/physci238002a0; GREEN HW, 1975, GEOL SOC AM BULL, V86, P846, DOI 10.1130/0016-7606(1975)86<846:FPIRFT>2.0.CO;2; HAURI E, 2002, EOS, V83, P383; HAURI EH, 1993, NATURE, V365, P221, DOI 10.1038/365221a0; JAMBON A, 1994, REV MINERAL, V30, P479; JAVOY M, 1982, NATURE, V300, P171, DOI 10.1038/300171a0; Kerrick DM, 2001, REV GEOPHYS, V39, P565, DOI 10.1029/2001RG000105; Kohlstedt DL, 1996, CONTRIB MINERAL PETR, V123, P345, DOI 10.1007/s004100050161; Marzoli A, 1999, SCIENCE, V284, P616, DOI 10.1126/science.284.5414.616; MATHEZ EA, 1987, J GEOPHYS RES-SOLID, V92, P3500, DOI 10.1029/JB092iB05p03500; McElwain JC, 1999, SCIENCE, V285, P1386, DOI 10.1126/science.285.5432.1386; NEWTON RC, 1975, EARTH PLANET SC LETT, V26, P239, DOI 10.1016/0012-821X(75)90091-6; Putnis A., 1992, INTRO MINERAL SCI; Saal AE, 2002, NATURE, V419, P451, DOI 10.1038/nature01073; TINGLE TN, 1988, J GEOPHYS RES-SOLID, V93, P15289, DOI 10.1029/JB093iB12p15289; TSONG IST, 1985, PHYS CHEM MINER, V12, P261, DOI 10.1007/BF00310338; WYLLIE PJ, 1976, CONTRIB MINERAL PETR, V54, P79, DOI 10.1007/BF00372117; ZHANG YX, 1993, EARTH PLANET SC LETT, V117, P331, DOI 10.1016/0012-821X(93)90088-Q	21	125	133	4	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2003	424	6947					414	416		10.1038/nature01828	http://dx.doi.org/10.1038/nature01828			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879066				2022-12-28	WOS:000184318400039
J	Shorter, E; Tyrer, P				Shorter, E; Tyrer, P			Separation of anxiety and depressive disorders: blind alley in psychopharmacology and classification of disease	BMJ-BRITISH MEDICAL JOURNAL			English	Article								ne current division between anxiety and depression is increasingly recognised as inadequate. In the community, most mood disorders present as a combination of depression and anxiety. Yet the Food and Drug Administration in the United States, which has become the world bellwether of drug approval, indicates drugs either for major depression or for the various forms of anxiety recognised by the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders (DSM). As a result, the pharmaceutical industry is compelled to develop drugs for diagnoses that are of questionable clinical relevance. This is one reason for the big slowdown in drug discovery in psychiatric drugs. A return to the former unitary classification of mood and anxiety disorders as nervousness or cothymia might represent a way out of this blind alley.	Univ London Imperial Coll Sci Technol & Med, Dept Psychol Med, Fac Med, London W2 1PD, England; Univ Toronto, Fac Med, Hist Med Program, Toronto, ON M5G 1VJ, Canada	Imperial College London; University of Toronto	Tyrer, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Psychol Med, Fac Med, St Marys Campus, London W2 1PD, England.	p.tyrer@imperial.ac.uk						American Psychiatric Association, DIAGN STAT MAN MENT; BASS A, 1999, BOSTON GLOBE    0410; BERO LA, 1992, NEW ENGL J MED, V327, P1135, DOI 10.1056/NEJM199210153271606; Blashfield RK, 1996, J NERV MENT DIS, V184, P4, DOI 10.1097/00005053-199601000-00002; Casey P, 2001, BRIT J PSYCHIAT, V179, P479, DOI 10.1192/bjp.179.6.479; Cauchon D., 2000, US TODAY        0925, pA1; DENBER HCB, 1988, RISE PSYCHOPHARMACOL, P371; *EUR AG EV MED PRO, CONC PAP DEV COMM PR; Healy D, 2000, HIST PSYCHIATR, V11, P393, DOI 10.1177/0957154X0001104405; HUDSON JI, 1990, AM J PSYCHIAT, V147, P552; Jenkins R, 1997, PSYCHOL MED, V27, P775, DOI 10.1017/S0033291797005308; Kendell R, 2003, AM J PSYCHIAT, V160, P4, DOI 10.1176/appi.ajp.160.1.4; Mendlewicz J, 2000, ACTA PSYCHIAT SCAND, V101, P5, DOI 10.1111/j.1600-0447.2000.tb10942.x; ROMACH M, 1995, AM J PSYCHIAT, V152, P1161; SCHOENBAUER R, 2002, STANDARD        0511; Shorter E, 2002, NAT REV DRUG DISCOV, V1, P1003, DOI 10.1038/nrd964; SPITZER R, 1984, COMMUNICATION   0508; Tyrer P, 1996, BRIT J PSYCHIAT, V168, P669, DOI 10.1192/bjp.168.6.669; Tyrer P, 2001, BRIT J PSYCHIAT, V179, P191, DOI 10.1192/bjp.179.3.191	19	73	74	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 19	2003	327	7407					158	160		10.1136/bmj.327.7407.158	http://dx.doi.org/10.1136/bmj.327.7407.158			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702WJ	12869462	Green Published			2022-12-28	WOS:000184247500025
J	Ling, H; Boudsocq, F; Plosky, BS; Woodgate, R; Yang, W				Ling, H; Boudsocq, F; Plosky, BS; Woodgate, R; Yang, W			Replication of a cis-syn thymine dimer at atomic resolution	NATURE			English	Article							DNA-POLYMERASE-ETA; CRYSTAL-STRUCTURE; SULFOLOBUS-SOLFATARICUS; XERODERMA-PIGMENTOSUM; EXCISION-REPAIR; ERROR-PRONE; DAMAGED DNA; Y-FAMILY; BYPASS; MUTATIONS	Ultraviolet light damages DNA by catalysing covalent bond formation between adjacent pyrimidines, generating cis-syn cyclobutane pyrimidine dimers (CPDs) as the most common lesion(1). CPDs block DNA replication by high-fidelity DNA polymerases, but they can be efficiently bypassed by the Y-family DNA polymerase pol eta(2,3). Mutations in POLH encoding pol h are implicated in nearly 20% of xeroderma pigmentosum, a human disease characterized by extreme sensitivity to sunlight and predisposition to skin cancer(4-6). Here we have determined two crystal structures of Dpo4, an archaeal pol eta homologue, complexed with CPD-containing DNA, where the 3' and 5' thymine of the CPD separately serves as a templating base. The 3' thymine of the CPD forms a Watson-Crick base pair with the incoming dideoxyATP, but the 5' thymine forms a Hoogsteen base pair with the dideoxyATP in syn conformation. Dpo4 retains a similar tertiary structure, but each unusual DNA structure is individually fitted into the active site for catalysis. A model of the pol eta-CPD complex built from the crystal structures of Saccharomyces cerevisiae apo-pol eta and the Dpo4-CPD complex suggests unique features that allow pol eta to efficiently bypass CPDs.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; NICHHD, Lab Genom Integr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Yang, W (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.		Yang, Wei/D-4926-2011; Yang, Wei/ABB-4785-2020; Ling, Hong/E-3729-2010	Yang, Wei/0000-0002-3591-2195; Yang, Wei/0000-0002-3591-2195; Woodgate, Roger/0000-0001-5581-4616	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001500] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036119, Z01DK036119] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aishima J, 2002, NUCLEIC ACIDS RES, V30, P5244, DOI 10.1093/nar/gkf661; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bunting KA, 2003, NUCLEIC ACIDS RES, V31, P1633, DOI 10.1093/nar/gkg273; Cohen GH, 1997, J APPL CRYSTALLOGR, V30, P1160, DOI 10.1107/S0021889897006729; Glick E, 2001, EMBO J, V20, P7303, DOI 10.1093/emboj/20.24.7303; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lehmann AR, 2002, MUTAT RES-FUND MOL M, V509, P23, DOI 10.1016/S0027-5107(02)00227-0; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park H, 2002, P NATL ACAD SCI USA, V99, P15965, DOI 10.1073/pnas.242422699; PARK JY, 1995, J BIOCHEM-TOKYO, V118, P989, DOI 10.1093/jb/118.5.989; Patel PH, 2001, J MOL BIOL, V308, P823, DOI 10.1006/jmbi.2001.4619; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; Silvian LF, 2001, NAT STRUCT BIOL, V8, P984, DOI 10.1038/nsb1101-984; Szekeres ES, 1996, J BACTERIOL, V178, P2559, DOI 10.1128/jb.178.9.2559-2563.1996; Thoma F, 1999, EMBO J, V18, P6585, DOI 10.1093/emboj/18.23.6585; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; VASSYLYEV DG, 1995, CELL, V83, P773, DOI 10.1016/0092-8674(95)90190-6; Washington MT, 2001, CELL, V107, P917, DOI 10.1016/S0092-8674(01)00613-4; Yang W, 2003, CURR OPIN STRUC BIOL, V13, P23, DOI 10.1016/S0959-440X(02)00003-9; Zhang H, 2002, NUCLEIC ACIDS RES, V30, P1262, DOI 10.1093/nar/30.5.1262; Zhou BL, 2001, MOL CELL, V8, P427, DOI 10.1016/S1097-2765(01)00310-0	30	188	189	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 28	2003	424	6952					1083	1087		10.1038/nature01919	http://dx.doi.org/10.1038/nature01919			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715QR	12904819				2022-12-28	WOS:000184984200050
J	Palenik, B; Brahamsha, B; Larimer, FW; Land, M; Hauser, L; Chain, P; Lamerdin, J; Regala, W; Allen, EE; McCarren, J; Paulsen, I; Dufresne, A; Partensky, F; Webb, EA; Waterbury, J				Palenik, B; Brahamsha, B; Larimer, FW; Land, M; Hauser, L; Chain, P; Lamerdin, J; Regala, W; Allen, EE; McCarren, J; Paulsen, I; Dufresne, A; Partensky, F; Webb, EA; Waterbury, J			The genome of a motile marine Synechococcus	NATURE			English	Article							CYANOBACTERIUM SYNECHOCOCCUS; SP PCC7942; POLYPEPTIDE; IDENTIFICATION; GENE; PROCHLOROCOCCUS; DEGRADATION; SEQUENCE; STRAINS; ECOLOGY	Marine unicellular cyanobacteria are responsible for an estimated 20-40% of chlorophyll biomass and carbon fixation in the oceans(1). Here we have sequenced and analysed the 2.4-megabase genome of Synechococcus sp. strain WH8102, revealing some of the ways that these organisms have adapted to their largely oligotrophic environment. WH8102 uses organic nitrogen and phosphorus sources and more sodium-dependent transporters than a model freshwater cyanobacterium. Furthermore, it seems to have adopted strategies for conserving limited iron stores by using nickel and cobalt in some enzymes, has reduced its regulatory machinery (consistent with the fact that the open ocean constitutes a far more constant and buffered environment than fresh water), and has evolved a unique type of swimming motility. The genome of WH8102 seems to have been greatly influenced by horizontal gene transfer, partially through phages. The genetic material contributed by horizontal gene transfer includes genes involved in the modification of the cell surface and in swimming motility. On the basis of its genome, WH8102 is more of a generalist than two related marine cyanobacteria(2).	Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA; Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; Joint Genome Inst, Walnut Creek, CA 94598 USA; Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; TIGR, Rockville, MD 20850 USA; CNRS, Biol Stn, UMR 7127, F-29682 Roscoff, France; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; J. Craig Venter Institute; Centre National de la Recherche Scientifique (CNRS); Woods Hole Oceanographic Institution	Palenik, B (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.		Hauser, Loren J/H-3881-2012; Partensky, Frédéric/B-9194-2018; Chain, Patrick/O-4140-2019; chain, patrick/B-9777-2013; Paulsen, Ian T/K-3832-2012; Palenik, Brian/AAA-1822-2020; Partensky, Frédéric/AAH-1170-2021; Land, Miriam L/A-6200-2011	Partensky, Frédéric/0000-0003-1274-4050; Chain, Patrick/0000-0003-3949-3634; Paulsen, Ian T/0000-0001-9015-9418; Palenik, Brian/0000-0002-3717-9046; Partensky, Frédéric/0000-0003-1274-4050; Land, Miriam L/0000-0001-7102-0031; Brahamsha, Bianca/0000-0002-5316-5939				Badger JH, 1999, MOL BIOL EVOL, V16, P512, DOI 10.1093/oxfordjournals.molbev.a026133; Badger MR, 2002, FUNCT PLANT BIOL, V29, P161, DOI 10.1071/PP01213; Brahamsha B, 1996, P NATL ACAD SCI USA, V93, P6504, DOI 10.1073/pnas.93.13.6504; Brahamsha B, 1996, APPL ENVIRON MICROB, V62, P1747, DOI 10.1128/AEM.62.5.1747-1751.1996; Bushman F., 2002, LATERAL DNA TRANSFER; Clark LL, 1998, NATURE, V393, P426, DOI 10.1038/30881; COLLIER JL, 1994, EMBO J, V13, P1039, DOI 10.1002/j.1460-2075.1994.tb06352.x; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DELORIMIER R, 1990, ARCH MICROBIOL, V153, P541, DOI 10.1007/BF00245263; Dolganov N, 1999, J BACTERIOL, V181, P610, DOI 10.1128/JB.181.2.610-617.1999; Ferris MJ, 1998, NATURE, V396, P226, DOI 10.1038/24297; Goto-Seki A, 1999, MOL MICROBIOL, V34, P473, DOI 10.1046/j.1365-2958.1999.01608.x; Harano Y, 1997, J BACTERIOL, V179, P5744, DOI 10.1128/jb.179.18.5744-5750.1997; Long RA, 2001, APPL ENVIRON MICROB, V67, P4975, DOI 10.1128/AEM.67.11.4975-4983.2001; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mann EL, 2002, LIMNOL OCEANOGR, V47, P976, DOI 10.4319/lo.2002.47.4.0976; Monger BC, 1999, LIMNOL OCEANOGR, V44, P1917, DOI 10.4319/lo.1999.44.8.1917; NOMURA M, 1995, PLANT PHYSIOL, V107, P703, DOI 10.1104/pp.107.3.703; Nyyssola A, 2000, J BIOL CHEM, V275, P22196, DOI 10.1074/jbc.M910111199; PALENIK B, 1998, PHOSPHORUS PLANT BIO, P26; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Paulsen IT, 2000, J MOL BIOL, V301, P75, DOI 10.1006/jmbi.2000.3961; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Scanlan DJ, 2002, FEMS MICROBIOL ECOL, V40, P1, DOI 10.1111/j.1574-6941.2002.tb00930.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toledo G, 1999, APPL ENVIRON MICROB, V65, P5247; Volz K., 1995, 2 COMPONENT SIGNAL T, P53; WATERBURY JB, 1986, PHOTOSYNTHETIC PICOP, P71; WILLEY JM, 1989, APPL ENVIRON MICROB, V55, P1888, DOI 10.1128/AEM.55.8.1888-1894.1989; Zehr JP, 2002, APPL ENVIRON MICROB, V68, P1015, DOI 10.1128/AEM.68.3.1015-1024.2002	30	516	966	1	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 28	2003	424	6952					1037	1042		10.1038/nature01943	http://dx.doi.org/10.1038/nature01943			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715QR	12917641	Bronze			2022-12-28	WOS:000184984200039
J	Chang, JC; Wooten, EC; Tsimelzon, A; Hilsenbeck, SG; Gutierrez, MC; Elledge, R; Mohsin, S; Osborne, CK; Chamness, GC; Allred, DC; O'Connell, P				Chang, JC; Wooten, EC; Tsimelzon, A; Hilsenbeck, SG; Gutierrez, MC; Elledge, R; Mohsin, S; Osborne, CK; Chamness, GC; Allred, DC; O'Connell, P			Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer	LANCET			English	Article							PATTERNS; DOXORUBICIN; RESISTANCE	Background Systemic chemotherapy for operable breast cancer substantially decreases the risk of death. Patients often have de novo resistance or incomplete response to docetaxel, one of the most active agents in this disease. We postulated that gene expression profiles of the primary breast cancer can predict the response to docetaxel. Methods We took core biopsy samples from primary breast tumours in 24 patients before treatment and then assessed tumour response to neoadjuvant docetaxel (four cycles, 100 mg/m(2) daily for 3 weeks) by cDNA analysis of RNA extracted from biopsy samples using HgU95-Av2 GeneChip. Findings From the core biopsy samples, we extracted sufficient total RNA (3-6 mug) for cDNA array analysis using HgU95-Av2 GeneChip. Differential patterns of expression of 92 genes correlated with docetaxel response (p=0.001). Sensitive tumours had higher expression of genes involved in cell cycle, cytoskeleton, adhesion, protein transport, protein modification, transcription, and stress or apoptosis; whereas resistant tumours showed increased expression of some transcriptional and signal transduction genes. In leave-one-out cross-validation analysis, ten of 11 sensitive tumours (90% specificity) and 11 of 13 resistant tumours (85% sensitivity) were correctly classified, with an accuracy of 88%. This 92-gene predictor had positive and negative predictive values of 92% and 83%, respectively. Correlation between RNA expression measured by the arrays and semiquantitative RT-PCR was also ascertained, and our results were validated in an independent set of six patients. Interpretation If validated, these molecular profiles could allow development of a clinical test for docetaxel sensitivity, thus reducing unnecessary treatment for women with breast cancer.	Baylor Coll Med, Breast Ctr, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Methodist Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston	Chang, JC (corresponding author), Baylor Coll Med, Breast Ctr, 1 Baylor Plaza,BCM 600, Houston, TX 77030 USA.	jcchang@breastcenter.tmc.edu	chang, jenny/G-7614-2015	chang, jenny/0000-0002-0890-9302; Wooten, Eric/0000-0002-8403-8668	NATIONAL CANCER INSTITUTE [R01CA050183] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA50183] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aapro MS, 2001, ONCOLOGIST, V6, P36, DOI 10.1634/theoncologist.6-4-376; ABE O, 1992, LANCET, V339, P71; Abe O, 1998, LANCET, V352, P930; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; [Anonymous], 1992, Lancet, V339, P1; Chan S, 1999, J CLIN ONCOL, V17, P2341, DOI 10.1200/JCO.1999.17.8.2341; Clarke M, 1998, LANCET, V351, P1451; Dumontet C, 1999, J CLIN ONCOL, V17, P1061, DOI 10.1200/JCO.1999.17.3.1061; Fisher B, 1998, J CLIN ONCOL, V16, P2672, DOI 10.1200/JCO.1998.16.8.2672; Hansen RK, 1999, BREAST CANCER RES TR, V56, P187; HENDERSON IC, 1998, P AN M AM SOC CLIN, V17, P101; Hortobagyi G, 1997, Oncology (Williston Park), V11, P11; Khan J, 1998, CANCER RES, V58, P5009; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Mamounas E P, 1997, Oncology (Williston Park), V11, P37; NABHOLTZ JM, 2001, P AN M AM SOC CLIN, V20, pA22; *NCBI, GEN EXPR OMN ACC NUM; OSBORNE CK, 1980, CANCER-AM CANCER SOC, V46, P2884, DOI 10.1002/1097-0142(19801215)46:12+<2884::AID-CNCR2820461429>3.0.CO;2-U; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Radmacher MD, 2002, J COMPUT BIOL, V9, P505, DOI 10.1089/106652702760138592; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Schadt EE, 2001, J CELL BIOCHEM, V84, P120, DOI 10.1002/jcb.10073; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Sgroi DC, 1999, CANCER RES, V59, P5656; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Van Poznak C, 2002, J CLIN ONCOL, V20, P2319, DOI 10.1200/JCO.2002.08.125; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; *WHIT I MIT CTR GE, PRIM 3	33	656	700	1	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2003	362	9381					362	369		10.1016/S0140-6736(03)14023-8	http://dx.doi.org/10.1016/S0140-6736(03)14023-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707FB	12907009				2022-12-28	WOS:000184498700009
J	Alonso, JM; Stepanova, AN; Leisse, TJ; Kim, CJ; Chen, HM; Shinn, P; Stevenson, DK; Zimmerman, J; Barajas, P; Cheuk, R; Gadrinab, C; Heller, C; Jeske, A; Koesema, E; Meyers, CC; Parker, H; Prednis, L; Ansari, Y; Choy, N; Deen, H; Geralt, M; Hazari, N; Hom, E; Karnes, M; Mulholland, C; Ndubaku, R; Schmidt, I; Guzman, P; Aguilar-Henonin, L; Schmid, M; Weigel, D; Carter, DE; Marchand, T; Risseeuw, E; Brogden, D; Zeko, A; Crosby, WL; Berry, CC; Ecker, JR				Alonso, JM; Stepanova, AN; Leisse, TJ; Kim, CJ; Chen, HM; Shinn, P; Stevenson, DK; Zimmerman, J; Barajas, P; Cheuk, R; Gadrinab, C; Heller, C; Jeske, A; Koesema, E; Meyers, CC; Parker, H; Prednis, L; Ansari, Y; Choy, N; Deen, H; Geralt, M; Hazari, N; Hom, E; Karnes, M; Mulholland, C; Ndubaku, R; Schmidt, I; Guzman, P; Aguilar-Henonin, L; Schmid, M; Weigel, D; Carter, DE; Marchand, T; Risseeuw, E; Brogden, D; Zeko, A; Crosby, WL; Berry, CC; Ecker, JR			Genome-wide Insertional mutagenesis of Arabidopsis thaliana	SCIENCE			English	Article							T-DNA; TRANSFORMATION; GENES; INTEGRATION; TARGET	Over 225,000 independent Agrobacterium transferred DNA (T-DNA) insertion events in the genome of the reference plant Arabidopsis thaliana have been created that represent near saturation of the gene space. The precise locations were determined for more than 88,000 T-DNA insertions, which resulted in the identification of mutations in more than 21,700 of the similar to29,454 predicted Arabidopsis genes. Genome-wide analysis of the distribution of integration events revealed the existence of a large integration site bias at both the chromosome and gene levels. Insertion mutations were identified in genes that are regulated in response to the plant hormone ethylene.	Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; Natl Res Council Canada, Inst Plant Biotechnol, Saskatoon, SK S7N 0W9, Canada; Univ Calif San Diego, Dept Family Prevent Med, San Diego, CA 92093 USA	Salk Institute; National Research Council Canada; University of California System; University of California San Diego	Ecker, JR (corresponding author), Salk Inst Biol Studies, Genom Anal Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ecker@salk.edu	Guzman, Plinio/A-3073-2012; Weigel, Detlef/C-1418-2008; Weigel, Detlef/AAR-3312-2021; Ecker, Joseph R/B-9144-2008; Schmid, Markus/I-4384-2015; Weigel, Detlef/GSJ-0799-2022; Alonso, Jose M/K-6826-2014; Stepanova, Anna/P-9575-2019	Weigel, Detlef/0000-0002-2114-7963; Ecker, Joseph R/0000-0001-5799-5895; Schmid, Markus/0000-0002-0068-2967; Weigel, Detlef/0000-0002-2114-7963; Alonso, Jose M/0000-0001-7087-1571; Stepanova, Anna/0000-0003-1018-4758; Wu, Emily/0000-0001-8160-0654; Koesema, Eric/0000-0002-7743-0127; Chen, Huaming/0000-0001-5289-7882				ALONSO J, UNPUB; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Bargmann CI, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews1005; Bechtold N, 2000, GENETICS, V155, P1875; Chen H. M., UNPUB; Desfeux C, 2000, PLANT PHYSIOL, V123, P895, DOI 10.1104/pp.123.3.895; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gong M, 2003, CURR OPIN GENET DEV, V13, P215, DOI 10.1016/S0959-437X(03)00018-2; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Haupt W, 2001, PLANT J, V27, P285, DOI 10.1046/j.1365-313x.2001.01087.x; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; McElver J, 2001, GENETICS, V159, P1751; Parinov S, 2000, CURR OPIN BIOTECH, V11, P157, DOI 10.1016/S0958-1669(00)00075-6; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Tzfira T, 2002, TRENDS CELL BIOL, V12, P121, DOI 10.1016/S0962-8924(01)02229-2; Tzfira T, 2000, MOL PLANT PATHOL, V1, P201, DOI 10.1046/j.1364-3703.2000.00026.x; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	25	4006	4179	13	503	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2003	301	5633					653	657		10.1126/science.1086391	http://dx.doi.org/10.1126/science.1086391			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893945				2022-12-28	WOS:000184473600042
J	Bergman, A; Siegal, ML				Bergman, A; Siegal, ML			Evolutionary capacitance as a general feature of complex gene networks	NATURE			English	Article							CANALIZATION; HSP90; ARCHITECTURE	An evolutionary capacitor buffers genotypic variation under normal conditions, thereby promoting the accumulation of hidden polymorphism. But it occasionally fails, thereby revealing this variation phenotypically(1).Theprincipal example of an evolutionary capacitor is Hsp90, a molecular chaperone that targets an important set of signal transduction proteins. Experiments in Drosophila and Arabidopsis have demonstrated three key properties of Hsp90: (1) it suppresses phenotypic variation under normal conditions and releases this variation when functionally compromised; (2) its function is overwhelmed by environmental stress; and (3) it exerts pleiotropic effects on key developmental processes(1,2). But whether these properties necessarily make Hsp90 a significant and unique facilitator of adaptation(1-10) is unclear. Here we use numerical simulations of complex gene networks, as well as genome-scale expression data from yeast single-gene deletion strains, to present a mechanism that extends the scope of evolutionary capacitance beyond the action of Hsp90 alone. We illustrate that most, and perhaps all, genes reveal phenotypic variation when functionally compromised, and that the availability of loss-of-function mutations accelerates adaptation to a new optimum phenotype. However, this effect does not require the mutations to be conditional on the environment. Thus, there might exist a large class of evolutionary capacitors whose effects on phenotypic variation complement the systemic, environment-induced effects of Hsp90.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Ctr Computat Genet & Biol Modeling, Stanford, CA 94305 USA	Stanford University; Stanford University	Siegal, ML (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	mlsiegal@stanford.edu		Siegal, Mark/0000-0001-6930-2988				Cossins A, 1998, NATURE, V396, P309, DOI 10.1038/24483; Dickinson WJ, 1999, NATURE, V399, P30, DOI 10.1038/19894; Edwards RJ, 2003, MOL BIOL EVOL, V20, P30, DOI 10.1093/molbev/msg001; Featherstone DE, 2002, BIOESSAYS, V24, P267, DOI 10.1002/bies.10054; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gibson G, 2000, BIOESSAYS, V22, P372, DOI 10.1002/(SICI)1521-1878(200004)22:4<372::AID-BIES7>3.0.CO;2-J; Hansen TF, 2001, THEOR POPUL BIOL, V59, P61, DOI 10.1006/tpbi.2000.1508; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; McLaren A, 1999, TRENDS GENET, V15, P169, DOI 10.1016/S0168-9525(99)01732-1; Meiklejohn CD, 2002, TRENDS ECOL EVOL, V17, P468, DOI 10.1016/S0169-5347(02)02596-X; Mitchell-Olds T, 2002, SCIENCE, V296, P2348, DOI 10.1126/science.1073846; Pigliucci M, 2002, NATURE, V417, P598, DOI 10.1038/417598a; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rice SH, 1998, EVOLUTION, V52, P647, DOI 10.1111/j.1558-5646.1998.tb03690.x; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Rutherford SL, 2000, BIOESSAYS, V22, P1095, DOI 10.1002/1521-1878(200012)22:12&lt;1095::AID-BIES7&gt;3.0.CO;2-A; SCHARLOO W, 1991, ANNU REV ECOL SYST, V22, P65, DOI 10.1146/annurev.es.22.110191.000433; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; STEARNS SC, 1995, J EVOLUTION BIOL, V8, P539, DOI 10.1046/j.1420-9101.1995.8050539.x; Tautz D, 2000, TRENDS GENET, V16, P475, DOI 10.1016/S0168-9525(00)02118-1; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wagner A, 1996, EVOLUTION, V50, P1008, DOI 10.1111/j.1558-5646.1996.tb02342.x; Wagner GP, 1997, EVOLUTION, V51, P329, DOI [10.2307/2411105, 10.1111/j.1558-5646.1997.tb02420.x]; Wagner GP, 2000, J THEOR BIOL, V203, P163, DOI 10.1006/jtbi.2000.1074; Wagner GP, 1999, J EXP ZOOL, V285, P116, DOI 10.1002/(SICI)1097-010X(19990815)285:2<116::AID-JEZ3>3.0.CO;2-P; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	27	364	370	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 31	2003	424	6948					549	552		10.1038/nature01765	http://dx.doi.org/10.1038/nature01765			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706LG	12891357				2022-12-28	WOS:000184454700042
J	Petit, L; Svane, A; Szotek, Z; Temmerman, WM				Petit, L; Svane, A; Szotek, Z; Temmerman, WM			First-principles calculations of PuO2 +/- x	SCIENCE			English	Article							PLUTONIUM DIOXIDE; WATER	The electronic structure of PuO2+/-x was studied using first-principles quantum mechanics, realized with the self-interaction corrected local spin density method. In the stoichiometric PuO2 compound, Pu occurs in the Pu(IV) oxidation state, corresponding to a localized f(4) shell. If oxygen is introduced onto the octahedral interstitial site, the nearby Pu atoms turn into Pu(V) (f(3)) by transferring electrons to the oxygen. Oxygen vacancies cause Pu(III) (f(5)) to form by taking up electrons released by oxygen. At T=0, the PuO2 compound is stable with respect to free oxygen, but the delicate energy balance suggests the possible deterioration of the material during long-term storage.	Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus C, Denmark; Oak Ridge Natl Lab, Comp Sci & Math Div, Oak Ridge, TN 37831 USA; Oak Ridge Natl Lab, Ctr Computat Sci, Oak Ridge, TN 37831 USA; SERC, Daresbury Lab, Warrington WA4 4AD, Cheshire, England	Aarhus University; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; STFC Daresbury Laboratory	Svane, A (corresponding author), Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus C, Denmark.	svane@phys.au.dk	Petit, Leon/B-5255-2008	Petit, Leon/0000-0001-6489-9922				Colarieti-Tosti M, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.195102; Colmenares C.A., 1975, PROG SOLID STATE CH, V9, P139; GARDNER ER, 1965, J INORG NUCL CHEM, V27, P541, DOI 10.1016/0022-1902(65)80259-7; HAIRE RG, 2001, MRS B, V689; Haschke JM, 2002, J ALLOY COMPD, V336, P124, DOI 10.1016/S0925-8388(01)01908-9; Haschke JM, 2000, SCIENCE, V287, P285, DOI 10.1126/science.287.5451.285; Haschke JM, 2001, J ALLOY COMPD, V314, P78, DOI 10.1016/S0925-8388(00)01222-6; HASCHKE JM, 1999, LA13537; KELLY PJ, 1987, J CHEM SOC FARAD T 2, V83, P1189, DOI 10.1039/f29878301189; Madic C, 2000, RECHERCHE, P22; Morales L, 2000, AIP CONF PROC, V532, P114; PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048; Petit L, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.216403; Skorodumova NV, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.166601; Straka M, 2001, THEOR CHEM ACC, V106, P393, DOI 10.1007/s002140100295; Strange P, 1999, NATURE, V399, P756, DOI 10.1038/21595; Temmerman WM, 1998, ELECTRONIC DENSITY FUNCTIONAL THEORY, P327; WEIGEL F, 1986, CHEM ACTINIDE ELEMEN, V1, P680	18	134	135	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 25	2003	301	5632					498	501		10.1126/science.1086505	http://dx.doi.org/10.1126/science.1086505			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12881566				2022-12-28	WOS:000184340500037
J	Santer, BD; Wehner, MF; Wigley, TML; Sausen, R; Meehl, GA; Taylor, KE; Ammann, C; Arblaster, J; Washington, WM; Boyle, JS; Bruggemann, W				Santer, BD; Wehner, MF; Wigley, TML; Sausen, R; Meehl, GA; Taylor, KE; Ammann, C; Arblaster, J; Washington, WM; Boyle, JS; Bruggemann, W			Contributions of anthropogenic and natural forcing to recent tropopause height changes	SCIENCE			English	Article							TROPICAL TROPOPAUSE; CLIMATE-CHANGE; TEMPERATURE; SIMULATIONS; 20TH-CENTURY; VARIABILITY; ATMOSPHERE; REANALYSES; MODEL; UNCERTAINTIES	Observations indicate that the height of the tropopause-the boundary between the stratosphere and troposphere-has increased by several hundred meters since 1979. Comparable increases are evident in climate model experiments. The latter show that human-induced changes in ozone and well-mixed greenhouse gases account for similar to80% of the simulated rise in tropopause height over 1979-1999. Their primary contributions are through cooling of the stratosphere (caused by ozone) and warming of the troposphere (caused by well-mixed greenhouse gases). A model-predicted fingerprint of tropopause height changes is statistically detectable in two different observational ("reanalysis") data sets. This positive detection result allows us to attribute overall tropopause height changes to a combination of anthropogenic and natural external forcings, with the anthropogenic component predominating.	Lawrence Livermore Natl Lab, Program Climate Model Diag & Intercomparison, Livermore, CA 94550 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; Natl Ctr Atmospher Res, Boulder, CO 80303 USA; Deutsch Zentrum Luft & Raumfahrt, Inst Phys Atmosphare, D-82234 Oberpfaffenhofen, Wessling, Germany; Univ Birmingham, Birmingham B15 2TT, W Midlands, England	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; National Center Atmospheric Research (NCAR) - USA; Helmholtz Association; German Aerospace Centre (DLR); University of Birmingham	Santer, BD (corresponding author), Lawrence Livermore Natl Lab, Program Climate Model Diag & Intercomparison, Livermore, CA 94550 USA.		Taylor, Karl E/F-7290-2011; Arblaster, Julie/C-1342-2010; Santer, Ben/ABA-1099-2021; Wehner, Michael/F-7841-2015; Wigley, Tom M.L./B-4705-2008; Ammann, Caspar M/A-4899-2011; Santer, Benjamin D/F-9781-2011	Taylor, Karl E/0000-0002-6491-2135; Arblaster, Julie/0000-0002-4287-2363; Wehner, Michael/0000-0001-5991-0082; 				Ammann CM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016875; Christy JR, 2000, J ATMOS OCEAN TECH, V17, P1153, DOI 10.1175/1520-0426(2000)017<1153:MTTDCA>2.0.CO;2; Dai A, 2001, J CLIMATE, V14, P485, DOI 10.1175/1520-0442(2001)014<0485:COTTAT>2.0.CO;2; Gibson J.K., 1997, EUR CENT MED RANG WE; Hansen J, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001143; Hasselmann KF., 1979, METEOROLOGY TROPICAL, P251; Highwood EJ, 1998, Q J ROY METEOR SOC, V124, P1579, DOI 10.1002/qj.49712454911; Highwood EJ, 2000, Q J ROY METEOR SOC, V126, P1515, DOI 10.1256/smsqj.56514; Hoinka KP, 1998, MON WEATHER REV, V126, P3303, DOI 10.1175/1520-0493(1998)126<3303:SOTGTP>2.0.CO;2; HOYT DV, 1993, J GEOPHYS RES-SPACE, V98, P18895, DOI 10.1029/93JA01944; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kiehl JT, 1999, J GEOPHYS RES-ATMOS, V104, P31239, DOI 10.1029/1999JD900991; MEARS CA, IN PRESS J CLIM; Meehl GA, 2003, J CLIMATE, V16, P426, DOI [10.1175/1520-0442(2003)016<0426:SAGGFA>2.0.CO;2, 10.1175/1520-0442(2003)016&lt;0426:SAGGFA&gt;2.0.CO;2]; Pawson S, 1999, CLIM DYNAM, V15, P241, DOI 10.1007/s003820050279; Ramaswamy V, 1996, NATURE, V382, P616, DOI 10.1038/382616a0; Ramaswamy V, 2001, REV GEOPHYS, V39, P71, DOI 10.1029/1999RG000065; Randel WJ, 2000, J GEOPHYS RES-ATMOS, V105, P15509, DOI 10.1029/2000JD900155; Randel WJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002595; REICHLER T, 1996, 57 DTSCH FORSCH LUFT; Roeckner E, 1999, J CLIMATE, V12, P3004, DOI 10.1175/1520-0442(1999)012<3004:TCCSWA>2.0.CO;2; SANTER BD, 1995, J GEOPHYS RES-OCEANS, V100, P10693, DOI 10.1029/95JC00683; Santer BD, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002258; Santer BD, 2003, SCIENCE, V300, P1280, DOI 10.1126/science.1082393; Santer BD, 1999, J GEOPHYS RES-ATMOS, V104, P6305, DOI 10.1029/1998JD200096; Santer BD, 1996, NATURE, V382, P39, DOI 10.1038/382039a0; Sausen R, 2003, METEOROL Z, V12, P131, DOI 10.1127/0941-2948/2003/0012-0131; Seidel DJ, 2001, J GEOPHYS RES-ATMOS, V106, P7857, DOI 10.1029/2000JD900837; Stott PA, 2000, SCIENCE, V290, P2133, DOI 10.1126/science.290.5499.2133; Tett SFB, 1996, SCIENCE, V274, P1170, DOI 10.1126/science.274.5290.1170; Washington WM, 2000, CLIM DYNAM, V16, P755, DOI 10.1007/s003820000079; World Meteorological Organization, 1957, WMO B, VIV, P134	32	321	353	0	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2003	301	5632					479	483		10.1126/science.1084123	http://dx.doi.org/10.1126/science.1084123			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12881562	Green Submitted			2022-12-28	WOS:000184340500032
J	Shearer, A; Stappers, B; O'Connor, P; Golden, A; Strom, R; Redfern, M; Ryan, O				Shearer, A; Stappers, B; O'Connor, P; Golden, A; Strom, R; Redfern, M; Ryan, O			Enhanced optical emission during Crab giant radio pulses	SCIENCE			English	Article							GAMMA-RAY PULSARS; RADIATION	We detected a correlation between optical and giant radio pulse emission from the Crab pulsar. Optical pulses coincident with the giant radio pulses were on average 3% brighter than those coincident with normal radio pulses. Combined with the lack of any other pulse pro. le changes, this result indicates that both the giant radio pulses and the increased optical emission are linked to an increase in the electron-positron plasma density.	Natl Univ Ireland Univ Coll Galway, Galway, Ireland; Stichting ASTRON, NL-7990 AA Dwingeloo, Netherlands; Sterrenkundig Inst Anton Pannekoek, NL-1098 SJ Amsterdam, Netherlands	Ollscoil na Gaillimhe-University of Galway; University of Amsterdam	Shearer, A (corresponding author), Natl Univ Ireland Univ Coll Galway, Newcastle Rd, Galway, Ireland.		Shearer, Andy/N-7609-2014	Shearer, Andy/0000-0001-7903-0074				ARONS J, 1979, SPACE SCI REV, V24, P437, DOI 10.1007/BF00172212; BLANDFORD RD, 1976, MON NOT R ASTRON SOC, V174, P59, DOI 10.1093/mnras/174.1.59; BUCKTON D, IN PRESS P SPIE, V4876; COGNARD I, 1996, ASTROPHYS J, V457, pL816; Golden A, 2000, ASTRON ASTROPHYS, V363, P617; Hankins TH, 2003, NATURE, V422, P141, DOI 10.1038/nature01477; HANKINS TH, 1971, ASTROPHYS J, V169, P487, DOI 10.1086/151164; Harding AK, 1998, ADV SPACE RES, V21, P251, DOI 10.1016/S0273-1177(97)00811-9; HEGYI D, 1971, IAU S, V46, P129; Johnston S, 2003, ASTROPHYS J, V590, pL95, DOI 10.1086/376826; JONES DHP, 1980, NATURE, V283, P50, DOI 10.1038/283050a0; LUNDGREN SC, 1995, ASTROPHYS J, V453, P433, DOI 10.1086/176404; Lyutikov M, 1999, MON NOT R ASTRON SOC, V305, P338, DOI 10.1046/j.1365-8711.1999.02443.x; Romani RW, 2001, ASTROPHYS J, V557, pL93, DOI 10.1086/323415; ROMANI RW, 1995, ASTROPHYS J, V438, P314, DOI 10.1086/175076; Romani RW, 1996, ASTROPHYS J, V470, P469, DOI 10.1086/177878; STAELIN DH, 1968, SCIENCE, V162, P1481, DOI 10.1126/science.162.3861.1481; STANDISH EM, 1982, ASTRON ASTROPHYS, V114, P297; Voute JLL, 2002, ASTRON ASTROPHYS, V385, P733, DOI 10.1051/0004-6361:20020123	20	94	95	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	2003	301	5632					493	495		10.1126/science.1084919	http://dx.doi.org/10.1126/science.1084919			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704LE	12881564	Green Submitted			2022-12-28	WOS:000184340500035
J	Agathon, A; Thisse, C; Thisse, B				Agathon, A; Thisse, C; Thisse, B			The molecular nature of the zebrafish tail organizer	NATURE			English	Article								Based on grafting experiments, Mangold and Spemann showed the dorsal blastopore lip of an amphibian gastrula to be able to induce a secondary body axis(1). The equivalent of this organizer region has been identified in different vertebrates including teleosts(2). However, whereas the graft can induce ectopic head and trunk, endogenous and ectopic axes fuse in the posterior part of the body(3,4), raising the question of whether a distinct organizer region is necessary for tail development. Here we reveal, by isochronic and heterochronic transplantation, the existence of a tail organizer deriving from the ventral margin of the zebrafish embryo, which is independent of the dorsal Spemann organizer. Loss-of-function experiments reveal that bone morphogenetic protein (BMP), Nodal and Wnt8 signalling pathways are required for tail development. Moreover, stimulation of naive cells by a combination of BMP, Nodal and Wnt8 mimics the tail-organizing activity of the ventral margin and induces surrounding tissues to become tail. In contrast to induction of the vertebrate head, known to result from the triple inhibition of BMP, Nodal and Wnt(5), here we show that induction of the tail results from the triple stimulation of BMP, Nodal and Wnt8 signalling pathways.	Inst Genet & Biol Mol & Cellulaire, CNRS, UMR 7104, INSERM,ULP, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Thisse, B (corresponding author), Inst Genet & Biol Mol & Cellulaire, CNRS, UMR 7104, INSERM,ULP, 1 Rue Laurent Fries,BP10142,CU Strasbourg, F-67404 Illkirch Graffenstaden, France.	thisse@igbmc.u-strasbg.fr		THISSE, Christine/0000-0002-8684-1681				Connors SA, 1999, DEVELOPMENT, V126, P3119; Furthauer M, 1999, DEV BIOL, V214, P181, DOI 10.1006/dbio.1999.9401; GONT LK, 1993, DEVELOPMENT, V119, P991; JOLY JS, 1993, DEVELOPMENT, V119, P1261; Kanki JP, 1997, DEVELOPMENT, V124, P881; KELLY GM, 1995, DEVELOPMENT, V121, P1787; KIMMEL CB, 1990, DEVELOPMENT, V108, P581; Knezevic V, 1998, DEVELOPMENT, V125, P1791; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Mangold O, 1933, NATURWISSENSCHAFTEN, V21, P761, DOI 10.1007/BF01503740; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Muller F, 2000, DEVELOPMENT, V127, P3889; Mullins MC, 1996, DEVELOPMENT, V123, P81; Myers DC, 2002, DEV BIOL, V243, P81, DOI 10.1006/dbio.2001.0523; Nikaido M, 1999, DEVELOPMENT, V126, P181; Oppenheimer JM, 1936, J EXP ZOOL, V72, P409, DOI 10.1002/jez.1400720304; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; RENUCCI A, 1996, DEVELOPMENT, V122, P735; Saude L, 2000, DEVELOPMENT, V127, P3407; Schier AF, 2001, CURR OPIN GENET DEV, V11, P393, DOI 10.1016/S0959-437X(00)00209-4; Schmid B, 2000, DEVELOPMENT, V127, P957; Shih J, 1996, DEVELOPMENT, V122, P1313; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; Thisse B, 2000, NATURE, V403, P425, DOI 10.1038/35000200; TUCKER AS, 1995, CURR BIOL, V5, P807, DOI 10.1016/S0960-9822(95)00158-8; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; Woo K, 1997, SCIENCE, V277, P254, DOI 10.1126/science.277.5323.254	28	164	168	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2003	424	6947					448	452		10.1038/nature01822	http://dx.doi.org/10.1038/nature01822			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879074				2022-12-28	WOS:000184318400048
J	Huls, G; Koornstra, JJ; Kleibeuker, JH				Huls, G; Koornstra, JJ; Kleibeuker, JH			Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas	LANCET			English	Review							FAMILIAL ADENOMATOUS POLYPOSIS; COLON-CANCER CELLS; RANDOMIZED-TRIAL; TUMOR-SUPPRESSOR; BETA-CATENIN; SULINDAC; MUTATIONS; CHEMOPREVENTION; PROLIFERATION; ACTIVATION	Context Colorectal cancer is the second most common cause of cancer-related mortality in the west. The high incidence and mortality make effective prevention an important public-health and economic issue. Non-steroidal anti-inflammatory drugs (NSAIDs) can inhibit colorectal-carcinogenesis and are among,the few agents known to be chemopreventive. Randomised trials have shown that sulindac and celecoxib suppress,the development of adenomatous polyps and cause regression of existing polyps in patients with familial adenomatous polyposis (FAP), who have a high risk for developing colorectal cancer. The mechanisms by which NSAIDs inhibit neoplastic growth are not fully known. Starting point. Two recently reported randomised placebo-controlled trials show a chemopreventive effect of aspirin in populations other than those with FAP (Robert Sandler and colleagues, N Engl J Med 2003; 348: 883-90; John Baron and colleagues, N Engl J Med 2003; 348: 891-99). In the Sandler study 635 patients with colorectal cancer were randomised to receive 325 mg aspirin or placebo daily. After a follow-up of around 31 months,, the mean number of adenomas was lower in the aspirin group than in the placebo group, corresponding to a relative risk of any recurrent adenoma in the aspirin group of 0.65. In the Baron study 1121 patients with colorectal adenomas were assigned to receive 81 or 325 mg aspirin or placebo daily. Follow-up colonoscopy, 32 months after the index endoscopy, showed an incidence of one or more adenomas of 38% in the 81 mg aspirin group, 45% in the 325 mg aspirin group, and 47% in the placebo group. Together, these studies indicate a moderate chemopreventive effect of aspirin in populations with an intermediate risk of developing colorectal cancer. Where next? The anticancer properties of NSAIDs have been demonstrated in vitro and in animal studies, epidemiological reports, and intervention studies. Several mechanisms through which NSAIDs alter colonic carcinogenesis have been elucidated, including the induction of apoptosis in neoplastic cells, via mechanisms dependent and independent of. cyclooxygenase. Some studies have suggested an important role for the cell-cycle regulating protein p21 in mediating the chemopreventive effect of sulindac. A decrease in p21 expression may be one of the main oncogenic events in the development of colorectal cancer. Thus p21 could be the, molecular link in the chemopreventive effects, of NSAIDs.	Univ Groningen Hosp, Dept Internal Med, NL-9700 RB Groningen, Netherlands; Univ Groningen Hosp, Dept Gastroenterol & Hepatol, NL-9700 RB Groningen, Netherlands	University of Groningen; University of Groningen	Huls, G (corresponding author), Univ Groningen Hosp, Dept Internal Med, POB 30-001, NL-9700 RB Groningen, Netherlands.	g.huls@int.azg.nl						Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Chan TA, 2002, LANCET ONCOL, V3, P166, DOI 10.1016/S1470-2045(02)00680-0; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; GIARDIELLO FM, 1993, NEW ENGL J MED, V328, P1313, DOI 10.1056/NEJM199305063281805; Giardiello FM, 2002, NEW ENGL J MED, V346, P1054, DOI 10.1056/NEJMoa012015; Goldberg Y, 1996, ONCOGENE, V12, P893; Hanif R, 1996, BIOCHEM PHARMACOL, V52, P237, DOI 10.1016/0006-2952(96)00181-5; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Kim PJ, 2003, LANCET, V362, P205, DOI 10.1016/S0140-6736(03)13910-4; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; LABAYLE D, 1991, GASTROENTEROLOGY, V101, P635, DOI 10.1016/0016-5085(91)90519-Q; LADENHEIM J, 1995, GASTROENTEROLOGY, V108, P1083, DOI 10.1016/0016-5085(95)90206-6; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; NUGENT KP, 1993, BRIT J SURG, V80, P1618, DOI 10.1002/bjs.1800801244; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Shih LM, 2001, P NATL ACAD SCI USA, V98, P2640, DOI 10.1073/pnas.051629398; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Yang WC, 2001, CANCER RES, V61, P6297	26	109	118	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 19	2003	362	9379					230	232		10.1016/S0140-6736(03)13915-3	http://dx.doi.org/10.1016/S0140-6736(03)13915-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702PJ	12885487				2022-12-28	WOS:000184232000025
J	Knobel, RG; Cleland, AN				Knobel, RG; Cleland, AN			Nanometre-scale displacement sensing using a single electron transistor	NATURE			English	Article							QUALITY FACTORS; SENSITIVITY; OSCILLATOR; NOISE	It has been a long-standing goal to detect the effects of quantum mechanics on a macroscopic mechanical oscillator(1-3). Position measurements of an oscillator are ultimately limited by quantum mechanics, where 'zero-point motion' fluctuations in the quantum ground state combine with the uncertainty relation to yield a lower limit on the measured average displacement. Development of a position transducer, integrated with a mechanical resonator, that can approach this limit could have important applications in the detection of very weak forces, for example in magnetic resonance force microsopy(4) and a variety of other precision experiments(5-7). One implementation that might allow near quantum-limited sensitivity is to use a single electron transistor (SET) as a displacement sensor(8-11): the exquisite charge sensitivity of the SET at cryogenic temperatures is exploited to measure motion by capacitively coupling it to the mechanical resonator. Here we present the experimental realization of such a device, yielding an unequalled displacement sensitivity of 2x10(-15) m Hz(-1/2) for a 116-MHz mechanical oscillator at a temperature of 30 mK-a sensitivity roughly a factor of 100 larger than the quantum limit for this oscillator.	Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, iQUEST, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Cleland, AN (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	cleland@physics.ucsb.edu	Cleland, Andrew/AAG-7581-2019					Abramovici A, 1996, PHYS LETT A, V218, P157, DOI 10.1016/0375-9601(96)00377-5; Armour AD, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.148301; Beck RG, 1998, APPL PHYS LETT, V73, P1149, DOI 10.1063/1.122112; Blencowe MP, 2000, APPL PHYS LETT, V77, P3845, DOI 10.1063/1.1331090; Bocko MF, 1996, REV MOD PHYS, V68, P755, DOI 10.1103/RevModPhys.68.755; Braginsky V. B., 1992, QUANTUM MEASUREMENT; CAVES CM, 1980, REV MOD PHYS, V52, P341, DOI 10.1103/RevModPhys.52.341; Cho A, 2003, SCIENCE, V299, P36, DOI 10.1126/science.299.5603.36; Cleland AN, 2002, APPL PHYS LETT, V81, P1699, DOI 10.1063/1.1497436; Cleland AN, 1996, APPL PHYS LETT, V69, P2653, DOI 10.1063/1.117548; Cleland AN, 1999, SENSOR ACTUAT A-PHYS, V72, P256, DOI 10.1016/S0924-4247(98)00222-2; Devoret MH, 2000, NATURE, V406, P1039, DOI 10.1038/35023253; FULTON TA, 1987, PHYS REV LETT, V59, P109, DOI 10.1103/PhysRevLett.59.109; GREYWALL DS, 1994, PHYS REV LETT, V72, P2992, DOI 10.1103/PhysRevLett.72.2992; Huang XMH, 2003, NATURE, V421, P496, DOI 10.1038/421496a; Knobel R, 2002, APPL PHYS LETT, V81, P532, DOI 10.1063/1.1493221; Knobel R, 2002, APPL PHYS LETT, V81, P2258, DOI 10.1063/1.1507616; Long JC, 2003, NATURE, V421, P922, DOI 10.1038/nature01432; Mamin HJ, 2001, APPL PHYS LETT, V79, P3358, DOI 10.1063/1.1418256; Schoelkopf RJ, 1998, SCIENCE, V280, P1238, DOI 10.1126/science.280.5367.1238; SIDLES JA, 1995, REV MOD PHYS, V67, P249, DOI 10.1103/RevModPhys.67.249; TOBAR ME, 1995, REV SCI INSTRUM, V66, P2751, DOI 10.1063/1.1146503; WHITE JD, 1993, JPN J APPL PHYS 2, V32, pL1571, DOI 10.1143/JJAP.32.L1571; Yang JL, 2000, APPL PHYS LETT, V77, P3860, DOI 10.1063/1.1330225; Yasumura KY, 2000, J MICROELECTROMECH S, V9, P117, DOI 10.1109/84.825786; Zhang Y, 2002, J APPL PHYS, V91, P4249, DOI 10.1063/1.1453494	27	508	515	5	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2003	424	6946					291	293		10.1038/nature01773	http://dx.doi.org/10.1038/nature01773			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867975				2022-12-28	WOS:000184183900035
J	Rieseberg, LH; Raymond, O; Rosenthal, DM; Lai, Z; Livingstone, K; Nakazato, T; Durphy, JL; Schwarzbach, AE; Donovan, LA; Lexer, C				Rieseberg, LH; Raymond, O; Rosenthal, DM; Lai, Z; Livingstone, K; Nakazato, T; Durphy, JL; Schwarzbach, AE; Donovan, LA; Lexer, C			Major ecological transitions in wild sunflowers facilitated by hybridization	SCIENCE			English	Article							HYBRID SPECIATION; TRANSGRESSIVE SEGREGATION; HELIANTHUS-PARADOXUS; EVOLUTION; ANCIENT; ASTERACEAE; ORIGINS	Hybridization is frequent in many organismal groups, but its role in adaptation is poorly understood. In sunflowers, species found in the most extreme habitats are ancient hybrids, and new gene combinations generated by hybridization are speculated to have contributed to ecological divergence. This possibility was tested through phenotypic and genomic comparisons of ancient and synthetic hybrids. Most trait differences in ancient hybrids could be recreated by complementary gene action in synthetic hybrids and were favored by selection. The same combinations of parental chromosomal segments required to generate extreme phenotypes in synthetic hybrids also occurred in ancient hybrids. Thus, hybridization facilitated ecological divergence in sunflowers.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Univ Lyon 1, Lab Biol Mol & Phytochim, F-69622 Villeurbanne, France; Univ Georgia, Dept Plant Pathol, Athens, GA 30602 USA; Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA	Indiana University System; Indiana University Bloomington; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University System of Georgia; University of Georgia; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Rieseberg, LH (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	lriesebe@indiana.edu	Raymond, Olivier/AAO-5868-2020; Donovan, Lisa A/H-4754-2016; Rieseberg, Loren H/B-3591-2013; Rosenthal, David/C-9559-2012; Lexer, Christian/N-3702-2013	Raymond, Olivier/0000-0002-9664-5377; Donovan, Lisa A/0000-0001-9814-0666; Rieseberg, Loren H/0000-0002-2712-2417; Rosenthal, David/0000-0002-4822-5861; Lexer, Christian/0000-0002-7221-7482	PHS HHS [R01 G59065] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ABBOTT RJ, 1992, TRENDS ECOL EVOL, V7, P401, DOI 10.1016/0169-5347(92)90020-C; Anderson E., 1949, INTROGRESSIVE HYBRID; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Buerkle CA, 2000, HEREDITY, V84, P441, DOI 10.1046/j.1365-2540.2000.00680.x; DANIN A, 1991, J ARID ENVIRON, V21, P193, DOI 10.1016/S0140-1963(18)30682-7; DEVICENTE MC, 1993, GENETICS, V134, P585; Ellstrand NC, 1996, P NATL ACAD SCI USA, V93, P5090, DOI 10.1073/pnas.93.10.5090; Gibson AC, 1998, BIOSCIENCE, V48, P911, DOI 10.2307/1313295; GOULD SJ, 1979, P ROY SOC LOND B BIO, V205, P581, DOI DOI 10.1098/RSPB.1979.0086; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; GRANT V, 1981, PLANT SPECIATION; Greig D, 2002, SCIENCE, V298, P1773, DOI 10.1126/science.1076374; GROSS BL, IN PRESS AM J BOT; HUBBS CL, 1955, SYST ZOOL, V4, P1, DOI 10.2307/2411933; Lexer C, 2003, MOL ECOL, V12, P1225, DOI 10.1046/j.1365-294X.2003.01803.x; MAYR E, 1992, AM J BOT, V79, P222, DOI 10.2307/2445111; MCCARTHY EM, 1995, HEREDITY, V74, P502, DOI 10.1038/hdy.1995.71; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Rieseberg LH, 1996, SCIENCE, V272, P741, DOI 10.1126/science.272.5262.741; RIESEBERG LH, 1991, AM J BOT, V78, P1218, DOI 10.2307/2444926; Rieseberg LH, 2000, EVOLUTION, V54, P859, DOI 10.1111/j.0014-3820.2000.tb00086.x; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Rosenthal DM, 2002, INT J PLANT SCI, V163, P387, DOI 10.1086/339237; Schemske, 2000, EVOLUTION, V54, P1069, DOI DOI 10.1111/J.0014-3820.2000.TB00111.X; Schwarzbach AE, 2002, MOL ECOL, V11, P1703, DOI 10.1046/j.1365-294X.2002.01557.x; Sokal RR, 1995, BIOMETRY; Ungerer MC, 1998, P NATL ACAD SCI USA, V95, P11757, DOI 10.1073/pnas.95.20.11757; Wagner W. H. Jun., 1970, Taxon, P146; Welch ME, 2002, EVOLUTION, V56, P2126, DOI 10.1111/j.0014-3820.2002.tb00138.x; Welch ME, 2002, AM J BOT, V89, P472, DOI 10.3732/ajb.89.3.472; Wendel J.F., 1998, MOL SYSTEMATICS PLAN, P265, DOI 10.1007/978-1-4615-5419-6_10	33	857	894	2	249	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2003	301	5637					1211	1216		10.1126/science.1086949	http://dx.doi.org/10.1126/science.1086949			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZC	12907807				2022-12-28	WOS:000185003500033
J	Eisenman, DP; Gelberg, L; Liu, HH; Shapiro, MF				Eisenman, DP; Gelberg, L; Liu, HH; Shapiro, MF			Mental health and health-related quality of life among adult Latino primary care patients living in the United States with previous exposure to political violence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTIMATE PARTNER ABUSE; PSYCHOLOGICAL SEQUELAE; POSTTRAUMATIC-STRESS; TORTURE; TRAUMA; REFUGEES; IMPACT; EXILE; SYMPTOMATOLOGY; WAR	Context Although political violence continues in parts of Central America, South America, and Mexico, little is known about its relationship to the health of Latino immigrants living in the United States. Objective To determine (1) rates of exposure to political violence among Latino adult primary care patients who have immigrated to the United States from Central America, South America, and Mexico and its impact on mental health and health-related quality of life and (2) frequency of disclosure of political violence to primary care clinicians. Design, Setting, and Participants Two-stage cluster design survey of a systematic sample of Latino immigrant adults in 3 community-based primary care clinics in Los Angeles, conducted from July 2001 to February 2002. Main Outcome Measures Reports of exposure to political violence in home country before immigrating to the United States and communication with clinicians about political violence; self-reported measures of health-related quality of life using the Medical Outcomes Study Short Form 36 (MOS SF-36); symptoms of depression, anxiety, and alcohol disorders using the Primary Care Evaluation of Mental Disorders (PRIME-MD); and symptoms of posttraumatic stress disorder (PTSD) using the PTSD Checklist-Civilian Version (PCL-C). Results A total of 638 (69%) of 919 eligible patients participated. The nonresponse rates did not differ by age, sex, recruitment sites, or clinic sessions. In weighted analyses, 54% of participants reported political violence experiences in their home countries, including 8% who reported torture. Of those exposed to political violence, 36% had symptoms of depression and 18% had symptoms of PTSD vs 20% and 8%, respectively, among those not exposed to political violence. Controlling for age, sex, country, years lived in the United States, acculturation, income, health insurance status, and recruitment site in a subsample of 512 participants (56%), those who reported political violence exposure were more likely to meet symptom criteria for PTSD (adjusted odds ratio [AOR], 3.4; 95% confidence interval [CI], 1.4-8.4) and to have symptoms of depression (AOR, 2.8; 95% CI, 1.4-5.4) and symptoms of panic disorder (AOR, 4.8; 95% CI, 1.6-14.4) than participants not reporting political violence. Those exposed to political violence reported more chronic pain and role limitations due to physical problems, as well as worse physical functioning and lower perceptions of general health than those who were not exposed to political violence. Only 3% of the 267 patients who had experienced political violence reported ever telling a clinician about it after immigrating; none reported their current physician asking about political violence. Conclusion Latino immigrants in primary care in Los Angeles have a high prevalence of exposure to political violence before immigrating to the United States and associated impairments in mental health and health-related quality of life.	Univ Calif Los Angeles, Sch Med, Div Gen Internal Med & Hlth Serv Res, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Family Med, Los Angeles, CA 90095 USA; RAND Corp, Hlth Sci Program, Santa Monica, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; RAND Corporation	Eisenman, DP (corresponding author), Univ Calif Los Angeles, Sch Med, Div Gen Internal Med & Hlth Serv Res, Dept Med, 911 Broxton Plaza, Los Angeles, CA 90095 USA.	deisenman@mednet.ucla.edu			BHP HRSA HHS [PE-19001] Funding Source: Medline	BHP HRSA HHS		Allden K, 1996, AM J PUBLIC HEALTH, V86, P1561, DOI 10.2105/AJPH.86.11.1561; *AMN INT, 2003, AMN INT ANN REP; BASOGLU M, 1994, AM J PSYCHIAT, V151, P76; Bauer HM, 2000, J GEN INTERN MED, V15, P811, DOI 10.1046/j.1525-1497.2000.91217.x; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; CERVANTES RC, 1989, HOSP COMMUNITY PSYCH, V40, P615; Cunningham M, 1997, AUST NZ J PSYCHIAT, V31, P555, DOI 10.3109/00048679709065078; Eisenman DP, 2000, WESTERN J MED, V172, P301, DOI 10.1136/ewjm.172.5.301; GOLDFELD AE, 1988, JAMA-J AM MED ASSOC, V259, P2725, DOI 10.1001/jama.259.18.2725; GOLDFELD AE, 1988, JAMA-J AM MED ASSOC, V260, P478; GREEN BL, 1995, INT HDB TRAUMATIC ST; Hays RD, 2000, PHARMACOECONOMICS, V18, P419, DOI 10.2165/00019053-200018050-00001; Heisler M, 2003, JAMA-J AM MED ASSOC, V289, P2135, DOI 10.1001/jama.289.16.2135; Holman EA, 2000, ARCH FAM MED, V9, P802, DOI 10.1001/archfami.9.9.802; Holtz TH, 1998, J NERV MENT DIS, V186, P24, DOI 10.1097/00005053-199801000-00005; KOSS MP, 1991, ARCH INTERN MED, V151, P342, DOI 10.1001/archinte.151.2.342; Lavik NJ, 1996, BRIT J PSYCHIAT, V169, P726, DOI 10.1192/bjp.169.6.726; Linzer M, 1996, AM J MED, V101, P526, DOI 10.1016/S0002-9343(96)00275-6; McCauley J, 1997, JAMA-J AM MED ASSOC, V277, P1362, DOI 10.1001/jama.277.17.1362; MOLLICA RF, 1987, AM J PSYCHIAT, V144, P1567; MOLLICA RF, 1993, JAMA-J AM MED ASSOC, V270, P581, DOI 10.1001/jama.270.5.581; Neugebauer R, 1999, AM J PUBLIC HEALTH, V89, P1473, DOI 10.2105/AJPH.89.10.1473; Nice DS, 1996, JAMA-J AM MED ASSOC, V276, P375, DOI 10.1001/jama.276.5.375; RAMPAL P, 1994, SCAND J GASTROENTERO, V29, P44, DOI 10.3109/00365529409091421; RAMSAY R, 1993, BRIT J PSYCHIAT, V162, P55, DOI 10.1192/bjp.162.1.55; RICHTERS JE, 1993, PSYCHIATRY, V56, P7; Robison J, 2002, J GERONTOL A-BIOL, V57, pM308, DOI 10.1093/gerona/57.5.M308; Rodriguez MA, 2001, J FAM PRACTICE, V50, P338; Schuster MA, 2001, NEW ENGL J MED, V345, P1507, DOI 10.1056/NEJM200111153452024; Shrestha NM, 1998, JAMA-J AM MED ASSOC, V280, P443, DOI 10.1001/jama.280.5.443; Silove D, 1997, BRIT J PSYCHIAT, V170, P351, DOI 10.1192/bjp.170.4.351; Sleath BL, 2001, ANN PHARMACOTHER, V35, P419; Spiegel PB, 2000, LANCET, V355, P2204, DOI 10.1016/S0140-6736(00)02404-1; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Stein MB, 2000, GEN HOSP PSYCHIAT, V22, P261, DOI 10.1016/S0163-8343(00)00080-3; STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907; Summerfield D, 1991, Med War, V7, P84, DOI 10.1080/07488009108408972; Sundquist J, 1996, SOC PSYCH PSYCH EPID, V31, P21; SUNDQUIST J, 1995, SCAND J PRIM HEALTH, V13, P135, DOI 10.3109/02813439508996750; THOMPSON M, 1995, AUST NZ J PSYCHIAT, V29, P84, DOI 10.3109/00048679509075896; *US BUR CENS, 2000, POP EST COUNT RAC HI; Vega WA, 1999, AM J PSYCHIAT, V156, P928, DOI 10.1176/ajp.156.6.928; WATCH H, 2002, HUMAN RIGHTS WATCH W; Willis BM, 2000, JAMA-J AM MED ASSOC, V284, P612, DOI 10.1001/jama.284.5.612; Willis GB, 1998, J NERV MENT DIS, V186, P283, DOI 10.1097/00005053-199805000-00004	45	132	137	4	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2003	290	5					627	634		10.1001/jama.290.5.627	http://dx.doi.org/10.1001/jama.290.5.627			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	708GH	12902366	Bronze			2022-12-28	WOS:000184558500017
J	Keenan, HT; Runyan, DK; Marshall, SW; Nocera, MA; Merten, DF; Sinal, SH				Keenan, HT; Runyan, DK; Marshall, SW; Nocera, MA; Merten, DF; Sinal, SH			A population-based study of inflicted traumatic brain injury in young children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SHAKEN IMPACT SYNDROME; ABUSIVE HEAD TRAUMA; BABY SYNDROME; INFANTS; RISK	Context Physical abuse is a leading cause of serious head injury and death in children aged 2 years or younger. The incidence of inflicted traumatic brain injury (TBI) in US children is unknown. Objective To determine the incidence of serious or fatal inflicted TBI in a defined US population of approximately 230000 children aged 2 years or younger. Design, Setting, and Subjects All North Carolina children aged 2 years or younger who were admitted to a pediatric intensive care unit or who died with a TBI in 2000 and 2001 were identified prospectively. Injuries were considered inflicted if accompanied by a confession or a medical and social service agency determination of abuse. Main Outcome Measure Incidence of inflicted TBI. Multivariate logistic regression models were used to compare children with inflicted injuries with those with non-inflicted injuries and with the general state population aged 2 years or younger. Results A total of 152 cases of serious or fatal TBI were identified, with 80 (53%) incurring inflicted TBI. The incidence of inflicted traumatic brain injury in the first 2 years of life was 17.0 (95% confidence interval [CI], 13.3-20.7) per 100000 person-years. Infants had a higher incidence than children in the second year of life (29.7 [95% CI, 22.9-36.7] vs 3.8 [95% CI, 1.3-6.4] per 100000 person-years). Boys had a higher incidence than girls (21.0 [95% CI, 15.1-26.6] vs 13.0 [95% CI, 8.4-17.7] per 100000 person-years). Relative to the general population, children who incurred an increased risk of inflicted injury were born to young mothers (less than or equal to21 years), non-European American, or products of multiple births. Conclusions In this population of North Carolina children, the incidence of inflicted TBI varied by characteristics of the injured children and their mothers. These data may be helpful for informing preventive interventions.	Univ N Carolina, Sch Med, Dept Social Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Orthoped, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Radiol, Chapel Hill, NC 27599 USA; Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC USA; Wake Forest Univ, Bowman Gray Sch Med, Brenner Childrens Hosp, Dept Pediat, Winston Salem, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Wake Forest University; Wake Forest Baptist Medical Center	Keenan, HT (corresponding author), Univ N Carolina, Sch Med, Dept Social Med, Wing D,CB7240, Chapel Hill, NC 27599 USA.		Runyan, Desmond/S-3974-2016	Runyan, Desmond/0000-0001-5571-9029; Marshall, Stephen/0000-0002-2664-9233	ODCDC CDC HHS [R49/CCR402444] Funding Source: Medline	ODCDC CDC HHS		Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; BRUCE DA, 1989, PEDIATR ANN, V18, P482, DOI 10.3928/0090-4481-19890801-07; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; GESSNER RR, 1995, ARCH PEDIAT ADOL MED, V149, P467; GROOTHUIS JR, 1982, PEDIATRICS, V70, P769; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Lane WG, 2002, JAMA-J AM MED ASSOC, V288, P1603, DOI 10.1001/jama.288.13.1603; LUDWIG S, 1984, ANN EMERG MED, V13, P104, DOI 10.1016/S0196-0644(84)80571-5; LUDWIG S, 1990, AJDC, V144, P724; *NC CTR HLTH STAT, HLTH STAT STAT CTR; Overpeck MD, 1998, NEW ENGL J MED, V339, P1211, DOI 10.1056/NEJM199810223391706; Sinal SH, 2000, CHILD ABUSE NEGLECT, V24, P1241, DOI 10.1016/S0145-2134(00)00177-0; STARLING SP, 1995, PEDIATRICS, V95, P259; STIER DM, 1993, PEDIATRICS, V91, P642; *US DEP HHS, 1988, INT CLASS DIS 9 REV	20	401	409	2	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2003	290	5					621	626		10.1001/jama.290.5.621	http://dx.doi.org/10.1001/jama.290.5.621			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708GH	12902365	Bronze			2022-12-28	WOS:000184558500016
J	Radcliffe, MJ; Lewith, GT; Turner, RG; Prescott, P; Church, MK; Holgate, ST				Radcliffe, MJ; Lewith, GT; Turner, RG; Prescott, P; Church, MK; Holgate, ST			Enzyme potentiated desensitisation in treatment of seasonal allergic rhinitis: double blind randomised controlled study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BETA-GLUCURONIDASE; HYPOSENSITIZATION; SUGARS	Objective To assess the efficacy of enzyme potentiated desensitisation in the treatment of severe summer hay fever poorly controlled by pharmacotherapy. Design Double blind randomised placebo controlled parallel group study. Setting Hospital in Hampshire. Participants 183 participants aged between 18 and 64 with a history of severe summer hay fever for at least two years; all were skin prick test positive to timothy grass pollen. 90 randomised to active treatment; 93 randomised to placebo. Interventions Active treatment: two injections of enzyme potentiated desensitisation, given between eight and 11 weeks apart, each comprising 200 Fishman units of beta glucuronidase, 50 pg 1,3-cyclohexanediol, 50 ng protamine sulphate, and a mixed inhaled allergen extract (pollen mixes for trees, grasses, and weeds; allergenic fungal spores; cat and dog danders; dust and storage mites) in a total volume of 0.05 ml buffered saline. Placebo: two injections of 0.05 ml buffered saline solution. Main outcome measures Proportion of problem-free days; global rhinoconjunctivitis quality of life scores assessed weekly during pollen season. Results The active treatment group and the placebo group did not differ in the proportion of problem-free days, quality of life scores, symptom severity scores, change in quantitative skin prick provocation threshold, or change in conjunctival provocation threshold. No clinically significant adverse reactions occurred. Conclusions Enzyme potentiated desensitisation showed no treatment effect in this study.	Univ Southampton, Southampton Gen Hosp, Sch Med, Infect Inflammat & Repair Res Div, Southampton S016 6YF, Hants, England; Univ Southampton, Royal S Hants Hosp, Sch Med, Community Clin Sci Res Div, Southampton SO14 0YG, Hants, England; N Hampshire Hosp, Basingstoke RG24 9NA, Hants, England; Univ Southampton, Fac Math Studies, Southampton SO17 1BJ, Hants, England	University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; Royal South Hants Hospital; University of Southampton	Radcliffe, MJ (corresponding author), Univ Southampton, Southampton Gen Hosp, Sch Med, Infect Inflammat & Repair Res Div, Southampton S016 6YF, Hants, England.	michael@radcliffe.net		Lewith, George/0000-0002-2364-3960				ANGELINI G, 1993, MEDIT J SURG MED, P253; [Anonymous], 1986, Br Med J (Clin Res Ed), V293, P948; Astarita C, 1996, J INVEST ALLERG CLIN, V6, P248; Bousquet J, 1998, ALLERGY, V53, P4; Caramia G, 1996, Allerg Immunol (Paris), V28, P308; Di Stanislao C, 1997, Allerg Immunol (Paris), V29, P39; Durham SR, 1999, NEW ENGL J MED, V341, P468, DOI 10.1056/NEJM199908123410702; FELL P, 1990, EUR J CLIN PHARMACOL, V38, P77, DOI 10.1007/BF00314808; Juniper EF, 2000, CLIN EXP ALLERGY, V30, P132; LONGO G, 1992, RIFORMA MED, V107, P171; MALLING HJ, 1987, ALLERGY, V42, P391, DOI 10.1111/j.1398-9995.1987.tb02226.x; MCEWEN LM, 1973, ANN ALLERGY, V31, P79; MCEWEN LM, 1973, ANN ALLERGY, V31, P543; MOLLER C, 1984, ALLERGY, V39, P37, DOI 10.1111/j.1398-9995.1984.tb01931.x	14	17	18	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 2	2003	327	7409					251	254		10.1136/bmj.327.7409.251	http://dx.doi.org/10.1136/bmj.327.7409.251			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708KP	12896934	Green Published, Bronze			2022-12-28	WOS:000184566300015
J	Seeman, E				Seeman, E			Periosteal bone formation - A neglected determinant of bone strength	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							WOMEN; GAIN		Univ Melbourne, Austin Hosp, Melbourne, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Seeman, E (corresponding author), Univ Melbourne, Austin Hosp, Melbourne, Vic, Australia.		Seeman, Ego/AAC-3656-2019	Seeman, Ego/0000-0002-9692-048X				BALENA R, 1992, J BONE MINER RES, V7, P1475; CURREY JD, 2002, BONES STRUCTURE MECH, P1; Duan YB, 2001, J BONE MINER RES, V16, P2267, DOI 10.1359/jbmr.2001.16.12.2267; Garn S, 1970, EARLIER GAIN LATER L, P3; Seeman E, 2003, ENDOCRIN METAB CLIN, V32, P25, DOI 10.1016/S0889-8529(02)00078-6	5	291	299	1	15	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2003	349	4					320	323		10.1056/NEJMp038101	http://dx.doi.org/10.1056/NEJMp038101			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703ZH	12878736				2022-12-28	WOS:000184312800002
J	Timmerman, R				Timmerman, R			Raccoon eyes and neuroblastoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Indiana Univ, Sch Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Timmerman, R (corresponding author), Indiana Univ, Sch Med, Indianapolis, IN 46202 USA.		Timmerman, Robert D/C-2222-2013						0	11	12	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2003	349	4					E4	E4		10.1056/ENEJMicm020675	http://dx.doi.org/10.1056/ENEJMicm020675			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703ZH	12878754				2022-12-28	WOS:000184312800010
J	Khanna, R; Kumar, A; Vaghela, JF; Sreenivas, V; Puliyel, JM				Khanna, R; Kumar, A; Vaghela, JF; Sreenivas, V; Puliyel, JM			Community based retrospective study of sex in infant mortality in India	BRITISH MEDICAL JOURNAL			English	Article							CHILDREN; PUNJAB	Objective To determine whether the imbalance in the sex ratio in India can be explained by less favourable treatment of girls in infancy. Design Analysis of results of verbal autopsy reports over a five year period. Setting Community health project in urban India. Main outcome measures Deaths from all causes in infants aged less than 1 year. Results The sex ratio at birth was 869 females per 1000 males. The mean infant mortality was 1.3 times higher in females than in males (72 v 55 per 1000). Diarrhoea was responsible for 22% of deaths overall, though twice as many girls died from diarrhoea. There were no significant differences in the numbers of deaths from causes such as birth asphyxia, septicaemia, prematurity, and congenital anomalies. In 10% of deaths there was no preceding illness and no satisfactory cause was found. Three out of every four such deaths were in girls. Conclusions The excess number of unexplained deaths and deaths due to treatable conditions such as diarrhoeal disease in girls may be because girls are regarded and treated less favourably in India.	St Stephens Hosp, Dept Community Med, Delhi 110054, India; All India Inst Med Sci, Dept Biostat, New Delhi 110029, India; St Stephens Hosp, Dept Paediat, Delhi 110054, India	St. Stephen's Hospital; All India Institute of Medical Sciences (AIIMS) New Delhi; St. Stephen's Hospital	Kumar, A (corresponding author), St Stephens Hosp, Dept Community Med, Delhi 110054, India.							BANG AT, 1992, B WORLD HEALTH ORGAN, V70, P499; BOOTH BE, 1994, BRIT MED J, V309, P1259, DOI 10.1136/bmj.309.6964.1259; Census of India, 2001, PROV POP TOT; Chatterjee M, 1990, REPORT INDIAN WOMEN; Choudhary R, 2002, HEALTH POLICY PLANN, V17, P420, DOI 10.1093/heapol/17.4.420; Claeson M, 2000, B WORLD HEALTH ORGAN, V78, P1192; *CTR ENQ HLTH ALL, 2001, LAW J SUPREME COURT, V5, P577; DASGUPTA M, 1987, POPUL DEV REV, V13, P77; DATTA N, 1988, Indian Journal of Pediatrics, V55, P599, DOI 10.1007/BF02868443; GHOSH S, 1987, B NUTR FDN INDIA, V8, P4; GHOSH S, 1997, B NUTR FDN INDIA, V8, P4; *INT I POP SCI OCR, 2002, NAT FAM HLTH SURV NF; KULKARNI S, 1986, RADICAL J HLTH, V1, P99; Lopez A. D., 1983, SEX DIFFERENTIALS MO; NAKAJIMA H, 1996, WORLD HLTH REPORT 19; PARK K, 1997, PARKS TXB PREVENTIVE, P370; *REG GEN IND, 1991, SURV CAUS DEATH RU 1; Shrivastava S P, 2001, Indian Pediatr, V38, P1022; *UN DEP EC SOC AFF, 1997, WORLD POP PROSP 1996	19	47	48	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 19	2003	327	7407					126	128A		10.1136/bmj.327.7407.126	http://dx.doi.org/10.1136/bmj.327.7407.126			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	702WJ	12869451	Green Published, Bronze			2022-12-28	WOS:000184247500014
J	Bland, PA; Artemieva, NA				Bland, PA; Artemieva, NA			Efficient disruption of small asteroids by Earth's atmosphere	NATURE			English	Article							IMPACTS; OBJECTS; MOTION; FLUX	Accurate modelling of the interaction between the atmosphere and an incoming bolide is a complex task, but crucial to determining the fraction of small asteroids that actually hit the Earth's surface. Most semi-analytical approaches have simplified the problem by considering the impactor as a strengthless liquid-like object ('pancake' models(1,2)), but recently a more realistic model has been developed that calculates motion, aerodynamic loading and ablation for each separate particle or fragment in a disrupted impactor(3,4). Here we report the results of a large number of simulations in which we use both models to develop a statistical picture of atmosphere-bolide interaction for iron and stony objects with initial diameters up to similar to1 km. We show that the separated-fragments model predicts the total atmospheric disruption of much larger stony bodies than previously thought. In addition, our data set of >1,000 simulated impacts, combined with the known pre-atmospheric flux of asteroids with diameters less than 1 km(5-12), elucidates the flux of small bolides at the Earth's surface. We estimate that bodies >220 m in diameter will impact every 170,000 years.	Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; Russian Acad Sci, Inst Dynam Geospheres, Moscow 117939, Russia	Imperial College London; Russian Academy of Sciences; Sadovsky Institute of Geosphere Dynamics of the Russian Academy of Sciences	Bland, PA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, Exhibit Rd,S Kensington Campus, London SW7 2AZ, England.	p.a.bland@imperial.ac.uk	Bland, Phil/M-9392-2018	Bland, Phil/0000-0002-4681-7898				Artemieva NA, 2001, J GEOPHYS RES-PLANET, V106, P3297, DOI 10.1029/2000JE001264; Binzel R. P., 2002, ASTEROIDS, VIII, P255; Bland PA, 1996, MON NOT R ASTRON SOC, V283, P551, DOI 10.1093/mnras/283.2.551; Brown P, 2002, NATURE, V420, P294, DOI 10.1038/nature01238; Bus SJ, 2002, ICARUS, V158, P146, DOI 10.1006/icar.2002.6856; CHAPMAN CR, 1994, NATURE, V367, P33, DOI 10.1038/367033a0; Grieve RAF, 1994, HAZARDS DUE COMETS A, P417; Halliday I, 1996, METORIT PLANET SCI, V31, P185, DOI 10.1111/j.1945-5100.1996.tb02014.x; HARRIS AW, IN PRESS P AST COM M; Hartmann WK, 1999, METEORIT PLANET SCI, V34, P167, DOI 10.1111/j.1945-5100.1999.tb01743.x; HILLS JG, 1993, ASTRON J, V105, P1114, DOI 10.1086/116499; Hughes DW, 2000, MON NOT R ASTRON SOC, V317, P429, DOI 10.1046/j.1365-8711.2000.03568.x; Ivanov B.A., 2002, ASTEROIDS, P89; IVANOV BA, 2001, CHRONOLOGY EVOLUTION, P87, DOI DOI 10.1007/978-94-017-1035-0_4; Matthews M. S., 1989, ASTEROIDS, VII; Melosh H.J., 1989, OXFORD MONOGRAPHS GE; Morbidelli A, 2002, ICARUS, V158, P329, DOI 10.1006/icar.2002.6887; MORRISON D, 1994, HAZARDS DUE COMETS A, P59; Nemtchinov IV, 1997, ICARUS, V130, P259, DOI 10.1006/icar.1997.5821; PASSEY QR, 1980, ICARUS, V42, P211, DOI 10.1016/0019-1035(80)90072-X; Rabinowitz D, 2000, NATURE, V403, P165, DOI 10.1038/35003128; Revelle DO, 1997, ANN NY ACAD SCI, V822, P284, DOI 10.1111/j.1749-6632.1997.tb48347.x; Schmidt R.M., 1987, INT J IMPACT ENG, V5, P543, DOI [DOI 10.1016/0734-743X(87)90069-8, 10.1016/0734-743X(87)90069-8]; Shuvalov VV, 2000, SOLAR SYST RES+, V34, P49; Stuart JS, 2001, SCIENCE, V294, P1691, DOI 10.1126/science.1065318; Ward SN, 2000, ICARUS, V145, P64, DOI 10.1006/icar.1999.6336	27	88	89	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2003	424	6946					288	291		10.1038/nature01757	http://dx.doi.org/10.1038/nature01757			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867974				2022-12-28	WOS:000184183900034
J	Daily, JP; Waldron, MA; Harris, NL; Brown, DF				Daily, JP; Waldron, MA; Harris, NL; Brown, DF			Case 22-2003: A 22-year-old man with chills and fever after a stay in South America - Plasmodium vivax malaria	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							AMEBIC LIVER-ABSCESS; FALCIPARUM-MALARIA; RETURNED TRAVELER; BARTONELLOSIS; CHLOROQUINE; MICROSCOPY; RESISTANCE; DIAGNOSIS; PARASITES; OUTBREAK		Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Massachusetts Gen Hosp, Clin Microbiol labs, Parasitol Sect, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Daily, JP (corresponding author), Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.							BAIRD JK, 1992, T ROY SOC TROP MED H, V86, P3, DOI 10.1016/0035-9203(92)90412-6; Baird JK, 1997, AM J TROP MED HYG, V56, P627, DOI 10.4269/ajtmh.1997.56.627; Bruni, 1997, J Travel Med, V4, P61, DOI 10.1111/j.1708-8305.1997.tb00781.x; Chamberlin J, 2000, J CLIN MICROBIOL, V38, P4269, DOI 10.1128/JCM.38.11.4269-4271.2000; Cooke AH, 1999, AM J TROP MED HYG, V60, P173, DOI 10.4269/ajtmh.1999.60.173; Cooper P, 1997, T ROY SOC TROP MED H, V91, P544, DOI 10.1016/S0035-9203(97)90019-5; DOHERTY JF, 1995, QJM-INT J MED, V88, P277; DOURADO HV, 1994, INFECT DIS CLIN N AM, V8, P207; Ellis BA, 1999, AM J TROP MED HYG, V61, P344; Felton JM, 1996, BRIT J HOSP MED, V55, P705; JARVETZ E, 1987, REV MED BIOL; KNOBLOCH J, 1983, AM J TROP MED HYG, V32, P727, DOI 10.4269/ajtmh.1983.32.727; LOOAREESUWAN S, 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P44; Magill AJ, 1998, INFECT DIS CLIN N AM, V12, P445, DOI 10.1016/S0891-5520(05)70013-1; Maguina C, 2000, INFECT DIS CLIN N AM, V14, P1, DOI 10.1016/S0891-5520(05)70215-4; MALTZ G, 1991, AM J GASTROENTEROL, V86, P704; MAWHORTER SD, 1999, TROPICAL INFECT DIS, V2, P1420; *NAT CTR INF DIS, TRAV HLTH; O'Brien D, 2001, CLIN INFECT DIS, V33, P603, DOI 10.1086/322602; Richards MW, 1998, AM J TROP MED HYG, V59, P859, DOI 10.4269/ajtmh.1998.59.859; RICKMAN LS, 1989, LANCET, V1, P68; RIECKMANN KH, 1989, LANCET, V2, P1183, DOI 10.1016/S0140-6736(89)91792-3; RODIER GR, 2000, HUNTERS TROPICAL MED, P1071; Ryan ET, 2002, NEW ENGL J MED, V347, P505, DOI 10.1056/NEJMra020118; Soto J, 2001, AM J TROP MED HYG, V65, P90, DOI 10.4269/ajtmh.2001.65.90; STEFFEN R, 1987, J INFECT DIS, V156, P84, DOI 10.1093/infdis/156.1.84; Suh KN, 1999, MED CLIN N AM, V83, P997; Weinman D., 1977, Parasitic protozoa. Volume IV. Babesia, Theileria, Myxosporida, Microsporida, Bartonellaceae, Anaplasmataceae, Ehrlichia, and Pneumocystis., P197; Whitby M, 1997, J ANTIMICROB CHEMOTH, V40, P749, DOI 10.1093/jac/40.6.749; Wilson ME, 1991, WORLD GUIDE INFECT D; World Health Organization, SCHIST; 1997, MMWR MORB MORTAL WKL, V46, P577; 2000, MMWR MORB MORTAL WKL, V49, P1004; 2001, MMWR MORB MORTAL WKL, V50, P21; 2000, EPIDEMIOL B, V21, P10; 2001, MMWR CDC SURVEILL SU, V50, P25	36	2	2	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2003	349	3					287	295		10.1056/NEJMcpc020030	http://dx.doi.org/10.1056/NEJMcpc020030			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701KA	12867613				2022-12-28	WOS:000184165700014
J	Lopez-Urrutia, A				Lopez-Urrutia, A			Allometry: How reliable is the biological time clock?	NATURE			English	Editorial Material							TEMPERATURE; SIZE		Plymouth Marine Lab, Plymouth PL1 3DH, Devon, England	Plymouth Marine Laboratory	Lopez-Urrutia, A (corresponding author), Plymouth Marine Lab, Citadel Hill, Plymouth PL1 3DH, Devon, England.	alop@pml.ac.uk	Lopez-Urrutia, Angel/L-2636-2014; Lopez-Urrutia, Angel/R-9475-2019					Belehradek J, 1926, NATURE, V118, P478, DOI 10.1038/118478b0; Belehradek J, 1926, NATURE, V118, P117, DOI 10.1038/118117a0; Belehradek J., 1935, PROTOPLASMA MONOGRAP, V8; Crozier WJ, 1924, P NATL ACAD SCI USA, V10, P461, DOI 10.1073/pnas.10.11.461; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gillooly JF, 2000, FRESHWATER BIOL, V44, P595, DOI 10.1046/j.1365-2427.2000.00607.x; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; Hellbrunn LV, 1925, SCIENCE, V62, P268, DOI 10.1126/science.62.1603.268; LUDWIG DANIEL, 1928, PHYSIOL ZOOL, V1, P358	9	3	3	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 17	2003	424	6946					269	270		10.1038/424269a	http://dx.doi.org/10.1038/424269a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701RZ	12867970				2022-12-28	WOS:000184183900029
J	Tarduno, JA; Duncan, RA; Scholl, DW; Cottrell, RD; Steinberger, B; Thordarson, T; Kerr, BC; Neal, CR; Frey, FA; Torii, M; Carvallo, C				Tarduno, JA; Duncan, RA; Scholl, DW; Cottrell, RD; Steinberger, B; Thordarson, T; Kerr, BC; Neal, CR; Frey, FA; Torii, M; Carvallo, C			The Emperor Seamounts: Southward motion of the Hawaiian hotspot plume in earth's mantle	SCIENCE			English	Article							PLATE MOTIONS; PACIFIC; ATLANTIC; APPARENT; FIELD	The Hawaiian-Emperor hotspot track has a prominent bend, which has served as the basis for the theory that the Hawaiian hotspot, fixed in the deep mantle, traced a change in plate motion. However, paleomagnetic and radiometric age data from samples recovered by ocean drilling de. ne an age-progressive paleolatitude history, indicating that the Emperor Sea-mount trend was principally formed by the rapid motion (over 40 millimeters per year) of the Hawaiian hotspot plume during Late Cretaceous to early-Tertiary times (81 to 47 million years ago). Evidence for motion of the Hawaiian plume affects models of mantle convection and plate tectonics, changing our understanding of terrestrial dynamics.	Univ Rochester, Dept Earth & Environm Sci, Rochester, NY 14627 USA; Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; Stanford Univ, Dept Geophys, Stanford, CA 94305 USA; Japan Marine Sci & Technol Ctr, Inst Frontier Res Earth Evolut, Yokosuka, Kanagawa 2370061, Japan; Univ Hawaii, Sch Ocean & Earth Sci & Technol, Dept Geol & Geophys, Honolulu, HI 96822 USA; Univ Notre Dame, Dept Civil Engn & Geol Sci, Notre Dame, IN 46556 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Okayama Univ Sci, Dept Biosphere Geosphere Syst Sci, Okayama 7000005, Japan; Univ Toronto, Dept Phys, Div Geophys, Mississauga, ON L5L 1C6, Canada	University of Rochester; Oregon State University; Stanford University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Hawaii System; University of Notre Dame; Massachusetts Institute of Technology (MIT); Okayama University of Science; University of Toronto; University Toronto Mississauga	Tarduno, JA (corresponding author), Univ Rochester, Dept Earth & Environm Sci, 601 Elmwood Ave, Rochester, NY 14627 USA.	john@earth.rochester.edu	Steinberger, Bernhard/ABB-9204-2021; Carvallo, Claire/Q-8118-2016; Neal, Clive R/C-2316-2014; Duncan, Robert A/A-2168-2013; Thordarson, Thorvaldur/M-2422-2015; Steinberger, Bernhard/AAG-7148-2019	Carvallo, Claire/0000-0002-0986-3203; Thordarson, Thorvaldur/0000-0003-4011-7185; Steinberger, Bernhard/0000-0002-3643-3049; Cottrell, Rory/0000-0003-4174-6389; Tarduno, John/0000-0002-0490-0124; Frey, Frederick/0000-0002-5403-5677				ATWATER T, 1989, E PACIFIC OCEAN HAWA, P21, DOI DOI 10.1130/DNAG-GNA-N.21; Becker TW, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000168; Berggren W. A., 1995, GEOCHRONOLOGY TIME S, P129, DOI DOI 10.2110/PEC.95.04.0129; Besse J, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2000JB000050; Bunge HP, 2000, NATURE, V405, P337, DOI 10.1038/35012586; Cottrell RD, 2003, TECTONOPHYSICS, V362, P321, DOI 10.1016/S0040-1951(02)00643-1; COX A, 1970, GEOPHYS J ROY ASTR S, V20, P253, DOI 10.1111/j.1365-246X.1970.tb06069.x; Dalrymple G.B., 1980, INITIAL REPORTS DEEP, V55, P659; Davaille A, 2002, EARTH PLANET SC LETT, V203, P621, DOI 10.1016/S0012-821X(02)00897-X; DiVenere V, 1999, EARTH PLANET SC LETT, V170, P105, DOI 10.1016/S0012-821X(99)00096-5; Ebinger CJ, 1998, NATURE, V395, P788, DOI 10.1038/27417; Engebretson D., 1985, GEOL SOC AM SPEC PAP, V206, P1, DOI DOI 10.1130/SPE206-P1; FISHER R, 1953, PROC R SOC LON SER-A, V217, P295, DOI 10.1098/rspa.1953.0064; GOLDREICH P, 1969, J GEOPHYS RES, V74, P2555, DOI 10.1029/JB074i010p02555; Jellinek AM, 2002, NATURE, V418, P760, DOI 10.1038/nature00979; Keller RA, 2000, NATURE, V405, P673, DOI 10.1038/35015057; Kono M., 1980, INITIAL REP DEEP SEA, V55, P737, DOI DOI 10.2973/DSDP.PR0C.55.135.1980; LIVERMORE RA, 1984, GEOPHYS J ROY ASTR S, V79, P939, DOI 10.1111/j.1365-246X.1984.tb02878.x; MCFADDEN PL, 1982, GEOPHYS J ROY ASTR S, V69, P307, DOI 10.1111/j.1365-246X.1982.tb04950.x; MCFADDEN PL, 1991, J GEOPHYS RES-SOLID, V96, P3923, DOI 10.1029/90JB02275; McKenzie J. A., 1980, INITIAL REP DEEP SEA, V55, P415, DOI DOI 10.2973/DSDP.PROC.55.115.1980; MOLNAR P, 1987, NATURE, V327, P587, DOI 10.1038/327587a0; MOLNAR P, 1973, NATURE, V246, P288, DOI 10.1038/246288a0; MORGAN WJ, 1971, NATURE, V230, P42, DOI 10.1038/230042a0; Muller RD, 1997, J GEOPHYS RES-SOL EA, V102, P3211, DOI 10.1029/96JB01781; NORTON IO, 1995, TECTONICS, V14, P1080, DOI 10.1029/95TC01256; Raymond C.A., 2000, HIST DYNAMICS GLOBAL, V121, P359; Richards MA, 1996, EARTH PLANET SC LETT, V137, P19, DOI 10.1016/0012-821X(95)00209-U; SHARP WD, 2002, EOS, V83, pF1282; Steinberger B, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2002GC000334; STEINBERGER BM, 2001, EUR UN GEOSC 11 M ST; TARDUNO JA, 1990, GEOPHYS RES LETT, V17, P101, DOI 10.1029/GL017i001p00101; Tarduno JA, 2002, EARTH PLANET SC LETT, V198, P533, DOI 10.1016/S0012-821X(02)00496-X; Tarduno JA, 2001, EARTH PLANET SC LETT, V184, P549, DOI 10.1016/S0012-821X(00)00348-4; Tarduno JA, 1997, EARTH PLANET SC LETT, V153, P171, DOI 10.1016/S0012-821X(97)00169-6; TARDUNO JA, 1995, NATURE, V378, P477, DOI 10.1038/378477a0; TARDUNO JA, 2002, P OC DRILL PROGR IN, V197; Van der Voo R, 2001, EARTH PLANET SC LETT, V187, P71, DOI 10.1016/S0012-821X(01)00285-0; WILSON JT, 1963, CAN J PHYS, V41, P863, DOI 10.1139/p63-094	39	273	290	0	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2003	301	5636					1064	1069		10.1126/science.1086442	http://dx.doi.org/10.1126/science.1086442			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	713RP	12881572				2022-12-28	WOS:000184872400031
J	Steinbrook, R				Steinbrook, R			Trial design and patient safety - The debate continues	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RESPIRATORY-DISTRESS-SYNDROME											BORROR K, 2003, COMMUNICATION   0703; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Drazen JM, 2003, NEW ENGL J MED, V348, P1377, DOI 10.1056/NEJMe030031; Steinbrook R, 2003, NEW ENGL J MED, V348, P1393, DOI 10.1056/NEJMhpr030349	4	22	22	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2003	349	7					629	630		10.1056/NEJMp038133	http://dx.doi.org/10.1056/NEJMp038133			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711FL	12917298				2022-12-28	WOS:000184728900002
J	Jansen, VAA; Stollenwerk, N; Jensen, HJ; Ramsay, ME; Edmunds, WJ; Rhodes, CJ				Jansen, VAA; Stollenwerk, N; Jensen, HJ; Ramsay, ME; Edmunds, WJ; Rhodes, CJ			Measles outbreaks in a population with declining vaccine uptake	SCIENCE			English	Article									Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England; Univ London Imperial Coll Sci Technol & Med, Dept Math, London SW7 2BZ, England; Hlth Protect Agcy, CDSC, London NW9 5EQ, England	University of London; Royal Holloway University London; Imperial College London; Health Protection Agency	Jansen, VAA (corresponding author), Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England.	vincent.jansen@rhul.ac.uk	Jansen, Vincent A A/C-8353-2009; Ramsay, Mary Elizabeth/S-8281-2016	Stollenwerk, Nico/0000-0001-9315-5586; Jansen, Vincent A.A./0000-0002-6518-2090; Ramsay, Mary Elizabeth/0000-0002-7156-7640				ANDERSON R M, 1991; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; GAY NJ, 1995, EPIDEMIOL INFECT, V115, P139, DOI 10.1017/S0950268800058209; Rhodes CJ, 1996, NATURE, V381, P600, DOI 10.1038/381600a0	4	248	258	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2003	301	5634					804	804		10.1126/science.1086726	http://dx.doi.org/10.1126/science.1086726			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907792				2022-12-28	WOS:000184615700035
J	Snow, A				Snow, A			Unnatural selection	NATURE			English	Editorial Material									Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Columbus, OH 43210 USA	Ohio State University	Snow, A (corresponding author), Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Columbus, OH 43210 USA.							Lassner M, 2001, CURR OPIN PLANT BIOL, V4, P152, DOI 10.1016/S1369-5266(00)00152-7; Nam YK, 2001, TRANSGENIC RES, V10, P353, DOI 10.1023/A:1016696104185; Nielsen KM, 2003, NAT BIOTECHNOL, V21, P227, DOI 10.1038/nbt0303-227; United States National Research Council, 2002, ENV EFF TRANSG PLANT	4	14	14	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					619	619		10.1038/424619a	http://dx.doi.org/10.1038/424619a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904767	Bronze			2022-12-28	WOS:000184578800021
J	Sabin, M; Cardozo, BL; Nackerud, L; Kaiser, R; Varese, L				Sabin, M; Cardozo, BL; Nackerud, L; Kaiser, R; Varese, L			Factors associated with poor mental health among Guatemalan refugees living in Mexico 20 years after civil conflict	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTTRAUMATIC-STRESS-DISORDER; POLITICAL REPRESSION; BOSNIAN REFUGEES; CHILDREN; TRAUMA; INSTRUMENT; DISABILITY; TERRORISM; THAILAND; SYMPTOMS	Context From 1981 to 2001, 46000 refugees who fled the 36-year civil conflict in Guatemala for Chiapas, Mexico were under the protection of the United Nations High Commissioner for Refugees. Objectives To estimate the prevalence of mental illness and factors associated with poor mental health of underserved Guatemalan refugee communities located in Chiapas, Mexico, since 1981 and to assess need for mental health services. Design, Setting, and Participants Cross-sectional survey of 183 households in 5 Mayan refugee camps in Chiapas representing an estimated 1546 residents (adults and children) conducted November-December 2000. Main Outcome Measures Symptom criteria of Posttraumatic Stress Disorder (PTSD), anxiety, and depression,as measured by the Harvard Trauma Questionnaire and Hopkins Symptom Checklist-25 (Hopkins-25). Results One adult (aged greater than or equal to16 years) per household (n = 170 respondents) who agreed to participate was included in the analysis, representing an estimated 93% of households. All respondents reported experiencing at least 1 traumatic event with a mean of 8.3 traumatic events per individual. Of the respondents, 20 (11.8%) had all symptom criteria for PTSD. Of the 160 who completed the Hopkins Symptom Checklist-25, 87 (54.4%) had anxiety symptoms and 62 (38.8%) had symptoms of depression. Witnessing the disappearance of family members (adjusted odds ratio [AOR], 4.58; 95% confidence interval [CI], 1.35-15.50), being close to death (AOR, 4.19, 95% 6, 1.03-17.00), or living with 9 to 15 persons in the same home (AOR, 3.69; 95% CI, 1.19-11.39) were associated with symptoms of PTSD. There was a protective factor found for lacking sufficient food (AOR, 0.08; 95% CI, 0.01-0.59). Elevated anxiety symptoms were associated with witnessing a massacre (AOR, 10.63; 95% CI, 4.31-26.22), being wounded (AOR, 3.22; 95% CI, 0.95-10.89), and experiencing 7 to 12 traumatic events (AOR, 2.67; 95% CI, 1.14-6.27) and 13 to 19 traumatic events (AOR, 2.26; 95% CI, 0.65-7.89). Elevated symptoms of depression were associated with being a woman (AOR, 3.64; 95% CI, 1.47-9.04), being widowed (AOR, 27.55; 95% CI, 2.54-299.27), being married (AOR, 1.93; 95% CI, 0.59-6.33), witnessing disappearances (AOR, 2.68; 95% CI, 1.16-6.19), experiencing 7 to 12 traumatic events (AOR, 1.57; 95% CI, 0.64-3.88), or experiencing 13 to 19 traumatic events (AOR, 7.44; 95% CI, 2.18-25.37). Conclusion Psychiatric morbidity related to human rights violations, traumatic events, and refugee status was common among Guatemalan refugees surveyed 20 years after the Guatemalan civil conflict.	Univ Georgia, Sch Social Work, Athens, GA 30602 USA; Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Int Emergencies & Refugee Hlth Branch, Atlanta, GA USA; UN High Commissioner Refugees, Suboff, Chiapas, Mexico	University System of Georgia; University of Georgia; Centers for Disease Control & Prevention - USA	Sabin, M (corresponding author), Univ Georgia, Sch Social Work, Tucker Hall, Athens, GA 30602 USA.			Sabin, Miriam/0000-0002-7758-8338				Allden K, 1996, AM J PUBLIC HEALTH, V86, P1561, DOI 10.2105/AJPH.86.11.1561; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Ball Patrick, 1999, STATE VIOLENCE GUATE; *COMM ASS REF, 2000, GUAT MEM; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; DESJARLAIS R, 1996, GLOBAL MENTAL HLTH P; EDELMAN L, 1998, INT HDB MULTIGENERAT; FARIAS PC, 1994, EXPERIENCIAS REFUGIO; HALPERIN DF, 1996, SALUD FRONTERA; LYKES MB, 1994, SOC SCI MED, V38, P543, DOI 10.1016/0277-9536(94)90250-X; MELVILLE MB, 1992, SOC SCI MED, V34, P533, DOI 10.1016/0277-9536(92)90209-9; Miller KE, 1996, CHILD DEV, V67, P89, DOI 10.1111/j.1467-8624.1996.tb01721.x; MILLER KE, 1994, AM J ORTHOPSYCHIAT, V64, P346, DOI 10.1037/h0079548; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; MOLLICA RF, 1987, AM J PSYCHIAT, V144, P497; Mollica RF, 1998, BRIT J PSYCHIAT, V173, P482, DOI 10.1192/bjp.173.6.482; Mollica RF, 1999, JAMA-J AM MED ASSOC, V282, P433, DOI 10.1001/jama.282.5.433; MOLLICA RF, 1993, JAMA-J AM MED ASSOC, V270, P581, DOI 10.1001/jama.270.5.581; Mollica RH, 2001, JAMA-J AM MED ASSOC, V286, P546, DOI 10.1001/jama.286.5.546; Munczek DS, 1998, SOC SCI MED, V47, P1699, DOI 10.1016/S0277-9536(98)00252-4; *OF DER HUM ARZ GU, 1999, NEV AG REC HIST MEM; SLUZKI CE, 1990, FAM PROCESS, V29, P131, DOI 10.1111/j.1545-5300.1990.00131.x; SPSS, 1999, STAT PROD SERV SOL S; TULLY SR, 1995, SOC SCI MED, V40, P1597, DOI 10.1016/0277-9536(94)00346-U; *UN HIGH COMM REF, 2003, GLOB REP CENTR AM ME; URRUTIA G, 1987, B MENNINGER CLIN, V51, P170	26	124	128	1	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2003	290	5					635	642		10.1001/jama.290.5.635	http://dx.doi.org/10.1001/jama.290.5.635			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	708GH	12902367				2022-12-28	WOS:000184558500018
J	Garry, DJ; Mammen, PPA				Garry, DJ; Mammen, PPA			Neuroprotection and the role of neuroglobin	LANCET			English	Editorial Material							MYOGLOBIN; MICE; BRAIN; MECHANISMS; PROTECTS; MEMBER		Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Garry, DJ (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA.							Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Couture M, 2001, J BIOL CHEM, V276, P36377, DOI 10.1074/jbc.M103907200; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Flogel U, 2001, P NATL ACAD SCI USA, V98, P735, DOI 10.1073/pnas.011460298; Garry DJ, 2003, TRENDS CARDIOVAS MED, V13, P111, DOI 10.1016/S1050-1738(02)00256-6; Garry DJ, 1998, NATURE, V395, P905, DOI 10.1038/27681; Godecke A, 1999, P NATL ACAD SCI USA, V96, P10495, DOI 10.1073/pnas.96.18.10495; Grange RW, 2001, AM J PHYSIOL-CELL PH, V281, pC1487, DOI 10.1152/ajpcell.2001.281.5.C1487; Mammen PPA, 2002, J HISTOCHEM CYTOCHEM, V50, P1591, DOI 10.1177/002215540205001203; Meeson AP, 2001, CIRC RES, V88, P713, DOI 10.1161/hh0701.089753; Shiva S, 2001, P NATL ACAD SCI USA, V98, P7212, DOI 10.1073/pnas.131128898; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; Zhang CG, 2002, BIOCHEM BIOPH RES CO, V290, P1411, DOI 10.1006/bbrc.2002.6360	14	38	44	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 2	2003	362	9381					342	343		10.1016/S0140-6736(03)14055-X	http://dx.doi.org/10.1016/S0140-6736(03)14055-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707FB	12907003				2022-12-28	WOS:000184498700004
J	Claeson, M; Gillespie, D; Mshinda, H; Troedsson, H; Victora, CG				Claeson, M; Gillespie, D; Mshinda, H; Troedsson, H; Victora, CG		Bellagio Study Grp Child Survival	Knowledge into action for child survival	LANCET			English	Article							MORTALITY; HEALTH	The child survival revolution of the 1980s contributed to steady decreases in child mortality in some populations, but much remains to be done. More than 10 million children will die this year, almost all of whom are poor. Two-thirds of these deaths could have been prevented if effective child survival interventions had reached all children and mothers who needed them. Translation of current knowledge into effective action for child survival will require leadership, strong health systems, targeted human and financial resources, and modified health system to ensure that poor children and mothers benefit. A group of concerned scientists and policy-makers issues a call to action to leaders, governments, and citizens to translate knowledge into action for child survival.	David & Lucile Packard Fdn, 300 2nd St, Los Altos, CA 94022 USA; World Bank, Washington, DC 20433 USA; Ifakara Hlth Res & Dev Ctr, Ifakara, Tanzania; WHO, CH-1211 Geneva, Switzerland; Univ Fed Pelotas, Pelotas, Brazil; ICDDR B, Dhaka, Bangladesh; Johns Hopkins Univ, Baltimore, MD 21218 USA; Aga Khan Univ, Karachi, Pakistan; Rockefeller Fdn, New York, NY USA; Cornell Univ, Ithaca, NY 14853 USA; UNICEF, New York, NY USA; Inst Invest Nutr, Lima, Peru; London Sch Hyg & Trop Med, London WC1, England; Makerere Univ, Inst Publ Hlth, Kampala, Uganda; Bill & Melinda Gates Fdn, Seattle, WA 98102 USA; Ctr Dis Control & Prevent, Atlanta, GA USA	The World Bank; Ifakara Health Institute; World Health Organization; Universidade Federal de Pelotas; International Centre for Diarrhoeal Disease Research (ICDDR); Johns Hopkins University; Aga Khan University; Cornell University; UNICEF; University of London; London School of Hygiene & Tropical Medicine; Makerere University; Bill & Melinda Gates Foundation; Centers for Disease Control & Prevention - USA	Gillespie, D (corresponding author), David & Lucile Packard Fdn, 300 2nd St, Los Altos, CA 94022 USA.	dgillespie@packard.org						Ahmad OB, 2000, B WORLD HEALTH ORGAN, V78, P1175; ANNAN KA, 2001, WE CHILDREN M PROMIS, P22; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; *BUR GLOB HLTH, 2003, US AG INT DEV; Claeson M, 2000, B WORLD HEALTH ORGAN, V78, P1234; DESAVIGNY D, 2002, 2 MIN HLTH; DONNELLY J, 2003, BOSTON GLOBE    0205; FISHMAN S, IN PRESS COMP QUANTI; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Sachs JD, 2001, MACR HLTH INV HLTH E; Schwartlander B, 2001, SCIENCE, V292, P2434, DOI 10.1126/science.1062876; Stover J, 2002, LANCET, V360, P73, DOI 10.1016/S0140-6736(02)09339-X; *UK MIN DEF, 2002, FUT AIRCR CARR CVF; UNICEF, STAT WORLDS CHILDR 1; *UNICEF, STAT WORLDS CHILDR 2; *UNICEF, 2001, PROGR WORLD SUMM CHI; United Nations, 2001, SECR GEN REP GEN ASS; United Nations Development Program, HUM DEV REP 1998; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; WAGSTAFF A, IN PRESS AM J PUBLIC; Walker N, 2002, LANCET, V360, P284, DOI 10.1016/S0140-6736(02)09550-8; *WORLD BANK, 2000, 20374 WORLD BANK; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Health Organization, WORLD HLTH REP 2002; World Health Organization, WORLD HLTH REP 2000	26	169	171	1	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2003	362	9380					323	327						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705UL	12892965				2022-12-28	WOS:000184413400026
J	Seo, DW; Li, HM; Guedez, L; Wingfield, PT; Diaz, T; Salloum, R; Wei, BY; Stetler-Stevenson, WG				Seo, DW; Li, HM; Guedez, L; Wingfield, PT; Diaz, T; Salloum, R; Wei, BY; Stetler-Stevenson, WG			TIMP-2 mediated inhibition of angiogenesis: An MMP-independent mechanism	CELL			English	Article							ENDOTHELIAL-CELL PROLIFERATION; PROTEIN-TYROSINE-PHOSPHATASE; TISSUE INHIBITOR; METALLOPROTEINASE INHIBITORS; TUMOR-GROWTH; ACTIVATION; CANCER; GENE; ALPHA-3-BETA-1; INVASION	Tissue inhibitors of metalloproteinases (TIMPs) suppress matrix metalloproteinase (MMP) activity critical for extracellular matrix turnover associated with both physiologic and pathologic tissue remodeling. We demonstrate here that TIMP-2 abrogates angiogenic factor-induced endothelial cell proliferation in vitro and angiogenesis in vivo independent of MMP inhibition. These effects require alpha3beta1 integrin-mediated binding of TIMP-2 to endothelial cells. Further,TIMP-2 induces a decrease in total protein tyrosine phosphatase (PTP) activity associated with beta1 integrin subunits as well as dissociation of the phosphatase SHP-1 from beta1. TIMP-2 treatment also results in a concomitant increase in PTP activity associated with tyrosine kinase receptors FGFR-1 and KDR. Our findings establish an unexpected, MMP-independent mechanism for TIMP-2 inhibition of endothelial cell proliferation in vitro and reveal an important component of the antiangiogenic effect of TIMP2 in vivo.	NCI, Canc Res Ctr, Vasc Biol Fac, Extracellular Matrix Pathol Sect, Bethesda, MD 20892 USA; NCI, Canc Res Ctr, Pathol Lab, Extracellular Matrix Pathol Sect, Bethesda, MD 20892 USA; NIAMSD, Prot Express Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Stetler-Stevenson, WG (corresponding author), NCI, Canc Res Ctr, Vasc Biol Fac, Extracellular Matrix Pathol Sect, Bethesda, MD 20892 USA.		Stetler-Stevenson, William/AAE-3501-2020; Stetler-Stevenson, William G/H-6956-2012; Guedez, Liliana/H-4951-2012	Stetler-Stevenson, William/0000-0002-5500-5808; Stetler-Stevenson, William G/0000-0002-5500-5808; Seo, Dong-Wan/0000-0003-4971-834X; Wingfield, Paul/0000-0002-9515-4752	NATIONAL CANCER INSTITUTE [Z01SC009179, ZIASC009179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041115, ZIAAR041115] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Baker AH, 1999, BRIT J CANCER, V79, P1347, DOI 10.1038/sj.bjc.6690217; Barazi HO, 2002, CANCER RES, V62, P1541; Bousquet C, 1998, J BIOL CHEM, V273, P7099, DOI 10.1074/jbc.273.12.7099; BRAUTIGAN DL, 1988, METHOD ENZYMOL, V159, P339; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; EMMERTBUCK MR, 1995, FEBS LETT, V364, P28, DOI 10.1016/0014-5793(95)00345-A; FASSLER R, 1995, J CELL BIOL, V128, P979, DOI 10.1083/jcb.128.5.979; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Guedez L, 2003, AM J PATHOL, V162, P1431, DOI 10.1016/S0002-9440(10)64276-9; Guedez L, 2001, BLOOD, V97, P1796, DOI 10.1182/blood.V97.6.1796; Guedez L, 1998, J CLIN INVEST, V102, P2002, DOI 10.1172/JCI2881; Guedez L, 2001, AM J PATHOL, V158, P1207, DOI 10.1016/S0002-9440(10)64070-9; Guo DQ, 2000, J BIOL CHEM, V275, P11216, DOI 10.1074/jbc.275.15.11216; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hoegy SE, 2001, J BIOL CHEM, V276, P3203, DOI 10.1074/jbc.M008157200; Imren S, 1996, CANCER RES, V56, P2891; Jiang YF, 2002, ONCOGENE, V21, P2245, DOI 10.1038/sj.onc.1205291; Jiang YF, 2001, CANCER RES, V61, P2365; Keilhack H, 1998, J BIOL CHEM, V273, P24839, DOI 10.1074/jbc.273.38.24839; LAU KHW, 1989, BIOCHEM J, V257, P23, DOI 10.1042/bj2570023; Maeshima Y, 2002, SCIENCE, V295, P140, DOI 10.1126/science.1065298; MURPHY AN, 1993, J CELL PHYSIOL, V157, P351, DOI 10.1002/jcp.1041570219; Nakagami H, 2002, ARTERIOSCL THROM VAS, V22, P238, DOI 10.1161/hq0202.104001; Perollet C, 1998, BLOOD, V91, P3289, DOI 10.1182/blood.V91.9.3289.3289_3289_3299; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Rehn M, 2001, P NATL ACAD SCI USA, V98, P1024, DOI 10.1073/pnas.031564998; STUPACK DG, 2002, ECM REMODELING REGUL; Sugiura T, 1999, J CELL BIOL, V146, P1375, DOI 10.1083/jcb.146.6.1375; Tartaglia M, 2001, DNA CELL BIOL, V20, P367, DOI 10.1089/10445490152122488; Tarui T, 2001, J BIOL CHEM, V276, P39562, DOI 10.1074/jbc.M101815200; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Wei Y, 2001, MOL BIOL CELL, V12, P2975, DOI 10.1091/mbc.12.10.2975; Wennerberg K, 2000, MOL CELL BIOL, V20, P5758, DOI 10.1128/MCB.20.15.5758-5765.2000; Wingfield PT, 1999, J BIOL CHEM, V274, P21362, DOI 10.1074/jbc.274.30.21362; Yanez-Mo M, 1998, J CELL BIOL, V141, P791, DOI 10.1083/jcb.141.3.791	39	407	435	0	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 25	2003	114	2					171	180		10.1016/S0092-8674(03)00551-8	http://dx.doi.org/10.1016/S0092-8674(03)00551-8			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887919	Bronze			2022-12-28	WOS:000184378700007
J	Zheng, L; Roeder, RG; Luo, Y				Zheng, L; Roeder, RG; Luo, Y			S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component	CELL			English	Article							OCT-1 POU DOMAIN; CELL-CYCLE; GENE-TRANSCRIPTION; DNA-BINDING; PROTEINS; REPLICATION; PHOSPHORYLATION; DEHYDROGENASE; CHAPERONES; EXPRESSION	We have isolated and functionally characterized a multicomponent Oct-1 coactivator, OCA-S which is essential for S phase-dependent histone H2B transcription. The p38 component of OCA-S binds directly to Oct-1, exhibits potent transactivation potential, is selectively recruited to the H2B promoter in S phase, and is essential for S phase-specific H2B transcription in vivo and in vitro. Surprisingly, p38 represents a nuclear form of glyceraldehyde-3-phosphate dehydrogenase, and binding to Oct-1, as well as OCA-S function, is stimulated by NAD(+) but inhibited by NADH. OCA-S also interacts with NPAT, a cyclin E/cdk2 substrate that is broadly involved in histone gene transcription. These studies thus link the H2B transcriptional machinery to cell cycle regulators, and possibly to cellular metabolic state (redox status), and set the stage for studies of the underlying mechanisms and the basis for coordinated histone gene expression and coupling to DNA replication.	Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA	Rockefeller University	Roeder, RG (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, 1230 York Ave, New York, NY 10021 USA.	roeder@mail.rockefeller.edu; luoy@mail.rockefeller.edu						Babb R, 1997, MOL CELL BIOL, V17, P7295, DOI 10.1128/MCB.17.12.7295; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Ewen ME, 2000, GENE DEV, V14, P2265, DOI 10.1101/gad.842100; Fan WH, 2002, J BIOL CHEM, V277, P8061, DOI 10.1074/jbc.M110225200; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Ford E, 1998, GENE DEV, V12, P3528, DOI 10.1101/gad.12.22.3528; Freije JMP, 1998, BIOCHEM SOC SYMP, P261; Frydman J, 1997, TRENDS BIOCHEM SCI, V22, P87, DOI 10.1016/S0968-0004(97)01005-0; Ge H, 1996, METHOD ENZYMOL, V274, P57; HAN M, 1987, CELL, V48, P589, DOI 10.1016/0092-8674(87)90237-6; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kimmins S, 2000, CELL STRESS CHAPERON, V5, P76, DOI 10.1379/1466-1268(2000)005<0076:MOSRAE>2.0.CO;2; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; LABELLA F, 1988, GENE DEV, V2, P32, DOI 10.1101/gad.2.1.32; LUO Y, 1992, CELL, V71, P231, DOI 10.1016/0092-8674(92)90352-D; LUO Y, 1995, MOL CELL BIOL, V15, P4115; Luo Y, 1999, COLD SPRING HARB SYM, V64, P119, DOI 10.1101/sqb.1999.64.119; Ma TL, 2000, GENE DEV, V14, P2298, DOI 10.1101/gad.829500; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Nelson DM, 2002, MOL CELL BIOL, V22, P7459, DOI 10.1128/MCB.22.21.7459-7472.2002; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; RONAI Z, 1993, INT J BIOCHEM, V25, P1073, DOI 10.1016/0020-711X(93)90123-V; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; SEGIL N, 1991, SCIENCE, V254, P1814, DOI 10.1126/science.1684878; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Takahashi Y, 2000, GENE DEV, V14, P804; Zhang QH, 2002, SCIENCE, V295, P1895; Zhao JY, 2000, GENE DEV, V14, P2283, DOI 10.1101/gad.827700; Zhao JY, 1998, GENE DEV, V12, P456, DOI 10.1101/gad.12.4.456	33	415	448	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 25	2003	114	2					255	266		10.1016/S0092-8674(03)00552-X	http://dx.doi.org/10.1016/S0092-8674(03)00552-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887926	Bronze			2022-12-28	WOS:000184378700014
J	Brook, BW; Sodhi, NS; Ng, PKL				Brook, BW; Sodhi, NS; Ng, PKL			Catastrophic extinctions follow deforestation in Singapore	NATURE			English	Article							CONSERVATION; FOREST; LESSONS; BIRD	The looming mass extinction of biodiversity in the humid tropics is a major concern for the future(1), yet most reports of extinctions in these regions are anecdotal or conjectural, with a scarcity of robust, broad-based empirical data(2-4). Here we report on local extinctions among a wide range of terrestrial and freshwater taxa from Singapore (540 km(2)) in relation to habitat loss exceeding 95% over 183 years(5,6). Substantial rates of documented and inferred extinctions were found, especially for forest specialists, with the greatest proportion of extinct taxa (34-87%) in butterflies, fish, birds and mammals. Observed extinctions were generally fewer, but inferred losses often higher, in vascular plants, phasmids, decapods, amphibians and reptiles (5-80%). Forest reserves comprising only 0.25% of Singapore's area now harbour over 50% of the residual native biodiversity. Extrapolations of the observed and inferred local extinction data, using a calibrated species-area model(7-9), imply that the current unprecedented rate of habitat destruction in Southeast Asia(10) will result in the loss of 13-42% of regional populations over the next century, at least half of which will represent global species extinctions.	Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan; No Terr Univ, Key Ctr Trop Wildlife Management, Darwin, NT 0909, Australia; Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Kyoto University; Charles Darwin University; National University of Singapore	Brook, BW (corresponding author), Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan.	barry.brook@ntu.edu.au; dbsns@nus.edu.sg	Ng, Peter/J-7393-2012; Brook, Barry W./G-2686-2011	Brook, Barry W./0000-0002-2491-1517				Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Araujo MB, 2000, BIOL CONSERV, V96, P331, DOI 10.1016/S0006-3207(00)00074-4; BIERREGAARD RO, 1992, BIOSCIENCE, V42, P859, DOI 10.2307/1312085; Brooks TM, 1999, CONSERV BIOL, V13, P1140, DOI 10.1046/j.1523-1739.1999.98341.x; Brooks TM, 1997, CONSERV BIOL, V11, P382, DOI 10.1046/j.1523-1739.1997.95493.x; Castelletta M, 2000, CONSERV BIOL, V14, P1870, DOI 10.1111/j.1523-1739.2000.99285.x; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Corlett R.T., 2000, P333; CORLETT RT, 1992, J BIOGEOGR, V19, P411, DOI 10.2307/2845569; DIAMOND J M, 1987, Conservation Biology, V1, P77, DOI 10.1111/j.1523-1739.1987.tb00012.x; Droege S, 1998, CONSERV BIOL, V12, P1134, DOI 10.1046/j.1523-1739.1998.96402.x; HEYWOOD VH, 1992, TROPICAL DEFORESTATION AND SPECIES EXTINCTION, P91; HEYWOOD VH, 1994, NATURE, V368, P105, DOI 10.1038/368105a0; Laurance WF, 1999, BIOL CONSERV, V91, P109, DOI 10.1016/S0006-3207(99)00088-9; Lim KS, 1997, BIRDS ILLUSTRATED FI; May RM, 2000, SCIENCE, V290, P2084, DOI 10.1126/science.290.5499.2084; Milner-Gulland EJ, 2001, TRENDS ECOL EVOL, V16, P686, DOI 10.1016/S0169-5347(01)02278-9; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Ng P. K., 1994, SINGAPORE RED DATA B; NG PKL, 1992, AQUAT CONSERV, V2, P255, DOI 10.1002/aqc.3270020305; Novacek MJ, 2001, P NATL ACAD SCI USA, V98, P5466, DOI 10.1073/pnas.091093698; Pitman NCA, 2002, SCIENCE, V298, P989, DOI 10.1126/science.298.5595.989; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Ridley H.N., 1900, J STRAITS BRANCH ROY, V33, P27; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Sodhi NS, 2000, CONSERV BIOL, V14, P1211, DOI 10.1046/j.1523-1739.2000.99416.x; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Turner IM, 1996, TRENDS ECOL EVOL, V11, P330, DOI 10.1016/0169-5347(96)10046-X; TURNER IM, 1994, CONSERV BIOL, V8, P705, DOI 10.1046/j.1523-1739.1994.08030705.x; WILLIAMSON M, 1989, PHILOS T ROY SOC B, V325, P457, DOI 10.1098/rstb.1989.0099	30	464	492	0	228	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 24	2003	424	6947					420	423		10.1038/nature01795	http://dx.doi.org/10.1038/nature01795			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879068				2022-12-28	WOS:000184318400041
J	Nelson, WG; De Marzo, AM; Isaacs, WB				Nelson, WG; De Marzo, AM; Isaacs, WB			Mechanisms of disease: Prostate cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ANDROGEN-RECEPTOR GENE; PROLIFERATIVE INFLAMMATORY ATROPHY; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; AUTOSOMAL-DOMINANT INHERITANCE; CELL-CYCLE ARREST; TUMOR-SUPPRESSOR; FAMILY-HISTORY; CYP17 GENE; SUSCEPTIBILITY LOCUS; HOMEOBOX GENE		Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Sch Med, Dept Oncol, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University	Nelson, WG (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Sch Med, Dept Oncol, Rm 151,Bunting Blaustein Canc Res Bldg, Baltimore, MD 21231 USA.	bnelson@jhmi.edu		De Marzo, Angelo/0000-0003-4847-5307				Abdulkadir SA, 2002, MOL CELL BIOL, V22, P1495, DOI 10.1128/MCB.22.5.1495-1503.2002; Ahlbom A, 1997, J NATL CANCER I, V89, P287, DOI 10.1093/jnci/89.4.287; Amler LC, 2000, CANCER RES, V60, P6134; Bartsch G, 2001, UROLOGY, V58, P417, DOI 10.1016/S0090-4295(01)01264-X; Beilin J, 2000, J MOL ENDOCRINOL, V25, P85, DOI 10.1677/jme.0.0250085; Bennett CL, 2002, J CLIN ONCOL, V20, P3599, DOI 10.1200/JCO.2002.11.085; Berry R, 2000, AM J HUM GENET, V67, P82, DOI 10.1086/302994; Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Bieberich CJ, 1996, J BIOL CHEM, V271, P31779, DOI 10.1074/jbc.271.50.31779; Bowen C, 2000, CANCER RES, V60, P6111; Brooks JD, 1998, CANCER EPIDEM BIOMAR, V7, P531; Brooks JD, 1996, CANCER RES, V56, P3814; Cairns P, 1997, CANCER RES, V57, P4997; Carpten J, 2002, NAT GENET, V30, P181, DOI 10.1038/ng823; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; Casey G, 2002, NAT GENET, V32, P582, DOI 10.1038/ng1021; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Chan JM, 2001, EPIDEMIOL REV, V23, P82, DOI 10.1093/oxfordjournals.epirev.a000799; Chang BL, 2001, INT J CANCER, V95, P354, DOI 10.1002/1097-0215(20011120)95:6<354::AID-IJC1062>3.0.CO;2-3; Chen C, 2001, EPIDEMIOL REV, V23, P30, DOI 10.1093/oxfordjournals.epirev.a000793; Chen H, 2002, CANCER RES, V62, P338; Chen LW, 2001, JNCI-J NATL CANCER I, V93, P1872, DOI 10.1093/jnci/93.24.1872; Cheville JC, 1998, MODERN PATHOL, V11, P324; Clark LC, 1998, BRIT J UROL, V81, P730; Clark LC, 1997, JAMA-J AM MED ASSOC, V277, P1520; CLEMENS MJ, 1978, CELL, V13, P565, DOI 10.1016/0092-8674(78)90329-X; Cohen JH, 2000, JNCI-J NATL CANCER I, V92, P61, DOI 10.1093/jnci/92.1.61; Cordon-Cardo C, 1998, JNCI-J NATL CANCER I, V90, P1284, DOI 10.1093/jnci/90.17.1284; Cote RJ, 1998, J NATL CANCER I, V90, P916, DOI 10.1093/jnci/90.12.916; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; CRAWFORD ED, 1989, NEW ENGL J MED, V321, P419, DOI 10.1056/NEJM198908173210702; Cui JS, 2001, AM J HUM GENET, V68, P1207, DOI 10.1086/320114; CULIG Z, 1993, MOL ENDOCRINOL, V7, P1541, DOI 10.1210/me.7.12.1541; De Marzo AM, 1999, AM J PATHOL, V155, P1985, DOI 10.1016/S0002-9440(10)65517-4; De Marzo AM, 1998, AM J PATHOL, V153, P911, DOI 10.1016/S0002-9440(10)65632-5; DEJAGER S, 1993, J CLIN INVEST, V92, P894, DOI 10.1172/JCI116664; Dennis LK, 2002, EPIDEMIOLOGY, V13, P72, DOI 10.1097/00001648-200201000-00012; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Dinkova-Kostova LT, 2000, FREE RADICAL BIO MED, V29, P231, DOI 10.1016/S0891-5849(00)00300-2; Dong JT, 2000, CANCER RES, V60, P3880; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; Eisenberger MA, 1998, NEW ENGL J MED, V339, P1036, DOI 10.1056/NEJM199810083391504; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Elo JP, 2001, ANN MED, V33, P130, DOI 10.3109/07853890109002068; ELO JP, 1996, BRIT J CANCER, V79, P156; EMMERTBUCK MR, 1995, CANCER RES, V55, P2959; Evans BAJ, 1996, PROSTATE, V28, P162, DOI 10.1002/(SICI)1097-0045(199603)28:3<162::AID-PROS3>3.0.CO;2-H; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Feneley MR, 1996, J CLIN PATHOL, V49, P741, DOI 10.1136/jcp.49.9.741; FLOYDSMITH G, 1981, SCIENCE, V212, P1030, DOI 10.1126/science.6165080; FRANKS LM, 1954, J PATHOL BACTERIOL, V68, P617, DOI 10.1002/path.1700680234; Furnari FB, 1998, CANCER RES, V58, P5002; GADDIPATI JP, 1994, CANCER RES, V54, P2861; Gann PH, 1999, CANCER RES, V59, P1225; GANN PH, 1994, J NATL CANCER I, V86, P281, DOI 10.1093/jnci/86.4.281; GANN PH, 1994, J NATL CANCER I, V86, P728; Gao XQ, 2001, P NATL ACAD SCI USA, V98, P15221, DOI 10.1073/pnas.261572998; GARDNER WA, 1992, PATHOLOGY PATHOBIOLO, P129; Ghadirian P, 1997, INT J CANCER, V70, P679, DOI 10.1002/(SICI)1097-0215(19970317)70:6<679::AID-IJC9>3.3.CO;2-3; Gibbs M, 1999, AM J HUM GENET, V64, P776, DOI 10.1086/302287; GIOVANNUCCI E, 1993, J NATL CANCER I, V85, P1571, DOI 10.1093/jnci/85.19.1571; Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P3320, DOI 10.1073/pnas.94.7.3320; Giovannucci E, 2001, EPIDEMIOL REV, V23, P159, DOI 10.1093/oxfordjournals.epirev.a000783; Glover FE, 1998, UROLOGY, V52, P441, DOI 10.1016/S0090-4295(98)00200-3; Gottschalk AR, 2001, CANCER RES, V61, P2105; Graff JR, 2000, J BIOL CHEM, V275, P24500, DOI 10.1074/jbc.M003145200; GRONBERG H, 1994, J UROLOGY, V152, P1484, DOI 10.1016/S0022-5347(17)32452-7; Gronberg H, 1997, AM J EPIDEMIOL, V146, P552, DOI 10.1093/oxfordjournals.aje.a009313; GROSS GA, 1993, CARCINOGENESIS, V14, P2313, DOI 10.1093/carcin/14.11.2313; Gsur A, 2000, INT J CANCER, V87, P434, DOI 10.1002/1097-0215(20000801)87:3<434::AID-IJC19>3.0.CO;2-G; Guo YP, 1997, CLIN CANCER RES, V3, P2269; Haapala K, 2001, LAB INVEST, V81, P1647, DOI 10.1038/labinvest.3780378; Habuchi T, 2000, CANCER RES, V60, P5710; HAENSZEL W, 1968, JNCI-J NATL CANCER I, V40, P43; Haiman CA, 2001, CANCER EPIDEM BIOMAR, V10, P743; Hakimi JM, 1997, CLIN CANCER RES, V3, P1599; Hankey BF, 1999, JNCI-J NATL CANCER I, V91, P1017, DOI 10.1093/jnci/91.12.1017; Hayes RB, 2000, BRIT J CANCER, V82, P718, DOI 10.1054/bjoc.1999.0986; He WW, 1997, GENOMICS, V43, P69, DOI 10.1006/geno.1997.4715; Heinonen OP, 1998, J NATL CANCER I, V90, P440, DOI 10.1093/jnci/90.6.440; Hobisch A, 1998, CANCER RES, V58, P4640; Hoekx L, 1998, Acta Urol Belg, V66, P1; Hoque A, 2001, CANCER CAUSE CONTROL, V12, P627, DOI 10.1023/A:1011277600059; Hsing AW, 2000, CANCER RES, V60, P5111; Hsing AW, 2000, INT J CANCER, V85, P60, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;60::AID-IJC11&gt;3.0.CO;2-B; Irvine RA, 2000, HUM MOL GENET, V9, P267, DOI 10.1093/hmg/9.2.267; IRVINE RA, 1995, CANCER RES, V55, P1937; JACOBSEN H, 1983, VIROLOGY, V125, P496, DOI 10.1016/0042-6822(83)90222-2; Jemal A, 2002, CA-CANCER J CLIN, V52, P119; Jemal A, 2002, CA-CANCER J CLIN, V52, P181; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; KAZEMIESFARJANI P, 1995, HUM MOL GENET, V4, P523, DOI 10.1093/hmg/4.4.523; Kibel AS, 2000, J UROLOGY, V164, P192, DOI 10.1016/S0022-5347(05)67493-9; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P2884, DOI 10.1073/pnas.042688999; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Kittles RA, 2001, CANCER EPIDEM BIOMAR, V10, P943; Knize MG, 1997, MUTAT RES-FUND MOL M, V376, P129, DOI 10.1016/S0027-5107(97)00035-3; Koivisto P, 1997, CANCER RES, V57, P314; Latil AG, 2001, CANCER-AM CANCER SOC, V92, P1130, DOI 10.1002/1097-0142(20010901)92:5<1130::AID-CNCR1430>3.0.CO;2-B; Laufer M, 2000, J UROLOGY, V164, P3, DOI 10.1016/S0022-5347(05)67436-8; LEE WH, 1994, P NATL ACAD SCI USA, V91, P11733, DOI 10.1073/pnas.91.24.11733; LEMARCHAND L, 1994, EPIDEMIOLOGY, V5, P276; Lesko SM, 1996, AM J EPIDEMIOL, V144, P1041, DOI 10.1093/oxfordjournals.aje.a008876; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; LIJINSKY W, 1964, SCIENCE, V145, P53, DOI 10.1126/science.145.3627.53; Lin XH, 2001, AM J PATHOL, V159, P1815, DOI 10.1016/S0002-9440(10)63028-3; Lunn RM, 1999, CARCINOGENESIS, V20, P1727, DOI 10.1093/carcin/20.9.1727; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Makridakis N, 1997, CANCER RES, V57, P1020; Makridakis NM, 1999, LANCET, V354, P975, DOI 10.1016/S0140-6736(98)11282-5; Marcelli M, 2000, CANCER RES, V60, P944; McMenamin ME, 1999, CANCER RES, V59, P4291; Millar DS, 1999, ONCOGENE, V18, P1313, DOI 10.1038/sj.onc.1202415; MONROE KR, 1995, NAT MED, V1, P827, DOI 10.1038/nm0895-827; MORGANTI G, 1956, Acta Genet Stat Med, V6, P304; MORGENTHALER PML, 1995, CARCINOGENESIS, V16, P713, DOI 10.1093/carcin/16.4.713; Mousses S, 2001, ONCOGENE, V20, P6718, DOI 10.1038/sj.onc.1204889; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Nam RK, 2001, UROLOGY, V57, P199, DOI 10.1016/S0090-4295(00)00928-6; Nazareth LV, 1996, J BIOL CHEM, V271, P19900, DOI 10.1074/jbc.271.33.19900; Nelson CP, 2001, CANCER RES, V61, P103; Nelson JE, 2000, ONCOL REP, V7, P169; Nelson WG, 2001, UROLOGY, V57, P39, DOI 10.1016/S0090-4295(00)00939-0; NEWMARK JR, 1992, P NATL ACAD SCI USA, V89, P6319, DOI 10.1073/pnas.89.14.6319; Norrish AE, 1998, INT J CANCER, V77, P511; Nupponen NN, 1998, AM J PATHOL, V153, P141, DOI 10.1016/S0002-9440(10)65554-X; Ornstein DK, 2001, J UROLOGY, V165, P1329, DOI 10.1016/S0022-5347(01)69894-X; Ostrander EA, 2000, AM J HUM GENET, V67, P1367, DOI 10.1086/316916; Page WF, 1997, PROSTATE, V33, P240; Parsons JK, 2001, PROSTATE, V49, P30, DOI 10.1002/pros.1115; Platt N, 2001, J CLIN INVEST, V108, P649, DOI 10.1172/JCI200113903; Platz EA, 1998, CANCER EPIDEM BIOMAR, V7, P379; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Putzi MJ, 2000, UROLOGY, V56, P828, DOI 10.1016/S0090-4295(00)00776-7; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Rennert H, 2002, AM J HUM GENET, V71, P981, DOI 10.1086/342775; REZNIK G, 1981, PROSTATE, V2, P261, DOI 10.1002/pros.2990020304; Roberts RO, 1998, UROLOGY, V51, P578, DOI 10.1016/S0090-4295(98)00034-X; Roberts RO, 2002, MAYO CLIN PROC, V77, P219, DOI 10.4065/77.3.219; Rodriguez C, 1997, EPIDEMIOLOGY, V8, P653, DOI 10.1097/00001648-199710000-00007; Rokman A, 2002, AM J HUM GENET, V70, P1299, DOI 10.1086/340450; Ruska KM, 1998, AM J SURG PATHOL, V22, P1073, DOI 10.1097/00000478-199809000-00005; Sadar MD, 2000, CANCER RES, V60, P5825; SAKR WA, 1994, IN VIVO, V8, P439; Schaid DJ, 1998, AM J HUM GENET, V62, P1425, DOI 10.1086/301862; SCHOENBERG MP, 1994, BIOCHEM BIOPH RES CO, V198, P74, DOI 10.1006/bbrc.1994.1011; Sciavolino PJ, 1997, DEV DYNAM, V209, P127, DOI 10.1002/(SICI)1097-0177(199705)209:1<127::AID-AJA12>3.0.CO;2-Z; Shah R, 2001, AM J PATHOL, V158, P1767, DOI 10.1016/S0002-9440(10)64132-6; Shi XB, 2002, CANCER RES, V62, P1496; SHIMIZU H, 1991, BRIT J CANCER, V63, P963, DOI 10.1038/bjc.1991.210; Shirai T, 1997, CANCER RES, V57, P195; SILVERMAN RH, 1988, J BIOL CHEM, V263, P7336; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; SPITZ MR, 1991, J UROLOGY, V146, P1305, DOI 10.1016/S0022-5347(17)38074-6; Stanford JL, 2002, CANCER EPIDEM BIOMAR, V11, P243; Stanford JL, 1997, CANCER RES, V57, P1194; Stapleton AMF, 1997, CLIN CANCER RES, V3, P1389; Steadman DJ, 2000, NUCLEIC ACIDS RES, V28, P2389, DOI 10.1093/nar/28.12.2389; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; Stuart GR, 2000, CANCER RES, V60, P266; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Suzuki H, 1996, PROSTATE, V29, P153, DOI 10.1002/1097-0045(199609)29:3<153::AID-PROS2990290303>3.0.CO;2-5; SUZUKI H, 1993, J STEROID BIOCHEM, V46, P759, DOI 10.1016/0960-0760(93)90316-O; Suzuki H, 1998, CANCER RES, V58, P204; TAKAHASHI S, 1995, CANCER RES, V55, P4114; TAKAHASHI S, 1994, CANCER RES, V54, P3574; Tan J, 1997, MOL ENDOCRINOL, V11, P450, DOI 10.1210/me.11.4.450; Taplin ME, 1999, CANCER RES, V59, P2511; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Teng DHF, 1997, CANCER RES, V57, P5221; Tilley WD, 1996, CLIN CANCER RES, V2, P277; VANDERKWAST TH, 1991, INT J CANCER, V48, P189, DOI 10.1002/ijc.2910480206; VELDSCHOLTE J, 1990, BIOCHIM BIOPHYS ACTA, V1052, P187, DOI 10.1016/0167-4889(90)90075-O; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; Verhage BAJ, 2001, UROLOGY, V57, P97, DOI 10.1016/S0090-4295(00)00891-8; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Voeller HJ, 1997, CANCER RES, V57, P4455; Wadelius M, 1999, PHARMACOGENETICS, V9, P635, DOI 10.1097/01213011-199910000-00010; Wang L, 2002, AM J HUM GENET, V71, P116, DOI 10.1086/341281; WHITTEMORE AS, 1995, AM J EPIDEMIOL, V141, P732, DOI 10.1093/oxfordjournals.aje.a117495; WHITTEMORE AS, 1995, JNCI-J NATL CANCER I, V87, P652, DOI 10.1093/jnci/87.9.652; WILSON MJ, 1990, PROSTATE, V16, P147, DOI 10.1002/pros.2990160206; Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587; Xia Y, 1997, P NATL ACAD SCI USA, V94, P6954, DOI 10.1073/pnas.94.13.6954; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477; Xu JF, 2001, AM J HUM GENET, V69, P341, DOI 10.1086/321967; Xu JF, 2002, NAT GENET, V32, P321, DOI 10.1038/ng994; Yang RM, 1998, J UROLOGY, V159, P941, DOI 10.1016/S0022-5347(01)63776-5; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008; Zha S, 2001, CANCER RES, V61, P8617; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; ZHANG YS, 1994, P NATL ACAD SCI USA, V91, P3147, DOI 10.1073/pnas.91.8.3147; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D; Zhou AM, 1997, EMBO J, V16, P6355, DOI 10.1093/emboj/16.21.6355	203	837	875	1	122	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 24	2003	349	4					366	381		10.1056/NEJMra021562	http://dx.doi.org/10.1056/NEJMra021562			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703ZH	12878745				2022-12-28	WOS:000184312800012
J	Travis, LB; Hill, DA; Dores, GM; Gospodarowicz, M; van Leeuwen, FE; Holowaty, E; Glimelius, B; Andersson, M; Wiklund, T; Lynch, CF; Van't Veer, MB; Glimelius, I; Storm, H; Pukkala, E; Stovall, M; Curtis, R; Boice, JD; Gilbert, E				Travis, LB; Hill, DA; Dores, GM; Gospodarowicz, M; van Leeuwen, FE; Holowaty, E; Glimelius, B; Andersson, M; Wiklund, T; Lynch, CF; Van't Veer, MB; Glimelius, I; Storm, H; Pukkala, E; Stovall, M; Curtis, R; Boice, JD; Gilbert, E			Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HORMONE REPLACEMENT THERAPY; 2ND MALIGNANT NEOPLASMS; MANTLE IRRADIATION; RADIATION-THERAPY; OVARIAN-FUNCTION; RISK; SURVIVORS; MORTALITY; ESTROGEN; COHORT	Context Second cancer is the leading cause of death in long-term survivors of Hodgkin disease (HD), with exceptionally high risks of breast cancer among women treated at a young age. Quantitative associations between radiotherapy dose delivered to the breast and administered chemotherapy have not been reported to date in large series, nor has the influence of ovarian exposures on subsequent risk. Objective To quantify the long-term risk of breast cancer associated with use of radiotherapy and chemotherapy to treat young women with HD. Design, Setting, and Subjects Matched case-control study of breast cancer within a cohort of 3817 female 1-year survivors of HD diagnosed at age 30 years or younger, between January 1, 1965, and December 31, 1994, and within 6 population-based cancer registries. The study was conducted March 1, 1996, through September 30, 1998. Main Outcome Measures Relative risk (RR) of breast cancer associated with radiation dose delivered to site of breast cancer or to ovaries and with cumulative dose of alkylating agents. Results Breast cancer occurred in 105 patients with HD who were matched to 266 patients with HD but without breast cancer. A radiation dose of 4 Gy or more delivered to the breast was associated with a 3.2-fold (95% confidence interval [CI], 1.4-8.2) increased risk, compared with the risk in patients who received lower doses and no alkylating agents. Risk increased to 9-fold (95% CI, 2.6-26.4) with a dose of more than 40 Gy (P<.001 for trend). Radiation risk did not vary appreciably by age at exposure or reproductive history. increased risks persisted for 25 or more years following radiotherapy (RR, 2.3; 95% CI, 0.5-16.5; P=.03 for trend with dose). Treatment with alkylating agents alone resulted in a reduced risk (RR, 0.6; 95% CI, 0.2-2.0) of breast cancer, and combined alkylating agents and radiotherapy in a 1.4-fold (95% CI, 0.6-3.5) increased risk. Risk of breast cancer decreased with increasing number of alkylating agent cycles (P=.003 for trend). Risk also was low (RR, 0.4; 95% CI, 0.1-1.1) among women who received 5 Gy or more delivered to ovaries compared with those who received lower doses. Conclusions Hormonal stimulation appears important for the development of radiation-induced breast cancer, as evidenced by the reduced risk associated with ovarian damage from alkylating agents or radiation. The high radiation-related risk, which did not diminish at the highest doses or the longest follow-up, however, suggests the need for lifetime surveillance and programs of patient and public awareness.	NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada; Netherlands Canc Inst, Amsterdam, Netherlands; Canc Care Ontario, Toronto, ON, Canada; Uppsala Univ, Uppsala, Sweden; Danish Canc Soc, Copenhagen, Denmark; Univ Helsinki, Cent Hosp, Helsinki, Finland; Univ Iowa, Iowa City, IA USA; Dr Daniel den Hoed Canc Ctr, NL-3008 AE Rotterdam, Netherlands; Finnish Canc Registry, FIN-00170 Helsinki, Finland; Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA; Int Epidemiol Inst, Rockville, MD USA; Vanderbilt Univ, Med Ctr, Nashville, TN USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Netherlands Cancer Institute; Cancer Care Ontario; Uppsala University; Danish Cancer Society; University of Helsinki; Helsinki University Central Hospital; University of Iowa; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Finnish Cancer Registry; University of Texas System; UTMD Anderson Cancer Center; Vanderbilt University	Travis, LB (corresponding author), NCI, Div Canc Epidemiol & Stat, NIH, Dept Hlth & Human Serv,EPS 7086,MSC 7238, Bethesda, MD 20892 USA.		Glimelius, Ingrid Cecilia/Q-1325-2015; Glimelius, Ingrid/AAJ-4986-2020	Glimelius, Ingrid Cecilia/0000-0001-6158-3041; Glimelius, Ingrid/0000-0001-6158-3041; Storm, Hans/0000-0001-7223-8198; Dores, Graca/0000-0002-3985-2935; Wiklund, Tom/0000-0002-9384-9614	DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS [N01CP091024, N01CP061120, N01CP061122, N01CP061121, N01CP061119] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CP-61122, N01-CP-61121, N01-CP-91024, N01-CP-61120, N02-CP-81005, N01-CP-61119, CP-33013-18] Funding Source: Medline	DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aisenberg AC, 1997, CANCER, V79, P1203, DOI 10.1002/(SICI)1097-0142(19970315)79:6<1203::AID-CNCR20>3.0.CO;2-2; Aisenberg AC, 1999, BLOOD, V93, P761, DOI 10.1182/blood.V93.3.761.403a27_761_779; [Anonymous], 2002, SEER CANC STAT REV 1; ARSENEAU JC, 1972, NEW ENGL J MED, V287, P1119, DOI 10.1056/NEJM197211302872204; Bhatia S, 1996, NEW ENGL J MED, V334, P745, DOI 10.1056/NEJM199603213341201; BOICE JD, 1989, INT J CANCER, V44, P7, DOI 10.1002/ijc.2910440103; Boice JD, 2001, MED PEDIATR ONCOL, V36, P508, DOI 10.1002/mpo.1122; BOICE JD, 1993, J NATL CANCER I, V85, P4, DOI 10.1093/jnci/85.1.4; BOKEMEYER C, 1994, ANN HEMATOL, V68, P105, DOI 10.1007/BF01727413; Breslow NE, 1980, IARC SCI PUBL, P5; Brusamolino E, 2000, HAEMATOLOGICA, V85, P1032; CANELLOS GP, 1992, NEW ENGL J MED, V327, P1478, DOI 10.1056/NEJM199211193272102; Canellos GP, 2002, ANN ONCOL, V13, P153, DOI 10.1093/annonc/mdf653; Chen CL, 2002, JAMA-J AM MED ASSOC, V287, P734, DOI 10.1001/jama.287.6.734; Christie DRH, 1998, INT J RADIAT ONCOL, V41, P223, DOI 10.1016/S0360-3016(97)00902-4; Clemons M, 2000, CANCER TREAT REV, V26, P291, DOI 10.1053/ctrv.2000.0174; Connors J M, 2001, Hematology Am Soc Hematol Educ Program, P178; DARBY SC, 1994, INT J CANCER, V56, P793, DOI 10.1002/ijc.2910560606; DEVITA VT, 1970, ANN INTERN MED, V73, P881, DOI 10.7326/0003-4819-73-6-881; Diller L, 2002, J CLIN ONCOL, V20, P2085, DOI 10.1200/JCO.2002.08.031; Dores GM, 2002, J CLIN ONCOL, V20, P3484, DOI 10.1200/JCO.2002.09.038; HANCOCK SL, 1993, J NATL CANCER I, V85, P25, DOI 10.1093/jnci/85.1.25; Henry-Amar M, 1992, Ann Oncol, V3 Suppl 4, P117; Hoppe RT, 1997, ANN ONCOL, V8, P115, DOI 10.1023/A:1008238908676; HORNING SJ, 1981, NEW ENGL J MED, V304, P1377, DOI 10.1056/NEJM198106043042301; Jolleys JV, 1996, MATURITAS, V23, P47, DOI 10.1016/0378-5122(95)00952-3; Lucraft HH, 2000, CLIN ONCOL-UK, V12, P276, DOI 10.1053/clon.2000.9173; MASHCHAK CA, 1982, AM J OBSTET GYNECOL, V144, P511, DOI 10.1016/0002-9378(82)90218-6; Mauch P, 1999, HODGKINS DIS; Mauch P M, 1995, Cancer J Sci Am, V1, P33; Meirow D, 2001, HUM REPROD UPDATE, V7, P535, DOI 10.1093/humupd/7.6.535; Neglia JP, 2001, J NATL CANCER I, V93, P618, DOI 10.1093/jnci/93.8.618; Ng AK, 1999, SEMIN HEMATOL, V36, P290; Parkin DM, 1997, CANC INCIDENCE 5 CON, VVII; PERSSON I, 1983, ACTA OBSTET GYN SCAN, V62, P289, DOI 10.3109/00016348309156224; PETERS MH, 1995, AM SURGEON, V61, P763; PETERS MV, 1950, AM J ROENTGENOL, V63, P299; *PHIL MED SYST, RAD ONC SYST PINN; Preston DL, 2002, RADIAT RES, V158, P220, DOI 10.1667/0033-7587(2002)158[0220:REOBCR]2.0.CO;2; PRESTON DL, 1991, EPICURE USERS GUIDE; Prosnitz LR, 2002, J CLIN ONCOL, V20, P2225, DOI 10.1200/JCO.2002.20.9.2225; RAY GR, 1970, RADIOLOGY, V96, P175, DOI 10.1148/96.1.175; Schairer C, 1997, INT J CANCER, V70, P150, DOI 10.1002/(SICI)1097-0215(19970117)70:2<150::AID-IJC2>3.0.CO;2-W; Schairer C, 2000, JAMA-J AM MED ASSOC, V283, P485, DOI 10.1001/jama.283.4.485; SHORE RE, 1980, PREV MED, V9, P815, DOI 10.1016/0091-7435(80)90024-9; STOVALL M, 1995, MED PHYS, V22, P63, DOI 10.1118/1.597525; STOVALL M, 1989, MED PHYS, V16, P726, DOI 10.1118/1.596331; Swerdlow AJ, 2000, J CLIN ONCOL, V18, P498, DOI 10.1200/JCO.2000.18.3.498; Titus-Ernstoff L, 1998, CANCER EPIDEM BIOMAR, V7, P783; Travis LB, 1999, NEW ENGL J MED, V340, P351, DOI 10.1056/NEJM199902043400504; Travis LB, 2002, JNCI-J NATL CANCER I, V94, P182, DOI 10.1093/jnci/94.3.182; TRAVIS LB, 2003, NEW ENGL J MED, V95, P971; TRICHOPOULOS D, 1972, JNCI-J NATL CANCER I, V48, P605; United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), 2000, SOURC EFF LON RAD; van Leeuwen FE, 2000, J CLIN ONCOL, V18, P487, DOI 10.1200/JCO.2000.18.3.487; VANLEEUWEN FE, IN PRESS J NATL CANC; Williams RS, 1999, CANCER, V86, P2138, DOI 10.1002/(SICI)1097-0142(19991115)86:10<2138::AID-CNCR36>3.0.CO;2-V; Wolden SL, 2000, J CLIN ONCOL, V18, P765, DOI 10.1200/JCO.2000.18.4.765; YAHALOM J, 1992, J CLIN ONCOL, V10, P1674, DOI 10.1200/JCO.1992.10.11.1674; ZELLMER DL, 1991, INT J RADIAT ONCOL, V21, P1343, DOI 10.1016/0360-3016(91)90296-G; 1983, BR J RADIOL S, V17, P1	61	447	454	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2003	290	4					465	475		10.1001/jama.290.4.465	http://dx.doi.org/10.1001/jama.290.4.465			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703JB	12876089	Bronze			2022-12-28	WOS:000184275300018
J	Walker, F				Walker, F			Precious adults: a lesson in grown-up congenital heart disease	LANCET			English	Editorial Material									UCL, NHS Trust, Heart Hosp, Grown Up Congenital Heart Unit, London, England	University College London Hospitals NHS Foundation Trust; University of London; University College London	Walker, F (corresponding author), UCL, NHS Trust, Heart Hosp, Grown Up Congenital Heart Unit, Westmoreland St, London, England.								0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 19	2003	362	9379					241	241		10.1016/S0140-6736(03)13918-9	http://dx.doi.org/10.1016/S0140-6736(03)13918-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702PJ	12885489				2022-12-28	WOS:000184232000027
J	Caraveo, PA; Bignami, GF; DeLuca, A; Mereghetti, S; Pellizzoni, A; Mignani, R; Tur, A; Becker, W				Caraveo, PA; Bignami, GF; DeLuca, A; Mereghetti, S; Pellizzoni, A; Mignani, R; Tur, A; Becker, W			Geminga's tails: A pulsar bow shock probing the interstellar medium	SCIENCE			English	Article							X-RAY; NEBULA; IDENTIFICATION; SUPERNOVA	We report the X-ray Multimirror Mission-Newton European Photon Imaging Camera observation of two elongated parallel x-ray tails trailing the pulsar Geminga. They are aligned with the object's supersonic motion, extend for similar to2', and have a nonthermal spectrum produced by electron-synchrotron emission in the bow shock between the pulsar wind and the surrounding medium. Electron lifetime against synchrotron cooling matches the source transit time over the x-ray features' length. Such an x-ray detection of a pulsar bow shock (with no Halpha emission) allows us to gauge the pulsar electron injection energy and the shock magnetic field while constraining the angle of Geminga's motion and the local matter density.	CNR, Ist Astrofis Spaziale & Fis Cosm, I-20133 Milan, Italy; Univ Toulouse 3, CNRS, Ctr Etud Spatiale Rayonnements, F-31062 Toulouse, France; Univ Pavia, Dipartimento Fis Nucl & Teor, I-27100 Pavia, Italy; European So Observ, D-85748 Garching, Germany; Max Planck Inst Extraterr Phys, D-85748 Garching, Germany	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale Astrofisica (INAF); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Pavia; European Southern Observatory; Max Planck Society	Caraveo, PA (corresponding author), CNR, Ist Astrofis Spaziale & Fis Cosm, Via Bassini 15, I-20133 Milan, Italy.	pat@mi.iasf.cnr.it	Caraveo, Patrizia/AAL-5708-2020	Caraveo, Patrizia/0000-0003-2478-8018; Pellizzoni, Alberto Paolo/0000-0002-4590-0040; Mignani, Roberto/0000-0002-8685-583X; Bignami, Giovanni/0000-0001-9582-2450; MEREGHETTI, SANDRO/0000-0003-3259-7801; De Luca, Andrea/0000-0001-6739-687X				BIGNAMI GF, 1993, NATURE, V361, P704, DOI 10.1038/361704a0; Bignami GF, 1996, ANNU REV ASTRON ASTR, V34, P331, DOI 10.1146/annurev.astro.34.1.331; BIGNAMI GF, 1983, ASTROPHYS J, V272, pL9, DOI 10.1086/184107; Caraveo PA, 1996, ASTROPHYS J, V461, pL91, DOI 10.1086/310012; Chatterjee S, 2002, ASTROPHYS J, V575, P407, DOI 10.1086/341139; CORDES JM, 1993, NATURE, V362, P133, DOI 10.1038/362133a0; Gaensler BM, 2002, ASTROPHYS J, V580, pL137, DOI 10.1086/345750; GEHRELS N, 1993, NATURE, V361, P706, DOI 10.1038/361706a0; GINZBURG VL, 1965, ANNU REV ASTRON ASTR, V3, P297, DOI 10.1146/annurev.aa.03.090165.001501; HALPERN JP, 1992, NATURE, V357, P222, DOI 10.1038/357222a0; Halpern JP, 1997, ASTROPHYS J, V477, P905, DOI 10.1086/303743; HALPERN JP, 1993, ASTROPHYS J, V415, P286, DOI 10.1086/173164; Kaspi VM, 2001, ASTROPHYS J, V562, pL163, DOI 10.1086/324757; Krautter J, 1999, ASTRON ASTROPHYS, V350, P743; LANG KR, 1992, ASTROPHYSICAL FORMUL, P52; MCKEE CF, 1980, ANNU REV ASTRON ASTR, V18, P219, DOI 10.1146/annurev.aa.18.090180.001251; Pellizzoni A, 2002, ASTRON ASTROPHYS, V393, pL65, DOI 10.1051/0004-6361:20021207; *SAS, SAS 5 3 3; SHORE SN, 1992, INTRO ASTROPHYSICAL, P107; Stappers BW, 2003, SCIENCE, V299, P1372, DOI 10.1126/science.1079841; Struder L, 2001, ASTRON ASTROPHYS, V365, pL18, DOI 10.1051/0004-6361:20000066; Turner MJL, 2001, ASTRON ASTROPHYS, V365, pL27, DOI 10.1051/0004-6361:20000087; WANG QD, 1993, NATURE, V364, P127, DOI 10.1038/364127a0; Wilkin FP, 1996, ASTROPHYS J, V459, pL31, DOI 10.1086/309939	24	83	84	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2003	301	5638					1345	1347		10.1126/science.1086973	http://dx.doi.org/10.1126/science.1086973			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717XQ	12881574				2022-12-28	WOS:000185116400030
J	Pengel, LHM; Herbert, RD; Maher, CG; Refshauge, KM				Pengel, LHM; Herbert, RD; Maher, CG; Refshauge, KM			Acute low back pain: systematic review of its prognosis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PLACEBO-CONTROLLED TRIAL; CHRONIC DISABILITY; EXERCISE THERAPY; GENERAL-PRACTICE; PRIMARY-CARE; HEALTH-CARE; BED REST; INJURY; PREDICTION; MANAGEMENT	Objectives To describe the course of acute low back pain and sciatica and to identify clinically important prognostic factors for these conditions. Design Systematic review. Data sources Searches of Medline, Embase, Cinahl, mid Science Citation Index, and iterative searches of bibliographies. Main outcome measures Pain, disability, and return to work. Results 15 studies of variable methodological quality were included. Rapid improvements in pain (mean reduction 58% of initial scores), disability (58%), and return to work (82% of those initially off work) occurred in one month. Further improvement was apparent until about three months. Thereafter levels for pain. disability, and return to work remained almost constant. 73% of patients had at least one recurrence within 12 months. Conclusions People with acute low back pain and associated disability usually improve rapidly within weeks. None the less, pain and disability are typically ongoing, and recurrences are common.	Univ Sydney, Sch Physiotherapy, Lidcombe, NSW 1825, Australia	University of Sydney	Herbert, RD (corresponding author), Univ Sydney, Sch Physiotherapy, POB 170, Lidcombe, NSW 1825, Australia.	R.Herbert@fhs.usyd.edu.au	Herbert, Rob/E-9442-2012; Maher, Christopher/AAC-6267-2019	Herbert, Rob/0000-0003-4188-9195; Maher, Christopher/0000-0002-1628-7857; Pengel, Liset/0000-0001-9620-8639				ALTMAN DG, 1994, J NATL CANCER I, V86, P829, DOI 10.1093/jnci/86.11.829; Altman DG, 2001, BMJ-BRIT MED J, V323, P224, DOI 10.1136/bmj.323.7306.224; Cooper JE, 1996, SPINE, V21, P2329, DOI 10.1097/00007632-199610150-00005; COSTE J, 1994, BRIT MED J, V308, P577, DOI 10.1136/bmj.308.6928.577; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DETTORI JR, 1995, SPINE, V20, P2303; FAAS A, 1995, SPINE, V20, P941, DOI 10.1097/00007632-199504150-00012; FAAS A, 1993, SPINE, V18, P1388; FORDYCE WE, 1986, J BEHAV MED, V9, P127, DOI 10.1007/BF00848473; Gatchel RJ, 1999, NEUROL CLIN, V17, P149, DOI 10.1016/S0733-8619(05)70119-5; Hazard RG, 1996, SPINE, V21, P945, DOI 10.1097/00007632-199604150-00008; Hazard RG, 2000, SPINE, V25, P1419, DOI 10.1097/00007632-200006010-00015; Hides J A, 2001, Spine (Phila Pa 1976), V26, pE243, DOI 10.1097/00007632-200106010-00004; HIDES JA, 1994, SPINE, V19, P165, DOI 10.1097/00007632-199401001-00009; KLENERMAN L, 1995, SPINE, V20, P478, DOI 10.1097/00007632-199502001-00012; Koes BW, 2001, SPINE, V26, P2504, DOI 10.1097/00007632-200111150-00022; Linton SJ, 2001, J OCCUP REHABIL, V11, P53, DOI 10.1023/A:1016656225318; MALMIVAARA A, 1995, NEW ENGL J MED, V332, P351, DOI 10.1056/NEJM199502093320602; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Reid S, 1997, J OCCUP REHABIL, V7, P1, DOI 10.1007/BF02765872; Rozenberg S, 2002, SPINE, V27, P1487, DOI 10.1097/00007632-200207150-00002; Schiottz-Christensen B, 1999, FAM PRACT, V16, P223, DOI 10.1093/fampra/16.3.223; Seferlis T, 1998, Eur Spine J, V7, P461; Seferlis T, 2000, J SPINAL DISORD, V13, P470, DOI 10.1097/00002517-200012000-00002; Shaw WS, 2001, DISABIL REHABIL, V23, P815; Sieben JM, 2002, EUR J PAIN, V6, P229, DOI 10.1053/eujp.2002.0341; Tate RB, 1999, SPINE, V24, P1930, DOI 10.1097/00007632-199909150-00012; Truchon M, 2000, J OCCUP REHABIL, V10, P117, DOI 10.1023/A:1009452019715; vanTulder MW, 1997, SPINE, V22, P2323, DOI 10.1097/00007632-199710150-00001; Waddell G, 2000, OCCUPATIONAL HLTH GU; WEBER H, 1993, SPINE, V18, P1433, DOI 10.1097/00007632-199309010-00006	32	536	551	0	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2003	327	7410					323	325		10.1136/bmj.327.7410.323	http://dx.doi.org/10.1136/bmj.327.7410.323			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	710JE	12907487	Bronze, Green Published			2022-12-28	WOS:000184676400019
J	van den Brink, W; Hendriks, VM; Blanken, P; Koeter, MWJ; van Zwieten, BJ; van Ree, JM				van den Brink, W; Hendriks, VM; Blanken, P; Koeter, MWJ; van Zwieten, BJ; van Ree, JM			Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials	BRITISH MEDICAL JOURNAL			English	Article							INSTRUMENT; DIAGNOSIS; DISORDERS; EFFICACY; ABUSE	Objective To determine whether supervised medical prescription of heroin can successfully treat addicts who do not sufficiently benefit from methadone maintenance treatment. Design Two open label randomised controlled trials. Setting Methadone maintenance programmes in six cities in the Netherlands. Participants 549 heroin addicts. Interventions Inhalable heroin (n = 375) or injectable heroin (n = 174) prescribed over 12 months. Heroin (maximum 1000 mg per day) plus methadone (maximum 150 mg per day) compared with methadone alone (inaximum 150 mg per day). Psychosocial treatment was offered throughout. Main outcome measures Dichotomous, multidomain response index, including validated indicators of physical health, mental status, and social functioning. Results Adherence was excellent with 12 month outcome data available for 94%) of the randomised participants. With intention to treat analysis, 12 month treatment with heroin plus methadone was significantly more effective than treatment with methadone alone in the trial of inhalable heroin (response rate 49.7% v 26.9%; difference 22.8%, 95% confidence interval 11.0% to 34.6%) and in the trial of injectable heroin (55.5% v 31.2%; difference 24.3%, 9.6% to 39.0%). Discontinuation of the coprescribed heroin resulted in a rapid deterioration in 82% (94/115) of those who responded to the coprescribed heroin. The incidence of serious adverse events was similar across treatment conditions. Conclusions Supervised coprescription of heroin is feasible, more effective, and probably as safe as methadone alone in reducing the many physical, mental, and social problems of treatment resistant heroin addicts.	Cent Comm Treatment Heroin Addicts CCBH, Stratenum, NL-3584 CG Utrecht, Netherlands; Amsterdam Inst Addict Res, NL-1105 BC Amsterdam, Netherlands; Parnassia Addict Res Ctr, The Hague, Netherlands; Netherlands Med Evaluat Board, The Hague, Netherlands; Univ Utrecht, Inst Neurosci, Utrecht, Netherlands	University of Amsterdam; Utrecht University	van den Brink, W (corresponding author), Cent Comm Treatment Heroin Addicts CCBH, Stratenum, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.		Blanken, Peter/C-1054-2008; Blanken, Peter/J-4209-2012	Blanken, Peter/0000-0003-4847-4259				ALI R, 1999, SUCHT, V45, P160; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Bammer G, 1999, SCIENCE, V284, P1277, DOI 10.1126/science.284.5418.1277; DEROGATIS LR, 1983, SCL90R ADM SCORING P, V2; *DRIESS FMHM, 1999, ONTW SIT METH GED TW; *DRIESS FMHM, 1990, METH NED; *DRIESS FMHM, 1992, METH NED; Farrell M, 1998, BMJ-BRIT MED J, V316, P639, DOI 10.1136/bmj.316.7132.639; Franken IHA, 2001, AM J ADDICTION, V10, P30; Hendriks VM, 2001, EUR NEUROPSYCHOPHARM, V11, P241, DOI 10.1016/S0924-977X(01)00091-8; HENDRIKS VM, 1990, J CONSULT CLIN PSYCH, V58, P158, DOI 10.1037/0022-006X.58.2.158; HUIZER H, 1987, PHARM WEEKBLAD, V9, P203, DOI 10.1007/BF02029331; *ICH STEER COMM, 1998, CPMHICG3395 ICH STEE; Kokkevi A., 1995, EUR ADDICT RES, V1, P208, DOI [10.1159/000259089, DOI 10.1159/000259089]; Marsden J, 1998, ADDICTION, V93, P1857, DOI 10.1046/j.1360-0443.1998.9312185711.x; McLellan A.T., 1985, GUIDE ADDICTION SEVE; *NAT DRUG MON, 2001, JAARB NDM 2001; Perneger TV, 1998, BMJ-BRIT MED J, V317, P13, DOI 10.1136/bmj.317.7150.13; Rehm J, 2001, LANCET, V358, P1417, DOI 10.1016/S0140-6736(01)06529-1; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Rounsaville BJ, 1993, DIAGNOSTIC SOURCE BO, P1; van den Brink W, 1999, J DRUG ISSUES, V29, P587, DOI 10.1177/002204269902900309; Wodak A, 1998, MED J AUSTRALIA, V168, P590, DOI 10.5694/j.1326-5377.1998.tb141441.x	23	210	212	2	12	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 9	2003	327	7410					310	312B		10.1136/bmj.327.7410.310	http://dx.doi.org/10.1136/bmj.327.7410.310			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	710JE	12907482	Green Published, Bronze			2022-12-28	WOS:000184676400014
J	Guerrero, I; Altaba, ARI				Guerrero, I; Altaba, ARI			Longing for ligand: Hedgehog, patched, and cell death	SCIENCE			English	Editorial Material							SONIC-HEDGEHOG; SIGNALING PATHWAY; HUMAN HOMOLOG; SPINAL-CORD; GROWTH; APOPTOSIS; GLI; MEDULLOBLASTOMA; INHIBITION; EXPRESSION		Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; NYU, Sch Med, Skirball Inst, New York, NY 10016 USA	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); New York University	Guerrero, I (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.	iguerrero@cbm.uam.es; ria@saturn.med.nyu.edu	Guerrero, Isabel/K-2518-2014	Guerrero, Isabel/0000-0001-6761-1218; Ruiz i Altaba, Ariel/0000-0003-2292-3933				Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Altaba ARI, 2002, NAT REV NEUROSCI, V3, P24; Aoto K, 2002, DEV BIOL, V251, P320, DOI 10.1006/dbio.2002.0811; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Burke R, 1996, DEVELOPMENT, V122, P2261; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; Charrier JB, 2001, DEVELOPMENT, V128, P4011; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Grachtchouk V, 2003, EMBO J, V22, P2741, DOI 10.1093/emboj/cdg271; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hall A, 1996, DEVELOPMENT, V122, P4085; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Johnson RL, 1997, COLD SPRING HARB SYM, V62, P205; Johnson RL, 2000, MOL CELL, V6, P467, DOI 10.1016/S1097-2765(00)00045-9; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Mullor JL, 1997, DEVELOPMENT, V124, P1227; Nilsson M, 2000, P NATL ACAD SCI USA, V97, P3438, DOI 10.1073/pnas.050467397; Thibert C, 2003, SCIENCE, V301, P843, DOI 10.1126/science.1085405; Vernooy SY, 2000, J CELL BIOL, V150, pF69, DOI 10.1083/jcb.150.2.F69; Williams JA, 2003, P NATL ACAD SCI USA, V100, P4616, DOI 10.1073/pnas.0732813100; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201	26	26	28	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2003	301	5634					774	776		10.1126/science.1088625	http://dx.doi.org/10.1126/science.1088625			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907783				2022-12-28	WOS:000184615700026
J	Thibert, C; Teillet, MA; Lapointe, F; Mazelin, L; Le Douarin, NM; Mehlen, P				Thibert, C; Teillet, MA; Lapointe, F; Mazelin, L; Le Douarin, NM; Mehlen, P			Inhibition of neuroepithelial patched-induced apoptosis by Sonic hedgehog	SCIENCE			English	Article							RECEPTORS UNC5H; NEURAL-TUBE; MECHANISM; SURVIVAL; DCC; SPECIFICATION; DEPENDENCE; DEFINES; CHICK; ACTS	During early development in vertebrates, Sonic hedgehog (Shh) is produced by the notochord and the floor plate. A ventrodorsal gradient of Shh directs ventrodorsal patterning of the neural tube. However, Shh is also required for the survival of neuroepithelial cells. We show that Patched (Ptc) induces apoptotic cell death unless its ligand Shh is present to block the signal. Moreover, the blockade of Ptc-induced cell death partly rescues the chick spinal cord defect provoked by Shh deprivation. Thus, the proapoptotic activity of unbound Ptc and the positive effect of Shh-bound Ptc on cell differentiation probably cooperate to achieve the appropriate spinal cord development.	Univ Lyon 1, CNRS, UMR 5534,Mol & Cellular Genet Ctr, Apoptosis Differentiat Lab, F-69622 Villeurbanne, France; CNRS, UMR 7128, Lab Embryol Cellulaire & Mol, F-94736 Nogent Sur Marne, France; Int Agcy Res Canc, F-69008 Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); World Health Organization; International Agency for Research on Cancer (IARC)	Mehlen, P (corresponding author), Univ Lyon 1, CNRS, UMR 5534,Mol & Cellular Genet Ctr, Apoptosis Differentiat Lab, F-69622 Villeurbanne, France.	mehlen@univ-lyon1.fr	Mazelin, Laetitia/AAD-9319-2020; Thibert, Chantal/D-4367-2019; THIBERT, Chantal/N-1828-2013	Mazelin, Laetitia/0000-0002-4001-2132; Thibert, Chantal/0000-0002-1516-5671; 				Aoto K, 2002, DEV BIOL, V251, P320, DOI 10.1006/dbio.2002.0811; Barnes EA, 2001, EMBO J, V20, P2214, DOI 10.1093/emboj/20.9.2214; Bordeaux MC, 2000, EMBO J, V19, P4056, DOI 10.1093/emboj/19.15.4056; Bredesen DE, 1998, CELL DEATH DIFFER, V5, P365, DOI 10.1038/sj.cdd.4400378; Britto J, 2002, NAT NEUROSCI, V5, P103, DOI 10.1038/nn797; Charrier JB, 1999, DEVELOPMENT, V126, P4771; Charrier JB, 2001, DEVELOPMENT, V128, P4011; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Forcet C, 2001, P NATL ACAD SCI USA, V98, P3416, DOI 10.1073/pnas.051378298; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Koike C, 2002, ONCOGENE, V21, P2670, DOI 10.1038/sj.onc.1205370; Le Douarin NM, 2000, CURR OPIN NEUROBIOL, V10, P23, DOI 10.1016/S0959-4388(99)00062-8; Le Douarin NM, 1998, INT J DEV BIOL, V42, P909; Llambi F, 2001, EMBO J, V20, P2715, DOI 10.1093/emboj/20.11.2715; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Miao NN, 1997, J NEUROSCI, V17, P5891; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Tanikawa C, 2003, NAT CELL BIOL, V5, P216, DOI 10.1038/ncb943; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thiebault K, 2003, P NATL ACAD SCI USA, V100, P4173, DOI 10.1073/pnas.0738063100; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Wicking C, 2001, CANCER LETT, V173, P1, DOI 10.1016/S0304-3835(01)00676-0; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916	29	250	260	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2003	301	5634					843	846		10.1126/science.1085405	http://dx.doi.org/10.1126/science.1085405			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907805				2022-12-28	WOS:000184615700048
J	Herrington, DM; Howard, TD				Herrington, DM; Howard, TD			From presumed benefit to potential harm - Hormone therapy and heart disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Wake Forest Univ, Sch Med, Dept Internal Med Cardiol, Winston Salem, NC 27109 USA; Wake Forest Univ, Sch Med, Dept Pediat, Winston Salem, NC 27109 USA	Wake Forest University; Wake Forest University	Herrington, DM (corresponding author), Wake Forest Univ, Sch Med, Dept Internal Med Cardiol, Winston Salem, NC 27109 USA.							Grady D, 2003, NEW ENGL J MED, V348, P1835, DOI 10.1056/NEJMp030038; Grodstein F, 2003, NEW ENGL J MED, V348, P645, DOI 10.1056/NEJMsb022365	2	66	66	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2003	349	6					519	521		10.1056/NEJMp038108	http://dx.doi.org/10.1056/NEJMp038108			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708JL	12904515				2022-12-28	WOS:000184563500001
J	Javey, A; Guo, J; Wang, Q; Lundstrom, M; Dai, HJ				Javey, A; Guo, J; Wang, Q; Lundstrom, M; Dai, HJ			Ballistic carbon nanotube field-effect transistors	NATURE			English	Article							DEVICES	A common feature of the single-walled carbon-nanotube field-effect transistors fabricated to date has been the presence of a Schottky barrier at the nanotube-metal junctions(1-3). These energy barriers severely limit transistor conductance in the 'ON' state, and reduce the current delivery capability-a key determinant of device performance. Here we show that contacting semiconducting single-walled nanotubes by palladium, a noble metal with high work function and good wetting interactions with nanotubes, greatly reduces or eliminates the barriers for transport through the valence band of nanotubes. In situ modification of the electrode work function by hydrogen is carried out to shed light on the nature of the contacts. With Pd contacts, the 'ON' states of semiconducting nanotubes can behave like ohmically contacted ballistic metallic tubes, exhibiting room-temperature conductance near the ballistic transport limit of 4e(2)/h (refs 4-6), high current-carrying capability (similar to25 muA per tube), and Fabry-Perot interferences (5) at low temperatures. Under high voltage operation, the current saturation appears to be set by backscattering of the charge carriers by optical phonons. High-performance ballistic nanotube field-effect transistors with zero or slightly negative Schottky barriers are thus realized.	Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA	Stanford University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Dai, HJ (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	hdai@stanford.edu	Javey, Ali/B-4818-2013; Dai, Hongjie/ABC-4574-2021	Javey, Ali/0000-0001-7214-7931; 				Appenzeller J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.126801; Fischer JE, 1997, PHYS REV B, V55, pR4921, DOI 10.1103/PhysRevB.55.R4921; Guo J, 2002, INTERNATIONAL ELECTRON DEVICES 2002 MEETING, TECHNICAL DIGEST, P711, DOI 10.1109/IEDM.2002.1175937; Guo J, 2002, IEEE T ELECTRON DEV, V49, P1897, DOI 10.1109/TED.2002.804696; Guo J, 2002, APPL PHYS LETT, V80, P3192, DOI 10.1063/1.1474604; Heinze S, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.106801; HEINZE S, 2003, UNEXPECTED SCALING P; Javey A, 2002, NAT MATER, V1, P241, DOI 10.1038/nmat769; Javey A, 2002, APPL PHYS LETT, V80, P1064, DOI 10.1063/1.1448850; Kane CL, 1998, EUROPHYS LETT, V41, P683, DOI 10.1209/epl/i1998-00214-6; Kim W, 2003, NANO LETT, V3, P193, DOI 10.1021/nl0259232; Kong J, 1998, NATURE, V395, P878, DOI 10.1038/27632; Kong J, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.106801; Leonard F, 1999, PHYS REV LETT, V83, P5174, DOI 10.1103/PhysRevLett.83.5174; Leonard F, 2000, PHYS REV LETT, V84, P4693, DOI 10.1103/PhysRevLett.84.4693; Liang WJ, 2001, NATURE, V411, P665, DOI 10.1038/35079517; MANDELIS A, 1993, PHYSICS CHEM TECHNOL; Martel R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.256805; Nakanishi T, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.073307; Odintsov AA, 2000, PHYS REV LETT, V85, P150, DOI 10.1103/PhysRevLett.85.150; RAHMAN A, IN PRESS IEEE T ELEC; RAHMAN A, IN PRESS IEEE T NANO; Rosenblatt S, 2002, NANO LETT, V2, P869, DOI 10.1021/nl025639a; Soh HT, 1999, APPL PHYS LETT, V75, P627, DOI 10.1063/1.124462; SZE SM, 1981, PHYSICS SEMICONDUCTO; White CT, 1998, NATURE, V393, P240, DOI 10.1038/30420; Wind SJ, 2002, APPL PHYS LETT, V80, P3817, DOI 10.1063/1.1480877; Yao Z, 2000, PHYS REV LETT, V84, P2941, DOI 10.1103/PhysRevLett.84.2941; Zhang Y, 2000, APPL PHYS LETT, V77, P3015, DOI 10.1063/1.1324731; Zhang Y, 2000, CHEM PHYS LETT, V331, P35, DOI 10.1016/S0009-2614(00)01162-3; Zhou CW, 2000, APPL PHYS LETT, V76, P1597, DOI 10.1063/1.126107	31	2563	2702	22	878	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2003	424	6949					654	657		10.1038/nature01797	http://dx.doi.org/10.1038/nature01797			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904787				2022-12-28	WOS:000184578800039
J	Matsuishi, S; Toda, Y; Miyakawa, M; Hayashi, K; Kamiya, T; Hirano, M; Tanaka, I; Hosono, H				Matsuishi, S; Toda, Y; Miyakawa, M; Hayashi, K; Kamiya, T; Hirano, M; Tanaka, I; Hosono, H			High-density electron anions in a nanoporous single crystal: [Ca24Al28O64](4+)(4e(-))	SCIENCE			English	Article							SPIN-RESONANCE ABSORPTION; METALS; OXIDE; ION	We removed similar to100% of clathrated oxygen ions from the crystallographic cages in a single crystal of 12CaO.7Al(2)O(3), leading to the formation of high-density (similar to2x10(21) cm(-3)) electrons highly localized in the cages. The resulting electron forms a structure that we interpret as an F+ center and migrates throughout the crystal by hopping to a neighboring cage with conductivity similar to100 siemens per centimeter, demonstrating that the encaged electron behaves as an anion. The electron anions couple antiferromagnetically with each other, forming a diamagnetic pair or singlet bipolaron. The resulting [Ca24Al28O64](4+)(4e(-)) may be regarded as a thermally and chemically stable single crystalline "electride."	Japan Sci & Technol Corp, ERATO, Hosono Transparent & Electroact Mat Project, Takatsu Ku, Kawasaki, Kanagawa 2130012, Japan; Tokyo Inst Technol, Mat & Struct Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; Univ Yamanashi, Ctr Crystal Sci & Technol, Yamanashi 4008511, Japan	Japan Science & Technology Agency (JST); Tokyo Institute of Technology; University of Yamanashi	Hosono, H (corresponding author), Japan Sci & Technol Corp, ERATO, Hosono Transparent & Electroact Mat Project, Takatsu Ku, KSP C-1232,3-2-1 Sakado, Kawasaki, Kanagawa 2130012, Japan.	hosono@msl.titech.ac.jp	Hosono, HIdeo/J-3489-2013; Hosono, Hideo/T-1845-2019; Hayashi, Katsuro/C-6157-2017; Kamiya, Toshio/E-8615-2014; Tanaka, Isao/D-1519-2012	Hosono, HIdeo/0000-0001-9260-6728; Hayashi, Katsuro/0000-0002-4413-6511; Kamiya, Toshio/0000-0002-8358-240X; Tanaka, Isao/0000-0002-2736-7107				Bartl H., 1970, NEUES JB MINER MONAT, V35, P547, DOI DOI 10.1680/JADCR.16.00045; Dye JL, 1997, INORG CHEM, V36, P3816, DOI 10.1021/ic970551z; DYSON FJ, 1955, PHYS REV, V98, P349, DOI 10.1103/PhysRev.98.349; Edwards PP, 1996, ACCOUNTS CHEM RES, V29, P23, DOI 10.1021/ar950152c; FEHER G, 1955, PHYS REV, V98, P337, DOI 10.1103/PhysRev.98.337; Hayashi K, 2002, NATURE, V419, P462, DOI 10.1038/nature01053; Hayashi K, 2002, J AM CHEM SOC, V124, P738, DOI 10.1021/ja016112n; HENDERSON B, 1968, ADV PHYS, V17, P749, DOI 10.1080/00018736800101386; HOSONO H, 1987, INORG CHEM, V26, P1192, DOI 10.1021/ic00255a003; Ichimura AS, 2002, J AM CHEM SOC, V124, P1170, DOI 10.1021/ja016554z; Imlach J. A., 1971, CEMENT CONCRETE RES, V1, P57, DOI DOI 10.1016/0008-8846(71)90083-4; Izumi F, 2000, MATER SCI FORUM, V321-3, P198, DOI 10.4028/www.scientific.net/MSF.321-324.198; JEEVARATNAM J, 1964, J AM CERAM SOC, V47, P105, DOI 10.1111/j.1151-2916.1964.tb15669.x; LACERDA M, 1988, NATURE, V332, P525, DOI 10.1038/332525a0; Miyakawa M, 2003, ADV MATER, V15, P1100, DOI 10.1002/adma.200304925; Mott N.F., 1979, ELECT PROCESSES NONC, Vsecond; Srdanov VI, 1998, PHYS REV LETT, V80, P2449, DOI 10.1103/PhysRevLett.80.2449; SUSHKO P, UNPUB; Watauchi S, 2002, J CRYST GROWTH, V237, P801, DOI 10.1016/S0022-0248(01)02038-3	19	634	659	14	290	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2003	301	5633					626	629		10.1126/science.1083842	http://dx.doi.org/10.1126/science.1083842			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893938				2022-12-28	WOS:000184473600034
J	Hien, TT; Turner, GDH; Mai, NTH; Phu, NH; Bethell, D; Blakemore, WF; Cavanagh, JB; Dayan, A; Medana, I; Weller, RO; Day, NPJ; White, NJ				Hien, TT; Turner, GDH; Mai, NTH; Phu, NH; Bethell, D; Blakemore, WF; Cavanagh, JB; Dayan, A; Medana, I; Weller, RO; Day, NPJ; White, NJ			Neuropathological assessment of artemether-treated severe malaria	LANCET			English	Article								In animals, high doses of intramuscular artemether and artemotil have been shown to cause an unusual pattern of selective damage to certain brainstem nuclei, especially those implicated in hearing and balance. We aimed to investigate whether a similar pattern arises in human adults. We examined the brainstems of adults who died after treatment with high dose artemether or quinine for severe falciparum malaria for evidence of a pattern of selective neuronal damage. Neuropathological findings were similar in recipients of quinine (n = 15) and artemether (n = 6; total artemether doses received 4-44 mg/kg). No evidence was recorded for artemether-induced neurotoxic effects.	Mahidol Univ, Fac Trop Med, Oxford Trop Med Res Programme, Wellcome Trust, Bangkok 10400, Thailand; Hosp Trop Dis, Ho Chi Minh City, Vietnam; John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England; Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; John Radcliffe Hosp, Ctr Trop Med, Oxford OX3 9DU, England; Univ Cambridge, Dept Vet Clin Med, Cambridge, England; Inst Psychiat, Dept Clin Neurosci, London, England; St Bartholomews Hosp, Dept Toxicol, London, England; Univ Southampton, Dept Neuropathol, Southampton, Hants, England	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; University of Oxford; University of Oxford; University of Cambridge; University of London; King's College London; University of London; Queen Mary University London; University of Southampton	White, NJ (corresponding author), Mahidol Univ, Fac Trop Med, Oxford Trop Med Res Programme, Wellcome Trust, 420-6 Rajvithi Rd, Bangkok 10400, Thailand.	fnnjw@diamond.mahidol.ac.th	White, Nick/AAC-6527-2019; Thi, Nguyen/AAM-7074-2020; White, Nicholas J/I-4629-2012	White, Nick/0000-0002-1897-1978; 				Hien TT, 1996, NEW ENGL J MED, V335, P76, DOI 10.1056/NEJM199607113350202; Medana IM, 2001, NEUROPATH APPL NEURO, V27, P421, DOI 10.1046/j.0305-1846.2001.00360.x; Nontprasert A, 2000, AM J TROP MED HYG, V62, P409, DOI 10.4269/ajtmh.2000.62.409; Petras JM, 1997, AM J TROP MED HYG, V56, P390, DOI 10.4269/ajtmh.1997.56.390; Stepniewska K, 2001, T ROY SOC TROP MED H, V95, P637, DOI 10.1016/S0035-9203(01)90104-X	5	38	39	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2003	362	9380					295	296		10.1016/S0140-6736(03)13974-8	http://dx.doi.org/10.1016/S0140-6736(03)13974-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705UL	12892962				2022-12-28	WOS:000184413400014
J	Kuiken, T; Fouchier, RAM; Schutten, M; Rimmelzwaan, GF; van Amerongen, G; van Riel, D; Laman, JD; de Jong, T; van Doornum, G; Lim, W; Ling, AE; Chan, PKS; Tam, JS; Zambon, MC; Gopal, R; Drosten, C; van der Werf, S; Escriou, N; Manuguerra, JC; Stohr, K; Peiris, JSM; Osterhaus, ADME				Kuiken, T; Fouchier, RAM; Schutten, M; Rimmelzwaan, GF; van Amerongen, G; van Riel, D; Laman, JD; de Jong, T; van Doornum, G; Lim, W; Ling, AE; Chan, PKS; Tam, JS; Zambon, MC; Gopal, R; Drosten, C; van der Werf, S; Escriou, N; Manuguerra, JC; Stohr, K; Peiris, JSM; Osterhaus, ADME			Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome	LANCET			English	Article							POLYMERASE-CHAIN-REACTION; HONG-KONG; EXPERIMENTAL-INFECTION; IDENTIFICATION; PATHOGENICITY; CHILDREN; OUTBREAK; DISEASE; GENE; PCR	Background The worldwide outbreak. of severe acute respiratory syndrome (SARS) is associated with a newly discovered coronavirus, SARS-associated coronavirus (SARS-CoV). We did clinical and experimental studies to assess the role of this virus in the cause of SARS. Methods We tested clinical and postmortem samples from 436 SARS patients in six countries for infection with SARS-CoV, human metapneumovirus, and other respiratory pathogens. We infected four cynomolgus macaques (Macaca fascicularis) with SARS-CoV in an attempt to replicate SARS and did necropsies on day 6 after infection. Findings SARS-CoV infection was diagnosed in 329 (75%) of 436 patients fitting the case definition of SARS; human metapneumovirus was diagnosed in 41 (12%) of 335, and other respiratory pathogens were diagnosed only sporadically. SARS-CoV was, therefore, the most likely causal agent of SARS. The four SARS-CoV-infected macaques excreted SARS-CoV from nose, mouth, and pharynx from 2 days after infection. Three of four macaques developed diffuse alveolar damage, similar to that in SARS patients, and characterised by epithelial necrosis, serosanguineous exudate, formation of hyaline membranes, type 2 pneumocyte hyperplasia, and the presence of syncytia. SARS-CoV was detected in pneumonic areas by virus isolation and RT-PCR, and was localised to alveolar epithelial cells and syncytia by immunohistochemistry and transmission electron microscopy. Interpretation Replication in SARS-CoV-infected macaques of pneumonia similar to that in human beings with SARS, combined with the high prevalence of SARS-CoV infection in SARS patients, fulfill the criteria required to prove that SARS-CoV is the primary cause of SARS.	Erasmus Med Ctr, Dept Virol, NL-3000 DR Rotterdam, Netherlands; Erasmus Med Ctr, Dept Immunol, NL-3000 DR Rotterdam, Netherlands; Erasmus Med Ctr, Dept Pathol, NL-3000 DR Rotterdam, Netherlands; Publ Hlth Lab Ctr, Govt Virus Unit, Kowloon, Hong Kong, Peoples R China; Singapore Gen Hosp, Dept Pathol, Singapore 0316, Singapore; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Hlth Protect Agcy, Enter Resp & Neurol Virus Lab, London, England; Bernhard Nocht Inst Trop Med, Dept Virol, Hamburg, Germany; Inst Pasteur, Unite Genet Mol Virus Resp, Paris, France; WHO, SARS Aetiol Study Grp, CH-1211 Geneva, Switzerland; Univ Hong Kong, Queen Mary Hosp, Dept Microbiol & Med, Hong Kong, Hong Kong, Peoples R China	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Singapore General Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Health Protection Agency; Bernhard Nocht Institut fur Tropenmedizin; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; World Health Organization; University of Hong Kong	Kuiken, T (corresponding author), Erasmus Med Ctr, Dept Virol, POB 1738, NL-3000 DR Rotterdam, Netherlands.	t.kuiken@erasmusmc.nl	Fouchier, Ron A/A-1911-2014; Chan, Paul KS/J-9360-2013; Escriou, Nicolas/A-2392-2016	Fouchier, Ron A/0000-0001-8095-2869; Chan, Paul KS/0000-0002-6360-4608; Escriou, Nicolas/0000-0002-1224-6839; van der WERF, Sylvie/0000-0002-1148-4456; Osterhaus, Albert/0000-0002-6074-1172; van Riel, Debby/0000-0001-9753-3564				BHATT PN, 1977, ARCH VIROL, V54, P345, DOI 10.1007/BF01314779; CHAN PKS, IN PRESS EMERG INFEC; CLAAS HC, 1990, EUR J CLIN MICROBIOL, V9, P864, DOI 10.1007/BF01967500; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; DUNGWORTH DL, 1993, PATHOLOGY DOMESTIC A, V2, P539; Fouchier RAM, 2000, J CLIN MICROBIOL, V38, P4096, DOI 10.1128/JCM.38.11.4096-4101.2000; Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a; JABRANE A, 1994, CAN VET J, V35, P86; LAI MMC, 1999, FIELDS VIROLOGY, P1163; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; MAHY BWJ, 1997, DICT VIROLOGY; Myers J.L., 1993, PULMONARY PATHOLOGY, P57; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; OTOOLE D, 1989, RES VET SCI, V47, P23, DOI 10.1016/S0034-5288(18)31226-8; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Peiris JSM, 2003, EMERG INFECT DIS, V9, P628; Peret TCT, 2002, J INFECT DIS, V185, P1660, DOI 10.1086/340518; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Reischl U, 2003, EUR J CLIN MICROBIOL, V22, P54, DOI 10.1007/s10096-002-0858-2; SCHNEIDERSCHAUL.S, 2002, EXPERT REV MOL MED; Stephensen CB, 1999, VIRUS RES, V60, P181, DOI 10.1016/S0168-1702(99)00017-9; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; *WHO, 2003, WKLY EPIDEMIOL REC, V78, P81; PCR PRIMERS SARS DEV; CUMULATIVE NUMBER RE; PNEUMONIA CHINA GUAN	29	755	818	8	122	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2003	362	9380					263	270		10.1016/S0140-6736(03)13967-0	http://dx.doi.org/10.1016/S0140-6736(03)13967-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705UL	12892955	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000184413400007
J	Sepulveda, C; Habiyambere, V; Amandua, J; Borok, M; Kikule, E; Mudanga, B; Ngoma, T; Solomon, B				Sepulveda, C; Habiyambere, V; Amandua, J; Borok, M; Kikule, E; Mudanga, B; Ngoma, T; Solomon, B			Quality care at the end of life in Africa	BRITISH MEDICAL JOURNAL			English	Article									WHO, Program Canc Control, CH-1211 Geneva 27, Switzerland; WHO, HIV AIDS Care, CH-1211 Geneva, Switzerland; Minist Hlth, Kampala, Uganda; Univ Zimbabwe, Sch Med, Dept Med, Harare, Zimbabwe; Hospice Africa Uganda, Kampala, Uganda; Minist Hlth, AIDS STD Unit, Gaborone, Botswana; Ocean Rd Canc Inst, Dar Es Salaam, Tanzania; Univ Addis Ababa, Radiotherapy Ctr, Addis Ababa, Ethiopia	World Health Organization; World Health Organization; University of Zimbabwe; Addis Ababa University	Sepulveda, C (corresponding author), WHO, Program Canc Control, Ave Appia 20, CH-1211 Geneva 27, Switzerland.		Ngoma, Twalib/L-7874-2019					Ferlay J, 2001, GLOBOCAN 2000 CANC I; *JOINT UN PROGR HI, 2002, REP GLOB HIV AIDS EP; Singer PA, 2002, BMJ-BRIT MED J, V324, P1291, DOI 10.1136/bmj.324.7349.1291; *UN DEV PROGR, 2002, HUM DEV REP 2002; WHO, 2001, WORLD HLTH REPORT 20; *WHO, SYMPT REL TERM ILLN; WHO, 1998, CANC PAIN REL PALL C; *WHO, 2002, SEAL ANT THER RES LT; WHO, 1996, CANC PAIN REL GUID; World Health Organization, 1990, CANC PAIN REL PALL C; World Health Organization, 2002, NAT CANC CONTR PROGR	11	85	86	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2003	327	7408					209	213		10.1136/bmj.327.7408.209	http://dx.doi.org/10.1136/bmj.327.7408.209			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	706DL	12881267	Green Published			2022-12-28	WOS:000184437300023
J	Jenkins, DJA; Kendall, CWC; Marchie, A; Faulkner, DA; Wong, JMW; de Souza, R; Emam, A; Parker, TL; Vidgen, E; Lapsley, KG; Trautwein, EA; Josse, RG; Leiter, LA; Connelly, PW				Jenkins, DJA; Kendall, CWC; Marchie, A; Faulkner, DA; Wong, JMW; de Souza, R; Emam, A; Parker, TL; Vidgen, E; Lapsley, KG; Trautwein, EA; Josse, RG; Leiter, LA; Connelly, PW			Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; PLASMA-CHOLESTEROL; NUT CONSUMPTION; PRIMARY PREVENTION; PLANT STEROLS; BLOOD-LIPIDS; RISK-FACTORS; MEN; REDUCTION	Context To enhance the effectiveness of diet in lowering cholesterol, recommendations of the Adult Treatment Panel III of the National Cholesterol Education Program emphasize diets low in saturated fat together with plant sterols and viscous fibers, and the American Heart Association supports the use of soy protein and nuts. Objective To determine whether a diet containing all of these recommended food components leads to cholesterol reduction comparable with that of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins). Design Randomized controlled trial conducted between October and December 2002. Setting and Participants Forty-six healthy, hyperlipidemic adults (25 men and 21 postmenopausal women) with a mean (SE) age of 59 (1) years and body mass index of 27.6 (0.5), recruited from a Canadian hospital-affiliated nutrition research center and the community. Interventions Participants were randomly assigned to undergo 1 of 3 interventions on an outpatient basis for 1 month: a diet very low in saturated fat, based on milled whole-wheat cereals and low-fat dairy foods (n=16; control); the same diet plus lovastatin, 20 mg/d (n = 14); or a diet high in plant sterols (1.0 g/1000 kcal), soy protein (21.4 g/1000 kcal), viscous fibers (9.8 g/1000 kcal), and almonds (14 g/1000 kcal) (n=16; dietary portfolio). Main Outcome Measures Lipid and C-reactive protein levels, obtained from fasting blood samples; blood pressure; and body weight; measured at weeks 0, 2, and 4 and compared among the 3 treatment groups. Results The control, statin, and dietary portfolio groups had mean (SE) decreases in low-density lipoprotein cholesterol of 8.0% (2.1%) (P=.002), 30.9% (3.6%) (P<.001), and 28.6% (3.2%) (P<.001), respectively. Respective reductions in C-reactive protein were 10.0% (8.6%) (P=.27),33.3% (8.3%) (P=.002), and 28.2% (10.8%) (P=.02). The significant reductions in the statin and dietary portfolio groups were all significantly different from changes in the control group. There were no significant differences in efficacy between the statin and dietary portfolio treatments. Conclusion In this study, diversifying cholesterol-lowering components in the same dietary portfolio increased the effectiveness of diet as a treatment of hypercholesterolemia.	St Michaels Hosp, Clin Nutr & Risk Factor Modificat Ctr, Toronto, ON M5C 2T2, Canada; St Michaels Hosp, Dept Med, Div Endocrinol & Metab, Toronto, ON M5C 2T2, Canada; Univ Toronto, Fac Med, Dept Nutr Sci, Toronto, ON, Canada; Univ Toronto, Fac Med, Dept Med, Toronto, ON, Canada; Univ Toronto, Fac Med, Dept Biochem, Toronto, ON, Canada; Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON, Canada; Almond Board Calif, Modesto, CA USA; Unilever Res Labs, Unilever Hlth Inst, Vlaardingen, Netherlands	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; Unilever	Jenkins, DJA (corresponding author), St Michaels Hosp, Clin Nutr & Risk Factor Modificat Ctr, 61 Queen St E, Toronto, ON M5C 2T2, Canada.	cyril.kendall@utoronto.ca	Wong, Julia M W/B-2048-2008; de Souza, Russell J/ABB-7735-2021; Leiter, Lawrence/AAG-4059-2020; Jenkins, David JA/A-1992-2009; Connelly, Philip W/B-7583-2012	de Souza, Russell J/0000-0001-8945-513X; Connelly, Philip W/0000-0001-7244-6843				Adler AJ, 1997, AM J CLIN NUTR, V65, P445, DOI 10.1093/ajcn/65.2.445; Albert CM, 2002, ARCH INTERN MED, V162, P1382, DOI 10.1001/archinte.162.12.1382; *ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI DOI 10.1016/S1062-1458(03)00049-7; ANDERSON JW, 1995, NEW ENGL J MED, V333, P276, DOI 10.1056/NEJM199508033330502; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Baum JA, 1998, AM J CLIN NUTR, V68, P545, DOI 10.1093/ajcn/68.3.545; Brown L, 1999, AM J CLIN NUTR, V69, P30; CARROLL KK, 1991, J AM DIET ASSOC, V91, P820; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; FINK PC, 1989, J CLIN CHEM CLIN BIO, V27, P261; FRASER GE, 1992, ARCH INTERN MED, V152, P1416, DOI 10.1001/archinte.152.7.1416; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GINSBERG HN, 1990, NEW ENGL J MED, V322, P574, DOI 10.1056/NEJM199003013220902; GRUNDY SM, 1986, NEW ENGL J MED, V314, P745, DOI 10.1056/NEJM198603203141204; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; Heber D, 1999, AM J CLIN NUTR, V69, P231; HEGSTED DM, 1965, AM J CLIN NUTR, V17, P281; Hu FB, 1998, BMJ-BRIT MED J, V317, P1341, DOI 10.1136/bmj.317.7169.1341; Hyson DA, 2002, J NUTR, V132, P703, DOI 10.1093/jn/132.4.703; Jenkins DJA, 2002, METABOLISM, V51, P1596, DOI 10.1053/meta.2002.35578; Jenkins DJA, 2002, CIRCULATION, V106, P1327, DOI 10.1161/01.CIR.0000028421.91733.20; Jenkins DJA, 2002, AM J CLIN NUTR, V76, P365, DOI 10.1093/ajcn/76.2.365; Jialal I, 2001, CIRCULATION, V103, P1933; Krauss RM, 2000, CIRCULATION, V102, P2284; Kris-Etherton PM, 1999, AM J CLIN NUTR, V70, p504S, DOI 10.1093/ajcn/70.3.504s; Kris-Etherton PM, 1999, AM J CLIN NUTR, V70, P1009; Law M, 2000, BMJ-BRIT MED J, V320, P861, DOI 10.1136/bmj.320.7238.861; LEES AM, 1977, ATHEROSCLEROSIS, V28, P325, DOI 10.1016/0021-9150(77)90180-0; Lipid Research Clinics, 1982, US DEP HLTH HUM SERV; Ludwig DS, 1999, JAMA-J AM MED ASSOC, V282, P1539, DOI 10.1001/jama.282.16.1539; Mussner MJ, 2002, METABOLISM, V51, P189, DOI 10.1053/meta.2002.29988; Olson BH, 1997, J NUTR, V127, P1973, DOI 10.1093/jn/127.10.1973; Ornish D, 1998, JAMA-J AM MED ASSOC, V280, P2001, DOI 10.1001/jama.280.23.2001; Pasternak RC, 2002, CIRCULATION, V106, P1024, DOI 10.1161/01.CIR.0000032466.44170.44; PEDERSEN TR, 1994, LANCET, V344, P1383; RAMSAY LE, 1991, BMJ-BRIT MED J, V303, P953, DOI 10.1136/bmj.303.6808.953; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; SAS, 1997, SAS STAT US GUID VER; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Sparrow CP, 2001, ARTERIOSCL THROM VAS, V21, P115, DOI 10.1161/01.ATV.21.1.115; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; US Food and Drug Administration, 2001, FOOD LAB HLTH CLAIMS, P15343; WARNICK GR, 1982, CLIN CHEM, V28, P1379; WATTS GF, 1992, LANCET, V339, P563, DOI 10.1016/0140-6736(92)90863-X; WEGGEMANS RM, IN PRESS EUR J CLIN; Yeh YY, 2001, J NUTR, V131, p989S, DOI 10.1093/jn/131.3.989S; [No title captured]; [No title captured]; 1999, FED REGISTER, V64, P57699	51	390	393	1	44	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 23	2003	290	4					502	510		10.1001/jama.290.4.502	http://dx.doi.org/10.1001/jama.290.4.502			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	703JB	12876093				2022-12-28	WOS:000184275300022
J	Zhao, YD; Dai, XH; Blackwell, HE; Schreiber, SL; Chory, J				Zhao, YD; Dai, XH; Blackwell, HE; Schreiber, SL; Chory, J			SIR1, an upstream component in auxin signaling identified by chemical genetics	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; AUX/IAA PROTEINS; RAPID INDUCTION; TRANSPORT; ROOT; GRAVITROPISM; DEGRADATION; REGULATOR; MECHANISM; MUTATION	Auxin is a plant hormone that regulates many aspects of plant growth and development. We used a chemical genetics approach to identify SIR1, a regulator of many auxin-inducible genes. The sir1 mutant was resistant to sirtinol, a small molecule that activates many auxin-inducible genes and promotes auxin-related developmental phenotypes. SIR1 is predicted to encode a protein composed of a ubiquitin-activating enzyme E1-like domain and a Rhodanese-like domain homologous to that of prolyl isomerase. We suggest a molecular context for how the auxin signal is propagated to exert its biological effects.	Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; Harvard Univ, Howard Hughes Med Inst, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Salk Inst Biol Studies, La Jolla, CA 92037 USA; HHMI, Plant Biol Lab, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Harvard University; Howard Hughes Medical Institute; Salk Institute; Howard Hughes Medical Institute	Zhao, YD (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.				NIGMS NIH HHS [1R01GM68631-01, 2R01GM52413] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068631, R01GM052413] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABEL S, 1994, P NATL ACAD SCI USA, V91, P326, DOI 10.1073/pnas.91.1.326; Bennett MJ, 1996, SCIENCE, V273, P948, DOI 10.1126/science.273.5277.948; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Friml J, 2002, PLANT MOL BIOL, V49, P273, DOI 10.1023/A:1015248926412; Furukawa K, 2000, J BIOL CHEM, V275, P7462, DOI 10.1074/jbc.275.11.7462; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; HAGEN G, 1985, MOL CELL BIOL, V5, P1197, DOI 10.1128/MCB.5.6.1197; Harper RM, 2000, PLANT CELL, V12, P757, DOI 10.1105/tpc.12.5.757; Hellmann H, 2002, SCIENCE, V297, P793, DOI 10.1126/science.1072831; HOBBIE L, 1994, PLANT CELL ENVIRON, V17, P525, DOI 10.1111/j.1365-3040.1994.tb00147.x; King JJ, 1995, PLANT CELL, V7, P2023, DOI 10.1105/tpc.7.12.2023; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; LEYSER HMO, 1993, NATURE, V364, P161, DOI 10.1038/364161a0; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Nieder Joerg, 1997, P275; Reed JW, 2001, TRENDS PLANT SCI, V6, P420, DOI 10.1016/S1360-1385(01)02042-8; Reinhardt D, 2000, PLANT CELL, V12, P507, DOI 10.1105/tpc.12.4.507; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Ruegger M, 1997, PLANT CELL, V9, P745, DOI 10.1105/tpc.9.5.745; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Schroeder DF, 2002, CURR BIOL, V12, P1462, DOI 10.1016/S0960-9822(02)01106-5; THEOLOGIS A, 1985, J MOL BIOL, V183, P53, DOI 10.1016/0022-2836(85)90280-3; TIMPTE C, 1994, GENETICS, V138, P1239; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306	27	134	140	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 22	2003	301	5636					1107	1110		10.1126/science.1084161	http://dx.doi.org/10.1126/science.1084161			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	713RP	12893885				2022-12-28	WOS:000184872400044
J	Selwyn, PA; Forstein, M				Selwyn, PA; Forstein, M			Overcoming the false dichotomy of curative vs palliative care for late-stage HIV/AIDS - "Let me live the way I want to live, until I can't"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTED PATIENTS; LONG-TERM-CARE; OF-LIFE CARE; ANTIRETROVIRAL THERAPY; VIRAL LOAD; SYMPTOM PREVALENCE; UNITED-STATES; DRUG-THERAPY; HEPATITIS-C	Recent advances in human immunodeficiency virus (HIV) therapy have significantly reduced HIV-related mortality in the developed world, but mortality rates have plateaued, and AIDS remains a leading cause of serious illness and death for young adults. The chronic nature of the HIV disease course and the increasing burden of cumulative HIV-related morbidity and treatment-related toxic effects pose new challenges to the care of patients overtime. Uncertainties about prognosis and the promise and limitations of rapidly evolving therapies have made decision making about advance care planning and end-of-life issues more complex and elusive than when the disease course was more uniform, rapid, and predictable. The emerging biomedical paradigm of highly active antiretroviral therapy (HAART) as the cornerstone of treatment has helped to transform HIV into a manageable chronic disease, yet at the same time has resulted in a more narrow focus and a de facto separation between disease-specific "curative" and symptom-specific "palliative" care for patients with HIV/AIDS. As patients survive longer in the latter stages of progressive HIV disease, they may in fact have increasing need for comprehensive symptom management as well as wide-ranging need for psychosocial, family, and care planning support. In the HAART era, the false dichotomy of curative vs palliative care for patients with HIV/AIDS must be supplanted by a more integrated model to provide comprehensive care for patients with advanced HIV disease and their families.	Montefiore Med Ctr, Albert Einstein Coll Med, Dept Family Med & Community Hlth, Bronx, NY 10467 USA; Harvard Univ, Sch Med, Cambridge Hosp, Dept Psychiat, Boston, MA USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Cambridge Health Alliance; Cambridge Hospital; Harvard Medical School	Selwyn, PA (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Family Med & Community Hlth, 3544 Jerome Ave, Bronx, NY 10467 USA.	selwyn@aecom.yu.edu	Harding, Richard/G-9729-2012					*AM AC HOSP PALL M, 2002, 14 ANN ASS AM AC HOS; [Anonymous], 2002, FAM SYST HEALTH, DOI [10.1037/h0089471, DOI 10.1037/H0089471]; BAXTER DJ, 1997, LEAST THESE MY BRETH; BLACKHALL LJ, 1995, JAMA-J AM MED ASSOC, V274, P820, DOI 10.1001/jama.274.10.820; Breitbart W, 1999, J PAIN SYMPTOM MANAG, V18, P203, DOI 10.1016/S0885-3924(99)00077-9; Breitbart W, 1998, J PAIN SYMPTOM MANAG, V15, P159, DOI 10.1016/S0885-3924(97)00260-1; Breitbart W, 1996, PAIN, V65, P243, DOI 10.1016/0304-3959(95)00217-0; Campo Rafael, 1997, DESIRE HEAL DOCTORS; *CDCP, 2000, HIV AIDS SURVEILLANC, V12, P1; Centers for Disease Control and Prevention, 2001, Morbidity and Mortality Weekly Report, V50, P430; Crawley L, 2000, JAMA-J AM MED ASSOC, V284, P2518, DOI 10.1001/jama.284.19.2518; CURRAN JW, 1985, SCIENCE, V229, P1352, DOI 10.1126/science.2994217; Curtis JR, 1997, J GEN INTERN MED, V12, P736, DOI 10.1046/j.1525-1497.1997.07158.x; Dalakas MC, 2001, J PERIPHER NERV SYST, V6, P14, DOI 10.1046/j.1529-8027.2001.006001014.x; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; DEMMER C, 2001, AM J HOSP PALLIAT CA, V1, P35; den Brinker M, 2000, AIDS, V14, P2895, DOI 10.1097/00002030-200012220-00011; Doyle D, 1998, OXFORD TXB PALLIATIV; Dube MP, 2000, CLIN INFECT DIS, V31, P1216; Dube MP, 2000, CLIN INFECT DIS, V31, P1467, DOI 10.1086/317491; Dybul Mark, 2002, MMWR Recomm Rep, V51, P1; ELLIS R, 1997, ARCH NEUROL-CHICAGO, V6, P416; Evans DL, 2002, AM J PSYCHIAT, V159, P1752, DOI 10.1176/appi.ajp.159.10.1752; Fantoni M, 1997, J PALLIATIVE CARE, V13, P9, DOI 10.1177/082585979701300203; FILBET M, 1994, J PALLIAT CARE, V10, P92; FOLEY F, 1994, J PALLIAT CARE, V10, P132; Fontaine A, 1999, J PAIN SYMPTOM MANAG, V18, P263, DOI 10.1016/S0885-3924(99)00078-0; Frenkel LM, 2001, NEW ENGL J MED, V344, P520, DOI 10.1056/NEJM200102153440710; GOEDERT JJ, 1987, JAMA-J AM MED ASSOC, V257, P331, DOI 10.1001/jama.257.3.331; Goodkin K, 1997, NEUROIMAG CLIN N AM, V7, P561; Goulet JL, 2000, J URBAN HEALTH, V77, P213, DOI 10.1007/BF02390532; *INT AIDS C, 2002, 14 INT AIDS C 2002 B; Kagawa-Singer M, 2001, JAMA-J AM MED ASSOC, V286, P2993, DOI 10.1001/jama.286.23.2993; KARASZ A, IN PRESS SOC SCI MED; Kelleher P, 1997, PALLIATIVE MED, V11, P152, DOI 10.1177/026921639701100210; Kravcik S, 1997, ARCH INTERN MED, V157, P2069, DOI 10.1001/archinte.157.18.2069; Larue F, 1997, BRIT MED J, V314, P23, DOI 10.1136/bmj.314.7073.23; LARUE L, 1994, J PALLIAT CARE, V10, P95; Lee LM, 2001, JAMA-J AM MED ASSOC, V285, P1308, DOI 10.1001/jama.285.10.1308; Lopez OL, 1998, J NEUROPSYCH CLIN N, V10, P343, DOI 10.1176/jnp.10.3.343; Lynn J, 2001, JAMA-J AM MED ASSOC, V285, P925, DOI 10.1001/jama.285.7.925; Martin DK, 1999, ARCH INTERN MED, V159, P86, DOI 10.1001/archinte.159.1.86; Mathews WC, 2000, MED CARE, V38, P750, DOI 10.1097/00005650-200007000-00007; McArthur JC, 1997, ANN NEUROL, V42, P689, DOI 10.1002/ana.410420504; McComsey GA, 2001, AIDS, V15, P321, DOI 10.1097/00002030-200102160-00004; Meadows J, 1999, AIDS PATIENT CARE ST, V13, P47, DOI 10.1089/apc.1999.13.47; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Moore RD, 2001, AIDS, V15, P617, DOI 10.1097/00002030-200103300-00011; MOSS V, 1990, AIDS (London), V4, pS235; Mouton C, 1997, ARCH FAM MED, V6, P342, DOI 10.1001/archfami.6.4.342; *NAT HOSP ORG, 1996, GUID DET PROGN SEL N; Navaie-Waliser M, 2002, AM J PUBLIC HEALTH, V92, P409, DOI 10.2105/AJPH.92.3.409; OGBUOKIRI J, 2003, CLIN GUIDE SUPPORTIV; ONeill JF, 2003, CLIN GUIDE SUPPORTIV; ONEILL WM, 1993, PAIN, V54, P3, DOI 10.1016/0304-3959(93)90093-5; Percy Walker, 1971, LOVE RUINS; Piscitelli SC, 2001, NEW ENGL J MED, V344, P984, DOI 10.1056/NEJM200103293441307; POLK BF, 1987, NEW ENGL J MED, V316, P61, DOI 10.1056/NEJM198701083160201; Powderly WG, 2002, J ACQ IMMUN DEF SYND, V29, pS28, DOI 10.1097/00126334-200202011-00005; Puoti M, 2000, J ACQ IMMUN DEF SYND, V24, P211; Rabkin JG, 1997, ARCH GEN PSYCHIAT, V54, P1049; Sansone GR, 2000, J URBAN HEALTH, V77, P166, DOI 10.1007/BF02390528; Scannell K., 1999, DEATH GOOD DOCTOR LE; SELIK RM, 1984, AM J MED, V76, P493, DOI 10.1016/0002-9343(84)90669-7; SELWYN P, 1998, SURVIVING FALL PERSO; Selwyn PA, 1998, ANN INTERN MED, V129, P899, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00012; Selwyn PA, 2000, J URBAN HEALTH, V77, P187, DOI 10.1007/BF02390530; SELWYN PA, 1992, NEW ENGL J MED, V327, P1697, DOI 10.1056/NEJM199212103272401; SELWYN PA, 2002, INNOVATIONS END OF L, V4; SELWYN RA, 2002, INNOVATIONS END OF L, V4; Shaer AJ, 2000, AM J NEPHROL, V20, P332, DOI 10.1159/000013610; Simpson DM, 1999, CLIN INFECT DIS, V29, P19, DOI 10.1086/520150; SINGER EJ, 1993, PAIN, V54, P15, DOI 10.1016/0304-3959(93)90094-6; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; Thiebaut R, 2000, CLIN INFECT DIS, V31, P1482, DOI 10.1086/317477; Valdez H, 2001, CLIN INFECT DIS, V32, P1487, DOI 10.1086/320164; Verghese Abraham, 1994, MY OWN COUNTRY DOCTO; Vogl D, 1999, J PAIN SYMPTOM MANAG, V18, P253, DOI 10.1016/S0885-3924(99)00066-4; Welch K, 2002, AIDS PATIENT CARE ST, V16, P75, DOI 10.1089/10872910252806126; Wenger NS, 2001, JAMA-J AM MED ASSOC, V285, P2880, DOI 10.1001/jama.285.22.2880; Wood CGA, 1997, BRIT MED J, V315, P1433, DOI 10.1136/bmj.315.7120.1433; 2001, MMWR MORB MORTAL WKL, V50, P1066; 1989, MMWR MORB MORTAL WKL, V38, P229; 1997, MMWR MORB MORTAL WKL, V46, P165; 1989, MMWR MORB MORTAL WKL, V38, P561	86	53	53	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2003	290	6					806	814		10.1001/jama.290.6.806	http://dx.doi.org/10.1001/jama.290.6.806			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	709VU	12915434				2022-12-28	WOS:000184647700032
J	Mellor, S				Mellor, S			Treatment of tennis elbow: the evidence	BRITISH MEDICAL JOURNAL			English	Review									Austin & Repatriat Med Ctr, Heidelberg, Vic 3123, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health	Mellor, S (corresponding author), Austin & Repatriat Med Ctr, Heidelberg, Vic 3123, Australia.							Cyriax JH, 1936, J BONE JOINT SURG, V18, P921; Smidt N, 2002, LANCET, V359, P657, DOI 10.1016/S0140-6736(02)07811-X; SOLVEBORN SA, 1995, CLIN ORTHOP RELAT R, P99; Spence D, 2002, BRIT MED J, V325, P587, DOI 10.1136/bmj.325.7364.587; VERHAAR J, 1993, J BONE JOINT SURG AM, V75A, P1034, DOI 10.2106/00004623-199307000-00010	5	6	8	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 9	2003	327	7410					330	330		10.1136/bmj.327.7410.330	http://dx.doi.org/10.1136/bmj.327.7410.330			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	710JE	12907490	Green Published			2022-12-28	WOS:000184676400025
J	Page, SL; Hawley, RS				Page, SL; Hawley, RS			Chromosome choreography: The meiotic ballet	SCIENCE			English	Review							SYNAPTONEMAL COMPLEX PROTEIN; SISTER-CHROMATID COHESION; CAENORHABDITIS-ELEGANS; MEIOSIS-I; DROSOPHILA-MELANOGASTER; AXIAL ELEMENTS; BUDDING YEAST; C-ELEGANS; RECOMBINATION; SEGREGATION	The separation of homologous chromosomes during meiosis in eukaryotes is the physical basis of Mendelian inheritance. The core of the meiotic process is a specialized nuclear division ( meiosis I) in which homologs pair with each other, recombine, and then segregate from each other. The processes of chromosome alignment and pairing allow for homolog recognition. Reciprocal meiotic recombination ensures meiotic chromosome segregation by converting sister chromatid cohesion into mechanisms that hold homologous chromosomes together. Finally, the ability of sister kinetochores to orient to a single pole at metaphase I allows the separation of homologs to two different daughter cells. Failures to properly accomplish this elegant chromosome dance result in aneuploidy, a major cause of miscarriage and birth defects in human beings.	Stowers Inst Med Res, Kansas City, MO 64110 USA	Stowers Institute for Medical Research	Hawley, RS (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.		Page, Scott L/B-4984-2009	Hawley, R. Scott/0000-0002-6478-0494				Banks JD, 2001, CURR BIOL, V11, pR128, DOI 10.1016/S0960-9822(01)00059-8; Bass HW, 2000, J CELL SCI, V113, P1033; Bickel SE, 2002, CURR BIOL, V12, P925, DOI 10.1016/S0960-9822(02)00846-1; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Burgess SM, 2002, ADV GENET, V46, P49; Carpenter ATC, 2003, GENETICS, V163, P1337; CARPENTER ATC, 1975, P NATL ACAD SCI USA, V72, P3186, DOI 10.1073/pnas.72.8.3186; Celerin M, 2000, EMBO J, V19, P2739, DOI 10.1093/emboj/19.11.2739; Cha RS, 2000, GENE DEV, V14, P493; Darlington C.D., 1932, RECENT ADV CYTOLOGY; Davis L, 2001, P NATL ACAD SCI USA, V98, P8395, DOI 10.1073/pnas.121005598; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Dernburg AF, 1996, CELL, V86, P135, DOI 10.1016/S0092-8674(00)80084-7; DOBSON MJ, 1994, J CELL SCI, V107, P2749; ELJPE M, 2003, J CELL BIOL, V160, P657; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HAWLEY RS, 1980, GENETICS, V94, P625; HAWLEY RS, 1992, DEV GENET, V13, P440, DOI 10.1002/dvg.1020130608; Hodges CA, 2002, HUM REPROD, V17, P1171, DOI 10.1093/humrep/17.5.1171; Hunt PA, 2003, CURR BIOL, V13, P546, DOI 10.1016/S0960-9822(03)00189-1; KANG JK, 2003, J CELL SCI, V116, P3069, DOI DOI 10.1242/JCS900614; Kapoor TM, 2002, J CELL BIOL, V157, P551, DOI 10.1083/jcb.200202073; Karpen GH, 1996, SCIENCE, V273, P118, DOI 10.1126/science.273.5271.118; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Lee BH, 2002, GENE DEV, V16, P1672, DOI 10.1101/gad.989302; Lemaire-Adkins R, 1997, J CELL BIOL, V139, P1611, DOI 10.1083/jcb.139.7.1611; Liu JG, 1996, EXP CELL RES, V226, P11, DOI 10.1006/excr.1996.0197; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; MAGUIRE MP, 1974, J THEOR BIOL, V48, P485, DOI 10.1016/S0022-5193(74)80017-2; Manheim EA, 2003, CURR BIOL, V13, P276, DOI 10.1016/S0960-9822(03)00050-2; McKee BD, 1996, CHROMOSOMA, V105, P135, DOI 10.1007/BF02509494; MCKIM KS, 1988, GENETICS, V120, P987; McKim KS, 1998, SCIENCE, V279, P876, DOI 10.1126/science.279.5352.876; MEUWISSEN RLJ, 1992, EMBO J, V11, P5091, DOI 10.1002/j.1460-2075.1992.tb05616.x; Moens PB, 2002, J CELL SCI, V115, P1611; NICKLAS RB, 1977, PHILOS T ROY SOC B, V277, P267, DOI 10.1098/rstb.1977.0017; NICKLAS RB, 1995, J CELL BIOL, V130, P929, DOI 10.1083/jcb.130.4.929; NICKLAS RB, 1974, GENETICS, V78, P205; Page J, 2003, J CELL SCI, V116, P551, DOI 10.1242/jcs.00252; Page SL, 2001, GENE DEV, V15, P3130, DOI 10.1101/gad.935001; Pasierbek P, 2001, GENE DEV, V15, P1349, DOI 10.1101/gad.192701; Pelttari J, 2001, MOL CELL BIOL, V21, P5667, DOI 10.1128/MCB.21.16.5667-5677.2001; Peoples TL, 2002, GENE DEV, V16, P1682, DOI 10.1101/gad.983802; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Pezzi N, 2000, FASEB J, V14, P581, DOI 10.1096/fasebj.14.3.581; Pidoux AL, 2000, CURR OPIN CELL BIOL, V12, P308, DOI 10.1016/S0955-0674(00)00094-6; Prieto I, 2001, NAT CELL BIOL, V3, P761, DOI 10.1038/35087082; RASMUSSEN SW, 1977, CHROMOSOMA, V60, P205, DOI 10.1007/BF00329771; Revenkova E, 2001, MOL CELL BIOL, V21, P6984, DOI 10.1128/MCB.21.20.6984-6998.2001; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Ross LO, 1996, P NATL ACAD SCI USA, V93, P4979, DOI 10.1073/pnas.93.10.4979; Sanford C, 2001, NUCLEIC ACIDS RES, V29, P2920, DOI 10.1093/nar/29.14.2920; Schmekel K, 1996, EXP CELL RES, V226, P20, DOI 10.1006/excr.1996.0198; Shonn MA, 2000, SCIENCE, V289, P300, DOI 10.1126/science.289.5477.300; Shonn MA, 2002, GENE DEV, V16, P1659, DOI 10.1101/gad.975802; Siomos MF, 2001, CURR BIOL, V11, P1825, DOI 10.1016/S0960-9822(01)00588-7; Storlazzi A, 1996, P NATL ACAD SCI USA, V93, P9043, DOI 10.1073/pnas.93.17.9043; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; SYM M, 1994, CELL, V79, P283, DOI 10.1016/0092-8674(94)90197-X; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Tung KS, 1998, GENETICS, V149, P817; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Vazquez J, 2002, CURR BIOL, V12, P1473, DOI 10.1016/S0960-9822(02)01090-4; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Yamamoto A, 2001, BIOESSAYS, V23, P526, DOI 10.1002/bies.1072; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	69	309	347	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 8	2003	301	5634					785	789		10.1126/science.1086605	http://dx.doi.org/10.1126/science.1086605			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	709FT	12907787				2022-12-28	WOS:000184615700030
J	Hamuy, M; Phillips, MM; Suntzeff, NB; Maza, J; Gonzalez, LE; Roth, M; Krisciunas, K; Morrell, N; Green, EM; Persson, SE; McCarthy, PJ				Hamuy, M; Phillips, MM; Suntzeff, NB; Maza, J; Gonzalez, LE; Roth, M; Krisciunas, K; Morrell, N; Green, EM; Persson, SE; McCarthy, PJ			An asymptotic-giant-branch star in the progenitor system of a type Ia supernova	NATURE			English	Article							DENSE WINDS; 1999EE; 1988Z	Stars that explode as supernovae come in two main classes. A type Ia supernova is recognized by the absence of hydrogen and the presence of elements such as silicon and sulphur in its spectrum; this class of supernova is thought to produce the majority of iron-peak elements in the Universe. They are also used as precise 'standard candles' to measure the distances to galaxies. While there is general agreement that a type Ia supernova is produced by an exploding white dwarf star(1), no progenitor system has ever been directly observed. Significant effort has gone into searching for circumstellar material to help discriminate between the possible kinds of progenitor systems(2), but no such material has hitherto been found associated with a type Ia supernova(3). Here we report the presence of strong hydrogen emission associated with the type Ia supernova SN2002ic, indicating the presence of large amounts of circumstellar material. We infer from this that the progenitor system contained a massive asymptotic-giant-branch star that lost several solar masses of hydrogen-rich gas before the supernova explosion.	Carnegie Inst Washington Observ, Pasadena, CA 91101 USA; Carnegie Observ, Las Campanas Observ, La Serena, Chile; Cerro Tololo Interamer Observ, Natl Opt Astron Observ, La Serena, Chile; Univ Chile, Dept Astron, Santiago, Chile; Univ Arizona, Steward Observ, Tucson, AZ 85721 USA	Carnegie Institution for Science; Carnegie Institution for Science; National Optical Astronomy Observatory; Universidad de Chile; University of Arizona	Hamuy, M (corresponding author), Carnegie Inst Washington Observ, 813 Santa Barbara St, Pasadena, CA 91101 USA.		Maza, José/I-5722-2016; Hamuy, Mario/G-7541-2016	Maza, José/0000-0003-2068-1328; Suntzeff, Nicholas/0000-0002-8102-181X; Phillips, Mark/0000-0003-2734-0796				Aretxaga I, 1999, MON NOT R ASTRON SOC, V309, P343, DOI 10.1046/j.1365-8711.1999.02830.x; Arnett D., 1996, SUPERNOVAE NUCLEOSYN; Chugai NN, 1997, ASTRON REP+, V41, P672; Chugai NN, 1997, ASTROPHYS SPACE SCI, V252, P225, DOI 10.1023/A:1000847125928; Cumming RJ, 1996, MON NOT R ASTRON SOC, V283, P1355, DOI 10.1093/mnras/283.4.1355; Germany LM, 2000, ASTROPHYS J, V533, P320, DOI 10.1086/308639; HAMUY M, 1993, PUBL ASTRON SOC PAC, V105, P787, DOI 10.1086/133231; Hamuy M, 2002, ASTRON J, V124, P417, DOI 10.1086/340968; Hamuy M, 1996, ASTRON J, V112, P2438, DOI 10.1086/118193; Hamuy M., 2003, PREPRINT; HAMUY M, IN PRESS CORE COLLAP; Henry RBC, 1999, PUBL ASTRON SOC PAC, V111, P919, DOI 10.1086/316403; IBEN I, 1983, ANNU REV ASTRON ASTR, V21, P271, DOI 10.1146/annurev.aa.21.090183.001415; Lentz EJ, 2002, ASTROPHYS J, V580, P374, DOI 10.1086/343073; Li WD, 2001, ASTROPHYS J, V546, P734, DOI 10.1086/318299; Livio M, 2001, SPACE TEL S, V13, P334; PHILLIPS MM, 1992, ASTRON J, V103, P1632, DOI 10.1086/116177; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; SCHLEGEL EM, 1990, MON NOT R ASTRON SOC, V244, P269; Stritzinger M, 2002, ASTRON J, V124, P2100, DOI 10.1086/342544; Strolger LG, 2002, ASTRON J, V124, P2905, DOI 10.1086/343058; SUNTZEFF NB, 1996, IAU COLLOQ, V145, P41; Turatto M, 2000, ASTROPHYS J, V534, pL57, DOI 10.1086/312653; TURATTO M, 1993, MON NOT R ASTRON SOC, V262, P128, DOI 10.1093/mnras/262.1.128; Weidemann V, 2000, ASTRON ASTROPHYS, V363, P647; WOODVASEY WM, 2002, 8019 IAU	27	318	321	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 7	2003	424	6949					651	654		10.1038/nature01854	http://dx.doi.org/10.1038/nature01854			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708QE	12904786	Green Submitted			2022-12-28	WOS:000184578800038
J	Bilukha, OO; Brennan, M; Woodruff, BA				Bilukha, OO; Brennan, M; Woodruff, BA			Death and injury from landmines and unexploded ordnance in Afghanistan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LAND MINES; MOZAMBIQUE	Context Afghanistan is one of the countries most affected by injuries due to landmines and unexploded ordnance. Objective To understand the epidemiological patterns and risk factors for injury due to landmines and unexploded ordnance. Design and Setting Analysis of surveillance data on landmine and unexploded ordnance injuries in Afghanistan collected by the International Committee of the Red Cross in 390 health facilities in Afghanistan. Surveillance data were used to describe injury trends, injury types, demographics, and risk behaviors of those injured and explosive types related to landmine and unexploded ordnance incidents. Participants A total of 1636 individuals injured by landmines and unexploded ordnance, March 2001 through June 2002. Results Eighty-one percent of those injured were civilians, 91.6% were men and boys, and 45.9% were younger than 16 years. Children were more likely to be injured by unexploded ordnance (which includes grenades, bombs, mortar shells, and cluster munitions), whereas adults were injured mostly by landmines. The most common risk behaviors for children were playing and tending animals; for adults, these risk behaviors were military activity and activities of economic necessity (eg, farming, traveling). The case-fatality rate of 9.4% is probably underestimated because surveillance predominantly detects those who survive long enough to receive medical care. Conclusions Landmine risk education should focus on hazards due to unexploded ordnance for children and on landmine hazards for adults and should address age-specific risk behaviors. Expanding community-based and clinic-based reporting will improve the sensitivity and representativeness of surveillance.	CDCP, Int Emergency & Refugee Hlth Branch, Div Emergency & Environm Hlth Serv, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA; CDP, Epidem Intelligence Serv, Epidemiol Program Off, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Bilukha, OO (corresponding author), CDCP, Int Emergency & Refugee Hlth Branch, Div Emergency & Environm Hlth Serv, Natl Ctr Environm Hlth, 4770 Buford Hwy,Mailstop F-48, Atlanta, GA 30341 USA.		Bilukha, Oleg/ABC-5095-2020					ANDERSSON N, 1995, BRIT MED J, V311, P718, DOI 10.1136/bmj.311.7007.718; ASCHERIO A, 1995, LANCET, V346, P721, DOI 10.1016/S0140-6736(95)91501-X; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P724; Coupland RM, 1999, BRIT MED J, V319, P410, DOI 10.1136/bmj.319.7207.410; Gall C, 2002, NY TIMES, pA15; Giannou C, 1997, BRIT MED J, V315, P1453, DOI 10.1136/bmj.315.7120.1453; Hanevik K, 2000, BRIT MED J, V321, P1189, DOI 10.1136/bmj.321.7270.1189; *INT CAMP BAN LAND, 2002, LANDM MON REP 2002; *INT COMM RED CROS, 2002, SEM ANN REP JAN JUN; Jeffrey SJ, 1996, J ACCID EMERG MED, V13, P343; Kakar F, 1996, Prehosp Disaster Med, V11, P2; *OFF HUM DEM PROGR, 1998, HIDD KILL GLOB LANDM; *TRANS ISL GOV AFG, 2002, AFGH NAT HLTH RES AS	13	49	50	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2003	290	5					650	653		10.1001/jama.290.5.650	http://dx.doi.org/10.1001/jama.290.5.650			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	708GH	12902369				2022-12-28	WOS:000184558500020
J	Nakagawa, Y; Matsusue, Y; Nakamura, T				Nakagawa, Y; Matsusue, Y; Nakamura, T			Osteochondral graft transplantation for steroid-induced osteonecrosis of the femoral condyle	LANCET			English	Editorial Material									Kyoto Univ, Fac Med, Dept Orthopaed Surg, Sakyo Ku, Kyoto 6068507, Japan; Shiga Univ Med Sci, Dept Orthopaed Surg, Otsu, Shiga, Japan	Kyoto University; Shiga University of Medical Science	Nakagawa, Y (corresponding author), Kyoto Univ, Fac Med, Dept Orthopaed Surg, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.								0	19	20	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 2	2003	362	9381					402	402		10.1016/S0140-6736(03)14031-7	http://dx.doi.org/10.1016/S0140-6736(03)14031-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707FB	12907017	Bronze			2022-12-28	WOS:000184498700025
J	Vasudevan, AR; Kabinoff, GS; Keltz, TN; Gitler, B				Vasudevan, AR; Kabinoff, GS; Keltz, TN; Gitler, B			Blunt chest trauma producing acute myocardial infarction in a rugby player	LANCET			English	Editorial Material							DISSECTION; INJURY		New York Med Coll, Sound Shore Med Ctr Westchester, Dept Cardiol, Westchester, NY 10802 USA; New York Med Coll, Sound Shore Med Ctr Westchester, Dept Med, Westchester, NY 10802 USA	New York Medical College; New York Medical College	Gitler, B (corresponding author), New York Med Coll, Sound Shore Med Ctr Westchester, Dept Cardiol, Westchester, NY 10802 USA.							FOUSSAS SG, 1989, ANGIOLOGY, V40, P313, DOI 10.1177/000331978904000412; Fu M, 1999, J FORMOS MED ASSOC, V98, P136; Ginzburg E, 1998, J TRAUMA, V45, P157, DOI 10.1097/00005373-199807000-00034; MARIK PE, 1990, S AFR MED J, V77, P586; SUTHERLAND GR, 1983, AM J CARDIOL, V52, P1099, DOI 10.1016/0002-9149(83)90540-4	5	26	30	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 2	2003	362	9381					370	370		10.1016/S0140-6736(03)14024-X	http://dx.doi.org/10.1016/S0140-6736(03)14024-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707FB	12907010				2022-12-28	WOS:000184498700010
J	Matsumoto, A; Comatas, KE; Liu, LM; Stamler, JS				Matsumoto, A; Comatas, KE; Liu, LM; Stamler, JS			Screening for nitric oxide-dependent protein-protein interactions	SCIENCE			English	Article								Because nitric oxide (NO) may be a ubiquitous regulator of cellular signaling, we have modified the yeast two-hybrid system to explore the possibility of NO-dependent protein-protein interactions. We screened for binding partners of procaspase-3, a protein implicated in apoptotic signaling pathways, and identified multiple NO-dependent interactions. Two such interactions, with acid sphingomyelinase and NO synthase, were shown to occur in mammalian cells dependent on endogenous NO. Nitrosylation may thus provide a broad-based mechanism for regulating interactions between proteins. If so, systematic proteomic analyses in which redox state and NO bioavailability are carefully controlled will reveal a large array of novel interactions.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University	Stamler, JS (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.			Matsumoto, Akio/0000-0002-3402-6992; Stamler, Jonathan/0000-0002-6866-1572				BREDT DS, 1992, J BIOL CHEM, V267, P10976; Bulotta S, 2001, J BIOL CHEM, V276, P6529, DOI 10.1074/jbc.M006535200; De Nadai C, 2000, P NATL ACAD SCI USA, V97, P5480, DOI 10.1073/pnas.070062397; Dimmeler S, 1997, J EXP MED, V185, P601, DOI 10.1084/jem.185.4.601; Eu JP, 2000, BIOCHEMISTRY-US, V39, P1040, DOI 10.1021/bi992046e; Haneline LS, 1998, BLOOD, V91, P4092; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; HURWITZ R, 1994, J BIOL CHEM, V269, P5440; Huwiler A, 1999, J BIOL CHEM, V274, P7190, DOI 10.1074/jbc.274.11.7190; Igarashi J, 1999, P NATL ACAD SCI USA, V96, P12583, DOI 10.1073/pnas.96.22.12583; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; Kumar A, 2002, NATURE, V415, P123, DOI 10.1038/415123a; Lipton SA, 2002, CELL, V111, P147, DOI 10.1016/S0092-8674(02)01046-2; Liu LM, 2000, P NATL ACAD SCI USA, V97, P4672, DOI 10.1073/pnas.090083597; Liu LM, 1999, CELL DEATH DIFFER, V6, P937, DOI 10.1038/sj.cdd.4400578; LIU PS, 1995, J BIOL CHEM, V270, P27179, DOI 10.1074/jbc.270.45.27179; Mannick JB, 2001, J CELL BIOL, V154, P1111, DOI 10.1083/jcb.200104008; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; MANNICK JB, 1994, CELL, V79, P1137, DOI 10.1016/0092-8674(94)90005-1; Matsumoto A., UNPUB; Nedvetsky PI, 2002, P NATL ACAD SCI USA, V99, P16510, DOI 10.1073/pnas.262701999; Schwandner R, 1998, J BIOL CHEM, V273, P5916, DOI 10.1074/jbc.273.10.5916; SESSA WC, 1995, J BIOL CHEM, V270, P17641, DOI 10.1074/jbc.270.30.17641; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Stennicke HR, 1998, J BIOL CHEM, V273, P27084, DOI 10.1074/jbc.273.42.27084; Takeda Y, 1999, J BIOL CHEM, V274, P10654, DOI 10.1074/jbc.274.15.10654; Zech B, 1999, J BIOL CHEM, V274, P20931, DOI 10.1074/jbc.274.30.20931	28	115	118	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2003	301	5633					657	661		10.1126/science.1079319	http://dx.doi.org/10.1126/science.1079319			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893946				2022-12-28	WOS:000184473600043
J	Rarity, JG				Rarity, JG			Getting entangled in free space	SCIENCE			English	Editorial Material									Univ Bristol, Dept Elect Engn, Bristol BS8 1UB, Avon, England	University of Bristol	Rarity, JG (corresponding author), Univ Bristol, Dept Elect Engn, Bristol BS8 1UB, Avon, England.							ASPECT A, 1982, PHYS REV LETT, V49, P1804, DOI 10.1103/PhysRevLett.49.1804; Aspelmeyer M, 2003, SCIENCE, V301, P621, DOI 10.1126/science.1085593; BELL JS, 1966, REV MOD PHYS, V38, P447, DOI 10.1103/RevModPhys.38.447; Jennewein T, 2000, PHYS REV LETT, V84, P4729, DOI 10.1103/PhysRevLett.84.4729; OU ZY, 1988, PHYS REV LETT, V61, P50, DOI 10.1103/PhysRevLett.61.50; RARITY JG, 1990, PHYS REV LETT, V64, P2495, DOI 10.1103/PhysRevLett.64.2495; Ribordy G, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.012309; SHIH YH, 1988, PHYS REV LETT, V61, P2921, DOI 10.1103/PhysRevLett.61.2921; TAPSTER PR, 1994, PHYS REV LETT, V73, P1923, DOI 10.1103/PhysRevLett.73.1923; Tittel W, 1998, PHYS REV LETT, V81, P3563, DOI 10.1103/PhysRevLett.81.3563; Weihs G, 1998, PHYS REV LETT, V81, P5039, DOI 10.1103/PhysRevLett.81.5039	11	0	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 1	2003	301	5633					604	605		10.1126/science.1087850	http://dx.doi.org/10.1126/science.1087850			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	706UN	12893930				2022-12-28	WOS:000184473600025
J	Kamal, M; Bailey, M				Kamal, M; Bailey, M			TRIPS: whose interests are being served?	LANCET			English	Editorial Material									Oxfam GB, Oxford OX2 7DZ, England		Kamal, M (corresponding author), Oxfam GB, Oxford OX2 7DZ, England.	mksmith@Oxfam.org.uk						[Anonymous], 2001, DECL TRIPS AGR PUBL; [Anonymous], 2000, WHO REP INF DIS; McLellan F, 2002, LANCET, V359, P1412, DOI 10.1016/S0140-6736(02)08397-6; Quick JD, 2002, B WORLD HEALTH ORGAN, V80, P913; *UNAIDS, 2002, REP GLOB HIV AIDS EP; *WHO, 1996, N106 WHO	6	2	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2003	362	9380					260	260		10.1016/S0140-6736(03)14004-4	http://dx.doi.org/10.1016/S0140-6736(03)14004-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705UL	12892952				2022-12-28	WOS:000184413400004
J	Steinsland, H; Valentiner-Branth, P; Gjessing, HK; Aaby, P; Molbak, K; Sommerfelt, H				Steinsland, H; Valentiner-Branth, P; Gjessing, HK; Aaby, P; Molbak, K; Sommerfelt, H			Protection from natural infections with enterotoxigenic Escherichia coli: longitudinal study	LANCET			English	Article							B-SUBUNIT VACCINE; COLONIZATION FACTORS; ANTIBODY-RESPONSES; GUINEA-BISSAU; ENTERO-TOXIN; DIARRHEA; IMMUNIZATION; DISEASES; CHILDREN; RISK	Background Enterotoxigenic Escherichia coli (ETEC) are an important cause of diarrhoea and diarrhoeal deaths in children living in developing countries and of travellers' diarrhoea. During the past 25 years, vaccine development efforts have been focused on induction of protective immunity against surface colonisation factors (CFs) and the heat-labile enterotoxin. Although vaccines that induce immunity to heat-labile toxin offer protection against diarrhoea from ETEC that produce this toxin, the benefit of including CIF antigens remains uncertain. We aimed to estimate the protection that natural ETEC infections induce against new infections. Methods In Guinea-Bissau, we followed up 200 neonates until up to age 2 years, most of whom were breastfed throughout the study. We collected stool specimens from the children every week irrespective of whether they had diarrhoea. As a measure of protection, we used Cox regression models to estimate the change in infection rates after a primary ETEC infection. We thus estimated the protection attributable to CFs, toxins, and to any other factors that could be shared by ETEC with the same toxin-CF profile. Findings ETEC infections induced a 47% (95% Cl 12 to 69) protection against new infections with ETEC that had the same toxin-CF profile; the corresponding estimate attributable to CFs was -1% (-40 to 27). Infection with heat-labile toxin-positive ETEC conferred a 45% (-1 to 70) protection against symptomatic infections with ETEC positive for this toxin. Interpretation For breastfed children living in endemic areas, other antigens are substantially more important than CFs for induction of protective immunity against ETEC infection.	Univ Bergen, Ctr Int Hlth, N-5021 Bergen, Norway; Natl Publ Hlth Lab, Bissau, Guinea Bissau; Univ Bergen, Gade Inst, Dept Microbiol & Immunol, Bergen, Norway; Bandim Hlth Project, Bissau, Guinea Bissau; Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; Univ Oslo, Sect Med Stat, Oslo, Norway	University of Bergen; University of Bergen; Aarhus University; Statens Serum Institut; University of Oslo	Sommerfelt, H (corresponding author), Univ Bergen, Ctr Int Hlth, Armauer Hansen Bldg, N-5021 Bergen, Norway.	halvor.sommerfelt@cih.uib.no	Gjessing, Hakon K/A-5871-2012; Sommerfelt, Halvor/ABD-3552-2020	Sommerfelt, Halvor/0000-0002-5670-9786; Aaby, Peter/0000-0001-8331-1389; Steinsland, Hans/0000-0001-7812-3463; Molbak, Kare/0000-0002-3100-4990				*ACT BIOT AB, ANN REP 2000, P3; AHREN CM, 1985, INFECT IMMUN, V50, P255; Alves AMB, 2000, VACCINE, V19, P788, DOI 10.1016/S0264-410X(00)00244-9; Ascon MA, 1998, INFECT IMMUN, V66, P5470; BLACK RE, 1990, REV INFECT DIS, V12, P73; CLEMENS JD, 1988, J INFECT DIS, V158, P372, DOI 10.1093/infdis/158.2.372; CRAVIOTO A, 1990, AM J EPIDEMIOL, V131, P886, DOI 10.1093/oxfordjournals.aje.a115579; EVANS D G, 1988, FEMS (Federation of European Microbiological Societies) Microbiology Immunology, V47, P117, DOI 10.1111/j.1574-6968.1988.tb02363.x; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; Hall ER, 2001, INFECT IMMUN, V69, P2853, DOI 10.1128/IAI.69.5.2853-2857.2001; Koprowski H, 2000, INFECT IMMUN, V68, P4884, DOI 10.1128/IAI.68.9.4884-4892.2000; LEVINE MM, 1986, FEMS S, V31, P143; LOPEZVIDA Y, 1990, J INFECT DIS, V162, P442, DOI 10.1093/infdis/162.2.442; Molbak K, 2000, DAN MED BULL, V47, P340; MOON HW, 1983, INFECT IMMUN, V39, P990, DOI 10.1128/IAI.39.2.990-992.1983; Moulton LH, 1997, INT J EPIDEMIOL, V26, P1334, DOI 10.1093/ije/26.6.1334; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Pacheco ABF, 1997, J CLIN MICROBIOL, V35, P1521, DOI 10.1128/JCM.35.6.1521-1525.1997; Pichel M, 2000, INFECT IMMUN, V68, P3280, DOI 10.1128/IAI.68.6.3280-3285.2000; Savarino SJ, 1998, J INFECT DIS, V177, P796, DOI 10.1086/517812; Sommerfelt H, 1996, J INFECT DIS, V174, P768, DOI 10.1093/infdis/174.4.768; Steinsland H, 2003, DIAGN MICR INFEC DIS, V45, P97, DOI 10.1016/S0732-8893(02)00504-7; Steinsland H, 2002, J INFECT DIS, V186, P1740, DOI 10.1086/345817; STOLL BJ, 1986, J INFECT DIS, V153, P527, DOI 10.1093/infdis/153.3.527; SVENNERHOLM AM, 1988, INFECT IMMUN, V56, P523, DOI 10.1128/IAI.56.2.523-528.1988; Therneau TM, 2000, MODELING SURVIVAL DA; von Sonnenburg F, 2000, LANCET, V356, P133, DOI 10.1016/S0140-6736(00)02451-X; *WHO, 1998, TECHN REV M JUN 7 8; Wolf MK, 1997, CLIN MICROBIOL REV, V10, P569, DOI 10.1128/CMR.10.4.569; Yu J, 2001, NAT BIOTECHNOL, V19, P548, DOI 10.1038/89297	30	74	76	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2003	362	9380					286	291		10.1016/S0140-6736(03)13971-2	http://dx.doi.org/10.1016/S0140-6736(03)13971-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705UL	12892959				2022-12-28	WOS:000184413400011
J	Homma, N; Takei, Y; Tanaka, Y; Nakata, T; Terada, S; Kikkawa, M; Noda, Y; Hirokawa, N				Homma, N; Takei, Y; Tanaka, Y; Nakata, T; Terada, S; Kikkawa, M; Noda, Y; Hirokawa, N			Kinesin superfamily protein 2A (KIF2A) functions in suppression of collateral branch extension	CELL			English	Article							CENTROMERE-ASSOCIATED KINESIN; NERVOUS-SYSTEM; AXON GUIDANCE; MICROTUBULE DYNAMICS; NEURONAL MIGRATION; GROWTH; FAMILY; IDENTIFICATION; STATHMIN; KATANIN	Through interactions with microtubules, the kinesin superfamily of proteins (KIFs) could have multiple roles in neuronal function and development. During neuronal development, postmitotic neurons develop primary axons extending toward targets, while other collateral branches remain short. Although the process of collateral branching is important for correct wiring of the brain, the mechanisms involved are not well understood. In this study, we analyzed kif2a(-/-) mice, whose brains showed multiple phenotypes, including aberrant axonal branching due to overextension of collateral branches. In kif2a(-/-) growth cones, microtubule-depolymerizing activity decreased. Moreover, many individual microtubules showed abnormal behavior at the kif2a(-/-) cell edge. Based on these results, we propose that KIF2A regulates microtubule dynamics at the growth cone edge by depolymerizing microtubules and that it plays an important role in the suppression of collateral branch extension.	Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Hirokawa, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo 1130033, Japan.		Kikkawa, Masahide/I-7958-2015	Kikkawa, Masahide/0000-0001-7656-8194; Terada, Sumio/0000-0001-5689-0186; Tanaka, Yosuke/0000-0001-5376-5726; Nakata, Takao/0000-0002-0629-0518				Ahmad FJ, 1999, J CELL BIOL, V145, P305, DOI 10.1083/jcb.145.2.305; AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; DiPaolo G, 1996, J CELL BIOL, V133, P1383, DOI 10.1083/jcb.133.6.1383; FUKATA Y, 2002, CELL BIOL, V4, P194; Goslin K., 1998, CULTURING NERVE CELL, P339; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; HIROKAWA N, 2002, MOL MOTORS, P79; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; KEYNES R, 1995, CELL, V83, P161, DOI 10.1016/0092-8674(95)90157-4; Kim AJ, 2000, J CELL SCI, V113, P3681; Kline-Smith SL, 2002, MOL BIOL CELL, V13, P2718, DOI 10.1091/mbc.E01-12-0143; KUANG RZ, 1994, J COMP NEUROL, V344, P270, DOI 10.1002/cne.903440208; Kuhn TB, 2000, J NEUROBIOL, V44, P126, DOI 10.1002/1097-4695(200008)44:2<126::AID-NEU4>3.0.CO;2-Z; LIN CH, 1993, J CELL BIOL, V121, P1369, DOI 10.1083/jcb.121.6.1369; Liu BP, 2001, CURR OPIN CELL BIOL, V13, P619, DOI 10.1016/S0955-0674(00)00260-X; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; Maney T, 2001, J BIOL CHEM, V276, P34753, DOI 10.1074/jbc.M106626200; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Moore AT, 2001, MOL BIOL CELL, V12, p437A; Morfini G, 1997, J CELL BIOL, V138, P657, DOI 10.1083/jcb.138.3.657; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; NODA Y, 1995, J CELL BIOL, V129, P157, DOI 10.1083/jcb.129.1.157; OLEARY DD, 1998, NEURON, V1, P901; OLEARY DD, 1998, COLD SPRING HARB SYM, V1, P901; OLEARY DDM, 1990, COLD SH Q B, V55, P453; Ozon S, 1998, J NEUROCHEM, V70, P2386; Ozon S, 2002, MOL BIOL CELL, V13, P698, DOI 10.1091/mbc.01-07-0362; Quarmby L, 2000, J CELL SCI, V113, P2821; Rakic P, 1996, P NATL ACAD SCI USA, V93, P9218, DOI 10.1073/pnas.93.17.9218; Santama N, 1998, EMBO J, V17, P5855, DOI 10.1093/emboj/17.20.5855; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; Stoeckli ET, 1998, CURR OPIN NEUROBIOL, V8, P73, DOI 10.1016/S0959-4388(98)80010-X; TAKAHASHI T, 1992, J NEUROCYTOL, V21, P185, DOI 10.1007/BF01194977; Takei Y, 1995, J CELL BIOL, V131, P1789, DOI 10.1083/jcb.131.6.1789; TANAKA E, 1995, J CELL BIOL, V128, P139, DOI 10.1083/jcb.128.1.139; TANAKA EM, 1991, J CELL BIOL, V115, P345, DOI 10.1083/jcb.115.2.345; Teng JL, 2001, J CELL BIOL, V155, P65, DOI 10.1083/jcb.200106025; TERASHIMA T, 1993, BRAIN RES, V617, P1, DOI 10.1016/0006-8993(93)90605-M; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; Waterman-Storer CM, 1998, BIOPHYS J, V75, P2059, DOI 10.1016/S0006-3495(98)77648-9; WORDEMAN L, 1995, J CELL BIOL, V128, P95, DOI 10.1083/jcb.128.1.95	49	219	227	1	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 25	2003	114	2					229	239		10.1016/S0092-8674(03)00522-1	http://dx.doi.org/10.1016/S0092-8674(03)00522-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	705CN	12887924	Bronze			2022-12-28	WOS:000184378700012
J	Kasthuri, N; Lichtman, JW				Kasthuri, N; Lichtman, JW			The role of neuronal identity in synaptic competition	NATURE			English	Article							SKELETAL-MUSCLE; ELIMINATION; REORGANIZATION; INNERVATION	In developing mammalian muscle, axon branches of several motor neurons co-innervate the same muscle fibre. Competition among them results in the strengthening of one and the withdrawal of the rest(1,2). It is not known why one particular axon branch survives or why some competitions resolve sooner than others(3). Here we show that the fate of axonal branches is strictly related to the identity of the axons with which they compete. When two neurons co-innervate multiple target cells, the losing axon branches in each contest belong to the same neuron and are at nearly the same stage of withdrawal. The axonal arbor of one neuron engages in multiple sets of competitions simultaneously. Each set proceeds at a different rate and heads towards a common outcome based on the identity of the competitor. Competitive vigour at each of these sets of local competitions depends on a globally distributed resource: neurons with larger arborizations are at a competitive disadvantage when confronting neurons with smaller arborizations. An accompanying paper tests the idea that the amount of neurotransmitter released is this global resource(4).	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Lichtman, JW (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	jeff@pcg.wustl.edu						BALICEGORDON RJ, 1994, NATURE, V372, P519, DOI 10.1038/372519a0; Barber MJ, 1999, J NEUROSCI, V19, P9975; BROWN MC, 1976, J PHYSIOL-LONDON, V261, P387, DOI 10.1113/jphysiol.1976.sp011565; Buffelli M, 2002, P NATL ACAD SCI USA, V99, P13200, DOI 10.1073/pnas.202471199; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gan WB, 1998, SCIENCE, V282, P1508, DOI 10.1126/science.282.5393.1508; JANSEN JKS, 1990, PROG NEUROBIOL, V34, P39, DOI 10.1016/0301-0082(90)90025-C; Keller-Peck CR, 2001, NEURON, V31, P381, DOI 10.1016/S0896-6273(01)00383-X; LICHTMAN JW, 1977, J PHYSIOL-LONDON, V273, P155, DOI 10.1113/jphysiol.1977.sp012087; Personius KE, 2000, BRAIN RES BULL, V53, P513, DOI 10.1016/S0361-9230(00)00384-1; Personius KE, 2001, NEURON, V31, P395, DOI 10.1016/S0896-6273(01)00369-5; PRESS WH, 1992, NUMERICAL RECIPES; PURVES D, 1980, SCIENCE, V210, P153, DOI 10.1126/science.7414326; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Walsh MK, 2003, NEURON, V37, P67, DOI 10.1016/S0896-6273(02)01142-X; Wong ROL, 2003, FUNDAMENTAL NEUROSCI, P533	18	98	101	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 24	2003	424	6947					426	430		10.1038/nature01836	http://dx.doi.org/10.1038/nature01836			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879070				2022-12-28	WOS:000184318400043
J	Lee, K; Jessop, H; Suswillo, R; Zaman, G; Lanyon, L				Lee, K; Jessop, H; Suswillo, R; Zaman, G; Lanyon, L			Endocrinology - Bone adaptation requires oestrogen receptor-alpha	NATURE			English	Article									Univ London Royal Vet Coll, Dept Vet Basic Sci, London NW1 0TU, England	University of London; University of London Royal Veterinary College	Lee, K (corresponding author), Univ London Royal Vet Coll, Dept Vet Basic Sci, 32 Belgrave Sq, London NW1 0TU, England.	llanyon@rvc.ac.uk						Ankrom MA, 1998, BIOCHEM J, V333, P787, DOI 10.1042/bj3330787; Hoyland JA, 1999, J PATHOL, V188, P294; Lee KCL, 2002, BONE, V31, P407, DOI 10.1016/S8756-3282(02)00842-6; Lim SK, 1999, J BONE MINER RES, V14, P1189, DOI 10.1359/jbmr.1999.14.7.1189; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Sutherland MK, 1996, BONE, V18, P361, DOI 10.1016/8756-3282(96)00016-6; Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298; TZUKERMAN MT, 1994, MOL ENDOCRINOL, V8, P21, DOI 10.1210/me.8.1.21; Zaman G, 2000, BONE, V27, P233, DOI 10.1016/S8756-3282(00)00324-0	9	242	264	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 24	2003	424	6947					389	389		10.1038/424389a	http://dx.doi.org/10.1038/424389a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	704BT	12879058	Green Submitted, Bronze			2022-12-28	WOS:000184318400031
J	Pullman, D; Latus, A				Pullman, D; Latus, A			Clinical trials, genetic add-ons, and the question of benefit-sharing	LANCET			English	Editorial Material							ETHICS	Discussion of benefit-sharing has become common in the sphere of human genetic research. Roughly, this term means that individuals or organisations who could reap financial rewards from research into human genetics have some obligation to share the benefits of this research, perhaps with the people who made the research possible in the first place, or with humankind more broadly. This idea has met with some acceptance, finding its way into policy recommendations and statements of several prominent groups. However, the issue of benefit-sharing is generally raised in the context of large-scale population-based genetic studies. Other sources of human DNA are often ignored. In particular, little attention has been paid to the increasingly common practice of collecting genetic samples as addons to clinical drug trials. Generally such trials do not specify a use for these samples, which are collected for purposes of potential future research. We argue that if a case for benefit-sharing can be made for genetic studies in general, it can be made for add-on studies as well. We suggest some ways in which benefit-sharing might be implemented for genetic add-on studies.	Mem Univ Newfoundland, Fac Med, St Johns, NF A1B 3V6, Canada; Mem Univ Newfoundland, Dept Philosophy, St Johns, NF A1B 3V6, Canada	Memorial University Newfoundland; Memorial University Newfoundland	Pullman, D (corresponding author), Mem Univ Newfoundland, Fac Med, St Johns, NF A1B 3V6, Canada.							Berg K, 2001, CLIN GENET, V59, P240, DOI 10.1034/j.1399-0004.2001.590404.x; El Setouhy M, 2002, SCIENCE, V298, P2133; FELDBAUM CB, 2003, BIO 2002 C TOR ONT J; Frank L, 1999, SCIENCE, V286, P1262, DOI 10.1126/science.286.5443.1262; Greely HT, 2001, PERSPECT BIOL MED, V44, P221, DOI 10.1353/pbm.2001.0026; *HUM GEN ORG ETH C, 2003, STAT BEN SHAR; LITMAN MM, 1997, HUMAN DNA LAW POLICY, P17; Merz JF, 2002, AM J HUM GENET, V70, P965, DOI 10.1086/339767; Rose H., 2003, COMMODIFICATION BIOI; *STANF WASH PROGR, 2003, WORLD SURV FUND GEN; *WHO, 2003, GEN WORLD HLTH REP A; *WHO HUM GEN PROGR, 2003, WHO M APR 2	12	7	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 19	2003	362	9379					242	244		10.1016/S0140-6736(03)13916-5	http://dx.doi.org/10.1016/S0140-6736(03)13916-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	702PJ	12885490				2022-12-28	WOS:000184232000028
J	Gomez-Gutierrez, J; Peterson, WT; De Robertis, A; Brodeur, RD				Gomez-Gutierrez, J; Peterson, WT; De Robertis, A; Brodeur, RD			Mass mortality of krill caused by parasitoid ciliates	SCIENCE			English	Article							EUPHAUSIID THYSANOESSA-INERMIS		Ctr Interdisciplinario Ciencias Marinas, La Paz 23096, BCS, Mexico; Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; Natl Marine Fisheries Serv, Natl Ocean & Atmospher Adm, NW Fisheries Sci Ctr, Newport, OR 97365 USA	Oregon State University; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA	Gomez-Gutierrez, J (corresponding author), Ctr Interdisciplinario Ciencias Marinas, La Paz 23096, BCS, Mexico.		Riley, Eleanor M/C-8960-2013	Riley, Eleanor M/0000-0003-3447-3570; Brodeur, Richard/0000-0002-6629-5564				ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; BRADBURY PC, 1994, PARASITIC PROTOZOA, V8, P139; CAPRIULO GM, 1991, MAR ECOL PROG SER, V72, P203, DOI 10.3354/meps072203; CAPRIULO GM, 1986, DIS AQUAT ORGAN, V1, P141; SIEGEL V, 2000, KRILL BIOL ECOLOGY F, P00103, DOI DOI 10.1002/9780470999493.CH5	5	63	69	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 18	2003	301	5631					339	339		10.1126/science.1085164	http://dx.doi.org/10.1126/science.1085164			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	702CG	12869754				2022-12-28	WOS:000184207300034
J	Rosenthal, N				Rosenthal, N			Medical progress: Prometheus's vulture and the stem-cell promise.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BONE-MARROW; PROGENITOR CELLS; CULTURE; DIFFERENTIATE; PLURIPOTENCY; REGENERATION; PLASTICITY; DERIVATION; PHENOTYPE; NEURONS		European Mol Biol Lab, Mouse Biol Programme, I-00016 Monterotondo, Rome, Italy	European Molecular Biology Laboratory (EMBL)	Rosenthal, N (corresponding author), European Mol Biol Lab, Mouse Biol Programme, Via Ramarini 32, I-00016 Monterotondo, Rome, Italy.	rosenthal@embl-monterotondo.it	Rosenthal, Nadia/O-7009-2015	Rosenthal, Nadia/0000-0002-7599-7365				Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Austin TW, 2003, MECH DEVELOP, V120, P131, DOI 10.1016/S0925-4773(02)00339-8; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; BONGSO A, 1994, HUM REPROD, V9, P2110, DOI 10.1093/oxfordjournals.humrep.a138401; Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0; Deasy BM, 2002, STEM CELLS, V20, P50, DOI 10.1634/stemcells.20-1-50; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Galli R, 2000, NAT NEUROSCI, V3, P986, DOI 10.1038/79924; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Grompe M, 2003, MECH DEVELOP, V120, P99, DOI 10.1016/S0925-4773(02)00336-2; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Kollet O, 2001, BLOOD, V97, P3283, DOI 10.1182/blood.V97.10.3283; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Kuehnle I, 2002, BMJ-BRIT MED J, V325, P372, DOI 10.1136/bmj.325.7360.372; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Liang LC, 2002, STEM CELLS, V20, P21, DOI 10.1634/stemcells.20-1-21; Lumelsky N, 2001, SCIENCE, V293, P428; McKinney-Freeman SL, 2002, P NATL ACAD SCI USA, V99, P1341, DOI 10.1073/pnas.032438799; Morshead CM, 2002, NAT MED, V8, P268, DOI 10.1038/nm0302-268; NAGY A, 1990, DEVELOPMENT, V110, P815; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Orkin SH, 2002, NAT IMMUNOL, V3, P323, DOI 10.1038/ni0402-323; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pittenger MF, 2000, CURR TOP MICROBIOL, V251, P3; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Shamblott MJ, 2001, P NATL ACAD SCI USA, V98, P113, DOI 10.1073/pnas.021537998; Shen HM, 2001, J IMMUNOL, V166, P5027, DOI 10.4049/jimmunol.166.8.5027; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Theise ND, 2003, SCIENCE, V299, p1317A, DOI 10.1126/science.1078412; THOMPSON S, 1984, J CELL SCI, V72, P37; Thomson JA, 1998, SCIENCE, V282, P1827; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Tsonis PA, 2002, DIFFERENTIATION, V70, P397, DOI 10.1046/j.1432-0436.2002.700802.x; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	57	125	147	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 17	2003	349	3					267	274		10.1056/NEJMra020849	http://dx.doi.org/10.1056/NEJMra020849			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701KA	12867611				2022-12-28	WOS:000184165700012
J	Das, P				Das, P			Resistance to antiretrovirals is a growing concern	LANCET			English	News Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2003	362	9380					300	300						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705UL	12892984				2022-12-28	WOS:000184413400017
J	Das, P				Das, P			Feeding risk cut for HIV-infected women	LANCET			English	News Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2003	362	9380					300	300						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	705UL	12892984				2022-12-28	WOS:000184413400019
